Citrus Sinensis ID: 042457
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 361 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.927 | 0.320 | 0.458 | 7e-90 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.914 | 0.294 | 0.455 | 6e-84 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.742 | 0.243 | 0.439 | 2e-62 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.894 | 0.293 | 0.393 | 3e-61 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.747 | 0.240 | 0.422 | 2e-57 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.891 | 0.300 | 0.364 | 3e-55 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.811 | 0.260 | 0.365 | 2e-52 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.930 | 0.269 | 0.325 | 2e-50 | |
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.947 | 0.578 | 0.360 | 3e-50 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.692 | 0.246 | 0.391 | 7e-50 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 331 bits (848), Expect = 7e-90, Method: Compositional matrix adjust.
Identities = 170/371 (45%), Positives = 242/371 (65%), Gaps = 36/371 (9%)
Query: 8 PPQEFKGNKG-----------KPQKVPSR---------LVVIILPIV--LLLILVCIFTF 45
PP F+GNK KP + S ++ I++PI+ ++++ VC F
Sbjct: 672 PPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIF 731
Query: 46 LCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSV 105
+C R K K T G+ S++++DG++ ++EII AT +FD KY IGTGG+G V
Sbjct: 732 ICFR--KRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKV 789
Query: 106 YRAQLPSGKIVALKKLHHSE----TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161
Y+A+LP+ I+A+KKL+ + + + + F E R L++IRHRN+VKL+GFC H++
Sbjct: 790 YKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRN 848
Query: 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISS 221
FL+Y+YM RGSL VL NDDEA +LDW KR+N+VK +AHALSY+H+D P+IVHRDISS
Sbjct: 849 TFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISS 908
Query: 222 NNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGV 281
NILL EA ++DFG A+LL DSSN + VAGT+GY+APELAY M VTEKCDV+ FGV
Sbjct: 909 GNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGV 968
Query: 282 VALEVLMGRHPGDLLSSF-----NPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFAC 336
+ LEV+ G HPGDL+S+ + + L + D R P P + + ++++ + K+A C
Sbjct: 969 LTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPE--IKEEVLEILKVALLC 1026
Query: 337 LRSKPKSRPTM 347
L S P++RPTM
Sbjct: 1027 LHSDPQARPTM 1037
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 6e-84, Method: Compositional matrix adjust.
Identities = 160/351 (45%), Positives = 242/351 (68%), Gaps = 21/351 (5%)
Query: 8 PPQEFKGNKGKPQKVPSRLVVIILPI--VLLLILVCIFTFL-CLRRPKVRKAKPTETKKT 64
P +E K KP+K + +V I++PI VL+++ +C TF C+R+ K++ + T+ +
Sbjct: 772 PCRELK----KPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPE-- 825
Query: 65 RCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHS 124
G+ S+++ DG+ +++II +T +FD + IGTGGY VYRA L I+A+K+LH +
Sbjct: 826 -TGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDT 883
Query: 125 -ETELA---FLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN 180
+ E++ + F E + L++IRHRN+VKL+GFC H++ FLIY+YM +GSL +L N
Sbjct: 884 IDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLAN 943
Query: 181 DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240
D+EA +L WTKR+N+VK +AHALSY+H+D I IVHRDISS NILL++ A ++DFG A
Sbjct: 944 DEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTA 1003
Query: 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN 300
+LL +DSSN + VAGT+GY+APE AYTM VTEKCDV+ FGV+ LE+++G+HPGDL+SS +
Sbjct: 1004 KLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLS 1063
Query: 301 PK----IMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM 347
+ L + D+R P + ++ + ++A CL++ P+SRPTM
Sbjct: 1064 SSPGEALSLRSISDERVLEPRGQNR--EKLLKMVEMALLCLQANPESRPTM 1112
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 124/282 (43%), Positives = 176/282 (62%), Gaps = 14/282 (4%)
Query: 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEAR 139
T++ ++ AT +F +G G G+VY+A++ G+++A+KKL+ + SF+ E
Sbjct: 788 TYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEIS 847
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
L +IRHRNIVKLYGFC H+ L+Y+YM +GSL L+ ++ LDW R I
Sbjct: 848 TLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGA 907
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHG 258
A L YLH+DC P IVHRDI SNNILL+ + +A V DFG+A+L+ S S + + VAG++G
Sbjct: 908 AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYG 967
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-------GDLLS----SFNPKIMLID 307
YIAPE AYTM VTEKCD++ FGVV LE++ G+ P GDL++ S I I+
Sbjct: 968 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIE 1027
Query: 308 LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
+ D R + +D+ + ++ LV KIA C + P SRPTMR
Sbjct: 1028 MFDARLDT--NDKRTVHEMSLVLKIALFCTSNSPASRPTMRE 1067
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (600), Expect = 3e-61, Method: Compositional matrix adjust.
Identities = 140/356 (39%), Positives = 205/356 (57%), Gaps = 33/356 (9%)
Query: 17 GKPQKVPSRLVVIILPIVL---LLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVW 73
GKP + S ++ I V+ L+L+ + +L +RRP A + + E S+
Sbjct: 728 GKPGGMRSSKIIAITAAVIGGVSLMLIALIVYL-MRRPVRTVASSAQDGQP---SEMSLD 783
Query: 74 NY---DGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKL---HHSETE 127
Y TF++++ AT++FD + +G G G+VY+A LP+G +A+KKL H
Sbjct: 784 IYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNN 843
Query: 128 LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQL 187
SF+ E L IRHRNIVKL+GFC H+ L+Y+YM +GSL +L D + L
Sbjct: 844 NNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNL 901
Query: 188 DWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL---H 244
DW+KR I A L+YLH+DC P I HRDI SNNILL+ K EA V DFG+A+++ H
Sbjct: 902 DWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPH 961
Query: 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-------GDLLS 297
S S + +AG++GYIAPE AYTM VTEK D++ +GVV LE+L G+ P GD+++
Sbjct: 962 SKS--MSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVN 1019
Query: 298 SFNPKI----MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
I + +LD R ++D+ ++ ++ V KIA C P +RP+MR+
Sbjct: 1020 WVRSYIRRDALSSGVLDARL--TLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQ 1073
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 123/291 (42%), Positives = 174/291 (59%), Gaps = 21/291 (7%)
Query: 78 RITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLES---- 133
R T ++I+ AT+ F Y +G G G+VY+A +PSGK +A+KKL + +
Sbjct: 806 RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865
Query: 134 -FQTEARLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWT 190
F+ E L +IRHRNIV+LY FC H+ L+Y+YM RGSL +L ++ +DW
Sbjct: 866 SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLH-GGKSHSMDWP 924
Query: 191 KRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-SSN 249
R I A L+YLH+DC P I+HRDI SNNIL++ EA V DFG+A+++ S +
Sbjct: 925 TRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKS 984
Query: 250 RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-------GDLLSSFNPK 302
+ VAG++GYIAPE AYTM VTEKCD++ FGVV LE+L G+ P GDL +
Sbjct: 985 VSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNH 1044
Query: 303 I----MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
I + ++LD + ++D ++ +I V+KIA C +S P RPTMR
Sbjct: 1045 IRDHSLTSEILDPYL-TKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMRE 1094
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 132/362 (36%), Positives = 197/362 (54%), Gaps = 40/362 (11%)
Query: 17 GKPQKVPSRLVVIILPIVLLLILVCIFT--FLCLRRPKVRKAKPTETKKTRCGDEFSV-W 73
G+ V S +V + ++L I + I L LR + K + ++FS W
Sbjct: 694 GQNNGVKSPKIVALTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPSTAEDFSYPW 753
Query: 74 NY----DGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKL----HHSE 125
+ IT I+ + D ++ IG G G VY+A++P+G IVA+KKL ++E
Sbjct: 754 TFIPFQKLGITVNNIVTSLTDENV---IGKGCSGIVYKAEIPNGDIVAVKKLWKTKDNNE 810
Query: 126 TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAI 185
+ ++SF E ++L IRHRNIVKL G+C +K L+Y Y G+L +L+ +
Sbjct: 811 EGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGNR--- 867
Query: 186 QLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
LDW R I A L+YLH+DC+P+I+HRD+ NNILL+SK EA +ADFG+A+L+ +
Sbjct: 868 NLDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLMMN 927
Query: 246 DSSNRTV---VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-----GDLL- 296
+ VAG++GYIAPE YTM +TEK DV+ +GVV LE+L GR GD L
Sbjct: 928 SPNYHNAMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGDGLH 987
Query: 297 ---------SSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM 347
+F P + ++D+ Q P DQ ++Q+++ IA C+ P RPTM
Sbjct: 988 IVEWVKKKMGTFEPALSVLDVKLQGLP----DQ-IVQEMLQTLGIAMFCVNPSPVERPTM 1042
Query: 348 RR 349
+
Sbjct: 1043 KE 1044
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (525), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 118/323 (36%), Positives = 181/323 (56%), Gaps = 30/323 (9%)
Query: 45 FLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDG-RITFEEIIVATEDFDIKYCIGTGGYG 103
F+CLRR RK +P + D + +G + +++ AT++ + KY IG G +G
Sbjct: 790 FICLRR---RKGRPEK-------DAYVFTQEEGPSLLLNKVLAATDNLNEKYTIGRGAHG 839
Query: 104 SVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163
VYRA L SGK+ A+K+L + + + +S E + ++RHRN++KL GF L K
Sbjct: 840 IVYRASLGSGKVYAVKRLVFA-SHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGL 898
Query: 164 LIYKYMRRGSLFCVLRN-DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222
++Y+YM +GSL+ VL + LDW+ R N+ +AH L+YLHYDC P IVHRDI
Sbjct: 899 MLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKPE 958
Query: 223 NILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVV 282
NIL++S LE + DFG+ARLL + + V GT GYIAPE A+ V + DV+ +GVV
Sbjct: 959 NILMDSDLEPHIGDFGLARLLDDSTVSTATVTGTTGYIAPENAFKTVRGRESDVYSYGVV 1018
Query: 283 ALEVLMGRHPGD---------------LLSSFNPKI--MLIDLLDQRAPSPIDDQTVIQD 325
LE++ + D LSS N + M+ ++D + D ++ +
Sbjct: 1019 LLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQ 1078
Query: 326 IILVSKIAFACLRSKPKSRPTMR 348
++ V+++A +C + P RPTMR
Sbjct: 1079 VMQVTELALSCTQQDPAMRPTMR 1101
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (506), Expect = 2e-50, Method: Compositional matrix adjust.
Identities = 130/399 (32%), Positives = 205/399 (51%), Gaps = 63/399 (15%)
Query: 8 PPQEFKGNKG----------------KPQKVPSRLVVIILPIVLL----LILVCIFTFLC 47
P F GN G K Q + +R VVII I L L+++ I F
Sbjct: 840 PADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFK 899
Query: 48 LRRPKVRKAKPTETKKTRCGDE--------FSVWNYDGRITFEEIIVATEDFDIKYCIGT 99
R +K T T F I +E+I+ AT + ++ IG+
Sbjct: 900 QRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGS 959
Query: 100 GGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159
GG G VY+A+L +G+ VA+KK+ + +L +SF E + L +IRHR++VKL G+C K
Sbjct: 960 GGSGKVYKAELENGETVAVKKILWKD-DLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSK 1018
Query: 160 K--CMFLIYKYMRRGSLFCVLRNDDEAIQ-----LDWTKRVNIVKSMAHALSYLHYDCIP 212
LIY+YM+ GS++ L D ++ LDW R+ I +A + YLH+DC+P
Sbjct: 1019 SEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVP 1078
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLL----HSDSSNRTVVAGTHGYIAPELAYTM 268
IVHRDI S+N+LL+S +EA + DFG+A++L +++ + T A ++GYIAPE AY++
Sbjct: 1079 PIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSL 1138
Query: 269 VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI---------------DLLDQRA 313
TEK DV+ G+V +E++ G+ P D S F ++ ++ L+D +
Sbjct: 1139 KATEKSDVYSMGIVLMEIVTGKMPTD--SVFGAEMDMVRWVETHLEVAGSARDKLIDPKL 1196
Query: 314 PS--PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRS 350
P ++ Q V +IA C ++ P+ RP+ R++
Sbjct: 1197 KPLLPFEEDAACQ----VLEIALQCTKTSPQERPSSRQA 1231
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (505), Expect = 3e-50, Method: Compositional matrix adjust.
Identities = 129/358 (36%), Positives = 187/358 (52%), Gaps = 16/358 (4%)
Query: 2 DSENAPPPQEFKGNKGKPQKVPSRLVVIILPIVLLLILVCIFTFL-CLRRPKVRKAK-PT 59
D P G K K +L++ V L+LV + F C K+ K + +
Sbjct: 217 DDSGNPSSHSQSGQNQK--KNSGKLLISASATVGALLLVALMCFWGCFLYKKLGKVEIKS 274
Query: 60 ETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALK 119
K G +++ D + ++II E + ++ IG GG+G+VY+ + GK+ ALK
Sbjct: 275 LAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALK 334
Query: 120 KLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR 179
++ + F F+ E +L I+HR +V L G+C L+Y Y+ GSL L
Sbjct: 335 RI--LKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALH 392
Query: 180 NDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239
E QLDW RVNI+ A LSYLH+DC P I+HRDI S+NILL+ LEA V+DFG+
Sbjct: 393 ERGE--QLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 450
Query: 240 ARLLHSDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGD---L 295
A+LL + S+ T+VAGT GY+APE + TEK DV+ FGV+ LEVL G+ P D +
Sbjct: 451 AKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFI 510
Query: 296 LSSFNPKIMLIDLLDQRAPSPIDDQTV----IQDIILVSKIAFACLRSKPKSRPTMRR 349
N L L+ ++ P I D ++ + + IA C+ P+ RPTM R
Sbjct: 511 EKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQCVSPSPEERPTMHR 568
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 105/268 (39%), Positives = 162/268 (60%), Gaps = 18/268 (6%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL--AFLESFQTEARLLSQIRHRNIVKLY 153
IG G G VY+A++ S ++A+KKL S ++ F E LL ++RHRNIV+L
Sbjct: 705 IGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLL 764
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQL--DWTKRVNIVKSMAHALSYLHYDCI 211
GF + K M ++Y++M G+L + + A +L DW R NI +AH L+YLH+DC
Sbjct: 765 GFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCH 824
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVT 271
P ++HRDI SNNILL++ L+A +ADFG+AR++ ++VAG++GYIAPE YT+ V
Sbjct: 825 PPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVD 884
Query: 272 EKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA-----------PSPIDDQ 320
EK D++ +GVV LE+L GR P L F + +++ + ++ P+ + +
Sbjct: 885 EKIDIYSYGVVLLELLTGRRP--LEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCR 942
Query: 321 TVIQDIILVSKIAFACLRSKPKSRPTMR 348
V ++++LV +IA C PK RP+MR
Sbjct: 943 YVQEEMLLVLQIALLCTTKLPKDRPSMR 970
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 361 | ||||||
| 296085303 | 789 | unnamed protein product [Vitis vinifera] | 0.927 | 0.424 | 0.608 | 1e-119 | |
| 359484066 | 843 | PREDICTED: probable LRR receptor-like se | 0.927 | 0.397 | 0.608 | 1e-119 | |
| 359484068 | 868 | PREDICTED: probable leucine-rich repeat | 0.936 | 0.389 | 0.587 | 1e-117 | |
| 224093626 | 1039 | predicted protein [Populus trichocarpa] | 0.880 | 0.306 | 0.628 | 1e-117 | |
| 296085307 | 874 | unnamed protein product [Vitis vinifera] | 0.936 | 0.386 | 0.587 | 1e-117 | |
| 224108669 | 811 | predicted protein [Populus trichocarpa] | 0.880 | 0.392 | 0.628 | 1e-117 | |
| 224098415 | 667 | predicted protein [Populus trichocarpa] | 0.922 | 0.499 | 0.598 | 1e-117 | |
| 224110038 | 964 | predicted protein [Populus trichocarpa] | 0.880 | 0.329 | 0.637 | 1e-117 | |
| 225465647 | 820 | PREDICTED: probable LRR receptor-like se | 0.825 | 0.363 | 0.655 | 1e-116 | |
| 359488983 | 758 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.473 | 0.548 | 1e-116 |
| >gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 435 bits (1119), Expect = e-119, Method: Compositional matrix adjust.
Identities = 216/355 (60%), Positives = 268/355 (75%), Gaps = 20/355 (5%)
Query: 11 EFKGNKG-----------KPQKVPSRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKPT 59
F NKG K + +R++VI L L L V + FL L R K RK +
Sbjct: 411 SFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFV-VLGFLLLSR-KTRKIQTK 468
Query: 60 ETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALK 119
E T+ GD FSVWNYDG+I +E+II ATEDFDIKYCIGTGGYGSVY+AQLP+G +VALK
Sbjct: 469 EIP-TKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALK 527
Query: 120 KLHHSETELA-FLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVL 178
KLH E + A +L+SFQ E ++LS+IRHRNIVKL G+CLHK+CMFLIY YM RGSL+CVL
Sbjct: 528 KLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVL 587
Query: 179 RNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238
N+ EA++LDW KRVN+VKS+ HA+ Y+H+DC P I+HRDISSNNILL+SKL+AF++DFG
Sbjct: 588 SNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFG 647
Query: 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLL-- 296
ARLLH DSSN+T++AGT+GYIAPELAYTMVVTEKCDV+ FGVVALE +MG+HPG+L
Sbjct: 648 TARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTL 707
Query: 297 --SSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
SS IML ++LD R PSP DQ V +D++LV +A C+ S P+SRPTM+
Sbjct: 708 LSSSSTQNIMLTNILDSRLPSP-QDQQVARDVVLVVWLALKCIHSNPRSRPTMQH 761
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 435 bits (1119), Expect = e-119, Method: Compositional matrix adjust.
Identities = 216/355 (60%), Positives = 268/355 (75%), Gaps = 20/355 (5%)
Query: 11 EFKGNKG-----------KPQKVPSRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKPT 59
F NKG K + +R++VI L L L V + FL L R K RK +
Sbjct: 465 SFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFV-VLGFLLLSR-KTRKIQTK 522
Query: 60 ETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALK 119
E T+ GD FSVWNYDG+I +E+II ATEDFDIKYCIGTGGYGSVY+AQLP+G +VALK
Sbjct: 523 EIP-TKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALK 581
Query: 120 KLHHSETELA-FLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVL 178
KLH E + A +L+SFQ E ++LS+IRHRNIVKL G+CLHK+CMFLIY YM RGSL+CVL
Sbjct: 582 KLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVL 641
Query: 179 RNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238
N+ EA++LDW KRVN+VKS+ HA+ Y+H+DC P I+HRDISSNNILL+SKL+AF++DFG
Sbjct: 642 SNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFG 701
Query: 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLL-- 296
ARLLH DSSN+T++AGT+GYIAPELAYTMVVTEKCDV+ FGVVALE +MG+HPG+L
Sbjct: 702 TARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMMGKHPGELFTL 761
Query: 297 --SSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
SS IML ++LD R PSP DQ V +D++LV +A C+ S P+SRPTM+
Sbjct: 762 LSSSSTQNIMLTNILDSRLPSP-QDQQVARDVVLVVWLALKCIHSNPRSRPTMQH 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1102), Expect = e-117, Method: Compositional matrix adjust.
Identities = 209/356 (58%), Positives = 267/356 (75%), Gaps = 18/356 (5%)
Query: 8 PPQEFKGNKG---KPQKVP------SRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKP 58
PP+ F NKG + + +P +++I L +L L V + L R+ + + K
Sbjct: 489 PPRVFGHNKGLCGEREGLPHCKRGHKTILIISLSTILFLSFVALGILLLSRKTRRNQTKA 548
Query: 59 TETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVAL 118
T TK GD FSVWNYDG+I +E+II ATEDFDIKYCIGTGGYGSVY+AQLP+G +VAL
Sbjct: 549 TSTKN---GDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYKAQLPTGNVVAL 605
Query: 119 KKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCV 177
KKLH E E +L+SFQ E ++LS+I+HRNI+KL+G+CLHK+CMFLIYKYM RGSL+CV
Sbjct: 606 KKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLYCV 665
Query: 178 LRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237
L N+ EA++LDW KRVN++KS+ HAL Y+H+D P I+HRD+SSNNILL+ KL+AF++DF
Sbjct: 666 LSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSNNILLDFKLDAFLSDF 725
Query: 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLL- 296
G ARLLH DSSN+T++AGT+GYIAPELAYTM VTEKCDV+ FGVVALE +MGRHP +L
Sbjct: 726 GTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSFGVVALETMMGRHPRELFT 785
Query: 297 ---SSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
SS IML D+LD R PSP D Q V +D++LV +A C+ S P+SRPTM+
Sbjct: 786 LLSSSSAQNIMLTDILDSRLPSPQDRQ-VARDVVLVVWLALKCIHSNPRSRPTMQH 840
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093626|ref|XP_002334827.1| predicted protein [Populus trichocarpa] gi|222875006|gb|EEF12137.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1101), Expect = e-117, Method: Compositional matrix adjust.
Identities = 203/323 (62%), Positives = 255/323 (78%), Gaps = 5/323 (1%)
Query: 27 VVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIV 86
+ I LPI I +C+ C + + +P E ++ GD FS+WNYDGRI +E+II
Sbjct: 682 IKIFLPITT--ISLCLLVLGCCSLSRCKATQP-EATSSKNGDLFSIWNYDGRIAYEDIIA 738
Query: 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETEL-AFLESFQTEARLLSQIR 145
ATE+FD++YCIGTGGYGSVYRAQLPSGK+VALKKLH E E AF +SF+ E LL+QIR
Sbjct: 739 ATENFDLRYCIGTGGYGSVYRAQLPSGKLVALKKLHRREAEEPAFDKSFKNEVELLTQIR 798
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
HR+IVKLYGFCLH++CMFL+Y+YM +GSLFC LRND A++L W KR +I+K +AHALSY
Sbjct: 799 HRSIVKLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSY 858
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
LH++C P IVHRDISS+N+LLNS+ ++FVADFGVARLL DSSN TV+AGT+GYIAPELA
Sbjct: 859 LHHECNPPIVHRDISSSNVLLNSESKSFVADFGVARLLDPDSSNNTVLAGTYGYIAPELA 918
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325
YTMVVTEKCDV+ FGVVALE LMGRHPGD+LSS I L ++LD R P P ++ VIQ+
Sbjct: 919 YTMVVTEKCDVYSFGVVALETLMGRHPGDILSSSARAITLKEVLDPRLPPP-TNEIVIQN 977
Query: 326 IILVSKIAFACLRSKPKSRPTMR 348
I +++ +AF+CL S PK RP+M+
Sbjct: 978 ICIIASLAFSCLHSNPKYRPSMK 1000
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 428 bits (1100), Expect = e-117, Method: Compositional matrix adjust.
Identities = 209/356 (58%), Positives = 267/356 (75%), Gaps = 18/356 (5%)
Query: 8 PPQEFKGNKG---KPQKVP------SRLVVIILPIVLLLILVCIFTFLCLRRPKVRKAKP 58
PP+ F NKG + + +P +++I L +L L V + L R+ + + K
Sbjct: 495 PPRVFGHNKGLCGEREGLPHCKRGHKTILIISLSTILFLSFVALGILLLSRKTRRNQTKA 554
Query: 59 TETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVAL 118
T TK GD FSVWNYDG+I +E+II ATEDFDIKYCIGTGGYGSVY+AQLP+G +VAL
Sbjct: 555 TSTKN---GDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYKAQLPTGNVVAL 611
Query: 119 KKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCV 177
KKLH E E +L+SFQ E ++LS+I+HRNI+KL+G+CLHK+CMFLIYKYM RGSL+CV
Sbjct: 612 KKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLYCV 671
Query: 178 LRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237
L N+ EA++LDW KRVN++KS+ HAL Y+H+D P I+HRD+SSNNILL+ KL+AF++DF
Sbjct: 672 LSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSNNILLDFKLDAFLSDF 731
Query: 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLL- 296
G ARLLH DSSN+T++AGT+GYIAPELAYTM VTEKCDV+ FGVVALE +MGRHP +L
Sbjct: 732 GTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSFGVVALETMMGRHPRELFT 791
Query: 297 ---SSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
SS IML D+LD R PSP D Q V +D++LV +A C+ S P+SRPTM+
Sbjct: 792 LLSSSSAQNIMLTDILDSRLPSPQDRQ-VARDVVLVVWLALKCIHSNPRSRPTMQH 846
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108669|ref|XP_002333361.1| predicted protein [Populus trichocarpa] gi|222836312|gb|EEE74733.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1098), Expect = e-117, Method: Compositional matrix adjust.
Identities = 203/323 (62%), Positives = 257/323 (79%), Gaps = 5/323 (1%)
Query: 27 VVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIV 86
+ I LPI + + + L R K + +PT K GD FS+WNYDGRI +E+II
Sbjct: 454 IKIFLPISTISLCLLCLGCCYLSRCKATQPEPTSLKN---GDLFSIWNYDGRIAYEDIIA 510
Query: 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETEL-AFLESFQTEARLLSQIR 145
ATE+FD++YCIG+GGYGSVYRAQLPSGK+VALKKLHH E E AF +SF+ E LL+QIR
Sbjct: 511 ATENFDLRYCIGSGGYGSVYRAQLPSGKLVALKKLHHREAEEPAFDKSFKNEVELLTQIR 570
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
HR+IV+LYGFCLH++CMFL+Y+YM +GSLFC LRND EA++L W KR +I+K +AHALSY
Sbjct: 571 HRSIVRLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVEAVELKWMKRAHIIKDIAHALSY 630
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
LH++C P IVHRDISS+N+LLNS+ ++FVADFGVARLL DSSN TV+AGT+GYIAPELA
Sbjct: 631 LHHECNPPIVHRDISSSNVLLNSESKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELA 690
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325
YTMVVTEKCDV+ FGVVALE LMG+HPGD+LSS + L ++LD R P P ++ VIQ+
Sbjct: 691 YTMVVTEKCDVYSFGVVALETLMGKHPGDILSSSARAMTLKEVLDPRLPPPT-NEIVIQN 749
Query: 326 IILVSKIAFACLRSKPKSRPTMR 348
I +++ +AF+CL S PKSRP+M+
Sbjct: 750 ICIIASLAFSCLHSNPKSRPSMK 772
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224098415|ref|XP_002334562.1| predicted protein [Populus trichocarpa] gi|222873082|gb|EEF10213.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1096), Expect = e-117, Method: Compositional matrix adjust.
Identities = 209/349 (59%), Positives = 266/349 (76%), Gaps = 16/349 (4%)
Query: 12 FKGNK---------GKPQKVPSRL--VVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTE 60
F+GNK P K R+ + I LPI + + + L R + + +PT
Sbjct: 316 FEGNKDLHPDFSNCSLPSKTNRRIHSIKIFLPITTISLCLLCLGCCYLSRCEATQPEPTS 375
Query: 61 TKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKK 120
+K G FS+WNYDGRI +E+II ATE+FD++YCIG+GGYGSVYRAQLPSGK+VALKK
Sbjct: 376 SKN---GGLFSIWNYDGRIAYEDIITATENFDLRYCIGSGGYGSVYRAQLPSGKLVALKK 432
Query: 121 LHHSETEL-AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR 179
LHH E E AF +SF+ E +LL+QIRHR+IVKLYGFCLH++CMFL+Y+YM +GSLFC LR
Sbjct: 433 LHHREAEEPAFDKSFKNEVKLLTQIRHRSIVKLYGFCLHQRCMFLVYEYMEKGSLFCALR 492
Query: 180 NDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239
ND EA++L W KR +I+K +AHALSYLH+DC P IVHRDISS+N+LLNS+ ++FVADFGV
Sbjct: 493 NDVEAVELKWMKRAHIIKDIAHALSYLHHDCNPPIVHRDISSSNVLLNSESKSFVADFGV 552
Query: 240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF 299
ARLL DSSN TV+AGT+GYIAPELAYTMVVTEKCDV+ FGVVALE LMG+HPGD+LSS
Sbjct: 553 ARLLDPDSSNHTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALETLMGKHPGDILSSS 612
Query: 300 NPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ L ++LD R P P ++ VIQ+I +++ +AF+CL S PK RP+M+
Sbjct: 613 ARAMTLKEVLDPRLPPPT-NEIVIQNICIIASLAFSCLHSNPKYRPSMK 660
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110038|ref|XP_002333164.1| predicted protein [Populus trichocarpa] gi|222835017|gb|EEE73466.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1096), Expect = e-117, Method: Compositional matrix adjust.
Identities = 206/323 (63%), Positives = 254/323 (78%), Gaps = 5/323 (1%)
Query: 27 VVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIV 86
+ I LPI + + + L R K + +PT K GD FS+WNYDGRI +E+II
Sbjct: 607 IKIFLPISTISLCLLCLGCCYLSRCKATQPEPTSLKN---GDLFSIWNYDGRIAYEDIIA 663
Query: 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETEL-AFLESFQTEARLLSQIR 145
ATE+FD++YCIG+GGYGSVYRAQLPSGK+VALKKLHH E E AF +SF+ E LL+QIR
Sbjct: 664 ATENFDLRYCIGSGGYGSVYRAQLPSGKLVALKKLHHREAEEPAFDKSFKNEVELLTQIR 723
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
HR+IVKLYGFCLH++CMFL+Y+YM +GSLFC LRND A++L W KR +I+K +AHALSY
Sbjct: 724 HRSIVKLYGFCLHQRCMFLVYEYMEKGSLFCALRNDVGAVELKWMKRAHIIKDIAHALSY 783
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
LH+DC P IVHRDISS+N+LLNS ++FVADFGVARLL DSSN TV+AGT+GYIAPELA
Sbjct: 784 LHHDCNPPIVHRDISSSNVLLNSVSKSFVADFGVARLLDPDSSNHTVLAGTYGYIAPELA 843
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325
YTMVVTEKCDV+ FG VALE LMGRHPGD+LSS I L ++LD R SP D+ VIQ+
Sbjct: 844 YTMVVTEKCDVYSFGAVALETLMGRHPGDILSSSARAITLKEVLDPRL-SPPTDEIVIQN 902
Query: 326 IILVSKIAFACLRSKPKSRPTMR 348
I +++ +AF+CL S PKSRP+M+
Sbjct: 903 ICIIATLAFSCLHSNPKSRPSMK 925
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 425 bits (1093), Expect = e-116, Method: Compositional matrix adjust.
Identities = 200/305 (65%), Positives = 247/305 (80%), Gaps = 7/305 (2%)
Query: 50 RPKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQ 109
R RK + E T+ GD FSVWNYDG+I +E+II ATEDFDIKYCIGTGGYGSVY+AQ
Sbjct: 490 RIITRKIQTKEIP-TKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQ 548
Query: 110 LPSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168
LP+G +VALKKLH ET E +L+SFQ E ++LS+IRHRNIVKL G+CLHK+CMFLIY Y
Sbjct: 549 LPTGNVVALKKLHGWETDEATYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNY 608
Query: 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228
M RGSL+CVL N+ EA++LDW KRVN+VKS+ HA+ Y+H+DC P I+HRDISSNNILL+S
Sbjct: 609 MGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDS 668
Query: 229 KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM 288
KL+AF++DFG +RLLH DSSN+T+++GT+GYIAPELAYTMVVTEKCDV+ FGVVALE +M
Sbjct: 669 KLDAFLSDFGTSRLLHPDSSNQTLLSGTYGYIAPELAYTMVVTEKCDVYSFGVVALETMM 728
Query: 289 GRHPGDLL----SSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSR 344
G+HPG+L SS IML D+LD R PSP DQ V +D++LV +A C+ S P+SR
Sbjct: 729 GKHPGELFTLLSSSSTQNIMLTDMLDSRLPSP-QDQQVARDVVLVVWLALKCIHSNPRSR 787
Query: 345 PTMRR 349
PTM+
Sbjct: 788 PTMQH 792
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1091), Expect = e-116, Method: Compositional matrix adjust.
Identities = 211/385 (54%), Positives = 278/385 (72%), Gaps = 26/385 (6%)
Query: 1 LDSENAPPPQEFKGNKGKPQKVPSR----------LVVIILPIVLLLILVCIFTFLCLRR 50
L+ + P + F NKG ++ R L++++ LL+ + I FL +R
Sbjct: 369 LEGQTRAPVEAFGHNKGLCGEIKGRPRCKKRHQITLIIVVSLSTTLLLSIAILGFLFHKR 428
Query: 51 PKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL 110
++RK + ET K + GD FS+W+YDG I +++II ATEDFDIKYCIGTGGYGSVYRAQL
Sbjct: 429 -RIRKNQLLETTKVKNGDLFSIWDYDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQL 487
Query: 111 PSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169
PSGK+VALKKLH E + +L+SF+ E ++L++IRHRNIVKL+GFCLHK+CMFL+YKYM
Sbjct: 488 PSGKVVALKKLHGWERGDPTYLKSFENEVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKYM 547
Query: 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229
+GSL+C+LR++ EA++LDW KRVN+VKS+A+ALSY+H+DC I+HRDISSNNILL+SK
Sbjct: 548 EKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLPIIHRDISSNNILLDSK 607
Query: 230 LEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMG 289
LEAFV+DFG ARLL +DSSNRT++ GT+GYIAPELAYTMVVTEKCD++ FG+VALE +MG
Sbjct: 608 LEAFVSDFGTARLLDNDSSNRTLLVGTYGYIAPELAYTMVVTEKCDIYSFGMVALETMMG 667
Query: 290 RHPGDLLSSFNP----KIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP 345
HPG+ ++S + L D+LD R SP Q V +I L+ +A CL S P+ RP
Sbjct: 668 MHPGEFVTSLSSSSTQNTTLKDVLDSRLSSPKSTQ-VANNIALIVSLALKCLHSNPQFRP 726
Query: 346 TMR---------RSFPNPEINPSLL 361
+M+ RSFP P SLL
Sbjct: 727 SMQEVSSKLVSTRSFPQPISTISLL 751
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 361 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.836 | 0.288 | 0.496 | 2.5e-81 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.833 | 0.268 | 0.468 | 9.8e-74 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.739 | 0.242 | 0.441 | 1.2e-56 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.736 | 0.241 | 0.431 | 3.7e-54 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.745 | 0.239 | 0.427 | 3.7e-53 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.828 | 0.505 | 0.376 | 5.4e-47 | |
| TAIR|locus:2058759 | 589 | FEI2 "FEI 2" [Arabidopsis thal | 0.772 | 0.473 | 0.392 | 3.8e-46 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.783 | 0.279 | 0.392 | 5.6e-46 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.745 | 0.433 | 0.393 | 1e-45 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.731 | 0.265 | 0.412 | 1.1e-45 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 797 (285.6 bits), Expect = 2.5e-81, Sum P(2) = 2.5e-81
Identities = 157/316 (49%), Positives = 225/316 (71%)
Query: 41 CIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTG 100
C F+C R+ + + T+++ G+ S++++DG++ ++EII AT +FD KY IGTG
Sbjct: 727 CAGIFICFRKRTKQIEEHTDSESG--GETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTG 784
Query: 101 GYGSVYRAQLPSGKIVALKKLHHS-ETELA---FLESFQTEARLLSQIRHRNIVKLYGFC 156
G+G VY+A+LP+ I+A+KKL+ + ++ ++ + F E R L++IRHRN+VKL+GFC
Sbjct: 785 GHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFC 843
Query: 157 LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVH 216
H++ FL+Y+YM RGSL VL NDDEA +LDW KR+N+VK +AHALSY+H+D P+IVH
Sbjct: 844 SHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVH 903
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDV 276
RDISS NILL EA ++DFG A+LL DSSN + VAGT+GY+APELAY M VTEKCDV
Sbjct: 904 RDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDV 963
Query: 277 FGFGVVALEVLMGRHPGDLLS--SFNPK---IMLIDLLDQRAPSPIDDQTVIQDIILVSK 331
+ FGV+ LEV+ G HPGDL+S S +P + L + D R P P + + ++++ + K
Sbjct: 964 YSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPE--IKEEVLEILK 1021
Query: 332 IAFACLRSKPKSRPTM 347
+A CL S P++RPTM
Sbjct: 1022 VALLCLHSDPQARPTM 1037
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 749 (268.7 bits), Expect = 9.8e-74, P = 9.8e-74
Identities = 148/316 (46%), Positives = 220/316 (69%)
Query: 41 CIFTFL-CLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGT 99
C TF C+R+ K++ + T+ + G+ S+++ DG+ +++II +T +FD + IGT
Sbjct: 803 CANTFTYCIRKRKLQNGRNTDPET---GENMSIFSVDGKFKYQDIIESTNEFDPTHLIGT 859
Query: 100 GGYGSVYRAQLPSGKIVALKKLHHS-ETELA---FLESFQTEARLLSQIRHRNIVKLYGF 155
GGY VYRA L I+A+K+LH + + E++ + F E + L++IRHRN+VKL+GF
Sbjct: 860 GGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGF 918
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
C H++ FLIY+YM +GSL +L ND+EA +L WTKR+N+VK +AHALSY+H+D I IV
Sbjct: 919 CSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIV 978
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCD 275
HRDISS NILL++ A ++DFG A+LL +DSSN + VAGT+GY+APE AYTM VTEKCD
Sbjct: 979 HRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCD 1038
Query: 276 VFGFGVVALEVLMGRHPGDLLSSFNPK----IMLIDLLDQRAPSPIDDQTVIQDIILVSK 331
V+ FGV+ LE+++G+HPGDL+SS + + L + D+R P + ++ + +
Sbjct: 1039 VYSFGVLILELIIGKHPGDLVSSLSSSPGEALSLRSISDERVLEPRGQNR--EKLLKMVE 1096
Query: 332 IAFACLRSKPKSRPTM 347
+A CL++ P+SRPTM
Sbjct: 1097 MALLCLQANPESRPTM 1112
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 592 (213.5 bits), Expect = 1.2e-56, P = 1.2e-56
Identities = 124/281 (44%), Positives = 176/281 (62%)
Query: 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEAR 139
T++ ++ AT +F +G G G+VY+A++ G+++A+KKL+ + SF+ E
Sbjct: 788 TYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEIS 847
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
L +IRHRNIVKLYGFC H+ L+Y+YM +GSL L+ ++ LDW R I
Sbjct: 848 TLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGA 907
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH-SDSSNRTVVAGTHG 258
A L YLH+DC P IVHRDI SNNILL+ + +A V DFG+A+L+ S S + + VAG++G
Sbjct: 908 AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYG 967
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-------GDLLS----SFNPKIMLID 307
YIAPE AYTM VTEKCD++ FGVV LE++ G+ P GDL++ S I I+
Sbjct: 968 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIE 1027
Query: 308 LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ D R + +D+ + ++ LV KIA C + P SRPTMR
Sbjct: 1028 MFDARLDT--NDKRTVHEMSLVLKIALFCTSNSPASRPTMR 1066
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 569 (205.4 bits), Expect = 3.7e-54, P = 3.7e-54
Identities = 123/285 (43%), Positives = 178/285 (62%)
Query: 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKL---HHSETELAFLESFQT 136
TF++++ AT++FD + +G G G+VY+A LP+G +A+KKL H SF+
Sbjct: 793 TFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRA 852
Query: 137 EARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIV 196
E L IRHRNIVKL+GFC H+ L+Y+YM +GSL +L D + LDW+KR I
Sbjct: 853 EILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIA 910
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-SSNRTVVAG 255
A L+YLH+DC P I HRDI SNNILL+ K EA V DFG+A+++ S + + +AG
Sbjct: 911 LGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAG 970
Query: 256 THGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-------GDLLS---SFNPKIML 305
++GYIAPE AYTM VTEK D++ +GVV LE+L G+ P GD+++ S+ + L
Sbjct: 971 SYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDAL 1030
Query: 306 ID-LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
+LD R ++D+ ++ ++ V KIA C P +RP+MR+
Sbjct: 1031 SSGVLDARLT--LEDERIVSHMLTVLKIALLCTSVSPVARPSMRQ 1073
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 560 (202.2 bits), Expect = 3.7e-53, P = 3.7e-53
Identities = 124/290 (42%), Positives = 175/290 (60%)
Query: 78 RITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLH-----HSETELAFLE 132
R T ++I+ AT+ F Y +G G G+VY+A +PSGK +A+KKL ++
Sbjct: 806 RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865
Query: 133 SFQTEARLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWT 190
SF+ E L +IRHRNIV+LY FC H+ L+Y+YM RGSL +L ++ +DW
Sbjct: 866 SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGG-KSHSMDWP 924
Query: 191 KRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-SSN 249
R I A L+YLH+DC P I+HRDI SNNIL++ EA V DFG+A+++ S +
Sbjct: 925 TRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKS 984
Query: 250 RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-------GDLLSSFNPK 302
+ VAG++GYIAPE AYTM VTEKCD++ FGVV LE+L G+ P GDL +
Sbjct: 985 VSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNH 1044
Query: 303 I----MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
I + ++LD + ++D ++ +I V+KIA C +S P RPTMR
Sbjct: 1045 IRDHSLTSEILDPYL-TKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMR 1093
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 5.4e-47, P = 5.4e-47
Identities = 118/313 (37%), Positives = 172/313 (54%)
Query: 47 CLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRITF--EEIIVATEDFDIKYCIGTGGYGS 104
C K+ K + K G S+ + G + + ++II E + ++ IG GG+G+
Sbjct: 261 CFLYKKLGKVEIKSLAKD-VGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319
Query: 105 VYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164
VY+ + GK+ ALK++ + F F+ E +L I+HR +V L G+C L
Sbjct: 320 VYKLAMDDGKVFALKRI--LKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 377
Query: 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNI 224
+Y Y+ GSL L + + QLDW RVNI+ A LSYLH+DC P I+HRDI S+NI
Sbjct: 378 LYDYLPGGSLDEAL-HVERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNI 436
Query: 225 LLNSKLEAFVADFGVARLLHSDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVA 283
LL+ LEA V+DFG+A+LL + S+ T+VAGT GY+APE + TEK DV+ FGV+
Sbjct: 437 LLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLV 496
Query: 284 LEVLMGRHPGD---LLSSFNPKIMLIDLLDQRAPSPIDDQTV----IQDIILVSKIAFAC 336
LEVL G+ P D + N L L+ ++ P I D ++ + + IA C
Sbjct: 497 LEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQC 556
Query: 337 LRSKPKSRPTMRR 349
+ P+ RPTM R
Sbjct: 557 VSPSPEERPTMHR 569
|
|
| TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.8e-46, P = 3.8e-46
Identities = 115/293 (39%), Positives = 165/293 (56%)
Query: 67 GDEFSVWNYDGRITF--EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHS 124
G S+ + G + + ++II E + ++ IG GG+G+VY+ + G + ALK++
Sbjct: 278 GGGASIVMFHGDLPYASKDIIKKLESLNEEHIIGCGGFGTVYKLSMDDGNVFALKRI--V 335
Query: 125 ETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEA 184
+ F F+ E +L I+HR +V L G+C L+Y Y+ GSL L E
Sbjct: 336 KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRGE- 394
Query: 185 IQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
QLDW RVNI+ A L+YLH+DC P I+HRDI S+NILL+ LEA V+DFG+A+LL
Sbjct: 395 -QLDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 453
Query: 245 SDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGD---LLSSFN 300
+ S+ T+VAGT GY+APE + TEK DV+ FGV+ LEVL G+ P D + FN
Sbjct: 454 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEKGFN 513
Query: 301 PKIMLIDLLDQ-RAPSPID---DQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
L L+ + RA +D + + + + IA C+ S P RPTM R
Sbjct: 514 IVGWLNFLISENRAKEIVDLSCEGVERESLDALLSIATKCVSSSPDERPTMHR 566
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 5.6e-46, P = 5.6e-46
Identities = 119/303 (39%), Positives = 175/303 (57%)
Query: 66 CGDEF-SVWNYDGRI-TFEEIIVATEDF--DIKYC--IGTGGYGSVYRAQLP-SGKIVAL 118
CGDE S + R+ F + D IK IG G G VY+A++ S ++A+
Sbjct: 668 CGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAV 727
Query: 119 KKLHHSETEL--AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFC 176
KKL S ++ F E LL ++RHRNIV+L GF + K M ++Y++M G+L
Sbjct: 728 KKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGD 787
Query: 177 VLRNDDEAIQL--DWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFV 234
+ + A +L DW R NI +AH L+YLH+DC P ++HRDI SNNILL++ L+A +
Sbjct: 788 AIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARI 847
Query: 235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-- 292
ADFG+AR++ ++VAG++GYIAPE YT+ V EK D++ +GVV LE+L GR P
Sbjct: 848 ADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLE 907
Query: 293 ---G---DLLSSFNPKIM-LIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP 345
G D++ KI I L + P+ + + V ++++LV +IA C PK RP
Sbjct: 908 PEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRP 967
Query: 346 TMR 348
+MR
Sbjct: 968 SMR 970
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 1.0e-45, P = 1.0e-45
Identities = 111/282 (39%), Positives = 163/282 (57%)
Query: 78 RITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTE 137
R T E++VAT++F K +G GG+G VY+ +L G +VA+K+L T+ L+ FQTE
Sbjct: 281 RFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQ-FQTE 339
Query: 138 ARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ-LDWTKRVNIV 196
++S HRN+++L GFC+ L+Y YM GS+ LR E LDW KR +I
Sbjct: 340 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIA 399
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-HSDSSNRTVVAG 255
A L+YLH C I+HRD+ + NILL+ + EA V DFG+A+L+ ++DS T V G
Sbjct: 400 LGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRG 459
Query: 256 THGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK-IMLID-----LL 309
T G+IAPE T +EK DVFG+GV+ LE++ G+ DL N IML+D L
Sbjct: 460 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLK 519
Query: 310 DQRAPSPIDDQT----VIQDIILVSKIAFACLRSKPKSRPTM 347
+++ S +D + V ++ + ++A C +S RP M
Sbjct: 520 EKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKM 561
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 464 (168.4 bits), Expect = 1.1e-45, Sum P(2) = 1.1e-45
Identities = 118/286 (41%), Positives = 170/286 (59%)
Query: 55 KAKPTETKKTRCGDEFSVWNYDGRITFEEIIVA-TEDFDIKYCIGTGGYGSVYRAQLPSG 113
K KP +K + ++ +++ G T E+I TED +I IG+GG G VYR +L SG
Sbjct: 654 KTKPLFKRKPKRTNKITIFQRVG-FTEEDIYPQLTED-NI---IGSGGSGLVYRVKLKSG 708
Query: 114 KIVALKKLHHSETELAFLES-FQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172
+ +A+KKL + ES F++E L ++RH NIVKL C ++ FL+Y++M G
Sbjct: 709 QTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENG 768
Query: 173 SLFCVLRNDDE--AIQ-LDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229
SL VL ++ E A+ LDWT R +I A LSYLH+D +P IVHRD+ SNNILL+ +
Sbjct: 769 SLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHE 828
Query: 230 LEAFVADFGVARLLHSDSSN------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVA 283
++ VADFG+A+ L + ++ + VAG++GYIAPE YT V EK DV+ FGVV
Sbjct: 829 MKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVL 888
Query: 284 LEVLMGRHPGDLLSSFNPKIMLIDLLDQRA---PSP-IDDQTVIQD 325
LE++ G+ P D SSF ++ + A PSP +D + QD
Sbjct: 889 LELITGKRPND--SSFGENKDIVKFAMEAALCYPSPSAEDGAMNQD 932
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00031862001 | SubName- Full=Chromosome undetermined scaffold_60, whole genome shotgun sequence; (722 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 361 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 8e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 9e-51
Identities = 73/261 (27%), Positives = 120/261 (45%), Gaps = 18/261 (6%)
Query: 91 FDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
++I +G G +G VY A+ +GK+VA+K + + E E ++L +++H NI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKK-IKKDRERILREIKILKKLKHPNI 59
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
V+LY + ++L+ +Y G LF +L+ + D + ++ + AL YLH
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARF--YLRQILSALEYLHSK 116
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
IVHRD+ NILL+ +ADFG+AR L T V GT Y+APE+
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-GTPEYMAPEVLLGKG 172
Query: 270 VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD--II 327
+ D++ GV+ E+L G+ P + + L + + P + I
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP---FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229
Query: 328 LVSKIAFACLRSKPKSRPTMR 348
L+ K L P+ R T
Sbjct: 230 LIRK----LLVKDPEKRLTAE 246
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-47
Identities = 78/262 (29%), Positives = 119/262 (45%), Gaps = 14/262 (5%)
Query: 91 FDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
+++ +G+G +G+VY+A+ GKIVA+K L + ++ + E R+L ++ H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
V+L K ++L+ +Y G LF L L + I + L YLH +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTM 268
I+HRD+ NILL+ +ADFG+A+ L SS+ T GT Y+APE L
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 269 VVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
K DV+ GV+ E+L G+ P G+ + I I P D+
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI----LGPPLEFDEPKWSSGS 230
Query: 327 ILVSKIAFACLRSKPKSRPTMR 348
+ CL P RPT
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 8e-45
Identities = 67/192 (34%), Positives = 108/192 (56%), Gaps = 9/192 (4%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G GG+G+VY A+ +GK VA+K + ++ + LE E +L ++ H NIVKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
+ ++L+ +Y GSL +L+ ++ +L + + I+ + L YLH I+
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLH-SN--GII 114
Query: 216 HRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVVTEK 273
HRD+ NILL+S + +ADFG+++LL SD S + GT Y+APE L +EK
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 274 CDVFGFGVVALE 285
D++ GV+ E
Sbjct: 175 SDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-40
Identities = 75/260 (28%), Positives = 121/260 (46%), Gaps = 25/260 (9%)
Query: 96 CIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154
+G G +GSVY A +G+++A+K + S LE+ + E R+LS ++H NIV+ YG
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 155 FCLHK-KCMFLIY-KYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+ K I+ +Y+ GSL +L+ + I+ +T+++ L+YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK-YTRQI------LEGLAYLHS 119
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAY 266
+ IVHRDI NIL++S +ADFG A+ L + V GT ++APE+
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
D++ G +E+ G+ P L + + I + P +D
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 327 ILVSKIAFACLRSKPKSRPT 346
+ CLR PK RPT
Sbjct: 237 LR------KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 42/270 (15%)
Query: 97 IGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +G VY+ L + VA+K L +E E F EA ++ ++ H NIV+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE-REEFLEEASIMKKLSHPNIVR 65
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
L G C + ++++ +YM G L LR E + L + + +A + YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE---- 119
Query: 212 PS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APEL 264
S VHRD+++ N L+ L ++DFG++R ++ D R G + APE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---KRGGGKLPIKWMAPES 175
Query: 265 AYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQ-----RAPSPID 318
T K DV+ FGV+ E+ +G P P + ++L+ R P P +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQP-------YPGMSNEEVLELLEDGYRLPRPEN 228
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ +++L C P+ RPT
Sbjct: 229 CPDELYELML------QCWAYDPEDRPTFS 252
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 43/270 (15%)
Query: 97 IGTGGYGSVYRAQL----PSGKI-VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +G VY+ +L K+ VA+K L +E +E F EAR++ ++ H N+VK
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ-IEEFLREARIMRKLDHPNVVK 65
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
L G C ++ ++++ +YM G L LR + + L ++ +A + YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLS--DLLSFALQIARGMEYLE---- 119
Query: 212 PS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPEL 264
S +HRD+++ N L+ L ++DFG++R L+ D R G ++APE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK----RGGKLPIRWMAPES 174
Query: 265 AYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQ-----RAPSPID 318
T K DV+ FGV+ E+ +G P P + ++L+ R P P +
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQP-------YPGMSNEEVLEYLKNGYRLPQPPN 227
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ D++L C P+ RPT
Sbjct: 228 CPPELYDLML------QCWAEDPEDRPTFS 251
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-39
Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 9/204 (4%)
Query: 90 DFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
F+I IG GG+G VY+A +GK VA+K + E E E ++L + +H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE--KKEKIINEIQILKKCKHPN 58
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
IVK YG L K ++++ ++ GSL +L++ ++ + + K + L YLH
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY--VCKELLKGLEYLHS 116
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
+ I+HRDI + NILL S E + DFG++ L SD+ R + GT ++APE+
Sbjct: 117 N---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMAPEVINGK 172
Query: 269 VVTEKCDVFGFGVVALEVLMGRHP 292
K D++ G+ A+E+ G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 72/266 (27%), Positives = 121/266 (45%), Gaps = 36/266 (13%)
Query: 97 IGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +G VY+ L VA+K L +E +E F EAR++ ++ H NIVK
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ-IEEFLREARIMRKLDHPNIVK 65
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
L G C ++ + ++ +YM G L LR + L + ++ +A + YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE---- 120
Query: 212 PS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APEL 264
S +HRD+++ N L+ L ++DFG++R L+ D + G + APE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV----KGGKLPIRWMAPES 175
Query: 265 AYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQT 321
T K DV+ FGV+ E+ +G P +S+ +++ L + R P P +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE----VLEYLKKGYRLPKPPNCPP 231
Query: 322 VIQDIILVSKIAFACLRSKPKSRPTM 347
+ ++L C P+ RPT
Sbjct: 232 ELYKLML------QCWAEDPEDRPTF 251
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-35
Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 23/265 (8%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
D + +G G G VY+ + P+GKI ALKK+H E F + E + L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESP 59
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV--NIVKSMAHALSY 205
+VK YG + + ++ +YM GSL +L+ + V I + + L Y
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLK-----KVGKIPEPVLAYIARQILKGLDY 114
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL- 264
LH I+HRDI +N+L+NSK E +ADFG++++L + GT Y++PE
Sbjct: 115 LHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI 172
Query: 265 ---AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321
+Y+ D++ G+ LE +G+ P + ++ + D PS ++
Sbjct: 173 QGESYSY----AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228
Query: 322 VIQDIILVSKIAFACLRSKPKSRPT 346
+ +S ACL+ PK RP+
Sbjct: 229 SPEFRDFIS----ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-35
Identities = 73/270 (27%), Positives = 123/270 (45%), Gaps = 35/270 (12%)
Query: 97 IGTGGYGSVYRAQLPSGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
+G G +G VY+ +L VA+K L +E + F EAR++ ++ H N+V+L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-EERKDFLKEARVMKKLGHPNVVRL 61
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRN------DDEAIQLDWTKRVNIVKSMAHALSYL 206
G C ++ ++L+ +YM G L LR E L ++ +A + YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
VHRD+++ N L+ L ++DFG++R ++ D R T G + A
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK---KTGGKLPIRWMA 175
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLL--DQRAPSPID 318
PE + T K DV+ FGV+ E+ +G P LS+ +++ L R P P
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----VLEYLRKGYRLPKPEY 231
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ +++L +C + P+ RPT
Sbjct: 232 CPDELYELML------SCWQLDPEDRPTFS 255
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 6e-34
Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 21/274 (7%)
Query: 90 DFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRH-R 147
+ I +G G +G VY A+ K+VALK L + +E F E ++L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
NIVKLY F + ++L+ +Y+ GSL +L+ L ++ + I+ + AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFV-ADFGVARLLHSDSSNRTVVA------GTHGYI 260
I+HRDI NILL+ DFG+A+LL S ++ A GT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 261 APELAYTMV---VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR----A 313
APE+ + + D++ G+ E+L G P + + + + ++ +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM 347
SP+ S + L PK+R +
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 1e-33
Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 43/284 (15%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
++I IG G +G VY + GK+ LK++ S E E ++L ++ H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ-------LDWTKRVNIVKSMAH 201
I+K Y K + ++ +Y G L ++ + + LDW V +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL---- 114
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS-NRTVVAGTHGYI 260
AL YLH I+HRDI NI L S + DFG++++L S +TVV GT Y+
Sbjct: 115 ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYL 170
Query: 261 APEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIMLIDLLDQRAP 314
+PEL Y K D++ G V E+ +HP G+ L KI+ +
Sbjct: 171 SPELCQNKPY----NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL------KGQY 220
Query: 315 SPIDDQ--TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356
PI Q + +++++ + L+ P+ RP++ + +P I
Sbjct: 221 PPIPSQYSSELRNLV------SSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 9e-31
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 90 DFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
++ + IG G +G VY+ L +G VA+K++ + + L+S E LL ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----NDDEAIQLDWTKRVNIVKSMAHAL 203
IVK G +++I +Y GSL +++ + V + L
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA--------VYVYQVLQGL 112
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
+YLH ++HRDI + NIL +ADFGVA L+ S + V GT ++APE
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+ + D++ G +E+L G P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 82/265 (30%), Positives = 130/265 (49%), Gaps = 28/265 (10%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKK--LHHSETELAFLESFQTEARLLSQIR 145
E F + CIG G +G VY+A + ++VA+K L +E E+ + Q E + LSQ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI---QQEIQFLSQCR 57
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
I K YG L +++I +Y GS +L+ +LD T I++ + L Y
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGLEY 113
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
LH + +HRDI + NILL+ + + +ADFGV+ L S S R GT ++APE+
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP-KIMLIDLLDQRAPSPIDDQTV-- 322
EK D++ G+ A+E+ G P LS +P +++ L+ + P ++
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP---LSDLHPMRVLF--LIPKNNPPSLEGNKFSK 225
Query: 323 -IQDIILVSKIAFACLRSKPKSRPT 346
+D + CL PK RP+
Sbjct: 226 PFKDFVS------LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 50/291 (17%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHH---SETELAFLESFQTEARLLSQIR 145
D+++ IG G +G+V + + GKI+ K++ + +E E L S E +L +++
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS---EVNILRELK 57
Query: 146 HRNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCVLRN--------DDEAIQLDWTKRVNI 195
H NIV+ Y + + + ++++ +Y G L +++ ++E I W I
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W----RI 110
Query: 196 VKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
+ + AL H P ++HRD+ NI L++ + DFG+A++L DSS
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 254 AGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK--IMLIDLLDQ 311
GT Y++PE M EK D++ G + E+ P F + + L + +
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP------FTARNQLQLASKIKE 224
Query: 312 RAPSPIDDQ------TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356
I + VI+ + L P RP+ P I
Sbjct: 225 GKFRRIPYRYSSELNEVIK----------SMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 9e-29
Identities = 78/266 (29%), Positives = 125/266 (46%), Gaps = 30/266 (11%)
Query: 89 EDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
E FDI +G G YGSVY+A +G++VA+K + E L+ E +L Q
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSP 58
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN-----DDEAIQLDWTKRVNIVKSMAHA 202
IVK YG ++++ +Y GS+ +++ +E I I+
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKG 111
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
L YLH + +HRDI + NILLN + +A +ADFGV+ L + R V GT ++AP
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT- 321
E+ + K D++ G+ A+E+ G+ P S +P + I ++ + P + D
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPP---YSDIHP-MRAIFMIPNKPPPTLSDPEK 224
Query: 322 VIQDII-LVSKIAFACLRSKPKSRPT 346
+ V K CL P+ RP+
Sbjct: 225 WSPEFNDFVKK----CLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 79/264 (29%), Positives = 131/264 (49%), Gaps = 42/264 (15%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH---RNIVKL 152
IG G YG+VYR +P+G++VALK ++ +T + Q E LLSQ+R NI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN-LDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRN---DDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
YG L +++I +Y GS+ +++ ++ I + I++ + AL Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKV 120
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
++HRDI + NIL+ + + DFGVA LL+ +SS R+ GT ++APE V
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPE-----V 172
Query: 270 VTE------KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ--- 320
+TE K D++ G+ E+ G P S + L+ + P ++D
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP----YSDVDAFRAMMLIPKSKPPRLEDNGYS 228
Query: 321 TVIQDIILVSKIAFACLRSKPKSR 344
++++ + ACL +PK R
Sbjct: 229 KLLREFVA------ACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 81/261 (31%), Positives = 126/261 (48%), Gaps = 29/261 (11%)
Query: 97 IGTGGYGSVYRA--QLPSGK--IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G +G V R +LP K VA+K L ++ L+ F TEA ++ Q H NI++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
G + + +I +YM GSL LR +D + + V +++ +A + YL
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG--YIAPE-LAYTMV 269
VHRD+++ NIL+NS L V+DFG++R L + T G + APE +AY
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-K 184
Query: 270 VTEKCDVFGFGVVALEVL-MGRHP-GDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTVIQD 325
T DV+ FG+V EV+ G P D+ +I ++ R P P+D + +
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDM-----SNQDVIKAVEDGYRLPPPMDCPSALYQ 239
Query: 326 IILVSKIAFACLRSKPKSRPT 346
++L C + RPT
Sbjct: 240 LML------DCWQKDRNERPT 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 78/274 (28%), Positives = 127/274 (46%), Gaps = 33/274 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+D+++ IG G VY A LP+ + VA+K++ E ++ + E + +SQ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHP 59
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
N+VK Y + ++L+ Y+ GSL ++++ LD ++K + L YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN----RTVVAGTHGYIAPE 263
+ +HRDI + NILL +ADFGV+ L R GT ++APE
Sbjct: 120 SN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 264 L-----AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP-KIMLIDLLDQRAPSPI 317
+ Y K D++ FG+ A+E+ G P S + P K++++ L Q P +
Sbjct: 177 VMEQVHGY----DFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTL--QNDPPSL 227
Query: 318 DDQTVIQDIILVSKIAF-----ACLRSKPKSRPT 346
+ D SK +F CL+ P RPT
Sbjct: 228 ETGA---DYKKYSK-SFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 82 EEIIVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQT 136
+ IV+ D Y IG G G VY+A +GK VA+KK+ + E
Sbjct: 8 LKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIIN 64
Query: 137 EARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIV 196
E ++ +H NIV Y L ++++ +YM GSL ++ + ++++ + +
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVC 122
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
+ + L YLH +++HRDI S+NILL+ +ADFG A L + S R V GT
Sbjct: 123 REVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGT 179
Query: 257 HGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
++APE+ K D++ G++ +E+ G P
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 77/268 (28%), Positives = 122/268 (45%), Gaps = 39/268 (14%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G +G VY A L +G+++A+K++ + + ++ E ++L ++H N+VK YG
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 156 CLHKKCMFLIYKYMRRGSLFCVL---RNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
+H++ +++ +Y G+L +L R DE + + + L+YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHV----IRV--YTLQLLEGLAYLHSH--- 118
Query: 213 SIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRTVV-------AGTHGYIA 261
IVHRDI NI L+ KL DFG A L +N T + AGT Y+A
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKL----GDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMA 171
Query: 262 PELAYTMVVTEK---CDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318
PE+ D++ G V LE+ G+ P L + +IM + P P
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-EFQIMFHVGAGHKPPIPDS 230
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPT 346
Q + + + CL S PK RPT
Sbjct: 231 LQLSPEGKDFLDR----CLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 79/246 (32%), Positives = 123/246 (50%), Gaps = 18/246 (7%)
Query: 93 IKYCIGTGGYGSVYRAQL-PSGK---IVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
I+ IG G +G V R +L GK VA+K L TE + F +EA ++ Q H N
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPN 66
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
I+ L G + + +I ++M G+L LR +D Q + V +++ +A + YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSE 124
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
+ VHRD+++ NIL+NS L V+DFG++R L D+S+ T + G I APE
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 264 LAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322
T DV+ +G+V EV+ G P +S N ++ D R P P+D T
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAIEQDYRLPPPMDCPTA 239
Query: 323 IQDIIL 328
+ ++L
Sbjct: 240 LHQLML 245
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 89/342 (26%), Positives = 155/342 (45%), Gaps = 43/342 (12%)
Query: 21 KVPSR-LVVIILPIVLLLILVCIFTFLCLRRPKVRKAKPTETKKTRCGDEFSVWNYDGRI 79
K PS + L++ + F F+ +R + K E + +F I
Sbjct: 624 KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI 683
Query: 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKI-VALKKLHHSETELAFLESFQTEA 138
T +I+ + ++ ++ I G G+ Y+ + + +K+++ + S +
Sbjct: 684 TINDILSSLKEENV---ISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIAD- 736
Query: 139 RLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS 198
+ +++H NIVKL G C +K +LI++Y+ +L VLRN L W +R I
Sbjct: 737 --MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIG 788
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
+A AL +LH C P++V ++S I+++ K E + + LL +D+ A
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---- 843
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI--------------M 304
Y+APE T +TEK D++GFG++ +E+L G+ P D + I M
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903
Query: 305 LIDLLDQRAPSPIDDQTVIQ-DIILVSKIAFACLRSKPKSRP 345
ID PS D +V Q +I+ V +A C + P +RP
Sbjct: 904 WID------PSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 78/273 (28%), Positives = 130/273 (47%), Gaps = 23/273 (8%)
Query: 90 DFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
DF+I IG G +G V++ + ++ A+K++ S+ E EAR+L+++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVL---RNDDEAIQLDWTKRVNIVKSMAHALSY 205
I++ Y L K + ++ +Y G L +L R W + I+ L++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAH 116
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPE 263
LH I+HRDI S N+ L++ + D GVA+LL SD++N T+V GT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIV-GTPYYLSPE 171
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323
L EK DV+ GVV E G+HP D + N +++ ++ P P+ Q
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALILKIIRGVFP-PV-SQMYS 226
Query: 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356
Q + ++ CL + RP + NP +
Sbjct: 227 QQLA---QLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 70/255 (27%), Positives = 114/255 (44%), Gaps = 18/255 (7%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G G V + P+GKI+A+K + E A + E +L + IV YG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
+ + + +YM GSL +L+ I ++ + ++ L+YLH I+
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKH--KII 123
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCD 275
HRD+ +NIL+NS+ + + DFGV+ L +S +T V GT Y+APE + K D
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFV-GTSSYMAPERIQGNDYSVKSD 181
Query: 276 VFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTVIQDIILVSKIA 333
++ G+ +E+ GR P +P + +LL P P +
Sbjct: 182 IWSLGLSLIELATGRFP--YPPENDPPDGIFELLQYIVNEPPP----RLPSGKFSPDFQD 235
Query: 334 F--ACLRSKPKSRPT 346
F CL P+ RP+
Sbjct: 236 FVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 78/243 (32%), Positives = 121/243 (49%), Gaps = 22/243 (9%)
Query: 97 IGTGGYGSVYRAQLP-SGK---IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G +G V+R L G+ VA+K L TE + F +EA ++ Q H NI++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHHNIIRL 71
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDD---EAIQLDWTKRVNIVKSMAHALSYLHYD 209
G K +I +YM G+L LR+ D + QL V +++ +A + YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYLSD- 125
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAY 266
+ VHRD+++ NIL+NS LE V+DFG++R+L D +G + APE
Sbjct: 126 --MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 267 TMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325
T DV+ FG+V EV+ G P +S N ++M R P+P+D + +
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--NHEVMKAINDGFRLPAPMDCPSAVYQ 241
Query: 326 IIL 328
++L
Sbjct: 242 LML 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-25
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G YG VY+A+ +G++VALKK+ + F + E +LL ++RH NIV+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 156 CLHKKC--MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
K ++++++YM L +L + + K +K + L YLH +
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC--YMKQLLEGLQYLHSN---G 120
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVVAGTHGYIAPEL----- 264
I+HRDI +NIL+N+ +ADFG+AR +S NR + T Y PEL
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI---TLWYRPPELLLGAT 177
Query: 265 AYTMVVTEKCDVFGFGVVALEVLMGR 290
Y + D++ G + E+ +G+
Sbjct: 178 RY----GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 96 CIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQT----EARLLSQIRHRNIV 150
+G G YG VY+A+ +G+IVALKK+ E E + E LL +++H NIV
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELKHPNIV 61
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210
KL ++ ++L+++Y L L + + K I+ + L+Y H
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHSHR 118
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-----A 265
I+HRD+ NIL+N +ADFG+AR T T Y APE+
Sbjct: 119 ---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
Y+ V D++ G + E++ G+ PGD
Sbjct: 176 YSTAV----DIWSVGCIFAEMITGKPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-24
Identities = 76/269 (28%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 90 DFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
D +K+ +G G YG VY VA+K L E+ E F EA ++ +I+H N
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPN 63
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+V+L G C + ++I ++M G+L LR + +++ + + ++ A+ YL
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEK 122
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPE-L 264
+ +HRD+++ N L+ VADFG++RL+ D+ T AG + APE L
Sbjct: 123 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESL 177
Query: 265 AYTMVVTEKCDVFGFGVVALEVL---MGRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDD 319
AY K DV+ FGV+ E+ M +PG LS + +LL++ R P
Sbjct: 178 AYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKGYRMERPEGC 230
Query: 320 QTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ +++ AC + P RP+
Sbjct: 231 PPKVYELMR------ACWQWNPSDRPSFA 253
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-24
Identities = 83/276 (30%), Positives = 130/276 (47%), Gaps = 43/276 (15%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALK--KLHHSETELAFLESFQTEARLLSQIR 145
ED+++ IG+G YG VY+A+ + +G++VA+K KL + E Q E +L + R
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD----FEIIQQEISMLKECR 58
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSL---FCVLRNDDEAIQLDWTKRVNIVKSMAHA 202
H NIV +G L + ++++ +Y GSL + V R +Q+ + R +
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KG 113
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
L+YLH +HRDI NILL + +ADFGV+ L + + R GT ++AP
Sbjct: 114 LAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170
Query: 263 ELA-------YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK--IMLIDLLDQRA 313
E+A Y KCD++ G+ A+E+ + P + +P + LI +
Sbjct: 171 EVAAVERKGGY----DGKCDIWALGITAIELAELQPP---MFDLHPMRALFLISKSNFPP 223
Query: 314 PSPIDDQ---TVIQDIILVSKIAFACLRSKPKSRPT 346
P D + V D I CL PK RPT
Sbjct: 224 PKLKDKEKWSPVFHDFIKK------CLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 5e-24
Identities = 75/260 (28%), Positives = 131/260 (50%), Gaps = 33/260 (12%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETEL-AFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G +G V+ VA+K L AFL+ EA+++ ++RH +V+LY
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ----EAQIMKKLRHDKLVQLYAV 69
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL---HYDCIP 212
C ++ ++++ +YM +GSL L+ E +L + V++ +A ++YL +Y
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLK-SGEGKKLRLPQLVDMAAQIAEGMAYLESRNY---- 124
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---APELAYTMV 269
+HRD+++ NIL+ L +ADFG+ARL+ D T G I APE A
Sbjct: 125 --IHRDLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGR 180
Query: 270 VTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTVIQDI 326
T K DV+ FG++ E++ GR P ++ N ++ ++ +++ R P P + + D+
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREV--LEQVERGYRMPRPPNCPEELYDL 236
Query: 327 ILVSKIAFACLRSKPKSRPT 346
+L C P+ RPT
Sbjct: 237 ML------QCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-24
Identities = 68/256 (26%), Positives = 122/256 (47%), Gaps = 25/256 (9%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156
+G G +G V+ + VA+K L + + F EA+++ ++RH +++LY C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 157 LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVH 216
++ ++++ + M+ GSL L+ L + +++ +A ++YL + +H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---APELAYTMVVTEK 273
RD+++ N+L+ VADFG+AR++ D G I APE A + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAALYNRFSIK 184
Query: 274 CDVFGFGVVALE-VLMGRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTVIQDIILVS 330
DV+ FG++ E V GR P ++ N ++ + +DQ R P P + DI+L
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMT--NAEV--LQQVDQGYRMPCPPGCPKELYDIML-- 238
Query: 331 KIAFACLRSKPKSRPT 346
C + P RPT
Sbjct: 239 ----DCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-23
Identities = 71/266 (26%), Positives = 135/266 (50%), Gaps = 25/266 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
E+F ++ +G+G +G V+ + VA+K L +L + FQ E + L ++RH++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKIL--KSDDLLKQQDFQKEVQALKRLRHKH 63
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
++ L+ C + +++I + M +GSL LR+ + + L +++ +A ++YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEE 122
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD---SSNRTVVAGTHGYIAPELA 265
+ +HRD+++ NIL+ L VADFG+ARL+ D SS++ + + + APE A
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAA 176
Query: 266 YTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTV 322
+ K DV+ FG++ E+ G+ P +++ + D + R P P
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE----VYDQITAGYRMPCPAKCPQE 232
Query: 323 IQDIILVSKIAFACLRSKPKSRPTMR 348
I I+L C ++P+ RP+ +
Sbjct: 233 IYKIML------ECWAAEPEDRPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 36/234 (15%)
Query: 85 IVATEDFDIKYCIGTGGYGSVYRAQLPSGK------IVALKKLHHSETELAFLESFQTEA 138
V + +K +G G +G V+ + + +VA+K L + + A + F+ EA
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA-RKDFEREA 59
Query: 139 RLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----------NDDEAIQL 187
LL+ +H NIVK YG C ++++YM G L LR D +L
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 188 DWTKRVNIVKSMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
++ + I +A + YL H+ VHRD+++ N L+ L + DFG++R ++
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVY 173
Query: 245 SDSSNRTVVAGTH----GYIAPE-LAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
+ R V G ++ PE + Y TE DV+ FGVV E+ G+ P
Sbjct: 174 TTDYYR--VGGHTMLPIRWMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 6e-23
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLH------HSETELAFLESFQTEARLLSQIRHRNI 149
+G G +G V + +GK+ A+K L E E TE +LS+I H I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-----TERNILSRINHPFI 55
Query: 150 VKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
VKL Y F +K ++L+ +Y G LF L + + + + AL YLH
Sbjct: 56 VKLHYAFQTEEK-LYLVLEYAPGGELFSHLSKE-GRFSEERARF--YAAEIVLALEYLHS 111
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL---- 264
I++RD+ NILL++ + DFG+A+ L S+ S GT Y+APE+
Sbjct: 112 L---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 265 AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y V D + GV+ E+L G+ P
Sbjct: 169 GYGKAV----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 91 FDIKYCIGTGGYGSVYRAQL-PSGKIVALK---KLHHSETELAFLESFQTEARLLSQIRH 146
F++ IG G +G V Q + K+ A+K K E + E R+L ++ H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSV--RNVLNERRILQELNH 59
Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSL-FCVLRN---DDEAIQLDWTKRVNIVKSMAH 201
+V L Y F + M+L+ + G L + + + +E ++ + +
Sbjct: 60 PFLVNLWYSFQDEEN-MYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVL 111
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
AL YLH I+HRDI +NILL+ + + DF +A + + T +GT GY+A
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMA 167
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE+ + D + GV A E L G+ P
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 69/268 (25%), Positives = 122/268 (45%), Gaps = 34/268 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
++ + IG G +G V G+ VA+K L + + ++F EA +++ +RH N
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCL---KDDSTAAQAFLAEASVMTTLRHPN 61
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+V+L G L ++++ +YM +GSL LR+ A+ + +++ + + YL
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEE 120
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
+ VHRD+++ N+L++ L A V+DFG+A+ S + + APE
Sbjct: 121 K---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTAPEALREK 174
Query: 269 VVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQ-------RAPSPIDDQ 320
+ K DV+ FG++ E+ GR P P+I L D++ AP +
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPHVEKGYRMEAPEGCPPE 227
Query: 321 TVIQDIILVSKIAFACLRSKPKSRPTMR 348
V K+ C P RPT +
Sbjct: 228 --------VYKVMKDCWELDPAKRPTFK 247
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 75/253 (29%), Positives = 119/253 (47%), Gaps = 17/253 (6%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G +G V++ + K+VA+K + E E +E Q E +LSQ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
L +++I +Y+ GS +L E LD T+ I++ + L YLH + +
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---KKI 123
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCD 275
HRDI + N+LL+ E +ADFGVA L R GT ++APE+ K D
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 276 VFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFA 335
++ G+ A+E+ G P S +P +L L+ + P ++ + + A
Sbjct: 184 IWSLGITAIELAKGEPPH---SELHPMKVLF-LIPKNNPPTLEGNYSKP----LKEFVEA 235
Query: 336 CLRSKPKSRPTMR 348
CL +P RPT +
Sbjct: 236 CLNKEPSFRPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-22
Identities = 71/253 (28%), Positives = 116/253 (45%), Gaps = 17/253 (6%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G +G V++ + ++VA+K + E E +E Q E +LSQ + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
L +++I +Y+ GS +LR A D + ++K + L YLH + +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KKI 123
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCD 275
HRDI + N+LL+ + + +ADFGVA L R GT ++APE+ K D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 276 VFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFA 335
++ G+ A+E+ G P S +P +L + P+ + + + A
Sbjct: 184 IWSLGITAIELAKGEPPN---SDMHPMRVLFLIPKNNPPTLTGEFSKP-----FKEFIDA 235
Query: 336 CLRSKPKSRPTMR 348
CL P RPT +
Sbjct: 236 CLNKDPSFRPTAK 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 8e-22
Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 36/264 (13%)
Query: 97 IGTGGYGSVYRA--QLPSGKI--VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
+G G +GSV + + SGK VA+K L E A + F EA +++Q+ H IV+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY-LHYDCI 211
G C + M L+ + G L L+ E D +K +AH ++ + Y
Sbjct: 62 IGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSD-------LKELAHQVAMGMAYLES 113
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPELAY 266
VHRD+++ N+LL ++ +A ++DFG++R L + S A T G + APE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECIN 171
Query: 267 TMVVTEKCDVFGFGVVALEVL-MGRHP-GDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTV 322
+ K DV+ +GV E G P G++ +++ +L+ R P P +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVI--AMLESGERLPRPEECPQE 226
Query: 323 IQDIILVSKIAFACLRSKPKSRPT 346
I I+L +C + +P+ RPT
Sbjct: 227 IYSIML------SCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-22
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 97 IGTGGYGSVYRAQ-LPSG---KI-VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G+G +G+VY+ +P G KI VA+K L + A E EA +++ + H ++V+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE-ILDEAYVMASVDHPHVVR 73
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ----LDWTKRVNIVKSMAHALSYLH 207
L G CL + LI + M G L +RN + I L+W V I K M SYL
Sbjct: 74 LLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGM----SYLE 126
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYIAPELA 265
+VHRD+++ N+L+ + + DFG+A+LL D G ++A E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 266 YTMVVTEKCDVFGFGVVALEVL-MGRHP 292
+ T K DV+ +GV E++ G P
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G YG VY+A+ +G+IVA+KK+ ++ E +LL ++ H NI+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
HK ++L++++M L+ +++ D L + + + + L++ H I+
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIK--DRQRGLPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKC 274
HRD+ N+L+N++ +ADFG+AR S T T Y APEL +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 275 DVFGFGVVALEVLMGR--HPGD 294
D++ G + E+L R PG
Sbjct: 181 DIWSVGCIFAELLSRRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 81/266 (30%), Positives = 125/266 (46%), Gaps = 32/266 (12%)
Query: 93 IKYCIGTGGYGSVY--RAQLPSGK--IVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
I+ IG G +G V R +LP + VA+K L TE F +EA ++ Q H N
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPN 66
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDD---EAIQLDWTKRVNIVKSMAHALSY 205
I+ L G K + ++ +YM GSL LR D IQL V +++ +A + Y
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKY 121
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAP 262
L D VHRD+++ NIL+NS L V+DFG++R+L D G + AP
Sbjct: 122 LS-DM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDD 319
E T DV+ +G+V EV+ G P +S+ + +I +++ R P+P+D
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VIKAIEEGYRLPAPMDC 234
Query: 320 QTVIQDIILVSKIAFACLRSKPKSRP 345
+ ++L C + RP
Sbjct: 235 PAALHQLML------DCWQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 73/253 (28%), Positives = 120/253 (47%), Gaps = 17/253 (6%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G +G VY+ + ++VA+K + E E +E Q E +LSQ I + YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYYGS 70
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
L +++I +Y+ GS +L+ L+ T I++ + L YLH + +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKI 123
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCD 275
HRDI + N+LL+ + + +ADFGVA L R GT ++APE+ K D
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 276 VFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFA 335
++ G+ A+E+ G P S +P +L L+ + +P ++ Q + A
Sbjct: 184 IWSLGITAIELAKGEPPN---SDLHPMRVLF-LIPKNSPPTLEGQYSKP----FKEFVEA 235
Query: 336 CLRSKPKSRPTMR 348
CL P+ RPT +
Sbjct: 236 CLNKDPRFRPTAK 248
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-21
Identities = 73/268 (27%), Positives = 129/268 (48%), Gaps = 28/268 (10%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR 145
+ E ++ +G G +G V+ VA+K L E+F EA+++ ++R
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 59
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
H +V+LY + ++ ++++ +YM +GSL L+ + L + V++ +A ++Y
Sbjct: 60 HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAY 117
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPEL 264
+ + VHRD+ + NIL+ L VADFG+ARL+ + + R + APE
Sbjct: 118 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 265 AYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-----RAPSPID 318
A T K DV+ FG++ E+ GR P P ++ ++LDQ R P P +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPPE 227
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ D++ C R +P+ RPT
Sbjct: 228 CPESLHDLMC------QCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-21
Identities = 74/258 (28%), Positives = 128/258 (49%), Gaps = 30/258 (11%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156
+G G +G V+ VA+K L E+F EA L+ Q++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYA-V 69
Query: 157 LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVH 216
+ ++ +++I +YM GSL L+ E I+L K +++ +A ++++ + +H
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVVTEK 273
RD+ + NIL++ L +ADFG+ARL+ + + T G + APE T K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 274 CDVFGFGVVALE-VLMGR--HPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTVIQDIIL 328
DV+ FG++ E V GR +PG NP++ I L++ R P P + + +++
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPG----MTNPEV--IQNLERGYRMPRPDNCPEELYELMR 237
Query: 329 VSKIAFACLRSKPKSRPT 346
C + KP+ RPT
Sbjct: 238 ------LCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 72/281 (25%), Positives = 125/281 (44%), Gaps = 47/281 (16%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156
+G G +G VY+AQ + A K+ E+E LE F E +LS+ +H NIV LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 157 LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN------IVKSMAHALSYLHYDC 210
++ ++++ ++ G+L ++I L+ + + + + M AL++LH
Sbjct: 72 FYENKLWILIEFCDGGAL--------DSIMLELERGLTEPQIRYVCRQMLEALNFLHSH- 122
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV 270
++HRD+ + NILL + +ADFGV+ S R GT ++APE+ V
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV----VA 176
Query: 271 TE---------KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ- 320
E K D++ G+ +E+ P NP +L+ + ++ P DQ
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPH---HELNPMRVLLKI--LKSEPPTLDQP 231
Query: 321 ----TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357
+ D + +CL P RPT +P ++
Sbjct: 232 SKWSSSFNDFLK------SCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-21
Identities = 75/268 (27%), Positives = 127/268 (47%), Gaps = 28/268 (10%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR 145
+ E + +G G +G V+ VA+K L ESF EA+++ ++R
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLR 59
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
H +V+LY + ++ ++++ +YM +GSL L+ D E L V++ +A ++Y
Sbjct: 60 HDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPEL 264
+ + +HRD+ S NIL+ L +ADFG+ARL+ + + R + APE
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 265 AYTMVVTEKCDVFGFGVVALE-VLMGRHPGDLLSSFNPKIMLIDLLDQ-----RAPSPID 318
A T K DV+ FG++ E V GR P P + ++L+Q R P P D
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVP-------YPGMNNREVLEQVERGYRMPCPQD 227
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ +++L C + P+ RPT
Sbjct: 228 CPISLHELML------QCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 8/172 (4%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G +G V++A+ +G+ VALKK+ E E + L +H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
H L+ +YM L VLR+++ + K ++ + ++Y+H + I+
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHAN---GIM 121
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAGTHGYIAPELAY 266
HRD+ N+L+++ +ADFG+ARL + + T Y APEL Y
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 7e-21
Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 87 ATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI- 144
T F++ IG G YG VY+A +G++VA+K + E E E + E +L +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYS 60
Query: 145 RHRNIVKLYGFCLHKKC------MFLIYKYMRRGS---LFCVLRNDDEAIQLDWTKRVNI 195
H NI YG + K ++L+ + GS L LR + ++ +W I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--I 118
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
++ L+YLH + ++HRDI NILL E + DFGV+ L S R G
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIG 175
Query: 256 THGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
T ++APE+ + DV+ G+ A+E+ G+ P
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 9e-21
Identities = 83/292 (28%), Positives = 124/292 (42%), Gaps = 64/292 (21%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G YG V + + +G+IVA+KK SE + ++ E ++L Q+RH NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
K ++L+++Y+ R +L +L + D + + + A++Y H +I+
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCHSH---NII 122
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAGTHGYIAPEL-----AYTMV 269
HRDI NIL++ + DFG AR L + ++ T T Y APEL Y
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 270 VTEKCDVFGFGVVALEVLMGR--HPGD----------------------LLSS---FN-- 300
V DV+ G + E+L G PGD L SS F
Sbjct: 183 V----DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 301 --PKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAF----ACLRSKPKSRPT 346
P+ + L++R P VS A ACLR PK R T
Sbjct: 239 AFPEPSQPESLERRYPG------------KVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 66/273 (24%), Positives = 131/273 (47%), Gaps = 30/273 (10%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKL----HHSETELAFLESFQTEARLLSQIRHRNIVK 151
+GTG + S Y+A+ + +G ++A+K++ + S + +E+ + E RL++++ H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVKSMAHALSYLHY 208
+ G L ++M GS+ +L EA+ +++T+++ LSYLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYLHE 121
Query: 209 DCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSN----RTVVAGTHGYIAPE 263
+ I+HRD+ N+L++S + +ADFG A L + + + + GT ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ--T 321
+ CDV+ G V +E+ + P + N ++ + I +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354
++D+ L CL +P+ RP R +P
Sbjct: 239 GLRDVTL------RCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-20
Identities = 68/258 (26%), Positives = 124/258 (48%), Gaps = 24/258 (9%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHH-SETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G+G +G V+ + VA+K + + +E F+E EA+++ ++ H N+V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQLYGV 67
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
C ++ +F++ +YM G L LR + +W +++ + A+ YL + +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FI 122
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---APELAYTMVVTE 272
HRD+++ N L+ V+DFG+AR + D T GT + PE+ +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 273 KCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331
K DV+ FGV+ EV G+ P + S N +++ R P T + I+
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFS--NSEVVESVSAGYRLYRPKLAPTEVYTIM---- 234
Query: 332 IAFACLRSKPKSRPTMRR 349
++C KP+ RP ++
Sbjct: 235 --YSCWHEKPEDRPAFKK 250
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-20
Identities = 61/210 (29%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHS-------ETELAFLESFQTEARLLSQIRHRN 148
IG+G +GSVY SG+++A+K++ + + + L++ E LL +++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
IV+ G L + + +Y+ GS+ +L N + T N V+ + L+YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHN 124
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS------SNRTVVAGTHGYIAP 262
I+HRDI NIL+++K ++DFG+++ L ++S R + G+ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
E+ T K D++ G + +E+L G+HP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 82/294 (27%), Positives = 115/294 (39%), Gaps = 67/294 (22%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSET---------ELAFLESFQTEARLLSQIRH 146
+G G GSV + +L +G I ALK + EL +S +
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK----------S 58
Query: 147 RNIVKLYGFCLHKK-CMFLI-YKYMRRGSLFCVLRNDDEAIQLDWTKRVN------IVKS 198
IVK YG L + I +Y GSL + + R+ I +S
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK-----VKKRGGRIGEKVLGKIAES 113
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-RLLHSDSSNRTVVAGTH 257
+ LSYLH I+HRDI +NILL K + + DFGV+ L++S + T GT
Sbjct: 114 VLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTS 167
Query: 258 GYIAPE----LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ-- 311
Y+APE Y++ DV+ G+ LEV R P P + I+LL
Sbjct: 168 FYMAPERIQGKPYSI----TSDVWSLGLTLLEVAQNRFP--FPPEGEPPLGPIELLSYIV 221
Query: 312 RAPSP--IDDQTV-------IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356
P+P D+ +D I CL P RPT +P I
Sbjct: 222 NMPNPELKDEPGNGIKWSEEFKDFIKQ------CLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-20
Identities = 65/252 (25%), Positives = 122/252 (48%), Gaps = 17/252 (6%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156
+G G +G V+ + VA+K L + ++F EA L+ ++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSV---QAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 157 LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVH 216
++ +++I +YM +GSL L++ DE ++ K ++ +A ++Y+ + +H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIH 126
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTMVVTEKCD 275
RD+ + N+L++ L +ADFG+AR++ + + R + APE T K D
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 276 VFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAF 334
V+ FG++ E++ G+ P +S N +M R P + + DI+
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQRGYRMPRMENCPDELYDIMKT----- 239
Query: 335 ACLRSKPKSRPT 346
C + K + RPT
Sbjct: 240 -CWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 7e-20
Identities = 55/234 (23%), Positives = 96/234 (41%), Gaps = 43/234 (18%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLE----SFQTEARLLSQ 143
+DF IG G + +V A+ + K A+K L + E + E +L++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL---DKRQLIKEKKVKYVKIEKEVLTR 57
Query: 144 I-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKS 198
+ H I+KLY ++ ++ + +Y G L +R D++ +
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-------YAAE 110
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--------- 249
+ AL YLH I+HRD+ NILL+ + + DFG A++L +SS
Sbjct: 111 ILLALEYLH-SK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 250 -----------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GT Y++PEL + D++ G + ++L G+ P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFL-ESFQTEARLLSQIRHRNIVKLYGF 155
IG G +G VY+ L VA+K T L F EA +L Q H NIVKL G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSI 214
C+ K+ ++++ + + GSL LR + +L K + + A + YL +CI
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNCI--- 115
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVV 270
HRD+++ N L+ ++DFG++R + TV G + APE
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 271 TEKCDVFGFGVVALEV 286
T + DV+ +G++ E
Sbjct: 173 TSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-19
Identities = 71/239 (29%), Positives = 118/239 (49%), Gaps = 36/239 (15%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQ----LPSGK--IVALKKLHHSETELAFLESFQTEAR 139
+ D +K+ +G G +G V+ A+ LP +VA+K L + +E A + FQ EA
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQD-FQREAE 59
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRND--DEAI----------QL 187
LL+ ++H++IV+ YG C + + ++++YMR G L LR+ D I QL
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 188 DWTKRVNIVKSMAHALSY---LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
+ + I +A + Y LH+ VHRD+++ N L+ L + DFG++R ++
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173
Query: 245 SDSSNRTVVAGTH----GYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSS 298
S R V G ++ PE T + D++ FGVV E+ G+ P LS+
Sbjct: 174 STDYYR--VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 44/273 (16%)
Query: 89 EDFDIKYCIGTGGYGSV----YRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI 144
++ + IG G +G V YR G VA+K + + T AFL EA +++Q+
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDATAQAFL----AEASVMTQL 56
Query: 145 RHRNIVKLYGFCLHKK-CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
RH N+V+L G + +K ++++ +YM +GSL LR+ ++ L + + A+
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAM 115
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS--DSSNRTVVAGTHGYIA 261
YL + + VHRD+++ N+L++ A V+DFG+ + S D+ V + A
Sbjct: 116 EYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTA 167
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQ-----RAPS 315
PE + K DV+ FG++ E+ GR P P+I L D++ + + +
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYKMDA 220
Query: 316 PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
P V+ D++ C +RP+
Sbjct: 221 PDGCPPVVYDVMK------QCWHLDAATRPSFL 247
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 97 IGTGGYGSVYRAQLPS-GKIVALKKLHHSETEL-AFLESFQTEARLLSQIRHRNIVKLYG 154
I G YG V+ A+ S G I A+K + ++ ++ TE +LSQ + +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
KK ++L+ +Y+ G L +L N DE D + + + AL YLH +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDE----DVAR--IYIAEIVLALEYLHSN-- 112
Query: 212 PSIVHRDISSNNILLNS----KLEAFVADFGVARL----LHSDSSNRTV----VAGTHGY 259
I+HRD+ +NIL++S KL DFG++++ + ++ + GT Y
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKL----TDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
IAPE+ ++ D + G + E L+G P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 4e-19
Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
+DF+ +GTG +G V + SGK ALK L ++ +L +E E R+L IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTK--RVNIVKSMAHALS 204
+V LYG ++L+ +Y+ G LF LR + +V AL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVL----ALE 115
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAPE 263
YLH IV+RD+ N+LL+S + DFG A+ + RT + GT Y+APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAPE 168
Query: 264 L----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+ Y V D + G++ E+L G P
Sbjct: 169 IILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 70/221 (31%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G YG VYRA+ SG+IVALKK+ S E LL +RH NIV+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 156 CL--HKKCMFLIYKYMRR--GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
+ H +FL+ +Y + SL D+ ++ ++ + L YLH +
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKCLMLQLLRGLQYLHENF- 128
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV- 270
I+HRD+ +N+LL K +ADFG+AR + T T Y APEL
Sbjct: 129 --IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 271 TEKCDVFGFGVVALEVLMGR--HPGDLLSSFNPKIMLIDLL 309
T D++ G + E+L + PG S ++I LL
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGK--SEIEQLDLIIQLL 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 53/284 (18%)
Query: 97 IGTGGYGSVYRA-----QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +GSV Q +G++VA+KKL HS E L F+ E +L ++H NIVK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV----NIVKSMAHALSY 205
G C ++ + L+ +Y+ GSL L+ E +LD K + I K M + L
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEY-LGS 126
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---AP 262
Y VHRD+++ NIL+ S+ + DFG+ ++L D V I AP
Sbjct: 127 KRY------VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 263 ELAYTMVVTEKCDVFGFGVVALEV----------------LMGRHPGDLLSSFNPKIMLI 306
E + DV+ FGVV E+ +MG + ++ LI
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH----LI 236
Query: 307 DLL--DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+LL + R P+P I I+ C + P RP+
Sbjct: 237 ELLKNNGRLPAPPGCPAEIYAIMK------ECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-19
Identities = 69/261 (26%), Positives = 117/261 (44%), Gaps = 22/261 (8%)
Query: 97 IGTGGYGSVY--RAQLPSGKIVALKK--LHHSETELAFLESFQTEARLLS-------QIR 145
+G+G +G VY R + ++ALK+ +H+ E ++ ++S Q+R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV-NIVKSMAHALS 204
H NIV+ Y L ++++ + L + E Q +R+ NI M AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
YLH + IVHRD++ NNI+L + + DFG+A+ S T V GT Y PE+
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSCPEI 184
Query: 265 AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324
EK DV+ FG + ++ + P S N + +++ P+ + +
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNMLSLATKIVEAVY-EPLPEGMYSE 240
Query: 325 DIILVSKIAFACLRSKPKSRP 345
D+ V +CL ++RP
Sbjct: 241 DVTDVIT---SCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-19
Identities = 64/257 (24%), Positives = 123/257 (47%), Gaps = 24/257 (9%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHH-SETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+GTG +G V + VA+K + S +E F+E EA+++ ++ H +V+LYG
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLSHEKLVQLYGV 67
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
C ++ ++++ +YM G L LR + Q ++ + + K + ++YL +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFI 122
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVVTE 272
HRD+++ N L++ + V+DFG++R + D +V G+ + PE+ +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLLYSKFSS 180
Query: 273 KCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331
K DV+ FGV+ EV +G+ P + ++ + L P ++ V
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEK--------VYA 232
Query: 332 IAFACLRSKPKSRPTMR 348
I ++C K + RPT +
Sbjct: 233 IMYSCWHEKAEERPTFQ 249
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 7e-19
Identities = 71/280 (25%), Positives = 135/280 (48%), Gaps = 40/280 (14%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKL--------HHSETELAFLESFQTEARLLSQIRHR 147
IG G YG VY A + +G+++A+K++ H + +++ ++E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVKSMAHALS 204
NIV+ GF ++ + + +Y+ GS+ LR +E + +T++V L+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------LEGLA 122
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS----DSSNRTVVAGTHGYI 260
YLH I+HRD+ ++N+L+++ ++DFG+++ S D+ + G+ ++
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWM 177
Query: 261 APEL--AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318
APE+ +Y+ + K D++ G V LE+ GR P + + L ++R+ PI
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFKLGNKRSAPPIP 234
Query: 319 DQTVIQDIILVSKIA----FACLRSKPKSRPTMRRSFPNP 354
+ +S +A AC P +RPT R +P
Sbjct: 235 PDVSMN----LSPVALDFLNACFTINPDNRPTARELLQHP 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 37/230 (16%)
Query: 87 ATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKK-LHHSETELAFLESFQTEARLLSQI 144
D++I +G G +G VY+A Q+ +G++VALKK L H+E + + + + E ++L ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64
Query: 145 RHRNIVKLYGFCLH--------KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIV 196
+H N+V L + + ++++ YM L +L N ++L ++ +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYM 121
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN------- 249
+ ++YLH + I+HRDI + NIL++++ +ADFG+AR N
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 250 ----RTVVAGTHGYIAPELA-----YTMVVTEKCDVFGFGVVALEVLMGR 290
T + T Y PEL YT V D++G G V E+ R
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 33/232 (14%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQL----PSGK--IVALKKLHHSETELAFLESFQTEAR 139
+ D +K +G G +G V+ A+ P+ +VA+K L + LA + FQ EA
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAE 59
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN---------DDEAIQ---- 186
LL+ ++H +IVK YG C + ++++YM+ G L LR D + Q
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 187 LDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
L ++ ++I +A + YL VHRD+++ N L+ + L + DFG++R ++S
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 247 SSNRTVVAGTHG-----YIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHP 292
R G H ++ PE T + DV+ FGV+ E+ G+ P
Sbjct: 177 DYYRV---GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG+G G+VY+ P+G++ ALK ++ + + E +L + H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
H + ++ ++M GSL D++ + ++ + + ++YLH IV
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-------DVARQILSGIAYLHRR---HIV 190
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHS--DSSNRTVVAGTHGYIAPE-----LAYTM 268
HRDI +N+L+NS +ADFGV+R+L D N +V GT Y++PE L +
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHGA 248
Query: 269 VVTEKCDVFGFGVVALEVLMGRHP 292
D++ GV LE +GR P
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 97 IGTGGYGSVYRAQL--PSGK-------IVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+G G +G VY+ +L P+ + I LK+ + + + F+ EA L+S ++H
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ----QEFRQEAELMSDLQHP 68
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSL--FCVLR---------NDDEAIQ--LDWTKRVN 194
NIV L G C ++ ++++Y+ G L F V + DE ++ LD + ++
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 195 IVKSMAHALSYL--HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
I +A + YL H+ VHRD+++ N L+ L ++DFG++R ++S R
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR-- 181
Query: 253 VAGTH----GYIAPELAYTMVVTEKCDVFGFGVVALEV 286
V ++ PE T + D++ FGVV E+
Sbjct: 182 VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 27/266 (10%)
Query: 97 IGTGGYGS--VYR----AQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+G G +G +YR L K V L +L E A E +LS ++H NI+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA-----LNEIVILSLLQHPNII 62
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210
Y + + + +Y G+L+ + + + + + + A+SY+H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA- 120
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV 270
I+HRDI + NI L + DFG++++L S+ S V GT Y++PEL +
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKY 178
Query: 271 TEKCDVFGFGVVALEVLMGRH--PGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328
K D++ G V E+L + + KI+ Q +P+ + I L
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV------QGNYTPVVSVYSSELISL 232
Query: 329 VSKIAFACLRSKPKSRPTMRRSFPNP 354
V + L+ P+ RPT P
Sbjct: 233 VH----SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-18
Identities = 71/260 (27%), Positives = 128/260 (49%), Gaps = 34/260 (13%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156
IG G +G+V + + +G+ VA+K + T AFLE E +++++ H+N+V+L G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQAFLE----ETAVMTKLHHKNLVRLLGVI 68
Query: 157 LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVH 216
LH ++++ + M +G+L LR A+ + + + +A + YL +VH
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 217 RDISSNNILLNSKLEAFVADFGVARL--LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKC 274
RD+++ NIL++ A V+DFG+AR+ + D+S V + APE + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSKS 178
Query: 275 DVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAP----SPIDDQTVIQDIILV 329
DV+ +GV+ EV GR P PK+ L ++ + P + +++
Sbjct: 179 DVWSYGVLLWEVFSYGRAP-------YPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT 231
Query: 330 SKIAFACLRSKPKSRPTMRR 349
S C ++PK RP+ +
Sbjct: 232 S-----CWETEPKKRPSFHK 246
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 6e-18
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQT---EARLLSQIRHRNIVKL 152
+G G Y VY+A +G+IVA+KK+ E + A T E +LL +++H NI+ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
HK + L++++M L V+++ + K + + L YLH +
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK--SYMLMTLRGLEYLHSN--- 121
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-----AYT 267
I+HRD+ NN+L+ S +ADFG+AR S + T T Y APEL Y
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYG 181
Query: 268 MVVTEKCDVFGFGVVALEVLMGRH--PGD 294
+ V D++ G + E+L+ PGD
Sbjct: 182 VGV----DMWSVGCIFAELLLRVPFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 7e-18
Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRH 146
+D + +GTG +G V+ + S ALK + E L + E R+L ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
I++L+ ++ ++++ +Y+ G LF LRN + + + + + AL YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYL 117
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAPELA 265
H IV+RD+ NILL+ + + DFG A+ L +RT + GT Y+APE+
Sbjct: 118 HSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTPEYLAPEVI 170
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIML 305
+ + D + G++ E+L+G P D KI+
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-18
Identities = 70/261 (26%), Positives = 114/261 (43%), Gaps = 24/261 (9%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKK--LHHSETELA--FLESFQTEARLLSQIRHRNIVKL 152
+G G YG+VY G+++A+K+ L S A E Q E LL ++H NIV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
G CL + + +++ GS+ +L + + K K + ++YLH +C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT------VVAGTHGYIAPELAY 266
+VHRDI NN++L + DFG AR L + T + GT ++APE+
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP-IDDQTVIQD 325
K D++ G E+ G+ P L+S + + + R P + D
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238
Query: 326 IILVSKIAFACLRSKPKSRPT 346
I V+ +CL RP+
Sbjct: 239 IDFVT----SCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-18
Identities = 66/252 (26%), Positives = 130/252 (51%), Gaps = 18/252 (7%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156
+G G +G V+ A VA+K + + E+F EA ++ ++H +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHDKLVKLHA-V 69
Query: 157 LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVH 216
+ K+ +++I ++M +GSL L++D E + K ++ +A ++++ + +H
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 125
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTMVVTEKCD 275
RD+ + NIL+++ L +ADFG+AR++ + + R + APE T K D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 276 VFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAF 334
V+ FG++ +E++ GR P +S NP+++ R P P + + +I++
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGYRMPRPENCPEELYNIMM------ 237
Query: 335 ACLRSKPKSRPT 346
C +++P+ RPT
Sbjct: 238 RCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 8e-18
Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 27/182 (14%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR---HRNIVKL 152
IG G YG+VY+A+ L +G+ VALKK+ +E S E LL Q+ H NIV+L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 153 YGFCL-----HKKCMFLIYKYMRRGSLFCVLRN------DDEAIQLDWTKRVNIVKSMAH 201
C + + L+++++ + L L E I+ ++++ +
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-------DLMRQLLR 118
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
+ +LH I VHRD+ NIL+ S + +ADFG+AR+ + + +VV T Y A
Sbjct: 119 GVDFLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-TLWYRA 174
Query: 262 PE 263
PE
Sbjct: 175 PE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 74/275 (26%), Positives = 134/275 (48%), Gaps = 21/275 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
ED + +G G GSV + + +P+G ++A KK+ H + + + E +++ + R
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSP 63
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
IV YG L++ + + ++M GSL + + I ++ + I ++ L+YL+
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGK--IAVAVVEGLTYLY 120
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
+ I+HRDI +NIL+NS+ + + DFGV+ L + ++ V GT Y++PE
Sbjct: 121 N--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV--GTSTYMSPERIQG 176
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHP-----GDLLSSFNPKIMLIDLLDQ--RAPSP-IDD 319
T K DV+ G+ +E+ +G+ P D +P + ++DLL Q + P P +
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP-MGILDLLQQIVQEPPPRLPS 235
Query: 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354
+D+ CL P RPT ++ P
Sbjct: 236 SDFPEDLRDFVDA---CLLKDPTERPTPQQLCAMP 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 64/262 (24%), Positives = 109/262 (41%), Gaps = 19/262 (7%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
DF + +G G YGSVY+ + L + ALK++ E E R+L+ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV-NIVKSMAHALSYLH 207
I+ L + ++ +Y G L + + +L + + I + L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
I+HRD+ S NILL + + D G++++L + + +T + GT Y+APE+
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA-KTQI-GTPHYMAPEVWKG 175
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325
+ K D++ G + E+ P + K+ R P QD
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-------RGKYPPIPPIYSQD 228
Query: 326 IILVSKIAFACLRSKPKSRPTM 347
+ + L+ KPK RP
Sbjct: 229 L---QNFIRSMLQVKPKLRPNC 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 28/191 (14%)
Query: 91 FDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
FDI IG G YG VY+A+ +G++VALKK+ + F + E ++L Q+ HRNI
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 150 VKLY----------GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR--VNIVK 197
V L F K +L+++YM L +L E+ + +++ + +K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL----ESGLVHFSEDHIKSFMK 123
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVV 253
+ L+Y H + +HRDI +NILLN+K + +ADFG+ARL +S+ S N+ +
Sbjct: 124 QLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 254 AGTHGYIAPEL 264
T Y PEL
Sbjct: 180 --TLWYRPPEL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 74/265 (27%), Positives = 110/265 (41%), Gaps = 35/265 (13%)
Query: 97 IGTGGYGSVYRAQL--PSGKI--VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
+G G +G V R + GK+ VA+K L S+ ++ F EA ++ + H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEA---IQLDWTKRVNIVKSMAHALSYLHYD 209
YG L M ++ + GSL LR D I V I M YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR----YLE-- 114
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLL------HSDSSNRTVVAGTHGYIAPE 263
+HRD+++ NILL S + + DFG+ R L + + V + APE
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCAPE 170
Query: 264 LAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIM-LIDLLDQRAPSPIDDQT 321
T + DV+ FGV E+ G P LS +I+ ID +R P
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQILKKIDKEGERLERPEACPQ 228
Query: 322 VIQDIILVSKIAFACLRSKPKSRPT 346
I +++L C P RPT
Sbjct: 229 DIYNVML------QCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 76/275 (27%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 97 IGTGGYGSVYRAQLP------SGKI-VALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
+G+G +G VY SG I VA+K L T+ E F EA L+S H NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHPNI 61
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ----LDWTKRVNIVKSMAHALSY 205
VKL G CL + ++I + M G L LR+ L + ++I +A Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 206 L---HYDCIPSIVHRDISSNNILLNSKLEAF-----VADFGVARLLHSDSSNRTVVAGTH 257
L H+ +HRD+++ N L++ K + DFG+AR ++ R G
Sbjct: 122 LEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 258 G--YIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAP 314
++APE T + DV+ FGV+ E+L +G+ P L++ +++ R
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTAGGRLQ 233
Query: 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
P + I ++ C P RPT R
Sbjct: 234 KPENCPDKIYQLMTN------CWAQDPSERPTFDR 262
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 63/253 (24%), Positives = 122/253 (48%), Gaps = 20/253 (7%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHH-SETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G+G +G V+ + + VA+K ++ + +E F+E EA+++ ++ H +V+LYG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYGV 67
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
C +K ++++ ++M G L LR + D +++ + + + YL + S +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFI 122
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG-THGYIAPELAYTMVVTEKC 274
HRD+++ N L++S V+DFG+ R + D + A + PE+ + K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 275 DVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIA 333
DV+ FGV+ EV G+ P + S++ M+ P V ++
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMT--------VYEVM 234
Query: 334 FACLRSKPKSRPT 346
++C KP+ RPT
Sbjct: 235 YSCWHEKPEGRPT 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 69/268 (25%), Positives = 126/268 (47%), Gaps = 28/268 (10%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR 145
+ E + +G G +G V+ VA+K L + E+F EA+++ ++R
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLR 59
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
H +V LY + ++ ++++ ++M +GSL L+ D L + V++ +A ++Y
Sbjct: 60 HDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAY 117
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPEL 264
+ + +HRD+ + NIL+ L +ADFG+ARL+ + + R + APE
Sbjct: 118 IER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 265 AYTMVVTEKCDVFGFGVVALE-VLMGRHPGDLLSSFNPKIMLIDLLDQ-----RAPSPID 318
A T K DV+ FG++ E V GR P P ++ ++L+Q R P P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVP-------YPGMVNREVLEQVERGYRMPCPQG 227
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ +++ + C + P RPT
Sbjct: 228 CPESLHELMKL------CWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 44/281 (15%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G YG V + + +G+IVA+KK SE + + E R+L Q+RH N+V L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ--LDWTKRVNIVKSMAHALSYLHYDCIPS 213
KK ++L+++++ L +D E LD ++ + + + + H +
Sbjct: 69 FRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHN 120
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-----AYTM 268
I+HRDI NIL++ + DFG AR L + T T Y APEL Y
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 269 VVTEKCDVFGFGVVALEVLMGR--HPGDL---------------------LSSFNPKIML 305
V D++ G + E+L G PGD + NP
Sbjct: 181 AV----DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ L + + P++ + +++ +A CLR P RP+
Sbjct: 237 MRLPEVKEIEPLEKRFPKLSGLVLD-LAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 97 IGTGGYGSVYRAQL-PSGKIVALKKL-HHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154
+G GG+G V ++ + ALK + E E +E +L + H IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214
KK ++++ +Y G L+ +LR + D + + A YLH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR---GI 114
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEK- 273
++RD+ N+LL+S + DFG A+ L S T GT Y+APE ++ K
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-GTPEYVAPE-----IILNKG 168
Query: 274 ----CDVFGFGVVALEVLMGRHP 292
D + G++ E+L GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-17
Identities = 68/263 (25%), Positives = 120/263 (45%), Gaps = 35/263 (13%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKK---LHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
+G+G +GSVY L G A+K+ +T ++ + E LLS+++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKSMAHALSYLHY 208
G + +++ + + GSL +L+ + I+L +T++ I+ L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQ--ILL----GLEYLHD 120
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL---- 264
+ VHRDI NIL+++ +ADFG+A+ + S ++ G+ ++APE+
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK-GSPYWMAPEVIAQQ 176
Query: 265 -AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323
Y + D++ G LE+ G+ P S + + + PI D
Sbjct: 177 GGYGLAA----DIWSLGCTVLEMATGKPP---WSQLEGVAAVFKIGRSKELPPIPDHLSD 229
Query: 324 QDIILVSKIAFACLRSKPKSRPT 346
+ + K CL+ P RPT
Sbjct: 230 EAKDFILK----CLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 85 IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEAR 139
IV+ D KY IG G G+VY A + +G+ VA+K+++ + E E
Sbjct: 11 IVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEIL 68
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
++ + +H NIV L ++++ +Y+ GSL V+ +D + + +
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 124
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
AL +LH + ++HRDI S+NILL + DFG + + S R+ + GT +
Sbjct: 125 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+APE+ K D++ G++A+E++ G P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 34/277 (12%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARL 140
+EI V E +G G YGSVY+ P+G +A+K++ E + + E +
Sbjct: 1 DEIEVLDE-------LGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDI 52
Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMA 200
L + IV YG + +++ +YM GSL + + I ++
Sbjct: 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVV 112
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
L +L + +I+HRD+ N+L+N + + DFGV+ L + + + G Y+
Sbjct: 113 KGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--GCQSYM 168
Query: 261 APE----------LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD 310
APE YT+ + DV+ G+ LE+ +GR+P + N L ++D
Sbjct: 169 APERIKSGGPNQNPTYTV----QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD 224
Query: 311 QRAPS-PIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P+ P QD V+K CL P RPT
Sbjct: 225 GDPPTLPSGYSDDAQD--FVAK----CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 1e-16
Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 30/228 (13%)
Query: 93 IKYCIGTGGYGSVYRAQL----PSGK--IVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+K +G G +G V+ A+ P +VA+K L + + F EA LL+ ++H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQH 66
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR----------NDDEAIQLDWTKRVNIV 196
+IVK YG C+ + ++++YM+ G L LR + +L ++ ++I
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
+ +A + YL VHRD+++ N L+ L + DFG++R ++S R G
Sbjct: 127 QQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV---GG 180
Query: 257 HG-----YIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSS 298
H ++ PE T + DV+ GVV E+ G+ P LS+
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 43/279 (15%)
Query: 97 IGTGGYGSVYRAQLP-----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +G V + +G+ VA+K L+HS E F+ E +L + H NIVK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-GEEQHRSDFEREIEILRTLDHENIVK 70
Query: 152 LYGFC--LHKKCMFLIYKYMRRGSLFCVLR----NDDEAIQLDWTKRVNIVKSMAHALSY 205
G C + + LI +Y+ GSL L+ + L ++ I K M + L
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDY-LGS 127
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---AP 262
Y +HRD+++ NIL+ S+ ++DFG+A++L D V I AP
Sbjct: 128 QRY------IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVL-MGRH----PGDLLSSFNPKIM------LIDLLD- 310
E T + DV+ FGV E+ G P + L L++LL
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 311 -QRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+R P P + D++ + C ++P+ RP+
Sbjct: 242 GERLPRPPSCPDEVYDLMKL------CWEAEPQDRPSFA 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 22/266 (8%)
Query: 97 IGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G YG V + + GK +KKL+ ++ + EA+LLSQ++H NIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 156 CLHKKCM-FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214
+ + +++ + G L+ L+ + + + V +A AL YLH I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHEK---HI 123
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKC 274
+HRD+ + N+ L V D G+AR+L + + + GT Y++PEL K
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183
Query: 275 DVFGFGVVALEVLMGRHPGDLLSSFNPKIM---LIDLLDQRAPS-PIDDQTVIQDIILVS 330
DV+ G E+ +H +FN K M + +++ + P P D + ++I
Sbjct: 184 DVWALGCCVYEMATLKH------AFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA-- 235
Query: 331 KIAFACLRSKPKSRPTMRRSFPNPEI 356
L +P+ RP+++ P I
Sbjct: 236 ----TMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 48/286 (16%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALK--KLHHSETELAFLESFQTEARLLSQIR 145
EDF++ IG+G YG VY+A+ + +G++ A+K KL E Q E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED----FAVVQQEIIMMKDCK 64
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
H NIV +G L + +++ ++ GSL + L ++ + + L Y
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYY 121
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
LH +HRDI NILL +ADFGV+ + + + R GT ++APE+A
Sbjct: 122 LHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 266 YTMVVTEK------CDVFGFGVVALEV------LMGRHPGDLL-----SSFNPKIMLIDL 308
V K CD++ G+ A+E+ + HP L S+F P
Sbjct: 179 ---AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP------- 228
Query: 309 LDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354
P D K+A L PK RPT + +P
Sbjct: 229 -----PKLKDKMKWSNSFHHFVKMA---LTKNPKKRPTAEKLLQHP 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 27/240 (11%)
Query: 91 FDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRN 148
F++ +G G YG VY+ + + +G++ A+K + +E E E + E +L + HRN
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKKYSHHRN 74
Query: 149 IVKLYGFCL------HKKCMFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAH 201
I YG + H ++L+ ++ GS+ +++N A++ DW I + +
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILR 132
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
L++LH ++HRDI N+LL E + DFGV+ L R GT ++A
Sbjct: 133 GLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189
Query: 262 PELAYT-----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316
PE+ + D++ G+ A+E+ G P L +P M L R P P
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP---LCDMHP--MRALFLIPRNPPP 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRA--QLPSGKIVALK-KLHHSETELAFLESFQTEARLLS 142
+ ED + CIG G +G VY+ P + +A+ K + T + E F EA ++
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHA 202
Q H +IVKL G ++++ + G L L+ + LD + ++ A
Sbjct: 63 QFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTA 119
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAGTHGYIA 261
L+YL VHRDI++ N+L++S + DFG++R L +S + + ++A
Sbjct: 120 LAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLM-GRHP 292
PE T DV+ FGV E+LM G P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 45/230 (19%)
Query: 92 DIKYC--IGTGGYGSVYRAQLPS------GKIVALKKLHHSETELAFLESFQTEARLLSQ 143
+I+Y IG G +G V++A+ P +VA+K L E FQ EA L+++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAE 64
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN-------------------DDEA 184
H NIVKL G C K M L+++YM G L LR+
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 185 IQLDWTKRVNIVKSMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
+ L T+++ I K +A ++YL + VHRD+++ N L+ + +ADFG++R
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 242 LLHSD-----SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEV 286
++S S N + ++ PE + T + DV+ +GVV E+
Sbjct: 179 NIYSADYYKASENDAIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 50/282 (17%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALK--KLHHSETELAFLESFQTEARLLSQIR 145
D+++ +G+G YG VY+A+ L +G++ A+K KL + Q E ++ + +
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD----FSLIQQEIFMVKECK 64
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
H NIV +G L ++ +++ +Y GSL + +L + + + L+Y
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAY 121
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
LH +HRDI NILL + +ADFGVA + + + R GT ++APE+A
Sbjct: 122 LHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178
Query: 266 YTMVVTEK-------CDVFGFGVVALEV------LMGRHPGDLL-----SSFNPKIMLID 307
EK CD++ G+ A+E+ + HP L S+F P
Sbjct: 179 ----AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP----K 230
Query: 308 LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
L D+ S + + +S L PK RPT R
Sbjct: 231 LKDKTKWSS-----TFHNFVKIS------LTKNPKKRPTAER 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 9e-16
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G YG V++ + +G+IVA+KK SE + + E R+L Q++H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKSMAHALSYLH-YDC 210
K+ + L+++Y L + +N + I+ I+ A+++ H ++C
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCHKHNC 121
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-----A 265
I HRD+ NIL+ + + + DFG AR+L + T T Y APEL
Sbjct: 122 I----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 266 YTMVVTEKCDVFGFGVVALEVLMG 289
Y V DV+ G V E+L G
Sbjct: 178 YGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 35/197 (17%)
Query: 91 FDIKYCIGTGGYGSVYRAQL---PSGKIVALKKLHHSETELAFLESFQTEAR---LLSQI 144
++I+ CIG G YG VY+A+ GK A+KK + + + Q+ R LL ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS--QSACREIALLREL 59
Query: 145 RHRNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV--NIVKSMA 200
+H N+V L L K ++L++ Y L+ +++ +A + ++VKS+
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLL 114
Query: 201 ----HALSYLHYDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSD-----S 247
+ + YLH + ++HRD+ NIL+ + + D G+ARL ++
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 248 SNRTVVAGTHGYIAPEL 264
+ VV T Y APEL
Sbjct: 172 LDPVVV--TIWYRAPEL 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 27/240 (11%)
Query: 91 FDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRN 148
F++ +G G YG VY+ + + +G++ A+K + + E E + E +L + HRN
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 64
Query: 149 IVKLYGFCLHKKC------MFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAH 201
I YG + K ++L+ ++ GS+ +++N ++ +W I + +
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILR 122
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
LS+LH ++HRDI N+LL E + DFGV+ L R GT ++A
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179
Query: 262 PELAYT-----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316
PE+ K D++ G+ A+E+ G P L +P L L R P+P
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMHPMRAL--FLIPRNPAP 234
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 7/193 (3%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G +G V+ + K+V +K++ + + Q E ++L + H NI++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
L K + ++ +Y G+L ++ ++ LD ++ + AL ++H I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTK---LIL 123
Query: 216 HRDISSNNILLNS-KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKC 274
HRD+ + NILL+ K+ + DFG++++L S S TVV GT YI+PEL +K
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPELCEGKPYNQKS 182
Query: 275 DVFGFGVVALEVL 287
D++ G V E+
Sbjct: 183 DIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 14/213 (6%)
Query: 85 IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEAR 139
IV+ D KY IG G G+V+ A + +G+ VA+K+++ + E E
Sbjct: 11 IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK--ELIINEIL 68
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
++ ++++ NIV L +F++ +Y+ GSL V+ +D + + +
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCREC 124
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
AL +LH + ++HRDI S+N+LL + DFG + + S R+ + GT +
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+APE+ K D++ G++A+E++ G P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 34/210 (16%)
Query: 96 CIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQT-----EARLLSQI-RHRN 148
+G G +GSVY A+ +G++VA+KK+ S++ E + L ++ H N
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKK------FYSWEECMNLREVKSLRKLNEHPN 59
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH- 207
IVKL ++ +++YM G+L+ +++ D + + +I+ + L+++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMK-DRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 208 --YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL- 264
+ HRD+ N+L++ +ADFG+AR + S T T Y APE+
Sbjct: 118 HGF------FHRDLKPENLLVSGPEVVKIADFGLAREIRS-RPPYTDYVSTRWYRAPEIL 170
Query: 265 ----AYTMVVTEKCDVFGFGVVALEVLMGR 290
+Y+ V D++ G + E+ R
Sbjct: 171 LRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 27/272 (9%)
Query: 91 FDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
F + +G G +GSV AQL S + VA+K L + +E F EA + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 147 RNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCVL---RNDDEAIQLDWTKRVNIVK 197
N++KL G L + +I +M+ G L L R +E L V +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
+A + YL + +HRD+++ N +LN + VADFG+++ ++S R A
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 258 --GYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAP 314
++A E V T DV+ FGV E++ G+ P + N +I + R
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYNYLIKGNRLK 235
Query: 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P D + +++ C +PK RP+
Sbjct: 236 QPPDCLEDVYELM------CQCWSPEPKCRPS 261
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 73/237 (30%), Positives = 109/237 (45%), Gaps = 36/237 (15%)
Query: 89 EDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEAR-LLSQIRH 146
+DFD+K +G G +G V + +G I A+K + S SF E R +LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRN-----DDEAIQLDWTKRVNIVKSMA 200
I +L Y F K ++L+ +Y G L +L D++ Q + V + S+
Sbjct: 61 PWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV- 118
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA----GT 256
H + Y VHRDI N+L++ +ADFG A L ++N+ V + GT
Sbjct: 119 HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARL---TANKMVNSKLPVGT 166
Query: 257 HGYIAPELAYTMVVTEK------CDVFGFGVVALEVLMGRHP---GDLLSSFNPKIM 304
YIAPE+ TM K CD + GV+A E++ GR P G ++N IM
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN-NIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
++++ I G YG VYRA+ +G+IVALKKL + + F + E +L +++H
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 148 NIVKL----YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
NIV + G L K ++++ +Y+ L ++ + K ++ + +
Sbjct: 65 NIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQLLSGV 119
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
++LH + I+HRD+ ++N+LLN++ + DFG+AR S T + T Y APE
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPE 176
Query: 264 LAY-TMVVTEKCDVFGFGVVALEVLMGR 290
L + D++ G + E+L +
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 89 EDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLH---HSETELAFLESFQTEARLLSQI 144
D IG G G V A +G+ VA+KK+ EL F E ++
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-----NEVVIMRDY 73
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVL---RNDDEAIQLDWTKRVNIVKSMAH 201
+H NIV++Y L ++++ +++ G+L ++ R ++E I + ++
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------ATVCLAVLK 126
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
ALS+LH ++HRDI S++ILL S ++DFG + + R + GT ++A
Sbjct: 127 ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE+ + + D++ G++ +E++ G P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHH---SETELAFLESFQTEARLLSQIRHRNIVKLY 153
IG+G +G V+ + VA+K + SE E F EA+++ ++ H +V+LY
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE------EDFIEEAQVMMKLSHPKLVQLY 65
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
G C + + L++++M G L LR + + + + + ++YL
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVV 270
++HRD+++ N L+ V+DFG+ R + D T GT + +PE+
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 271 TEKCDVFGFGVVALEVLM-GRHPGD 294
+ K DV+ FGV+ EV G+ P +
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 91 FDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
++I IG G +G +Y A+ S + +K++ ++ + E+ + E LL++++H NI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 150 VKLYGFCLHKKCMFLIYKY-----------MRRGSLFCVLRNDDEAIQLDWTKRVNIVKS 198
V + +F++ +Y +RG LF E L W ++++
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF------SEDQILSWFVQISL--- 112
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTVVAGTH 257
L ++H I+HRDI S NI L+ + A + DFG+AR L+ GT
Sbjct: 113 ---GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166
Query: 258 GYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y++PE+ K D++ G V E+ +HP
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 64/241 (26%)
Query: 97 IGTGGYGSVYRAQ------LPSGKIVALKKLHH--SETEL-AFLESFQTEARLLSQIRHR 147
+G G +G V +A VA+K L S +EL L F LL Q+ H
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN----LLKQVNHP 63
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR----------------------NDDE-- 183
+++KLYG C + LI +Y + GSL LR N DE
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 184 -----AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238
I W I + M + L+ + +VHRD+++ N+L+ + ++DFG
Sbjct: 124 LTMGDLISFAW----QISRGMQY-LAEM------KLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 239 VARLLHSD------SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRH 291
++R ++ + S R V ++A E + + T + DV+ FGV+ E++ +G +
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228
Query: 292 P 292
P
Sbjct: 229 P 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 65/270 (24%), Positives = 99/270 (36%), Gaps = 67/270 (24%)
Query: 116 VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL- 174
VA+K L ++ A E F E ++LS++ NI +L G C + +I +YM G L
Sbjct: 49 VAVKVLRPDASDNA-REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 175 ----FCVLRNDDEAIQLDWTKR-------VNIVKSMAHALSYLHYDCIPSIVHRDISSNN 223
V A I M + L L++ VHRD+++ N
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRY-LESLNF------VHRDLATRN 160
Query: 224 ILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVVTEKCDVFGF 279
L+ +ADFG++R L+S R V G ++A E T K DV+ F
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYR--VQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218
Query: 280 GVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQTVIQDIIL---------- 328
GV E+L L + P + DQ VI++
Sbjct: 219 GVTLWEILT--------------------LCREQPYEHLTDQQVIENAGHFFRDDGRQIY 258
Query: 329 ----------VSKIAFACLRSKPKSRPTMR 348
+ ++ C R + RPT R
Sbjct: 259 LPRPPNCPKDIYELMLECWRRDEEDRPTFR 288
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 4e-15
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 85 IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEAR 139
IV+ D KY IG G G+VY A + +G+ VA+K+++ + E E
Sbjct: 11 IVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK--ELIINEIL 68
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
++ + ++ NIV L ++++ +Y+ GSL V+ +D + + +
Sbjct: 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 124
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
AL +LH + ++HRDI S+NILL + DFG + + S R+ + GT +
Sbjct: 125 LQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+APE+ K D++ G++A+E++ G P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 74/259 (28%), Positives = 112/259 (43%), Gaps = 40/259 (15%)
Query: 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYR-AQLPSGKIVALKKLHH-SETELAFLESFQT 136
+ E + T+ ++I IG G YG VY+ G + A+K L S+ + E +
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD----EEIEA 67
Query: 137 EARLLSQI-RHRNIVKLYG-FCLHKKC----MFLIYKYMRRGS--------LFCVLRNDD 182
E +L + H N+VK YG F K ++L+ + GS L C R D+
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 183 EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242
I I+ L +LH + I+HRD+ NNILL ++ + DFGV+
Sbjct: 128 AMISY-------ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 243 LHSDSSNRTVVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLS 297
L S R GT ++APE+ Y +CDV+ G+ A+E+ G P L
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP---LF 234
Query: 298 SFNPKIMLIDLLDQRAPSP 316
+P L + R P P
Sbjct: 235 DMHPVKTLFKI--PRNPPP 251
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 69/263 (26%), Positives = 119/263 (45%), Gaps = 36/263 (13%)
Query: 97 IGTGGYGSVYRAQLPS-GKIVALKKLHHS---ETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G +G V+ +L + VA+K + + + FL+ EAR+L Q H NIV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ----EARILKQYSHPNIVRL 58
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
G C K+ ++++ + ++ G LR E +L + + +V++ A + YL
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH-- 114
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-------YIAPE-L 264
+HRD+++ N L+ K ++DFG++R V A T G + APE L
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 265 AYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323
Y +E DV+ FG++ E +G P LS+ + + ++Q P +
Sbjct: 169 NYGRYSSES-DVWSFGILLWEAFSLGAVPYANLSNQQTR----EAIEQGVRLPCPELCPD 223
Query: 324 QDIILVSKIAFACLRSKPKSRPT 346
V ++ C P RP+
Sbjct: 224 A----VYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+DF+ +G G G V + PSG I+A +KL H E + A E ++L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIRNQIIRELKVLHECNSP 59
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV--NIVKSMAHA--- 202
IV YG + + ++M GSL VL+ R+ NI+ ++ A
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---------AGRIPENILGKISIAVLR 110
Query: 203 -LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
L+YL I+HRD+ +NIL+NS+ E + DFGV+ L +N V GT Y++
Sbjct: 111 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMS 166
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE T + D++ G+ +E+ +GR+P
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 23/266 (8%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156
+G G +G VY+A+ +A K+ +++E LE + E +L+ H IVKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 157 LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVH 216
++++ ++ G++ ++ D + + I + M AL YLH I+H
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ--VICRQMLEALQYLHSM---KIIH 133
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE---- 272
RD+ + N+LL + +ADFGV+ R GT ++APE+ + +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 273 -KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP---SPIDDQTVIQDIIL 328
K D++ G+ +E+ P L NP +L+ + P P +D +
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHEL---NPMRVLLKIAKSEPPTLSQPSKWSMEFRDFL- 249
Query: 329 VSKIAFACLRSKPKSRPTMRRSFPNP 354
K A L P++RP+ + +P
Sbjct: 250 --KTA---LDKHPETRPSAAQLLEHP 270
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 96 CIGTGGYGSVYRA-QLPSGKIVALKKLH------HSETELAFLESFQTEARLLSQIRHRN 148
+G G +G VY + +G+ +A+K++ ++ E+ LE E +LL ++H
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC---EIQLLKNLQHER 65
Query: 149 IVKLYGFCLHKKCMFLIY-KYMRRGSLFCVLRND---DEAIQLDWTKRVNIVKSMAHALS 204
IV+ YG CL I+ +YM GS+ L+ E + +T+++ +
Sbjct: 66 IVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVE 118
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL---HSDSSNRTVVAGTHGYIA 261
YLH + IVHRDI NIL +S + DFG ++ L S + V GT +++
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE+ K DV+ G +E+L + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 29/234 (12%)
Query: 97 IGTGGYGSVYRA-QLPSGKIV----ALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G+G +G+VY+ +P G+ V A+K L+ + A +E F EA +++ + H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 73
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ----LDWTKRVNIVKSMAHALSYLH 207
L G CL + L+ + M G L + + I L+W V I K M YL
Sbjct: 74 LLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQIAKGMM----YLE 126
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYIAPELA 265
+VHRD+++ N+L+ S + DFG+ARLL D G ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 266 YTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLD--QRAPSP 316
+ T + DV+ +GV E++ G P D + P + DLL+ +R P P
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI----PTREIPDLLEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 72/274 (26%), Positives = 115/274 (41%), Gaps = 27/274 (9%)
Query: 97 IGTGGYGSVYRAQLPSGKI---VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLY 153
+G G +GSV QL VA+K + + + +E F +EA + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 154 GFCLHKK------CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
G CL +I +M+ G L L + +VK M S +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPELA 265
Y S +HRD+++ N +LN + VADFG+++ +++ R + +IA E
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186
Query: 266 YTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTV 322
V T K DV+ FGV E+ G+ P + N +I D L Q R P D
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIY--DYLRQGNRLKQPPDCLDG 242
Query: 323 IQDIILVSKIAFACLRSKPKSRP---TMRRSFPN 353
+ ++ +C PK RP T+R
Sbjct: 243 LYSLM------SSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 52/200 (26%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKL---HHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G G V A + SG+ VA+K + EL F E ++ +H+N+V++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHQNVVEM 83
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
Y L + ++++ ++++ G+L ++ +L+ + + +S+ AL YLH
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ--- 136
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE 272
++HRDI S++ILL ++DFG + D R + GT ++APE+
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 273 KCDVFGFGVVALEVLMGRHP 292
+ D++ G++ +E++ G P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 71/270 (26%), Positives = 117/270 (43%), Gaps = 42/270 (15%)
Query: 97 IGTGGYGSVYRAQL-------PSGKIVALKKL----HHSETELAFLESFQTEARLLSQI- 144
+G G +G V A K VA+K L H SE E + +E +++S +
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMK-VAVKMLKPTAHSSERE-----ALMSELKIMSHLG 96
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
H NIV L G C + +I +Y G L LR E+ L ++ +A ++
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMA 155
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYI 260
+L + +HRD+++ N+LL + DFG+AR + +DS+ VV G ++
Sbjct: 156 FLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN--YVVKGNARLPVKWM 210
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVL---MGRHPGDLL-SSFNPKIMLIDLLDQRAPSP 316
APE + V T + DV+ +G++ E+ +PG + S F I + Q +P
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAP 270
Query: 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ + I C + P RPT
Sbjct: 271 AE----------IYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 85 IVATEDFDIKYC----IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEAR 139
IV+ D KY IG G G+VY A + +G+ VA+++++ + E E
Sbjct: 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEIL 69
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
++ + ++ NIV L ++++ +Y+ GSL V+ +D + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 125
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
AL +LH + ++HRDI S+NILL + DFG + + S R+ + GT +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+APE+ K D++ G++A+E++ G P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 75/272 (27%), Positives = 120/272 (44%), Gaps = 32/272 (11%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQ---TE 137
EEI V + IG G +G+VY A + ++VA+KK+ +S + E +Q E
Sbjct: 20 EEIFVGLHE------IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN--EKWQDIIKE 71
Query: 138 ARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVK 197
+ L Q++H N ++ G L + +L+ +Y GS +L + +Q + I
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQ--EVEIAAITH 128
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
L+YLH + +HRDI + NILL + +ADFG A S SS GT
Sbjct: 129 GALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFVGTP 181
Query: 258 GYIAPELAYTMVVTE---KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP 314
++APE+ M + K DV+ G+ +E L R P L + N L + +P
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPP--LFNMNAMSALYHIAQNDSP 238
Query: 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ ++ CL+ P+ RP
Sbjct: 239 TLQSNEWTDS----FRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 72/269 (26%), Positives = 116/269 (43%), Gaps = 33/269 (12%)
Query: 97 IGTGGYGSVYRAQL--PSGKI--VALKKLH---HSETELAFLESFQTEARLLSQIRHRNI 149
+G G +GSV QL G VA+K + H+ +E+ E F +EA + H N+
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI---EEFLSEAACMKDFDHPNV 63
Query: 150 VKLYGFCLHKKCM------FLIYKYMRRGSLFCVL---RNDDEAIQLDWTKRVNIVKSMA 200
+KL G C + +I +M+ G L L R +L + + +A
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--G 258
+ YL + +HRD+++ N +L + VADFG+++ ++S R
Sbjct: 124 LGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317
+IA E V T K DV+ FGV E+ G+ P + N +I R P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHEIYDYLRHGNRLKQPE 238
Query: 318 DDQTVIQDIILVSKIAFACLRSKPKSRPT 346
D + D++ ++C R+ PK RPT
Sbjct: 239 DCLDELYDLM------YSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 97 IGTGGYGSV-YRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G+G YG+V +G VA+KKL+ F + E RLL ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 156 CLHKKCM------FLIYKYMRR--GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
+ +L+ +M G L + ++ IQ +V M L Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYIH 135
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
I+HRD+ N+ +N E + DFG+AR +DS V T Y APE+
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV-TRWYRAPEVILN 189
Query: 268 -MVVTEKCDVFGFGVVALEVLMGR 290
M T+ D++ G + E+L G+
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 7/204 (3%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+DF+ +G G G V + Q ++ +KL H E + A E ++L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
IV YG + + ++M GSL VL+ + + I + +V+I ++ L+YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK-EAKRIPEEILGKVSI--AVLRGLAYLRE 121
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
I+HRD+ +NIL+NS+ E + DFGV+ L +N V GT Y++PE
Sbjct: 122 K--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQGT 177
Query: 269 VVTEKCDVFGFGVVALEVLMGRHP 292
+ + D++ G+ +E+ +GR+P
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 59/266 (22%), Positives = 115/266 (43%), Gaps = 29/266 (10%)
Query: 97 IGTGGYGSVYRAQLPSG------KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+G G +G V+ A+ +V +K L ++ E E F+ E + ++ H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-FRRELDMFRKLSHKNVV 71
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ------LDWTKRVNIVKSMAHALS 204
+L G C + ++I +Y G L LR + L ++V + +A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS---NRTVVAGTHGYIA 261
+L VHRD+++ N L++S+ E V+ +++ +++ ++ ++A
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR--WLA 186
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320
PE + K DV+ FGV+ EV G P + + +L L + P+ +
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP---FYGLSDEEVLNRLQAGKLELPVPEG 243
Query: 321 TVIQDIILVSKIAFACLRSKPKSRPT 346
+ + K+ C PK RP+
Sbjct: 244 CPSR----LYKLMTRCWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 14/224 (6%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156
+G G +G VY+AQ ++A K+ +++E LE + E +L+ H NIVKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 157 LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVH 216
++ ++++ ++ G++ V+ + + + V K AL+YLH + I+H
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV--CKQTLEALNYLHEN---KIIH 126
Query: 217 RDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE---- 272
RD+ + NIL + +ADFGV+ R GT ++APE+ +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 273 -KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPS 315
K DV+ G+ +E+ P L NP +L+ + P+
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHEL---NPMRVLLKIAKSEPPT 227
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 97 IGTGGYGSVYRAQL-PSGKIVALKKL---HHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G G V A + SGK+VA+KK+ EL F E ++ +H N+V++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 82
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVL---RNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
Y L ++++ +++ G+L ++ R ++E I + ++ ALS LH
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLHAQ 135
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
++HRDI S++ILL ++DFG + + R + GT ++APEL +
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 270 VTEKCDVFGFGVVALEVLMGRHP 292
+ D++ G++ +E++ G P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 38/221 (17%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVALKKLHHS---ETELAFLESFQTEARLLSQIRHR 147
+G G +G VY VA+K L S + E FL EA ++S+ H+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL----MEALIMSKFNHQ 69
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR----NDDEAIQLDWTKRVNIVKSMAHAL 203
NIV+L G + F++ + M G L LR + L + + +A
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 204 SYL---HYDCIPSIVHRDISSNNILLNSKLE---AFVADFGVARLLHSDSSNRTVVAGTH 257
YL H+ +HRDI++ N LL K A +ADFG+AR ++ S R G
Sbjct: 130 KYLEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK---GGR 180
Query: 258 G-----YIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
++ PE + T K DV+ FGV+ E+ +G P
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG+G YG V A +G+ VA+KK+ + +L + E +LL +RH NI+ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 156 CLHKKCM-----FLIYKYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKSMAHALSYL 206
+++ + M L V+++ D+ IQ + + L YL
Sbjct: 68 LRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQY-------FLYQILRGLKYL 119
Query: 207 HYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-----VVAGTHGY 259
H S ++HRD+ +NIL+NS + + DFG+AR + D + VV T Y
Sbjct: 120 H-----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV--TRWY 172
Query: 260 IAPELAYTMVVTEKC----DVFGFGVVALEVLMGRH--PG 293
APEL ++ + + D++ G + E+L + PG
Sbjct: 173 RAPEL---LLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 62/258 (24%), Positives = 114/258 (44%), Gaps = 30/258 (11%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHH---SETELAFLESFQTEARLLSQIRHRNIVKLY 153
+G G +G V++ L VA+K E ++ FL +EAR+L Q H NIVKL
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFL----SEARILKQYDHPNIVKLI 58
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIP 212
G C ++ ++++ + + G LR + ++ + V A ++YL +CI
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI- 115
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARL----LHSDSSNRTVVAGTHGYIAPELAYTM 268
HRD+++ N L+ ++DFG++R ++S S + + + APE
Sbjct: 116 ---HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYG 169
Query: 269 VVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327
+ + DV+ +G++ E +G P +++ + + P D
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDD------- 222
Query: 328 LVSKIAFACLRSKPKSRP 345
V K+ C KP++RP
Sbjct: 223 -VYKVMQRCWDYKPENRP 239
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 32/208 (15%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G+G YGSV A +G+ VA+KKL F + E LL ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 156 CLHKKCM------FLIYKYMR------RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
+L+ YM+ G ++ +Q +V M L
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPL-----SEDKVQY-------LVYQMLCGL 130
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
Y+H I+HRD+ N+ +N E + DFG+AR H+D+ V T Y APE
Sbjct: 131 KYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV-TRWYRAPE 184
Query: 264 LAYT-MVVTEKCDVFGFGVVALEVLMGR 290
+ M + D++ G + E+L G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 30/267 (11%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQ---TEARLLSQIRHRNIVKL 152
IG G +G+VY A+ + + ++VA+KK+ +S + E +Q E R L Q+RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
G L + +L+ +Y GS +L + +Q + I L+YLH
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEV--EIAAICHGALQGLAYLHSHER- 136
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM---V 269
+HRDI + NILL +ADFG A L+ +N V GT ++APE+ M
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLV--SPANSFV--GTPYWMAPEVILAMDEGQ 190
Query: 270 VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP--SPIDDQTVIQDII 327
K DV+ G+ +E+ + P L + N L + +P S D ++ +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247
Query: 328 LVSKIAFACLRSKPKSRPTMRRSFPNP 354
+CL+ P+ RP+ +
Sbjct: 248 D------SCLQKIPQDRPSSEELLKHR 268
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 73/226 (32%), Positives = 110/226 (48%), Gaps = 50/226 (22%)
Query: 91 FDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEAR-------LLS 142
++I +G G YG V++A + ++VALKK+ AF T+A+ L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD-----AF--RNATDAQRTFREIMFLQ 61
Query: 143 QIR-HRNIVKLYGFCLHK----KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVK 197
++ H NIVKL + K K ++L+++YM L V+R + I D KR I+
Sbjct: 62 ELGDHPNIVKLLN--VIKAENDKDIYLVFEYMET-DLHAVIRAN---ILEDVHKRY-IMY 114
Query: 198 SMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--- 252
+ AL Y+H S ++HRD+ +NILLNS +ADFG+AR L N
Sbjct: 115 QLLKALKYIH-----SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 253 ---VAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGR 290
VA T Y APE+ YT V D++ G + E+L+G+
Sbjct: 170 TDYVA-TRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKL---HHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G G V A + +GK VA+KK+ EL F E ++ H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHENVVDM 84
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVL---RNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
Y L ++++ +++ G+L ++ R ++E I + S+ ALSYLH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------ATVCLSVLRALSYLHNQ 137
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
++HRDI S++ILL S ++DFG + + R + GT ++APE+ +
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194
Query: 270 VTEKCDVFGFGVVALEVLMGRHP 292
+ D++ G++ +E++ G P
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 97 IGTGGYGSVYR---AQLPSGKI---VALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+G G +G VY + G+ VA+K ++ + + +E F EA ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLR----NDDEA---IQLDWTKRVNIVKSMAHAL 203
+L G + ++ + M +G L LR + K + + +A +
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG----- 258
+YL VHRD+++ N ++ L + DFG+ R ++ R G G
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK---GGKGLLPVR 186
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVL 287
++APE V T K DV+ FGVV E+
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 66/254 (25%), Positives = 111/254 (43%), Gaps = 21/254 (8%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRH 146
+DF+I IG G +G V ++ +G++ A+K L+ E + A F+ E +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMA-HALSY 205
R I L+ + ++L+ Y G L +L ++ + D + +A ++
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHGYIAPEL 264
L Y VHRDI +N+LL+ +ADFG L +D + ++ VA GT YI+PE+
Sbjct: 121 LGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 265 AYTM-----VVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIM----LIDLLDQRA 313
M +CD + GV E+L G P + L KIM
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234
Query: 314 PSPIDDQTVIQDII 327
+ + +I+ +I
Sbjct: 235 DVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 91 FDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLES-FQTEARLLSQIRHRN 148
+DI IG GG G VY A P + VALKK+ +E L+ F EA++ + + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
IV +Y C ++ Y+ +L +L++ + L +K + S+ LS H
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHK 121
Query: 209 DC-----IPS--IVHRDISSNNILLNSKLEAFVADFGVA---------------RLLHSD 246
C + S ++HRD+ +NILL E + D+G A +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 247 SSNRTV---VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
S+ T+ + GT Y+APE + +E D++ GV+ ++L P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 35/224 (15%)
Query: 97 IGTGGYGSVYRAQL-------PSGKI-VALKKLHHSETELAFLESFQTEARLLSQI-RHR 147
+G G +G V A+ P + VA+K L TE L +E ++ I +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-LSDLVSEMEMMKMIGKHK 81
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSL---------------FCVLRNDDEAIQLDWTKR 192
NI+ L G C +++I +Y +G+L + + R DE Q+ +
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE--QMTFKDL 139
Query: 193 VNIVKSMAHALSYL-HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
V+ +A + YL CI HRD+++ N+L+ +ADFG+AR +++ +
Sbjct: 140 VSCTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 252 VVAGTH--GYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
G ++APE + V T + DV+ FGV+ E+ +G P
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 70/257 (27%), Positives = 117/257 (45%), Gaps = 26/257 (10%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQ---TEARLLSQIRHRNIVKL 152
IG G +G+VY A+ + + ++VA+KK+ +S + E +Q E + L +I+H N ++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
G L + +L+ +Y GS +L + +Q + I L+YLH
Sbjct: 91 KGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ--EVEIAAITHGALQGLAYLHSH--- 144
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE 272
+++HRDI + NILL + +ADFG A + +S GT ++APE+ M +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQ 200
Query: 273 ---KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILV 329
K DV+ G+ +E+ + P FN M + SP D
Sbjct: 201 YDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESPTLQSNEWSDYF-- 253
Query: 330 SKIAFACLRSKPKSRPT 346
+CL+ P+ RPT
Sbjct: 254 RNFVDSCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 70/262 (26%), Positives = 124/262 (47%), Gaps = 24/262 (9%)
Query: 92 DIKY--CIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
DI+Y +G G G+VY+A L + +I+A+K + T + + +E +L +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPY 60
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
I+ YG + + + ++M GSL V R E + V +VK + + S
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-DVYRKIPE--HVLGRIAVAVVKGLTYLWSL--- 114
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
I+HRD+ +N+L+N++ + + DFGV+ L +S +T V GT+ Y+APE
Sbjct: 115 ----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYV-GTNAYMAPERISGE 168
Query: 269 VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL----DQRAPSPIDDQTVIQ 324
DV+ G+ +E+ +GR P + +M + LL D+ P Q +
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228
Query: 325 DIILVSKIAFACLRSKPKSRPT 346
+ +++ C+R +PK RP
Sbjct: 229 FVHFITQ----CMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 36/279 (12%)
Query: 84 IIVATEDFDIKYCIGTGGYGSVYRA-QLPSG---KI-VALKKLHHSETELAFLESFQTEA 138
I+ TE IK +G+G +G+VY+ +P G KI VA+K+L + + A E EA
Sbjct: 3 ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EA 60
Query: 139 RLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS 198
+++ + + ++ +L G CL LI + M G L +R + I + +N
Sbjct: 61 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQ 117
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH- 257
+A ++YL +VHRD+++ N+L+ + + DFG+A+LL +D G
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 258 -GYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLD--QRA 313
++A E + T + DV+ +GV E++ G P D + P + +L+ +R
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILEKGERL 230
Query: 314 PSP----IDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
P P ID V I C SRP R
Sbjct: 231 PQPPICTID----------VYMIMVKCWMIDADSRPKFR 259
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 4e-13
Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 33/271 (12%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLH------HSETELAFLESFQTEARLLSQIRHRNI 149
+G G +G VY + +G+ +A K++ + E++ LE E +LL ++H I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALE---CEIQLLKNLQHERI 66
Query: 150 VKLYGFCLH---KKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVKSMAHAL 203
V+ YG CL +K + + +YM GS+ L+ E++ +T+++ +
Sbjct: 67 VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGM 119
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT---VVAGTHGYI 260
SYLH + I VHRDI NIL +S + DFG ++ L + + T V GT ++
Sbjct: 120 SYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320
+PE+ K DV+ G +E+L + P + + + + Q +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP---WAEYEAMAAIFKIATQPTNPQLPSH 233
Query: 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSF 351
+ I F R +P + +R F
Sbjct: 234 ISEHARDFLGCI-FVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 53/284 (18%)
Query: 97 IGTGGYGSVYRAQL-----PSGKI-VALKKLHHSETELAFLESFQTEARLLSQI-RHRNI 149
+G G +G V +A+ P+ VA+K L TE + +E ++ I +H+NI
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHKNI 78
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----------NDDEAIQLDWTKR--VNIV 196
+ L G C + ++++ +Y G+L LR +D + T++ V+
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 197 KSMAHALSYL-HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS-DSSNRTVVA 254
+A + +L CI HRD+++ N+L+ +ADFG+AR +H D +T
Sbjct: 139 YQVARGMEFLASKKCI----HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT--- 191
Query: 255 GTHG-----YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI---MLI 306
T+G ++APE + V T + DV+ FGV+ E+ L S P I L
Sbjct: 192 -TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT------LGGSPYPGIPVEELF 244
Query: 307 DLLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
LL + R P Q Q+ + + C P RPT +
Sbjct: 245 KLLKEGYRMEKP---QNCTQE---LYHLMRDCWHEVPSQRPTFK 282
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 97 IGTGGYGSVYRA---QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLY 153
+G+G +G+V + S K VA+K L + + A + EA ++ Q+ + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
G C + M L+ + G L L+ + + + T+ V+ V SM + YL +
Sbjct: 63 GICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQV-SMG--MKYLEET---N 115
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPELAYTM 268
VHRD+++ N+LL ++ A ++DFG+++ L +D + A THG + APE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNYY 173
Query: 269 VVTEKCDVFGFGVVALE 285
+ K DV+ FGV+ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 97 IGTGGYGSVYRAQLPSGKI-VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G YG VY A+ S ++ +A+K++ E + +++ E L S ++HRNIV+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRN------DDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
+ + + GSL +LR+ D+E + +TK++ L YLH +
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLHDN 127
Query: 210 CIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
IVHRDI +N+L+N+ ++DFG ++ L + GT Y+APE
Sbjct: 128 ---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE----- 179
Query: 269 VVTEK--------CDVFGFGVVALEVLMGRHP 292
V +K D++ G +E+ G+ P
Sbjct: 180 -VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 19/202 (9%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEAR-LLSQIRHRNIVKLY 153
I G +GSVY A+ +G A+K L S+ + + + E ++ Q + KLY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 154 GFCLHKKCMFLIYKYMRRG---SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210
K ++L+ +Y+ G SL L E DW K + + + LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE----DWAK--QYIAEVVLGVEDLHQR- 116
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV 270
I+HRDI N+L++ + DFG++R N+ V GT Y+APE +
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFV-GTPDYLAPETILGVGD 170
Query: 271 TEKCDVFGFGVVALEVLMGRHP 292
+ D + G V E L G P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 26/257 (10%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQ---TEARLLSQIRHRNIVKL 152
IG G +G+VY A+ + + ++VA+KK+ +S + E +Q E R L ++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
G L + +L+ +Y GS +L + +Q + + L+YLH
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ--EVEIAAVTHGALQGLAYLHSH--- 134
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE 272
+++HRD+ + NILL+ + DFG A ++ + GT ++APE+ M +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQ 190
Query: 273 ---KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILV 329
K DV+ G+ +E L R P FN M + SP +
Sbjct: 191 YDGKVDVWSLGITCIE-LAERKP----PLFNMNAMSALYHIAQNESPALQSGHWSEYF-- 243
Query: 330 SKIAFACLRSKPKSRPT 346
+CL+ P+ RPT
Sbjct: 244 RNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLH-HSETELAFLESFQTEARLLSQIRHRNIVKLYG 154
IG G YG VY+A+ +G++VALKK+ +ETE + E LL ++ H NIVKL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTK----RVNIVKS----MAHALSYL 206
+ ++L+++++ + D +D + + ++KS + L++
Sbjct: 67 VIHTENKLYLVFEFL----------HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LA 265
H ++HRD+ N+L+N++ +ADFG+AR T T Y APE L
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
+ D++ G + E++ R PGD
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 24/263 (9%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+++ +G G +G Q + S + A+K++ ++ A +E + EA LL++++H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA-VEDSRKEAVLLAKMKHPN 59
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDD-----EAIQLDWTKRVNIVKSMAHAL 203
IV ++++ +Y G L ++ E L W M +
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGV 113
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
++H ++HRDI S NI L + + DFG ARLL S + GT Y+ PE
Sbjct: 114 QHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323
+ M K D++ G + E+ +HP S N LI + Q + P+
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----LILKVCQGSYKPLPSHYSY 226
Query: 324 QDIILVSKIAFACLRSKPKSRPT 346
+ L+ ++ + P+SRP+
Sbjct: 227 ELRSLIKQM----FKRNPRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHR 147
DF++ +GTG +G V A+ +G+ A+K L E ++ ++ E +L ++ H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
IV + + ++ + +++ G LF LR + N V HA L
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--------RFPNDVAKFYHAELVLA 130
Query: 208 YDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAPEL 264
++ + S I++RD+ N+LL++K V DFG A+ + +RT + GT Y+APE+
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEV 186
Query: 265 AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+ + D + GV+ E + G P
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLL---SQIRHRNIVKL 152
IG G YG+VY+A+ P SG VALK + E S E LL H NIV+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 153 YGFCLHKKC-----MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
C + + L+++++ + + + + + K ++++ L +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFLH 125
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
+CI VHRD+ NIL+ S + +ADFG+AR ++S T V T Y APE+
Sbjct: 126 ANCI---VHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 268 MVVTEKCDVFGFGVVALEVL 287
D++ G + E+
Sbjct: 182 STYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 89 EDFDIKYCIGTGGYGSVYR-AQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+DF+ +G G G V++ + PSG I+A +KL H E + A E ++L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
IV YG + + ++M GSL VL+ I +V+I ++ L+YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSI--AVIKGLTYLR 120
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
I+HRD+ +NIL+NS+ E + DFGV+ L +N V GT Y++PE
Sbjct: 121 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPERLQG 176
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHP 292
+ + D++ G+ +E+ +GR+P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 9e-13
Identities = 59/188 (31%), Positives = 88/188 (46%), Gaps = 33/188 (17%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKK-LHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154
IG G +G V++A+ + +IVALKK L +E E F + E ++L ++H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIE 78
Query: 155 FCLHKKCMFLIYKYMRRGSLFCV-----------LRNDDEAIQLDWTKRVNIVKSMAHAL 203
C K + YK GS + V L N + L K+V +K + + L
Sbjct: 79 ICRTKATPYNRYK----GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV--MKMLLNGL 132
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-------SNRTVVAGT 256
Y+H + I+HRD+ + NIL+ +ADFG+AR +NR V T
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV---T 186
Query: 257 HGYIAPEL 264
Y PEL
Sbjct: 187 LWYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 73/270 (27%), Positives = 116/270 (42%), Gaps = 40/270 (14%)
Query: 97 IGTGGYGSVYRAQL----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G +G VY L A+K L+ T+L +E F E ++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 153 YGFCLHKKCMFLI-YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM-------AHALS 204
G CL + L+ YM+ G L +R++ VK + A +
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGME 112
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----Y 259
YL VHRD+++ N +L+ VADFG+AR ++ D +V T +
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIY-DKEYYSVHNHTGAKLPVKW 168
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318
+A E T T K DV+ FGV+ E++ G P + SF+ + L+ +R P
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQPEY 226
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ +++L +C KP+ RPT
Sbjct: 227 CPDPLYEVML------SCWHPKPEMRPTFS 250
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 97 IGTGGYG-SVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G +G ++ GK +K+++ S+ E + E +LS ++H NIV+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 156 CLHKKCMFLIYKYMRRGSLFC-------VLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
++++ Y G L+ VL +D+ LDW ++ + AL ++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI--LDWFVQICL------ALKHVHD 119
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
I+HRDI S NI L + DFG+AR+L+S GT Y++PE+
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176
Query: 269 VVTEKCDVFGFGVVALEVLMGRH 291
K D++ G V E+ +H
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 97 IGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQ---TEARLLSQIRHRNIVKL 152
+G GG+G V Q+ +GK+ A KKL ++ L + ++ E R+L+++ R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKL--NKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 153 -YGFCLHKKCMFLIYKYMRRGSL-FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210
Y F K + L+ M G L + + D+E + + L +LH
Sbjct: 59 AYAF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL----AY 266
I++RD+ N+LL++ ++D G+A L S AGT G++APEL Y
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHP 292
V D F GV E++ R P
Sbjct: 175 DFSV----DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 71/254 (27%), Positives = 114/254 (44%), Gaps = 27/254 (10%)
Query: 90 DFDIKYCIGTGGYGSVYRAQLPSG----KIVALKKLHHSE--TELAFLESFQTEARLLSQ 143
+F++ +GTG YG V+ + SG K+ A+K L + + E +TE ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 144 IRHRN-IVKL-YGFCLHKKCMFLIYKYMRRGSLFCVL----RNDDEAIQLDWTKRVNIVK 197
IR +V L Y F K + LI Y+ G LF L R ++ +Q+
Sbjct: 61 IRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKEQEVQI-------YSG 112
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGT 256
+ AL +LH I++RDI NILL+S + DFG+++ H D R GT
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 257 HGYIAPELAYTMVV--TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID-LLDQRA 313
Y+AP++ + D + GV+ E+L G P + N + + +L
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 229
Query: 314 PSPIDDQTVIQDII 327
P P + + +DII
Sbjct: 230 PYPQEMSALAKDII 243
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 47/230 (20%)
Query: 97 IGTGGYGSVYRAQL----------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-R 145
+G G +G V RA+ V + K + ++ +LA L S E L+ I +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLIS---EMELMKLIGK 76
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSL---------------FCVLRNDDEAIQLDWT 190
H+NI+ L G C + +++I +Y +G+L F + + +E QL +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE--QLSFK 134
Query: 191 KRVNIVKSMAHALSYLHYD-CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH----- 244
V+ +A + YL CI HRD+++ N+L+ +ADFG+AR +H
Sbjct: 135 DLVSCAYQVARGMEYLESRRCI----HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 245 -SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
S+ R V ++APE + V T + DV+ FG++ E+ +G P
Sbjct: 191 KKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSG-KIVALKKLHHSET-ELAFLESFQTEARLLSQIRH 146
EDF+I IG G +G V +L + K+ A+K L+ E + A F+ E +L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTK----RVNIVKSMAHA 202
+ I L+ + ++L+ Y G L +L ++ + D + + I H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-RLLHSDSSNRTVVAGTHGYIA 261
L Y VHRDI +NIL++ +ADFG +L+ + +V GT YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 262 PELAYTMV-----VTEKCDVFGFGVVALEVLMGRHP 292
PE+ M +CD + GV E+L G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 3e-12
Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 19/152 (12%)
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
+ N +KLY K LI Y++ G LF +L+ + + L + I++ + AL+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALND 124
Query: 206 LHYDCIPSIVHRDISSNNILLN-SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
LH +I+H DI N+L + +K ++ D+G+ +++ + S GT Y +PE
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPE- 176
Query: 265 AYTMVVTEKCDV-FGF---GVVALEVLMGRHP 292
+ DV F + GV+ E+L G+HP
Sbjct: 177 ---KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSG-KIVALKKLHHSET-ELAFLESFQTEARLLSQIRH 146
+DF+I IG G +G V ++ +I A+K L+ E + A F+ E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMA-HALSY 205
+ I L+ + ++L+ Y G L +L ++ + D + +A H++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHGYIAPEL 264
LHY VHRDI +N+LL+ +ADFG ++ D + ++ VA GT YI+PE+
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 265 AYTM-----VVTEKCDVFGFGVVALEVLMGRHP 292
M +CD + GV E+L G P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 9/199 (4%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQ-TEARLLSQIRHRNIVKL-Y 153
+G GG+G V Q+ +GK+ A KKL + E E ++L ++ R IV L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
F K + L+ M G L + N E + + + L +LH
Sbjct: 61 AF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR---R 115
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEK 273
IV+RD+ N+LL+ ++D G+A L AGT GY+APE+ V
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 274 CDVFGFGVVALEVLMGRHP 292
D F G E++ GR P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEAR------- 139
+F I+ IG G + VY+A L G++VALKK+ E +AR
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-------IFEMMDAKARQDCLKEI 53
Query: 140 -LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV-NIVK 197
LL Q+ H N++K + + ++ + G L ++++ + +L + +
Sbjct: 54 DLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV 113
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
+ AL ++H I+HRDI N+ + + + D G+ R S ++ + GT
Sbjct: 114 QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 258 GYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y++PE + K D++ G + E+ + P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+G +G VY+ L + VA+K L + E E F+ EA + S+++H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSL--FCVLR---------NDDEAIQ--LDWTKRVNIVK 197
L G ++ + +I+ Y L F V+R +DD+ ++ L+ V+IV
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 198 SMAHALSYL--HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
+A + +L H+ +VH+D+++ N+L+ KL ++D G+ R ++ +++ + G
Sbjct: 132 QIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVY--AADYYKLMG 184
Query: 256 TH----GYIAPELAYTMVVTEKCDVFGFGVVALEVL 287
+++PE + D++ +GVV EV
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 47/282 (16%)
Query: 92 DIKY--CIGTGGYGSVYRAQLPSGKI---VALKKLHHSETELAFLESFQTEARLLSQI-R 145
DIK+ IG G +G V +A++ + A+K++ ++ F E +L ++
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGH 66
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN-------------DDEAIQLDWTKR 192
H NI+ L G C H+ ++L +Y G+L LR + A L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 193 VNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
++ +A + YL +HRD+++ NIL+ A +ADFG++R
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVY 177
Query: 253 VAGTHG-----YIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP--GDLLSSFNPKIM 304
V T G ++A E V T DV+ +GV+ E++ +G P G + K+
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237
Query: 305 LIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
L++ P DD+ V + C R KP RP+
Sbjct: 238 QGYRLEK--PLNCDDE--------VYDLMRQCWREKPYERPS 269
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 93 IKYCIGTGGYGSVYRA--QLPSGK--IVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
I+ +GTG +G + R +LPS + VA+ L ++ F EA L Q H N
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRR-GFLAEALTLGQFDHSN 67
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
IV+L G M ++ +YM G+L LR + QL + + ++ +A + YL
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSE 125
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFG-----VARLLHSDSSNRTVVAGTHGYIAPE 263
VH+ ++++ +L+NS L ++ F + +++ S ++ V + APE
Sbjct: 126 ---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPE 178
Query: 264 LAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
+ DV+ FG+V EV+ G P
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G YG VY+A+ + + +ALKK+ + + + E LL +++H NIV+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLD----WTKRVNIVKS----MAHALSYLH 207
+K ++L+++Y+ + D +D + K ++K+ + ++Y H
Sbjct: 70 VHSEKRLYLVFEYL----------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPEL-- 264
++HRD+ N+L++ + A +ADFG+AR T T Y APE+
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 265 ---AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
Y+ V D++ G + E++ + PGD
Sbjct: 177 GSRHYSTPV----DIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 41/280 (14%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKI---VALKKLHHSETELAFLESFQTEARLLSQI- 144
ED + IG G +G V RA + + A+K L +E F E +L ++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH-RDFAGELEVLCKLG 60
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRND-----DEAIQLD------WTKRV 193
H NI+ L G C ++ +++ +Y G+L LR D A + T +
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ- 119
Query: 194 NIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
+++ + + + Y +HRD+++ N+L+ L + +ADFG++R V
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEVYV 173
Query: 254 AGTHG-----YIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP--GDLLSSFNPKIML 305
T G ++A E V T K DV+ FGV+ E++ +G P G + K+
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP 345
+++ P DD+ V ++ C R +P RP
Sbjct: 234 GYRMEK--PRNCDDE--------VYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 32/221 (14%)
Query: 97 IGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G +G +Y+ L ++VA+K L + E FQ EA L++++ H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNIVC 71
Query: 152 LYGFCLHKKCMFLIYKYMRRGSL--FCVLR----------NDDEAIQ--LDWTKRVNIVK 197
L G ++ + ++++Y+ +G L F ++R ++D ++ LD ++I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 198 SMAHALSYL--HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
+A + YL H+ VH+D+++ NIL+ +L ++D G++R ++S R V
Sbjct: 132 QIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR-VQPK 185
Query: 256 TH---GYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
+ ++ PE + D++ FGVV E+ G P
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-12
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G Y +VY+ + +GK+VALK + E E + + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
K+ + L+++Y+ L + + + K + + LSY+H I+
Sbjct: 72 IHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL--FLFQLLRGLSYIHQR---YIL 125
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKC- 274
HRD+ N+L++ E +ADFG+AR S + T Y P++ C
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCL 185
Query: 275 DVFGFGVVALEVLMG 289
D++G G + +E++ G
Sbjct: 186 DMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 45/220 (20%)
Query: 97 IGTGGYGSVYRAQLPSGKI-VALKKLHHSETELAFLESFQT---------EARLLSQIRH 146
+G+G YG V A VA+KKL FQ+ E RLL + H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL---------SRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 147 RNIVKLYG-FC-----LHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVK 197
N++ L F + ++L+ M L +++ D+ IQ +V
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQF-------LVY 125
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
+ L Y+H I+HRD+ +NI +N E + DFG+AR H+D VA T
Sbjct: 126 QILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEMTGYVA-TR 179
Query: 258 GYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGR--HPGD 294
Y APE+ M + D++ G + E+L G+ PG
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 47/149 (31%), Positives = 77/149 (51%), Gaps = 13/149 (8%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G YG+V++A+ + +IVALK++ + + S E LL +++H+NIV+LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 156 CLHKKCMFLIYKYMRRG--SLFCVLRNDDEAIQLDWTKRVNIVKS-MAHALSYLHYDCIP 212
K + L+++Y + F D + IVKS M L L +
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP---------EIVKSFMFQLLKGLAFCHSH 118
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVAR 241
+++HRD+ N+L+N E +ADFG+AR
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 90 DFDIKY----CIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI 144
D +Y IG+G YG V A SGK VA+KK+ H+ + E ++L
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 145 RHRNIVKLYGFCLHK----KCMFLIYKYMRRGSLFCVLRND----DEAIQLDWTKRVNIV 196
+H NI+ + K ++++ M L ++ +D +E I+ +
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRY-------FL 113
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR----TV 252
+ L Y+H + +HRD+ +N+L+N E + DFG+AR L S + T
Sbjct: 114 YQLLRGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 253 VAGTHGYIAPELAYTMV-VTEKCDVFGFGVVALEVLMGRH--PG 293
T Y APEL ++ T D++ G + E+L R PG
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 64/234 (27%), Positives = 100/234 (42%), Gaps = 49/234 (20%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQT------------EARLLSQ 143
+G G YG V +A +GKIVA+KK+ E + Q E +++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
I+H NI+ L + + L+ M L V+ D I+L ++ I+ + + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV---DRKIRLTESQVKCILLQILNGL 132
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT------------ 251
+ LH +HRD+S NI +NSK +ADFG+AR + T
Sbjct: 133 NVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 252 ----VVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
VV T Y APEL Y D++ G + E+L G+ PG+
Sbjct: 190 MTSKVV--TLWYRAPELLMGAEKY----HFAVDMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 52/288 (18%)
Query: 89 EDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+ IG G YG V A P+G VA+KK+ E + + + E ++L + +H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHE 63
Query: 148 NIVKLY------GFCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVKS 198
NI+ + F ++++ + M L+ +++ ++ IQ +
Sbjct: 64 NIIGILDIIRPPSFESFND-VYIVQELMET-DLYKLIKTQHLSNDHIQY-------FLYQ 114
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL---LHSDSSNRTVVAG 255
+ L Y+H +++HRD+ +N+LLN+ + + DFG+AR+ H + T
Sbjct: 115 ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 256 THGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGR--HPG-DLLSSFNPKIMLI- 306
T Y APE+ YT + D++ G + E+L R PG D L ++ LI
Sbjct: 172 TRWYRAPEIMLNSKGYTKAI----DIWSVGCILAEMLSNRPLFPGKDYLH----QLNLIL 223
Query: 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKP-KSRPTMRRSFPN 353
+L PS D +I S A ++S P K + + FPN
Sbjct: 224 GVLG--TPSQEDLNCII------SLRARNYIKSLPFKPKVPWNKLFPN 263
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-11
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 45/274 (16%)
Query: 97 IGTGGYGSVYRAQLPSGKI---VALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKL 152
IG G +G V +A++ + A+K++ ++ F E +L ++ H NI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINL 61
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRND-------------DEAIQLDWTKRVNIVKSM 199
G C H+ ++L +Y G+L LR A L + ++ +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG- 258
A + YL +HRD+++ NIL+ A +ADFG++R V T G
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGR 172
Query: 259 ----YIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP--GDLLSSFNPKIMLIDLLDQ 311
++A E V T DV+ +GV+ E++ +G P G + K+ L++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232
Query: 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP 345
P DD+ V + C R KP RP
Sbjct: 233 --PLNCDDE--------VYDLMRQCWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 97 IGTGGYGSVYRA--QLPSGKI-VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLY 153
+G+G +G V + ++ +I VA+K L +E E + + EA ++ Q+ + IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLK-NENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
G C + M L+ + G L L + I + N+V+ M + Y +
Sbjct: 62 GVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLEGKN 115
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG-----YIAPELAYTM 268
VHRD+++ N+LL ++ A ++DFG+++ L +D S A + G + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINFR 173
Query: 269 VVTEKCDVFGFGVVALEVL-MGRHP 292
+ + DV+ +G+ E G+ P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHR 147
DF I +G GGYG V+ A+ +G+IVALK++ S L + TE +L+ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 148 NIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRN-----DDEAIQLDWTKRVNIVKSMAH 201
+VKL Y F + ++L +Y+ G +L N +D A R + + M
Sbjct: 62 WLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-------RFYMAE-MFE 112
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR----LLHSDSSNRTVVAGTH 257
A+ LH +HRD+ N L+++ + DFG+++ +S V G+
Sbjct: 113 AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-------VVGSP 162
Query: 258 GYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y+APE+ D + G + E L G P
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 97 IGTGGYGSVYRAQL------PSGKI--VALKKLHHSETELAFLESFQTEARLLSQI-RHR 147
+G G +G V A+ ++ VA+K L TE L +E ++ I +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHK 84
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSL-------------FCVLRNDDEAIQLDWTKRVN 194
NI+ L G C +++I +Y +G+L +C QL + V+
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 195 IVKSMAHALSYL-HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS-DSSNRTV 252
+A + YL CI HRD+++ N+L+ +ADFG+AR +H D +T
Sbjct: 145 CAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT- 199
Query: 253 VAGTHG-----YIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
T+G ++APE + + T + DV+ FGV+ E+ +G P
Sbjct: 200 ---TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-11
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQT--EARLLSQIRHRNIVKL- 152
+G G +G V + SGK A+K L E +A E T E+R+L RH + L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
Y F + F++ +Y+ G LF L + + D T+ + AL YLH
Sbjct: 62 YSFQTKDRLCFVM-EYVNGGELFFHL-SRERVFSEDRTRFYG--AEIVSALDYLHSG--- 114
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE 272
IV+RD+ N++L+ + DFG+ + +D++ GT Y+APE+
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 273 KCDVFGFGVVALEVLMGRHP 292
D +G GVV E++ GR P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 73/284 (25%), Positives = 125/284 (44%), Gaps = 49/284 (17%)
Query: 97 IGTGGYGSVYRAQL-------PSGKI-VALKKLHHSETELAFLESFQTEARLLSQI-RHR 147
+G G +G V A+ P+ + VA+K L T+ L +E ++ I +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHK 78
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRND-----DEAI--------QLDWTKRVN 194
NI+ L G C ++++ +Y +G+L LR D + QL + V+
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 195 IVKSMAHALSYL-HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS-DSSNRTV 252
+A + YL CI HRD+++ N+L+ +ADFG+AR +H+ D +T
Sbjct: 139 CAYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT- 193
Query: 253 VAGTHG-----YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID 307
T+G ++APE + V T + DV+ FGV+ E+ G P L
Sbjct: 194 ---TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---LGGSPYPGIPVEELFK 247
Query: 308 LLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
LL + R P ++ ++ + C + P RPT ++
Sbjct: 248 LLKEGHRMDKP---ANCTHELYMIMR---ECWHAVPSQRPTFKQ 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 40/259 (15%)
Query: 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKL---HHSETELAFLESF 134
I F+ ++ ++I IG G YG V++ +G A+K L H + E+
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI------ 61
Query: 135 QTEARLLSQIR-HRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCVLRNDDEAIQLD 188
+ E +L + H N+VK YG K ++L+ + GS+ +++ L
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG-----FLK 116
Query: 189 WTKRVN--IVKSMAH----ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242
+R+ I+ + H L +LH + +HRD+ NNILL ++ + DFGV+
Sbjct: 117 RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173
Query: 243 LHSDSSNRTVVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLS 297
L S R GT ++APE+ +CDV+ G+ A+E+ G P L+
Sbjct: 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP---LA 230
Query: 298 SFNPKIMLIDLLDQRAPSP 316
+P L + R P P
Sbjct: 231 DLHPMRALFKI--PRNPPP 247
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLH---HSETELAFLESFQTEARLLSQIRHRNIVKL 152
+G G +G VY +G+ +A+K++ S + + + E +LL + H IV+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 153 YGFCLH---KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
YG CL ++ + + ++M GS+ L++ A+ + T++ + + +SYLH +
Sbjct: 70 YG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYT--RQILEGVSYLHSN 125
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS---DSSNRTVVAGTHGYIAPELAY 266
I VHRDI NIL +S + DFG ++ L + + V GT +++PE+
Sbjct: 126 MI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHP 292
K D++ G +E+L + P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 24/155 (15%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLH-HSETELAFLESFQTEARLLSQIRHRNIVKLYG 154
IG G YG VY+A+ +G+IVALKK+ +E E + + E LL ++ H NIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLD 65
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV----NIVKS----MAHALSYL 206
+ ++L+++++ + D +D + ++KS + ++Y
Sbjct: 66 VVHSENKLYLVFEFL----------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
H ++HRD+ N+L++ + +ADFG+AR
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 65/235 (27%), Positives = 107/235 (45%), Gaps = 36/235 (15%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL----PSGKIVALKKLHHSE----TELAFLESFQTEARL 140
EDFD+ IG G +G V QL S ++ A+K L E ++ AF F E +
Sbjct: 43 EDFDVIKVIGRGAFGEV---QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF---FWEERDI 96
Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTK--RVNIVKS 198
++ IV+L+ K ++++ +YM G L ++ N D I W + +V +
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLA 154
Query: 199 MA--HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA-G 255
+ H++ + +HRD+ +N+LL+ +ADFG + ++ R A G
Sbjct: 155 LDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205
Query: 256 THGYIAPELAYTMVVT----EKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIM 304
T YI+PE+ + +CD + GV E+L+G P D L KIM
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKI--VALKKLHHSET-ELAFLESFQTEARLLSQIR 145
EDF+ +GTG +G V A + VA+K+ S+ + ++ +E ++L+ I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV-NIVKSMAHALS 204
H V LYG + ++L+ +++ G F LR + KR N V A
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN---------KRFPNDVGCFYAAQI 140
Query: 205 YLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIA 261
L ++ + S IV+RD+ N+LL+ + DFG A+++ + RT + GT YIA
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----RTYTLCGTPEYIA 196
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE+ + + D + G+ E+L+G P
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 60/261 (22%), Positives = 115/261 (44%), Gaps = 15/261 (5%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHR 147
+F I+ IG G + VYRA L G VALKK+ + + E LL Q+ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV-NIVKSMAHALSYL 206
N++K Y + + ++ + G L ++++ + +L K V + AL ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H ++HRDI N+ + + + D G+ R S ++ + GT Y++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324
K D++ G + E+ + P GD ++ ++ L ++Q P+ +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS----LCKKIEQCDYPPLPSDHYSE 235
Query: 325 DIILVSKIAFACLRSKPKSRP 345
++ ++ C+ P+ RP
Sbjct: 236 EL---RQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 97 IGTGGYGSVY---------RAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+G G +G+VY +L K + + +L+ +ET A E A+LLS++ H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE-----AQLLSKLDHP 62
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
IVK + L + +I +Y L C L + + + L +H
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT--LSENQVCEWFIQLLLGVH 120
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
Y I+HRD+ + NI L + L + DFGV+RLL T GT Y++PE
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 268 MVVTEKCDVFGFGVVALEVLMGRH 291
K D++ G + E+ H
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAH 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G Y +VY+ + +G+IVALK++H E + + E L+ +++H NIV+L+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 156 CLHKKCMFLIYKYMRRG-SLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL----SYLHYDC 210
+ + L+++YM + + A+ N VKS + L ++ H +
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTHGVRGALDP------NTVKSFTYQLLKGIAFCHEN- 119
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLH---SDSSNRTVVAGTHGYIAPE-LAY 266
++HRD+ N+L+N + E +ADFG+AR + SN V T Y AP+ L
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLG 174
Query: 267 TMVVTEKCDVFGFGVVALEVLMGR 290
+ + D++ G + E++ GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 91 FDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
F++ +G G YG V + + + +IVA+KK SE E+ E ++L ++ NI
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
V+L + ++L+++Y+ + L + + K + + + A+ + H +
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWCHKN 119
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVAR-LLHSDSSNRTVVAGTHGYIAPELAYTM 268
IVHRDI N+L++ + DFG AR L ++N T T Y +PEL
Sbjct: 120 ---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 269 VVTEKCDVFGFGVVALEVLMGR--HPGD 294
+ D++ G + E+ G+ PG+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 66/252 (26%), Positives = 104/252 (41%), Gaps = 62/252 (24%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQT-----EARLLS 142
+DF+ IG G +G V Q +G I A+KKL SE LE Q E +L+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE----MLEKEQVAHVRAERDILA 56
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDD----EAIQLDWTKRVNIVKS 198
+ + +VKLY + ++LI +Y+ G + +L D E + + + + S
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS---------- 248
+ H L Y +HRDI +N+LL++K ++DFG+ L
Sbjct: 117 I-HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 249 ------------------------NRTVVA----GTHGYIAPELAYTMVVTEKCDVFGFG 280
NR +A GT YIAPE+ ++CD + G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 281 VVALEVLMGRHP 292
V+ E+L+G P
Sbjct: 227 VIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 13/150 (8%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G YG VY+ + +G+IVA+KK+ E + E LL +++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS----MAHALSYLHYDCI 211
+ + ++LI+++ L L+ +++ +VKS + + + H
Sbjct: 68 LMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-- 120
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVAR 241
++HRD+ N+L+++K +ADFG+AR
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 136 TEARLLSQIRHRNIVKLYG-FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN 194
TEA +L I H +I++L G F +K ++ +Y + L+C L D +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAICDI---LA 186
Query: 195 IVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-V 253
I +S+ A+ YLH + I+HRDI + NI +N + + DFG A ++N+
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 254 AGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP--------GDLLSSFNPKIML 305
AGT APEL D++ G+V E+ GD S + +I L
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS--DRQIKL 301
Query: 306 IDLLDQRAPS--PIDDQTVIQDIILVSKIAFACLRS--KPKSRPT 346
I P+ PID Q + +I + +S KP SRP
Sbjct: 302 IIRRSGTHPNEFPIDAQANLDEIYIGL-----AKKSSRKPGSRPL 341
|
Length = 391 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 77/266 (28%), Positives = 119/266 (44%), Gaps = 35/266 (13%)
Query: 97 IGTGGYGSVYRA-QLPSG---KI-VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G+G +G+VY+ +P G KI VA+K L + + A E EA +++ + + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAGVGSPYVCR 73
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ----LDWTKRVNIVKSMAHALSYLH 207
L G CL L+ + M G L +R + + I L+W V I K M SYL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGM----SYLE 126
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH--GYIAPELA 265
+VHRD+++ N+L+ S + DFG+ARLL D + G ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 266 YTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLD--QRAPSPIDDQTV 322
T + DV+ +GV E++ G P D + P + DLL+ +R P P
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI----PAREIPDLLEKGERLPQPPICT-- 237
Query: 323 IQDIILVSKIAFACLRSKPKSRPTMR 348
I V I C + RP R
Sbjct: 238 ----IDVYMIMVKCWMIDSECRPRFR 259
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 64/280 (22%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQ--IRHR-----N 148
+G G YG V + + +P+G I+A+K++ + + S Q + RLL I R
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRAT------VNS-QEQKRLLMDLDISMRSVDCPY 61
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ------LDWTKRV------NIV 196
V YG +F R G ++ + D ++ D + I
Sbjct: 62 TVTFYG------ALF------REGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIA 109
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
S+ AL YLH S++HRD+ +N+L+N + + DFG++ L DS +T+ AG
Sbjct: 110 VSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGC 166
Query: 257 HGYIAPEL--------AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDL 308
Y+APE Y + K DV+ G+ +E+ GR P D S P L +
Sbjct: 167 KPYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYD--SWKTPFQQLKQV 220
Query: 309 LDQRAPS-PIDDQTV-IQDIILVSKIAFACLRSKPKSRPT 346
+++ +P P + + QD + CL+ K RP
Sbjct: 221 VEEPSPQLPAEKFSPEFQDFVNK------CLKKNYKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-11
Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 13/127 (10%)
Query: 100 GGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159
G YG +++ + V LK L S + ESF A ++SQ+ H+++V YG C+
Sbjct: 20 GDYGELHKTE------VLLKVLDKSHRN--YSESFFEAASMMSQLSHKHLVLNYGVCVCG 71
Query: 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDI 219
++ +Y++ GSL L+ + I + W ++ + K +A AL +L + H ++
Sbjct: 72 DESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGNV 126
Query: 220 SSNNILL 226
+ N+LL
Sbjct: 127 CAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE----TELAFLESFQTEARLLSQ 143
ED+D+ IG G +G V + S K+ A+K L E ++ AF F E +++
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAF 99
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
+V+L+ K ++++ +YM G L ++ N D + W K + AL
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYT--AEVVLAL 155
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR------LLHSDSSNRTVVAGTH 257
+H ++HRD+ +N+LL+ +ADFG ++ D++ GT
Sbjct: 156 DAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-----VGTP 207
Query: 258 GYIAPELAYTM----VVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIM 304
YI+PE+ + +CD + GV E+L+G P D L KIM
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 97 IGTGGYGSVY--RAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154
+G G Y +V+ R++L + +VALK++ E A + + E LL ++H NIV L+
Sbjct: 13 LGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRND-----DEAIQLDWTKRVNIVK-SMAHALSYLHY 208
++C+ L+++Y L +D D L V I + LSY H
Sbjct: 71 IIHTERCLTLVFEY---------LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYT 267
I+HRD+ N+L+N K E +ADFG+AR + + T Y P+ L +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178
Query: 268 MVVTEKCDVFGFGVVALEVLMGR 290
+ D++G G + E+ GR
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 91 FDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
+ I+ IG G YG V A +G+ VA+KK++ ++ E +LL +RH +I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 150 VKLYGFCLHK-----KCMFLIYKYMRRGSLFCVLR-NDD---EAIQLDWTKRVNIVKSMA 200
V++ L K ++++++ M L V++ NDD E Q + +
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQF-------FLYQLL 113
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTH 257
AL Y+H ++ HRD+ NIL N+ + + DFG+AR+ +D+ T T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 258 GYIAPEL--AYTMVVTEKCDVFGFGVVALEVLMGR 290
Y APEL ++ T D++ G + EVL G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHH---SETELAFLESFQTEARLLSQIRHRNIVKL 152
+G G +G VY +G+ +A+K++ S+ + + + E +LL +RH IV+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 153 YGFCLH---KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
YG CL +K + + +YM GS+ L+ A+ + T+R + + +SYLH +
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYT--RQILQGVSYLHSN 125
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT---VVAGTHGYIAPELAY 266
I VHRDI NIL +S + DFG ++ + + + T V GT +++PE+
Sbjct: 126 MI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHP 292
K DV+ +E+L + P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 97 IGTGGYGSVYRA-QLPSG---KI-VALKKLHHSETELAFLESFQTEARL-LSQIRHRNIV 150
+G+G +G+V++ +P G KI VA+K + F E T+ L + + H IV
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI--TDHMLAMGSLDHAYIV 72
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ----LDWTKRVNIVKSMAHALSYL 206
+L G C + L+ + GSL +R +++ L+W V I K M YL
Sbjct: 73 RLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGM----YYL 125
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD------SSNRTVVAGTHGYI 260
+ VHR++++ NILL S +ADFGVA LL+ D S ++T + ++
Sbjct: 126 EEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WM 178
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVL 287
A E T + DV+ +GV E++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAF-LESFQTEARLLS-QIRHRNIVKLY 153
+G G +G V+ A+L + + A+K L + +E E R+LS H + LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
K+ +F + +Y+ G L +++ + D + + L +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSK---G 116
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEK 273
IV+RD+ +NILL++ +ADFG+ + + GT YIAPE+
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 274 CDVFGFGVVALEVLMGRHP 292
D + FGV+ E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 66/268 (24%), Positives = 116/268 (43%), Gaps = 34/268 (12%)
Query: 51 PKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL 110
P +RK K + R D + ++ + ED+++ IG G +G V +
Sbjct: 13 PALRKNKNIDNFLNRYKDTIN--------KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 64
Query: 111 PS-GKIVALKKLHHSE----TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165
S K+ A+K L E ++ AF F E +++ +V+L+ + ++++
Sbjct: 65 KSTRKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121
Query: 166 YKYMRRGSLFCVLRNDD--EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNN 223
+YM G L ++ N D E +T V + H++ + +HRD+ +N
Sbjct: 122 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKPDN 172
Query: 224 ILLNSKLEAFVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTM----VVTEKCDVFG 278
+LL+ +ADFG ++ + R A GT YI+PE+ + +CD +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 279 FGVVALEVLMGRHP--GDLLSSFNPKIM 304
GV E+L+G P D L KIM
Sbjct: 233 VGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 97 IGTGGYGSVYRAQ--LPSGKIVALKKLH-HSETELAFLESFQTEA--RLLSQIRHRNIVK 151
IG G YG V++A+ G+ VALK++ + E L + + A R L H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 152 LYGFCLHKKC-----MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
L+ C + + L+++++ + + + + + + K +++ + L +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDFL 126
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H +VHRD+ NIL+ S + +ADFG+AR ++S T V T Y APE+
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAPEVLL 182
Query: 267 TMVVTEKCDVFGFGVVALEVLMGR 290
D++ G + E+ +
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G+G YGSV A +G VA+KKL + + E RLL ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 156 CLHKKCM------FLIYKYMRR--GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
+ + +L+ M ++ + D+ +Q ++ + L Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIH 137
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
I+HRD+ +N+ +N E + DFG+AR H+D VA T Y APE+
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLN 191
Query: 268 -MVVTEKCDVFGFGVVALEVLMGR 290
M + D++ G + E+L GR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 115 IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174
+VA+K L T+ A F E +++S++++ NI++L G C+ + +I +YM G L
Sbjct: 46 LVAVKMLRADVTKTA-RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 175 FCVLRNDD------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228
L + A + N++ S + Y + VHRD+++ N L+ +
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 229 KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV----TEKCDVFGFGVVAL 284
+ADFG++R L+S R + G +A+ ++ T DV+ FGV
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 285 EV--LMGRHPGDLLS 297
E+ L P LLS
Sbjct: 223 EMFTLCKEQPYSLLS 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 73/280 (26%), Positives = 119/280 (42%), Gaps = 39/280 (13%)
Query: 97 IGTGGYGSV--YR---AQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +G V Y A +G++VA+K L E ++ E +L + H NIVK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 152 LYGFCLHK--KCMFLIYKYMRRGSLFCVL-RNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
G C + K + LI +Y+ GSL L ++ QL + + + ++YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHS 125
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELA 265
+HRD+++ N+LL++ + DFG+A+ + V + A E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 266 YTMVVTEKCDVFGFGVVALEVLMG-----RHPGDLLSSFNPK------IMLIDLLD--QR 312
+ DV+ FGV E+L P PK + LI+LL+ R
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242
Query: 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352
P P + Q++ ++ K C ++ K RPT R P
Sbjct: 243 LPCPKN---CPQEVYILMK---NCWETEAKFRPTFRSLIP 276
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 97 IGTGGYGSVY--RAQLP--SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
+G G +G V+ R +G++ A+K L + ++ + E +L+++ H IVKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 153 -YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVK----SMAHALSYLH 207
Y F K ++LI ++R G LF L + + D VK +A AL +LH
Sbjct: 64 HYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED-------VKFYLAELALALDHLH 115
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
I++RD+ NILL+ + + DFG+++ GT Y+APE+
Sbjct: 116 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHP 292
T+ D + FGV+ E+L G P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 85 IVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI 144
+VA+ + + + G G V+ A P + K+ T L EA LL +
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL-------IEAMLLQNV 114
Query: 145 RHRNIVKLYGFCLHKK--CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHA 202
H +++++ + CM L + L+ L + +D + + I K +
Sbjct: 115 NHPSVIRMKDTLVSGAITCMVLPH---YSSDLYTYLTKRSRPLPID--QALIIEKQILEG 169
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
L YLH I+HRD+ + NI +N + + D G A+ + +AGT AP
Sbjct: 170 LRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLGLAGTVETNAP 225
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVL 287
E+ K D++ G+V E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 90 DFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSE--TELAFLESFQTEARLLSQ 143
+F++ +GTG YG V+ + GK+ A+K L + + E +TE ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 144 IRHRN-IVKL-YGFCLHKKCMFLIYKYMRRGSLFCVL----RNDDEAIQLDWTKRVNIVK 197
+R +V L Y F K + LI Y+ G LF L + +++ +
Sbjct: 61 VRRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEVRV-------YIA 112
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGT 256
+ AL +LH I++RDI NILL+S+ + DFG+++ ++ R GT
Sbjct: 113 EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 257 HGYIAPEL------AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y+APE+ + V D + GV+ E+L G P
Sbjct: 170 IEYMAPEVIRGGSGGHDKAV----DWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 90 DFDIKYCIGTGGYGSVYRAQLPSG----KIVALKKLHHSE--TELAFLESFQTEARLLSQ 143
+F++ +GTG YG V+ + +G K+ A+K L + + +E +TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 144 IRHRN-IVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNI---VKS 198
+R +V L Y F K + LI Y+ G +F L Q D +
Sbjct: 61 VRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHL------YQRDNFSEDEVRFYSGE 113
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGTH 257
+ AL +LH IV+RDI NILL+S+ + DFG+++ S+ RT GT
Sbjct: 114 IILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 258 GYIAPELAYTMVVTEKC-DVFGFGVVALEVLMGRHP 292
Y+APE+ K D + G++ E+L G P
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 63/256 (24%), Positives = 108/256 (42%), Gaps = 53/256 (20%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSE----TELAFLESFQTEARLLSQ 143
+DF++ IG G +G V+ + +G++ A+K L S+ ++A + E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH---VRAERDILAD 57
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
IVKLY ++ ++L+ +YM G L +L D + + + + AL
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD-VFPEETARF--YIAELVLAL 114
Query: 204 SYLH---YDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-------------------- 240
+H + +HRDI +NIL+++ +ADFG+
Sbjct: 115 DSVHKLGF------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 241 -----RLLHSDSSNRTV----VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRH 291
+ D R V GT YIAPE+ +CD + GV+ E+L G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 292 P---GDLLSSFNPKIM 304
P L ++N KI+
Sbjct: 229 PFYSDTLQETYN-KII 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G Y +VY+ + + +VALK++ E A + + E LL ++H NIV L+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
+K + L+++Y+ + L L + +I + K + + L+Y H ++
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL--FLFQLLRGLNYCHRR---KVL 126
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVVTEKC 274
HRD+ N+L+N + E +ADFG+AR + + T Y P+ L + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186
Query: 275 DVFGFGVVALEVLMGR 290
D++G G + E+ GR
Sbjct: 187 DMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 66/285 (23%), Positives = 123/285 (43%), Gaps = 44/285 (15%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKI-------VALKKLHHSETELAFLESFQTEA 138
VA E + +G G +G VY + G + VA+K ++ + + +E F EA
Sbjct: 3 VAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEA 60
Query: 139 RLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLD-------WTK 191
++ + ++V+L G + +I + M RG L LR+ ++ + K
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 192 RVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
+ + +A ++YL+ + VHRD+++ N ++ + DFG+ R ++ R
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 252 VVAGTHG-----YIAPELAYTMVVTEKCDVFGFGVVALEV-LMGRHPGDLLSSFNPKIML 305
G G +++PE V T DV+ FGVV E+ + P +S N +++
Sbjct: 178 ---GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--NEQVLR 232
Query: 306 I----DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
LLD+ P D++ ++ C + PK RP+
Sbjct: 233 FVMEGGLLDKPDNCP--------DMLF--ELMRMCWQYNPKMRPS 267
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 51/245 (20%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRH 146
+DF+ IG G +G V Q +G I A+K L ++ E + + E +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDD----EAIQLDWTKRVNIVKSMAHA 202
+VK++ K+ ++LI +++ G + +L D EA Q + V + ++ H
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQ 119
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-------------RLLHSDSS- 248
L + +HRDI +N+LL++K ++DFG+ L H+ S
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170
Query: 249 -----------------NRTVVA----GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL 287
NR +A GT YIAPE+ + CD + GV+ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 288 MGRHP 292
+G P
Sbjct: 231 IGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQT--EARLLSQIRHRNIVKL- 152
+G G +G V + +G+ A+K L E +A E T E+R+L RH + L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS-MAHALSYLHYDCI 211
Y F H + F++ +Y G LF L + ++ +R + + AL YLH
Sbjct: 62 YAFQTHDRLCFVM-EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-- 114
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVT 271
+V+RDI N++L+ + DFG+ + SD + GT Y+APE+
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 272 EKCDVFGFGVVALEVLMGRHP 292
D +G GVV E++ GR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 7/198 (3%)
Query: 97 IGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQ-TEARLLSQIRHRNIVKLYG 154
+G GG+G V Q+ +GK+ A KKL + E+ E R+L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214
K + L+ M G L + N D + + + L L + I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQRE---RI 123
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKC 274
V+RD+ NILL+ + ++D G+A + + R V GT GY+APE+ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTFSP 182
Query: 275 DVFGFGVVALEVLMGRHP 292
D +G G + E++ G+ P
Sbjct: 183 DWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHH----SETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +G V + +G+ A+K L ++ E+A TE R+L RH +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTA 59
Query: 152 L-YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS-MAHALSYLHYD 209
L Y F H + F++ +Y G LF L + ++ R + + AL YLH +
Sbjct: 60 LKYSFQTHDRLCFVM-EYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSE 114
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
++V+RD+ N++L+ + DFG+ + D + GT Y+APE+
Sbjct: 115 --KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 270 VTEKCDVFGFGVVALEVLMGRHP 292
D +G GVV E++ GR P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 54/224 (24%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQ-----IRHRN-- 148
IG G +G+V + PSG I+A+K++ + E + L +R +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIR--------STVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 149 -IVKLYGFCLHKK----CMFLI-------YKYMRRGSLFCVLR-NDDEAIQLDWTKRVNI 195
IVK YG + CM L+ YKY ++ VL+ E I V
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKY-----VYEVLKSVIPEEILGKIA--VAT 116
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG 255
VK AL+YL + I+HRD+ +NILL+ + DFG++ L DS +T AG
Sbjct: 117 VK----ALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDAG 169
Query: 256 THGYIAPEL-------AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y+APE Y + + DV+ G+ EV G+ P
Sbjct: 170 CRPYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEAR---LLSQIRHRNIVKL 152
IG G +G V A+ GK A+K L + L E A LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQ-KKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 153 -YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
Y F +K ++ + ++ G LF L+ + + + +A AL YLH
Sbjct: 62 HYSFQTTEK-LYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS--- 114
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVT 271
+IV+RD+ NILL+S+ + DFG+ + + S T GT Y+APE+
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 272 EKCDVFGFGVVALEVLMGRHP 292
D + G V E+L G P
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 51/245 (20%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRH 146
EDF+ IG G +G V Q +G + A+K L ++ E + + E +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDD----EAIQLDWTKRVNIVKSMAHA 202
+VK++ K ++LI +++ G + +L D E Q + V + S+ H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQ 119
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-------------RLLHSDSS- 248
L + +HRDI +N+LL+SK ++DFG+ L HS S
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170
Query: 249 -----------------NRTVVA----GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL 287
NR +A GT YIAPE+ + CD + GV+ E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 288 MGRHP 292
+G P
Sbjct: 231 IGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G+G YGSV A + VA+KKL L E RLL ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 156 CLHKKCM------FLIYKYMRR--GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
+ +L+ M ++ + DE +Q ++ + L Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKYIH 135
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
I+HRD+ +N+ +N E + DFG+AR +D VA T Y APE+
Sbjct: 136 S---AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVA-TRWYRAPEIMLN 189
Query: 268 -MVVTEKCDVFGFGVVALEVLMGR--HPGD 294
M + D++ G + E+L G+ PG+
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G Y +VY+ + +G++VALK++ E A + + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDI 71
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV---NIVK----SMAHALSYLHY 208
KK + L+++Y+ D +D + V+ + L+Y H
Sbjct: 72 IHTKKTLTLVFEYLDT----------DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS---SNRTVVAGTHGYIAPE-- 263
++HRD+ N+L++ + E +ADFG+AR S SN V T Y P+
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV---TLWYRPPDVL 175
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLMGR 290
L T T D++G G + E+ GR
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 46/144 (31%), Positives = 69/144 (47%), Gaps = 12/144 (8%)
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLH---SDSSNRTVVAGTHGYIAPELAYTMVV 270
++HRDI S NILL S + DFG +++ SD RT GT Y+APE+
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAPEIWRRKPY 222
Query: 271 TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVS 330
++K D+F GV+ E+L + P D + ++M L + P P +Q+I+
Sbjct: 223 SKKADMFSLGVLLYELLTLKRPFDGENM--EEVMHKTLAGRYDPLPPSISPEMQEIVT-- 278
Query: 331 KIAFACLRSKPKSRPTMRRSFPNP 354
A L S PK RP+ + P
Sbjct: 279 ----ALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG- 154
+G G +G V A+ +G+ VA+KK+ + + E +LL +RH NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 155 FCLHKKCMFLIYKYMRR--GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
F + ++ + + + L + + IQ + + L Y+H
Sbjct: 78 FISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-------FLYQILRGLKYVHS---A 127
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVT 271
+VHRD+ +NIL+N + + DFG+AR+ T T Y APE+ T
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 272 EKCDVFGFGVVALEVLMGR--HPG-DLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328
+ D++ G + E+L G+ PG D ++ F+ ++ DLL +P DD VI I
Sbjct: 185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFS---IITDLLG----TPPDD--VINTICS 235
Query: 329 VSKIAFACLRSKPKSRPT-MRRSFPNPE 355
+ + F ++S PK P F N +
Sbjct: 236 ENTLRF--VQSLPKREPVPFSEKFKNAD 261
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 27/208 (12%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G +G V+ P GK VALKK+ + L + E ++L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 156 -------CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+ ++++ + M+ ++ + + D K + + L YLH
Sbjct: 68 LQPPHIDPFEE--IYVVTELMQSDLHKIIVSP--QPLSSDHVKV--FLYQILRGLKYLHS 121
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS-NRTVVAGTHGYIAPELA-- 265
I+HRDI N+L+NS + DFG+AR+ D S + T T Y APE+
Sbjct: 122 ---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 266 ---YTMVVTEKCDVFGFGVVALEVLMGR 290
YT V D++ G + E+L R
Sbjct: 179 SRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 52/175 (29%), Positives = 90/175 (51%), Gaps = 14/175 (8%)
Query: 97 IGTGGYGSVYRAQL----PSGKIVALKKLHHSETELAFLESFQTEAR--LLSQIRHRNIV 150
+G GGYG V++ + +GKI A+K L + ++ T+A +L ++H IV
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 151 KL-YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
L Y F K ++LI +Y+ G LF L + E I ++ T + + ++ AL +LH
Sbjct: 64 DLIYAFQTGGK-LYLILEYLSGGELFMHL--EREGIFMEDTACFYLSE-ISLALEHLHQQ 119
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
I++RD+ NILL+++ + DFG+ + + + GT Y+APE+
Sbjct: 120 ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 46/271 (16%)
Query: 100 GGYGSVYRAQLPSGK-------IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
G +G ++ L K V K H SE ++ L E+ LL + H+NI+ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLL---LQESCLLYGLSHQNILPI 73
Query: 153 YGFC--LHKKCMFLIYKYMRRGSLFCVLRN-----DDEAIQLDWTKRVNIVKSMAHALSY 205
C + F++Y YM G+L L+ + L + V++ +A +SY
Sbjct: 74 LHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-----HS--DSSNRTVVAGTHG 258
LH ++H+DI++ N +++ +L+ + D ++R L H D+ NR V
Sbjct: 133 LHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV-----K 184
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALE-VLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317
++A E + DV+ FGV+ E + +G+ P + F L D R PI
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD--GYRLAQPI 242
Query: 318 D--DQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ D+ L + +A C P+ RP+
Sbjct: 243 NCPDE-------LFAVMAC-CWALDPEERPS 265
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 11/200 (5%)
Query: 97 IGTGGYGSVYRAQLPSG-KIVALKKLHHSETELAFLESFQTEAR--LLSQIRHRNIVKL- 152
IG G +G V A+ + K A+K L E R LL ++H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
+ F K ++ + Y+ G LF L+ E L+ R +A AL YLH
Sbjct: 63 FSFQTADK-LYFVLDYINGGELFYHLQR--ERCFLEPRARF-YAAEIASALGYLHS---L 115
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE 272
+IV+RD+ NILL+S+ + DFG+ + + + GT Y+APE+ +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 273 KCDVFGFGVVALEVLMGRHP 292
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 97 IGTGGYGSVY--RAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154
+G G Y +V+ R++L + +VALK++ E A + + E LL ++H NIV L+
Sbjct: 14 LGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNI-VKSMAHALSYLHYDCIPS 213
K + L+++Y+ + + + D+ + V I + + L+Y H
Sbjct: 72 IVHTDKSLTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVVTE 272
++HRD+ N+L+N + E +ADFG+AR + + T Y P+ L + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
Query: 273 KCDVFGFGVVALEVLMGR 290
+ D++G G + E+ GR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 7/198 (3%)
Query: 97 IGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQ-TEARLLSQIRHRNIVKLYG 154
+G GG+G V Q+ +GK+ A KKL + ES E ++L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214
K + L+ M G L + + EA + + V + L LH + I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE---RI 123
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKC 274
V+RD+ NILL+ ++D G+A + + + V GT GY+APE+ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSP 182
Query: 275 DVFGFGVVALEVLMGRHP 292
D + G + E++ G+ P
Sbjct: 183 DWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 97 IGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQ-TEARLLSQIRHRNIVKLYG 154
+G GG+G V Q+ +GK+ A K+L + ES E ++L ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 155 FCLHKKCMFLIYKYMRRGSL-FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
K + L+ M G L F + + + + + + + L LH + +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE--RALFYAAEILCGLEDLHRE---N 122
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEK 273
V+RD+ NILL+ ++D G+A + S R V GT GY+APE+ T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQRYTLS 181
Query: 274 CDVFGFGVVALEVLMGRHP 292
D +G G + E++ G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 16/222 (7%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALK----KLHHSETELAFLESFQTEARLLSQI-RHRNIV 150
IG G Y V +L + +I A+K +L + + ++ ++ QTE + Q H +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWV---QTEKHVFEQASNHPFLV 59
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210
L+ + +F + +Y+ G L ++ +L ++ AL+YLH
Sbjct: 60 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER- 115
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV 270
I++RD+ +N+LL+S+ + D+G+ + + GT YIAPE+
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 271 TEKCDVFGFGVVALEVLMGRHPGDLL-SSFNPKIMLIDLLDQ 311
D + GV+ E++ GR P D++ SS NP D L Q
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 62/250 (24%), Positives = 106/250 (42%), Gaps = 46/250 (18%)
Query: 116 VALKKL--HHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS 173
V LK L H + LAF E+ A L+SQ+ H ++ ++G C+ ++ +++ G
Sbjct: 47 VVLKVLDPSHRDIALAFFET----ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGP 102
Query: 174 LFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK---- 229
L LR + + + W ++ + + +A ALSYL ++VH ++ + NILL
Sbjct: 103 LDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157
Query: 230 -LEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVVTEKCDVFGFGVVALE 285
F+ +D GV+ S + +IAPE + ++ D + FG LE
Sbjct: 158 GTSPFIKLSDPGVSFTALSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 286 V-------LMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLR 338
+ L R P + + K L + PS + T+I CL
Sbjct: 214 ICFDGEVPLKERTPSEKERFYEKKHRLPE------PSCKELATLISQ----------CLT 257
Query: 339 SKPKSRPTMR 348
+P RP+ R
Sbjct: 258 YEPTQRPSFR 267
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 11/113 (9%)
Query: 116 VALKKLH--HSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS 173
V LK L H + LAF E+ A ++ Q+ H++IV LYG C+ ++ +++ G
Sbjct: 35 VILKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 174 LFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL 226
L + + + W + + K +A ALSYL +VH ++ + NILL
Sbjct: 91 LDLFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 13/201 (6%)
Query: 97 IGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEAR---LLSQIRHRNIVKL 152
IG G +G V A+ S G A+K L +T L E A LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQ-KKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 153 -YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
Y F +K ++ + Y+ G LF L+ E L+ R +A A+ YLH
Sbjct: 62 HYSFQTAEK-LYFVLDYVNGGELFFHLQR--ERCFLEPRARF-YAAEVASAIGYLHS--- 114
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVT 271
+I++RD+ NILL+S+ + DFG+ + + GT Y+APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 272 EKCDVFGFGVVALEVLMGRHP 292
D + G V E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 60/265 (22%), Positives = 112/265 (42%), Gaps = 23/265 (8%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHR 147
+F I+ IG G + VYRA L K VALKK+ E + + E LL Q+ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLD-----WTKRVNIVKSMAHA 202
N++K + + ++ + G L +++ + +L W V + ++ H
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
S ++HRDI N+ + + + D G+ R S ++ + GT Y++P
Sbjct: 123 HSR-------RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320
E + K D++ G + E+ + P GD ++ F+ L ++Q P+ +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS----LCQKIEQCDYPPLPTE 231
Query: 321 TVIQDIILVSKIAFACLRSKPKSRP 345
+ + ++ C+ P RP
Sbjct: 232 HYSEKL---RELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 136 TEARLLSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTK--R 192
TE+R+L RH + L Y F H + F++ +Y G LF L + D +
Sbjct: 44 TESRVLQNTRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRE-RVFSEDRARFYG 101
Query: 193 VNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
IV AL YLH C +V+RD+ N++L+ + DFG+ + SD +
Sbjct: 102 AEIVS----ALGYLH-SC--DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154
Query: 253 VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GT Y+APE+ D +G GVV E++ GR P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKL------HHSETELAFLESFQTEARLLSQIRHRNI 149
+G GG+G V Q+ +GK+ A KKL S ++A LE +L ++ I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEK-----EILEKVNSPFI 55
Query: 150 VKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
V L Y F K + L+ M G L + N E L+ + ++ + + +LH
Sbjct: 56 VNLAYAF-ESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS 113
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
IV+RD+ N+LL+ + ++D G+A L D T AGT+GY+APE+
Sbjct: 114 ---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEE 169
Query: 269 VVTEKCDVFGFGVVALEVLMGRHP 292
+ D F G E++ GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 115 IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174
+VA+K L + A F E ++LS+++ NI++L G C+ + + +I +YM G L
Sbjct: 48 LVAVKILRPDANKNA-RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI----------------VHRD 218
L + D + N AH L + Y + + VHRD
Sbjct: 107 NQFLSSH---HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163
Query: 219 ISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVVTEKC 274
+++ N L+ L +ADFG++R L++ R + G ++A E T
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYR--IQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 275 DVFGFGVVALEVLM 288
DV+ FGV E+LM
Sbjct: 222 DVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 67/285 (23%), Positives = 116/285 (40%), Gaps = 62/285 (21%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-- 145
D + IG+G G VY+ + +G ++A+K++ + + + R+L +
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-------EENKRILMDLDVV 67
Query: 146 ---HR--NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN------ 194
H IVK YG+ + +F+ + M + L KR+
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLL-----------KRIQGPIPED 114
Query: 195 ----IVKSMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-RLLHSD 246
+ ++ AL YL H ++HRD+ +NILL++ + DFG++ RL+ D
Sbjct: 115 ILGKMTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV--D 167
Query: 247 SSNRTVVAGTHGYIAPELAYTMVVTEK----CDVFGFGVVALEVLMGRHPGDLLSS-FNP 301
S +T AG Y+APE K DV+ G+ +E+ G+ P + F
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE- 226
Query: 302 KIMLIDLLDQRAPSPIDDQTVIQDII-LVSKIAFACLRSKPKSRP 345
+L +L + PS ++ D V CL + RP
Sbjct: 227 --VLTKILQEEPPSLPPNEGFSPDFCSFVDL----CLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 112 SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMFLIYKYM 169
+G+ VA+K L E+ + + E +L + H NIVK G C + LI +++
Sbjct: 32 TGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 170 RRGSLFCVLRNDDEAIQLDWTKR--VNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN 227
GSL L + I L + V I K M + L Y VHRD+++ N+L+
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY-LGSRQY------VHRDLAARNVLVE 143
Query: 228 SKLEAFVADFGVARLLHSDSSNRTVVAGTHG---YIAPELAYTMVVTEKCDVFGFGVVAL 284
S+ + + DFG+ + + +D TV + APE DV+ FGV
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203
Query: 285 EVL 287
E+L
Sbjct: 204 ELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 57/231 (24%)
Query: 92 DIKY----CIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAF---LESFQT--EARLL 141
D KY IG G YG V A + + VA+KK+ + AF +++ +T E +LL
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-----AFDNRIDAKRTLREIKLL 58
Query: 142 SQIRHRNIVKLYGFCLHKKCM-----------FLIYKYMRRGSLFCVLRND----DEAIQ 186
+ H N++ + K M +++Y+ M L ++R+ D+ Q
Sbjct: 59 RHLDHENVIAI------KDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQ 111
Query: 187 LDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
+ + L Y+H +++HRD+ +N+LLN+ + + DFG+AR
Sbjct: 112 Y-------FLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161
Query: 247 SSNRTVVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
T T Y APEL YT + DV+ G + E L+GR P
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAI----DVWSVGCIFAE-LLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQT--EARLLSQIRHRNIVKLY 153
IG G +G V + + + +I ALK + + ++ E T E +L+Q+ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
+ ++L+ ++ G LF L+ + + D ++ + AL LH +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHK---FN 113
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEK 273
+++RD+ NILL+ + + DFG+ +L D GT Y+APEL T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 274 CDVFGFGVVALEVLMGRHP 292
D + GV+ E+L G P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIR-HRNIVKLY 153
+G G +G V A+L SG++ A+K L + +E TE R+LS R H + +LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 154 GFCLHK-KCMFLIYKYMRRGSLFCVL---RNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
C +F + +++ G L + R DEA + + AL +LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI------TSALMFLHDK 115
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
I++RD+ +N+LL+ + +ADFG+ + + + GT YIAPE+ M+
Sbjct: 116 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 270 VTEKCDVFGFGVVALEVLMGRHP 292
D + GV+ E+L G P
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 7/198 (3%)
Query: 97 IGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQ-TEARLLSQIRHRNIVKLYG 154
+G GG+G V Q+ +GK+ A KKL + E+ E ++L ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214
K + L+ M G L + N D + V + L LH + I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLHRE---RI 123
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKC 274
V+RD+ NILL+ ++D G+A + + R V GT GY+APE+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVVKNERYTFSP 182
Query: 275 DVFGFGVVALEVLMGRHP 292
D +G G + E++ G+ P
Sbjct: 183 DWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 97 IGTGGYGSVYRAQLPSGK----IVALKK---LHHSETELAFLESFQTEARLLS-QIRHRN 148
+G G +G V A+L I ALKK L + E +E R+L+ H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVER-----RVLALAWEHPF 57
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+ L+ K+ +F + +Y+ G L + + + + D + + L +LH
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
I++RD+ +N+LL+ +ADFG+ + + + GT YIAPE+
Sbjct: 115 K---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 269 VVTEKCDVFGFGVVALEVLMGRHP 292
E D + FGV+ E+L+G+ P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G Y +VY+ +G++VALK + +TE + EA LL ++H NIV L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
K+ + +++YM L + + N+ M L L Y I+
Sbjct: 72 IHTKETLTFVFEYMHT-DLAQYMIQHPGGLH-----PYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE--LAYTMVVTEK 273
HRD+ N+L++ E +ADFG+AR S + T Y P+ L T +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA- 184
Query: 274 CDVFGFGVVALEVLMGR 290
D++G G + +E+L G+
Sbjct: 185 LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 32/211 (15%)
Query: 97 IGTGGYGSVYRAQLPSGKIVA---LKKLHHSET---ELAFLESFQTEARLLSQIRHRNIV 150
IG G +G V + G A +K+L S T +L FL+ Q ++ H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQP----YRELNHPNVL 58
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH----ALSYL 206
+ G C+ L+ ++ G L LR++ + K V ++ MA L +L
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWL 116
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG----YIAP 262
H +H D++ N L + L + D+G+A L + + H ++AP
Sbjct: 117 HQA---DFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAP 171
Query: 263 ELA-------YTMVVTEKCDVFGFGVVALEV 286
EL T+K +++ GV E+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 97 IGTGGYGSVYRAQLPSGK----IVALKK---LHHSETELAFLESFQTEARLLSQI-RHRN 148
+G G +G V A+L + LKK L + +E TE R+L+ +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD-----VECTMTEKRVLALAGKHPF 57
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+ +L+ K +F + +Y+ G L ++ + D + + L +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHE 114
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268
I++RD+ +N+LL+S+ +ADFG+ + + GT YIAPE+
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 269 VVTEKCDVFGFGVVALEVLMGRHP 292
D + GV+ E+L G+ P
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 11/200 (5%)
Query: 97 IGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEAR--LLSQIRHRNIVKL- 152
IG G +G V A+ + GK A+K L + R LL ++H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
Y F K F++ Y+ G LF L+ E + R +A AL YLH
Sbjct: 63 YSFQTADKLYFVL-DYVNGGELFFHLQR--ERSFPEPRARF-YAAEIASALGYLHS---L 115
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE 272
+I++RD+ NILL+S+ + DFG+ + S + GT Y+APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 273 KCDVFGFGVVALEVLMGRHP 292
D + G V E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 15/162 (9%)
Query: 136 TEARLLSQIRHRNIVKLYGFCLHKK--CMFL-IYKYMRRGSLFCVLRNDDEAIQLDWTKR 192
E +L I HR I+ L K CM + YK LF + D + L +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYV---DRSGPLPLEQA 187
Query: 193 VNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL--HSDSSNR 250
+ I + + AL+YLH I+HRD+ + NI L+ A + DFG A L H D+
Sbjct: 188 ITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 251 TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+GT +PEL K D++ G+V E+ +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 16/221 (7%)
Query: 97 IGTGGYGSVYRAQLPSG-KIVALK----KLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
IG G Y V +L +I A+K +L H + ++ ++ QTE + Q +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWV---QTEKHVFEQASSNPFLV 59
Query: 152 LYGFCLHKKC-MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210
C +FL+ +Y+ G L ++ +L + AL++LH
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER- 115
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV 270
I++RD+ +N+LL++ + D+G+ + + GT YIAPE+
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 271 TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311
D + GV+ E++ GR P D+++ NP + D L Q
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITD-NPDMNTEDYLFQ 213
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 97 IGTGGYGSVYRAQL---PSGKI--------VALKKLHHS-ETELAFLESFQTEARLLSQI 144
+G G + ++Y+ L I V LK L LAF E+ A L+SQ+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET----ASLMSQL 58
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
H+++VKLYG C+ + + ++ +Y++ G L L + + L W ++++ K +A AL
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115
Query: 205 YLHYDCIPSIVHRDISSNNILL 226
YL +VH ++ NIL+
Sbjct: 116 YLEDK---KLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 89 EDFDIKYCIGTGGYGSVY-------RAQLPSGKIVALKKLHHSETELAFLESFQTEARLL 141
EDF+ I G YG+VY R + KI + ++ + F+E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER-----DIL 55
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH 201
+ + +V ++ K+ + ++ +Y+ G +L+N A+ +D R+ +++
Sbjct: 56 TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVD-MARMYFAETVL- 112
Query: 202 ALSYLH-YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-----------LHSDSSN 249
AL YLH Y IVHRD+ +N+L+ S + DFG++++ H +
Sbjct: 113 ALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 250 RTV----VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
R V GT YIAPE+ + D + G++ E L+G P
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAF-LESFQTEARLLS-QIRHRNIVKLY 153
+G G +G V A+L G+ A+K L + +E E R+L+ + + LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
K+ +F + +++ G L +++ + D + + L +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---G 116
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEK 273
I++RD+ +N++L+ +ADFG+ + + + GT YIAPE+ + T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176
Query: 274 CDVFGFGVVALEVLMGRHP 292
D + FGV+ E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 18/185 (9%)
Query: 115 IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174
+VA+K L + A F E +++S+++ NI++L C+ + +I +YM G L
Sbjct: 48 LVAVKMLREDANKNA-RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 175 ---FCVLRNDDEAIQLD-----WTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL 226
+ A + D ++ + + +A + YL + VHRD+++ N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163
Query: 227 NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV----TEKCDVFGFGVV 282
+ADFG++R L+S R + G +++ ++ T DV+ FGV
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 283 ALEVL 287
E+L
Sbjct: 222 LWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 97 IGTGGYGSVYRAQL-PSGKIVALKKLHHSE-TELAFLESFQTEARLL---SQIRHRNIVK 151
+G G +G V A+ +G++ A+K L + +ES E R+ + RH +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
L+ + + + +Y G L + D + V + L YLH +
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN-- 120
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVAR--LLHSDSSNRTVVAGTHGYIAPEL----A 265
IV+RD+ +N+LL+++ +ADFG+ + + D + + GT ++APE+ +
Sbjct: 121 -KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--STFCGTPEFLAPEVLTETS 177
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHP--GD 294
YT V D +G GV+ E+L+G P GD
Sbjct: 178 YTRAV----DWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 63/259 (24%), Positives = 103/259 (39%), Gaps = 67/259 (25%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSET----ELAFLESFQTEARLLSQ 143
EDF IG G +G V Q +GKI A+K L SE +LA +++ E +L++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKA---ERDVLAE 57
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDD---EAIQLDWTKRVNIVKSMA 200
+V LY + ++LI +++ G L +L D E + + +
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA-------------RLLHSDS 247
H L + +HRDI +NIL++ ++DFG++ +LL S
Sbjct: 118 HKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 248 S------------------------------NRTVVA----GTHGYIAPELAYTMVVTEK 273
+ NR ++A GT YIAPE+ ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 274 CDVFGFGVVALEVLMGRHP 292
CD + G + E L+G P
Sbjct: 229 CDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 58/195 (29%), Positives = 88/195 (45%), Gaps = 26/195 (13%)
Query: 112 SGKIVALKKLH--HSETELAFLESFQTEARLLSQIRHRNIVKLY--GFCLHKKCMFLIYK 167
+G VA+K L E E F+ E L +++ H NIV L G +F +++
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQR-ARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 168 YMRRGSLFCVLRNDDEAIQLDWTKRV--NIVKSMAHALSYLHYDCIPSIVHRDISSNNIL 225
Y+ +L VL D A+ T R+ ++ ++A A H IVHRD+ NI+
Sbjct: 60 YVPGRTLREVLAADG-ALPAGETGRLMLQVLDALACA----HNQ---GIVHRDLKPQNIM 111
Query: 226 LNS---KLEAFVADFGVARLL---HSDSSNR----TVVAGTHGYIAPELAYTMVVTEKCD 275
++ + A V DFG+ LL T V GT Y APE VT D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 276 VFGFGVVALEVLMGR 290
++ +G++ LE L G+
Sbjct: 172 LYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
E+F I I G +G VY + + K+ A+K + ++ + Q E L+ +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRG---SLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
IV LY ++L+ +Y+ G SL + DE + + + + +A AL
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY------ISEVALAL 117
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242
YLH I+HRD+ +N+L++++ + DFG++++
Sbjct: 118 DYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 49/248 (19%), Positives = 99/248 (39%), Gaps = 35/248 (14%)
Query: 96 CIGTGGYGSVYRAQLPSGKIVALKKLH---HSETELAFLESFQTEARLLSQIRHRNIVKL 152
C + + + P+ +VA+KK++ S+ +L L Q E Q++H NI+
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLL---QQEIITSRQLQHPNILPY 64
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRN------DDEAIQLDWTKRVNIVKSMAHALSYL 206
+ ++++ M GS +L+ + AI I+K + +AL Y+
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-------ILKDVLNALDYI 117
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR-LLHSDSSNRTVVAGTHG------Y 259
H +HR + +++ILL+ + ++ + ++ R V +
Sbjct: 118 HSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 260 IAPELAYTMV--VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317
++PE+ + EK D++ G+ A E+ G P ML++ + P +
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP---FKDMPATQMLLEKVRGTVPCLL 231
Query: 318 DDQTVIQD 325
D T
Sbjct: 232 DKSTYPLY 239
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 26/202 (12%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKL---HHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G + V +AQ +GK A+K + S ++ L Q RL H NI++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP---HPNILRL 63
Query: 153 YGFCLHKK--CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV-NIVKSMAHALSYLHYD 209
+K + L+++ M +L+ +++ + KRV + + + +L ++H +
Sbjct: 64 IEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMHRN 119
Query: 210 CIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
I HRDI NIL+ KL ADFG R ++S T T Y APE
Sbjct: 120 ---GIFHRDIKPENILIKDDILKL----ADFGSCRGIYSKPP-YTEYISTRWYRAPECLL 171
Query: 267 TM-VVTEKCDVFGFGVVALEVL 287
T K D++ G V E+L
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIR-HRNIVKLY 153
+G G +G V A+L + ++ A+K L + ++ TE R+L+ H + L+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVL---RNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210
K +F + +Y+ G L + R DE + V + AL +LH
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL------ALMFLHRH- 115
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV 270
+++RD+ +NILL+++ +ADFG+ + + T GT YIAPE+ +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 271 TEKCDVFGFGVVALEVLMGRHP 292
D + GV+ E++ G+ P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 56/235 (23%), Positives = 88/235 (37%), Gaps = 51/235 (21%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYG 154
+G G G V+ +L +GK+ ALK L E + ++ TE +L+ + H + LY
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH----ALSYLHYDC 210
+ + L+ Y G LF +L+ Q + + A AL YLH
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQR-----QPGKCLSEEVARFYAAEVLLALEYLH--- 120
Query: 211 IPSIVHRDISSNNILLN-------------------SKLEAFVADFGVARLLHSDSSNRT 251
+ IV+RD+ NILL+ + G R + + T
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 252 VVA----------GTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GT YIAPE+ + V D + G++ E+L G P
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQT--EARLLSQIRHRNIVKLY 153
IG G +G VY+ + + +I A+K L E +A E T E +L + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI-VAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 154 G--FCLHKKC-MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNI-VKSMAHALSYLH-Y 208
G F ++L+ YM G LF L+ + + R + + AL +LH Y
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVLALEHLHKY 115
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL---- 264
D IV+RD+ NILL++ + DFG+++ +D+ GT Y+APE+
Sbjct: 116 D----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 265 -AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
YT V D + GV+ E+ G P
Sbjct: 172 KGYTKHV----DFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 48/208 (23%), Positives = 92/208 (44%), Gaps = 9/208 (4%)
Query: 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHR 147
DF+ +G G +G V A+ + ++ A+K L + +E E R+L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 148 NIVKLYGFCLHK-KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
+ C ++ + +Y+ G L + + + + + V ++ L +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H I++RD+ +N++L+S+ +ADFG+ + D GT YIAPE+
Sbjct: 118 HRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGD 294
+ D + +GV+ E+L G+ P D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 20/140 (14%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVV 270
+HRD+++ NILL+ + DFG+AR ++ D V G+ ++APE + V
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSARLPLKWMAPESIFDKVY 253
Query: 271 TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVS 330
T + DV+ FGV+ E+ L +S P + + + QR + D T ++ +
Sbjct: 254 TTQSDVWSFGVLLWEIF------SLGASPYPGVQINEEFCQR----LKDGTRMRAPENAT 303
Query: 331 ----KIAFACLRSKPKSRPT 346
+I AC + PK RPT
Sbjct: 304 PEIYRIMLACWQGDPKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 35/118 (29%), Positives = 63/118 (53%), Gaps = 12/118 (10%)
Query: 181 DDEAIQLDWTKRVNIVKSMAHALSYL-HYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239
+++ + LD ++ +A +S+L +CI HRD+++ NILL + DFG+
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGL 260
Query: 240 ARLLHSDSSNRTVVAGTH----GYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
AR + +DS+ VV G ++APE + V T + DV+ +G++ E+ +G P
Sbjct: 261 ARDIRNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 51/252 (20%), Positives = 103/252 (40%), Gaps = 25/252 (9%)
Query: 104 SVYRAQLPSGKIVALKKLHHSETEL-AFLESFQTEARLLSQIRHRNIVKLYGF----CLH 158
S+Y+ + K V ++ ++ + E + L +I NI+K+YGF
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH-YDCIPSIVHR 217
+ LI +Y RG L VL + L + ++++ L L+ Y P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 218 DISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV--VTEKCD 275
+++S + L+ + + G+ ++L S Y + ++ + T K D
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV---NFMVYFSYKMLNDIFSEYTIKDD 204
Query: 276 VFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFA 335
++ GVV E+ G+ P + L++ ++I+ + P+D I+ I+ A
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-KLPLDCPLEIKCIVE------A 257
Query: 336 CLRSKPKSRPTM 347
C RP +
Sbjct: 258 CTSHDSIKRPNI 269
|
Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 32/100 (32%), Positives = 56/100 (56%), Gaps = 12/100 (12%)
Query: 199 MAHALSYL-HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
+A + +L +CI HRD+++ N+LL A + DFG+AR + +DS+ VV G
Sbjct: 221 VAQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--YVVKGNA 274
Query: 258 ----GYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
++APE + V T + DV+ +G++ E+ +G+ P
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-LHSDSSNRTVVAGTH 257
+A L +LH I++RD+ +N++L+++ +ADFG+ + + + RT GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165
Query: 258 GYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGD 294
YIAPE+ + D + FGV+ E+L G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 97 IGTGGYGSV---YRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLY 153
IG+G G V Y A L + VA+KKL + E L+ + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
+K + +L+ + M +L V++ ++LD + ++ M + +LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 136
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
I+HRD+ +NI++ S + DFG+AR + S T T Y APE+
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG 192
Query: 268 MVVTEKCDVFGFGVVALEVLMGRH----PG-DLLSSFNPKI 303
M E D++ G + E M RH PG D + +N I
Sbjct: 193 MGYKENVDIWSVGCIMGE--MVRHKILFPGRDYIDQWNKVI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 17/200 (8%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG+G G V A G VA+KKL + E LL + H+NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 156 CLHKKCM------FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
+K + +L+ + M +L V+ + LD + ++ M + +LH
Sbjct: 89 FTPQKSLEEFQDVYLVMELMD-ANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHS- 141
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
I+HRD+ +NI++ S + DFG+AR ++ V T Y APE+ M
Sbjct: 142 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMG 198
Query: 270 VTEKCDVFGFGVVALEVLMG 289
E D++ G + E++ G
Sbjct: 199 YKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 26/81 (32%), Positives = 44/81 (54%)
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEK 273
I++RD+ +N++L+S+ +ADFG+ + D GT YIAPE+ +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 274 CDVFGFGVVALEVLMGRHPGD 294
D + FGV+ E+L G+ P +
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 65/282 (23%), Positives = 115/282 (40%), Gaps = 38/282 (13%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRA---QLPSGKI---VALKKLHHSETELAFLESFQTEAR 139
V+ E + +G G +G VY + G+ VA+K ++ S + +E F EA
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEAS 61
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-------NDDEAIQLDWTKR 192
++ ++V+L G + ++ + M G L LR N+ +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 193 VNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
+ + +A ++YL+ VHRD+++ N ++ + DFG+ R ++ R
Sbjct: 122 IQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK- 177
Query: 253 VAGTHG-----YIAPELAYTMVVTEKCDVFGFGVVALEV-LMGRHPGDLLSSFNPKIMLI 306
G G ++APE V T D++ FGVV E+ + P LS+ ++
Sbjct: 178 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235
Query: 307 D--LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
D LDQ P +++ C + PK RPT
Sbjct: 236 DGGYLDQPDNCPERVTDLMR----------MCWQFNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 22/154 (14%)
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFC----VLRNDDEAIQLDWTKRVNIVKSMAHAL 203
N+V L+ + + + +FL+ ++ G L+ L +E ++ W M AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAE------MVVAL 98
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
LH + IV RD++ NNILL+ + + F + DS + V Y APE
Sbjct: 99 DALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-EDSCDGEAVENM--YCAPE 152
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLMGR-----HP 292
+ TE CD + G + E+L G+ HP
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 51/204 (25%), Positives = 81/204 (39%), Gaps = 18/204 (8%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN-----IV 150
IG GG+G VY + +GK+ A+K L ++ E+ R++ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWT-KRVNIVKSMAHALSYLHYD 209
Y F K F I M G L L + + I+ + H +
Sbjct: 62 MTYAFHTPDKLCF-ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--- 117
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTM 268
+V+RD+ NILL+ ++D G+A + +V GTHGY+APE L
Sbjct: 118 ----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVLQKGT 171
Query: 269 VVTEKCDVFGFGVVALEVLMGRHP 292
D F G + ++L G P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 20/140 (14%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVV 270
+HRD+++ NILL+ + DFG+AR ++ D V G ++APE + V
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPESIFDKVY 252
Query: 271 TEKCDVFGFGVVALEVL-MGR--HPG-DLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
T + DV+ FGV+ E+ +G +PG + F + L + RAP +
Sbjct: 253 TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--LKEGTRMRAPEYATPE------ 304
Query: 327 ILVSKIAFACLRSKPKSRPT 346
+ I C + P+ RPT
Sbjct: 305 --IYSIMLDCWHNNPEDRPT 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 64/292 (21%), Positives = 130/292 (44%), Gaps = 52/292 (17%)
Query: 90 DFDIKYCIGTGGYGSVY-----RAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQ 143
++++ IG G +G V+ R Q K ++ + L E E ++ +
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-----QLVIEVNVMRE 68
Query: 144 IRHRNIVKLYGFCLHK--KCMFLIYKYMRRGSLFCVLRNDDEAIQL----DWTKRVNIVK 197
++H+NIV+ L+K + ++++ ++ G L RN + ++ + V+I +
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLS---RNIQKCYKMFGKIEEHAIVDITR 125
Query: 198 SMAHALSYLH-YDCIPS---IVHRDISSNNILLNSKLE-----------------AFVAD 236
+ HAL+Y H P+ ++HRD+ NI L++ + A + D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 237 FGVARLLHSDSSNRTVVAGTHGYIAPELAY--TMVVTEKCDVFGFGVVALEVLMGRHPGD 294
FG+++ + +S + V GT Y +PEL T +K D++ G + E+ G+ P
Sbjct: 186 FGLSKNIGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
Query: 295 LLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
++F+ LI L + PI ++ +I++ + + + K RP+
Sbjct: 245 KANNFS---QLISELKRGPDLPIKGKSKELNILIKNLLNLSA-----KERPS 288
|
Length = 1021 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 39/163 (23%), Positives = 68/163 (41%), Gaps = 19/163 (11%)
Query: 134 FQTEARLLSQIRHRNIVKL--------YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAI 185
+ E L ++ H NI+K+ + + +K F +Y +M + D +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDR 263
Query: 186 QLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
L R I+K + A+ Y+H ++HRDI NI LN + + DFG A
Sbjct: 264 PLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
Query: 246 DSSNRTV-VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL 287
+ GT +PE+ E D++ G++ L++L
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 47/186 (25%), Positives = 76/186 (40%), Gaps = 30/186 (16%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN-IVKLYG 154
IG G YG VY+A+ +GK+VALKK E + E LL + IV+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL-- 66
Query: 155 FCLH-------KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR-------VNIVKSMA 200
+ K ++L+++Y+ + D +D R +KS
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYL----------DSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 201 HALSYLHYDCIP-SIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHG 258
+ L C ++HRD+ N+L++ + +AD G+ R + T T
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176
Query: 259 YIAPEL 264
Y APE+
Sbjct: 177 YRAPEV 182
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 91 FDIKYC-IGTGGYGSVYRAQLPSGKI---VALKKLHHSETELAFLESFQTEARLLSQIRH 146
F+ + C +G G YG VY+A+ GK ALK++ + + S E LL +++H
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISM----SACREIALLRELKH 57
Query: 147 RNIVKLYG-FCLHK-KCMFLIYKYMRRGSLFCVL------RNDDEAIQLDWTKRVNIVKS 198
N++ L F H + ++L++ Y L+ ++ + + + +QL + +++
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILL----NSKLEAFVADFGVARLLHS---DSSNRT 251
+ + YLH + ++HRD+ NIL+ + +AD G ARL +S ++
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 252 VVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVL 287
V T Y APEL T+ D++ G + E+L
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 97 IGTGGYGSV---YRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLY 153
IG+G G V Y A L + VA+KKL + E L+ + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 154 GFCLHKKCM------FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
+K + +++ + M +L V++ ++LD + ++ M + +LH
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH 143
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
I+HRD+ +NI++ S + DFG+AR + V T Y APE+
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILG 199
Query: 268 MVVTEKCDVFGFGVVALEVLMGR--HPG-DLLSSFNPKI 303
M E D++ G + E++ G PG D + +N I
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 91 FDIKYC-IGTGGYGSVYRAQLPSG---KIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
F+ + C +G G YG VY+A+ G + ALK++ + + S E LL +++H
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM----SACREIALLRELKH 57
Query: 147 RNIVKLYGFCLH--KKCMFLIYKYMRRGSLFCVL------RNDDEAIQLDWTKRVNIVKS 198
N++ L L + ++L++ Y L+ ++ + + + +QL +++
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILL----NSKLEAFVADFGVARLLHS---DSSNRT 251
+ + YLH + ++HRD+ NIL+ + +AD G ARL +S ++
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 252 VVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVL 287
V T Y APEL T+ D++ G + E+L
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 19/194 (9%)
Query: 107 RAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166
R P K+VA + + E + A+ S E L+ H IVK + + LI
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYARS---ELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY---LHYDCIPS--IVHRDISS 221
+Y G L ++ I+ + + + L Y L D + S ++HRD+ S
Sbjct: 145 EYGSGGDL-------NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197
Query: 222 NNILLNSKLEAFVADFGVARLLHSDSSNRTVVA---GTHGYIAPELAYTMVVTEKCDVFG 278
NI L + DFG ++ +SDS + V + GT Y+APEL ++K D++
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQ-YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256
Query: 279 FGVVALEVLMGRHP 292
GV+ E+L P
Sbjct: 257 LGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 4/111 (3%)
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
AL++LH I++RD+ +N+LL+++ + D+G+ + + GT YIA
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLL-SSFNPKIMLIDLLDQ 311
PE+ D + GV+ E++ GR P D++ S NP D L Q
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 22/206 (10%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEAR-LLSQIRHRN----IV 150
IG GG+G VY + +GK+ A+K L ++ E+ R +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVKSMAHALSYLH 207
Y F K F I M G L L EA + + + L ++H
Sbjct: 62 MSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL------GLEHMH 114
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAY 266
+V+RD+ NILL+ ++D G+A + +V GTHGY+APE L
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPEVLQK 169
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHP 292
+ D F G + ++L G P
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 7/83 (8%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVV 270
+HRD+++ NILL+ + DFG+AR ++ D V G ++APE + V
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVY 258
Query: 271 TEKCDVFGFGVVALEVL-MGRHP 292
T + DV+ FGV+ E+ +G P
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 48/232 (20%)
Query: 91 FDI--KYC----IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQ 143
FD+ +Y +G G G V+ A K VA+KK+ T+ ++ E +++ +
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRR 58
Query: 144 IRHRNIVKLY--------------GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDW 189
+ H NIVK+Y G ++++ +YM L N E L
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSE 113
Query: 190 TKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSS 248
+ + L Y+H +++HRD+ N+ +N++ L + DFG+AR++ S
Sbjct: 114 EHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170
Query: 249 NR-----TVVAGTHGYIAPELA-----YTMVVTEKCDVFGFGVVALEVLMGR 290
++ +V T Y +P L YT + D++ G + E+L G+
Sbjct: 171 HKGYLSEGLV--TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 20/142 (14%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH----GYIAPELAYTMVV 270
VHRD+++ N+LL + DFG+AR + DS+ V G+ ++APE + +
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDNLY 316
Query: 271 TEKCDVFGFGVVALEVL-MG--RHPGDLL-SSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
T DV+ +G++ E+ +G +PG ++ S+F KI R P + DI
Sbjct: 317 TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK----SGYRMAKPDHATQEVYDI 372
Query: 327 ILVSKIAFACLRSKPKSRPTMR 348
++ C S+P+ RP+
Sbjct: 373 MV------KCWNSEPEKRPSFL 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG- 154
IG+G G V A +G+ VA+KKL + + E L+ + H+NI+ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 155 FCLHKKC-----MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
F K ++L+ + M +L V++ D LD + ++ M + +LH
Sbjct: 84 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHS- 136
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
I+HRD+ +NI++ S + DFG+AR + V T Y APE+ M
Sbjct: 137 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMG 193
Query: 270 VTEKCDVFGFGVVALEVLMGR--HPGD 294
E D++ G + E++ G PG
Sbjct: 194 YKENVDIWSVGCIMGEMIRGTVLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 57/227 (25%)
Query: 97 IGTGGYG---SVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKL 152
+G G YG S A+ + VA+KK+ + ++ + E +LL R H+NI L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM-----AH------ 201
Y M +++ L+ +E ++ D + I++S AH
Sbjct: 68 YD-------MDIVFPGNFNE-LYLY----EELMEADLHQ---IIRSGQPLTDAHFQSFIY 112
Query: 202 ----ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAG-- 255
L Y+H +++HRD+ N+L+N+ E + DFG+AR S N AG
Sbjct: 113 QILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR---GFSENPGENAGFM 166
Query: 256 -----THGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
T Y APE+ +YT + DV+ G + E L+GR P
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAI----DVWSVGCILAE-LLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 97 IGTGGYGSVYRAQLPSG---KIVALKKLHHS---ETELAFLESFQTEARLLSQIRHRNIV 150
IG G +G V ++ SG V +K+L S + ++ FLE EA+ ++H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE----EAQPYRSLQHSNLL 58
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQL--DWTKRVNIVKSMAHALSYLHY 208
+ G C L+ ++ G L LR+ +A + D T + +A L +LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD----SSNRTVVAGTHGYIAPEL 264
+ + +H D++ N LL + L + D+G++ + + + ++ V +IAPEL
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR--WIAPEL 173
Query: 265 -----AYTMVV--TEKCDVFGFGVVALEVL-MGRHP 292
+VV T++ +V+ GV E+ +G P
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 18/168 (10%)
Query: 137 EARLLSQIRHRNIVKLYGFCLHK----KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR 192
EARLL ++ H ++ L + C+ L KY R L+ L L +
Sbjct: 210 EARLLRRLSHPAVLALLD--VRVVGGLTCLVLP-KY--RSDLYTYL--GARLRPLGLAQV 262
Query: 193 VNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
+ + + A+ Y+H + I+HRDI + N+L+N + + DFG A S
Sbjct: 263 TAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319
Query: 253 --VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSS 298
+AGT APE+ T D++ G+V E + H L S+
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAV--HTASLFSA 365
|
Length = 461 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 24/165 (14%)
Query: 93 IKYCIGTGGYGSVYRAQLPSGKIV---ALKKLHHSETELAFLE-----SFQTEARL---- 140
I IG GG+G VY Q S + A+ K+ + E E +E + ++
Sbjct: 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWK 75
Query: 141 -LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ--LDWTKRV--NI 195
+ I H I K YG K+C + Y+++ L N E + K++ NI
Sbjct: 76 NIHNIDHLGIPKYYGCGSFKRCR-MYYRFILLEKLV---ENTKEIFKRIKCKNKKLIKNI 131
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240
+K M L Y+H I H DI NI+++ ++ D+G+A
Sbjct: 132 MKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 54/248 (21%), Positives = 99/248 (39%), Gaps = 65/248 (26%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSET----ELAFLESFQTEARLLSQIRHRNIVK 151
IG G +G V ++ + + A+K L ++ + A +++ E +L++ + +VK
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQL----DWTKRVNIVKSMAHALSYLH 207
LY K ++ + Y+ G + +L I+L + R I + + A+ +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLL------IRLGIFEEDLARFYIAE-LTCAIESVH 118
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVA---RLLH-------------------- 244
+HRDI +NIL++ + DFG+ R H
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 245 --SDSSNRTV------------------VAGTHGYIAPELAYTMVVTEKCDVFGFGVVAL 284
S+ + + GT YIAPE+ T+ CD + GV+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 285 EVLMGRHP 292
E+L+G+ P
Sbjct: 236 EMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 53/251 (21%), Positives = 101/251 (40%), Gaps = 67/251 (26%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSE----TELAFLESFQTEARLLSQIRHRNIVK 151
+G G +G V A ++ + + A+K L + ++A +++ E +L++ + +VK
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKA---ERDILAEADNEWVVK 65
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDD---EAIQLDWTKRVNIVKSMAHALSYLHY 208
LY K ++ + Y+ G + +L + E + + + + H + +
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF--- 122
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVA---RLLHS-------------------- 245
+HRDI +NIL++ + DFG+ R H+
Sbjct: 123 ------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 246 --DSSN-------RTV---------------VAGTHGYIAPELAYTMVVTEKCDVFGFGV 281
D SN +T+ + GT YIAPE+ T+ CD + GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 282 VALEVLMGRHP 292
+ E+L+G+ P
Sbjct: 237 ILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 24/149 (16%), Positives = 53/149 (35%), Gaps = 19/149 (12%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV--KLYG 154
+ G VY V LK E + E +L + + + K+
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKINPSREKGADR----EREVAILQLLARKGLPVPKVLA 60
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214
+L+ +++ + ++ ++ +I + +A L+ LH + +
Sbjct: 61 SGESDGWSYLLMEWI----------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVL 110
Query: 215 VHRDISSNNILL-NSKLEAFVADFGVARL 242
H D+ NIL+ + K+ + D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGII-DWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 4/76 (5%)
Query: 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH---GYIAPELAYTMVVT 271
VHRD+++ N+L+ + DFG+AR + DS N T ++APE + + T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDS-NYISKGSTFLPLKWMAPESIFNNLYT 319
Query: 272 EKCDVFGFGVVALEVL 287
DV+ FG++ E+
Sbjct: 320 TLSDVWSFGILLWEIF 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 361 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.21 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.77 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.71 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.42 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.41 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.4 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.28 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.23 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.19 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.1 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.06 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.94 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.84 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.81 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.81 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.7 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.5 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.44 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.44 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.44 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.37 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.31 | |
| PLN02236 | 344 | choline kinase | 97.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.07 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.94 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.79 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.69 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.68 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.52 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.27 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.27 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.23 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.06 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.92 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.89 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.6 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.39 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 95.37 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-56 Score=401.87 Aligned_cols=272 Identities=38% Similarity=0.643 Sum_probs=226.7
Q ss_pred CCCCcCHHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 042457 75 YDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154 (361)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 154 (361)
....++++++..+|++|+..+.||+|+||.||+|.+++|+.||||++....... ..+|.+|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 345689999999999999999999999999999999999999999887765542 356999999999999999999999
Q ss_pred EEeeCC-eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeE
Q 042457 155 FCLHKK-CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF 233 (361)
Q Consensus 155 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k 233 (361)
||.+.+ ..+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+.+.+.|+||||||+|||+|+++++|
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 999998 599999999999999999986654 789999999999999999999999988999999999999999999999
Q ss_pred EeeecCccccCCCCCCcccc-cccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcc---h------
Q 042457 234 VADFGVARLLHSDSSNRTVV-AGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK---I------ 303 (361)
Q Consensus 234 l~Dfg~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~------ 303 (361)
|+|||+++............ .||.+|+|||+...+..+.|+||||||++|+||+||+.+.+........ .
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999996654311111222 7999999999999999999999999999999999999887753311111 1
Q ss_pred ---hHhhhhcccCCCCCCChhh-HHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 304 ---MLIDLLDQRAPSPIDDQTV-IQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 304 ---~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...++++..+.. .... ...+..+..++..|++.+|.+||+|.|+++
T Consensus 298 ~~~~~~eiiD~~l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HCcchhheeCCCccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 122233333221 1112 156667999999999999999999999764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=380.26 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=219.9
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-eEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK-CMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 167 (361)
+++..+.||+|..|+||++.++ +++.+|+|++... .+.+..+++.+|+++++..+||+||.+||.|..+. ...++||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 3445677999999999999764 6889999999443 34455688999999999999999999999999998 5999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||++|+|++++...+ .+++...-+++.+|++||.|||+ + +|+||||||+|||++..|++||+|||.+..+...
T Consensus 159 YMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999998764 58999999999999999999996 6 9999999999999999999999999999887554
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCc--ccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLL--SSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+... ...+.-..+..++.+..+......
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~---- 306 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGE---- 306 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCccc----
Confidence 445567999999999999999999999999999999999999998764 223444556677776655443331
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...++..++..||++||.+|||++|+++|||+++.
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 12258899999999999999999999999999863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=393.55 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=223.6
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.+|...+.||+|||+.+|.++. .+|+.||+|++..... .....+...+|+++.+.++|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999976 8899999999976432 2223577889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|+|++++|..+++... ++++.+++.++.||+.||.|||++ +|+|||||..|+++++++++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998544 799999999999999999999999 9999999999999999999999999999999888
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.......+||+.|.|||++....++..+||||+||+||-|+.|++||+... .......+.......|.....
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~---vkety~~Ik~~~Y~~P~~ls~----- 243 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT---VKETYNKIKLNEYSMPSHLSA----- 243 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---HHHHHHHHHhcCcccccccCH-----
Confidence 788888899999999999999999999999999999999999999998543 223334444444444433222
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
+..+||.++|++||.+|||+++||.|+||+..
T Consensus 244 -~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 244 -EAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred -HHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 37788999999999999999999999999653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=377.25 Aligned_cols=262 Identities=25% Similarity=0.351 Sum_probs=216.2
Q ss_pred HhcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchH-----HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETEL-----AFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
..+.|.+.+.||+|+||.|-+| ..++|+.||||++....... .......+|+++|++++|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3455777889999999999999 55689999999997654321 11234579999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC---CCeEEeee
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK---LEAFVADF 237 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Df 237 (361)
..|+||||++||.|.+.+-.+. .+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999987765 467777789999999999999999 99999999999999766 77999999
Q ss_pred cCccccCCCCCCccccccccccccccccccccc---CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV---TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP 314 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 314 (361)
|+|+... ........+||+.|.|||++.+... ..+.|+||+||+||-+++|.+||.+... .......+..++..
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~--~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT--DPSLKEQILKGRYA 400 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC--CccHHHHHhcCccc
Confidence 9999875 4455667889999999999876543 3478999999999999999999985442 33345666666665
Q ss_pred CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.....+ .+-.++..+||.+||..||++|||+.|+|+||||+..
T Consensus 401 f~p~~w--~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 401 FGPLQW--DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred ccChhh--hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 433322 2223468899999999999999999999999999853
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=384.68 Aligned_cols=252 Identities=31% Similarity=0.532 Sum_probs=207.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-eEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK-CMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 166 (361)
..++.+.+.+|+|+||+||+|.+.+...||||++..........+.|.+|+.+|.+++|||||+++|+|.... ..++||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3344445569999999999999954444999999877654444689999999999999999999999999987 799999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEEeCCCCCCeeeCCCC-CeEEeeecCccccC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS-IVHRDISSNNILLNSKL-EAFVADFGVARLLH 244 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~ 244 (361)
||+++|+|..+++.. ....+++..+++++.|||+||.|||++ + |+||||||+|||++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999874 223799999999999999999999999 7 99999999999999997 99999999998765
Q ss_pred CCCCCccccccccccccccccc--ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh-cc-cCCCCCCCh
Q 042457 245 SDSSNRTVVAGTHGYIAPELAY--TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL-DQ-RAPSPIDDQ 320 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~ 320 (361)
......+...||..|||||++. ...++.|+||||||++||||+||+.||...... .....+. .. ++..+...
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~~~~Rp~~p~~~- 271 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVVGGLRPPIPKEC- 271 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcCCCCCCCccC-
Confidence 4433444467999999999999 569999999999999999999999999876651 1222222 22 22222222
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+..++.+||+.||+.||++.+++.
T Consensus 272 -----~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 -----PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -----CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 224788888999999999999999873
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-53 Score=378.43 Aligned_cols=254 Identities=28% Similarity=0.483 Sum_probs=210.9
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
+.+++..+.+.+.+.||+|.||+||.|.++....||+|.++...... +.|.+|+++|++++|+|||+++|+|..++.
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 34445555666778899999999999999877799999998865543 678899999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
++||||||+.|+|.++|+... ...++..+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+++
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred eEEEEEecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence 999999999999999999833 23689999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCc-ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhh-cccCCCCCC
Q 042457 242 LLHSDSSNR-TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLL-DQRAPSPID 318 (361)
Q Consensus 242 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 318 (361)
....+.... ....-...|.|||.+..+.++.|||||||||+||||+| |+.|+...+..+ .+..+- ..+++.|..
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLELLERGYRLPRPEG 428 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHHHHhccCcCCCCCC
Confidence 554444322 22234568999999999999999999999999999999 999987655322 222222 224445544
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
.+. .+.+++..||+.+|++|||++.+.
T Consensus 429 CP~------~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 429 CPD------EVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCH------HHHHHHHHHhhCCcccCCCHHHHH
Confidence 333 488999999999999999998654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=358.69 Aligned_cols=259 Identities=26% Similarity=0.462 Sum_probs=212.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..+|.+.+.||+|+||+||+|++. ++..||||.+....-.....+.+..|+.+|+.++|||||++++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999999999999764 5899999999887655556788999999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC------CCeEEeeecCc
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK------LEAFVADFGVA 240 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~------~~~kl~Dfg~~ 240 (361)
|||.||+|.++++..+ .+++...+.++.|+|.||++||++ +|+||||||.|||++.. -.+||+|||++
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999876 699999999999999999999999 99999999999999765 45899999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
+.+.. .......+|++-|||||++...+|+.|+|+||+|+++||+++|+.||+.... ...+..+.......+....
T Consensus 163 R~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~---~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 163 RFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP---KELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred hhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH---HHHHHHHhccccccCchhh
Confidence 98863 3334556899999999999999999999999999999999999999885443 1111111111111111100
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.....+.+++...++.+|.+|-++.+-+.|+++...
T Consensus 239 ---~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 239 ---ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ---hccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 011124567778888999999999999999988654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-51 Score=351.93 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=222.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
..++|++.+.||+|+||+||.++. ++++.+|+|++++...- ....+...+|..+|.+++||.||+++-.|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356799999999999999999954 56899999999876432 2245788899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|+||+.||.|..+|++.+ .+++..+.-++..|+.||.|||+. +|+||||||+|||+|++|.++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999998776 699999999999999999999999 99999999999999999999999999999766
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC-ChhhH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID-DQTVI 323 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 323 (361)
.........+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+ .......+...+...+.. .+.
T Consensus 177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~---~~~~~~~I~~~k~~~~p~~ls~-- 251 (357)
T KOG0598|consen 177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED---VKKMYDKILKGKLPLPPGYLSE-- 251 (357)
T ss_pred cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc---HHHHHHHHhcCcCCCCCccCCH--
Confidence 66666667899999999999999999999999999999999999999987543 344455566665333222 221
Q ss_pred HHHHHHHHHHhhhcCCCCCCCC----CccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRP----TMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RP----s~~eil~hp~~~~ 358 (361)
...+++.+.|+.||++|. ++.+|-+||||+.
T Consensus 252 ----~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 252 ----EARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred ----HHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 377888999999999995 7899999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-52 Score=345.77 Aligned_cols=263 Identities=25% Similarity=0.379 Sum_probs=221.8
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
+.|+...++|+|+||.||+++.+ +|+.||||++..+..+....+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 34677788999999999999765 69999999999888877777888999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
||+..-|.++=+... .++...+.+++.|++.|+.|+|++ +++||||||+|||++.++.+||||||+|+.+..+.
T Consensus 82 ~~dhTvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 999877766554444 478899999999999999999999 99999999999999999999999999999998777
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc---------------
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ--------------- 311 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------------- 311 (361)
...+.++.|..|.|||.+.+ .+|....||||+||++.||++|.+.|...++.+.-......+..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 77788889999999999887 78999999999999999999999999887776544433332222
Q ss_pred ---cCCCCCCChhhH----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 312 ---RAPSPIDDQTVI----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 312 ---~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
..|.+...+... .....+.++++.||+.||.+|+|.+|++.||||+
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 112222211111 1122478999999999999999999999999994
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=381.62 Aligned_cols=257 Identities=26% Similarity=0.449 Sum_probs=213.5
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEE
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 155 (361)
.-.++...+....+.||+|+||+||+|+.. +...||||.++...... ...+|++|++++..++|||||+++|+
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-ARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-HHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 334556677788889999999999999653 34579999999876653 35889999999999999999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCc-----------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCe
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDE-----------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNI 224 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Ni 224 (361)
|.+++..++|+|||..|+|.++|+...+ ..+++..+.+.|+.|||.||.||-++ .+|||||..+|+
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNC 634 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNC 634 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhc
Confidence 9999999999999999999999975321 23489999999999999999999999 999999999999
Q ss_pred eeCCCCCeEEeeecCccccCCCCCCcc--cccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCc
Q 042457 225 LLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNP 301 (361)
Q Consensus 225 ll~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 301 (361)
||.++..|||+|||+++.+.+..+... ...-..+|||||.++.+++|.+||||||||+|||+++ |+.||...+.
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--- 711 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--- 711 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---
Confidence 999999999999999998765443321 2234679999999999999999999999999999999 9999876553
Q ss_pred chhHhhhhcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 302 KIMLIDLLDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 302 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
...+..+..++. +.|...+ .++++|+..||+.+|.+|||++||-
T Consensus 712 ~EVIe~i~~g~lL~~Pe~CP------~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 712 QEVIECIRAGQLLSCPENCP------TEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHHcCCcccCCCCCC------HHHHHHHHHHhhcCcccCCCHHHHH
Confidence 334444444443 3333322 3599999999999999999999973
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=366.21 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=221.3
Q ss_pred hcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
...|..-.+||+|+.|.||.+ +..+++.||||++....... .+-+.+|+.+|+..+|+|||+++..|...+.+|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 345777788999999999999 45678999999997765543 366889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|||+||+|.+.+... .+++.++..|++.+++||+|||.+ +|+|||||.+|||++.+|.+||+|||+|..+...
T Consensus 350 Eym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 999999999998766 489999999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
...+...+||+.|||||+.....|.++.||||||++++||+-|.+||-... +...+.-+.....+.........
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---PlrAlyLIa~ng~P~lk~~~klS--- 496 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIATNGTPKLKNPEKLS--- 496 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---hHHHHHHHhhcCCCCcCCccccC---
Confidence 777888899999999999999999999999999999999999999976533 33344444444444332222221
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++.+||+.|+++|+|++|+|+||||+.
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 24889999999999999999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=341.11 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=208.4
Q ss_pred CCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeE-EEeeCCe-EEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG-FCLHKKC-MFLIY 166 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~ 166 (361)
+|.+.++||+|+||+||++ ...+|..+|.|.++-...+....+....|+.+|++++|||||++++ .+.+++. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4666778999999999999 5678999999999877666666788999999999999999999999 4444444 89999
Q ss_pred EeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 167 KYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIP-SIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~-~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|+|.+|+|..+++... ....+++..+++++.|++.||.++|+.... .+.||||||.||+++.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999987632 334689999999999999999999994321 38999999999999999999999999999998
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
+........+|||.||+||.+.+..|+.+|||||+||++|||..-++||.... .......+..... ++..+....
T Consensus 180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~KI~qgd~-~~~p~~~YS- 254 (375)
T KOG0591|consen 180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCKKIEQGDY-PPLPDEHYS- 254 (375)
T ss_pred chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHHHHHcCCC-CCCcHHHhh-
Confidence 88877888899999999999999999999999999999999999999998652 1222233333322 223322222
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCc
Q 042457 325 DIILVSKIAFACLRSKPKSRPTM 347 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~ 347 (361)
..+..|+..|+..||+.||+.
T Consensus 255 --~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 255 --TDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred --hHHHHHHHHHccCCcccCCCc
Confidence 248889999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=351.21 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=208.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC--eEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK--CMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l 164 (361)
..++...+.||+|+||.||++... +|...|||.....+... .+.+.+|+.+|++++|||||+++|...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 345667788999999999999765 48999999987764333 577889999999999999999999855544 6999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-CCCeEEeeecCcccc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLL 243 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~ 243 (361)
.|||+++|+|.+++.+.+. .+++..+.++..||++||+|||++ +++||||||+|||++. ++.+||+|||++...
T Consensus 94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999999988764 589999999999999999999999 9999999999999999 799999999999877
Q ss_pred CCCC---CCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 244 HSDS---SNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 244 ~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
.... .......||+.|||||++..+ ....++|||||||++.||+||+.||... .........+......+....
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P~ip~ 246 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLPEIPD 246 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCCCCCc
Confidence 6311 223346799999999999853 3445999999999999999999999875 222222333332221111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
. ......+++.+|++.||++|||++++|+|||+++.
T Consensus 247 ~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 247 S----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred c----cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1 11247889999999999999999999999999763
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=359.33 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=218.4
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch---HHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCC
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE---LAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKK 160 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 160 (361)
...++|.+.+.||+|+||.|+.|.. .+|..||+|.+...... ....+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4456799999999999999999954 47899999976654111 122456668999999998 999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeeecC
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGV 239 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~ 239 (361)
..++||||+.||+|.+++.+.+ ++.+....+++.|++.|++|||++ +|+||||||+|+|+|.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998844 688899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccc-cC-ccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCC
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMV-VT-EKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (361)
+.............+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||++. +.......+.......+.
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~---~~~~l~~ki~~~~~~~p~ 244 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS---NVPNLYRKIRKGEFKIPS 244 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc---cHHHHHHHHhcCCccCCC
Confidence 987753444556678999999999999876 75 7999999999999999999999872 223334445555555554
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
... ...+..|+.+|+..||.+|+|+.+|++||||++
T Consensus 245 ~~~-----S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 245 YLL-----SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CcC-----CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 431 124788999999999999999999999999997
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=356.63 Aligned_cols=265 Identities=21% Similarity=0.328 Sum_probs=216.2
Q ss_pred HHhcCCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCC-eE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKK-CM 162 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~ 162 (361)
...++|.+.++||.|.||.||+|+ ..+|..||||+++..-...+. -.-++|+..|++++ ||||+++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 345678889999999999999995 457899999999876554332 23458999999998 999999999999988 89
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++|||||+ .+|+.+++..+ ..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+.
T Consensus 86 ~fVfE~Md-~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeeHHhhh-hhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 99999995 59999998773 3799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCccccccccccccccccc-ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCC----
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI---- 317 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 317 (361)
+.+.+. .+.++.|..|.|||++. .+.|+.+.|+|++|||++|+.+-++.|.+.++.|.-....+++........
T Consensus 160 v~SkpP-YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 160 VRSKPP-YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cccCCC-cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 865443 34567899999999765 678999999999999999999999998877765544444333332111110
Q ss_pred ------------CChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 318 ------------DDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 318 ------------~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...... .......+++.+|+++||.+|||++|.|+||||+.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 000111 12345789999999999999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=345.19 Aligned_cols=265 Identities=25% Similarity=0.421 Sum_probs=221.0
Q ss_pred HHhcCCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
...+.|++...||.|..++||+|. .+.++.||||++........ .+.+.+|+..|+.++||||++++..|..+..+|+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 445679999999999999999994 56789999999987665544 7889999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||.||.+|++.+++...-.. .+++..+..|++++++||.|||++ |.+|||+|+.|||++++|.+||+|||.+..+.
T Consensus 102 VmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999864332 489999999999999999999999 99999999999999999999999999876654
Q ss_pred CCCCCc----ccccccccccccccccc--cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 245 SDSSNR----TVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 245 ~~~~~~----~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
...... ....||+.|||||++.. ..|+.|+||||||+...||.+|+.||..+.. -.++...+.+.++.+..
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKVLLLTLQNDPPTLLT 254 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHHHHHHhcCCCCCccc
Confidence 433222 44579999999999653 4589999999999999999999999886554 33344455555543322
Q ss_pred C----hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 319 D----QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. +........+.+++..||++||.+|||+.++|+|+||++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~ 298 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK 298 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence 1 112222345889999999999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=354.46 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=219.9
Q ss_pred HHhcCCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETE-LAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
...++|.+.+.||+|+|++|++|+ ...++.+|||++.+..-- .....-+..|-+.|.+| .||.|++++-.|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 445679999999999999999995 457899999998654321 11234566788889999 899999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
|+|+||+++|+|.++|++.+ .+++.-.+.++.+|+.||+|||++ |||||||||+|||+|+|++++|+|||-++.
T Consensus 150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999999876 699999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCC-----------C--cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh
Q 042457 243 LHSDSS-----------N--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 243 ~~~~~~-----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 309 (361)
+..... . ....+||..|.+||++.....+..+|+|+|||++|+|+.|++||....+ ......++
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~ 300 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQ 300 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHH
Confidence 743211 1 1447899999999999999999999999999999999999999876543 34455666
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 310 DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.-....+...+. .+.+|+++.|..||.+|+|.+||-+||||..
T Consensus 301 ~l~y~fp~~fp~------~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 301 ALDYEFPEGFPE------DARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HhcccCCCCCCH------HHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 666655555442 3788999999999999999999999999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=350.01 Aligned_cols=267 Identities=24% Similarity=0.356 Sum_probs=216.3
Q ss_pred hcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 164 (361)
.+.|+.+++||+|.||.||+| ...+|+.||+|++...........-..+|+.+|++++||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 345777888999999999999 456899999999988876666667788999999999999999999998876 68999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|+|||++ +|..++.... ..++..++..++.|++.||+|+|.+ ++.|||||.+|||||++|.+||+|||+|+.+.
T Consensus 196 VFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 8888887654 3699999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCC-cccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCC------
Q 042457 245 SDSSN-RTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP------ 316 (361)
Q Consensus 245 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 316 (361)
..... .+..+-|..|.|||++.+ ..|+.+.|+||.||||.||++|++.|....+.++...+..++.......
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 65433 455678999999998886 4699999999999999999999999877665433333322222211100
Q ss_pred --------CC-ChhhHH-----HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 317 --------ID-DQTVIQ-----DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 317 --------~~-~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
.. ...... ......+|+..+|..||.+|.|+.++|+|+||+.+.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 00 000011 113467899999999999999999999999996543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=322.74 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=217.5
Q ss_pred cCCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.+|...+.||+|.||.||+|+ ..+|+.||||+++..+..........+|++.|+.++|+||+.++++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357778889999999999994 5689999999998876554445678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
||+ .+|+..+++... .++..++..++.++++|++|||.+ .|.||||||.|+|++.+|.+||+|||+++.+....
T Consensus 82 fm~-tdLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 599999987653 689999999999999999999999 99999999999999999999999999999987766
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC-------------
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA------------- 313 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 313 (361)
......+.|..|.|||.+.| ..|+...|+||.||++.||+.|.+-|...++.++-....+.+....
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 66555578999999998875 5689999999999999999999988876665443333322222211
Q ss_pred ------CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 314 ------PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 314 ------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+.+..............+|+.+++..||.+|+|+.|+|+|+||+.
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 111111111112234689999999999999999999999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=357.08 Aligned_cols=263 Identities=25% Similarity=0.435 Sum_probs=218.1
Q ss_pred CcCHHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 042457 78 RITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCL 157 (361)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 157 (361)
+.+.++|++..+++.+...||+|+||+||+|.| -|. ||||++.....+.+..+.|..|+..+++-+|.||+-+.|+|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w-hGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRW-HGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccc-ccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 345688899999999999999999999999998 444 999999998888888999999999999999999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
.+.. .||+.||+|.+|+.+++-... .++..+.+.|+.|||+||.|||.+ +|+|+|||+.||++.++++|||+||
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 9887 999999999999999987664 689999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCC--CCCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 238 GVARLLHSD--SSNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 238 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
|++...... ........|...|||||++. ..+|+..+||||||+++|||+||..||.. .. .+..+..+-.+
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~--~dqIifmVGrG- 608 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QN--RDQIIFMVGRG- 608 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CC--hhheEEEeccc-
Confidence 998754332 22333455788999999886 45789999999999999999999999882 22 11112222222
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+............+.+|+..||..++++||++.+||.
T Consensus 609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1112222222334446899999999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=322.04 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=221.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|+..+.||.|+||.|.+++.+ +|..+|+|++....- ...+.+...+|..+|+.+.||.++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45778889999999999999765 688999999976643 4455688899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||.+||-|.+++++.+ +++....+.++.+|+.||+|||+. +|++|||||+|||+|.+|.+||+|||+++.....
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999999877 699999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.-+.+||+.|+|||++.+..+..++|.||||+++|||+.|.+||..... ......++......|......
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~fP~~fs~~---- 267 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVKFPSYFSSD---- 267 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcccCCcccCHH----
Confidence 4456899999999999999999999999999999999999999875443 455677777777666554443
Q ss_pred HHHHHHHhhhcCCCCCCC-----CCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSR-----PTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~R-----Ps~~eil~hp~~~~ 358 (361)
+.+|+...++.|-.+| +-..+|-.||||+.
T Consensus 268 --~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 268 --AKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred --HHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 7788889999999999 46679999999986
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=348.26 Aligned_cols=249 Identities=23% Similarity=0.296 Sum_probs=205.4
Q ss_pred CeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 95 YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
+.||+|+||.||++.. .+|+.||+|++..... .......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3599999999999965 4789999999875432 2223456788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccc
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 252 (361)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 9999987654 589999999999999999999999 9999999999999999999999999998754333333444
Q ss_pred ccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHH
Q 042457 253 VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKI 332 (361)
Q Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 332 (361)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+... ...+.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~~p~~~------~~~~~~l 225 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEIRFPRTL------SPEAKSL 225 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCC------CHHHHHH
Confidence 5699999999999999999999999999999999999999864322 222222332222222211 1247889
Q ss_pred HhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 333 AFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 333 i~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
+.+||+.||++|| ++.++++||||+.
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=344.94 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=216.4
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
...++|+++..||+|+||+||+++. .+|..+|+|+++.+.. ...+++.+..|-.+|...++|.||+++-.|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3557899999999999999999954 5799999999998765 3445688999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
|||||.+||++..+|...+ .|++..+..++.+.+.|+..||+. |++||||||+|+|||..|++||+|||++..+
T Consensus 218 LiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999998776 699999999999999999999999 9999999999999999999999999998543
Q ss_pred CC-----------------------CCC-----Cc-------------------ccccccccccccccccccccCccchh
Q 042457 244 HS-----------------------DSS-----NR-------------------TVVAGTHGYIAPELAYTMVVTEKCDV 276 (361)
Q Consensus 244 ~~-----------------------~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv 276 (361)
.. +.. .. ...+|||.|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 21 000 00 01359999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc--CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC---ccccc
Q 042457 277 FGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR--APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT---MRRSF 351 (361)
Q Consensus 277 ~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil 351 (361)
||||||||||+.|.+||..... ......+...+ +..|...... .+..+||.+|+. ||++|.- ++||-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp---~~T~rkI~nwr~~l~fP~~~~~s----~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETP---QETYRKIVNWRETLKFPEEVDLS----DEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhhhccCCCcCccc----HHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 9999999999999999875443 33333343333 2233222222 357889999999 9999985 99999
Q ss_pred cCCCCCC
Q 042457 352 PNPEINP 358 (361)
Q Consensus 352 ~hp~~~~ 358 (361)
+||||+.
T Consensus 444 ~HPfF~~ 450 (550)
T KOG0605|consen 444 KHPFFKG 450 (550)
T ss_pred cCCcccc
Confidence 9999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=351.59 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=222.2
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|.+.+.||+|+||.||||+. .+.+.||+|.+.+.......++.+.+|+++++.++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4677788899999999999954 468899999998877777778899999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+.| +|..+|.... .++++.+..++.++..||.|||+. +|.|||+||.|||++.++.+|++|||+++......
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9977 9999998776 699999999999999999999999 99999999999999999999999999999887766
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
...+...||+-|||||+..+..|+..+|.||+||++||+++|++||-..+. ......+.......+.... .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si---~~Lv~~I~~d~v~~p~~~S------~ 225 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI---TQLVKSILKDPVKPPSTAS------S 225 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH---HHHHHHHhcCCCCCccccc------H
Confidence 666677899999999999999999999999999999999999999864332 1223334444443333222 2
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.+..++...|.+||.+|.|-.+++.|||++..
T Consensus 226 ~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 37788889999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=367.97 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=213.7
Q ss_pred cCCCCcCeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
....+.+.||.|.||+||+|+++- ...||||.++....+. +..+|+.|+.+|.+++||||+++.|+......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek-qrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH-HHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 345677899999999999997752 3479999999876554 46899999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|+|||+||+|+.+|+.+++ ++++.+..-++++||.||.||.+. ++|||||.++||||+.+..+|++|||+++.+.
T Consensus 708 iTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999998875 599999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCCCc-ccccc--cccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 245 SDSSNR-TVVAG--THGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 245 ~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
.+.... +...| ..+|.|||.+...+++.++||||||++|||.++ |..||.+.+..+ ....--.+.++|.|++.+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--VIkaIe~gyRLPpPmDCP 860 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VIKAIEQGYRLPPPMDCP 860 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--HHHHHHhccCCCCCCCCc
Confidence 665332 22222 469999999999999999999999999999998 999988766422 222222334566777655
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.. +.+|+++||++|-.+||++.||+.+
T Consensus 861 ~a------L~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AA------LYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HH------HHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 43 8889999999999999999999854
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=339.99 Aligned_cols=258 Identities=23% Similarity=0.273 Sum_probs=206.8
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.|+..+.||+|+||.||++.. .+|+.||+|.+...... ......+.+|+.+++.++|+|++++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999965 57899999998654322 2223467889999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999888754322 2589999999999999999999999 99999999999999999999999999997653322
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh-hhcccCCCCCCChhhHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID-LLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 326 (361)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.............. +.......+... .
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------s 229 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKF------S 229 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccC------C
Confidence 22334689999999999999999999999999999999999999975443221111111 111111111111 1
Q ss_pred HHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
..+.+|+.+||+.||.+||+ ++++++||||++
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 24788999999999999997 899999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=326.23 Aligned_cols=266 Identities=23% Similarity=0.267 Sum_probs=216.2
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--CCeEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--KKCMFLI 165 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 165 (361)
++|+..+.|++|+||.||+|+. .+++.||+|+++........--..++|+.+|.+++|||||.+-.+... -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4577788899999999999965 478999999998876544434456799999999999999999888764 3569999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
||||++ +|.+++.+-. .++...+...++.|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999976 8999988755 3689999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC-----
Q 042457 246 DSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD----- 319 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 319 (361)
+....+..+-|..|.|||++.+ ..|+.+.|+||+|||+.|++++++.|...+..++-....+.+..........
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 8777777788999999998876 5689999999999999999999999887776554443333332211100000
Q ss_pred ------------hh---hHH---HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 320 ------------QT---VIQ---DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 320 ------------~~---~~~---~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
.. ... ....-.+|+..+|..||.+|.|++|.|+|+||.+..
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 00 000 113456889999999999999999999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=341.86 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=209.8
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999764 689999999865432 2223467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++.....++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997654 588999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.......+....
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~------ 222 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYEKILAGKLEFPRHLD------ 222 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCcCCCccCC------
Confidence 2234589999999999988899999999999999999999999875432 2223333333333222211
Q ss_pred HHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+||+ ++++++||||+.
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 24788999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=346.77 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=210.3
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999764 688999999875432 2233467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999997654 578889999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+...+
T Consensus 172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~p~~~~------ 239 (329)
T PTZ00263 172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEKILAGRLKFPNWFD------ 239 (329)
T ss_pred c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCCcCCCCCCC------
Confidence 2 234689999999999998899999999999999999999999865332 2223334444333332211
Q ss_pred HHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+||+ ++++++||||++
T Consensus 240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 13778999999999999997 799999999976
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=343.50 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=203.7
Q ss_pred eeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
||+|+||.||++... +++.||+|.+..... .......+..|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999764 588999999865321 223346788999999999999999999999999999999999999999
Q ss_pred hhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccccc
Q 042457 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254 (361)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 254 (361)
.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||+++.............
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 99997654 589999999999999999999999 999999999999999999999999999876433333334456
Q ss_pred ccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHh
Q 042457 255 GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAF 334 (361)
Q Consensus 255 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 334 (361)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+...+ ..+.+++.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~li~ 225 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NEMYRKILQEPLRFPDGFD------RDAKDLLI 225 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCCCCCcCC------HHHHHHHH
Confidence 89999999999999999999999999999999999999875332 2222333333322222211 24788999
Q ss_pred hhcCCCCCCCC---CccccccCCCCCC
Q 042457 335 ACLRSKPKSRP---TMRRSFPNPEINP 358 (361)
Q Consensus 335 ~cl~~dP~~RP---s~~eil~hp~~~~ 358 (361)
+||+.||.+|| ++.|+++||||++
T Consensus 226 ~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 226 GLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred HHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 99999999997 4789999999986
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=340.07 Aligned_cols=261 Identities=23% Similarity=0.284 Sum_probs=201.7
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|.+.+.||+|+||.||+|... +++.||+|.++...... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46888999999999999999654 68899999987543221 13467789999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++ +|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 9975 89888865432 478899999999999999999999 99999999999999999999999999997654433
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc--------------
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR-------------- 312 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 312 (361)
.......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...................
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 33334567899999998765 568899999999999999999999986543211100000000000
Q ss_pred ----CCCCCCChh---hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 313 ----APSPIDDQT---VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 313 ----~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+....... .........+++.+||+.||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000000000 00011246789999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=340.57 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=204.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||+|... +++.||+|++........ ...+.+|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 467999999999999999999765 688999999875443221 245678999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+. ++|.+++..... .++...+..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||++......
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 83 EYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred ECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 9995 678777765432 578899999999999999999999 9999999999999999999999999998765433
Q ss_pred CCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH-hhhhccc------------
Q 042457 247 SSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML-IDLLDQR------------ 312 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~------------ 312 (361)
........++..|+|||++.+ ..++.++||||+||++|||++|+.||............ .......
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 333344568899999998765 45788999999999999999999999754321111000 0000000
Q ss_pred ------CC--CCCCChhhHH---HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 313 ------AP--SPIDDQTVIQ---DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 313 ------~~--~~~~~~~~~~---~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.. .+......+. ....+.+++.+||+.||++|||++|+++||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 0000000000 01247789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=346.73 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=200.0
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|+..+.||+|+||.||+|... +|+.||||++..... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4556778999999999999754 689999999865433 23356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+.. ..++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||++........
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986532 356677889999999999999999 999999999999999999999999999987644333
Q ss_pred Ccccccccccccccccccc-----cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 249 NRTVVAGTHGYIAPELAYT-----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||......+.......+..........
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 298 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPA----- 298 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCC-----
Confidence 3334568999999998743 234568999999999999999999997333222111111111111111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.....+.+++.+||+.||++|||+.|+++||||.+.
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 111248899999999999999999999999999875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=340.07 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=206.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|.+.+.||+|+||.||+++.. +++.||+|++..........+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999775 57899999987654444445678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|++++++..+..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMPN---GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765544322 588999999999999999999999 99999999999999999999999999998764322
Q ss_pred C-CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc----------------
Q 042457 248 S-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD---------------- 310 (361)
Q Consensus 248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---------------- 310 (361)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+..........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 2 22334688999999999888899999999999999999999999975432111111111000
Q ss_pred --ccCCCCCCChhh-----HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 311 --QRAPSPIDDQTV-----IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 311 --~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
...+........ ......+.+++.+||+.||++|||++|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000000000000 0012348899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=345.48 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=209.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC--CCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS--GKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
.++|.+.+.||+|+||.||+|...+ +..||+|.+..... .....+.+..|+.+++.++||||+++++++...+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468889999999999999997543 36899999865432 22234678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997654 588999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+...+
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~---- 252 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKILEGIIYFPKFLD---- 252 (340)
T ss_pred CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHHHHhcCCCCCCCCCC----
Confidence 32 2234689999999999988899999999999999999999999875432 2223333333332222211
Q ss_pred HHHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
..+.+++.+|++.||++|+ |++++++||||+.
T Consensus 253 --~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 253 --NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred --HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 1367899999999999995 9999999999975
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=342.66 Aligned_cols=260 Identities=24% Similarity=0.321 Sum_probs=208.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||+|+||.||++... +|..+|+|.+..... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 467999999999999999999764 688899999876433 233567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999997654 5889999999999999999999852 5999999999999999999999999998765332
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh----------------------
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM---------------------- 304 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~---------------------- 304 (361)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 22334689999999999988999999999999999999999999864321100000
Q ss_pred ---------------------HhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 305 ---------------------LIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 305 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...+.....+.... ......+.+|+.+||+.||++|||++|+++||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN----GVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCC----ccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00000000000000 0012347899999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=346.74 Aligned_cols=259 Identities=22% Similarity=0.299 Sum_probs=209.9
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+|... +|+.||+|++..... .......+..|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999765 588999999875432 1223467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997654 588999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc--ccCCCCCCChhhHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD--QRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 324 (361)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. .....+........
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~ 228 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENLKYWKETLQRPVYDDPRFN 228 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHHHHHHhccccccCCCCCccccc
Confidence 223346899999999999889999999999999999999999998754321 11111111 11111111100011
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+++.+||+.+|.+|||++++++||||++.
T Consensus 229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 229 LSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred cCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 12357889999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=348.60 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=219.4
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccC-cchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHS-ETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
-|++.+.||.|+.|.|-+|+. .+|+.+|||++... .........+.+|+-+|+.+.|||++++++++.+...+|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 367788899999999999965 57999999999766 3333344667899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|-|++++...+ ++.+.+..++++||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|..- .+.
T Consensus 93 yv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE-VPG 165 (786)
T ss_pred ecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc-cCC
Confidence 999999999998776 689999999999999999999999 9999999999999999999999999999754 334
Q ss_pred CCcccccccccccccccccccccC-ccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVT-EKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.-....+|++.|.|||++++.+|. .++||||.|||||.|+||+.||++ .+....+..+..+....|.....
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~MPs~Is~----- 237 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFEMPSNISS----- 237 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCcccCCCcCCH-----
Confidence 445567899999999999998875 699999999999999999999984 23455667777777766644333
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+..+|+.+|+..||++|.|++||++|||++.
T Consensus 238 -eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 238 -EAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred -HHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 3778888999999999999999999999975
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=341.35 Aligned_cols=249 Identities=23% Similarity=0.299 Sum_probs=204.0
Q ss_pred CeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 95 YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
+.||+|+||.||++.. .+|+.||+|++..... .......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3599999999999965 4689999999875422 2233467888999999999999999999999999999999999999
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccc
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 252 (361)
+|..++.... .+++.++..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 9998887654 589999999999999999999999 9999999999999999999999999998754333333344
Q ss_pred ccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHH
Q 042457 253 VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKI 332 (361)
Q Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 332 (361)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+... ...+.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~~p~~~------~~~~~~l 225 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDIKFPRTL------SADAKSL 225 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCccCCCCC------CHHHHHH
Confidence 5689999999999988899999999999999999999999864332 112222222222222211 1247889
Q ss_pred HhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 333 AFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 333 i~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
+.+||+.||++|| ++.|+++||||+.
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 226 LSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=340.95 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=204.5
Q ss_pred CeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 95 YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
+.||+|+||.||++.. .+|+.||+|++..... .......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3599999999999965 4689999999875422 2223466778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccc
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 252 (361)
+|..++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++............
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 9998887654 589999999999999999999999 9999999999999999999999999998754333333344
Q ss_pred ccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHH
Q 042457 253 VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKI 332 (361)
Q Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 332 (361)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.... ..+.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~~~p~~~~------~~~~~l 225 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIRFPRTLS------PEAKSL 225 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCCCCCC------HHHHHH
Confidence 5689999999999988999999999999999999999999864332 2222222222222222211 247889
Q ss_pred HhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 333 AFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 333 i~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
+.+||+.||.+|| ++.++++||||.+
T Consensus 226 i~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred HHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 9999999999998 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=370.49 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=211.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCC--CC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPS--GK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
...+..+.+.||+|.||.||.|...+ |. .||||.+....... ...+|.+|..+|++++|||||+++|+|.+..
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~-~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ-EVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH-HHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 35667778889999999999997643 33 49999998765543 3688999999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCc----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEee
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDE----AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVAD 236 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D 236 (361)
..++++|||++|+|..+|++.+. ...++....+.++.|||+|+.||+++ ++|||||.++|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999998632 34689999999999999999999999 999999999999999999999999
Q ss_pred ecCccccCCCCCCcccc--cccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC
Q 042457 237 FGVARLLHSDSSNRTVV--AGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 237 fg~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
||+|+.+.......... .-..+|||||.+..+.++.|+|||||||++||++| |..||......+ ....-...+++
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v~~~~~~ggRL 923 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--VLLDVLEGGRL 923 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--HHHHHHhCCcc
Confidence 99999665443332221 23468999999999999999999999999999999 999987665422 22223344466
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
+.|...+. .+.+++.+||+.+|++||++..|++
T Consensus 924 ~~P~~CP~------~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPPSYCPE------KLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCCCh------HHHHHHHHHccCChhhCccHHHHHh
Confidence 65555443 3889999999999999999999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=350.04 Aligned_cols=240 Identities=29% Similarity=0.493 Sum_probs=202.0
Q ss_pred CCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEecc
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
+...+-||.|+.|.||+|++ .++.||||+++.-. ..+++.|++|+|+||+.+.|+|.....+|||||||.
T Consensus 126 IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhhccCcccceeeeec-cCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 34456699999999999999 67889999886432 257899999999999999999999999999999999
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 250 (361)
.|-|+..|+..+ .++......|..+||.||.|||.+ .|+|||||+-||||..+..+||+|||-++..... ...
T Consensus 196 ~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STk 268 (904)
T KOG4721|consen 196 QGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STK 268 (904)
T ss_pred cccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhh
Confidence 999999999876 688889999999999999999999 9999999999999999999999999998876433 455
Q ss_pred ccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc--CCCCCCChhhHHHHHH
Q 042457 251 TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR--APSPIDDQTVIQDIIL 328 (361)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 328 (361)
....||..|||||++.+.+.++|.|||||||+||||+||..||.+.+....- .-+-.+. ++.|...+ .-
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---wGVGsNsL~LpvPstcP------~G 339 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---WGVGSNSLHLPVPSTCP------DG 339 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---EeccCCcccccCcccCc------hH
Confidence 5678999999999999999999999999999999999999998876543211 1111121 22222222 23
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
+.-|+++||+..|.+|||+.+|+.|.-+
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 6778889999999999999999999544
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=340.91 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=218.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
...|.....||+|.||.||+|.. ..++.||+|++.......+ .+.+.+|+.++..++++||.++||.+..+..++++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 34566778899999999999955 4688999999977655433 678899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|||.||++.+.|+... .+++..+.-+++++..|+.|||.+ +.+|||||+.|||+..+|.+|++|||.+..+...
T Consensus 91 ey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999998765 457788888999999999999999 9999999999999999999999999999888777
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.......+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+ ...+.-+-...+|.... +..
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---mrvlflIpk~~PP~L~~-----~~S 236 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---MRVLFLIPKSAPPRLDG-----DFS 236 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---ceEEEeccCCCCCcccc-----ccC
Confidence 7667788999999999999988999999999999999999999999876554 22222233333332222 111
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++..||++||+.|||+.++|+|+|+++
T Consensus 237 ~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 237 PPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 24888999999999999999999999999976
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=311.39 Aligned_cols=257 Identities=29% Similarity=0.429 Sum_probs=218.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
-++|++.+.||+|.||.||.|+.+ ++-.||+|++..+.-. .....++.+|+++-+.++||||+++|+++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 456889999999999999999654 6778999998765432 22336788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
+||.++|.+...|+..... .++......++.|+|.|+.|+|.. +++||||||+|+|++..+..||+|||-+..-
T Consensus 101 lEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA-- 174 (281)
T ss_pred EEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec--
Confidence 9999999999999854432 688888999999999999999999 9999999999999999999999999988643
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
+...+...+||..|.+||...+..++...|+|++|++.||++.|.+||+... ......++..-....|...+.
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~p~~is~---- 247 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKFPSTISG---- 247 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccCCcccCh----
Confidence 3556677889999999999999999999999999999999999999998665 233344444444444433222
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...++|.+|+.++|.+|.+..|+++|||+.+.
T Consensus 248 --~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 248 --GAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred --hHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 37888999999999999999999999999764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=336.45 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=197.9
Q ss_pred cCCCCcCeeeecCceeEEEEEe--CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC---CCCcceeeeEEEee-----
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL--PSGKIVALKKLHHSETELAFLESFQTEARLLSQI---RHRNIVKLYGFCLH----- 158 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----- 158 (361)
++|++.+.||+|+||.||+|.. .+|+.||+|.+............+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999975 2468899999875543322234455677766655 69999999999863
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 589888865432 2488999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCC-
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI- 317 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (361)
++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+......+......+...
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 99765433 2233446899999999998888999999999999999999999998764432111111110000000000
Q ss_pred ------------CChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 318 ------------DDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 318 ------------~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
...... .....+.+++.+||+.||++|||+.|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 000000 112346799999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=338.77 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=205.0
Q ss_pred CeeeecCceeEEEEEe----CCCCEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 95 YCIGTGGYGSVYRAQL----PSGKIVALKKLHHSET--ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+.||+|+||.||+++. .+++.||+|++..... .......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999965 3578999999875422 122235677899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++.... .+.+..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987654 578888999999999999999999 999999999999999999999999999875443333
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+.... ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~~~~~~~~~~~~~~~~~~~------~~ 226 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---KKTIDKILKGKLNLPPYLT------PE 226 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC------HH
Confidence 33445689999999999888899999999999999999999999875432 2223333333333222211 24
Q ss_pred HHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 329 VSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 329 l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
+.+++.+||+.||++|| +++++++||||+.
T Consensus 227 ~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 227 ARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 78999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=347.78 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=210.4
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchH-HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL-AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||+|... +|+.||+|++....... .....+..|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999765 68999999987543211 33467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999997663 689999999999999999999998 9999999999999999999999999999766443
Q ss_pred C-----------------------------CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcc
Q 042457 247 S-----------------------------SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLS 297 (361)
Q Consensus 247 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 297 (361)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3 12233468999999999999999999999999999999999999987544
Q ss_pred cCCcchhHhhhhc--ccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC-ccccccCCCCCC
Q 042457 298 SFNPKIMLIDLLD--QRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT-MRRSFPNPEINP 358 (361)
Q Consensus 298 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~hp~~~~ 358 (361)
. ......+.. .....+.... ....+.+++.+|++ ||.+||+ ++++++||||++
T Consensus 235 ~---~~~~~~i~~~~~~~~~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 235 L---QETYNKIINWKESLRFPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred H---HHHHHHHhccCCcccCCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 2 222222322 1111111111 11247888999997 9999999 999999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=338.80 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=202.6
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||++... +++.||+|++..... .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999764 678999999875422 223345677888888776 899999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|..++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 99998886554 589999999999999999999999 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCc------chhHhhhhcccCCCCCCChhhHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP------KIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
...||..|+|||++.+..++.++||||||+++|||++|+.||........ ......+.......+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~----- 229 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS----- 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC-----
Confidence 45689999999999999999999999999999999999999964322111 1112222333332222211
Q ss_pred HHHHHHHHhhhcCCCCCCCCCc------cccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTM------RRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~------~eil~hp~~~~ 358 (361)
..+.+++.+||+.||++|||+ .++++||||+.
T Consensus 230 -~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 230 -VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred -HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 247789999999999999994 79999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=338.55 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=204.2
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||++... +++.||+|+++.... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 35999999999999764 688999999975432 223346678899999988 799999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 99998886554 589999999999999999999999 999999999999999999999999999875333333334
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC------cchhHhhhhcccCCCCCCChhhHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN------PKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
...||..|+|||++.+..++.++|+|||||++|||++|+.||+...... .......+.......+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----- 229 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS----- 229 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC-----
Confidence 4568999999999999999999999999999999999999997433211 11122223333332222211
Q ss_pred HHHHHHHHhhhcCCCCCCCCC------ccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPT------MRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs------~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+||| +.++++||||+.
T Consensus 230 -~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 230 -VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred -HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 24788999999999999997 689999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=339.92 Aligned_cols=257 Identities=26% Similarity=0.345 Sum_probs=205.7
Q ss_pred CCCCcCeeeecCceeEEEEEe----CCCCEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL----PSGKIVALKKLHHSET--ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
+|++.+.||+|+||.||+++. .+|+.||+|++..... .....+.+..|+.+++.+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999864 3688999999865321 222345678899999999 589999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987654 588999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCC-Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcch-hHhhhhcccCCCCCCC
Q 042457 243 LHSDSS-NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI-MLIDLLDQRAPSPIDD 319 (361)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 319 (361)
...... ......||..|+|||++.+. .++.++|||||||++|||++|+.||.......... ....+.....+.+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI 234 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 533222 22335689999999998765 47889999999999999999999997543322221 1222222222222111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
...+.+++.+||+.||++|| +++++++||||++
T Consensus 235 ------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 235 ------GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred ------CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 12478899999999999999 7889999999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=338.21 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=203.5
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||++... +++.||+|++..... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999764 588999999875321 122345677888888876 699999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 99999887654 589999999999999999999999 999999999999999999999999999876433333334
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+.... ..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~------~~~~~ 225 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILNDEVVYPTWLS------QDAVD 225 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCCCCCCCCC------HHHHH
Confidence 45689999999999988899999999999999999999999875432 2223333333322222111 24788
Q ss_pred HHhhhcCCCCCCCCCc------cccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTM------RRSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~------~eil~hp~~~~ 358 (361)
++.+||+.||.+||++ +++++||||+.
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999998 89999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=344.60 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=200.5
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-----CeEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK-----KCMF 163 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 163 (361)
+|++.+.||+|+||.||+|.. .+|+.||||++............+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999965 4689999999875433333345688999999999999999999988643 2489
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68988887554 589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCC---Ccccccccccccccccccc--cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhh----------
Q 042457 244 HSDSS---NRTVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDL---------- 308 (361)
Q Consensus 244 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---------- 308 (361)
..... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.............+.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 1233468999999998865 67889999999999999999999998654321100000000
Q ss_pred -------------hcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 309 -------------LDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 309 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+.. .........+.+++.+||+.||++|||++|+++||||+.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFS-QKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchH-HhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 0000000000 000001124678999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=338.17 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=203.4
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHH---hcCCCCcceeeeEEEeeCCeEEEE
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLL---SQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
|++.+.||+|+||.||+|... +|+.||||+++.... .....+.+..|..++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999664 689999999875431 122234566666554 567899999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|..++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999888643 589999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+...+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~~p~~~~----- 225 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSIVNDEVRYPRFLS----- 225 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCCC-----
Confidence 33334445689999999999998999999999999999999999999875432 2222333333322222211
Q ss_pred HHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+|| ++.++++||||+.
T Consensus 226 -~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 226 -REAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred -HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 2477899999999999999 6889999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=337.30 Aligned_cols=254 Identities=21% Similarity=0.318 Sum_probs=206.8
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCC-CcceeeeEEEeeCCeEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRH-RNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 166 (361)
+|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+..|..++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999764 578899999875422 22234667889999999976 56888999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999887654 588999999999999999999999 9999999999999999999999999998754333
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........||..|+|||++.+..++.++|||||||++|||+||+.||..... ......+.......+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~~~------ 225 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIMEHNVSYPKSLS------ 225 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC------
Confidence 3333445689999999999999999999999999999999999999875432 2223333333332222211
Q ss_pred HHHHHHHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+|++. +++++||||+.
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 247789999999999999987 79999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=340.39 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=207.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
..++|++.+.||+|+||.||++... ++..+|+|.+...... .....+.+|+++++.++|+||+++++++...+..++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 3578999999999999999999765 6888999988764332 2346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... .+++.....++.+++.||.|||+.. +++|+||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999997654 5788999999999999999999742 699999999999999999999999999876532
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh-------------------
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI------------------- 306 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~------------------- 306 (361)
. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 2 1223458899999999988889999999999999999999999986432211000000
Q ss_pred ---------------------hhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 307 ---------------------DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 307 ---------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.............. .....+.+|+.+||+.||++|||+.|+++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSG---VFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCC---CcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00000000000000 011247899999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=340.67 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=204.4
Q ss_pred CeeeecCceeEEEEEe----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEecc
Q 042457 95 YCIGTGGYGSVYRAQL----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
+.||+|+||.||++.. .+|+.||+|++............+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999864 368899999997654333334567789999999999999999999999999999999999
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 250 (361)
+|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999999986543 589999999999999999999999 99999999999999999999999999987654433333
Q ss_pred ccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHH
Q 042457 251 TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVS 330 (361)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 330 (361)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.......+...+ ..+.
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i~~~~~~~p~~~~------~~~~ 226 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMILKAKLGMPQFLS------PEAQ 226 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC------HHHH
Confidence 345689999999999888889999999999999999999999875432 2222333333332222111 2477
Q ss_pred HHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 331 KIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 331 ~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
+++.+||+.||++||| +.++++||||+.
T Consensus 227 ~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 227 SLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 8999999999999999 556999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=339.93 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=203.3
Q ss_pred CeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 95 YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
+.||+|+||.||++.. .+|+.||+|.+..... .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3599999999999965 4789999999875422 1223456778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
+|..++.... .+++..+..++.|++.||+|||+ . +++||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 9998887654 58999999999999999999997 6 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.... ..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~------~~~~~ 225 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEIRFPRTLS------PEAKS 225 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCCCCCCCCC------HHHHH
Confidence 45689999999999988999999999999999999999999864332 1222222222222222211 24788
Q ss_pred HHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 332 IAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
++.+||+.||++|+ ++.++++||||+.
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 99999999999997 9999999999985
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=330.35 Aligned_cols=253 Identities=25% Similarity=0.307 Sum_probs=202.7
Q ss_pred eeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
||+|+||+||++... +|+.||+|.+...... ....+.+..|+.+++.++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999654 6889999998654322 22345677899999999999999999999999999999999999999
Q ss_pred hhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcccc
Q 042457 175 FCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253 (361)
Q Consensus 175 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 253 (361)
..++.... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 88875422 233689999999999999999999999 99999999999999999999999999997665443333445
Q ss_pred cccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcc-hhHhhhhcccCCCCCCChhhHHHHHHHHHH
Q 042457 254 AGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK-IMLIDLLDQRAPSPIDDQTVIQDIILVSKI 332 (361)
Q Consensus 254 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 332 (361)
.||..|+|||.+.+..++.++||||||+++|||++|+.||......... .............+.. ....+.++
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l 231 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK------FSPASKSF 231 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCccc------CCHHHHHH
Confidence 6899999999999999999999999999999999999998754322111 1111222211111111 12247889
Q ss_pred HhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 333 AFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 333 i~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
+.+||+.||++|| |++++++||||++
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999999999 7789999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=337.35 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=204.0
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||+|+.. +++.||+|++..... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999764 578999999875422 222345677888888866 799999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
++|..++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 99998887654 588999999999999999999999 999999999999999999999999999876543333344
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||..|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+...+ ..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~------~~~~~ 225 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESILHDDVLYPVWLS------KEAVS 225 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC------HHHHH
Confidence 45689999999999988999999999999999999999999875432 2233333333332222211 24788
Q ss_pred HHhhhcCCCCCCCC-------CccccccCCCCCC
Q 042457 332 IAFACLRSKPKSRP-------TMRRSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RP-------s~~eil~hp~~~~ 358 (361)
++.+||+.||++|| +++++++||||+.
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=342.40 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=201.7
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||+||++... +++.||+|++..... .......+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999654 688999999875432 2233467888999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997654 589999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCC
Q 042457 247 SS-----------------------------------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRH 291 (361)
Q Consensus 247 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~ 291 (361)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0112468999999999999999999999999999999999999
Q ss_pred CCCCcccCCcchhHhhhhcc--cCCCCCCChhhHHHHHHHHHHHhhhcC--CCCCCCCCccccccCCCCCC
Q 042457 292 PGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTVIQDIILVSKIAFACLR--SKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 292 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~eil~hp~~~~ 358 (361)
||..... ......+... ....+...... ..+.+++.+++. .++..||+++||++||||+.
T Consensus 235 Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~~s----~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 235 PFCSETP---QETYKKVMNWKETLIFPPEVPIS----EKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CCCCCCH---HHHHHHHHcCcCcccCCCcCCCC----HHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCC
Confidence 9975432 2222223221 11111111111 124555655443 34446799999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=337.55 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=210.0
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.+.....+.++||+|.||.|.++....+..||||.++....... ..+|.+|+++|.+++||||++++|+|..++.+++|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~-r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA-RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH-HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 45566677889999999999999998889999999987665433 57899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
+|||++|+|.+++..+.... ..-....+|+.||+.||+||.+. ++|||||.++|+|+|+++++||+|||+++.+..
T Consensus 614 ~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999998764322 45566788999999999999999 999999999999999999999999999997765
Q ss_pred CCCCc--ccccccccccccccccccccCccchhhhHHHHHHHHHh--CCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 246 DSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM--GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 246 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
..... ...+-..+|||||.+..++++.++|||+||+++||+++ ...||+...+.+...............-. ...
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~-l~~ 768 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV-LSR 768 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee-ccC
Confidence 54432 22345689999999999999999999999999999876 67898766554333333333332211000 000
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
+.-....+.+++..||..|.++|||++++-.
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1112234789999999999999999999843
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=346.78 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=210.5
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeCC--C--CE-EEEEEeccCc-chHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLPS--G--KI-VALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYG 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 154 (361)
.+.|+...++..+.++||+|+||.||+|++.. + .. ||||..+... .......+|.+|+++|++++|||||+++|
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34566667778888999999999999996643 2 23 8999998633 45566789999999999999999999999
Q ss_pred EEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEE
Q 042457 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFV 234 (361)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl 234 (361)
++.....+++|||+|.||+|.++|++... .++..++.+++.+.|.||+|||+. +++||||.++|+|++.++.+||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEe
Confidence 99999999999999999999999998764 589999999999999999999999 9999999999999999999999
Q ss_pred eeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC
Q 042457 235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 235 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
+|||+++.-...........-..+|+|||.+....++.++|||||||++||+++ |..||..... ......+.....
T Consensus 304 SDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~kI~~~~~ 380 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKAKIVKNGY 380 (474)
T ss_pred CccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHHHHHhcCc
Confidence 999998765311111111124579999999999999999999999999999999 8999876543 233344433332
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+... .....+..++.+||..+|++||||.++.+
T Consensus 381 r~~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 381 RMPIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred cCCCCC----CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 222221 12224777888999999999999998763
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=344.02 Aligned_cols=256 Identities=24% Similarity=0.346 Sum_probs=206.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+++.. +|+.||||++..... .......+..|+.+++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999764 689999999975432 2233466888999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987654 589999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC--------------------------------------CcccccccccccccccccccccCccchhhhHHHHHHHHHh
Q 042457 247 SS--------------------------------------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM 288 (361)
Q Consensus 247 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t 288 (361)
.. ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012358999999999998899999999999999999999
Q ss_pred CCCCCCCcccCCcchhHhhhhcccC--CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC---ccccccCCCCCC
Q 042457 289 GRHPGDLLSSFNPKIMLIDLLDQRA--PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT---MRRSFPNPEINP 358 (361)
Q Consensus 289 g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~hp~~~~ 358 (361)
|+.||..... ......+..... ..+.... ....+.+++.+|+. +|.+|++ +.|+++||||+.
T Consensus 235 G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~----~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 235 GYPPFCSDNP---QETYRKIINWKETLQFPDEVP----LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCCCCCCH---HHHHHHHHcCCCccCCCCCCC----CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999875432 122222222221 1111110 11246788889996 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=343.59 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=202.4
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.|.+.+.||+|+||+||+|.. .+++.||+|++..... .....+.+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999965 4688999999975432 22345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987654 588889999999999999999999 99999999999999999999999999975431100
Q ss_pred C-----------------------------------------------CcccccccccccccccccccccCccchhhhHH
Q 042457 248 S-----------------------------------------------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFG 280 (361)
Q Consensus 248 ~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 280 (361)
. ......||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 01124689999999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCcccCCcchhHhhhhc--ccCCCCCCChhhHHHHHHHHHHHhh--hcCCCCCCCCCccccccCCCC
Q 042457 281 VVALEVLMGRHPGDLLSSFNPKIMLIDLLD--QRAPSPIDDQTVIQDIILVSKIAFA--CLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 281 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~eil~hp~~ 356 (361)
|++|||++|+.||..... ......+.. .....+..... ...+.+++.+ |+..+|..||++.|+++||||
T Consensus 236 ~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~----s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f 308 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIPPQVKL----SPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308 (381)
T ss_pred hHHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCCCCCCC----CHHHHHHHHHHccCcccccCCCCHHHHhcCccc
Confidence 999999999999975432 111222221 11111111111 1135667766 556677779999999999999
Q ss_pred CC
Q 042457 357 NP 358 (361)
Q Consensus 357 ~~ 358 (361)
++
T Consensus 309 ~~ 310 (381)
T cd05626 309 SE 310 (381)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=340.60 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=219.2
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
..-++|.+.+.||+|.||+|+++..+ +++.+|||++++..- ..+..+..+.|.+++... +||.+++++++++..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 44577999999999999999999765 578999999987753 334467888899988877 599999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
|.||||+.||++..+.+.. .+++..+..++..|+.||.|||++ +|++||||.+|||+|.+|.+||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999955554433 599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
.-.......+.+||+.|||||++.+..|+.+.|.|||||+||||+.|..||...+. +.....++......|...+.
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~FdsI~~d~~~yP~~ls~- 593 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVFDSIVNDEVRYPRFLSK- 593 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCCCCCCCcccH-
Confidence 65555667778999999999999999999999999999999999999999875432 34445555555554444332
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
+...+++++|.++|++|.-+ ++|-+||||+.
T Consensus 594 -----ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 594 -----EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred -----HHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 36788889999999999965 78999999985
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=334.25 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=203.7
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||++... +++.||+|+++.... .......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999765 578999999875432 222345677888888877 799999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|..++.... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 99998887654 589999999999999999999999 999999999999999999999999999875433333333
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.......+... ...+.+
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~------~~~~~~ 225 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSILEDEVRYPRWL------SKEAKS 225 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCCCCCcC------CHHHHH
Confidence 45689999999999999999999999999999999999999875432 222223333322222211 124789
Q ss_pred HHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
++.+||+.||.+|||+ .++++||||+.
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=333.03 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=199.8
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQ-IRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||+|... +++.||+|.++.... .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999764 578899999875422 11223445566666664 4899999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|..++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...........
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 99999887654 588999999999999999999999 999999999999999999999999999976543333344
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+.... ..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~------~~~~~ 225 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDRPHFPRWIS------KEAKD 225 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC------HHHHH
Confidence 45689999999999988899999999999999999999999875432 2222233332222222111 23778
Q ss_pred HHhhhcCCCCCCCCCcc-ccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTMR-RSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~~-eil~hp~~~~ 358 (361)
++.+||+.||.+||++. ++++||||+.
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 99999999999999975 8889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=337.88 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=200.4
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCL 157 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 157 (361)
.+..++|.+.+.||+|+||.||+|.. .+++.||+|++...... .....+..|+.++..+ +||||++++++|.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA-SEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch-HHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 35567899999999999999999964 23568999998754332 2346788999999999 8999999999988
Q ss_pred eCC-eEEEEEEeccCCChhhhhccCCc-----------------------------------------------------
Q 042457 158 HKK-CMFLIYKYMRRGSLFCVLRNDDE----------------------------------------------------- 183 (361)
Q Consensus 158 ~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 183 (361)
..+ ..+++|||+++|+|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 654 58999999999999999865321
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC--cccccc
Q 042457 184 ------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAG 255 (361)
Q Consensus 184 ------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g 255 (361)
...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 12478889999999999999999999 9999999999999999999999999999765332221 122345
Q ss_pred cccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHh
Q 042457 256 THGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAF 334 (361)
Q Consensus 256 t~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 334 (361)
+..|+|||++.+..++.++||||||+++|||++ |..||...... ................. .....+.+++.
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~-----~~~~~l~~li~ 311 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRLKDGTRMRAPE-----NATPEIYRIML 311 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHhcCCCCCCCC-----CCCHHHHHHHH
Confidence 678999999998899999999999999999997 99998754321 11112222221111111 11124789999
Q ss_pred hhcCCCCCCCCCcccccc
Q 042457 335 ACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 335 ~cl~~dP~~RPs~~eil~ 352 (361)
+||+.||++|||+.|+++
T Consensus 312 ~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 312 ACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHccCChhhCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=333.95 Aligned_cols=254 Identities=21% Similarity=0.322 Sum_probs=207.0
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 166 (361)
+|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999665 578999999875432 122235566788888777 5899999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999998887654 588999999999999999999999 9999999999999999999999999998754433
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.......+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s------ 225 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVAYPKSMS------ 225 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCcCC------
Confidence 3334445689999999999999999999999999999999999999875432 2233334433333222211
Q ss_pred HHHHHHHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
..+.+++.+|++.||.+|++. .++++||||+.
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 247889999999999999985 79999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=328.17 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=196.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhc--CCCCcceeeeEEEeeCC----e
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQ--IRHRNIVKLYGFCLHKK----C 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~ 161 (361)
-....+...+|+|+||.||+|++ +++.||||++...+ .+.|.+|-++.+. ++|+||+++++.-.... .
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 34455667799999999999999 66999999997543 4778888888875 58999999999887665 7
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeEEeCCCCCCeeeCCCCCeEEe
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC------IPSIVHRDISSNNILLNSKLEAFVA 235 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------~~~i~H~dlk~~Nill~~~~~~kl~ 235 (361)
++||++|.++|+|.++|..+ .++|....+++..+++||+|||+.. .|+|+|||||++||||.+|+++.|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 99999999999999999877 5999999999999999999999764 4789999999999999999999999
Q ss_pred eecCccccCCCCC--Cccccccccccccccccccccc------CccchhhhHHHHHHHHHhCCCCCC--Cccc-------
Q 042457 236 DFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVV------TEKCDVFGFGVVALEVLMGRHPGD--LLSS------- 298 (361)
Q Consensus 236 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~slG~~l~el~tg~~p~~--~~~~------- 298 (361)
|||++..+..... .....+||.+|||||++.+... -.+.||||+|.+||||++...-+. ...+
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999988764433 2334679999999999876432 237899999999999998764432 1111
Q ss_pred ---CC---cchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccc
Q 042457 299 ---FN---PKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349 (361)
Q Consensus 299 ---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 349 (361)
.. .+.....+.+...|...+.......+..+++.+..||..||+.|.|+.=
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 01 1111222233333333333333455667999999999999999999863
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=342.84 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=208.1
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
...++|.+.+.||+|+||.||+++.. +++.||+|.+..... .....+.+..|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44567999999999999999999664 688999999864322 1222355778999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999998654 478888899999999999999999 9999999999999999999999999999766
Q ss_pred CCCCC-Cccccccccccccccccccc----ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 244 HSDSS-NRTVVAGTHGYIAPELAYTM----VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~ 269 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDHKNSLTFP 269 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCcCCCC
Confidence 43322 22345689999999988643 478899999999999999999999875432 22223333322111111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCC--CCCccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKS--RPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~hp~~~~ 358 (361)
.. ......+.+++.+||+.+|.+ |||+.|+++||||+.
T Consensus 270 ~~--~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 270 DD--IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred Cc--CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 10 011124788999999999988 999999999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=332.66 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=199.9
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQ-IRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||+|... +|+.||+|.++.... .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999765 688999999875421 11223556677777775 4899999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|..++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||+++..........
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 99999887643 588999999999999999999999 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||..|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+.... ..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~ 225 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVDTPHYPRWIT------KESKD 225 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCCC------HHHHH
Confidence 45689999999999999999999999999999999999999875432 1222222222222221111 24778
Q ss_pred HHhhhcCCCCCCCCCc-cccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTM-RRSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~-~eil~hp~~~~ 358 (361)
++.+||+.||++||++ +++++||||+.
T Consensus 226 li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 226 ILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 9999999999999998 58999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=327.88 Aligned_cols=258 Identities=23% Similarity=0.268 Sum_probs=206.8
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
+|++.+.||+|+||.||++.. .+++.||+|.+...... ......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999975 46899999998754322 2223557789999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865322 2589999999999999999999999 99999999999999999999999999987654322
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh-hhcccCCCCCCChhhHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID-LLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 326 (361)
......|+..|+|||++.+..++.++||||+|+++||+++|+.||.............. +.......+. ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 229 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE------KFS 229 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc------ccC
Confidence 22334688999999999888899999999999999999999999975433211111111 1111111111 112
Q ss_pred HHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||++|| +++++++||||.+
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 2478999999999999999 8889999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=340.67 Aligned_cols=256 Identities=21% Similarity=0.271 Sum_probs=201.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..+|++.+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++......++++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 46799999999999999999965 4688999997532 34678999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|++. ++|..++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 163 e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred ecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9995 68888876543 588999999999999999999999 9999999999999999999999999998654322
Q ss_pred C-CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC----cchhHhhhhc-----------
Q 042457 247 S-SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN----PKIMLIDLLD----------- 310 (361)
Q Consensus 247 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~----------- 310 (361)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+-.....+ ....+..+..
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1 22233568999999999998899999999999999999999998764322111 0000111100
Q ss_pred ---------------ccCCCCCCC---hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 311 ---------------QRAPSPIDD---QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 311 ---------------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+... .........+.+|+.+||+.||++|||++|+|+||||++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000000000 001122345789999999999999999999999999986
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=331.60 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=199.8
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhc-CCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQ-IRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||+|... +++.||+|.++.... .....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999764 578999999875421 11223456677777775 4899999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|.+++.... .+++.++..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 99999987643 588999999999999999999999 999999999999999999999999999875433333333
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+... ...+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~------~~~~~~ 225 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDNPCYPRWL------TREAKD 225 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCccC------CHHHHH
Confidence 45689999999999988899999999999999999999999875432 122222222222111111 124778
Q ss_pred HHhhhcCCCCCCCCCcc-ccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTMR-RSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~~-eil~hp~~~~ 358 (361)
++.+||+.||++||++. ++++||||++
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 99999999999999997 8999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=328.73 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=209.0
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
|++.+.||+|+||+||++... +++.+|+|.+...............|+..+++++|+||+++++++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999765 4568999999988766554455567999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
++++|.+++.... .+++..+..++.|+++||.+||+. +++|+||||+||++++++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccc---cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999998332 689999999999999999999999 9999999999999999999999999999765333334
Q ss_pred ccccccccccccccccc-ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 250 RTVVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
.....++..|+|||.+. +..++.++||||+|+++|+|++|..||......+..................... .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 232 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR--EKSEE 232 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT--TSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc--hhHHH
Confidence 44556889999999988 8889999999999999999999999988652212222222222211111111000 00135
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
+.+++.+||+.||++|||+.++++||||
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 8999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=342.56 Aligned_cols=255 Identities=20% Similarity=0.299 Sum_probs=201.9
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.|...+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999965 4688999999875432 22335678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987654 578889999999999999999999 99999999999999999999999999975321100
Q ss_pred -----------------------------------------------CCcccccccccccccccccccccCccchhhhHH
Q 042457 248 -----------------------------------------------SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFG 280 (361)
Q Consensus 248 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG 280 (361)
.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001123589999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCcccCCcchhHhhhhccc--CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC---ccccccCCC
Q 042457 281 VVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR--APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT---MRRSFPNPE 355 (361)
Q Consensus 281 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~hp~ 355 (361)
|++|||++|+.||..... ......+.... ...+..... ...+.+++.+|+ .+|.+|++ +.|+++|||
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~~----s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 307 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIPPQAKL----SPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF 307 (382)
T ss_pred HHHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCCCcccC----CHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence 999999999999975432 11222222211 111111111 113566666665 59999997 999999999
Q ss_pred CCC
Q 042457 356 INP 358 (361)
Q Consensus 356 ~~~ 358 (361)
|+.
T Consensus 308 f~~ 310 (382)
T cd05625 308 FKT 310 (382)
T ss_pred cCC
Confidence 976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=332.96 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=200.1
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHH-HHhcCCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEAR-LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||+||+|... +|+.||+|++..... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 35999999999999764 689999999865432 1112234445544 56789999999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|..++.... .+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 99999987654 588999999999999999999999 999999999999999999999999999875433333344
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+... ...+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~------~~~~~~ 225 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYDNILNKPLRLKPNI------SVSARH 225 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCC------CHHHHH
Confidence 45689999999999998999999999999999999999999875332 222233333332222211 124788
Q ss_pred HHhhhcCCCCCCCCCc----cccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTM----RRSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~----~eil~hp~~~~ 358 (361)
++.+||+.||.+||++ .++++||||+.
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999998 49999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.92 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=203.1
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||++... +++.||+|++..... .....+.+..|..++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999764 678999999976432 223346688899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|..++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 99998887554 589999999999999999999999 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC---Ccc-hhHhhhhcccCCCCCCChhhHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF---NPK-IMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... .....+.......+...+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~------~ 228 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS------V 228 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCC------H
Confidence 456899999999999999999999999999999999999999643321 111 112222222222222111 2
Q ss_pred HHHHHHhhhcCCCCCCCCCc------cccccCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTM------RRSFPNPEINP 358 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~------~eil~hp~~~~ 358 (361)
.+.+++.+||+.||.+||++ .++++||||+.
T Consensus 229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 37789999999999999985 59999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=327.21 Aligned_cols=263 Identities=22% Similarity=0.279 Sum_probs=202.8
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|++.+.||+|++|.||+|... +++.||+|.+............+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999764 689999999876543333346678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
++ ++|.+++........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 68888886644434689999999999999999999999 999999999999999999999999999876543332
Q ss_pred Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc---------------
Q 042457 249 NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR--------------- 312 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------------- 312 (361)
......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2233456889999998765 457889999999999999999999987543211110000000000
Q ss_pred --CCCCCC---ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 313 --APSPID---DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 313 --~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+.... ..........+.+++.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000000 00000011246789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=319.49 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=211.4
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|.+.+.||+|++|.||++... +++.|++|.+............+..|+++++.++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999764 688999999876544444467889999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999997642 23689999999999999999999999 999999999999999999999999999887654443
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
......++..|+|||+..+..++.++|+||||+++|||++|+.||..... ......+.....+.... .....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~ 228 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKIIRGVFPPVSQ-----MYSQQ 228 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCcc-----ccCHH
Confidence 33445688899999999988899999999999999999999999875432 22222233322221111 11224
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
+.+++.+||+.+|++||++.++++|||+
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 8899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=338.11 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=207.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||++... +|+.||+|+++.... .....+.+..|+.+++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999654 688999999976433 2233467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++..... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999976532 589999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCC-ccccccccccccccccc------ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC--CCCC
Q 042457 247 SSN-RTVVAGTHGYIAPELAY------TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA--PSPI 317 (361)
Q Consensus 247 ~~~-~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 317 (361)
... .....||+.|+|||++. +..++.++||||||+++|||++|+.||..... ......+..... ..+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~ 232 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRFLKFPE 232 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCccCCCC
Confidence 322 23346899999999886 45677899999999999999999999875432 112222222211 1111
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.. .....+.+|+..|++ +|.+|||++++++||||++
T Consensus 233 ~~----~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 233 DP----KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CC----CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 10 011247788889998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=339.48 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=206.7
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
+....++|++.+.||+|+||.||+++.. +++.+|+|.+..... .....+.+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445678999999999999999999765 578999999864322 12223567889999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999999998654 478889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-Cccccccccccccccccccc----ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCC
Q 042457 242 LLHSDSS-NRTVVAGTHGYIAPELAYTM----VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316 (361)
Q Consensus 242 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 316 (361)
....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+........
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~ 267 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VGTYSKIMDHKNSLN 267 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCcccC
Confidence 7643222 22345699999999998654 378899999999999999999999975432 122233333221111
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCC--CCCccccccCCCCCC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKS--RPTMRRSFPNPEINP 358 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~hp~~~~ 358 (361)
.... ......+.+++..|++.++.+ |||+.|+++||||+.
T Consensus 268 ~p~~--~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 268 FPED--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred CCCc--ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 1110 111124678888999865544 899999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=341.52 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=203.0
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||++.. .+|+.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999965 4789999999865332 2233567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987654 588899999999999999999999 9999999999999999999999999998633210
Q ss_pred CC-------------C----------------------------------cccccccccccccccccccccCccchhhhH
Q 042457 247 SS-------------N----------------------------------RTVVAGTHGYIAPELAYTMVVTEKCDVFGF 279 (361)
Q Consensus 247 ~~-------------~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 279 (361)
.. . .....||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 001358999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCcccCCcchhHhhhhcc--cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCC---CCccccccCC
Q 042457 280 GVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSR---PTMRRSFPNP 354 (361)
Q Consensus 280 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~hp 354 (361)
||++|||++|+.||..... ......+... ....+.... ....+.+++.+|+. +|.+| +|+.|+++||
T Consensus 235 Gvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~----~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS---HETYRKIINWRETLYFPDDIH----LSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred chhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCCCCCC----CCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 9999999999999875432 1112222221 111111100 11247788889997 66665 6999999999
Q ss_pred CCCC
Q 042457 355 EINP 358 (361)
Q Consensus 355 ~~~~ 358 (361)
||+.
T Consensus 307 ~~~~ 310 (377)
T cd05629 307 FFRG 310 (377)
T ss_pred CcCC
Confidence 9974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=342.87 Aligned_cols=256 Identities=20% Similarity=0.286 Sum_probs=202.3
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+++. .+++.||+|.+..... .......+.+|+++++.++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999999965 4689999999865332 1223466889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997654 578888999999999999999999 9999999999999999999999999997532100
Q ss_pred C-------------------------------------------CCcccccccccccccccccccccCccchhhhHHHHH
Q 042457 247 S-------------------------------------------SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVA 283 (361)
Q Consensus 247 ~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l 283 (361)
. .......||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 001123689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCcccCCcchhHhhhhccc--CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCC---CccccccCCCCCC
Q 042457 284 LEVLMGRHPGDLLSSFNPKIMLIDLLDQR--APSPIDDQTVIQDIILVSKIAFACLRSKPKSRP---TMRRSFPNPEINP 358 (361)
Q Consensus 284 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~hp~~~~ 358 (361)
|||++|+.||...... .....+.... ...+.... ....+.+++.+|+ .+|.+|+ |+.|+++||||+.
T Consensus 235 yell~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 235 YEMLVGQPPFLADTPA---ETQLKVINWETTLHIPSQAK----LSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred eehhhCCCCCCCCCHH---HHHHHHhccCccccCCCCCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 9999999999754421 1111222111 11111111 1113566777766 5999999 9999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=321.76 Aligned_cols=262 Identities=22% Similarity=0.359 Sum_probs=205.3
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
++.+++++.....||+|+||.||+|... ++..|++|.+....... .+.+.+|+.+++.++|+||+++++++..++..
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY--VQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH--HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 3455666777778999999999999754 67889999887654332 46788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-CCCeEEeeecCcc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-KLEAFVADFGVAR 241 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~ 241 (361)
++++||+++++|.+++.........++..+..++.|++.||+|||+. +++|+||||+||+++. ++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 99999999999999997643222237888899999999999999999 9999999999999976 6789999999987
Q ss_pred ccCCCCCCcccccccccccccccccccc--cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTMV--VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
.............++..|+|||++.+.. ++.++||||||+++|+|++|+.||......................+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (268)
T cd06624 158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES- 236 (268)
T ss_pred ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcc-
Confidence 6544333333345788999999886543 7889999999999999999999986433211111111111111111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
....+.+++.+||+.+|.+|||+.|+++||||
T Consensus 237 -----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 237 -----LSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----cCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 11247889999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=331.65 Aligned_cols=263 Identities=20% Similarity=0.278 Sum_probs=203.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|.+.+.||+|+||.||+|... +++.||+|.+....... ....+.+|+.++++++|+||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56888999999999999999764 67889999987543322 12457789999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++ +|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 85 YLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9975 78777765432 478899999999999999999999 99999999999999999999999999987654433
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc---------------
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ--------------- 311 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------------- 311 (361)
.......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+...........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 33334457889999998764 46789999999999999999999998754332111111111000
Q ss_pred ---cCCCCCCCh---hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 312 ---RAPSPIDDQ---TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 312 ---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+...... ........+.+++.+||+.||.+|||+.|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 000000000 00001124678999999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=317.74 Aligned_cols=267 Identities=24% Similarity=0.295 Sum_probs=210.3
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeeCC------
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN-IVKLYGFCLHKK------ 160 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------ 160 (361)
..|...++||+|+||+||+|+. .+|+.||+|++.....++..-....+|+.+++.++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4456667799999999999954 47899999999876543222345679999999999999 999999999877
Q ss_pred eEEEEEEeccCCChhhhhccCCcc-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEA-IQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
..++|+||++ .+|..++...... ..++...+..++.|++.||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 7899999995 5999999875522 3466688999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc------
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR------ 312 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------ 312 (361)
++...-+....+..++|..|.|||++.+. .|+...||||+||++.||++++.-|...++.+......+.+...
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 99776555556666789999999998876 79999999999999999999999887766533222222222211
Q ss_pred ---------CCCCCCC-hhh-HH-H---HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 313 ---------APSPIDD-QTV-IQ-D---IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 313 ---------~~~~~~~-~~~-~~-~---~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...+... ... .. . .....+++.+|++.+|.+|.|++.+++||||++.
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0000000 000 00 0 0247789999999999999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=311.35 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=214.0
Q ss_pred HhcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.+++|++-+.||+|.|+.|+++ ..++|+.+|+|.+....-.....+++.+|+.+-+.++||||+++...+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3556777888999999999998 556789899988765544444467888999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCCeEEeeecCccc
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARL 242 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~ 242 (361)
+|+|.|++|..-+-.. .-+++...-..+.||+++|.|+|.+ +|+|||+||+|+++.. .--+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997544332 2467788889999999999999999 9999999999999943 34589999999998
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
+. +........||++|||||++...+++..+|||+-|++||-|+.|+.||.+.+. ......+..+....+......
T Consensus 163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~I~~g~yd~~~~~w~~ 238 (355)
T KOG0033|consen 163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQIKAGAYDYPSPEWDT 238 (355)
T ss_pred eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHhccccCCCCcccCc
Confidence 86 55555667899999999999999999999999999999999999999876432 334455555544433322111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. ..+..+|+.+||..||.+|.|+.|.|+|||+++
T Consensus 239 i--s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 239 V--TPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred C--CHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 1 124788999999999999999999999999976
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=320.04 Aligned_cols=254 Identities=29% Similarity=0.480 Sum_probs=208.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+.+.+|+++++.++|+|++++++++......++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 4678889999999999999998764 78999999865432 478889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999999865432 689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ....... ........ ....
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~~~~~~-~~~~~~~~--~~~~ 226 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IFMIPNK-PPPTLSDP--EKWS 226 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hhhhccC-CCCCCCch--hhcC
Confidence 3333344578899999999888899999999999999999999999875433211 1111111 11111111 1112
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..+.+++.+||+.||++|||+.|+++||||
T Consensus 227 ~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 227 PEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 247889999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=309.84 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=214.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc------hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeC
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET------ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHK 159 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 159 (361)
-+.|.-.+.||.|..+.|-++.. .+|..+|+|++..... .....+...+|+.+|+++ .||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 34567777899999999988844 4688899998854322 234456778999999998 699999999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
...++|+|.|+.|.|.++|.+.- .+++...++|++|+.+|+.|||.+ +|+||||||+|||+|++.+++|+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 99999999999999999998654 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccc------cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYT------MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
++.+.... .....+||++|+|||.+.. ..|+...|+|+.|++||.|+.|.+||....+ -.++..+..+..
T Consensus 170 a~~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---mlMLR~ImeGky 245 (411)
T KOG0599|consen 170 ACQLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---MLMLRMIMEGKY 245 (411)
T ss_pred eeccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HHHHHHHHhccc
Confidence 99886543 3445689999999998753 3478899999999999999999999875432 334555666655
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........ +......+||.+||+.||.+|.|++|.|+||||.+
T Consensus 246 qF~speWa--dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 246 QFRSPEWA--DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred ccCCcchh--hccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 43332222 22235889999999999999999999999999954
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=330.14 Aligned_cols=254 Identities=21% Similarity=0.324 Sum_probs=206.0
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 166 (361)
+|+..+.||+|+||.||++... +|+.||+|++..... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999654 688999999875422 1223456778888888885 577888999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987654 589999999999999999999999 9999999999999999999999999998764433
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........||..|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~p~~~~------ 225 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIMEHNVSYPKSLS------ 225 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCccCC------
Confidence 3333445689999999999988899999999999999999999999875432 2223333333332222211
Q ss_pred HHHHHHHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
..+.+++.+||+.+|.+|++. +++++||||+.
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 226 KEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred HHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 247789999999999999985 68999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=323.31 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=203.9
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeC----
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHK---- 159 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~---- 159 (361)
.+++.|++.+.||+|+||.||+|... +++.||+|.+...... ...+..|+.+++++ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 35677888999999999999999654 6889999998755432 25677899999998 799999999998753
Q ss_pred --CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 160 --KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 160 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
...+++|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 458999999999999999876432 2588999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
|++..............|+..|+|||++. +..++.++||||||+++|||++|+.||........ ........
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~ 232 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRNP 232 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---HHHHhcCC
Confidence 99976644333344456889999999875 34578899999999999999999999865432111 11111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
....... .....+.+++.+||+.||.+|||+.++++||||
T Consensus 233 ~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 APRLKSK----KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCC----CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 1111000 111247899999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=318.70 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=210.0
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-----CC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-----KK 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~ 160 (361)
....|...+.||+|+||.|+.+.. .+|+.||||++...-......+...+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 345566678899999999999954 578999999998655545556788899999999999999999998876 24
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
.+|+|+|+| +.+|...++.+. .++......++.|+++||.|+|+. +++||||||+|++++.+...||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 689999999 679999998775 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCC--CCCccccccccccccccccc-ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh-------------
Q 042457 241 RLLHSD--SSNRTVVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM------------- 304 (361)
Q Consensus 241 ~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~------------- 304 (361)
+..... ....+..+.|..|.|||++. ...|+.+.||||.||||.||++|++-|.+.+..++-..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987643 22345567899999999765 57799999999999999999999999876554321111
Q ss_pred -------HhhhhcccCCCCCCC-hhh-HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 305 -------LIDLLDQRAPSPIDD-QTV-IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 305 -------~~~~~~~~~~~~~~~-~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+...+..+... ... ...-....+|+.+||..||.+|+|++|.|+|||+.+
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 111222111111110 000 011124778999999999999999999999999975
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=321.98 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=203.1
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... ......+..|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3678889999999999999964 5788999999865432 2234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|..+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 99999996542 467888999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcc----hhHhhhhcccCCCCCCChhhH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK----IMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 323 (361)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... .....+.....+......
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 224 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ--- 224 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCc---
Confidence 223346889999999999888999999999999999999999998653322111 111111111111110100
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+.+++.+||+.||++||+++|+++||||+.
T Consensus 225 -~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 225 -FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred -CCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 1124788999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=321.28 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=219.1
Q ss_pred hcCCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
..+|++.+.||+|.||.|-++. ...|+.||||.++.+.. +.+.+-.+.+|+++|+.++||||+.++.+|.+.+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4568888899999999999994 46899999999877653 344566788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||..+|.|++|+...+ .+++.+.+.+++||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 99999999999998876 699999999999999999999999 99999999999999999999999999997664
Q ss_pred CCCCcccccccccccccccccccccC-ccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVT-EKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
+....+..+|++-|.+||++.+.+|. +..|-||||++||-|+.|..||+..+. +.....+..+....|...+
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQIs~GaYrEP~~PS---- 277 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQISRGAYREPETPS---- 277 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHhhcccccCCCCCc----
Confidence 34455677899999999999998874 789999999999999999999886543 4445555555554443322
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
...-||+|||..||++|-|+.+|..|.|++
T Consensus 278 ---dA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 278 ---DASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ---hHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 256788899999999999999999999985
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=339.05 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=202.9
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-----eEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK-----CMF 163 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 163 (361)
+|++.+.||+|+||.||++.. .+|+.||+|++..........+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999975 47899999998754333333467889999999999999999999998776 789
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+|+||+. ++|.+.+.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57877776543 589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCC-Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh--------------
Q 042457 244 HSDSS-NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID-------------- 307 (361)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-------------- 307 (361)
..... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+......+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 43222 22234578899999988764 478999999999999999999999975443211111100
Q ss_pred ------hhcccCCCCCCCh---hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 308 ------LLDQRAPSPIDDQ---TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 308 ------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+.......+.... ........+.+|+.+||+.||++|||+.|+++||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 0000000000000 00001234789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.97 Aligned_cols=256 Identities=22% Similarity=0.371 Sum_probs=208.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..+|.+.+.||+|+||.||+|.. .+++.|++|.+....... .+.+..|+.+++.++|+|++++++.+......++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 35788889999999999999965 468899999987654432 366889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++... .+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred cccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999998643 478999999999999999999999 9999999999999999999999999998765443
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..........+. .... ....
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~-~~~~--~~~~ 243 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATNGTPE-LQNP--EKLS 243 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH---hHHHHhcCCCCC-CCCc--cccC
Confidence 333333468889999999988888999999999999999999999987543211 111111111111 1101 1112
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||++|||+.++++||||..
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 34788999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=324.96 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=209.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..+|.+.+.||+|+||.||++.. .+++.||+|.+....... .+.+..|+.+++.++|+|++++++++...+..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 46788999999999999999975 579999999987654432 366789999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.+. .+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999998653 478899999999999999999999 9999999999999999999999999998766444
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........+++.|+|||.+.+..++.++|+||||+++|++++|+.||......... ........+.... .....
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~---~~~~~ 242 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNGTPELQN---PERLS 242 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---eeeccCCCCCCCC---ccccC
Confidence 33333456888999999998888999999999999999999999998654331111 1111111111111 11112
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++.+||+.+|++|||+.++++||||+.
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 24788999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=330.04 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=199.8
Q ss_pred CeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHH-HHhcCCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEAR-LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||++.. .+|+.+|+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3599999999999965 4689999999865422 1122344555554 56779999999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|..++.... .+++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 99998887554 589999999999999999999999 999999999999999999999999999875433333344
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||..|+|||++.+..++.++|||||||++|||++|+.||..... ......+........... ...+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~ 225 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AEMYDNILHKPLVLRPGA------SLTAWS 225 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HHHHHHHHcCCccCCCCC------CHHHHH
Confidence 45689999999999999999999999999999999999999875432 222233333322222111 124778
Q ss_pred HHhhhcCCCCCCCCCcc----ccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTMR----RSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~~----eil~hp~~~~ 358 (361)
++.+|++.+|.+||++. ++++||||+.
T Consensus 226 ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 226 ILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 89999999999999885 8999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=322.62 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=205.2
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.|+..+.||+|+||.||++... +++.||+|.+...... ......+..|+.++++++|+|++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667788999999999999654 6889999998654322 2223557789999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998864332 2588999999999999999999999 99999999999999999999999999987653322
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||......................... ....
T Consensus 157 ~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 230 (285)
T cd05630 157 T-IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE-----KFSP 230 (285)
T ss_pred c-ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCc-----cCCH
Confidence 2 223468999999999998889999999999999999999999997543211111111111111110000 0112
Q ss_pred HHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
.+.+++.+||+.||++||| ++|+++||||++
T Consensus 231 ~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 231 DARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 4788999999999999999 899999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=321.74 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=204.2
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
|++.+.||+|+||.||+|... ++..+++|.+..... ...+.+..|+++++.++|+|++++++++...+..++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 566788999999999999765 477889998865432 23567889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
++++|..++..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 85 AGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 99999988765322 589999999999999999999999 9999999999999999999999999998765433333
Q ss_pred ccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 250 RTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.....++..|+|||++. +..++.++||||||+++|||++|+.||..... ............+.... . ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-~--~~ 233 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLAQ-P--SR 233 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCCCCCCC-c--cc
Confidence 33456889999999874 34577899999999999999999999875432 11222222221111111 0 11
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+.+++.+||+.||.+|||+.++++||||+.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 1235889999999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=328.25 Aligned_cols=260 Identities=25% Similarity=0.358 Sum_probs=218.8
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCcchH-HHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETEL-AFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 163 (361)
....|.+.+.||+|.||.||++..+. |+.+|+|.+....... ...+.+.+|+.+|+++. ||||+.+.+.+.....++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45568888999999999999997654 9999999997665422 13467889999999998 999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC----CCeEEeeecC
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK----LEAFVADFGV 239 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~ 239 (361)
+|||++.||.|.+.+... .+++.....++.|++.++.|||+. +++||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998766 289999999999999999999999 99999999999999543 4799999999
Q ss_pred ccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||....... ....+...........
T Consensus 186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~---~~~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE---IFLAILRGDFDFTSEP 261 (382)
T ss_pred ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH---HHHHHHcCCCCCCCCC
Confidence 998766 556677889999999999999999999999999999999999999998765422 2234444444322222
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
... ....+.+++..|+..||.+|+|+.++|+|||++..
T Consensus 262 w~~--is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 262 WDD--ISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ccc--cCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 111 12358899999999999999999999999999863
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=333.32 Aligned_cols=257 Identities=21% Similarity=0.358 Sum_probs=221.4
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe-EEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC-MFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 166 (361)
++|...+.+|+|+||.++..+.+ +++.+++|.+..........+...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888899999999999999654 67899999998776555555688899999999999999999999999988 99999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
+||+||++.+.+...+ ...+++.++.+|+.|++.|+.|||++ .|+|||||+.||+++.++.++|+|||+++.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998765 34689999999999999999999988 9999999999999999999999999999998877
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC-CCCCCChhhHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA-PSPIDDQTVIQD 325 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 325 (361)
........||+.||+||.+.+.+|..|+|||||||++|||++-+++|...+. ......+..... +.+.. .
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~~~~~~Plp~~------y 230 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKINRGLYSPLPSM------Y 230 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHhhccCCCCCcc------c
Confidence 6667778899999999999999999999999999999999999999876543 333344444432 22222 1
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+..++..|++.+|..||++.++|.+|.++.
T Consensus 231 s~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 231 SSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred cHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 224888999999999999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=317.56 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=201.4
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhc--CCCCcceeeeEEEeeCC
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQ--IRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~ 160 (361)
-.....++..+.+.||+|.||+||+|.| .|+.||||++...+. +.+.+|.++++. ++|+||+.+++.-..++
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE-----RSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch-----hhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 3344567788999999999999999999 788899999987664 455667777665 59999999998776543
Q ss_pred ----eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEEeCCCCCCeeeCCCCC
Q 042457 161 ----CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD-----CIPSIVHRDISSNNILLNSKLE 231 (361)
Q Consensus 161 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-----~~~~i~H~dlk~~Nill~~~~~ 231 (361)
.+|||++|.++|||+|+|... .++....++++..+|.||+|||.. ..|.|.|||||+.||||..++.
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 589999999999999999875 599999999999999999999964 4578999999999999999999
Q ss_pred eEEeeecCccccCCCCC----Ccccccccccccccccccccc------cCccchhhhHHHHHHHHHhC----------CC
Q 042457 232 AFVADFGVARLLHSDSS----NRTVVAGTHGYIAPELAYTMV------VTEKCDVFGFGVVALEVLMG----------RH 291 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg----------~~ 291 (361)
+.|+|+|+|........ .....+||.+|||||++...- .-..+||||||.++||+... +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 99999999977655432 234457999999999986432 12368999999999999742 36
Q ss_pred CCCCcccCCcch--hHhhhhccc-CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccc
Q 042457 292 PGDLLSSFNPKI--MLIDLLDQR-APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349 (361)
Q Consensus 292 p~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 349 (361)
||.+..+.++.. +..-+..++ .|.........+.+..+.++++.||..+|.-|.|+-.
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALR 495 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence 777665555433 222222232 3333334445566777999999999999999998643
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=316.75 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=205.4
Q ss_pred CCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcc----hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSET----ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+|...+.||+|+||.||+|...+|+.+|+|.+..... .......+.+|++.++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999888899999998865432 223346688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
+||+++++|.+++.+.. .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997654 578999999999999999999999 999999999999999999999999999876532
Q ss_pred CC------CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 246 DS------SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 246 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~ 231 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---MFYIGAHRGLMPRLP 231 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---HHHhhhccCCCCCCC
Confidence 11 111234578899999999988899999999999999999999999875432111 111111101111110
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
. .....+.+++.+||+.+|++|||+.|+++||||
T Consensus 232 ~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 232 D---SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred C---CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 112247889999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=334.51 Aligned_cols=262 Identities=23% Similarity=0.274 Sum_probs=201.7
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-----
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK----- 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 160 (361)
..++|.+.+.||+|+||.||++.. .+|..||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999965 46899999999765444444567889999999999999999999987543
Q ss_pred -eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 161 -CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 161 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
..++||||+++ +|...+.. .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 47999999965 56555532 478889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh---------------
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM--------------- 304 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~--------------- 304 (361)
++...... ......+|..|+|||.+.+..++.++||||||+++|+|++|+.||......+....
T Consensus 170 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 170 ARTACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 97543322 22334688999999999999999999999999999999999999975432110000
Q ss_pred ----HhhhhcccCCCCCCC--------------hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 305 ----LIDLLDQRAPSPIDD--------------QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 305 ----~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...........+... .........+.+|+.+||+.||++|||+.|+++||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000111110000000 000001234789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.26 Aligned_cols=262 Identities=25% Similarity=0.369 Sum_probs=205.8
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|++|.||+|... +|+.||+|++..........+.+.+|+.+++.++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999775 58999999987554332233567899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|..++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888776543 589999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc---------------
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ--------------- 311 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------------- 311 (361)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...........
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 33333457788999998765 55788999999999999999999998754432111111110000
Q ss_pred ---cCCCCCCChhh----HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 312 ---RAPSPIDDQTV----IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 312 ---~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..+.+...... ......+.+++.+||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00000000000 0112347899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=316.31 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=206.1
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE---LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
++|.+.+.||+|++|.||++.. .+++.+|+|.+...... ......+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788999999999999999965 46899999998654321 2234578899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
++||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987654 578899999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCc---ccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 245 SDSSNR---TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 245 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .................
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~-- 230 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIATQPTNPQLPS-- 230 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHHHhccCCCCCCCc--
Confidence 322111 2345778999999999888999999999999999999999998654321 11112211111111110
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.....+.+++.+||+.+|.+|||+.|+++||||
T Consensus 231 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 231 --HVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 111247889999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=327.35 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=199.1
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHH-HHhcCCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEAR-LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||+|+.. +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999764 688999999865432 1122234555554 67889999999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
++|...+.... .++...+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 99998886543 578889999999999999999999 999999999999999999999999999875433333334
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+.... ..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~------~~~~~ 225 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDNILHKPLQLPGGKT------VAACD 225 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHHHhcCCCCCCCCCC------HHHHH
Confidence 45689999999999888899999999999999999999999875431 2223333333332222211 24788
Q ss_pred HHhhhcCCCCCCCCCcc----ccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTMR----RSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~~----eil~hp~~~~ 358 (361)
++.+||+.||.+||++. ++++||||+.
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 226 LLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred HHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 99999999999999865 9999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=346.16 Aligned_cols=262 Identities=24% Similarity=0.267 Sum_probs=211.0
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC---
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK--- 160 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 160 (361)
....++|.+.+.||+|+||+||++.. .+|+.||||.+............+.+|+..+..++|+|++++.+.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999964 57899999998766544444677889999999999999999988775432
Q ss_pred -----eEEEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEE
Q 042457 161 -----CMFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFV 234 (361)
Q Consensus 161 -----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl 234 (361)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 3689999999999999986532 223689999999999999999999999 9999999999999999999999
Q ss_pred eeecCccccCCCC--CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 235 ADFGVARLLHSDS--SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 235 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~~~~~~~~~~~ 261 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHKTLAGR 261 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCC
Confidence 9999997654322 122345689999999999999999999999999999999999999875332 22222233222
Q ss_pred CC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 313 AP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 313 ~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.. .+... ...+.+++.+||+.||.+|||+.++++|||++.
T Consensus 262 ~~~~~~~~------~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 262 YDPLPPSI------SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCCCC------CHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 21 11111 124889999999999999999999999999764
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=314.55 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=207.8
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-CCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 167 (361)
+|++.+.||+|++|.||++... +++.||+|.+..........+.+..|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999654 57889999987654444445678899999999999999999998764 446899999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|.+++..... ..+++.++..++.+++.|+++||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999876432 2589999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
.......+++.|+|||.+.+..++.++||||||+++++|++|+.||..... ............+.... ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~ 228 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLVYRIIEGKLPPMPK-----DYSP 228 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCcc-----ccCH
Confidence 334445688899999999988899999999999999999999999864321 22222333332221111 1122
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+.+++.+||+.||++|||+.++++||||
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 58899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=336.49 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=203.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|+..+.||+|+||.||++... +++.||+|++..... .......+..|+.++..++|+||+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999664 689999999875332 2233567888999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.+.. .+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999997654 588999999999999999999999 9999999999999999999999999998754221
Q ss_pred CC-----------------------------------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCC
Q 042457 247 SS-----------------------------------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRH 291 (361)
Q Consensus 247 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~ 291 (361)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0112468999999999999999999999999999999999999
Q ss_pred CCCCcccCCcchhHhhhhccc--CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC---ccccccCCCCCC
Q 042457 292 PGDLLSSFNPKIMLIDLLDQR--APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT---MRRSFPNPEINP 358 (361)
Q Consensus 292 p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~hp~~~~ 358 (361)
||..... ......+.... ...+..... ...+.+++.+|+. ||.+|++ +.|+++||||+.
T Consensus 235 Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~~----s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 235 PFCSETP---QETYRKVMNWKETLVFPPEVPI----SEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCCCH---HHHHHHHHcCCCceecCCCCCC----CHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 9875432 12222222211 111111111 1136677777764 9999995 789999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=321.91 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=206.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch------------HHHHHHHHHHHHHHhcCCCCcceeee
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE------------LAFLESFQTEARLLSQIRHRNIVKLY 153 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~niv~~~ 153 (361)
--++|.+...||+|.||.|-+|+. .+++.||||++...... ..-.+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 346799999999999999999954 47899999999654321 11235788999999999999999999
Q ss_pred EEEeeC--CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC
Q 042457 154 GFCLHK--KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE 231 (361)
Q Consensus 154 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~ 231 (361)
.+..+. +.+|||+|||..|.+...=.... .++..++++++.++..||.|||.+ +|+||||||+|+|++++|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~---els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKP---ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcc---cccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 998874 57999999999998765432221 289999999999999999999999 9999999999999999999
Q ss_pred eEEeeecCccccCCCC-----CCcccccccccccccccccccc----cCccchhhhHHHHHHHHHhCCCCCCCcccCCcc
Q 042457 232 AFVADFGVARLLHSDS-----SNRTVVAGTHGYIAPELAYTMV----VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK 302 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 302 (361)
+||+|||.+....... .......||+.|+|||...++. .+.+.||||+||+||-|+.|+.||-+... .
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---~ 325 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---L 325 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---H
Confidence 9999999987652221 1123367999999999887632 35689999999999999999999865432 1
Q ss_pred hhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 303 IMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.....+....+..+... +....+.+||+++|.+||+.|.+..+|-.|||..+.
T Consensus 326 ~l~~KIvn~pL~fP~~p----e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPENP----EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHhcCcccCCCcc----cccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 22334444444444332 222358899999999999999999999999998764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=320.43 Aligned_cols=242 Identities=19% Similarity=0.303 Sum_probs=195.7
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEee----CCeEEEEEEec
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLH----KKCMFLIYKYM 169 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 169 (361)
..||+|++|.||+|.+ +|+.||||++..... .....+.+.+|+.++++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5699999999999998 789999999976543 22335778899999999999999999999977 34689999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
++|+|.+++.... .+++.....++.+++.||.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999998654 5889999999999999999999742 77899999999999999999999999987654322
Q ss_pred cccccccccccccccccc--cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 250 RTVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+.......+... ....
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~----~~~~ 249 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLIINKNNSLKLPL----DCPL 249 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCCCCCC----cCcH
Confidence 22357889999999876 6789999999999999999999999975432 222222322222211111 1122
Q ss_pred HHHHHHhhhcCCCCCCCCCcccccc
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.+.+++.+||+.||++|||++|+++
T Consensus 250 ~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 250 EIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHH
Confidence 5889999999999999999999985
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=324.16 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=208.5
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.+|++.+.||.|++|.||+|.. .+|+.|++|.+....... .+.+.+|+..++.++|+|++++++++...+..++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK--KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch--HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4688899999999999999964 578999999987544322 3678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|..++... .+++.++..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 97 YLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred ecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999988653 489999999999999999999999 99999999999999999999999999987665443
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
.......++..|+|||.+.+..++.++||||||+++|++++|+.||....... ..........+..... .....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~---~~~~~ 243 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNGTPELQNP---EKLSP 243 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCCcccCCc---ccCCH
Confidence 33334468889999999988889999999999999999999999987544311 1111111111111010 01112
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+.+++.+||+.||++|||+.++++||||+.
T Consensus 244 ~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 4778999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.78 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=195.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------ 159 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 159 (361)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 456799999999999999999976 4688999998864332 234799999999999999999887532
Q ss_pred --CeEEEEEEeccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-CeEEe
Q 042457 160 --KCMFLIYKYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-EAFVA 235 (361)
Q Consensus 160 --~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~ 235 (361)
...++||||+++ +|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 246799999975 666665431 1223689999999999999999999999 999999999999998665 69999
Q ss_pred eecCccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc--
Q 042457 236 DFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR-- 312 (361)
Q Consensus 236 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 312 (361)
|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+............
T Consensus 214 DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9999987643322 223467899999998765 468999999999999999999999997544321111111111000
Q ss_pred ------------CCCCCCChhhH------HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 313 ------------APSPIDDQTVI------QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 313 ------------~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+....... .....+.+|+.+||++||.+|||+.|+++||||++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 00000000000 01235789999999999999999999999999964
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=321.28 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=207.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
..+.|++.+.||+|+||.||+|... +++.+++|.+..... ...+.+..|+.+++.++|+|++++++.+..++..++|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 3467889999999999999999765 588999999876543 2357788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|..++.+... .+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 88 IEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 999999999888765432 589999999999999999999999 999999999999999999999999999876443
Q ss_pred CCCCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 246 DSSNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
.........++..|+|||++. ...++.++||||||+++|||++|+.||..... ............+.....
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~- 238 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLSQP- 238 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCCccCCCC-
Confidence 333334456788999999874 34467899999999999999999999865432 111222222211111110
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
......+.+++.+||+.||++||++.++++||||+.
T Consensus 239 --~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 239 --SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred --cccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 111124788999999999999999999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=315.76 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=210.4
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||.|+||.||+|... ++..+++|++....... ....+.+|+..++.++|+|++++++.+...+..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 46888999999999999999754 67899999987554333 45788999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
++++++|.+++........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999997654333689999999999999999999999 99999999999999999999999999987765433
Q ss_pred CC----ccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 248 SN----RTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 248 ~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
.. .....++..|+|||.+... .++.++|+||||+++|||++|+.||...... ...........+........
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETGADY 233 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCcccc
Confidence 22 1334578899999988766 7899999999999999999999998754332 11222222221111111100
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
......+.+++.+||+.||++|||+.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 1112357899999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=326.84 Aligned_cols=249 Identities=23% Similarity=0.286 Sum_probs=197.8
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHH-HHHhcCCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEA-RLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||++... +++.||+|++...... ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 35999999999999765 5788999998754321 11123344444 456788999999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
++|.+++.... .+.......++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 99999987654 577888899999999999999999 999999999999999999999999999875433333344
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+... ...+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~------~~~~~~ 225 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILNKPLQLKPNI------TNSARH 225 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHHHhCCcCCCCCC------CHHHHH
Confidence 45689999999999999999999999999999999999999875432 122223332222211111 124788
Q ss_pred HHhhhcCCCCCCCCCcc----ccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTMR----RSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~~----eil~hp~~~~ 358 (361)
++.+||+.||.+||++. ++++|+||+.
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 99999999999999987 7999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=333.92 Aligned_cols=267 Identities=20% Similarity=0.294 Sum_probs=209.1
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
+.++....++|.+.+.||+|+||.||++... +++.+|+|.+..... .....+.+.+|..+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455666789999999999999999999765 678999999864322 22223567789999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
.+..++||||+++|+|.+++... .++...+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999998654 478888999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC-Cccccccccccccccccccc----ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 239 VARLLHSDSS-NRTVVAGTHGYIAPELAYTM----VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 239 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~ 264 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHKN 264 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCC
Confidence 9987643322 22345689999999998653 378899999999999999999999975432 122233332221
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCC--CCCccccccCCCCCCC
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKS--RPTMRRSFPNPEINPS 359 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~hp~~~~~ 359 (361)
....... ......+.+++.+|+..++.+ ||++.|+++||||++.
T Consensus 265 ~~~~~~~--~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 265 SLTFPDD--NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred cccCCCc--CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 1111110 011224778888999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=327.51 Aligned_cols=259 Identities=17% Similarity=0.269 Sum_probs=199.2
Q ss_pred CcCeeeec--CceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 93 IKYCIGTG--GYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 93 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
+.+.||+| +|++||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 6899999965 57899999999766544444567888999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC-
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS- 248 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 248 (361)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999865322 1488999999999999999999999 999999999999999999999999986543321111
Q ss_pred ------Ccccccccccccccccccc--cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC------
Q 042457 249 ------NRTVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP------ 314 (361)
Q Consensus 249 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 314 (361)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .........+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCcccccccc
Confidence 0112346678999999875 4588999999999999999999999975332110 0000000000
Q ss_pred -----------------------------CCC-----CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 315 -----------------------------SPI-----DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 315 -----------------------------~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+. ...........+.+++.+||+.||++|||++|+++||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000 00000111235789999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=321.39 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=209.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||.|+||.||++... ++..+|+|........ ..+.+..|++++++++|+|++++++.+......++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE--ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 456888999999999999999764 6889999998755332 3467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 82 EFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999999876432 589999999999999999999999 9999999999999999999999999998765444
Q ss_pred CCCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 247 SSNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
........++..|+|||.+. ...++.++|+||||+++|||++|+.||..... ......+.....+......
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~- 232 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKILKSEPPTLDQPS- 232 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCCCcCCcc-
Confidence 43444456889999999874 34567899999999999999999999875432 1122222222111111100
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.....+.+++.+||+.+|.+|||+.++++||||++.
T Consensus 233 --~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 233 --KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred --cCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 111247889999999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.40 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=202.6
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-----
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK----- 159 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 159 (361)
...++|.+.+.||+|+||.||++.. ..++.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999965 3688999999976544444456788999999999999999999988654
Q ss_pred -CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 160 -KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
...++||||+++ +|...+.. .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 56666542 478889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh--------------
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM-------------- 304 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-------------- 304 (361)
+++..... .......+|..|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99765332 222334689999999999988899999999999999999999999875432110000
Q ss_pred -----HhhhhcccCC--------------CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 305 -----LIDLLDQRAP--------------SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 305 -----~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.......... .+............+.+++.+||+.||++|||+.|+++||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0000000000 00000000011234789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=342.79 Aligned_cols=255 Identities=20% Similarity=0.229 Sum_probs=206.6
Q ss_pred CCCCcCeeeecCceeEEEEEeC-C-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-S-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.|.+.+.||+|++|.||++... + ++.||+|........ ....+..|+.+++.++||||+++++++...+..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER--QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3888999999999999999543 3 678888876544332 23567789999999999999999999999999999999
Q ss_pred eccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 168 YMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 168 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|+++|+|.+++... .....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999888642 2233688999999999999999999999 9999999999999999999999999999876433
Q ss_pred CC--CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC-CCCCChhhH
Q 042457 247 SS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQTVI 323 (361)
Q Consensus 247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 323 (361)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... .+...
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~---- 295 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQVLYGKYDPFPCPV---- 295 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCccC----
Confidence 22 12344689999999999998999999999999999999999999864332 2222333322221 11111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+.+++.+||+.||++|||+.+++.|||++.
T Consensus 296 --s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 --SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred --CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 124788999999999999999999999999853
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=317.51 Aligned_cols=252 Identities=24% Similarity=0.279 Sum_probs=198.6
Q ss_pred eeecCceeEEEEEeC-CCCEEEEEEeccCcchH-HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL-AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
||+|+||.||++... +|+.+|+|.+....... .....+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999654 68999999986433211 1124456799999999999999999999999999999999999999
Q ss_pred hhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccccc
Q 042457 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254 (361)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 254 (361)
.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA 155 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence 988865432 2588999999999999999999999 99999999999999999999999999987654322 223345
Q ss_pred ccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC-CcchhHhhhhcccCCCCCCChhhHHHHHHHHHHH
Q 042457 255 GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF-NPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIA 333 (361)
Q Consensus 255 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 333 (361)
|+..|+|||++.+..++.++||||+||++|||++|+.||...... ................... .....+.+++
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li 230 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ-----NFTEESKDIC 230 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccc-----cCCHHHHHHH
Confidence 889999999998888999999999999999999999998754321 1111122222222111111 1122478999
Q ss_pred hhhcCCCCCCCCCc----cccccCCCCCC
Q 042457 334 FACLRSKPKSRPTM----RRSFPNPEINP 358 (361)
Q Consensus 334 ~~cl~~dP~~RPs~----~eil~hp~~~~ 358 (361)
.+||+.||++||++ ++++.||||+.
T Consensus 231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 99999999999999 56779999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=314.08 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=208.8
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|++.+.||+|+||.+|++.. .+|+.||+|.+............+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999965 4688999999876543333356788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++..... ..+++.+++.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998875432 2478899999999999999999999 999999999999999999999999999976654333
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
......++..|+|||.+.+..++.++|+||||+++++|++|+.||.... .......+..+..+.... .....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~ 228 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN---MKNLVLKIIRGSYPPVSS-----HYSYD 228 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC---HHHHHHHHhcCCCCCCcc-----cCCHH
Confidence 3333457889999999988889999999999999999999999986432 222223333333221111 11224
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
+.+++.+||+.+|++||++.++++||||
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 8899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=333.03 Aligned_cols=262 Identities=22% Similarity=0.268 Sum_probs=202.1
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------ 159 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 159 (361)
..++|.+.+.||+|+||.||++.. ..++.||||++............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999965 4688999999976544333456788999999999999999999987643
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999965 67666642 478889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh-------------
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI------------- 306 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~------------- 306 (361)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 173 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 173 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 97653322 2233468999999999999999999999999999999999999997543211100000
Q ss_pred ------hhhcccCCCC--------------CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 307 ------DLLDQRAPSP--------------IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 307 ------~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.... ............+.+++.+||+.||.+|||+.|+|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0000000000 000000001234789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=318.27 Aligned_cols=256 Identities=31% Similarity=0.468 Sum_probs=210.7
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||.|++|.||+|... +++.||+|.+..... ......+.+|+.+++.++|+|++++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36788899999999999999764 688999999876542 2234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999999998764 589999999999999999999999 99999999999999999999999999998775543
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
.......++..|+|||.+.+..++.++||||||+++|+|+||+.||..... ......+.....+...... ...
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~ 225 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPPSLEGNK----FSK 225 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCCCCcccc----cCH
Confidence 334445678899999999988899999999999999999999999865432 1111122222111111110 122
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.+.+++.+||..||++|||++++++||||++.
T Consensus 226 ~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 47889999999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=323.85 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=201.7
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|.+.+.||+|+||.||+|... +++.||+|.+........ ...+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46888999999999999999664 688999999865433221 2456789999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|++ ++|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 997 588888765432 578999999999999999999999 99999999999999999999999999997654333
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh------------cc---
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL------------DQ--- 311 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~------------~~--- 311 (361)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................ ..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 33333457889999998765 457889999999999999999999987543211000000000 00
Q ss_pred ---cCCCCCCCh---hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 312 ---RAPSPIDDQ---TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 312 ---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+...... ........+.+++.+||+.||.+|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 000000000 00001124778999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=322.36 Aligned_cols=261 Identities=26% Similarity=0.334 Sum_probs=195.1
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC---CCCcceeeeEEEeeC-----C
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI---RHRNIVKLYGFCLHK-----K 160 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~-----~ 160 (361)
+|++.+.||+|+||.||+|... +|+.||+|.+............+..|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999664 688999999875432221123445666666654 799999999988652 4
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++++||+++ +|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 58999999974 88888865432 2489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc---------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ--------- 311 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------- 311 (361)
....... ......++..|+|||++.+..++.++||||+||++|||++|+.||......+...........
T Consensus 156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 156 RIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 7654322 222345788999999998888999999999999999999999998644321110011110000
Q ss_pred ------cCC-CCCC--ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 312 ------RAP-SPID--DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 312 ------~~~-~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
... .... ..........+.+++.+||+.||++|||+.|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 0000 00000112347899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=321.40 Aligned_cols=267 Identities=26% Similarity=0.390 Sum_probs=209.6
Q ss_pred cCHHHHHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEE
Q 042457 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFC 156 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 156 (361)
++..++..++++|.+.+.||+|+||.||++.. .+++.+|+|.+...... ...+..|+.+++++ +|||++++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV---DEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH---HHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 44556666788999999999999999999966 46889999998654332 25567889999988 899999999998
Q ss_pred eeC-----CeEEEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 157 LHK-----KCMFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 157 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
... +..++|+||+++++|.++++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 754 35899999999999999886421 223589999999999999999999999 999999999999999999
Q ss_pred CeEEeeecCccccCCCCCCccccccccccccccccccc-----ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH
Q 042457 231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-----VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML 305 (361)
Q Consensus 231 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 305 (361)
.++|+|||++..............++..|+|||.+... .++.++||||||+++|||++|+.||..... ....
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~ 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTL 242 (291)
T ss_pred CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHH
Confidence 99999999988665433333344678899999987543 367899999999999999999999865432 1112
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
..+.....+.... . ......+.+++.+||+.+|++|||+.|+++||||+
T Consensus 243 ~~~~~~~~~~~~~-~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 243 FKIPRNPPPTLLH-P--EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHhcCCCCCCCc-c--cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2222221111111 1 11123488999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=319.41 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=206.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||.||++... +|..||+|.+..... ......+.+|+.++++++|+||+++++.+...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36788899999999999999775 789999998875432 2234678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|..++........+++..+..++.+++.||.|||+.. +++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999999998876533336899999999999999999999632 8999999999999999999999999998765322
Q ss_pred CCcccccccccccccccccccc------cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 248 SNRTVVAGTHGYIAPELAYTMV------VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..............+.....+....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 232 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS--- 232 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc---
Confidence 222345788999999875543 4789999999999999999999986543221111222222222211111
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+++.+||+.+|++||+++++++||||..
T Consensus 233 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 233 --GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred --ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 12234788999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=315.19 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=203.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+.++++++||||+++++++...+..++|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~--~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD--FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch--HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45789999999999999999975 578899999987554322 356788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 86 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999999987543 588999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 247 SSNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
........++..|+|||.+. ...++.++|+||||+++|||++|+.||......... ..........+.. ....
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~-~~~~ 235 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLMSKSNFQPPKL-KDKT 235 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---eeeecCCCCCCCC-cccc
Confidence 33333446888999999874 345778999999999999999999998643321111 1111111111100 0001
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPE 355 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~ 355 (361)
.....+.+++.+||+.+|++|||++++++|+|
T Consensus 236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 236 KWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 11235889999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.65 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=201.4
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-----
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK----- 159 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 159 (361)
...++|.+.+.||+|+||.||+|.. .+++.||||.+..........+.+.+|+.+++.++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999965 4688999999876544333346677899999999999999999987643
Q ss_pred -CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 160 -KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
...+++++++ +++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3478999988 78898887643 589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh--------
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL-------- 309 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-------- 309 (361)
++...... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......+.........
T Consensus 164 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 164 LARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred cceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865432 233468899999999876 568899999999999999999999986533211000000000
Q ss_pred ------------cccCCCCCCChh--hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 310 ------------DQRAPSPIDDQT--VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 310 ------------~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
......+..... .......+.+++.+||+.||.+|||+.|+++||||.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 000000000000 0000123678999999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=325.65 Aligned_cols=259 Identities=25% Similarity=0.330 Sum_probs=201.2
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||++... +++.||+|++..... .....+.+..|..++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999764 588999999864322 2223456888999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999975322 588899999999999999999999 9999999999999999999999999998765433
Q ss_pred CC-Ccccccccccccccccccc-----cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc--CCCCCC
Q 042457 247 SS-NRTVVAGTHGYIAPELAYT-----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR--APSPID 318 (361)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 318 (361)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .....+.... ...+..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~ 232 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKEHFQFPPD 232 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCcccCCCc
Confidence 22 2233468999999999863 45788999999999999999999998754321 1112222211 111111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCC--CCCCCccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKP--KSRPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~eil~hp~~~~ 358 (361)
... ....+.+++.+|+..++ ..||+++++++||||+.
T Consensus 233 ~~~---~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 233 VTD---VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred cCC---CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 100 11236777778775544 44889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=322.53 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=197.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC-----------------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcce
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS-----------------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 150 (361)
.++|.+.+.||+|+||.||++.+++ +..||+|.+...... .....+.+|+.++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-NARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-HHHHHHHHHHHHHhhcCCCCee
Confidence 4578889999999999999997532 336999998765432 3356789999999999999999
Q ss_pred eeeEEEeeCCeEEEEEEeccCCChhhhhccCC----------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 042457 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDD----------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214 (361)
Q Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i 214 (361)
++++++...+..++||||+++|+|.+++.... ....+++..+.+++.|++.||.|||+. ++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 99999999999999999999999999885421 112478889999999999999999999 99
Q ss_pred EEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh--CC
Q 042457 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM--GR 290 (361)
Q Consensus 215 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~ 290 (361)
+|+||||+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999765432211 122335778999999988889999999999999999987 55
Q ss_pred CCCCCcccCCcchhHhhhhcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 291 HPGDLLSSFNPKIMLIDLLDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 291 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.||.................... ....... ......+.+++.+||+.||++|||+.||.+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRP--PPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCC--CCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 67764432111111111111100 0000000 001124889999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=310.94 Aligned_cols=260 Identities=23% Similarity=0.295 Sum_probs=219.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
-+.|++.+.||.|.-|+||+++..+ +..+|+|++.+.... .........|.++|+.++||.++.+|+.++.++..|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3457778889999999999998864 589999999766542 33456788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
||||+||+|..+.+++... .+++..++.++..++-||+|||.. |||.|||||+||||.++|++-|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999998876544 699999999999999999999999 999999999999999999999999998744311
Q ss_pred ---------------------------------C-C----------------------CCcccccccccccccccccccc
Q 042457 246 ---------------------------------D-S----------------------SNRTVVAGTHGYIAPELAYTMV 269 (361)
Q Consensus 246 ---------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~ 269 (361)
. . ......+||.+|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0011235899999999999999
Q ss_pred cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC---
Q 042457 270 VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT--- 346 (361)
Q Consensus 270 ~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs--- 346 (361)
.+.+.|.|+|||++|||+.|..||.... .+..+.+++.+....+... .....+.+||++.|.+||.+|.-
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~---~~~Tl~NIv~~~l~Fp~~~----~vs~~akDLIr~LLvKdP~kRlg~~r 384 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSN---NKETLRNIVGQPLKFPEEP----EVSSAAKDLIRKLLVKDPSKRLGSKR 384 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCC---chhhHHHHhcCCCcCCCCC----cchhHHHHHHHHHhccChhhhhcccc
Confidence 9999999999999999999999987644 4556777777776655443 22234889999999999999999
Q ss_pred -ccccccCCCCCC
Q 042457 347 -MRRSFPNPEINP 358 (361)
Q Consensus 347 -~~eil~hp~~~~ 358 (361)
+.||-+||||+.
T Consensus 385 GA~eIK~HpFF~g 397 (459)
T KOG0610|consen 385 GAAEIKRHPFFEG 397 (459)
T ss_pred chHHhhcCccccC
Confidence 999999999986
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.97 Aligned_cols=264 Identities=19% Similarity=0.280 Sum_probs=196.9
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC------CCcceeeeE
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR------HRNIVKLYG 154 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~ 154 (361)
+++...+++|++.+.||+|+||.||+|.. .+++.||||+++..... .+.+..|+.+++.++ |.+++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY---TRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh---HHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 34445678899999999999999999965 46788999998653221 234455666666654 456889999
Q ss_pred EEeeC-CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCC--
Q 042457 155 FCLHK-KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKL-- 230 (361)
Q Consensus 155 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~-- 230 (361)
++... ...++|||++ +++|.+++.... .+++..+..++.||+.||.|||+ . +|+||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcc
Confidence 88765 5789999988 778888886554 58999999999999999999997 5 899999999999998765
Q ss_pred --------------CeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCc
Q 042457 231 --------------EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLL 296 (361)
Q Consensus 231 --------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 296 (361)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999875432 2233456899999999999999999999999999999999999999754
Q ss_pred ccCCcchhHhhhhccc--------------------CC-CCCCChh------------hHHHHHHHHHHHhhhcCCCCCC
Q 042457 297 SSFNPKIMLIDLLDQR--------------------AP-SPIDDQT------------VIQDIILVSKIAFACLRSKPKS 343 (361)
Q Consensus 297 ~~~~~~~~~~~~~~~~--------------------~~-~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~ 343 (361)
...+............ .. .+..... .......+.+|+.+||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 4311111111110000 00 0000000 0001134779999999999999
Q ss_pred CCCccccccCCCCCC
Q 042457 344 RPTMRRSFPNPEINP 358 (361)
Q Consensus 344 RPs~~eil~hp~~~~ 358 (361)
|||++|+|+||||++
T Consensus 429 R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 429 RLNARQMTTHPYVLK 443 (467)
T ss_pred CCCHHHHhcCccccc
Confidence 999999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=361.73 Aligned_cols=246 Identities=28% Similarity=0.507 Sum_probs=193.5
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
..+...+.||+|+||.||+|.. .+|..||||++...... ...|++.+++++||||++++|+|.+.+..++|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 4577888999999999999976 57899999998754332 1245888999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.++++ .++|.++.+++.|+++||+|||..+.++++||||||+||+++.++..++. ||........
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999996 38999999999999999999997666699999999999999999888875 6654432211
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH-----------hhhhcccCCCC
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML-----------IDLLDQRAPSP 316 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-----------~~~~~~~~~~~ 316 (361)
....++..|+|||++.+..++.++|||||||++|||+||+.||+........... ....+.....
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG- 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC-
Confidence 1235788999999999999999999999999999999999998643322111110 0111111111
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
...........+.+++.+||+.||++||||+|+++.
T Consensus 912 -~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 -DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 111223455568899999999999999999999864
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=320.10 Aligned_cols=258 Identities=25% Similarity=0.340 Sum_probs=204.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||.||++... +|..+|+|.+..... ......+.+|++++++++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36888999999999999999654 678899998875433 2334678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|.+++.... .+++..+..++.|++.||.|||+.. +++|+||||+||+++.++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 80 HMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999997653 5889999999999999999999732 89999999999999999999999999987553221
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh---------------------
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI--------------------- 306 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~--------------------- 306 (361)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 223457889999999888889999999999999999999999986432111000000
Q ss_pred ------------hhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 307 ------------DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 307 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.......+. ... ......+.+++.+||+.||++|||++|+++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPK-LPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred ccchhhHHHHHHHHhcCCCcc-CcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 000000000 000 001224789999999999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=334.81 Aligned_cols=258 Identities=23% Similarity=0.383 Sum_probs=205.2
Q ss_pred CCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-C-----CcceeeeEEEeeCCeE
Q 042457 90 DFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-H-----RNIVKLYGFCLHKKCM 162 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~ 162 (361)
+|.+.+.||+|+||.|.+| ...+++.||||+++.... ...+-..|+.+|..++ | -|+|++++++...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 7899999999999999999 456799999999987543 3466778999999986 4 3899999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC--CCeEEeeecCc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK--LEAFVADFGVA 240 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~ 240 (361)
|||+|.. ..+|+++++.+... .++...++.++.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.+
T Consensus 264 ciVfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999998 56999999987655 589999999999999999999999 99999999999999654 46999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh-------------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID------------- 307 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~------------- 307 (361)
+.....-. ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|...+..+.-....+
T Consensus 339 c~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 86543222 45678899999999999999999999999999999999887765443211000000
Q ss_pred --------------------------------------hhcccCCCCC--CCh-hhHHHHHHHHHHHhhhcCCCCCCCCC
Q 042457 308 --------------------------------------LLDQRAPSPI--DDQ-TVIQDIILVSKIAFACLRSKPKSRPT 346 (361)
Q Consensus 308 --------------------------------------~~~~~~~~~~--~~~-~~~~~~~~l~~li~~cl~~dP~~RPs 346 (361)
..+...+... ... ....+-..+.+++++||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0011111000 000 01122345789999999999999999
Q ss_pred ccccccCCCCCC
Q 042457 347 MRRSFPNPEINP 358 (361)
Q Consensus 347 ~~eil~hp~~~~ 358 (361)
+.|.|+||||+.
T Consensus 496 p~qal~Hpfl~~ 507 (586)
T KOG0667|consen 496 PAQALNHPFLTG 507 (586)
T ss_pred HHHHhcCccccc
Confidence 999999999984
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=317.08 Aligned_cols=257 Identities=22% Similarity=0.261 Sum_probs=204.3
Q ss_pred CCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 91 FDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
|+..+.||+|+||+||++.. .+++.+|+|.+...... ......+..|+++++.++|+|++++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999966 46889999998654322 12234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988865332 2589999999999999999999999 99999999999999999999999999987653322
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH-hhhhcccCCCCCCChhhHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML-IDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||............ ..........+.. ...
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 230 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK------FSE 230 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCcc------CCH
Confidence 222346899999999998888999999999999999999999998754321111111 1111111111111 112
Q ss_pred HHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
.+.+|+..||+.||++||| +.++++|+||+.
T Consensus 231 ~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 231 EAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred HHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 4788999999999999999 789999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=321.55 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=205.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999775 58999999987654433334678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|..+..... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988776543 489999999999999999999999 99999999999999999999999999988765444
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc----------------
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD---------------- 310 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---------------- 310 (361)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+..........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 33334557889999998765 4577899999999999999999999864332110000000000
Q ss_pred -ccCCCCCCChhh-----HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 311 -QRAPSPIDDQTV-----IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 311 -~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
............ ......+.+++.+||+.+|++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000000000000 0112358899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=317.14 Aligned_cols=264 Identities=25% Similarity=0.409 Sum_probs=208.3
Q ss_pred cCHHHHHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEE
Q 042457 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFC 156 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 156 (361)
.++.++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+...... ...+..|+.+++++ +|+|++++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE---EEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH---HHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 45666667888999999999999999999976 46889999998654322 35677899999988 799999999998
Q ss_pred ee------CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 157 LH------KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 157 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
.. .+..+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 63 4578999999999999999875432 2478888999999999999999999 999999999999999999
Q ss_pred CeEEeeecCccccCCCCCCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH
Q 042457 231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML 305 (361)
Q Consensus 231 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 305 (361)
.++|+|||++..............++..|+|||.+. +..++.++|+||||+++|||++|+.||....... ..
T Consensus 159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~ 235 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR---AL 235 (282)
T ss_pred CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh---hh
Confidence 999999999876543333334456888999999875 3457889999999999999999999986543211 11
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
............. ......+.+++.+||+.||.+|||+.|+++||||
T Consensus 236 ~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 236 FLIPRNPPPKLKS----KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hhHhhCCCCCCcc----cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1111111111110 0112258899999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=319.62 Aligned_cols=266 Identities=25% Similarity=0.394 Sum_probs=207.4
Q ss_pred cCHHHHHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEE
Q 042457 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFC 156 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 156 (361)
+.++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+...... ...+..|+.+++.+ +|+|++++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch---HHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 44566677889999999999999999999965 46889999988654332 25577899999998 699999999988
Q ss_pred e-----eCCeEEEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 157 L-----HKKCMFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 157 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
. .++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 4 3456899999999999998875321 223588899999999999999999999 999999999999999999
Q ss_pred CeEEeeecCccccCCCCCCcccccccccccccccccc-----cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH
Q 042457 231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML 305 (361)
Q Consensus 231 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 305 (361)
.++|+|||++..............|+..|+|||++.. ..++.++||||+|+++|||++|+.||....... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~~ 238 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---AL 238 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---HH
Confidence 9999999998766443333344568899999998753 447889999999999999999999987543211 11
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
........+. ...... ....+.+++.+||+.||++|||+.|+++|+||
T Consensus 239 ~~~~~~~~~~-~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 239 FKIPRNPPPT-LHQPEL--WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred hhccccCCCc-ccCCCC--cCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1111111111 100000 11247889999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.48 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=204.4
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-------hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-------ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
+|.+...||+|++|.||+|.. .+++.+|+|.+..... .....+.+..|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778899999999999965 4688999998865432 12234678899999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++++||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997654 578899999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCC------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCC
Q 042457 242 LLHSDSS------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPS 315 (361)
Q Consensus 242 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 315 (361)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...........+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~ 231 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKIGENASPE 231 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHHhccCCCc
Confidence 7643211 112234788999999998888999999999999999999999998754321 1112222211111
Q ss_pred CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 316 PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
... .....+.+++.+||+.||.+||++.|+++||||
T Consensus 232 ~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 232 IPS-----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CCc-----ccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 111 112347889999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=333.23 Aligned_cols=259 Identities=21% Similarity=0.262 Sum_probs=202.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
...+|.+.+.||+|+||.||++... .+..||+|.+.... ...+|+++++.++||||+++++++......+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 4567999999999999999999653 35789999886532 2457999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
++||++. ++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++...
T Consensus 163 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999995 68888884433 689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc---------
Q 042457 244 HSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR--------- 312 (361)
Q Consensus 244 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 312 (361)
...... .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..+....
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 433222 223468999999999999999999999999999999999999986543221111111111100
Q ss_pred ----------------CCCCCCChhh---HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 313 ----------------APSPIDDQTV---IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 313 ----------------~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...+...... ......+.+++.+||..||++|||+.|+|+||||++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0000000000 0011246789999999999999999999999999864
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=321.59 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=203.5
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
|.....||+|+||.||++... ++..||||.+..... ...+.+.+|+..++.++|+|++++++.+...+..++||||+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 333456999999999999654 688999999865433 22467889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 102 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 102 EGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 999999988543 488999999999999999999999 9999999999999999999999999998765443333
Q ss_pred cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHH
Q 042457 250 RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILV 329 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 329 (361)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.. ..+...... ......+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~-~~~~~~~~~--~~~~~~~ 248 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRIRD-NLPPRVKDS--HKVSSVL 248 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh-cCCCccccc--cccCHHH
Confidence 344568899999999988889999999999999999999999987533211 1111111 111111110 0111247
Q ss_pred HHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 330 SKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 330 ~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+++.+||+.||.+|||++|+++||||+.
T Consensus 249 ~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 249 RGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 78999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=330.20 Aligned_cols=260 Identities=24% Similarity=0.366 Sum_probs=202.8
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEE
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGF 155 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 155 (361)
.+....++|++.+.||+|+||.||+|.. .++..||||+++..... ...+.+.+|+.+++.+ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 3445567899999999999999999963 24568999999754432 2246788999999999 89999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCc----------------------------------------------------
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDE---------------------------------------------------- 183 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------- 183 (361)
|...+..++||||+++|+|.++++....
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 9999999999999999999998864321
Q ss_pred --------------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 184 --------------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 184 --------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
...+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceec
Confidence 12478899999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 244 HSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 244 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..................
T Consensus 265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~ 341 (375)
T cd05104 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIKEGYRMLSPEC 341 (375)
T ss_pred cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHHHhCccCCCCCC
Confidence 433221 111234567999999999999999999999999999998 88898654321 111222222111111100
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
....+.+++.+||+.||++|||+.|+++.
T Consensus 342 ----~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 342 ----APSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 11248899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=327.64 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=196.3
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
....+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++...+..++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 44568999999999999999999764 5678999975432 23468999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|+|++. ++|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 135 v~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEccC-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999995 688888765432 589999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCC-CCCcccCCc------chhHhhhhccc--CCC
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-GDLLSSFNP------KIMLIDLLDQR--APS 315 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p-~~~~~~~~~------~~~~~~~~~~~--~~~ 315 (361)
.. .......||..|+|||++.+..++.++|||||||++|||+++..| |........ ...+..+.... .+.
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 22 222334589999999999998999999999999999999985544 433211100 00011111100 000
Q ss_pred CCC---Ch--------------------hh---HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 316 PID---DQ--------------------TV---IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 316 ~~~---~~--------------------~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
... .. .. .........++.+||+.||.+|||+.|+|+||||++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000 00 00 001123456899999999999999999999999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=315.24 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=200.7
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
..++|++.+.||+|+||.||+|.+. .+..||+|.++..... ...+.+.+|+..+++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 3467888999999999999999653 3568999999865433 2346788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999999876432 589999999999999999999999 999999999999999999999999998765
Q ss_pred cCCCCCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 243 LHSDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 243 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+.+... .+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~-~~~~~- 231 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFR-LPAPR- 231 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC-CCCCC-
Confidence 4222111 112234578999999999999999999999999999876 99998754331 12222222211 11111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.....+.+++.+||+.+|++|||+++|++
T Consensus 232 ---~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 232 ---NCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ---CCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 11224888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=312.21 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=201.1
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCc---chHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--CCeE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE---TELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--KKCM 162 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 162 (361)
.+|...+.||+|+||.||+|.. .++..|++|.+.... ........+.+|+.+++.++|+||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999965 468899999886432 222335678899999999999999999998875 3568
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999987654 478899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCC---CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 243 LHSDS---SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 243 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ .+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~~-~~~~~ 231 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPT-NPQLP 231 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCCC-CCCCc
Confidence 53211 112224478899999999888899999999999999999999999875432 111111111111 11110
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
......+..++ +||..+|++|||++|+++||||+.
T Consensus 232 ---~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~~ 266 (266)
T cd06651 232 ---SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQL 266 (266)
T ss_pred ---hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccccC
Confidence 11112355666 788899999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=317.19 Aligned_cols=246 Identities=33% Similarity=0.537 Sum_probs=191.7
Q ss_pred CcCeeeecCceeEEEEEeC-----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 93 IKYCIGTGGYGSVYRAQLP-----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
+.+.||.|.||.||+|.+. .+..|+||.++..... ...+.+.+|++.+++++||||++++|+|...+..++|+|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE-EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH-HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc-ccceeeeeccccccccccccccccccccccccccccccc
Confidence 4567999999999999875 2568999999664333 236889999999999999999999999998888999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.++|..... ..+++..+..|+.|++.||+|||+. +++|+||+++||++++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999987621 2589999999999999999999999 99999999999999999999999999998763222
Q ss_pred C--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCC-CCCChhhH
Q 042457 248 S--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPS-PIDDQTVI 323 (361)
Q Consensus 248 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 323 (361)
. ..........|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.+..... +...+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~--- 231 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQGQRLPIPDNCP--- 231 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHTTEETTSBTTSB---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccceeccchh---
Confidence 1 1222346778999999998889999999999999999999 7899765432 22233333332221 11111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+.+++..||+.||++|||+.++++
T Consensus 232 ---~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 ---KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 24788999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=315.27 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=203.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||+|.. .+++.||+|.++...... ...+.+|+.+++.++||||+++++.+...+..++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED--FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 35677788899999999999965 468899999987654322 356788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++.+++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999999987654 589999999999999999999999 9999999999999999999999999998766443
Q ss_pred CCCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 247 SSNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
........|+..|+|||.+. ...++.++|+||||+++|+|++|+.||....... ............+... ...
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~-~~~ 235 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKLK-DKM 235 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhccCCCCCccc-ccC
Confidence 33334456899999999874 4557889999999999999999999975433211 1111111111111000 000
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPE 355 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~ 355 (361)
.....+.+++.+||+.+|++|||++++++|||
T Consensus 236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 11124788999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=311.23 Aligned_cols=259 Identities=28% Similarity=0.431 Sum_probs=214.4
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|++|.||++... +++.|++|++...... .....+..|+..+.+++|+|++++++++...+..++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888899999999999999775 5899999998776543 335788999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|+++++|.+++.... .+++..++.++.|+++|++|||+ . +++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 80 YMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999997653 68999999999999999999999 8 9999999999999999999999999999876544
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..............+.....+.. ... ...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~ 229 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL-PAE---EFS 229 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCC-Ccc---cCC
Confidence 4443345678899999999888899999999999999999999999876543122222222332222111 111 012
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++.+||+.+|++|||+.|+++||||+.
T Consensus 230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 35889999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=308.15 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=210.4
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|+..+.||+|+||.||.++. .+++.+++|.+............+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999854 4688999999876654444457788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997653 23589999999999999999999999 999999999999999999999999999987654443
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
......++..|+|||.+.+..++.++||||||+++|||++|..||..... ......+.......... .....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~ 228 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVVKIVQGNYTPVVS-----VYSSE 228 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCCCCcc-----ccCHH
Confidence 33445688999999999888889999999999999999999999864321 22222333322221111 11224
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
+.+++.+||+.+|.+|||+.++++|||+
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 7889999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=327.52 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=196.0
Q ss_pred eeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC---CCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI---RHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
||+|+||.||+|... +|+.||+|++..... .......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999654 689999999864322 112233455666666655 699999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||++...........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 99998887654 589999999999999999999999 999999999999999999999999999876443333344
Q ss_pred ccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVS 330 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 330 (361)
...||..|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+.......+... ....+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~-----~~~~~~ 226 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYRNIAFGKVRFPKNV-----LSDEGR 226 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHHHHHcCCCCCCCcc-----CCHHHH
Confidence 45689999999988754 478999999999999999999999865332 122222322222222111 112477
Q ss_pred HHHhhhcCCCCCCCC----CccccccCCCCCC
Q 042457 331 KIAFACLRSKPKSRP----TMRRSFPNPEINP 358 (361)
Q Consensus 331 ~li~~cl~~dP~~RP----s~~eil~hp~~~~ 358 (361)
+++.+||+.||.+|| ++.++++||||+.
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 899999999999998 7899999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=315.95 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=210.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||++... +++.+|+|.+..... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999764 689999999865432 2233567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999997654 689999999999999999999999 9999999999999999999999999998776443
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ......+.......+... .
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~------~ 222 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKILEGKVRFPSFF------S 222 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCccCCccC------C
Confidence 2234578899999999888889999999999999999999999865431 222233333333322221 1
Q ss_pred HHHHHHHhhhcCCCCCCCC-----CccccccCCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINPS 359 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~~ 359 (361)
..+.+++.+||+.||.+|| +++|+++||||+..
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 2478899999999999999 99999999999763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=318.89 Aligned_cols=265 Identities=26% Similarity=0.327 Sum_probs=206.2
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE---LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+|.+.+.||+|++|.||+|... +|+.||+|.+...... ......+..|+++++.++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999764 6899999999765433 22335677899999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+ +++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999997654 2589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc-------------
Q 042457 246 DSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ------------- 311 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------------- 311 (361)
.........++..|+|||.+.+ ..++.++||||||+++|||++|..||......+...........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 4333333456788999998754 45788999999999999999998887644331110000000000
Q ss_pred -----cCCCCCC-ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 312 -----RAPSPID-DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 312 -----~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
....... ..........+.+++.+||+.||++|||++|+++||||++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0000000 000011124578999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=317.49 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=201.8
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|+..+.||.|++|.||+|... +|+.||||.+............+..|++++++++||||+++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999664 689999999876544333346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 688888865432 2589999999999999999999999 999999999999999999999999999876544333
Q ss_pred Ccccccccccccccccccccc-cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC--------------
Q 042457 249 NRTVVAGTHGYIAPELAYTMV-VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA-------------- 313 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 313 (361)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......+......+......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 333344678899999876644 58899999999999999999999864332111100000000000
Q ss_pred -CCCCCChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 314 -PSPIDDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 314 -~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..+....... .....+.+++.+||+.||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000000000 011246789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=309.51 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=209.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||.|+||.||+|... +++.+++|.+...... ..+.+..|+.++++++||||+++++++...+..+++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 467888999999999999999764 5788999998765443 3577889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... .++...+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred eCCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999999876522 588999999999999999999999 9999999999999999999999999998766543
Q ss_pred CCCccccccccccccccccccc---ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTM---VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
........++..|+|||.+.+. .++.++|+||||+++|||++|+.||...... .............+. .....
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~~~~~~~~~~~~-~~~~~ 230 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALFLISKSNFPPPK-LKDKE 230 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCcc-ccchh
Confidence 3333345678899999998776 7889999999999999999999998754321 111111112111111 11112
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPE 355 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~ 355 (361)
.....+.+++.+||+.+|.+|||+.+++.|+|
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 22345889999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=319.76 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=189.2
Q ss_pred cCeeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--CCeEEEEEEe
Q 042457 94 KYCIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--KKCMFLIYKY 168 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 168 (361)
..+||+|+||.||+|... +++.||+|.+...... ..+.+|+.++++++||||+++++++.. ....++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 357999999999999754 4678999998754432 446789999999999999999998864 4568999999
Q ss_pred ccCCChhhhhccCC------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee----CCCCCeEEeeec
Q 042457 169 MRRGSLFCVLRNDD------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL----NSKLEAFVADFG 238 (361)
Q Consensus 169 ~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg 238 (361)
+. ++|.+++.... ....+++..+..++.|++.||.|||+. +++||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 47877765321 123588999999999999999999999 99999999999999 456789999999
Q ss_pred CccccCCCCC---Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCc------chhHhhh
Q 042457 239 VARLLHSDSS---NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP------KIMLIDL 308 (361)
Q Consensus 239 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~ 308 (361)
+++....... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||........ ......+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 9987643322 2233568999999998876 4588999999999999999999999864322100 0000011
Q ss_pred hcccC-------------CC--------------CCCChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 309 LDQRA-------------PS--------------PIDDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 309 ~~~~~-------------~~--------------~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..... +. ........ .....+.+|+.+||+.||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 00 00000000 001236789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=318.32 Aligned_cols=259 Identities=22% Similarity=0.306 Sum_probs=199.7
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|++.+.||+|+||.||+|... +|+.||+|.+............+.+|+.+++.++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999764 689999999876543333345677899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
++ ++|.+++..... .+++..++.++.||++||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 478777764332 589999999999999999999999 999999999999999999999999999976544333
Q ss_pred Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh------------------
Q 042457 249 NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL------------------ 309 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~------------------ 309 (361)
......++..|+|||.+.+. .++.++||||||+++|||+||..|+...... ......+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 33334578899999987664 4688999999999999999999885432211 11111000
Q ss_pred cccCCCCCCChhh-----HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 310 DQRAPSPIDDQTV-----IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 310 ~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
............. ......+.+++.+||+.||.+|||++|+++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0000000000000 0112347889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=310.06 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=208.0
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--CCeEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--KKCMFLIY 166 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 166 (361)
+|++.+.||.|+||.||++.. .+|+.+|+|.+..........+.+..|+.+++.++|+|++++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999965 468899999987655545556778899999999999999999998764 45689999
Q ss_pred EeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 167 KYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLH-----YDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh-----~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
||+++++|.+++.... ....+++..++.++.|++.||.||| +. +++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999986532 2336899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
..............++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ......+.....+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~-~~~-- 231 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIKEGKFR-RIP-- 231 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHhcCCCC-CCc--
Confidence 8775544323445688999999999888899999999999999999999999875431 1222222222211 111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
......+.+++.+|++.+|++|||+++|++|||+
T Consensus 232 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 232 --YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred --cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 1112358899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=314.39 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=209.4
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|+..+.||+|++|.||++... +++.+++|.+...... ...+.+.+|++.+++++||||+++++.+...+..++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 35777888999999999999775 6889999998765443 335678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|+++++|.+++.... ..++...+..++.|++.|++|||+ . +++|+||+|+||++++++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999999997653 268899999999999999999999 7 9999999999999999999999999998765332
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC--cchhHhhhhcccCCCCCCChhhHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN--PKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .............+..... .
T Consensus 155 ~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 228 (265)
T cd06605 155 LAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG----K 228 (265)
T ss_pred Hhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh----h
Confidence 211 1557889999999988899999999999999999999999986543211 1111222222221111110 0
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+++.+||..||++|||+.|++.||||++.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 22247899999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.15 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=203.2
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeE
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYG 154 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 154 (361)
+.+....++|++.+.||+|+||.||+|.. .++..||+|.+....... ..+.+.+|+.+++.+ +|+||+++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD-EREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH-HHHHHHHHHHHHHhhccCCceeeEee
Confidence 34456677899999999999999999863 234579999997654332 346788999999999 8999999999
Q ss_pred EEeeCCeEEEEEEeccCCChhhhhccCC----------------------------------------------------
Q 042457 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDD---------------------------------------------------- 182 (361)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------- 182 (361)
+|...+..++||||+++|+|.++++...
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999999999999885421
Q ss_pred ---------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 183 ---------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 183 ---------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
....+++..+++++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~ 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence 012478899999999999999999999 99999999999999999999999999997654332
Q ss_pred CC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 248 SN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 248 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.. .....++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..................
T Consensus 267 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~---- 339 (374)
T cd05106 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---SKFYKMVKRGYQMSRPDF---- 339 (374)
T ss_pred ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---HHHHHHHHcccCccCCCC----
Confidence 11 112234567999999988899999999999999999997 99998754321 111222222111111111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||+.||.+|||+.++++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0124889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=308.70 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=207.7
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|...+.||+|+||.||+|... +++.|++|.++.........+.+..|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999754 688999999987765545568899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++.... .+++..+..++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999997653 478899999999999999999999 999999999999999999999999999887644332
Q ss_pred Ccc----cccccccccccccccccc---cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC-CCCCCCh
Q 042457 249 NRT----VVAGTHGYIAPELAYTMV---VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA-PSPIDDQ 320 (361)
Q Consensus 249 ~~~----~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 320 (361)
... ...++..|+|||++.+.. ++.++||||||+++||+++|+.||..... .......+..... ..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~-- 230 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHKPPIPDS-- 230 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhcCCCCCCCcc--
Confidence 211 245788999999988766 88999999999999999999999875432 1111111111111 11111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
......+.+++.+||+.+|++|||+.+++.|||+
T Consensus 231 --~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 231 --LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred --cccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1112247789999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=318.89 Aligned_cols=253 Identities=29% Similarity=0.453 Sum_probs=205.4
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
.|+..+.||+|+||.||+|... ++..||+|.+....... ..+.+..|+.++++++|+||+++++++...+..++|+||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3556677999999999999654 57889999987544332 346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++... .+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999988643 588999999999999999999999 999999999999999999999999999976654333
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ....+.....+. .. ......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~-~~----~~~~~~ 228 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFLIPKNSPPT-LE----GQYSKP 228 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhhhhcCCCCC-CC----cccCHH
Confidence 3333457889999999988889999999999999999999999986433211 111111111111 11 111234
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+.+++.+||+.+|++|||+.++++||||+.
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 229 FKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 789999999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=311.37 Aligned_cols=247 Identities=24% Similarity=0.434 Sum_probs=201.2
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
++|++.+.||+|+||.||++.+.++..+|+|.+...... .+.+..|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 458888999999999999999988889999998754433 25688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++|+|.+++..... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.++.......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 81 MENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999875432 588999999999999999999999 999999999999999999999999999876533222
Q ss_pred C-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-CCCCCChhhHHH
Q 042457 249 N-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-PSPIDDQTVIQD 325 (361)
Q Consensus 249 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 325 (361)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..... ..+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~------ 226 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFRLYRPKLA------ 226 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCCCCCCCCC------
Confidence 1 122234568999999988889999999999999999999 8999865432 112222222221 111111
Q ss_pred HHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.+|.+|||+.++++
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 124889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=334.79 Aligned_cols=257 Identities=22% Similarity=0.283 Sum_probs=198.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.+|.+.+.||+|+||.||++... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 36888999999999999999765 478899996432 335689999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
++. ++|.+++..... .+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||+++......
T Consensus 241 ~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 994 688888765432 589999999999999999999999 99999999999999999999999999997654322
Q ss_pred C--CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC----CcchhHhhhhccc------CCC
Q 042457 248 S--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF----NPKIMLIDLLDQR------APS 315 (361)
Q Consensus 248 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~----~~~~~~~~~~~~~------~~~ 315 (361)
. ......||..|+|||++.+..++.++|||||||++|||++|..|+-..... .....+.+++... .+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2 122346899999999999999999999999999999999987654221110 0001111111110 000
Q ss_pred -------------------CCCChhhH----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 316 -------------------PIDDQTVI----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 316 -------------------~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
+......+ .....+.+|+.+||+.||.+|||+.|+|+||||+..
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~~ 461 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQSK 461 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCCC
Confidence 00000000 111247789999999999999999999999999863
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.35 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=208.8
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
..|+..+.||+|+||.||+|... ++..||+|.+...... .....+..|+.++++++|+||+++++++...+..++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45777888999999999999764 5889999998754432 234778899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|.+++... .+++.+...++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 83 YLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999998753 478899999999999999999999 99999999999999999999999999997765433
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ..........+ .. ......
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~-~~----~~~~~~ 227 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLFLIPKNNPP-TL----TGEFSK 227 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---HhhhhhcCCCC-CC----chhhhH
Confidence 33334457889999999988889999999999999999999999987543211 11111111111 11 112234
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.+.+++.+||+.+|++|||+.++++||||.+.
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 228 PFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 58899999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=318.63 Aligned_cols=259 Identities=23% Similarity=0.312 Sum_probs=210.9
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|++|.||++... +++.+|+|.+...... ....+.+..|+++++.++|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999765 4899999999765433 234567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987542 23689999999999999999999999 9999999999999999999999999998654321
Q ss_pred CC-----------------------------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcc
Q 042457 247 SS-----------------------------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLS 297 (361)
Q Consensus 247 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 297 (361)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 0112357888999999998889999999999999999999999986443
Q ss_pred cCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC----ccccccCCCCCC
Q 042457 298 SFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT----MRRSFPNPEINP 358 (361)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~hp~~~~ 358 (361)
. ......+.......+.... ....+.+++.+||+.||++||| ++|+++||||++
T Consensus 237 ~---~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 237 R---DETFSNILKKEVTFPGSPP----VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred h---HHHHHHHhcCCccCCCccc----cCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 2 2223333333332222211 2235889999999999999999 999999999976
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.30 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=207.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||+|+||+||++... +|+.||+|.+..... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 356778889999999999999654 688999998865433 233577889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.+++.||.|||+.. +++|+||+|+||++++++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999999887644 5899999999999999999999732 8999999999999999999999999998654322
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC----cc----hhHhhhhcccCCCCCC
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN----PK----IMLIDLLDQRAPSPID 318 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~----~~----~~~~~~~~~~~~~~~~ 318 (361)
. .....++..|+|||++.+..++.++|+||||+++|++++|+.||....... .. ...........+....
T Consensus 158 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 158 I--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred c--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 1 223468899999999888889999999999999999999999997544310 00 0111122111111111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
......+.+++.+||+.||++|||+.|+++||||.+.
T Consensus 236 ----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 236 ----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 1122358899999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.76 Aligned_cols=259 Identities=24% Similarity=0.319 Sum_probs=201.9
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||++... +++.+|+|.+..... .......+..|..++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999765 477899999864322 2222355788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++..... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976432 588999999999999999999999 9999999999999999999999999998765333
Q ss_pred CC-Cccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC--CCCCC
Q 042457 247 SS-NRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA--PSPID 318 (361)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 318 (361)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+..... ..+..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~ 232 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHKERFQFPAQ 232 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH---HHHHHHHhCCCccccCCCc
Confidence 22 223346899999999876 34578899999999999999999999875432 112222222211 11111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCC--CCCccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKS--RPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~hp~~~~ 358 (361)
.. .....+.+++.+|+..++.+ |+++.|+++||||+.
T Consensus 233 ~~---~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 233 VT---DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred cc---cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 10 11124677888888654444 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.69 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=208.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..+|.+.+.||+|+||.||++.. .+++.|++|.+....... .+.+..|+.+++.++|||++++++++...+..++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH--HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 36788899999999999999964 468899999986543332 367889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.+. .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999998754 478899999999999999999999 9999999999999999999999999998765444
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........++..|+|||.+.+..++.++|+||||+++|++++|+.||......... ........+.. .. .....
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~-~~--~~~~~ 242 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNGTPEL-QN--PEKLS 242 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe---eehhcCCCCCC-CC--ccccC
Confidence 33334446888999999998888899999999999999999999999754332111 11111111110 00 11112
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++.+||+.+|++||++.+++.||||+.
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 24788999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=309.72 Aligned_cols=258 Identities=24% Similarity=0.429 Sum_probs=206.4
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc----hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET----ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
+|+..+.||+|++|.||++.. .+++.||+|.+..... .....+.+..|+..+++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999964 5789999999865432 12235788999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-CeEEeeecCcccc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLL 243 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 243 (361)
|+||+++++|.+++.+.. .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997644 588999999999999999999999 999999999999998776 5999999998766
Q ss_pred CCCCCC----cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 244 HSDSSN----RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 244 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP- 233 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCc-
Confidence 443211 122457889999999988889999999999999999999999986443322222222221111111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
......+.+++.+||+.+|++|||+.++++||||+
T Consensus 234 ---~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 234 ---EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 11123478899999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=313.49 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=199.3
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-----eEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK-----CMF 163 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 163 (361)
.|...+.+|.|+||.||+|... +++.||||+.-.+..-. ..|+.+|+.++|||||++.-+|.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 3566788999999999999765 46899999886554321 27899999999999999999887643 346
Q ss_pred EEEEeccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeeecCcc
Q 042457 164 LIYKYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVAR 241 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~ 241 (361)
+|||||+. +|...++.. .....++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||+|||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 888877741 1123577788889999999999999998 99999999999999987 899999999999
Q ss_pred ccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC-------
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA------- 313 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 313 (361)
.+.....+ .....|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+..++-....+++....
T Consensus 175 ~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 175 VLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 88766555 44567889999998775 5799999999999999999999999987665332222222221100
Q ss_pred --C-----CCCCCh------hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 314 --P-----SPIDDQ------TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 314 --~-----~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. .+.... ..........+|+.++++++|.+|.|+.|++.||||++
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 0 000000 00111234789999999999999999999999999975
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=307.48 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=205.2
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET---ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+|+..+.||+|++|.||+|... +++.|++|.+..... ..+..+.+..|+.+++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667788999999999999775 789999999865432 233457788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
+||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997654 588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccccccccccccccccccc-cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc-ccCCCCCCChhhH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMV-VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD-QRAPSPIDDQTVI 323 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 323 (361)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ........ ...+. ...
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~-~~~---- 225 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AAVFKIGRSKELPP-IPD---- 225 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HHHHHHHhcccCCC-cCC----
Confidence 33 223345788999999887766 899999999999999999999998754421 11111111 11111 110
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.....+.+++.+||+.+|++|||+.+++.|||+
T Consensus 226 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 226 HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 011247789999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=314.48 Aligned_cols=261 Identities=27% Similarity=0.384 Sum_probs=206.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|++|.||+|... +++.||+|.++.........+.+.+|+++++.++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999765 58899999987654444445778899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|++++.+..+..... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877776665433 489999999999999999999999 99999999999999999999999999988765443
Q ss_pred C-Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc---------------
Q 042457 248 S-NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD--------------- 310 (361)
Q Consensus 248 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------------- 310 (361)
. ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+..........
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 2 22334578889999998887 889999999999999999999999875432111000000000
Q ss_pred --c-cCCCCCCChhhH------HHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 311 --Q-RAPSPIDDQTVI------QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 311 --~-~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
. ..+.. ...... .....+.+++++||+.+|++|||++++++||||
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 235 FAGVAFPEP-SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccCCC-CCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 00000 000000 013458899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=310.73 Aligned_cols=254 Identities=29% Similarity=0.454 Sum_probs=216.3
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
-|.++.+||+|+||.||++.+ ..|+.+|||.+..... ++++..|+.+|++.+.+++|++||.+.....+|+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 366788899999999999954 4799999999876543 57888999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
|.-|+..+.++..+. ++++.++..++.+.+.||+|||.. .-+|||||+.|||++.+|.+||+|||.+..+...-.
T Consensus 110 CGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 999999999986554 799999999999999999999999 889999999999999999999999999987765555
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
.+....||+-|||||++..-.|..++||||||+...||..|++||.+...... .-.+-..++.....+..|.. .
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----IFMIPT~PPPTF~KPE~WS~--~ 258 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----IFMIPTKPPPTFKKPEEWSS--E 258 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----eEeccCCCCCCCCChHhhhh--H
Confidence 56667899999999999999999999999999999999999999886654221 11111222222333333333 5
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+.+++++||-++|++|-|+.++++|||++.
T Consensus 259 F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred HHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 889999999999999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=310.55 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=208.8
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
+|++.+.||.|+||.||++... +++.||+|.+..... .....+.+.+|++.+++++||||+++++.+...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999765 589999999875432 22345788999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999997653 688999999999999999999999 99999999999999999999999999987654332
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......................+.. ...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 227 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPAT------WST 227 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCccc------CcH
Confidence 2233457889999999988889999999999999999999999987654321222222222111211111 113
Q ss_pred HHHHHHhhhcCCCCCCCCCc--cccccCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTM--RRSFPNPEI 356 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~--~eil~hp~~ 356 (361)
.+.+++.+||+.||.+||++ +|+++||||
T Consensus 228 ~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 58899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=321.51 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=203.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||+++.. +++.||+|.+..... .......+..|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999764 678899999865321 2223456788999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976332 588899999999999999999999 9999999999999999999999999999766433
Q ss_pred CC-Ccccccccccccccccccc-----cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc--CCCCCC
Q 042457 247 SS-NRTVVAGTHGYIAPELAYT-----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR--APSPID 318 (361)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~ 318 (361)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ......+.... .+.+..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~ 232 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHEERFQFPSH 232 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH---HHHHHHHHcCCCcccCCCc
Confidence 22 2233468999999998865 4678899999999999999999999874332 11222222211 111111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCC--CCCccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKS--RPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~hp~~~~ 358 (361)
.. .....+.+++.+|+..++.+ |++++++++||||+.
T Consensus 233 ~~---~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 233 IT---DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred cc---cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 11 11224778888988876554 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=310.87 Aligned_cols=253 Identities=29% Similarity=0.460 Sum_probs=206.7
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
-|++.+.||+|+||.||+|.. .++..||+|........ .....+.+|+..+++++|+||+++++++..++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 467788899999999999965 46889999988654432 2346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++... .+++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999998653 488999999999999999999999 999999999999999999999999999876644333
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+.....+. ... .....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~----~~~~~ 228 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNNPPT-LEG----NYSKP 228 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCCCCC-CCc----ccCHH
Confidence 33334578899999999888889999999999999999999999864332 11111121121111 111 11224
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+.+++.+||+.+|.+||++.++++||||.+
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 788999999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=306.85 Aligned_cols=254 Identities=22% Similarity=0.374 Sum_probs=206.2
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|+..+.||+|+||.||++.. .+++.+|+|.+............+..|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999965 4688999999876554444467889999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeeecCccccCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDS 247 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~~~ 247 (361)
+++++|.+++..... ..+++..+..++.+++.|++|||++ +++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999976432 2578999999999999999999999 99999999999999865 457999999998764432
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ................. . ...
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-~----~~~ 227 (256)
T cd08220 157 K-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTFAPISD-R----YSP 227 (256)
T ss_pred c-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCCCCCCC-C----cCH
Confidence 2 2234578899999999888889999999999999999999999865432 22222222222211111 1 112
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+.+++.+||+.+|++|||+.|+++||||
T Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 228 DLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 47899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=309.78 Aligned_cols=258 Identities=25% Similarity=0.438 Sum_probs=202.8
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc--------hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET--------ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
+|...+.||+|+||.||+|.. .+|+.+|+|.+..... .....+.+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466778899999999999964 4689999998864321 1123456888999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++|+||+++++|.++++... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999997763 689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC--Ccccccccccccccccccccc--cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCC
Q 042457 241 RLLHSDSS--NRTVVAGTHGYIAPELAYTMV--VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316 (361)
Q Consensus 241 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 316 (361)
........ ......++..|+|||.+.+.. ++.++|+||||+++||+++|..||...... ....+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 232 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AAMFKLGNKRSAPP 232 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HHHHHhhccccCCc
Confidence 76533211 122345788999999887654 788999999999999999999998643221 11111111111111
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
............+.+++.+||+++|++|||++++++|||+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 1111111122358889999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=318.41 Aligned_cols=267 Identities=28% Similarity=0.349 Sum_probs=203.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 164 (361)
.++|++.+.||+|+||.||+|... +|+.||+|.+............+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999764 689999999875543322224566899999999999999999998765 56899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+.+ +|.+++.... ..+++.++..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999964 7888876543 2689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc-----------
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR----------- 312 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 312 (361)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 43333333345778999998765 557899999999999999999999987543321111111110000
Q ss_pred -----C--C-CCCCC-hh-hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 313 -----A--P-SPIDD-QT-VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 313 -----~--~-~~~~~-~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
. . .+... .. .......+.+++.+||+.||++|||++|+++||||++.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 0 0 00000 00 000123467899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=311.29 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=205.1
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|++.+.||+|++|.||+|... +|+.||+|++............+.+|+.++++++|+|++++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999764 689999999977654334457788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+ +++|.+++.... ..+++.+++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987544 2589999999999999999999999 999999999999999999999999999987654332
Q ss_pred -Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc--------------
Q 042457 249 -NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR-------------- 312 (361)
Q Consensus 249 -~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 312 (361)
......++..|+|||.+.+. .++.++||||+|+++|||++|+.||...................
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 12234578899999987654 46889999999999999999988875433211000000000000
Q ss_pred --CCCCCCChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 313 --APSPIDDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 313 --~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
...+....... .....+.+++.+||+.+|++|||++++++||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00000000000 1124588999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=316.86 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=203.0
Q ss_pred cCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 94 KYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
...||+|+||.||++... +++.||+|.+....... .+.+.+|+..++.++|||++++++++..++..++++||++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch--HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 446999999999999654 68999999986544322 366889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccc
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 252 (361)
+|.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++............
T Consensus 104 ~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 104 ALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 999887543 488999999999999999999999 9999999999999999999999999998765444333344
Q ss_pred ccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHH
Q 042457 253 VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKI 332 (361)
Q Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 332 (361)
..++..|+|||++.+..++.++||||||+++|||++|+.||..... ......+........... ......+.++
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~l~~~ 250 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPPKLKNA---HKISPVLRDF 250 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCCCcccc---CCCCHHHHHH
Confidence 5688999999999888899999999999999999999999864332 111111111111111110 0111247889
Q ss_pred HhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 333 AFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 333 i~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
+.+||+.+|++|||++++++||||.+-
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccC
Confidence 999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=311.20 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=205.7
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCC----
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKK---- 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~---- 160 (361)
++++|++.+.||+|++|.||+|... +++.+++|.+...... .+.+..|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5678999999999999999999764 5788999998765432 36788999999999 7999999999997644
Q ss_pred --eEEEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 161 --CMFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 161 --~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999886532 123689999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCcccccccccccccccccc-----cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYT-----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
|++..............++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~ 234 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFKIPRNP 234 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHHhhccC
Confidence 998766443333344568889999998753 3467899999999999999999999864322 12222222222
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+. .... ......+.+++.+||+.||++|||+.|+++|||+
T Consensus 235 ~~~-~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 PPT-LKSP--ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCC-CCch--hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 111 1111 1122357899999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=310.60 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=205.2
Q ss_pred CCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
|...+.||+|++|.||++.. .+++.+++|++....... .+.+.+|+.+++.++|+|++++++++...+..++++||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR--RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 44557899999999999975 478899999886543322 356889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
++++|.+++... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 99 EGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 999999998762 588999999999999999999999 9999999999999999999999999988765443333
Q ss_pred cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHH
Q 042457 250 RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILV 329 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 329 (361)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ............+..... ......+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~l 245 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLPPKLKNL---HKVSPRL 245 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCCCCCccc---ccCCHHH
Confidence 3344588899999999888899999999999999999999999864322 111222222211111111 0112258
Q ss_pred HHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 330 SKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 330 ~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+++.+||+.+|++|||+.++++||||++
T Consensus 246 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 246 RSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred HHHHHHHcccChhhCcCHHHHccCccccc
Confidence 89999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=311.14 Aligned_cols=265 Identities=27% Similarity=0.359 Sum_probs=206.1
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMFLI 165 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 165 (361)
++|+..+.||.|++|.||++... +++.+|+|.+...... .....+.+|++++++++||||+++++++... +..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 36788899999999999999764 6889999998755432 3357788999999999999999999998653 468999
Q ss_pred EEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 166 YKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|||+++++|.+++.... ....++...+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999998875421 223578899999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCccc--CCcchhHhhhhcccCCCCCCC-hh
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSS--FNPKIMLIDLLDQRAPSPIDD-QT 321 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~ 321 (361)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...............+..... ..
T Consensus 157 ~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 157 NSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred cccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 2221 223467889999999888899999999999999999999999875532 111111111121111111110 10
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.......+.+++.+||+.+|++|||+.|+++||||++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 01112358899999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=294.93 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=209.8
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC---
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK--- 160 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 160 (361)
.+..++|.+.+.||+|||+-||.++ ..++..+|+|++.....+ ..+..++|++..++++|||++++++++..+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~--~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE--DIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH--HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 3567889999999999999999995 567889999999887743 3588899999999999999999999886543
Q ss_pred --eEEEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 161 --CMFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 161 --~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
+.|++++|...|+|.+.++... ....+++.++++|+.++++||.+||+.. ++++|+||||.|||+.+++.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence 4999999999999999987643 2336899999999999999999999882 24999999999999999999999999
Q ss_pred cCccccCCCCCC---------ccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH
Q 042457 238 GVARLLHSDSSN---------RTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML 305 (361)
Q Consensus 238 g~~~~~~~~~~~---------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 305 (361)
|.++...-.... ......|..|.|||.+. +...++++|||||||+||+|+.|..||+.... ......
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla 252 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA 252 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE
Confidence 998765332211 12234788999999875 44578899999999999999999999986554 222233
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+...+...|.... ..+.+.+++++|++.||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~~~----yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSR----YSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCCC----ccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 334444444443332 22358899999999999999999999864
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=310.80 Aligned_cols=252 Identities=26% Similarity=0.462 Sum_probs=206.0
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.+..+|.+.+.||+|+||.||+|...++..+++|.+....... ...+..|+.+++.++|+||+++++++...+..++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK--QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh--HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3456788899999999999999998889999999987654422 36788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.+... ..+++.++..++.|++.|+.|||+. +++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 999999999999976432 3589999999999999999999999 999999999999999999999999999977644
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCCChhhH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDDQTVI 323 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 323 (361)
.........++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+... ..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~----- 228 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITAGYRMPCPAK----- 228 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHhCCcCCCCCC-----
Confidence 3332233345678999999988889999999999999999998 8999865432 1122222222 1111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||+.||.+|||++++++
T Consensus 229 -~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 229 -CPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1124789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=312.64 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=201.9
Q ss_pred cCCCCcCeeeecCceeEEEEEeCC------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPS------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
++|++.+.||+|+||.||+|.... ...||+|.+..... ......+.+|+..++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468888999999999999997533 25799999875543 23356788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC
Q 042457 163 FLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~ 229 (361)
+++|||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999865321 13588999999999999999999999 99999999999999999
Q ss_pred CCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHh
Q 042457 230 LEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLI 306 (361)
Q Consensus 230 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 306 (361)
+.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~ 237 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIE 237 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence 9999999999876533221 1222346788999999988889999999999999999998 9999875432 12222
Q ss_pred hhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+...... +.. ......+.+|+.+||+.||.+|||++||+++
T Consensus 238 ~i~~~~~~-~~~----~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLL-PCP----EDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcC-CCc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22222221 111 1112358899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=316.05 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=203.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMFLI 165 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 165 (361)
++|++.+.||+|+||.||+|... +++.+++|.++...........+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999775 588999999976554433345677899999999999999999999877 889999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
+||++ ++|.+++..... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 489888876442 589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc-------------
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ------------- 311 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------------- 311 (361)
.........++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+...........
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 43333344578899999988654 4688999999999999999999998754321111000000000
Q ss_pred -----cCCCCCC----ChhhHH-HHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 312 -----RAPSPID----DQTVIQ-DIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 312 -----~~~~~~~----~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
....... ...... ....+.+++.+||+.||++|||+.|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0000000 000000 12347889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.71 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=187.9
Q ss_pred CeeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--CCeEEEEEEec
Q 042457 95 YCIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--KKCMFLIYKYM 169 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~ 169 (361)
.+||+|+||.||+|... ++..||+|.+...... ..+.+|+.+++.++||||+++++++.. ....++++||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 57999999999999764 3578999998754332 456789999999999999999998864 45789999998
Q ss_pred cCCChhhhhccC------CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee----CCCCCeEEeeecC
Q 042457 170 RRGSLFCVLRND------DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL----NSKLEAFVADFGV 239 (361)
Q Consensus 170 ~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~ 239 (361)
.+ +|.+++... .....+++..+..++.|++.||.|||+. +++||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 65 777666421 1223588999999999999999999999 99999999999999 5567899999999
Q ss_pred ccccCCCCC---Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCc------chhHhhhh
Q 042457 240 ARLLHSDSS---NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP------KIMLIDLL 309 (361)
Q Consensus 240 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~~~ 309 (361)
++....... ......+|..|+|||.+.+ ..++.++||||||+++|||+||+.||........ ........
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 986643322 1233467899999998876 4578999999999999999999999864322100 00000000
Q ss_pred cc--------------cCC----------CCCCChhhH--------HHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 310 DQ--------------RAP----------SPIDDQTVI--------QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 310 ~~--------------~~~----------~~~~~~~~~--------~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.. ... ......... .....+.+|+.+||+.||.+|||+.|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 000 000000000 001236789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=314.03 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=200.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|++|.||+|... +++.||+|.+....... ....+.+|+++++.++|+||+++++++...+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 56888899999999999999765 68899999986543221 12446689999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++ +|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9975 89888875443 578999999999999999999999 99999999999999999999999999987553332
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcch-hHhhhhccc-------------
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI-MLIDLLDQR------------- 312 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~------------- 312 (361)
.......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......... ...+.....
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 22223346788999998765 457889999999999999999999986443110000 000000000
Q ss_pred -----CCCCCCCh-----hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 313 -----APSPIDDQ-----TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 313 -----~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
........ ........+.+++.+||+.+|++|||+.|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000000 000111346789999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=317.78 Aligned_cols=251 Identities=24% Similarity=0.418 Sum_probs=198.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
..+|++.+.||+|+||.||+|.+. +|+ .||+|.+..... ....+.+..|+.+++.++||||++++|+|... ..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 456899999999999999999753 333 489999875433 23346788999999999999999999999875 47
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++++||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 899999999999999986543 578899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc--ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 243 LHSDSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 243 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |+.||+...... ...........+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~~~~~~ 234 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQPP 234 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhCCCCCCCCC
Confidence 65433221 11224668999999999999999999999999999998 999987543211 122222221111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
. ....+.+++.+||+.||.+|||+.+++.+
T Consensus 235 ~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 I----CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred C----CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1 11247889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=310.19 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=202.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..++|++.++||+|+||.||+|...++..||+|.+...... .+.+..|+.+++.++|+||+++++.+...+..+++|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh---HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 45678999999999999999999888889999998654332 367889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999875432 2588899999999999999999999 9999999999999999999999999999876432
Q ss_pred CCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 247 SSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... .....++..|+|||.+.+..++.++||||||+++|+|+| |+.||..... ......+... ...+....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~-~~~~~~~~---- 228 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRG-YRMPRMEN---- 228 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcC-CCCCCCCC----
Confidence 211 122335678999999988889999999999999999998 9999864332 1122222222 11111111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||+.+|++|||++++.+
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 229 CPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1124788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=306.37 Aligned_cols=249 Identities=23% Similarity=0.421 Sum_probs=201.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
++|.+.+.||+|+||.||+|.+.++..+|+|.+...... .+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 457888899999999999998877778999998754432 25688999999999999999999999998889999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 81 ~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 81 MSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999976433 589999999999999999999999 999999999999999999999999999876543322
Q ss_pred Cc-ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 249 NR-TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 249 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+........... ..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~-----~~ 227 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRLYRPHL-----AS 227 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCCCCCCC-----CC
Confidence 11 12235568999999988889999999999999999999 9999865432 112222222222111111 11
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.+++.+||+.||.+|||+.+++++
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 358899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=307.90 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=203.9
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCc-chHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||+|... +++.||||.+.... ........+..|+++++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999754 78999999876533 23333467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 167 KYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
||+++++|.+++.... ....++...+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886422 123578899999999999999999999 999999999999999999999999999877654
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.........++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ...... .........+.. ....
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~-~~~~~~~~~~~~---~~~~ 233 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLC-QKIEQCDYPPLP---TEHY 233 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHH-HHHhcCCCCCCC---hhhc
Confidence 33333344578899999999888889999999999999999999999854321 111111 122211111111 1112
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
...+.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 234 SEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred CHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 2358899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=313.53 Aligned_cols=261 Identities=23% Similarity=0.283 Sum_probs=199.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
++++|.+.+.||+|+||.||+|.. .+|+.||+|.+....... ....+.+|+.+++.++|+||+++++++...+..++|
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 356799999999999999999965 468899999986543221 123567899999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
+||+. +++.+++..... .+.+..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred Eeccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 99996 677666654322 477888999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc--------------
Q 042457 246 DSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD-------------- 310 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------------- 310 (361)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...+.....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhh
Confidence 3333333457889999998865 35788999999999999999999998754321 000000000
Q ss_pred -------ccCCC--CCCChh---hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 311 -------QRAPS--PIDDQT---VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 311 -------~~~~~--~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..... +..... .......+.+++.+|++.||.+|||++|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 000000 00112347789999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=312.05 Aligned_cols=258 Identities=26% Similarity=0.405 Sum_probs=211.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++.|+..+.||+|++|.||+|... ++..+++|++..... ..+.+..|++.++.++|+|++++++.+...+..+++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4566888888999999999999776 688999999976544 246788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999998754 3689999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .....+.....+.... . ...
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-~--~~~ 242 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLITTKGIPPLKN-P--EKW 242 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCcc-h--hhC
Confidence 333333345778999999998888999999999999999999999998654321 1122222222211111 1 001
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+.+++.+||+.+|.+|||+.++++||||++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 234889999999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=310.60 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=202.0
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
+.+++|++.+.||+|+||.||+|... .+..||+|.+...... .....+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 46778999999999999999998653 3567999998654332 2346788999999999999999999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCc-------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCe
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDE-------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEA 232 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~ 232 (361)
...++||||+++++|.+++..... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 999999999999999999865321 22468889999999999999999999 99999999999999999999
Q ss_pred EEeeecCccccCCCCCCc--ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhh
Q 042457 233 FVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 233 kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 309 (361)
+|+|||++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ........
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~ 235 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVM 235 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence 999999987654322211 12235678999999988889999999999999999999 7888864332 22222222
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 310 DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.......... ....+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EGGLLDKPDN-----CPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCCcCCCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222111111 11248899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=306.24 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=201.8
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCc---chHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE---TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCM 162 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 162 (361)
++|.+.+.||+|+||.||+|.. .+|..||+|.+.... ......+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788899999999999999976 458999999886432 1223356788999999999999999999988764 468
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
+++|||+++++|.+++.... .+++...++++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 478889999999999999999999 999999999999999999999999999876
Q ss_pred cCCCC---CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 243 LHSDS---SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 243 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ .+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~-~~~~- 230 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPT-NPVL- 230 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHHHHhcCCC-CCCC-
Confidence 53221 112234578899999999888899999999999999999999999875422 111122211111 1111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
.......+.+++.+|+. +|++|||++|+++|||+.
T Consensus 231 --~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 231 --PPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 11122347788889985 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=346.50 Aligned_cols=265 Identities=21% Similarity=0.341 Sum_probs=207.0
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--Ce
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KC 161 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 161 (361)
....++|.+.+.||+|+||.||++... ++..||+|.+............+..|+.+++.++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445578999999999999999999664 577899999876554444457889999999999999999999988653 56
Q ss_pred EEEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeEEeCCCCCCeeeCC--------
Q 042457 162 MFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCI----PSIVHRDISSNNILLNS-------- 228 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~----~~i~H~dlk~~Nill~~-------- 228 (361)
+|+||||+++++|.++|.... ....+++..++.|+.||+.||+|||+... .+|+|+||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999987532 12368999999999999999999998521 25999999999999964
Q ss_pred ---------CCCeEEeeecCccccCCCCCCcccccccccccccccccc--cccCccchhhhHHHHHHHHHhCCCCCCCcc
Q 042457 229 ---------KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGRHPGDLLS 297 (361)
Q Consensus 229 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 297 (361)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2348999999997654322 2233468999999998854 457899999999999999999999987433
Q ss_pred cCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 298 SFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.. ..+...+......+.... ...+.+|+..||+.+|.+|||+.|+|.||||+.
T Consensus 248 ~~---~qli~~lk~~p~lpi~~~-----S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 248 NF---SQLISELKRGPDLPIKGK-----SKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred cH---HHHHHHHhcCCCCCcCCC-----CHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 21 112222222222221111 124889999999999999999999999999974
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=314.03 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=200.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCe-----
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKC----- 161 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----- 161 (361)
++|++.+.||+|+||.||+|... +|+.||+|..............+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999764 6899999998765433333456788999999995 6999999999987665
Q ss_pred EEEEEEeccCCChhhhhccCCc--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-CCCeEEeeec
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDE--AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-KLEAFVADFG 238 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg 238 (361)
.+++|||+++ +|.+++..... ...+++..++.++.||+.||.|||+. +++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 78887764322 23689999999999999999999999 9999999999999998 8899999999
Q ss_pred CccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc-----
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR----- 312 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 312 (361)
++..............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98765433332233356788999998765 457899999999999999999999986543211110000000000
Q ss_pred -----------CCC--CCCChh-hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 313 -----------APS--PIDDQT-VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 313 -----------~~~--~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
.+. +..... .......+.+++.+||++||.+|||++|+++||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 000000 001123478999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.13 Aligned_cols=255 Identities=30% Similarity=0.498 Sum_probs=205.5
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC---CCcceeeeEEEeeCCeEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR---HRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 165 (361)
.|+..+.||+|+||.||+|.. .+++.||+|.+...... .....+.+|+.+++.++ |||++++++++......+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 467788899999999999975 57899999998654332 22466788999999886 99999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.++++.. .+++...+.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 81 MEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999999998654 589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.........|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... .......+.......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~--- 226 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM----MLIPKSKPPRLEDNG--- 226 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh----hccccCCCCCCCccc---
Confidence 4433344568889999998765 44688999999999999999999998754321111 111111111111110
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+++.+||+.||++|||+.+++.||||++.
T Consensus 227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 227 YSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 12358889999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=307.78 Aligned_cols=252 Identities=23% Similarity=0.418 Sum_probs=203.0
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+..++|++.+.||+|++|.||+|...+++.||+|.++..... .+.+.+|+.++++++|+|++++++++...+..+++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 456678999999999999999998878888999998765432 35688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999999997644 23589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCc-ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 246 DSSNR-TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 246 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
..... .....+..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+... ...+...
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~-~~~~~~~---- 227 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQG-YRMPCPP---- 227 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcC-CCCCCCC----
Confidence 22211 11123457999999988889999999999999999999 9999864332 1122222222 1111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.....+.+++.+||+.+|.+||+++++++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11235889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=311.16 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=206.6
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
++..++|++.+.||+|+||.||+|... .+..||+|.+....... ....+.+|+..++.++|+||+++++++..
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH-HHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 356788999999999999999999643 24579999987554322 23567889999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCc-------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDE-------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE 231 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~ 231 (361)
.+..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 9999999999999999999965321 23467788999999999999999999 9999999999999999999
Q ss_pred eEEeeecCccccCCCCCCc--ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhh
Q 042457 232 AFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDL 308 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 308 (361)
++|+|||+++......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~~ 234 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKFV 234 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence 9999999987654322211 11234678999999988889999999999999999999 7888864332 2222222
Q ss_pred hcccCC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc------CCCCCC
Q 042457 309 LDQRAP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP------NPEINP 358 (361)
Q Consensus 309 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~------hp~~~~ 358 (361)
...... .+... ...+.+++.+||+.||++|||+.++++ ||||+.
T Consensus 235 ~~~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 235 MDGGYLDQPDNC------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred HcCCCCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 222211 11111 125889999999999999999999987 999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.82 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=210.8
Q ss_pred CCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
|.++..||.|+||.||++..++ +-..|-|++..... +.+++|+-|+++|..++||+||++++.|...+.++++.|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse--EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE--EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch--hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4555669999999999997654 44556677655443 33789999999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
.||-....+-.-+. .++..++.-+++|++.||.|||++ +|+|||||+.|||++-+|.++|+|||.+.........
T Consensus 112 ~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred CCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 99999887755332 689999999999999999999999 9999999999999999999999999998665554555
Q ss_pred ccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 250 RTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.....||+.|||||+.. ..+|+.++||||||+.|.||..+.+|-.. .++-..+..+....+|.....+ .|.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe---lnpMRVllKiaKSePPTLlqPS-~Ws 262 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE---LNPMRVLLKIAKSEPPTLLQPS-HWS 262 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc---cchHHHHHHHhhcCCCcccCcc-hhh
Confidence 66678999999999865 46789999999999999999999999554 3444445555555554433322 222
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.++++.||.+||..||++.++|+||||+.
T Consensus 263 --~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 263 --RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred --hHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 25889999999999999999999999999984
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=306.56 Aligned_cols=255 Identities=21% Similarity=0.358 Sum_probs=206.4
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|.+.+.||+|+||.||+|... +|..+|+|.+..........+.+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999765 578899999876533323346778999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC-eEEeeecCccccCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE-AFVADFGVARLLHSDS 247 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~~ 247 (361)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999875432 2579999999999999999999999 9999999999999988854 6999999998765433
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
.......|+..|+|||.+.+..++.++|+||||+++||+++|+.||..... ................. ....
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~ 228 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---HQLVLKICQGYFAPISP-----NFSR 228 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcccCCCCCC-----CCCH
Confidence 333334588899999998888899999999999999999999999864322 12222222222221111 0112
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+.+++.+||+.+|++|||++++++||||
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 229 DLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 48889999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=311.47 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=200.7
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
|++.+.||.|++|.||+|... +|..||+|++..........+.+.+|++.++.++|+|++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567788999999999999764 7999999998765433333456788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
+ ++|.+++..... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689988865432 3589999999999999999999999 9999999999999999999999999999765433222
Q ss_pred ccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhh------------------hc
Q 042457 250 RTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDL------------------LD 310 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~------------------~~ 310 (361)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.............+. ..
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2333468889999987654 5688999999999999999999998654321110000000 00
Q ss_pred ccCCCCCCC--hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 311 QRAPSPIDD--QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 311 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
......... .........+.+++.+||+.||.+|||++|+++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000000000 0000011347899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.05 Aligned_cols=251 Identities=29% Similarity=0.451 Sum_probs=202.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
.++|++.+.||+|+||.||+|.+.. ...||+|.+...... .....+..|+..+++++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD-KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh-HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 4578899999999999999997742 457999998765433 23467889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
++|||+++++|.+++..... .+++..+..++.|++.|++|||+. +++|+||||+||++++++.++|+|||++...
T Consensus 82 iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 82 IITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999976543 689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCCC
Q 042457 244 HSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDD 319 (361)
Q Consensus 244 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 319 (361)
...... .....++..|+|||.+.+..++.++||||||+++||+++ |..||..... ......+... ..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~- 232 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRLPPPMD- 232 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCCCCCCC-
Confidence 422211 112234578999999988889999999999999999998 9999864332 1112222222 1121111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
....+.+++.+||+.+|++|||++|++++
T Consensus 233 -----~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 233 -----CPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12247899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=309.50 Aligned_cols=260 Identities=23% Similarity=0.391 Sum_probs=199.1
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHH-HhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARL-LSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||++... +|+.||+|++......... ..+..|+.. ++..+|||++++++++...+..+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 46888999999999999999764 6899999998765433222 344455554 66678999999999999999999999
Q ss_pred EeccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 167 KYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 167 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
||++ ++|.+++... .....+++..++.++.|++.||+|||++. +++|+||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9996 6887777542 22246899999999999999999999853 799999999999999999999999999876533
Q ss_pred CCCCcccccccccccccccccc----cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 246 DSSNRTVVAGTHGYIAPELAYT----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... .............+.....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~-- 231 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSPQLPAE-- 231 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCCCCCcc--
Confidence 21 2222457888999998764 4468899999999999999999999864321 1111222222211111111
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.....+.+++.+||+.+|.+|||++++++||||++.
T Consensus 232 --~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 232 --KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred --ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 111247899999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=310.61 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=203.0
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|++.+.||+|++|.||+|... +|+.||+|.+....... ....+..|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 5788899999999999999775 68899999987654322 135567899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++ +|.+++........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 985 8888886654344689999999999999999999999 999999999999999999999999999976544333
Q ss_pred Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh-----------ccc----
Q 042457 249 NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL-----------DQR---- 312 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-----------~~~---- 312 (361)
......++..|++||.+.+ ..++.++||||||+++|+|++|+.||......+......+.. ...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 3333457889999998765 456889999999999999999999987543211100000000 000
Q ss_pred CCCCCCChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 313 APSPIDDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 313 ~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
...+....... .....+.+++.+|++.||.+|||+.|+++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00000000000 112347899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=305.19 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=203.8
Q ss_pred eeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
||.|++|.||++... +++.+|+|.+...... ....+.+..|+.+++.++|+||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999775 4889999998754432 23346788999999999999999999999999999999999999999
Q ss_pred hhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccccc
Q 042457 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254 (361)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 254 (361)
.+++.+.. .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 99997654 488999999999999999999998 99999999999999999999999999998764432 222345
Q ss_pred ccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc--ccCCCCCCChhhHHHHHHHHHH
Q 042457 255 GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD--QRAPSPIDDQTVIQDIILVSKI 332 (361)
Q Consensus 255 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l 332 (361)
++..|+|||.+.+..++.++|+||||+++|+|++|..||..... +.......+.. .....+... ...+.++
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 226 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLEFPNYI------DKAAKDL 226 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCCCCccc------CHHHHHH
Confidence 78899999998888899999999999999999999999875442 12222233332 111111111 2358899
Q ss_pred HhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 333 AFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 333 i~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
+.+||+.+|++||+ ++|+++||||++
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 99999999999999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=302.60 Aligned_cols=255 Identities=29% Similarity=0.454 Sum_probs=211.1
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMFLIY 166 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 166 (361)
+|...+.||+|++|.||+|... +++.|++|.+..........+.+.+|+..+++++|+||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999775 688999999877665444567899999999999999999999999988 8899999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999997654 689999999999999999999998 9999999999999999999999999999876554
Q ss_pred CC--CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 247 SS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.. ......++..|+|||.+.+...+.++||||||+++|+|++|..||.... +....................
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~---- 228 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPPEIPEH---- 228 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCcCCCcc----
Confidence 32 1334557889999999988889999999999999999999999987654 111222222211111111111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
....+.+++.+|++.||++|||+.|+++||||
T Consensus 229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 229 LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred cCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 12358899999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.88 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=201.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|++|.||+|... +|+.||+|.+..........+.+..|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999764 68899999987654333334678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-CCCeEEeeecCccccCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLLHSD 246 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~ 246 (361)
|++ ++|.+++..... ..+++..+..++.||+.||+|||+. +++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 578777754432 2467888899999999999999999 9999999999999985 567999999999765433
Q ss_pred CCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC------------
Q 042457 247 SSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA------------ 313 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------ 313 (361)
........++..|+|||.+.+ ..++.++||||+|+++|+|+||+.||......+.............
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 332333456889999998765 4578899999999999999999999875432111110100000000
Q ss_pred -----CC-CCCCh--hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 314 -----PS-PIDDQ--TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 314 -----~~-~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+. ..... ........+.+++.+|++.+|++||++.++++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00 00000 00011224788999999999999999999999999975
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=327.18 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=210.4
Q ss_pred eeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 96 CIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
.||+|.||+||-|+.. +...+|||.+...+... .+-+..|+.+-++++|.|||+++|.|.+++..-+.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~--~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE--VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh--hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 4999999999999765 45679999987665433 46788999999999999999999999999999999999999999
Q ss_pred hhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC-CCCCeEEeeecCccccCCCCCCcccc
Q 042457 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN-SKLEAFVADFGVARLLHSDSSNRTVV 253 (361)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~ 253 (361)
.++|+..=+...-++..+-.+.+||++||.|||++ .|||||||-+|||++ -.|.+||+|||-++.+..-+......
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 99998754422337888889999999999999999 999999999999995 57899999999999887766667778
Q ss_pred cccccccccccccccc--cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 254 AGTHGYIAPELAYTMV--VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 254 ~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
.||.-|||||++..++ |..++|||||||.+.||.||++||.........+...-.....++.|. +...+...
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe------elsaeak~ 810 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE------ELSAEAKN 810 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH------HHHHHHHH
Confidence 8999999999998654 788999999999999999999999866553333333333333333222 22234788
Q ss_pred HHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 332 IAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 332 li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
+|++|+.+||.+||+++++|+.||++..
T Consensus 811 FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 811 FILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHcCCCcccCccHHHhccCcccccC
Confidence 9999999999999999999999999764
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=317.93 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=200.5
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCL 157 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 157 (361)
.++.++|++.+.||+|+||.||+|... +++.||+|++....... ....+..|+.++.++ +|+||++++++|.
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-EYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-HHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 345678999999999999999999532 35789999987654332 246678899999999 8999999999887
Q ss_pred eC-CeEEEEEEeccCCChhhhhccCCc-----------------------------------------------------
Q 042457 158 HK-KCMFLIYKYMRRGSLFCVLRNDDE----------------------------------------------------- 183 (361)
Q Consensus 158 ~~-~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 183 (361)
.. ...++++||+++++|.+++.....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 568899999999999988854211
Q ss_pred -----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC--ccccccc
Q 042457 184 -----AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGT 256 (361)
Q Consensus 184 -----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt 256 (361)
...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||++..+...... .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 12689999999999999999999999 9999999999999999999999999999876433221 1223456
Q ss_pred ccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhh
Q 042457 257 HGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFA 335 (361)
Q Consensus 257 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 335 (361)
..|+|||++.+..++.++|||||||++|||++ |..||...... ................. .....+.+++.+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~ 311 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEFCRRLKEGTRMRAPE----YATPEIYSIMLD 311 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHHHHHHhccCCCCCCc----cCCHHHHHHHHH
Confidence 78999999999999999999999999999998 99998653221 11111111111111110 112348899999
Q ss_pred hcCCCCCCCCCccccccC
Q 042457 336 CLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 336 cl~~dP~~RPs~~eil~h 353 (361)
||+.+|++|||+.|+++|
T Consensus 312 cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 312 CWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=307.24 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=200.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..+|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+|++.++.++|+||+++++++...+..+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH---HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 456888899999999999999764 5889999998754322 467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999865432 2589999999999999999999999 9999999999999999999999999999766433
Q ss_pred CCCc-ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 247 SSNR-TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.... ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .. ................
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~-~~~~~~~~~~~~~~~~---- 229 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQ-VYELLEKGYRMERPEG---- 229 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HH-HHHHHHCCCCCCCCCC----
Confidence 2211 11224568999999988899999999999999999998 9999864332 11 1111221111111111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
....+.+++.+||+.||++|||+.++++.
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 12358899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.49 Aligned_cols=248 Identities=25% Similarity=0.447 Sum_probs=199.9
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
.+|.+.+.||+|+||.||+|...++..+|+|.+...... ...+.+|+++++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 457788899999999999998877788999998654432 25678899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++..... .+++..++.++.|++.|++|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 81 MANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999876443 589999999999999999999999 999999999999999999999999999876533221
Q ss_pred C-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCCChhhHHH
Q 042457 249 N-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDDQTVIQD 325 (361)
Q Consensus 249 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 325 (361)
. .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+... ....+.. .
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~------~ 226 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESVSAGYRLYRPKL------A 226 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHHcCCcCCCCCC------C
Confidence 1 111223457999999988889999999999999999999 89998754331 112222211 1111111 1
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
...+.+++.+||+.+|++|||+.|+++.
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 2258899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=323.56 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=215.9
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
.+++|+....++...++||-|.||.||.|.|+. ...||||.++.+..+ .++|+.|+.+|+.++|||+|+++|+|..
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe---veEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh---HHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 457888888889999999999999999998865 557999999876654 5899999999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
+...|||+|||..|+|.+||++.+.. .++.--.+.++.||+.||.||..+ +++||||..+|+||.++..+|++|||
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence 99999999999999999999987644 466677889999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCccc-ccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc--CC
Q 042457 239 VARLLHSDSSNRTV-VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR--AP 314 (361)
Q Consensus 239 ~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~--~~ 314 (361)
+++.+..+.+.... .--.+.|.|||.+.-+.++.|+|||+||++|||+.| |-.||...+.. ..+.+++.. +.
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----qVY~LLEkgyRM~ 486 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYGLLEKGYRMD 486 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----HHHHHHhcccccc
Confidence 99998766554322 223568999999999999999999999999999999 99998765432 233333332 23
Q ss_pred CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
.+...+. .+++|++.||+++|.+||++.|+-
T Consensus 487 ~PeGCPp------kVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 487 GPEGCPP------KVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCCCCH------HHHHHHHHHhcCCcccCccHHHHH
Confidence 3333332 489999999999999999999874
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.70 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=203.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... +..+.+.+|+++++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 356788889999999999999763 3478999998765443 234788999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCc-----------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDE-----------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
.+++|||+++++|.+++...+. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 9999999999999999975421 23578999999999999999999999 999999999999999999
Q ss_pred CeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhh
Q 042457 231 EAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLID 307 (361)
Q Consensus 231 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 307 (361)
.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||..... ......
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~ 236 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIEC 236 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH
Confidence 999999999876533221 1222345678999999999999999999999999999999 9999864432 222222
Q ss_pred hhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 308 LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
+........... ....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQGRLLQRPRT-----CPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcCCcCCCCCC-----CCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 222222221111 1124889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=316.08 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=210.8
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 163 (361)
.+....|++.++||.||.+.||++...+.+.+|+|++.....+.+.+..|..|+.+|.++ .|.+|+++++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 345567899999999999999999988888999998876666667789999999999999 5999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+|||+- ..+|..+|+..... ...| .++.+..|++.++.++|++ ||||.||||.|+|+-. |.+||+|||+|..+
T Consensus 437 mvmE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred EEeecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 999986 56999999876543 3345 7788999999999999999 9999999999998865 58999999999988
Q ss_pred CCCCCC--cccccccccccccccccccc-----------cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc
Q 042457 244 HSDSSN--RTVVAGTHGYIAPELAYTMV-----------VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD 310 (361)
Q Consensus 244 ~~~~~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 310 (361)
..+... ....+||..||+||.+.... .+.++||||+|||||+|+.|+.||..+.... ..+..+.+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--aKl~aI~~ 587 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--AKLHAITD 587 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH--HHHHhhcC
Confidence 665433 34567999999999885433 4578999999999999999999987654211 12233333
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 311 QRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+...-.... ++.++++.||+.||.+|||..++|+|||++.
T Consensus 588 P~~~Iefp~~~~~~---~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 588 PNHEIEFPDIPEND---ELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCccccccCCCCch---HHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 32211111111111 2788999999999999999999999999986
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=305.62 Aligned_cols=251 Identities=27% Similarity=0.466 Sum_probs=201.9
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+..++|++.++||+|+||.||+|...+++.||+|.+...... .+.+..|+.++++++|+|++++++++. .+..+++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 456788999999999999999999888999999998765543 257889999999999999999999874 4568999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++..... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999999875432 3689999999999999999999999 999999999999999999999999999976642
Q ss_pred CCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 246 DSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ....... ......+....
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~-~~~~~~~~~~~--- 227 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNL-ERGYRMPRPDN--- 227 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH-HcCCCCCCCCC---
Confidence 222 1222335678999999988889999999999999999999 9999875432 1111111 22211111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||+.+|++|||++++++
T Consensus 228 -~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 228 -CPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1225889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=294.89 Aligned_cols=264 Identities=22% Similarity=0.374 Sum_probs=216.8
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCL 157 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 157 (361)
+++++...+++. ||+|+|+.|-.+ .+.+|..+|||++.+..... .....+|++++.+. .|+||+.++++|+
T Consensus 74 ~F~d~YkLt~e~-----LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs--R~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 74 KFEDMYKLTSEL-----LGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS--RSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred hHHHHHHhHHHH-----hcCccceeeeeeeeeccchhhhhhhhhcCCchH--HHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 477777777655 999999999988 56789999999998775543 46788999999998 5999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC---eEE
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE---AFV 234 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl 234 (361)
++...|||||-|.||+|..++++.. .+++.+..++..+|+.||.|||.+ ||.||||||+|||...... +||
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999998765 699999999999999999999999 9999999999999976554 799
Q ss_pred eeecCccccCCCC-------CCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCc-
Q 042457 235 ADFGVARLLHSDS-------SNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP- 301 (361)
Q Consensus 235 ~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~- 301 (361)
+||.+...+.... ......+|+..|||||+.. ...|+.+.|.||||+|+|-|++|.+||......+-
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 9999986543221 1123457889999999763 34588899999999999999999999987655332
Q ss_pred -----------chhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 302 -----------KIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 302 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+.....+-++....|..+..... .+..+++...+..|+.+|.++.++++|||++.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS--~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHIS--SEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhh--HHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 22344555555555555443333 35678999999999999999999999999975
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=309.64 Aligned_cols=258 Identities=22% Similarity=0.294 Sum_probs=205.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||++... +++.|++|.+..... .......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999764 578999999876542 1223467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997654 588999999999999999999999 9999999999999999999999999988642110
Q ss_pred CC---------------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 247 SS---------------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 247 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
.. ......++..|+|||.+.+..++.++|+||||+++||+++|..||.... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~~~~~~ 231 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQVISD 231 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Confidence 00 0112346788999999988889999999999999999999999986432 12222333322
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC---ccccccCCCCCC
Q 042457 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT---MRRSFPNPEINP 358 (361)
Q Consensus 312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~hp~~~~ 358 (361)
....+.... .....+.+++.+||+.||++||| +.++++||||..
T Consensus 232 ~~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 232 DIEWPEGDE---ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCCCccc---cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 222221111 11224789999999999999998 688999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=303.72 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=204.2
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+|... +|+.||+|.++.... .....+.+.+|++++++++|+|++++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999776 789999998864332 2223567889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 167 KYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
||+++++|.+++.... ....+++.++..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 233589999999999999999999999 999999999999999999999999999876644
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.........++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..............+ +... ...
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~---~~~ 233 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYP-PLPA---DHY 233 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCC-CCCh---hhc
Confidence 33333344578899999999888899999999999999999999999854321 111111111111111 1111 112
Q ss_pred HHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.+|++|||+.+|++
T Consensus 234 ~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 234 SEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 235889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=308.21 Aligned_cols=253 Identities=23% Similarity=0.407 Sum_probs=199.5
Q ss_pred cCCCCcCeeeecCceeEEEEEe-----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
.+|++.+.||+|+||.||+|.. .++..|++|.+...... .....+.+|+++++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4578889999999999999974 35678999999754432 33467889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCC--------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC
Q 042457 164 LIYKYMRRGSLFCVLRNDD--------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~ 229 (361)
++|||+++++|.+++.... ....+++.+.+.++.|++.||+|||+. +++|+||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 9999999999999985321 123578899999999999999999999 99999999999999999
Q ss_pred CCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHh
Q 042457 230 LEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLI 306 (361)
Q Consensus 230 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 306 (361)
+.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++ |..||..... ... .
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~-~ 236 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEV-I 236 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHH-H
Confidence 9999999999976543221 1222335678999999988889999999999999999998 9999864332 111 1
Q ss_pred hhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.........+.... ....+.+++.+||+.||.+||++.+|+++
T Consensus 237 ~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKRQLLPCSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCcCCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 22222111111111 11247889999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=321.03 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=201.0
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFC 156 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 156 (361)
+....++|.+.+.||+|+||.||+|... .+..||||++...... ...+.+.+|++++++++ ||||++++++|
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS-SEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 3455778999999999999999999752 2346999999765433 22467899999999996 99999999999
Q ss_pred eeCCeEEEEEEeccCCChhhhhccCCc-----------------------------------------------------
Q 042457 157 LHKKCMFLIYKYMRRGSLFCVLRNDDE----------------------------------------------------- 183 (361)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 183 (361)
...+..++||||+++|+|.+++.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999988754210
Q ss_pred ----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCC
Q 042457 184 ----------------------------------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNN 223 (361)
Q Consensus 184 ----------------------------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~N 223 (361)
...+++..+..++.|++.||+|||+. +++|+||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHh
Confidence 12478888999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCC
Q 042457 224 ILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFN 300 (361)
Q Consensus 224 ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~ 300 (361)
||+++++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~- 346 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD- 346 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-
Confidence 9999999999999999976543222 1122346678999999988889999999999999999997 99998653221
Q ss_pred cchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 301 PKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
......+... ...+... .....+.+++.+||+.||++|||+.++.+
T Consensus 347 -~~~~~~~~~~-~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 -STFYNKIKSG-YRMAKPD----HATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred -HHHHHHHhcC-CCCCCCc----cCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 1111111111 1111111 11234889999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=304.76 Aligned_cols=256 Identities=21% Similarity=0.320 Sum_probs=203.4
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|++|.||++.. .+|+.+|||.+..... .......+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678888999999999999975 5789999998865432 2333467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 167 KYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 233689999999999999999999999 999999999999999999999999999876654
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... +.......+.....+ +... ...
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~---~~~ 233 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYP-PLPS---DHY 233 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCCCC-CCCc---ccc
Confidence 43333344688899999999888899999999999999999999999864321 111111111111111 1110 112
Q ss_pred HHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 234 SEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred cHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 235889999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=306.57 Aligned_cols=249 Identities=21% Similarity=0.229 Sum_probs=191.8
Q ss_pred eeeecCceeEEEEEe-CCCCEEEEEEeccCcchHH-HHHHHHHHHHHH---hcCCCCcceeeeEEEeeCCeEEEEEEecc
Q 042457 96 CIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELA-FLESFQTEARLL---SQIRHRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
.||+|+||.||++.. .+++.+|+|.+........ ....+..|..++ ...+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999976 4688999998865432111 112233444333 34479999999999999999999999999
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 250 (361)
+++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 999999887654 589999999999999999999999 99999999999999999999999999987553322 2
Q ss_pred cccccccccccccccc-ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHH
Q 042457 251 TVVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILV 329 (361)
Q Consensus 251 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 329 (361)
....|+..|+|||.+. +..++.++||||+|+++|||++|+.||......................+.. ....+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 226 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS------FSPEL 226 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccc------cCHHH
Confidence 2345899999999876 4567899999999999999999999997543322211111111111111111 12247
Q ss_pred HHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 330 SKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 330 ~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
.+++.+||+.||.+|| |++|+++||||+.
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 8899999999999999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=312.57 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=197.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------ 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 160 (361)
-++|++.+.||+|+||.||+|... +++.||+|.+............+.+|+.++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346889999999999999999764 6889999998654433222345668999999999999999999987654
Q ss_pred --eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 161 --CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 161 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
..++||||+.+ +|.+.+..... .+++.+++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999964 78777765432 589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC----ccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 239 VARLLHSDSSN----RTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 239 ~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
++......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99766432221 1223467889999987664 368899999999999999999999865432111111111111000
Q ss_pred C----------------CCCCChhhH-------HHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 314 P----------------SPIDDQTVI-------QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 314 ~----------------~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
+ .+....... .....+.+++.+||+.||.+|||++|+++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 000000000 001246789999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=299.73 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=211.5
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|.+.+.||.|+||.||++... +++.+++|++............+..|++.++.++|+|++++.+.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999764 688999999987655444567788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 169 MRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 169 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
+++++|.+++.... ....+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 123689999999999999999999999 99999999999999999999999999998765544
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
.......+++.|+|||...+..++.++|+||+|+++|+|++|+.||..... ................. ....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~ 229 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELALKILKGQYPPIPS-----QYSS 229 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---HHHHHHHhcCCCCCCCC-----CCCH
Confidence 333445688899999998888899999999999999999999999865432 22222222222211111 1112
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+.+++.+||+.+|++|||+.++++||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 47889999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=311.08 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=217.7
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.-|.+.+.||+|.|..|-++++ -+|..||||++.....+......+.+|++.|+.++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3477888899999999999943 489999999998877666556788899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC-CCCCeEEeeecCccccCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN-SKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~ 246 (361)
.-.+|+|++|+-+... .+++....+++.||..|+.|+|+. .+|||||||+||.+. .-|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999977654 488889999999999999999999 999999999999775 4588999999999766433
Q ss_pred CCCcccccccccccccccccccccC-ccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVT-EKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
......+|+..|.|||++.+..|+ ++.||||||+|||.|++|+.||....+ ...+..+++-....|....
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmImDCKYtvPshvS----- 243 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIMDCKYTVPSHVS----- 243 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhhcccccCchhhh-----
Confidence 334556799999999999998876 689999999999999999999886544 3344555555555443322
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+..+||..||..||.+|-|.++|..++|++.
T Consensus 244 -~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 244 -KECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred -HHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 24889999999999999999999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=299.66 Aligned_cols=253 Identities=27% Similarity=0.440 Sum_probs=210.5
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|++.+.||+|++|.||++... +++.|++|.+..........+.+.+|++++++++|+|++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999654 678999999987765445567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999987653 689999999999999999999999 999999999999999999999999999987755444
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
......++..|+|||...+..++.++||||+|+++|+|++|+.||..... ............+.... .....
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~ 226 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDDHPPLPE-----GISPE 226 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhccCCCCCCC-----CCCHH
Confidence 33445678899999998887789999999999999999999999875432 11122222121111111 01224
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
+.+++.+||+.+|++|||+.+++.||||
T Consensus 227 ~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 227 LKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 7899999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=302.30 Aligned_cols=241 Identities=23% Similarity=0.354 Sum_probs=193.1
Q ss_pred eeeecCceeEEEEEe---CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 96 CIGTGGYGSVYRAQL---PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
.||+|+||.||+|.+ .++..+|+|+++.........+.+..|+.+++.++|+||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999964 357889999987665555556789999999999999999999998864 4678999999999
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC---
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--- 249 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 249 (361)
+|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997544 588999999999999999999999 9999999999999999999999999999866443221
Q ss_pred cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCChhhHHHHH
Q 042457 250 RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQTVIQDII 327 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 327 (361)
.....++..|+|||.+.+..++.++|+||||+++|||++ |+.||...... .....+..+. .+.+... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~~~~~~~~~~~~------~~ 225 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIESGERMECPQRC------PP 225 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHCCCCCCCCCCC------CH
Confidence 111223578999999888888999999999999999998 99998754321 1122222211 1112111 12
Q ss_pred HHHHHHhhhcCCCCCCCCCcccccc
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.+.+++.+||+.||++|||+.+|.+
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHH
Confidence 4789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=305.42 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=199.3
Q ss_pred eeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
||+|+||+||++... +|+.+|+|.+...... ......+..|+++++.++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999654 6889999998654321 22235667899999999999999999999999999999999999999
Q ss_pred hhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccccc
Q 042457 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254 (361)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 254 (361)
.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 999876543 2589999999999999999999999 9999999999999999999999999998765432 2223345
Q ss_pred ccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh-hhhcccCCCCCCChhhHHHHHHHHHHH
Q 042457 255 GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI-DLLDQRAPSPIDDQTVIQDIILVSKIA 333 (361)
Q Consensus 255 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li 333 (361)
++..|+|||.+.+..++.++||||||+++|+|++|+.||............. .........+... ...+.+++
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~li 229 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF------SPEAKDLC 229 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccC------CHHHHHHH
Confidence 7789999999988889999999999999999999999987544311111111 1111111111111 22478999
Q ss_pred hhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 334 FACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 334 ~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
.+||+.||.+|| ++.++++||||++
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 230 EALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 999999999999 7777999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=303.85 Aligned_cols=251 Identities=27% Similarity=0.466 Sum_probs=200.2
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+..++|++.+.||+|+||.||+|...++..+|+|.+....... +.+.+|+.++++++|+|++++++++. .+..+++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 3456788899999999999999998888899999987654432 56889999999999999999999885 4568999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++..... ..+++.++..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999875432 2589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 246 DSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
.... .....++..|+|||.+.+..++.++|+||||+++|||++ |..||..... ......+... ...+...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~-~~~~~~~---- 226 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERG-YRMPCPQ---- 226 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcC-CCCCCCC----
Confidence 3221 112234567999999888889999999999999999999 8999865432 1222222222 1111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.....+.+++.+||+++|++|||+.++.+
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 11235889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=315.72 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=201.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------ 159 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 159 (361)
..++|+..+.||+|+||.||++.. .+|+.||+|.+............+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999965 4789999999875433333346677899999999999999999988644
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999996 478777653 278889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh---------------
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM--------------- 304 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~--------------- 304 (361)
+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........
T Consensus 165 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 165 ARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred ceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 976543222 2234578899999999999999999999999999999999999864332100000
Q ss_pred ----HhhhhcccCCC--------------CC-CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 305 ----LIDLLDQRAPS--------------PI-DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 305 ----~~~~~~~~~~~--------------~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........... +. ...........+.+++.+||+.||++|||+.|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00000000000 00 00000012334789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=300.09 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=203.7
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|++.+.||+|+||.||++... +++.+|+|.+...... ...+.+..|+.+++.++|+|++++++.+...+..+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4778899999999999999654 6889999998654332 2346788899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++..... ..++...++.++.|++.||.|||+. +++|+||||+||++++++.++++|||.+........
T Consensus 80 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 80 CDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999998865322 2578899999999999999999999 999999999999999999999999999976654433
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||..... ......+.......... .....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~ 227 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLILKVCQGSYKPLPS-----HYSYE 227 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHHHHHhcCCCCCCCc-----ccCHH
Confidence 33445688899999999888899999999999999999999999874332 12222222222221111 11124
Q ss_pred HHHHHhhhcCCCCCCCCCccccccC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
+.+++.+||+.||++|||+.++++-
T Consensus 228 ~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 228 LRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHhCCcccCCCHHHHhhc
Confidence 7889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=308.13 Aligned_cols=250 Identities=22% Similarity=0.378 Sum_probs=201.5
Q ss_pred CeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCC
Q 042457 95 YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS 173 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 173 (361)
..||+|+||.||++.. .+|+.||+|++...... ....+..|+.+++.++|+|++++++++...+..+++|||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh--HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 4599999999999976 47899999998654332 24678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcccc
Q 042457 174 LFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253 (361)
Q Consensus 174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 253 (361)
|.+++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.............
T Consensus 104 L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 104 LTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 99987543 478999999999999999999999 99999999999999999999999999987664433333445
Q ss_pred cccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHH
Q 042457 254 AGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIA 333 (361)
Q Consensus 254 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 333 (361)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .... ......+...... ......+.+++
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~-~~~~~~~~~~~~~--~~~~~~l~~li 250 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK-MIRDNLPPKLKNL--HKVSPSLKGFL 250 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH-HHHhhCCcccCCc--ccCCHHHHHHH
Confidence 6888999999988888899999999999999999999998643221 1111 1111111111000 01112477889
Q ss_pred hhhcCCCCCCCCCccccccCCCCCCC
Q 042457 334 FACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 334 ~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.+||+.||.+||++.++++||||.+.
T Consensus 251 ~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 251 DRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred HHHHhCCcccCcCHHHHhcChHHhcc
Confidence 99999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=300.80 Aligned_cols=243 Identities=25% Similarity=0.413 Sum_probs=192.7
Q ss_pred eeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 96 CIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
.||+|+||.||+|... +++.+|+|....... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 5899999999999764 788999998765432 23346788999999999999999999999999999999999999999
Q ss_pred hhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc--cc
Q 042457 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--TV 252 (361)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~ 252 (361)
.+++..... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999875432 588999999999999999999999 99999999999999999999999999987543221111 11
Q ss_pred ccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 253 VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...+..|+|||.+.+..++.++||||||+++|||++ |..||....... . ..........+... .....+.+
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~-~~~~~~~~~~~~~~----~~~~~~~~ 227 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---T-REAIEQGVRLPCPE----LCPDAVYR 227 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---H-HHHHHcCCCCCCcc----cCCHHHHH
Confidence 123457999999988889999999999999999998 888886543211 1 11111111111111 11225888
Q ss_pred HHhhhcCCCCCCCCCcccccc
Q 042457 332 IAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 332 li~~cl~~dP~~RPs~~eil~ 352 (361)
++.+||+.+|++|||+.++++
T Consensus 228 li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 228 LMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=330.40 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=207.0
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeCCC-CEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEE-EeeC--
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLPSG-KIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGF-CLHK-- 159 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~~-- 159 (361)
.+...++.+.+.|.+|||+.||.+....+ ..+|+|++...+. ..++...+|+++|+.|. |+|||.+++. ....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de--~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE--EALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH--HHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 45667788899999999999999987666 9999999887643 34788999999999996 9999999993 3221
Q ss_pred ----CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEe
Q 042457 160 ----KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVA 235 (361)
Q Consensus 160 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~ 235 (361)
-+++|+||||+||.|-+++...... .|++.++++|+.|+++|+++||.. .|+|+|||||.+||||+.+++.|||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence 2588999999999999999864433 499999999999999999999976 5579999999999999999999999
Q ss_pred eecCccccCCCCCCcc---------cccccccccccccc---cccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcch
Q 042457 236 DFGVARLLHSDSSNRT---------VVAGTHGYIAPELA---YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI 303 (361)
Q Consensus 236 Dfg~~~~~~~~~~~~~---------~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 303 (361)
|||.+........... ...-|+.|.|||++ .+..+++|+|||+|||+||-|+....||+....
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----- 263 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----- 263 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----
Confidence 9999876543331111 12368899999976 477899999999999999999999999986543
Q ss_pred hHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 304 MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..++......|.... ....+.+||..||+.||++||++-|++.+
T Consensus 264 --laIlng~Y~~P~~p~----ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 264 --LAILNGNYSFPPFPN----YSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred --eeEEeccccCCCCcc----HHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 345556555554322 22358999999999999999999999854
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=306.19 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=199.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCC------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPS------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
.+++|.+.+.||+|++|.||+|...+ +..|++|......... ....+..|+.+++.++|+||+++++++.+.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-DESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45678999999999999999997643 5679999886544322 2367889999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCc----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC---CeE
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDE----AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL---EAF 233 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~k 233 (361)
..+++|||+++++|.+++..... ...+++..+.+++.||+.|++|||+. +++|+||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 99999999999999999876432 12589999999999999999999999 999999999999998654 589
Q ss_pred EeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhc
Q 042457 234 VADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLD 310 (361)
Q Consensus 234 l~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 310 (361)
|+|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .....+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVTG 236 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHc
Confidence 9999999866322211 111223467999999988889999999999999999997 99998754321 11111111
Q ss_pred c-cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 311 Q-RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 311 ~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
. ....+... ...+.+++.+||+.+|++|||+.++++|
T Consensus 237 ~~~~~~~~~~------~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GGRLDPPKGC------PGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCcCCCCCCC------CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 11111111 1247889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=316.60 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=208.9
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeCC---C--CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLPS---G--KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
+++..+.....++||.|.||.||+|.+.+ | -.||||..+.+..... .+.|+.|..+|++++||||++++|+|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34445556667789999999999996633 3 3589999987665443 6899999999999999999999999987
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
.. .|+|||.++-|-|..+|+.+.. .++......++.||+.+|+|||+. .+|||||..+||||.....+||+|||
T Consensus 463 ~P-~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 QP-MWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred cc-eeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence 65 7999999999999999987765 588889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCc-ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCC
Q 042457 239 VARLLHSDSSNR-TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSP 316 (361)
Q Consensus 239 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 316 (361)
+++.+..+.... ....-...|||||.+.-..++.++|||.||+.|||+++ |..||......+.-..+. ...++|.|
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE--nGeRlP~P 614 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE--NGERLPCP 614 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec--CCCCCCCC
Confidence 999887655432 22234668999999999999999999999999999998 999998766544322221 23455555
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
...+.. +..|+.+||++||.+||++.|+.
T Consensus 615 ~nCPp~------LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 615 PNCPPA------LYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCCChH------HHHHHHHHhccCcccCCcHHHHH
Confidence 554443 77889999999999999999875
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=303.41 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=195.5
Q ss_pred CCCcCeeeecCceeEEEEEeCCC-C--EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------Ce
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPSG-K--IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------KC 161 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 161 (361)
|.+.+.||+|+||.||+|.+.++ . .+|+|.++.........+.+..|+..++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35677899999999999987543 2 589999876644444467889999999999999999999988542 24
Q ss_pred EEEEEEeccCCChhhhhccCC---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 162 MFLIYKYMRRGSLFCVLRNDD---EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
.++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +++|+||||+|||+++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 223589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-C
Q 042457 239 VARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-P 314 (361)
Q Consensus 239 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~ 314 (361)
+++........ .....++..|+|||...+..++.++||||||+++|||++ |+.||..... ......+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~ 234 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQGNRLK 234 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCCCC
Confidence 99876433221 122235678999999998889999999999999999999 8889865332 111222222211 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+.. ....+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~------~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPD------CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCC------CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1111 11247899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=305.35 Aligned_cols=252 Identities=25% Similarity=0.440 Sum_probs=200.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
..+|.+.+.||+|+||.||++.. .++..+|+|.+...... ....+..|++++++++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN--ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 45788899999999999999964 23456899988755432 34678899999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCC----------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC
Q 042457 162 MFLIYKYMRRGSLFCVLRNDD----------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE 231 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~ 231 (361)
.+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999999986432 123489999999999999999999999 9999999999999999999
Q ss_pred eEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhh
Q 042457 232 AFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDL 308 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 308 (361)
++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i 235 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECI 235 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence 999999999765432211 122235678999999988889999999999999999998 8999864432 2222233
Q ss_pred hcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 309 LDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
........... ....+.+++.+||+.||.+|||++++++
T Consensus 236 ~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 236 TQGRVLQRPRT-----CPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HcCCcCCCCCC-----CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33222211111 1124889999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.43 Aligned_cols=263 Identities=23% Similarity=0.344 Sum_probs=198.0
Q ss_pred CCCCcCeeeecCceeEEEEEeC---CCCEEEEEEeccCc-chHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP---SGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMF 163 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 163 (361)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999764 47899999987643 1112235677899999999999999999999988 7899
Q ss_pred EEEEeccCCChhhhhccCC--ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC----CCCeEEeee
Q 042457 164 LIYKYMRRGSLFCVLRNDD--EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS----KLEAFVADF 237 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~----~~~~kl~Df 237 (361)
+||||+++ +|.+++.... ....++...+..++.|++.||+|||+. +++|+||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666654322 122588999999999999999999999 9999999999999999 899999999
Q ss_pred cCccccCCCCC---Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCc------chhHhh
Q 042457 238 GVARLLHSDSS---NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP------KIMLID 307 (361)
Q Consensus 238 g~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------~~~~~~ 307 (361)
|++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543322 1223457888999998765 4578899999999999999999999875433210 000000
Q ss_pred hh--------------------------cccCCCCCCChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 308 LL--------------------------DQRAPSPIDDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 308 ~~--------------------------~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
+. ......+....... .....+.+++.+||+.||++|||+.|+++||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 00000000000000 112347899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=307.69 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=201.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.+.|+..+.||+|+||.||+|... +|+.||+|.+..... .......+.+|+++++.++|||++++.++|...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 456888899999999999999764 689999999864432 233346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
+||+. |++.+++..... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 567666653322 589999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 246 DSSNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
. ....++..|+|||.+. ...++.++||||||+++|||+||+.||...... .....+.....+....
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~---- 236 (307)
T cd06607 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNDSPTLSS---- 236 (307)
T ss_pred C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHHHHHhcCCCCCCCc----
Confidence 2 2235778899999874 456788999999999999999999998643321 1111121111111111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
......+.+++.+||+.||++|||+.+++.||||.+.
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 1112358899999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=302.95 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=198.5
Q ss_pred CCCcCeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe-----
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC----- 161 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 161 (361)
|.+.+.||+|+||.||+|.... +..||+|.++...........+..|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678889999999999997642 3679999998665544456789999999999999999999999876554
Q ss_pred -EEEEEEeccCCChhhhhccCC---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 162 -MFLIYKYMRRGSLFCVLRNDD---EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 162 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
.++++||+++++|..++.... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 223689999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCC
Q 042457 238 GVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAP 314 (361)
Q Consensus 238 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 314 (361)
|+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .............
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~ 234 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRHGNRL 234 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC
Confidence 999866433221 112234668999999988889999999999999999999 8899865432 1122222222111
Q ss_pred -CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 315 -SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 315 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+.. ....+.+++.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQPED------CLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCcC------CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111 12258899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=296.60 Aligned_cols=252 Identities=30% Similarity=0.483 Sum_probs=206.6
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|...+.||+|++|.||++... +++.+++|++..... .....+.+|++.++.++|+|++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4677889999999999999775 688999999976654 2357888999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++.... ..+++..+..++.|++.++.+||.. +++|+||+|+||++++++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 79 CSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 99999999987653 2589999999999999999999998 999999999999999999999999999877654332
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIIL 328 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (361)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...........+.... . ......
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-~--~~~~~~ 226 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIATNGPPGLRN-P--EKWSDE 226 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHhcCCCCcCc-c--cccCHH
Confidence 33446788999999998888899999999999999999999998754321 1111111111111111 1 101234
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPE 355 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~ 355 (361)
+.+++.+||+.||++|||+.|+++|||
T Consensus 227 ~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 227 FKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 889999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=308.35 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=198.3
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 167 (361)
+|...+.||+|+||.||++... +|+.+|+|.+...... .....+..|+..+.++. |+||+++++++...+..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4555677999999999999654 6899999998765433 23467889999999996 9999999999999999999999
Q ss_pred eccCCChhhhhcc--CCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 168 YMRRGSLFCVLRN--DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 168 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|+.. ++.++... ......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 55443321 111236899999999999999999999742 899999999999999999999999999876543
Q ss_pred CCCCccccccccccccccccccc---ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTM---VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .............+.. .....
T Consensus 161 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~-~~~~~ 236 (288)
T cd06616 161 SIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPIL-SNSEE 236 (288)
T ss_pred CCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcC-CCcCC
Confidence 222 2223578899999998765 688999999999999999999999875431 1111122222211111 11111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
......+.+|+.+||+.||++|||++++++||||++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 112235889999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=308.92 Aligned_cols=257 Identities=24% Similarity=0.401 Sum_probs=202.9
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFC 156 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 156 (361)
+.+..++|++.+.||+|+||.||++... +...+|+|.+....... ....+.+|+.+++++ +|+||+++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3455677889999999999999999753 23679999987654332 346688999999999 799999999999
Q ss_pred eeCCeEEEEEEeccCCChhhhhccC-------------CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCC
Q 042457 157 LHKKCMFLIYKYMRRGSLFCVLRND-------------DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNN 223 (361)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~N 223 (361)
...+..+++|||+++|+|.++++.. .....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence 9999999999999999999998642 1233689999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCC
Q 042457 224 ILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFN 300 (361)
Q Consensus 224 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~ 300 (361)
|++++++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++||+++ |..||.....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 99999999999999999866433221 111234567999999888889999999999999999998 9999764332
Q ss_pred cchhHhhhhcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 301 PKIMLIDLLDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 301 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
............ ..+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 241 -~~~~~~~~~~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 -EELFKLLKEGYRMEKPQN------CTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -HHHHHHHHcCCcCCCCCC------CCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 111111111111 11111 12248899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=310.01 Aligned_cols=257 Identities=18% Similarity=0.241 Sum_probs=196.4
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCC
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGS 173 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~ 173 (361)
.+.+|.|+++.||++.. +++.||+|++..........+.+..|+..++.++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33455556666666655 79999999997664444456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC-----
Q 042457 174 LFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----- 248 (361)
Q Consensus 174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 248 (361)
|.+++..... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||.+........
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999976432 2578899999999999999999999 999999999999999999999999998865532211
Q ss_pred --Ccccccccccccccccccc--cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC-----------
Q 042457 249 --NRTVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA----------- 313 (361)
Q Consensus 249 --~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 313 (361)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... ..... .....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEK-VRGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HhccCccccccCchhh
Confidence 1122346778999998865 357889999999999999999999987543211 00000 00000
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 314 -----------------PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 314 -----------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...............+.+++.+||+.||++|||++|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 000000001111234788999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=327.69 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=201.9
Q ss_pred CCCcCeeeecCceeEEEEEe-CCCC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 91 FDIKYCIGTGGYGSVYRAQL-PSGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
....++||+|+||+||+|.| +.|+ +||+|++.......+ ..++++|+..|.+++|||+++++|+|.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~-s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA-SIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh-hHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 44567899999999999954 4443 689999876554332 478999999999999999999999999877 8899
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
++|++.|+|.++++..+. .+.....+.|..|||+||.|||.+ +++||||.++||||..-..+||.|||+++.+..
T Consensus 776 tq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999998665 578889999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCccccc--ccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 246 DSSNRTVVA--GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 246 ~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
+........ -.+.|||-|.+....++.++|||||||.+||++| |..|++.....+....+. ...+++.|.....
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle--~geRLsqPpiCti- 927 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE--KGERLSQPPICTI- 927 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh--ccccCCCCCCccH-
Confidence 654433332 3568999999999999999999999999999999 999988765433222211 1122444433332
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
.+.-++.+||..|+..||+++++.
T Consensus 928 -----DVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 928 -----DVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred -----HHHHHHHHHhccCcccCccHHHHH
Confidence 377888899999999999999875
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=301.09 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=203.7
Q ss_pred eeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
||.|+||.||++... +|+.+++|.+..... .....+.+..|++++++++|+||+++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 489999999865433 223456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC------
Q 042457 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS------ 248 (361)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~------ 248 (361)
.+++.+.. .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997654 589999999999999999999999 999999999999999999999999999876543321
Q ss_pred --CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 249 --NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 249 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
......++..|+|||...+...+.++||||||+++|++++|+.||..... ..............+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~----~~ 227 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEIFQNILNGKIEWPEDVE----VS 227 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCcCCCcccc----CC
Confidence 22334578899999998888889999999999999999999999865432 2222223222222222110 12
Q ss_pred HHHHHHHhhhcCCCCCCCCCc---cccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTM---RRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~---~eil~hp~~~~ 358 (361)
..+.+++.+||+.+|.+|||+ .++++||||++
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 357899999999999999999 99999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=305.59 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=203.7
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
|.+.+.||+|++|.||++... +|+.+++|.+............+..|+..+++++|+||+++++++...+..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999764 6889999998766544334567888999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
++ +|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 75 8887776643 2689999999999999999999999 9999999999999999999999999999776544322
Q ss_pred ccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc----------------
Q 042457 250 RTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR---------------- 312 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------------- 312 (361)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+............
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2234577889999988776 78999999999999999999999986544321111110000000
Q ss_pred --CCC--CCC-ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 313 --APS--PID-DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 313 --~~~--~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+. ... ..........+.+++.+||++||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000 000 00011123458899999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.91 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=194.3
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
++|++.+.||+|+||.||+|.+. +|+ .+++|.+..... .....++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 46788899999999999999763 344 478888754332 2234677788889999999999999998864 4578
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++..
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 89999999999999975432 589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 244 HSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 244 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ...+........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 235 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLLEKGERLAQPQI 235 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcCCCCCC
Confidence 43221 1223346778999999988889999999999999999998 99998654321 11222222111111111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||+.||++|||+.|+++
T Consensus 236 ----~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 236 ----CTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ----CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1124678899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=302.58 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=199.1
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..++|.+.++||+|+||.||+|...++..||+|.+...... .+.+..|+++++.++|+||+++++++.. +..++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 45679999999999999999998877778999999754432 2568899999999999999999998754 5579999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999975432 2578999999999999999999999 9999999999999999999999999999766433
Q ss_pred CCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 247 SSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... .....++..|+|||...+..++.++||||||+++|||+| |+.||..... ......+.... ..+.. ..
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~-~~~~~----~~ 227 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGY-RMPCP----PE 227 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhcCC-CCCCc----cc
Confidence 221 122345678999999988889999999999999999999 8888864432 11122222211 11111 11
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 2235789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=298.12 Aligned_cols=254 Identities=21% Similarity=0.332 Sum_probs=197.3
Q ss_pred HHHHHHhcCCCCcCee--eecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 042457 82 EEIIVATEDFDIKYCI--GTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCL 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 157 (361)
.+.....++|.+.+.+ |+|+||.||++.. .++..+|+|......... .|......+ +|+|++++++.+.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 3444445677777776 9999999999965 468889999986543221 122222222 7999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-CeEEee
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-EAFVAD 236 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~D 236 (361)
..+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999997654 689999999999999999999999 999999999999999998 999999
Q ss_pred ecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh-HhhhhcccCCC
Q 042457 237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM-LIDLLDQRAPS 315 (361)
Q Consensus 237 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~ 315 (361)
||++...... ....++..|+|||++.+..++.++||||||+++|||++|+.||........... ...........
T Consensus 154 fg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T PHA03390 154 YGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229 (267)
T ss_pred CccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence 9998765432 223578899999999988899999999999999999999999974432211111 11111111111
Q ss_pred CCCChhhHHHHHHHHHHHhhhcCCCCCCCCC-ccccccCCCCCC
Q 042457 316 PIDDQTVIQDIILVSKIAFACLRSKPKSRPT-MRRSFPNPEINP 358 (361)
Q Consensus 316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~hp~~~~ 358 (361)
+. .....+.+++.+||+.+|.+||+ ++|+++||||+.
T Consensus 230 ~~------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 230 IK------NVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred cc------ccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 11 12224889999999999999996 699999999973
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=316.40 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=201.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-----Ce
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK-----KC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 161 (361)
.++|.+.+.||+|+||.||++.. .+|+.||||.+............+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788999999999999999965 4689999999875433222245677899999999999999999988654 34
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++++||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 68888887554 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh-------------
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID------------- 307 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~------------- 307 (361)
.............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 66443333334457889999998764 4688999999999999999999999864321100000000
Q ss_pred -------hhcccCCCCCC--ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 308 -------LLDQRAPSPID--DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 308 -------~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........+.. ..........+.+++.+||+.+|++|||++|+++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00000000000 0000011234789999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=308.48 Aligned_cols=265 Identities=28% Similarity=0.373 Sum_probs=202.1
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC----
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK---- 160 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 160 (361)
...++|++.+.||+|+||.||+|... +|+.||+|.+............+..|++++++++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999775 5889999999765433333356778999999999999999999987654
Q ss_pred ------eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEE
Q 042457 161 ------CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFV 234 (361)
Q Consensus 161 ------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl 234 (361)
..++++||+++ ++...+.... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 6666665432 2589999999999999999999999 9999999999999999999999
Q ss_pred eeecCccccCCCCC-Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 235 ADFGVARLLHSDSS-NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 235 ~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...................
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999986644332 1122345778999998764 457889999999999999999999987543211111111111111
Q ss_pred CCCCC---------------------CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 313 APSPI---------------------DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 313 ~~~~~---------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+... ...........+.+++.+||+.||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 00000 000000012358899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=297.00 Aligned_cols=243 Identities=23% Similarity=0.384 Sum_probs=195.1
Q ss_pred eeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCChh
Q 042457 96 CIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF 175 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 175 (361)
.||+|+||.||+|...+++.+|+|.+...... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 58999999999999888999999998765433 22456889999999999999999999999999999999999999999
Q ss_pred hhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC-ccccc
Q 042457 176 CVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-RTVVA 254 (361)
Q Consensus 176 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~ 254 (361)
+++..... .+++..+..++.+++.+|.|||+. +++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99865432 578999999999999999999999 9999999999999999999999999998754322211 11223
Q ss_pred ccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-CCCCCChhhHHHHHHHHHH
Q 042457 255 GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-PSPIDDQTVIQDIILVSKI 332 (361)
Q Consensus 255 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 332 (361)
++..|+|||++.+..++.++||||||+++||+++ |..||..... ......+..... ..+.. ....+.++
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~l 226 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAREQVEKGYRMSCPQK------CPDDVYKV 226 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCCCCCCCCC------CCHHHHHH
Confidence 4567999999988889999999999999999998 9999864432 111122221111 11111 12358899
Q ss_pred HhhhcCCCCCCCCCccccccC
Q 042457 333 AFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 333 i~~cl~~dP~~RPs~~eil~h 353 (361)
+.+||+.+|++|||+.++++.
T Consensus 227 i~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 227 MQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHHcccCcccCCCHHHHHHH
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=301.27 Aligned_cols=251 Identities=27% Similarity=0.493 Sum_probs=204.0
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+..++|.+.+.||+|+||.||++..++++.||+|.+...... .+.+.+|+.++++++|+|++++++++......+++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 456789999999999999999998888889999998765443 35688999999999999999999999998899999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++..... ..+++..+..++.+++.|+.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EeccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999976432 2589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCChhh
Q 042457 246 DSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQTV 322 (361)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 322 (361)
.... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||..... ......+.... .+.+...
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~--- 229 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYRMPRPPNC--- 229 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC---
Confidence 2111 112224568999999988889999999999999999999 9999864332 22222222221 1111111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.+|++|||++++++
T Consensus 230 ---~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 230 ---PEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 225889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=304.74 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=202.1
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCC-----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-C
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPS-----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-K 159 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~ 159 (361)
+..++|.+.+.||+|+||.||+|...+ +..|++|.+..... ....+.+.+|+.++++++|+|++++++++.. .
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-EIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 456788999999999999999997755 68899999875433 3335778899999999999999999999876 4
Q ss_pred CeEEEEEEeccCCChhhhhccCCcc-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEE
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEA-----IQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFV 234 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl 234 (361)
...++++||+++++|.+++...... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 6789999999999999998764322 4689999999999999999999999 9999999999999999999999
Q ss_pred eeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc
Q 042457 235 ADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 235 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
+|||+++.+...... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... . .......
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~-~~~~~~~ 234 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---E-MAAYLKD 234 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---H-HHHHHHc
Confidence 999999765432211 112335678999999988889999999999999999999 99998754321 1 1111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
......... ....+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 GYRLAQPIN----CPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCCCCCc----CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111111110 1124789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=303.96 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=202.8
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
+..++|.+.+.||+|+||.||+|... .+..||+|.+...... .....+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 34567888999999999999999663 2468999998755432 2346788999999999999999999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCc-------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCe
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDE-------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEA 232 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~ 232 (361)
...++||||+++++|.+++..... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 999999999999999999865321 22478899999999999999999999 99999999999999999999
Q ss_pred EEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhh
Q 042457 233 FVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 233 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 309 (361)
||+|||+++....... ......++..|+|||.+.+..++.++||||||+++||+++ |..||..... ........
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh
Confidence 9999999876543321 1222345778999999988889999999999999999998 9999864332 22222222
Q ss_pred cccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 310 DQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 310 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.... ..+... ...+.+++.+||+.+|++|||+.++++.
T Consensus 236 ~~~~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 236 DGGHLDLPENC------PDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred cCCCCCCCCCC------CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 2211 112111 2358899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=300.75 Aligned_cols=250 Identities=21% Similarity=0.237 Sum_probs=193.7
Q ss_pred eeeecCceeEEEEEe-CCCCEEEEEEeccCcchH-HHHHHHHHHH---HHHhcCCCCcceeeeEEEeeCCeEEEEEEecc
Q 042457 96 CIGTGGYGSVYRAQL-PSGKIVALKKLHHSETEL-AFLESFQTEA---RLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
.||+|+||.||++.. .+++.||+|.+....... .....+..|. ..++..+||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999965 468899999886543211 1112233333 34455689999999999999999999999999
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 250 (361)
+++|..++.... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 999999886543 689999999999999999999999 99999999999999999999999999987553322 2
Q ss_pred cccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHH
Q 042457 251 TVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILV 329 (361)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 329 (361)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||......................+... ...+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------s~~~ 226 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF------SPEL 226 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcC------CHHH
Confidence 234688999999998744 688999999999999999999999976533222221111111111111111 1248
Q ss_pred HHHHhhhcCCCCCCCC-----CccccccCCCCCCC
Q 042457 330 SKIAFACLRSKPKSRP-----TMRRSFPNPEINPS 359 (361)
Q Consensus 330 ~~li~~cl~~dP~~RP-----s~~eil~hp~~~~~ 359 (361)
.+++.+|+..+|.+|| ++.++++||||++.
T Consensus 227 ~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 8899999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.67 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=199.7
Q ss_pred cCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.+|.+.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+..+++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH--HHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 45788889999999999999642 3456899988654432 236788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC
Q 042457 163 FLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~ 229 (361)
++||||+++++|.+++..... ...+++..++.++.|++.|++|||++ +++|+||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 999999999999999865321 22489999999999999999999999 99999999999999999
Q ss_pred CCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHh
Q 042457 230 LEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLI 306 (361)
Q Consensus 230 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 306 (361)
+.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||..... .....
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIE 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH
Confidence 9999999999976543221 1122345778999999998899999999999999999999 9999764332 11222
Q ss_pred hhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
............. ....+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQGRVLERPRV-----CPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCCCCCcc-----CCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 2222222211111 1224889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=315.68 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=203.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee----CCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH----KKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 162 (361)
..+|++.+.||+|++|.||+|.. .+|+.||+|++............+..|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46789999999999999999965 468999999987654333335677789999999999999999998763 3468
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++|+||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 68988886554 589999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCC----cccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh----------
Q 042457 243 LHSDSSN----RTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID---------- 307 (361)
Q Consensus 243 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---------- 307 (361)
....... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 123467889999998765 4588999999999999999999999965432110000000
Q ss_pred ----------hhcccCCCCCCC--hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 308 ----------LLDQRAPSPIDD--QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 308 ----------~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
............ .........+.+++.+||+.+|.+|||+.++++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 000000000000 000111345889999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=304.07 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=197.4
Q ss_pred CCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
+|.+.+.||+|+||.||+|... ....+++|.+...... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4678889999999999999652 2357899988755443 23467889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCC---------------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCC
Q 042457 164 LIYKYMRRGSLFCVLRNDD---------------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~ 222 (361)
+++||+.+++|.+++.... ....+++..++.++.|++.||.|||+. +++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 9999999999999876421 123588999999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccC
Q 042457 223 NILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSF 299 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~ 299 (361)
||++++++.++|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999998765332221 122335678999999888889999999999999999999 9999864332
Q ss_pred CcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 300 NPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
. ............+.... ....+.+++.+||+.+|++|||+.|+++
T Consensus 236 --~-~~~~~~~~~~~~~~~~~----~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 --E-RLFNLLKTGYRMERPEN----CSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred --H-HHHHHHhCCCCCCCCCC----CCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1 12222222111111111 1124789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=298.21 Aligned_cols=246 Identities=28% Similarity=0.466 Sum_probs=201.4
Q ss_pred CeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEecc
Q 042457 95 YCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
+.||+|+||.||++.... +..|++|.+....... ..+.+..|++.++.++|+|++++++++......+++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 358999999999997753 7889999998765543 35788899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCc------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 171 RGSLFCVLRNDDE------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 171 ~g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
+++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999987521 23689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCC--CCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCCh
Q 042457 245 SDS--SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQ 320 (361)
Q Consensus 245 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 320 (361)
... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||..... ........... ...+...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~- 232 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGYRLPKPEYC- 232 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCccC-
Confidence 432 22233457889999999988889999999999999999999 6999876532 22222222211 1111111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
...+.+++.+||+.||++|||+.|++++
T Consensus 233 -----~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 233 -----PDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2358899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=327.54 Aligned_cols=269 Identities=18% Similarity=0.210 Sum_probs=191.9
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCC--CCEEEEEEe---------------ccCcchHHHHHHHHHHHHHHhcCCCCcc
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPS--GKIVALKKL---------------HHSETELAFLESFQTEARLLSQIRHRNI 149 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~---------------~~~~~~~~~~~~~~~e~~~l~~l~h~ni 149 (361)
..++|++.+.||+|+||+||++.... +...+.|.+ +...........+.+|+.++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999986432 222222211 0011112234568899999999999999
Q ss_pred eeeeEEEeeCCeEEEEEEeccCCChhhhhccCCc--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC
Q 042457 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDE--AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN 227 (361)
Q Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~ 227 (361)
+++++++...+..+++++++. ++|.+++..... .......+...++.|++.||.|||+. +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 567666644321 11234567788999999999999999 999999999999999
Q ss_pred CCCCeEEeeecCccccCCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh
Q 042457 228 SKLEAFVADFGVARLLHSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI 306 (361)
Q Consensus 228 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 306 (361)
.++.+||+|||++..+..... ......||..|+|||++.+..++.++|||||||++|||++|..++...........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987654332 2223568999999999999999999999999999999999875432211111111111
Q ss_pred hhhccc------CCC-----------------CCCChhhHH---HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 307 DLLDQR------APS-----------------PIDDQTVIQ---DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 307 ~~~~~~------~~~-----------------~~~~~~~~~---~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.+.... .+. +........ ....+.+++.+||+.||.+|||+.|+|+||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 111100 000 000000000 01235677889999999999999999999999764
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=303.47 Aligned_cols=257 Identities=23% Similarity=0.282 Sum_probs=194.9
Q ss_pred CCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeC--CeEEEEE
Q 042457 91 FDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHK--KCMFLIY 166 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 166 (361)
|++.+.||+|+||.||+|.. .+++.||+|.++........ .....|+..+.++. |+|++++++++.+. +..++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 56778899999999999965 46889999998765333222 23457888888885 99999999999987 8899999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||++ ++|.+.+.... ..+++.++..++.|++.||.|||+. +++|+||+|+||+++. +.+||+|||++......
T Consensus 80 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 80 ELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred ecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9997 57777776533 2589999999999999999999999 9999999999999999 99999999999866433
Q ss_pred CCCccccccccccccccccc-ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc-----------ccC-
Q 042457 247 SSNRTVVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD-----------QRA- 313 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~~- 313 (361)
... ....++..|+|||.+. +..++.++|||||||++|||++|+.||......+.......... ...
T Consensus 153 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PPY-TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCc-CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 222 2245788999999764 45678899999999999999999999865432111000000000 000
Q ss_pred ---CCCCCChh-----hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 314 ---PSPIDDQT-----VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 314 ---~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..+..... .......+.+++.+||+++|++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00000000 01123468999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.02 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=203.4
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEE
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGF 155 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~ 155 (361)
++.+..++|.+.+.||+|+||.||+|.+. .+..||+|++........ .+.+..|+.++.++. ||||++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-KQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-HHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 45666778888999999999999999753 346799999986543332 356889999999997 9999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCc----------------------------------------------------
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDE---------------------------------------------------- 183 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------- 183 (361)
|...+..++|+||+++|+|.++++....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999864321
Q ss_pred -------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCC
Q 042457 184 -------------------------------------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDIS 220 (361)
Q Consensus 184 -------------------------------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk 220 (361)
...+++..++.++.|++.||.|||+. +++|+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCC
Confidence 12467888999999999999999998 99999999
Q ss_pred CCCeeeCCCCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcc
Q 042457 221 SNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLS 297 (361)
Q Consensus 221 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~ 297 (361)
|+|||+++++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999976532221 1122346788999999988889999999999999999998 899986433
Q ss_pred cCCcchhHhhhhccc--CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 298 SFNPKIMLIDLLDQR--APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 298 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.. .......... ...+... ...+.+++.+||+.+|.+||++++|++.
T Consensus 347 ~~---~~~~~~~~~~~~~~~p~~~------~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 347 MN---EQFYNAIKRGYRMAKPAHA------SDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred ch---HHHHHHHHcCCCCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 21 1111222211 1111111 1258899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=298.07 Aligned_cols=242 Identities=21% Similarity=0.355 Sum_probs=190.5
Q ss_pred eeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 96 CIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
.||+|+||.||+|.+. ++..||+|.+..... ....+.+.+|+.++++++|+||+++++++.. +..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999653 355799999876543 3334678999999999999999999998864 5689999999999
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc--
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-- 250 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 250 (361)
+|.+++..... .+++..+++++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 80 PLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999875332 589999999999999999999999 99999999999999999999999999997654332211
Q ss_pred -ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-CCCCCChhhHHHHH
Q 042457 251 -TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-PSPIDDQTVIQDII 327 (361)
Q Consensus 251 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 327 (361)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+..... ..+.. ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~------~~~ 225 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIEQGKRLDCPAE------CPP 225 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCCCCCCCC------CCH
Confidence 11223568999999888889999999999999999997 99998754321 11222222211 11111 122
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+.+++.+||+.||++||++.+|.+.
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 47889999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=313.40 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=199.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-----e
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK-----C 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~ 161 (361)
+++|.+.+.||+|+||.||+|.. .+|+.||+|.+...... .....+..|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 46799999999999999999965 47899999998643322 23466788999999999999999999876543 5
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++++||+.+ +|.+++... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 7999999964 787777543 589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCC---cccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc-----
Q 042457 242 LLHSDSSN---RTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR----- 312 (361)
Q Consensus 242 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 312 (361)
........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 65432221 122457889999998654 568899999999999999999999986432111000000000000
Q ss_pred --------------CCCCCCCh---hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 313 --------------APSPIDDQ---TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 313 --------------~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.+...... ........+.+++.+||+.||++|||+.|+++||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000000 000112347899999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.94 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=199.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
.++|.....||+|+||.||++... ++..+++|.+..... .....+..|++.++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 356788899999999999999642 356799998875443 234678999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCc------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDE------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~ 229 (361)
.++++||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++|+||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 9999999999999999875432 12588999999999999999999999 99999999999999999
Q ss_pred CCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHh
Q 042457 230 LEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLI 306 (361)
Q Consensus 230 ~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 306 (361)
+.++|+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~ 235 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIE 235 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHH
Confidence 99999999998755332211 112234678999999998899999999999999999998 9999864332 11122
Q ss_pred hhhcccCC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 307 DLLDQRAP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 307 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
........ .+... ...+.+++.+||+.||.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~~------~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 236 CITQGRELERPRTC------PPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHcCccCCCCCCC------CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22222111 11111 124789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=301.28 Aligned_cols=257 Identities=26% Similarity=0.339 Sum_probs=198.5
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC---CCCcceeeeEEEeeCCe-----
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI---RHRNIVKLYGFCLHKKC----- 161 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 161 (361)
|++.+.||+|+||.||+|... +++.+|+|.+............+..|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567788999999999999876 489999999975544333234566777766655 69999999999998776
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+++|||+.+ +|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999999974 78888865432 2589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc---------
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR--------- 312 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 312 (361)
........ ....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+. ...+.+..
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMAL-TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCccc-ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhcC
Confidence 76433222 223468889999999988899999999999999999999999875443111 11111100
Q ss_pred ---------CCCCCC---ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 313 ---------APSPID---DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 313 ---------~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+.... ..........+.+++.+||+.||.+||++.|+++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000000 00011123457899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.85 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=198.8
Q ss_pred CCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
+|++.+.||+|+||.||+|... ++..||+|++...... ...+.+..|+.+++.++||||+++++++...+..+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4667788999999999999753 2478999999765432 23467889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 164 LIYKYMRRGSLFCVLRNDD-------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
+++||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999885321 123478889999999999999999999 999999999999999999
Q ss_pred CeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhh
Q 042457 231 EAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLID 307 (361)
Q Consensus 231 ~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 307 (361)
.+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ......
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEM 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 9999999998765332211 122335678999999988889999999999999999998 8888765332 222233
Q ss_pred hhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 308 LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
+....... ... .....+.+++.+||+.+|.+|||+++|++.
T Consensus 239 i~~~~~~~-~~~----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLP-CPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCC-CCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 33332211 111 112248899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=299.76 Aligned_cols=250 Identities=29% Similarity=0.455 Sum_probs=199.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
..+|++.+.||+|+||.||+|... .+..+|+|.++..... ...+.+..|+.++++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356888999999999999999653 2347999998764433 23568899999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
++|||+++++|.+++..... .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999999976542 579999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcc---cccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCC
Q 042457 244 HSDSSNRT---VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPID 318 (361)
Q Consensus 244 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 318 (361)
........ ...++..|+|||.+.+..++.++|+||||+++||+++ |..||......+ ....+.+.. .+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 233 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEEGYRLPAPMD 233 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhCCCcCCCCCC
Confidence 44322111 1123567999999988889999999999999999887 999987543311 122222221 111111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||+.+|.+|||+.++++
T Consensus 234 ------~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 234 ------CPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------CCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 1224788999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.31 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=198.4
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEee
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLH 158 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 158 (361)
...++|++.+.||+|+||.||+|.. .+++.||||.++..... .....+.+|+.++.++ +|+||++++++|..
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 4456899999999999999999963 35788999999765433 2246788999999999 68999999998876
Q ss_pred C-CeEEEEEEeccCCChhhhhccCCc------------------------------------------------------
Q 042457 159 K-KCMFLIYKYMRRGSLFCVLRNDDE------------------------------------------------------ 183 (361)
Q Consensus 159 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 183 (361)
. ...+++|||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 467899999999999998864321
Q ss_pred ----------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC--cc
Q 042457 184 ----------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RT 251 (361)
Q Consensus 184 ----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~ 251 (361)
...+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 12368888999999999999999999 9999999999999999999999999998765332221 11
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCChhhHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQTVIQDIILV 329 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 329 (361)
...++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........... ...+... ...+
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~~ 311 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRMRAPDYT------TPEM 311 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCCCCCCCCC------CHHH
Confidence 2235667999999988889999999999999999997 99998653321 11111111111 1111111 1247
Q ss_pred HHHHhhhcCCCCCCCCCccccccC
Q 042457 330 SKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 330 ~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+++.+||+.||++|||+.|+++|
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=302.41 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=207.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 165 (361)
++|.+.+.||+|+||.||++... +|+.||+|++..... .....+.+..|..++++++ |+||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999764 789999999875332 2223467888999999998 99999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999998654 689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCC--------------------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH
Q 042457 246 DSS--------------------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML 305 (361)
Q Consensus 246 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 305 (361)
... ......++..|+|||...+..++.++|+||||++++++++|+.||..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence 221 11223467899999998888899999999999999999999999875542 1112
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCc----cccccCCCC
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM----RRSFPNPEI 356 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~hp~~ 356 (361)
..........+... ...+.+++.+||+.+|++|||+ +++++||||
T Consensus 232 ~~~~~~~~~~~~~~------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 232 QKILKLEYSFPPNF------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHhcCCCCCCcc------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 22222222222111 2247899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.16 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=198.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..++|.+...||+|++|.||++...++..+|+|.+...... .+.+.+|+.++++++|+|++++++++. .+..+++|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 34568888999999999999998877778999988654332 256788999999999999999999875 45689999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 80 EFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999976432 2578999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 247 SSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... .....++..|+|||...+..++.++||||||+++|||++ |+.||..... .......... ...+... .
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~-~~~~~~~----~ 227 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERG-YRMPCPQ----G 227 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcC-CCCCCCc----c
Confidence 221 122335678999999988889999999999999999999 8999875332 1122222222 1111111 1
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||++||++|||++++++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1235889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=300.26 Aligned_cols=250 Identities=25% Similarity=0.365 Sum_probs=194.1
Q ss_pred CCCcCeeeecCceeEEEEEe-----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEE
Q 042457 91 FDIKYCIGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMF 163 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 163 (361)
|.+.+.||+|+||.||++.+ .+++.||+|.+...... .....+.+|+++++.++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 37888999999999988643 36788999998765432 2346788999999999999999999998764 4589
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
++|||+++++|.+++... .+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999998754 489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCc-----------chhHhhhh
Q 042457 244 HSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP-----------KIMLIDLL 309 (361)
Q Consensus 244 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-----------~~~~~~~~ 309 (361)
...... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+........ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 433221 1122356679999999888899999999999999999999999764321100 00011111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 310 DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
......+.. ......+.+++.+||+.+|++|||++++++
T Consensus 238 ~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCP----KNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCC----CCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111101 011235889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.10 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=197.2
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999764 589999999875432 2233467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCC--------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 167 KYMRRGSLFCVLRNDD--------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
||++|++|.+++.... .....++..++.++.|+++||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 112466788899999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC------------------CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC
Q 042457 239 VARLLHSDS------------------SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN 300 (361)
Q Consensus 239 ~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 300 (361)
++....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 997652111 00112358999999999999999999999999999999999999987533211
Q ss_pred cchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 301 PKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
...... ...+............+.+++.+|++.||++||+..+.+
T Consensus 239 --i~~~~~----i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 239 --ISYRDV----ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred --hhhhhh----ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 111111 111111000111123478899999999999998654433
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.23 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=196.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|++.+.||+|+||.||+|.+ .+|+ .||+|.+...... ...+.+..|+.+++.++|+||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-KANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH-HHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 46788899999999999999975 3444 4899998754433 2346788999999999999999999999764 47
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++++||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 899999999999999976432 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc--ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 243 LHSDSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 243 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
........ ....++..|+|||...+..++.++||||||+++|||++ |..||...... .....+......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~ 234 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDLLEKGERLPQPP 234 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcCCCCc
Confidence 64332211 11234678999999988889999999999999999998 99998643321 1112222211111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
. ....+.+++.+||+.||++|||+.++++
T Consensus 235 ~----~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 235 I----CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred c----CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 1224788999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=318.15 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=206.0
Q ss_pred CCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCc--chHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe--EEEEE
Q 042457 92 DIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE--TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC--MFLIY 166 (361)
Q Consensus 92 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~ 166 (361)
+....||+|+|-+||+|.. .+|-.||--.++..+ ......+.|..|+.+|+.|+|+||++++.++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3455699999999999954 357777655443332 223345889999999999999999999999987654 78899
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeeecCccccCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHS 245 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~~~ 245 (361)
|.|..|+|..|+.+.+ .++...+..|++||++||.|||++ .|+|+|||||.+||+|+++ |.|||+|+|+|.....
T Consensus 123 EL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999998876 688999999999999999999987 6789999999999999876 8999999999987754
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.. .....|||.|||||+.. ..|++..||||||+.|+||+|+..||..-. ++......+..+..|.....-.
T Consensus 199 s~--aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~kV~---- 269 (632)
T KOG0584|consen 199 SH--AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALSKVK---- 269 (632)
T ss_pred cc--cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhhccC----
Confidence 33 33378999999999876 789999999999999999999999986432 2334445555555543222111
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..++.++|.+|+.. .++|||+.|+|+||||+..
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 12488999999999 9999999999999999864
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=299.30 Aligned_cols=237 Identities=22% Similarity=0.329 Sum_probs=186.2
Q ss_pred eeeecCceeEEEEEeCC-------------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 96 CIGTGGYGSVYRAQLPS-------------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.||+|+||.||+|.+.+ ...|++|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 58999999999997532 23589998765433 2346788899999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC-------eEEe
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE-------AFVA 235 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-------~kl~ 235 (361)
+++|||+++++|..++..... .+++..+..++.|++.||+|||+. +++|+||||+|||++.++. ++++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988865432 589999999999999999999999 9999999999999987654 8999
Q ss_pred eecCccccCCCCCCccccccccccccccccc-ccccCccchhhhHHHHHHHHH-hCCCCCCCcccCCcchhHhhhhcccC
Q 042457 236 DFGVARLLHSDSSNRTVVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 236 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+....... .........
T Consensus 155 d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~~~ 226 (262)
T cd05077 155 DPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KERFYEGQC 226 (262)
T ss_pred CCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HHHHHhcCc
Confidence 99998654322 2234678899999876 566889999999999999998 5888876432211 111111111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..... ....+.+++.+||+.||.+||++.+|+++
T Consensus 227 ~~~~~------~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 MLVTP------SCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred cCCCC------ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11111 11247899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=304.15 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=195.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeCC-CC--EEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPS-GK--IVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
++|++.+.||+|+||.||+|...+ +. .+++|.++..... ...+.+..|+.++.++ +||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH-HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 468889999999999999997643 33 4788888743322 2246788999999999 79999999999999999999
Q ss_pred EEEeccCCChhhhhccCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC
Q 042457 165 IYKYMRRGSLFCVLRNDD-------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE 231 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~ 231 (361)
++||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 999999999999986532 112488999999999999999999999 9999999999999999999
Q ss_pred eEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhc
Q 042457 232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLD 310 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 310 (361)
+||+|||++........ ......+..|+|||...+..++.++||||||+++|||++ |..||..... .........
T Consensus 158 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~~~~~ 233 (297)
T cd05089 158 SKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ 233 (297)
T ss_pred EEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhc
Confidence 99999999864321111 111223457999999988889999999999999999998 9999865432 111222222
Q ss_pred ccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 311 QRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 311 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
... ..+.. ....+.+++.+||+.+|.+|||+.++++.
T Consensus 234 ~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYRMEKPRN------CDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 211 11111 11247899999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=301.14 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=203.2
Q ss_pred CCCCcCeeeecCceeEEEEEe----CCCCEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL----PSGKIVALKKLHHSET--ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
+|++.+.||+|+||.||++.. .+|..||+|++..... .....+.+..|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999965 3788999999875432 112346678899999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++|+||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+|||+++++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999987654 578899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCC-Cccccccccccccccccccc--ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh-HhhhhcccCCCCCC
Q 042457 243 LHSDSS-NRTVVAGTHGYIAPELAYTM--VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM-LIDLLDQRAPSPID 318 (361)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 318 (361)
...... ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||........... .........+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 234 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc
Confidence 543221 12234578899999988653 467899999999999999999999864332211111 12222222222111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
....+.+++.+||+.||++|| +++++++||||++
T Consensus 235 ------~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 235 ------MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred ------CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 112478899999999999997 8999999999976
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=302.32 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=201.0
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEEEEEE
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMFLIYK 167 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 167 (361)
|++.+.||+|++|.||+|... +|+.+|+|.+............+..|+++++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567788999999999999765 588999999987643333346788999999999999999999999988 78999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888876543 2689999999999999999999999 99999999999999999999999999998665433
Q ss_pred C-Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC------------
Q 042457 248 S-NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA------------ 313 (361)
Q Consensus 248 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------ 313 (361)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....................
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 1 1222346788999997764 4578999999999999999999999875442111111111000000
Q ss_pred -----CCCCCCh---hhHHH--HHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 314 -----PSPIDDQ---TVIQD--IILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 314 -----~~~~~~~---~~~~~--~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
....... ..... ...+.+++.+||+.+|.+|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0000000 00001 3457899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=306.27 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=196.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCC--EEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK--IVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 163 (361)
.++|++.+.||+|+||.||+|... ++. .+++|.+..... ......+.+|++++.++ +|+||+++++++...+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC-HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 356888899999999999999764 444 467777764332 23346788999999999 8999999999999999999
Q ss_pred EEEEeccCCChhhhhccCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 164 LIYKYMRRGSLFCVLRNDD-------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
+++||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++||||||+|||++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 9999999999999987532 123578999999999999999999999 999999999999999999
Q ss_pred CeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhh
Q 042457 231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 231 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 309 (361)
.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||+| |..||...... .......
T Consensus 162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHHh
Confidence 99999999986432111 1111224567999999888889999999999999999998 99998643321 1111111
Q ss_pred cc-cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 310 DQ-RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 310 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.. ....+.. ....+.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLEKPLN------CDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCCCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 1111111 11247899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=304.45 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=199.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC-----------------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcce
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS-----------------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 150 (361)
.++|++.+.||+|+||.||++...+ +..||+|.+...... ...+.+.+|++++++++|+|++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEe
Confidence 4678999999999999999986542 245899998765443 3357788999999999999999
Q ss_pred eeeEEEeeCCeEEEEEEeccCCChhhhhccCCc--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCC
Q 042457 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDE--------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222 (361)
Q Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~ 222 (361)
++++++..++..++++||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999876431 22589999999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh--CCCCCCCccc
Q 042457 223 NILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM--GRHPGDLLSS 298 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~ 298 (361)
||++++++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999876533221 1222345678999999988889999999999999999998 6777754332
Q ss_pred CCcchhHhhhhcc----cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 299 FNPKIMLIDLLDQ----RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 299 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
. ......... ........ .......+.+++.+||+.||++|||+.||++
T Consensus 240 ~---~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 Q---QVIENAGHFFRDDGRQIYLPR--PPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred H---HHHHHHHhccccccccccCCC--ccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 1 111111111 00000000 0011135889999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.43 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=197.2
Q ss_pred Ceeeec--CceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTG--GYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
..||.| +||+||++.. .+|+.||+|.+..........+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 8999999976 4799999999876654445567888999999999999999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC--
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-- 249 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 249 (361)
++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999876432 2488999999999999999999999 9999999999999999999999999865433221111
Q ss_pred -----ccccccccccccccccccc--ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC--------
Q 042457 250 -----RTVVAGTHGYIAPELAYTM--VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP-------- 314 (361)
Q Consensus 250 -----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 314 (361)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...... ............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---QMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHhcCCCCCCcccccc
Confidence 1112345679999998763 4788999999999999999999998754321 111111100000
Q ss_pred ---------------------------------CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 315 ---------------------------------SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 315 ---------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..............+.+|+.+||+.||++|||+.|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 00000111122345889999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=315.92 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=207.3
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.|...+.||+|+||.||.++. .+.+.||||++..+.. ..+...++..|+..|++++|||++.+-|+|....+.|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 456677799999999999954 4678999999876543 23345789999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
||- |+-.+++.-... ++.+-.+..|+.+.++||+|||+. +.+|||||+.|||+++.|.|||+|||.+.....
T Consensus 107 YCl-GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 994 577777754432 588888999999999999999999 999999999999999999999999999976543
Q ss_pred CCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 248 SNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
....+||+.|||||++. .+.|+-+.||||||++..||.-.++|.-.. +.-..++-+..+..|... ...|.
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM---NAMSALYHIAQNesPtLq--s~eWS 251 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPTLQ--SNEWS 251 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc---hHHHHHHHHHhcCCCCCC--CchhH
Confidence 33467999999999875 578999999999999999999999994332 333344444444443322 22233
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
+ .+..++..||++-|.+|||..++|.|+|+..+
T Consensus 252 ~--~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 252 D--YFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred H--HHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 3 58899999999999999999999999999653
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=312.80 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=205.1
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-----eEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK-----CMF 163 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 163 (361)
+|.+.+.||+|++|.||+|... +|+.||+|.+..........+.+..|+..++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999765 4899999998765433334567889999999999999999999998775 789
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
++|||++ ++|.+++.... .+++..+..++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58888887654 689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC---Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhh-----------
Q 042457 244 HSDSS---NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDL----------- 308 (361)
Q Consensus 244 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~----------- 308 (361)
..... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54431 22334578889999998877 7899999999999999999999998754421100000000
Q ss_pred ---------hcccCCC-CCCCh-hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 309 ---------LDQRAPS-PIDDQ-TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 309 ---------~~~~~~~-~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....... ..... ........+.+++.+||+.+|++|||+.++++||||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0000000 00000 00001234789999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=297.08 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=200.8
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++|+|++++++++...+..++||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 356788899999999999999987 588999999976544 3467889999999999999999999999989999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.++.....
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999876542 2589999999999999999999999 9999999999999999999999999999766322
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.. ....+..|+|||.+.+..++.++||||||+++||+++ |+.||..... .......... ....... ..
T Consensus 156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~-~~~~~~~----~~ 224 (256)
T cd05039 156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKG-YRMEAPE----GC 224 (256)
T ss_pred cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcC-CCCCCcc----CC
Confidence 21 2234567999999988889999999999999999997 9999865432 1111111111 1111111 11
Q ss_pred HHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 235889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=303.74 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=201.9
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCL 157 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 157 (361)
....++|.+.+.||+|+||.||++... .+..||+|.++..... ...+.+.+|+.+++++ +|+||+++++++.
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS-SEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh-HHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 445567999999999999999999641 3457999998765432 2346788999999999 7999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
..+..+++|||+++|+|.++++.... ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++++||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999975432 2389999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCC
Q 042457 238 GVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAP 314 (361)
Q Consensus 238 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 314 (361)
|++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .............
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~---~~~~~~~~~~~~~ 262 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV---DSKFYKLIKEGYR 262 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc---hHHHHHHHHcCCc
Confidence 999765433211 112235678999999988889999999999999999998 9999865432 1111222222111
Q ss_pred CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...... ....+.+++.+||+.+|++|||+.|+++
T Consensus 263 ~~~~~~----~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 MAQPEH----APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111110 1124889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=296.87 Aligned_cols=248 Identities=23% Similarity=0.425 Sum_probs=200.2
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
.+|.+.+.||+|+||.||++.+.++..+|+|.+....... ..+..|++++++++|||++++++++......++++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 4677889999999999999988778899999987554332 5688999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++..... .+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 81 MEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999999875432 578999999999999999999999 999999999999999999999999999876533221
Q ss_pred C-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCCChhhHHH
Q 042457 249 N-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDDQTVIQD 325 (361)
Q Consensus 249 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 325 (361)
. .....++.+|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+... ....+...
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~------ 226 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGFRLYKPRLA------ 226 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCCCCCCCCCC------
Confidence 1 112234578999999988889999999999999999998 9999864332 1122222211 11111111
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
...+.+++.+||+.+|++|||+.+++++
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 1248899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=297.37 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=187.5
Q ss_pred eeeecCceeEEEEEeCC---CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 96 CIGTGGYGSVYRAQLPS---GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
.||+|+||.||+|...+ +..+|+|.+....... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ-EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999997643 4579999987655432 2357888999999999999999999999999999999999999
Q ss_pred ChhhhhccCC--ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC--
Q 042457 173 SLFCVLRNDD--EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS-- 248 (361)
Q Consensus 173 ~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 248 (361)
+|.+++.... .....++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987533 123467788889999999999999999 999999999999999999999999999875433221
Q ss_pred Cccccccccccccccccccc-------ccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc--cCCCCCC
Q 042457 249 NRTVVAGTHGYIAPELAYTM-------VVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPID 318 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 318 (361)
......++..|+|||++.+. .++.++|+||||+++|||++ |+.||........ ....+... ..+.+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVREQQLKLPKPRL 235 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHhhcccCCCCCCcc
Confidence 11223467889999987542 35789999999999999997 9999875433211 11111111 1111111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
... ....+.+++..|| .+|++|||++||+.
T Consensus 236 ~~~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 236 KLP---LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCC---CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 111 1123677888998 58999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=301.86 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=197.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-----------------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcce
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-----------------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 150 (361)
.++|++.+.||+|+||.||++... ++..+|+|.+..... ......+..|+.+++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcc
Confidence 467899999999999999998532 234689999875533 22346788999999999999999
Q ss_pred eeeEEEeeCCeEEEEEEeccCCChhhhhccCCc--------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCC
Q 042457 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDE--------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222 (361)
Q Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~ 222 (361)
++++++...+..+++|||+++++|.+++..... ...+++.++..++.|++.||+|||+. +++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 999999999999999999999999999875321 12478889999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh--CCCCCCCccc
Q 042457 223 NILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM--GRHPGDLLSS 298 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~ 298 (361)
||+++.++.++|+|||++..+...... .....++..|+|||...++.++.++||||||+++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999998765432211 111234578999998888889999999999999999998 7788764432
Q ss_pred CCcchhHhhhhcc-----cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 299 FNPKIMLIDLLDQ-----RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 299 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
............. ..+.+.. ....+.+++.+||+.||++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPAL------CPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCC------CCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1111111111100 1111111 1135889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=296.85 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=194.6
Q ss_pred CeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHH-hcCCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLL-SQIRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||+|.. .+|+.||+|.+..... .......+..|...+ ...+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4589999999999966 4688999999875432 122223444555444 455899999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..... ..
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 99999997654 588999999999999999999999 999999999999999999999999999875432 22
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...++..|+|||.+.+..++.++||||||+++|||++|..||..... ..............+.... ......+.+
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 226 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINWPEEVK--EFCSPEAVD 226 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCCCCccc--ccCCHHHHH
Confidence 33578899999999888889999999999999999999999864332 2222222222211111111 011234889
Q ss_pred HHhhhcCCCCCCCCCc---cccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTM---RRSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~---~eil~hp~~~~ 358 (361)
++.+||+.+|++|||+ .|++.||||++
T Consensus 227 ~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 227 LINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred HHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 9999999999999965 69999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=306.43 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=199.6
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC--------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP--------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFC 156 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 156 (361)
+..++|.+.+.||+|+||.||++... ++..+|+|.+...... .....+..|+.+++++ +|+||+++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh-HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 33467899999999999999999652 2357999999765332 2246788899999999 799999999999
Q ss_pred eeCCeEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCC
Q 042457 157 LHKKCMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNN 223 (361)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~N 223 (361)
...+..++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+. +++|+||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999975421 12588999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeeecCccccCCCCCCc--ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCC
Q 042457 224 ILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFN 300 (361)
Q Consensus 224 ill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~ 300 (361)
|+++.++.++|+|||++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 999999999999999987654322111 11224568999999988889999999999999999998 8888764321
Q ss_pred cchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 301 PKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.. ............... .....+.+++.+||+.+|.+|||+.+++++
T Consensus 249 -~~-~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 -EE-LFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred -HH-HHHHHHcCCCCCCCC----cCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 11 111222221111111 112247889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=297.56 Aligned_cols=252 Identities=25% Similarity=0.446 Sum_probs=201.1
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
++..++|++.+.||+|+||.||++...++..+|+|.+...... .+.+.+|+.+++.++|+|++++++++.. ...++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhH---HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 3456789999999999999999998878888999988754322 3678899999999999999999999887 77899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
+|||+++++|.+++..... ..+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999999976432 2578999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 245 SDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
..... .....++..|+|||++.+..++.++|+||||+++|++++ |+.||..... ..... ........+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~-~~~~~~~~~~~~--- 226 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIR-ALERGYRMPRPE--- 226 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHH-HHhCCCCCCCcc---
Confidence 32211 122235677999999988889999999999999999999 9999875432 11111 112221111111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.....+.+++.+||+.+|++||++.++++
T Consensus 227 -~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 227 -NCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 11235889999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=295.03 Aligned_cols=242 Identities=25% Similarity=0.388 Sum_probs=191.7
Q ss_pred CeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEecc
Q 042457 95 YCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
++||+|+||.||+|.+.. +..+|+|.+...... ...+.+..|+.+++.++|+|++++++++. .+..+++|||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 369999999999996532 268999998866553 33467889999999999999999999876 456899999999
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 250 (361)
+++|.+++.... .+++..+..++.|++.||+|||.. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999997654 589999999999999999999999 99999999999999999999999999998664333221
Q ss_pred c---cccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 251 T---VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 251 ~---~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
. ...++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ......+.... ..+.... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~-~~~~~~~----~~ 224 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGE-RLPRPEE----CP 224 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCC-cCCCCCC----CC
Confidence 1 1123467999999988889999999999999999998 9999875432 11112221221 1111111 11
Q ss_pred HHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 24789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.52 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=196.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC---------------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceee
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS---------------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 152 (361)
.++|++.+.||+|+||.||++...+ ...||+|.+..... ......+.+|++++++++|+|++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 4678999999999999999986532 23589999875433 2334678899999999999999999
Q ss_pred eEEEeeCCeEEEEEEeccCCChhhhhccCCc---------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCC
Q 042457 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDE---------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNN 223 (361)
Q Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~N 223 (361)
++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999864321 12468899999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh--CCCCCCCcccC
Q 042457 224 ILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM--GRHPGDLLSSF 299 (361)
Q Consensus 224 ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~~ 299 (361)
|++++++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999998765332211 112234678999999988889999999999999999998 56677644321
Q ss_pred CcchhHhhhhcc--cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 300 NPKIMLIDLLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 300 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
............ ......... .....+.+++.+||+.||++|||+++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 110001111110 000000000 01125889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=299.32 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=195.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--C
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--K 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~ 160 (361)
.++|++.+.||+|+||.||++.. .++..||+|.+..... ...+.+..|+++++.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 35688889999999999999974 2578999999875543 2346788999999999999999999987643 4
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++|+||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 68999999999999999975432 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc---ccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC-----c----c---hhH
Q 042457 241 RLLHSDSSNR---TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN-----P----K---IML 305 (361)
Q Consensus 241 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-----~----~---~~~ 305 (361)
.......... ....++..|+|||.+.+..++.++||||||+++|||++|..++....... . . ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 8764332211 11223456999999988889999999999999999999877654222100 0 0 001
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+........+... .....+.+++.+||+.+|++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 236 IELLKNNGRLPAPP----GCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHHhcCCcCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 11111111111111 111248899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=305.23 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=199.4
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC--------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP--------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGF 155 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 155 (361)
....++|.+.+.||+|+||.||+++.. .+..+|+|.++..... .....+..|+.+++.+ +||||++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-HHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 344567888999999999999999642 2457999998754432 3356788999999999 69999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCC
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~ 222 (361)
+...+..+++|||+++|+|.+++..... ...+++.++..++.|++.||.|||++ +++|+||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 9999999999999999999999965321 23589999999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeeecCccccCCCCCCc--ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccC
Q 042457 223 NILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSF 299 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~ 299 (361)
||++++++.+||+|||+++......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~- 242 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV- 242 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999997654322111 11223457999999988889999999999999999999 8899864332
Q ss_pred CcchhHhhhhcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 300 NPKIMLIDLLDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 300 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
............ ..+.. ....+.+++.+||+.||++|||+.|+++
T Consensus 243 --~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 --EELFKLLREGHRMDKPSN------CTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred --HHHHHHHHcCCCCCCCCC------CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111222222211 11111 1124778999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=300.64 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=200.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
..++|++.+.||+|+||.||++... ++..||+|.+...... .....+..|+.++++++|||++++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4567899999999999999999753 4678999998755432 23467889999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCC-------------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCC
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDD-------------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISS 221 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~ 221 (361)
..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++|+||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 9999999999999999986421 112478889999999999999999999 999999999
Q ss_pred CCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCccc
Q 042457 222 NNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSS 298 (361)
Q Consensus 222 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~ 298 (361)
+||++++++.++|+|||++......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999998765332211 112234567999999988889999999999999999998 8888754332
Q ss_pred CCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 299 FNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
......+....... ... .....+.+++.+||+.||++|||+.|+++
T Consensus 239 ---~~~~~~~~~~~~~~-~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 239 ---EEVIYYVRDGNVLS-CPD----NCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred ---HHHHHHHhcCCCCC-CCC----CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 12222222222211 111 11235889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=299.59 Aligned_cols=237 Identities=23% Similarity=0.349 Sum_probs=184.9
Q ss_pred eeeecCceeEEEEEeCC-------------------------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcce
Q 042457 96 CIGTGGYGSVYRAQLPS-------------------------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 150 (361)
.||+|+||.||+|.+.. ...|++|.+..... .....+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999996421 13589998865433 2346788899999999999999
Q ss_pred eeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
+++++|......++||||+++|+|..++..... .+++..+..++.|++.||+|||+. +++||||||+|||++.++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999999875432 578899999999999999999999 999999999999997643
Q ss_pred -------CeEEeeecCccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHH-hCCCCCCCcccCCc
Q 042457 231 -------EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNP 301 (361)
Q Consensus 231 -------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~-tg~~p~~~~~~~~~ 301 (361)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||........
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999987543222 12246778999998865 56889999999999999985 69999875432111
Q ss_pred chhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 302 KIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..........+.... ..+.+++.+||+.+|++|||+.+++++
T Consensus 231 ----~~~~~~~~~~~~~~~------~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ----ERFYEKKHRLPEPSC------KELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ----HHHHHhccCCCCCCC------hHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 112222211111111 147889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=294.89 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=196.0
Q ss_pred CeeeecCceeEEEEEeCC--CC--EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEecc
Q 042457 95 YCIGTGGYGSVYRAQLPS--GK--IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
+.||+|++|.||+|.+.+ ++ .||+|.+...... ...+.+..|+..+++++|+||+++++.+.. ...++++||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 358999999999997643 33 6999999876654 446789999999999999999999999988 88999999999
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC-
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN- 249 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 249 (361)
+++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 9999999976543 3689999999999999999999999 9999999999999999999999999999876442221
Q ss_pred --cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 250 --RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 250 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+........... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~----~~~ 227 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDKEGERLERPE----ACP 227 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhcCCcCCCCc----cCC
Confidence 112346778999999988889999999999999999999 999986443211 1111111111111111 112
Q ss_pred HHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 35889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=295.92 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=199.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CC---CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SG---KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
.++|...+.||+|+||.||+|... ++ ..+++|.+...... ...+.+..|++++++++|+|++++.+++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 457888899999999999999764 23 37999998755332 22467889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++|+||||+||++++++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999999875432 589999999999999999999999 9999999999999999999999999998766
Q ss_pred CCCCCCc---ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 244 HSDSSNR---TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 244 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
....... .....+..|+|||++.+..++.++||||||+++||+++ |+.||..... ......+.... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~-~~~~~~ 233 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGF-RLPAPM 233 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCC-CCCCCC
Confidence 4322211 11123457999999988889999999999999999998 9999865432 12222222221 111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.....+.+++.+||+.+|++||++.++++
T Consensus 234 ----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 234 ----DCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ----CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11234789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=309.86 Aligned_cols=263 Identities=28% Similarity=0.410 Sum_probs=200.8
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeC--CeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHK--KCM 162 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~ 162 (361)
..++|.+.+.||+|+||.||+|... +|+.+|+|++............+..|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999765 688999998865433223345677899999999 999999999998754 368
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898888654 578899999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCC-----Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh---------
Q 042457 243 LHSDSS-----NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID--------- 307 (361)
Q Consensus 243 ~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--------- 307 (361)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643321 1223457889999998754 5578899999999999999999999865432111000000
Q ss_pred -----------hhcc---cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 308 -----------LLDQ---RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 308 -----------~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.... ....+.. .........+.+++.+||+.||++|||+.++++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 0000 0000000 000001235789999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=297.33 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=186.0
Q ss_pred eeeecCceeEEEEEeCC---CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 96 CIGTGGYGSVYRAQLPS---GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
.||+|+||.||+|...+ ...+++|.+..... ......+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999996543 34688888765433 233467889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCc--cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC--
Q 042457 173 SLFCVLRNDDE--AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS-- 248 (361)
Q Consensus 173 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 248 (361)
+|.+++..... ....++.....++.|++.|++|||+. +++||||||+||++++++.+||+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 22356788899999999999999999 999999999999999999999999999865432221
Q ss_pred Cccccccccccccccccc-------ccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc---CCCCC
Q 042457 249 NRTVVAGTHGYIAPELAY-------TMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR---APSPI 317 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~ 317 (361)
......++..|+|||+.. ...++.++||||||+++|||++ |..||...... .......... .+.+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHhhccCccCCCCc
Confidence 112233567899999864 3456789999999999999999 78887654321 1122222221 11111
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
... .....+.+++..|| .||++|||+++|++-
T Consensus 235 ~~~---~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 235 LDL---KYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred ccc---cCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 111 11123567778888 599999999998753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=292.50 Aligned_cols=245 Identities=27% Similarity=0.358 Sum_probs=203.2
Q ss_pred eeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 97 IGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 97 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
||+|+||.||++... +++.+++|.+...... ......+..|+.+++.++|+|++++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 5889999998765432 22356788999999999999999999999999999999999999999
Q ss_pred hhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccccc
Q 042457 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254 (361)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 254 (361)
.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99997654 589999999999999999999998 999999999999999999999999999977654433334456
Q ss_pred ccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHh
Q 042457 255 GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAF 334 (361)
Q Consensus 255 gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 334 (361)
++..|+|||...+...+.++|+||||+++|++++|+.||..... ......+.......+... ...+.+++.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~------~~~l~~~i~ 225 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPLRFPEFL------SPEARDLIS 225 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCCCCCCC------CHHHHHHHH
Confidence 78899999999888889999999999999999999999865432 222223333222222221 124788999
Q ss_pred hhcCCCCCCCCCc---cccccCCCC
Q 042457 335 ACLRSKPKSRPTM---RRSFPNPEI 356 (361)
Q Consensus 335 ~cl~~dP~~RPs~---~eil~hp~~ 356 (361)
+||..||++|||+ +++++||||
T Consensus 226 ~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 226 GLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999999 899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.33 Aligned_cols=260 Identities=25% Similarity=0.321 Sum_probs=203.0
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
|+..+.||+|++|.||+|... +++.+|+|.+..........+.+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456778999999999999765 5899999999876433333467788999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
+ ++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999997653 2589999999999999999999999 9999999999999999999999999999776543333
Q ss_pred ccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh-----------------cc
Q 042457 250 RTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL-----------------DQ 311 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-----------------~~ 311 (361)
.....++..|+|||.+.+. .++.++||||||+++||+++|+.||................ +.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 3334457789999988766 78999999999999999999999986543211100000000 00
Q ss_pred cCCCCCCChh---hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 312 RAPSPIDDQT---VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 312 ~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..+....... .......+.+++.+||+.||++||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000000000 00112358899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=303.75 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=201.1
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEe--------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQL--------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGF 155 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 155 (361)
.+...+|.+.+.||+|+||.||+++. .++..||+|.+..... ....+.+.+|+.+++.+ +||||++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 34567788899999999999999964 1345799999875433 23356788999999999 89999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCC
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~ 222 (361)
+...+..+++|||+++++|.+++..... ...+++.++..++.|++.||.|||+. +++|+||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence 9999999999999999999999875321 23578899999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccC
Q 042457 223 NILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSF 299 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~ 299 (361)
||++++++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++||+++ |..||.....
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~- 245 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV- 245 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-
Confidence 999999999999999999866432221 122235678999999988889999999999999999998 7888754322
Q ss_pred CcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 300 NPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
......+...... .... .....+.+++.+||+.+|.+|||+.|+++.
T Consensus 246 --~~~~~~~~~~~~~-~~~~----~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 246 --EELFKLLKEGHRM-DKPA----NCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred --HHHHHHHHcCCcC-CCCC----CCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1112222221111 1111 112358889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=294.63 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=201.9
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCc---chHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE---TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCM 162 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 162 (361)
.+|++.+.||+|+||.||+|.. .+++.||+|.+.... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999965 468999999875322 1233456788999999999999999999998764 468
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++++||+++++|.+++.... .+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987644 478899999999999999999999 999999999999999999999999999976
Q ss_pred cCCCC---CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 243 LHSDS---SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 243 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~p- 231 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPMLP- 231 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHcCCCCCCCC-
Confidence 53321 112234578899999999888889999999999999999999999875422 11122222211111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
......+.+++.+||+ +|.+|||+.+++.|||.
T Consensus 232 ---~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 232 ---DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 1112248899999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=299.87 Aligned_cols=260 Identities=22% Similarity=0.357 Sum_probs=199.8
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
.-++|.+.+.||+|+||.||+|...+ ++.||||.++....... ...+..|+..+.+. +|+||+++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 34568888999999999999998864 89999999976543322 34566677766666 59999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
+|||+. +++.+++..... .+++..+..++.|++.||+|||+.. +++|+||+|+||++++++.++|+|||++..+.
T Consensus 92 v~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EeeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999985 477766654332 6899999999999999999999732 89999999999999999999999999987654
Q ss_pred CCCCCcccccccccccccccccccc----cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMV----VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .............+......
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCCCCCCC
Confidence 3222 22234778899999886553 78899999999999999999999864321 11122222322221111110
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+++.+||+.||++|||++++++||||+.
T Consensus 244 ---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 244 ---GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred ---CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 11224889999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=306.85 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=196.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------ 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 160 (361)
.++|.+.+.||+|+||.||+|... +++.+|+|++............+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999764 6889999998654332222345678999999999999999999875433
Q ss_pred --eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 161 --CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 161 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
..++|+||+.+ ++...+.... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999965 6666665432 2589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC-----------cccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh
Q 042457 239 VARLLHSDSSN-----------RTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI 306 (361)
Q Consensus 239 ~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 306 (361)
++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99765432211 112346788999998765 457889999999999999999999987544321111111
Q ss_pred hhhcccC------------------CCCCCCh---hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 307 DLLDQRA------------------PSPIDDQ---TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 307 ~~~~~~~------------------~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
....... ....... ........+.+++.+||+.||++|||+.|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 1100000 0000000 000111347899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=293.48 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=208.2
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|++.+.||+|+||.||++... +++.+++|.+............+..|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999654 678999999876554444456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 169 MRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 169 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999886622 123689999999999999999999999 9999999999999999999999999999776543
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ......+.....+.. . .....
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-~----~~~~~ 227 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKYPPI-P----PIYSQ 227 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCC-c----hhhCH
Confidence 22234578899999999888899999999999999999999999875432 111222222222211 1 12223
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.+.+++.+||+.+|++|||+.++++||++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 228 DLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 58899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=308.03 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=203.7
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
..++...+++|.+.+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|+.++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 455666789999999999999999999964 5789999999876543333346678899999999999999999988643
Q ss_pred ------CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeE
Q 042457 160 ------KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF 233 (361)
Q Consensus 160 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k 233 (361)
...+++++++ +++|.+++... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3467888876 78998887643 489999999999999999999999 999999999999999999999
Q ss_pred EeeecCccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh---
Q 042457 234 VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL--- 309 (361)
Q Consensus 234 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--- 309 (361)
|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||................
T Consensus 161 l~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 161 ILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred Eeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998764322 223457889999998765 567889999999999999999999986433211000000000
Q ss_pred -----------------cc--cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 310 -----------------DQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 310 -----------------~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.. ..+..............+.+++.+|++.||.+|||+.++++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00 00000000000001124789999999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=297.03 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=198.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeCC-C---CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPS-G---KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
.+|++.+.||+|+||.||+|.... + ..||+|.+..... ......|..|+.+++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 347788999999999999997643 3 3699999876533 2335789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 83 ITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999876432 589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCcc---ccc--ccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCC
Q 042457 245 SDSSNRT---VVA--GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPI 317 (361)
Q Consensus 245 ~~~~~~~---~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 317 (361)
....... ... .+..|+|||.+.+..++.++||||||+++||+++ |..||...... .....+... ..+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~~~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDYRLPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCcCCCcc
Confidence 3222111 111 2357999999998889999999999999999887 99998654321 111222111 112221
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.. ...+.+++.+||+.+|.+||+++++++.
T Consensus 235 ~~------~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 235 DC------PTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred cC------CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 2247889999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=294.76 Aligned_cols=245 Identities=25% Similarity=0.400 Sum_probs=195.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-CCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 166 (361)
..+|.+.+.||+|+||.||++.. .|..||+|..+.... .+.+..|+.++++++|+|++++++++.. .+..++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCch----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 35788899999999999999987 578899999865432 3568899999999999999999997654 56789999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999876442 2488999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+... ....... ..
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~-~~~~~~~----~~ 224 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKG-YKMDAPD----GC 224 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcC-CCCCCCC----CC
Confidence 2 12234568999999988889999999999999999998 9999764321 1111111111 1111111 11
Q ss_pred HHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 224788999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.41 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=196.9
Q ss_pred cCCCCcCeeeecCceeEEEEEe-----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--Ce
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KC 161 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 161 (361)
+.|.+.+.||+|+||.||++.+ .++..||+|.++.... ......+.+|+.+++.++|+|++++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4578889999999999999974 3578899999875543 23356789999999999999999999999875 56
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||+++++|.+++..... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999999865432 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC--------Ccc---hhHhh
Q 042457 242 LLHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF--------NPK---IMLID 307 (361)
Q Consensus 242 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--------~~~---~~~~~ 307 (361)
.+...... .....++..|+|||.+.+..++.++||||||+++|||++++.|+...... ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66433221 12234667899999988888999999999999999999987764321100 000 00111
Q ss_pred hhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 308 LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
........+.... ....+.+++.+||+.||++|||+++++++
T Consensus 238 ~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGKRLPRPPN----CPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCccCCCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1111111111111 12358899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=307.19 Aligned_cols=264 Identities=24% Similarity=0.270 Sum_probs=199.3
Q ss_pred cCCC-CcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHH------------HHHHHHHHHHHHhcCCCCcceeeeE
Q 042457 89 EDFD-IKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELA------------FLESFQTEARLLSQIRHRNIVKLYG 154 (361)
Q Consensus 89 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~~~~ 154 (361)
++|. +.+.||+|+||.||+|... +++.||+|.+........ ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3467999999999999754 689999999865432210 0124678999999999999999999
Q ss_pred EEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEE
Q 042457 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFV 234 (361)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl 234 (361)
++...+..+++|||+. ++|.+++.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999996 68988886543 588999999999999999999999 9999999999999999999999
Q ss_pred eeecCccccCCC--------------CCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccC
Q 042457 235 ADFGVARLLHSD--------------SSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSF 299 (361)
Q Consensus 235 ~Dfg~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 299 (361)
+|||++...... ........++..|+|||.+.+. .++.++|+||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998765411 1111223467789999988764 4688999999999999999999998754432
Q ss_pred CcchhHhhhhcccCCC------------------CCCC-hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 300 NPKIMLIDLLDQRAPS------------------PIDD-QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 300 ~~~~~~~~~~~~~~~~------------------~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
................ +... .........+.+++.+||+.+|++|||++|++.||||+..
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 1111111111100000 0000 0000112357899999999999999999999999999874
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=300.25 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=200.4
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
+.|...+.||+|+||.||++.. .++..||+|.+..... .......+..|++.++.++|+|++++++++...+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3467788899999999999975 4688999999875432 2233467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+.+ +|.+.+..... .+++.++..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99974 77777654322 589999999999999999999999 9999999999999999999999999988654322
Q ss_pred CCCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 247 SSNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
....++..|+|||.+. ...++.++||||||+++|||++|+.||..... ......+.....+.....
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~---- 247 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPTLQSN---- 247 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhccCCCCCCc----
Confidence 2235788999999873 45688899999999999999999999764321 122222222222111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+++.+||+.+|.+|||+.++++|+|+..
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 11124789999999999999999999999999855
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.77 Aligned_cols=244 Identities=24% Similarity=0.399 Sum_probs=195.7
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
+.||+|+||.||++...+++.|++|.+...... .....+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 358999999999998877999999998765543 3357789999999999999999999999999999999999999999
Q ss_pred hhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc--cc
Q 042457 175 FCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--TV 252 (361)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~ 252 (361)
.+++..... .+++..+..++.+++.+++|||++ +++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 80 ~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 80 LTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999876432 578999999999999999999999 99999999999999999999999999987654222111 11
Q ss_pred ccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 253 VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
...+..|+|||.+.+..++.++|+||||+++|||+| |..||...... . ...........+... .....+.+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~-~~~~~~~~~~~~~~~----~~~~~~~~ 226 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---Q-TRERIESGYRMPAPQ----LCPEEIYR 226 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---H-HHHHHhcCCCCCCCc----cCCHHHHH
Confidence 223567999999988889999999999999999999 88887654321 1 111111111111110 11235889
Q ss_pred HHhhhcCCCCCCCCCcccccc
Q 042457 332 IAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 332 li~~cl~~dP~~RPs~~eil~ 352 (361)
++.+||+.+|.+|||+.|+++
T Consensus 227 li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 227 LMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=308.06 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=196.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------ 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 160 (361)
..+|...+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999975 46899999998754333333456789999999999999999999987542
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++|+||+.. +|..+... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46999999864 67665421 478999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc---------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD--------- 310 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------- 310 (361)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+..
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHH
Confidence 754321 223457888999998765 468889999999999999999999997543211 0110000
Q ss_pred --------------ccCCCCCCChhh--HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 311 --------------QRAPSPIDDQTV--IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 311 --------------~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+...... ......+.+++.+||+.||++|||+.+++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 000000000000 001124779999999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=306.32 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=201.2
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeC--------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLP--------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYG 154 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 154 (361)
+++...+|.+.+.||+|+||.||++... .+..||+|.+...... ...+.+..|+.+++++ +|+||+++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-HHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 3445567899999999999999999642 1236899988754332 3357788999999999 7999999999
Q ss_pred EEeeCCeEEEEEEeccCCChhhhhccCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCC
Q 042457 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDD-------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISS 221 (361)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~ 221 (361)
+|...+..++++||+++|+|.+++.... ....+++.++..++.|++.||+|||+. +++|+||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp 162 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA 162 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence 9999999999999999999999987532 123588999999999999999999999 999999999
Q ss_pred CCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCccc
Q 042457 222 NNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSS 298 (361)
Q Consensus 222 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~ 298 (361)
+||++++++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999765432211 111224567999999999889999999999999999998 8888764332
Q ss_pred CCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 299 FNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
......+...... .... .....+.+++.+||+.+|++|||+.|++++
T Consensus 243 ---~~~~~~~~~~~~~-~~~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 ---EELFKLLKEGHRM-DKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ---HHHHHHHHcCCCC-CCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 1122222222111 1111 111247899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.83 Aligned_cols=262 Identities=23% Similarity=0.275 Sum_probs=212.6
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchH-HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETEL-AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
+..+.|+.-+.||+|+||.||-++. .+|+.+|.|.+....... ......+.|-.+|.+++.+.||.+--.+...+.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3456788889999999999999955 479999999886543211 11245678999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+|+..|.||+|.-+|.+.+. ..+++..++.++.+|+.||.+||.+ +||.|||||+|||+|+.|+++|+|+|+|..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999987664 3589999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH-hhhhcccCCCCCCChhh
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML-IDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 322 (361)
........ .+||.+|||||++.++.|+...|.||+||++|||+.|+.||.....-.....+ ..+.......+..
T Consensus 338 ~~g~~~~~-rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~k---- 412 (591)
T KOG0986|consen 338 PEGKPIRG-RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDK---- 412 (591)
T ss_pred CCCCcccc-ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccc----
Confidence 65544333 37999999999999999999999999999999999999999765543333222 2222221111111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
-.....++....|++||++|. .++++-+||||+.
T Consensus 413 --FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 413 --FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred --cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 112467778889999999997 5568999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.16 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=198.5
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEEEEe
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
|.+.+.||+|++|+||+|... +++.|++|++........ .....+|+..+++++ |+|++++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567788999999999999875 578899999875543221 233457899999998 99999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+ +++|.+++..... ..+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 80 M-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred C-CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 9 8899888876542 2589999999999999999999999 999999999999999999999999999976643222
Q ss_pred Cccccccccccccccccc-ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc----------------
Q 042457 249 NRTVVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ---------------- 311 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------- 311 (361)
.....++..|+|||.+. +..++.++|+||||+++|||++|+.||......+...........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 22345788899999875 455789999999999999999999998654321111100000000
Q ss_pred --cCCCCCCC--h-hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 312 --RAPSPIDD--Q-TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 312 --~~~~~~~~--~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..+..... . ........+.+++.+||+.||++|||++|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00000000 0 000112358899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.83 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=202.3
Q ss_pred CCCCcCeeeecCceeEEEEEe----CCCCEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL----PSGKIVALKKLHHSET--ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
+|.+.+.||+|++|.||++.. .+++.||||.++.... .....+.+..|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999864 3578899999875422 122345678999999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987543 588999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCC-cccccccccccccccccccc--cCccchhhhHHHHHHHHHhCCCCCCCcccCCc-chhHhhhhcccCCCCCC
Q 042457 243 LHSDSSN-RTVVAGTHGYIAPELAYTMV--VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP-KIMLIDLLDQRAPSPID 318 (361)
Q Consensus 243 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 318 (361)
....... .....++..|+|||.+.+.. .+.++||||||+++|||++|..||........ ............+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT 234 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcc
Confidence 5433221 22345788999999987655 78899999999999999999999864322111 11112222222222211
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCc---cccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTM---RRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~---~eil~hp~~~~ 358 (361)
. ...+.+++.+||+.||++|||+ .++++||||+.
T Consensus 235 ~------~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 235 M------SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred c------CHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 1 1247889999999999999995 56699999976
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=297.29 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=198.6
Q ss_pred CCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 91 FDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
|...+.||+|+||.||+|.. .+|+.|++|.+..... .......+..|+++++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567799999999999975 4688999999865432 223346788899999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+. +++.+++..... .+++.++..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 577777654332 589999999999999999999999 999999999999999999999999998864321
Q ss_pred Cccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 249 NRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.....++..|+|||.+. ...++.++||||||+++|||++|..||..... ............+...... .
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~----~ 245 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTLQSNE----W 245 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCccc----c
Confidence 22345788999999874 45678899999999999999999999765432 1111222222111111100 1
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...+.+++.+||+.+|.+||++.+++.||||+..
T Consensus 246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 1247889999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.31 Aligned_cols=243 Identities=26% Similarity=0.433 Sum_probs=188.8
Q ss_pred eeeecCceeEEEEEeCC-CC--EEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 96 CIGTGGYGSVYRAQLPS-GK--IVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
.||+|+||.||+|...+ +. .+++|.+..... ....+.+..|+++++++ +||||+++++++...+..+++|||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999997753 43 468888874332 22246788999999999 799999999999999999999999999
Q ss_pred CChhhhhccCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 172 GSLFCVLRNDD-------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 172 g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
++|.+++.... ....+++.++..++.|++.|++|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 122478999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSP 316 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 316 (361)
++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||..... .......... ....+
T Consensus 158 l~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 233 (270)
T cd05047 158 LSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQGYRLEKP 233 (270)
T ss_pred Cccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhCCCCCCCC
Confidence 985322111 1111223567999999988889999999999999999997 9999864332 1111112111 11111
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.. ....+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~------~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 234 LN------CDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred Cc------CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 11 1124789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=284.65 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=209.9
Q ss_pred HhcCCCCc-CeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEee----C
Q 042457 87 ATEDFDIK-YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLH----K 159 (361)
Q Consensus 87 ~~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~ 159 (361)
.+++|.+. ++||-|-.|.|-.+.. .+|+.+|+|++.... ...+|+++--.. .|||||.++++|.+ .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 35566665 4699999999999854 478999999997543 344677765444 79999999998875 3
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCCeEEee
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVAD 236 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~D 236 (361)
..+.+|||.|+||.|++.+++.+. ..+++.++-.|+.||+.|+.|||+. +|.||||||+|+|... |..+||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 578899999999999999987653 3699999999999999999999999 9999999999999954 45689999
Q ss_pred ecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC-CcchhHhhhhcccCCC
Q 042457 237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF-NPKIMLIDLLDQRAPS 315 (361)
Q Consensus 237 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~ 315 (361)
||+++.... .......+-|+.|.|||++...+|+...|+||+||+||-|++|.+||-..... -...+..++..+....
T Consensus 208 fGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 208 FGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 999986543 34455667899999999999999999999999999999999999998654432 2334556666666665
Q ss_pred CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 316 PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
|....... .+...++|+.+|..+|.+|.|++|+++|||+.+.
T Consensus 287 P~pEWs~V--Se~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 287 PEPEWSCV--SEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CChhHhHH--HHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 55433222 2347789999999999999999999999999874
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.81 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=187.9
Q ss_pred CeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-CCeEEEEEEec
Q 042457 95 YCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYM 169 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 169 (361)
+.||+|+||.||+|... ++..||+|.+..... ....+.+..|+.+++.++|||++++++++.. ++..++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 35899999999999753 245799998864332 2235678899999999999999999998764 55689999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC-
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS- 248 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~- 248 (361)
.+++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999975432 467788899999999999999999 999999999999999999999999999876533211
Q ss_pred ---CcccccccccccccccccccccCccchhhhHHHHHHHHHhC-CCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 249 ---NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMG-RHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 249 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
......++..|+|||.+.+..++.++||||||+++|||++| ..||..... ................. .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-~---- 226 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGRRLLQPE-Y---- 226 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCCCCCCCC-c----
Confidence 11123356789999998888899999999999999999995 566653322 11222222222111111 0
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
....+.+++.+||+.+|++||++.++++.
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11248899999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=299.08 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=199.7
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCc-chHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
+.|...+.||+|+||.||+|... +++.+|+|.+.... ........+.+|+++++.++|+|++++++++...+..++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999754 67889999886432 22233467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+. |++.+.+..... .+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 577777654332 578999999999999999999999 9999999999999999999999999998765332
Q ss_pred CCCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 247 SSNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
....++..|+|||.+. ...++.++||||||+++|+|++|+.||..... ............+.....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~---- 237 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPALQSG---- 237 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH---HHHHHHHhhcCCCCcCcc----
Confidence 2235788999999874 35678899999999999999999999764332 111222222222111110
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.....+.+++.+||+.+|++||++.++++|||+...
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 112247889999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=294.46 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=197.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
..+|++.+.||+|+||.||+|... +|. .+|+|.+..... ......+.+|+..+++++|+|++++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 456888899999999999999764 233 589998876544 2335678899999999999999999999987 778
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999976543 489999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCCCcc--cccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCC
Q 042457 243 LHSDSSNRT--VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPID 318 (361)
Q Consensus 243 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 318 (361)
......... ...++..|+|||.+....++.++|+||||+++||+++ |+.||..... ......+.... .+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLLEKGERLPQPPI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhCCCCCCCCCC
Confidence 643322111 1223568999999888889999999999999999999 9999875432 11122222221 111211
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.. ..+.+++.+||..||++|||+.++++
T Consensus 236 ~~------~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CT------IDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CC------HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11 24778899999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.91 Aligned_cols=235 Identities=26% Similarity=0.410 Sum_probs=186.8
Q ss_pred CeeeecCceeEEEEEeCCCC-----------EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 95 YCIGTGGYGSVYRAQLPSGK-----------IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 35899999999999775432 5788877654432 4778899999999999999999999988 7789
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-------CeEEee
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-------EAFVAD 236 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-------~~kl~D 236 (361)
+|+||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|
T Consensus 77 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999999976543 588999999999999999999999 999999999999999887 799999
Q ss_pred ecCccccCCCCCCccccccccccccccccccc--ccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC
Q 042457 237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTM--VVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 237 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
||++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+........ . ... ....
T Consensus 152 fg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~--~~~-~~~~ 223 (259)
T cd05037 152 PGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-E--RFY-QDQH 223 (259)
T ss_pred CCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-H--HHH-hcCC
Confidence 999876543 2223466789999998776 78999999999999999999 5777765432111 1 111 1111
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+.... ..+.+++.+||+.+|.+|||+.++++
T Consensus 224 ~~~~~~~------~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RLPMPDC------AELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCc------hHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111111 35889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=308.62 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=201.7
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe----
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC---- 161 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 161 (361)
..++|.+.+.||+|++|.||+|... +++.||+|++............+.+|+.+++.++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999765 57899999987654333334667789999999999999999998876554
Q ss_pred --EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 162 --MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 162 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
.++|+||+ +++|.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 67999888753 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC-----
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA----- 313 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 313 (361)
+...... .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||....... ....+.+...
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~ 238 (343)
T cd07851 165 ARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHH
Confidence 9765432 223457888999998765 467889999999999999999999986433211 1111111000
Q ss_pred ------------------CCCCCC--hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 314 ------------------PSPIDD--QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 314 ------------------~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...... .........+.+++.+||+.||++|||+.++++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 000000 000001235889999999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=292.56 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=198.7
Q ss_pred CCCCcCeeeecCceeEEEEEeCC--CCEEEEEEeccCc--------chHHHHHHHHHHHHHHhc-CCCCcceeeeEEEee
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLPS--GKIVALKKLHHSE--------TELAFLESFQTEARLLSQ-IRHRNIVKLYGFCLH 158 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 158 (361)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... ........+..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999998754 6889999875432 122334567788888875 799999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCCCeEEee
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKLEAFVAD 236 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~D 236 (361)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887542 122368999999999999999999996 5 899999999999999999999999
Q ss_pred ecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCC
Q 042457 237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316 (361)
Q Consensus 237 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 316 (361)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ......+.......
T Consensus 158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~- 232 (269)
T cd08528 158 FGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEAVYEP- 232 (269)
T ss_pred ccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHHhhccCCc-
Confidence 99998654433 33345588899999999988899999999999999999999999864322 11122222222211
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.... .....+.+++.+||+.||++|||+.|+.++
T Consensus 233 ~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 LPEG---MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCcc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 1110 011248889999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.23 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=201.3
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-CCeE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCM 162 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 162 (361)
...+++|++.+.||.|+||.||++.. .+|+.||+|++..........+.+..|+++++.++|||++++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678899999999999999999964 478999999886543332334677889999999999999999999876 4578
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++++||+ +++|.+++... .+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 56888887643 478888889999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc-----------
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD----------- 310 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~----------- 310 (361)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.............+...
T Consensus 158 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 158 QDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred cCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 4321 222356788999998765 5689999999999999999999999865432110000000000
Q ss_pred ---------c-cCCCCCCChhhH-HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 311 ---------Q-RAPSPIDDQTVI-QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 311 ---------~-~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. ....+....... .....+.+++.+||+.+|++|||+.+++.||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 0 000000000000 01235889999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=314.76 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=208.0
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC--CCC--EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP--SGK--IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
.+..+...+.++||+|.||.|++|.|. +|+ .||||.++...... ...+|++|+.+|.+++|+|++++||+..+ .
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 344555667788999999999999775 344 68999998766543 46899999999999999999999999988 5
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
...+|+|.++.|+|.+.|++ .....|-......++.|||.||.||..+ ++|||||..+|+|+.....+||+|||+.
T Consensus 184 p~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred hhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccce
Confidence 68899999999999999998 3344688889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccc---cccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCC
Q 042457 241 RLLHSDSSNRTVV---AGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSP 316 (361)
Q Consensus 241 ~~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 316 (361)
+.+.......... .-...|+|||.+....++.++|||+|||++|||+| |..||......+.... .+ -.++++.+
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~-iD-~~erLpRP 337 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN-ID-AGERLPRP 337 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh-cc-ccccCCCC
Confidence 9886544333211 12457999999999999999999999999999999 8999876554221111 11 23344444
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp 354 (361)
..... .++++++.||..+|.+|||+..|.+.-
T Consensus 338 k~cse------dIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 338 KYCSE------DIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCChH------HHHHHHHHhccCCccccccHHHHHHhH
Confidence 44332 489999999999999999999986443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=305.61 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=217.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
....|.+...||+|.|+.|.+|+. .+|..||||.+.....+......+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346688999999999999999965 4689999999988877666667789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+.+|.+++++.+.+ .........++.|+..+++|||++ .|+|||||++|+||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence 99999999999999877 455588899999999999999999 99999999999999999999999999998876
Q ss_pred CCCCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
........+|++.|.|||++.+..+ .+++|+||+|+++|-|+.|..||++..- .......+.+....+.....
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---k~Lr~rvl~gk~rIp~~ms~--- 280 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---KELRPRVLRGKYRIPFYMSC--- 280 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---ccccchheeeeecccceeec---
Confidence 3344556789999999999998765 5799999999999999999999985432 22223334444333333222
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+++++++-.+|.+|++++++..|.|...
T Consensus 281 ---dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 281 ---DCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred ---hhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 2667888999999999999999999999864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.06 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=198.7
Q ss_pred CCCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCc---chHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSE---TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+|.+.+.||+|+||.||++.... +..+++|.++... ........+..|+.+++.++|||++++++++...+..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999996643 4445566554321 1222234566789999999999999999999999999999
Q ss_pred EEeccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 166 YKYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
+||+++++|.+++... .....+++..++.++.|++.|+.|||+. +++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 1223689999999999999999999999 9999999999999976 569999999987764
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
..........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ............+.. . ..
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~----~~ 228 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPSL-P----ET 228 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHcCCCCCC-c----ch
Confidence 443333345578899999998888889999999999999999999999864321 112222222222111 1 11
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
....+.+++.+||+.+|++||++.|+++||||
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred hcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 12357889999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=280.23 Aligned_cols=255 Identities=20% Similarity=0.330 Sum_probs=201.0
Q ss_pred CCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEec
Q 042457 92 DIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 92 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
+....||+|+.|.|++.+.. +|...|||.+.......+ .+.++..++++..- ++|.||+.+|+|..+..+++-||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 33455999999999999765 589999999987766543 46677777777665 4899999999999999999999988
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
...++.+++.... ++++.-+-++...++.||.||-+++ +|+|||+||+|||+|+.|++|++|||++..+.... .
T Consensus 174 -s~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-A 247 (391)
T KOG0983|consen 174 -STCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-A 247 (391)
T ss_pred -HHHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-c
Confidence 4456666655433 5778778899999999999999886 99999999999999999999999999997765433 3
Q ss_pred ccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 250 RTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.+...|.+.|||||.+. ...|+.++||||||+.++||.||+.||..-.. .-..+..+++..++.........
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln~ePP~L~~~~gFS--- 322 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLNEEPPLLPGHMGFS--- 322 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHhcCCCCCCcccCcC---
Confidence 33446889999999875 34688899999999999999999999875332 12234445554443222222111
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++..||.+|+.+||...++|+|||++.
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 13788999999999999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=293.55 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=197.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
..++|.+.+.||+|+||.||+|...+ ...|++|....... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 34568888999999999999997643 24689998875543 2334678899999999999999999999875 457
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++++|.+++..... .+++..++.++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 899999999999999976432 589999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCCC
Q 042457 243 LHSDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDD 319 (361)
Q Consensus 243 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 319 (361)
....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+... ..+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 233 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENGERLPMPPNC 233 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCcCCCCCCC
Confidence 5443221 122234567999999888889999999999999999996 99998754432 111222221 11111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
...+.+++.+|+..+|++|||+.++++.
T Consensus 234 ------~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 234 ------PPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ------CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1258889999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.96 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=201.0
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC----
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK---- 160 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 160 (361)
...++|.+.+.||+|+||.||++.. .+|..||||++............+..|+.+++.++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999964 47899999998654433333466889999999999999999999987653
Q ss_pred --eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 161 --CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 161 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
..++||||+ +++|.+++... .+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 77898887643 589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc-----
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR----- 312 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 312 (361)
++...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|+.||....... ....+....
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD---QLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 98765332 223356889999998865 457889999999999999999999987543211 000000000
Q ss_pred -----------------CCCCCCChh-h--HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 313 -----------------APSPIDDQT-V--IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 313 -----------------~~~~~~~~~-~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+....... . ......+.+++.+|++.||++|||+.++++||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 000000000 0 001124779999999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=291.10 Aligned_cols=244 Identities=25% Similarity=0.425 Sum_probs=195.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
++|.+.+.||+|+||.||++.. +++.||+|....... .+.+.+|+.++++++|+|++++++++.... .+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT----AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch----HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEEC
Confidence 4588899999999999999986 778899999865432 356889999999999999999999987654 7999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 80 MSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999976432 2578999999999999999999999 99999999999999999999999999987543221
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...... .....+.......+.. ....
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-----~~~~ 224 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECVEKGYRMEPPE-----GCPA 224 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhCCCCCCCCC-----cCCH
Confidence 11234567999999988889999999999999999998 99998654321 1112222221111111 1123
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+.+++.+||+.+|++|||++++++.
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 57899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=286.65 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=199.3
Q ss_pred CCCcCeeeecCceeEEEEEeCC-----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPS-----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+.+.+.||.|+||.||++...+ +..||+|.+....... ..+.+..|+..++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567889999999999997754 4789999997654432 357888999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++...... .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 80 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999999764421 289999999999999999999999 999999999999999999999999999976654
Q ss_pred CCCCcc-cccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 246 DSSNRT-VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 246 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
...... ...++..|+|||.+.+..++.++||||+|+++++|++ |+.||..... ................. .
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-~--- 228 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGYRLPKPE-N--- 228 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCCCCCC-c---
Confidence 322211 2236789999999888889999999999999999998 8888765322 22222222222211111 1
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||+.||++|||+.|+++
T Consensus 229 -~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 229 -CPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -CCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 1224888999999999999999999876
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=293.47 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=200.1
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--CCe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--KKC 161 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~ 161 (361)
+.|.+.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+..|++.++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 45777889999999999999753 3678999999866554 345789999999999999999999999987 557
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+++|||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 8999999999999999976543 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc---ccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCc-----------chhHhh
Q 042457 242 LLHSDSSNR---TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP-----------KIMLID 307 (361)
Q Consensus 242 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-----------~~~~~~ 307 (361)
......... ....++..|+|||...+..++.++||||||+++|||++|+.|+........ ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322211 112345679999999888899999999999999999999999754322110 011112
Q ss_pred hhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 308 LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
........+... .....+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLPRPP----SCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCCCCc----cCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222211111111 11235889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=290.67 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=202.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
.++|+....||+|+||.||+|+.. +.+.|++|.+...... ...+.+..|++++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 367888999999999999999753 3467999988654432 235778999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCcc------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEe
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEA------IQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVA 235 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~ 235 (361)
.++||||+++++|.+++...... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 99999999999999999765422 2589999999999999999999999 99999999999999999999999
Q ss_pred eecCccccCCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC
Q 042457 236 DFGVARLLHSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 236 Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~~~~~ 236 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQAGKL 236 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHHcCCc
Confidence 9999865432221 2223346778999999888888999999999999999999 8888864332 122222222222
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.... ....+.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~~~~----~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 ELPVPEG----CPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 2111111 11258899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=289.41 Aligned_cols=246 Identities=20% Similarity=0.295 Sum_probs=183.2
Q ss_pred eeeecCceeEEEEEeCCC---CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 96 CIGTGGYGSVYRAQLPSG---KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
.||+|+||.||+|...++ ..+++|.+...... ...+.+.+|+..++.++||||+++++.|......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999965443 34667776654332 23478899999999999999999999999999999999999999
Q ss_pred ChhhhhccCCc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC--CC
Q 042457 173 SLFCVLRNDDE-AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SN 249 (361)
Q Consensus 173 ~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 249 (361)
+|.+++..... ....++..+..++.|++.||+|||+. +++|+||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 22467777889999999999999999 99999999999999999999999999976432211 11
Q ss_pred cccccccccccccccccc-------cccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCC---CCCC
Q 042457 250 RTVVAGTHGYIAPELAYT-------MVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAP---SPID 318 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 318 (361)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... .........+... .+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhcccccCCCcc
Confidence 223457889999998743 245789999999999999997 5778764332 1111222111111 1111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
... ....+.+++..|| .+|++|||++++++
T Consensus 235 ~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 235 ELP---YSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCC---CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 101 1124677888999 67999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=304.42 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=195.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------- 159 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------- 159 (361)
..+|.+.+.||.|+||.||+|.. .+|+.||+|.+...... ..+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~--~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc--hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 36788999999999999999965 46889999998765442 246788999999999999999999776543
Q ss_pred -------CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-CCC
Q 042457 160 -------KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-KLE 231 (361)
Q Consensus 160 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~ 231 (361)
...++++||++ ++|.+++... .+++..++.++.|++.||.|||+. +++|+||||+||+++. ++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 35789999997 5888887543 488999999999999999999999 9999999999999974 567
Q ss_pred eEEeeecCccccCCCCCC---cccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh-
Q 042457 232 AFVADFGVARLLHSDSSN---RTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI- 306 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~- 306 (361)
++|+|||++......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 899999998765332111 122346888999997654 567889999999999999999999996443211000000
Q ss_pred ------------------hhhcccCCCCCCChh--hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 307 ------------------DLLDQRAPSPIDDQT--VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 307 ------------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
............... .......+.+++.+||+.||.+|||+.|+++||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000000000000000 0011134778999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=296.68 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=195.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|+..+.||+|+||.||+|... +|. .||+|.+....... ....+.+|+.+++.++||||++++|+|... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-ANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH-HHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 456778889999999999999753 443 57899887554322 235688999999999999999999999764 46
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++++||+++|+|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 799999999999999876432 478899999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 243 LHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 243 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ............+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~~~~ 234 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR----EIPDLLEKGERLPQPP 234 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHCCCCCCCCC
Confidence 6433221 222335678999999988889999999999999999998 89998653321 1122222211111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
. ....+.+++.+||..+|++||++.++++.
T Consensus 235 ~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 235 I----CTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred C----CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 11247889999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=299.75 Aligned_cols=261 Identities=22% Similarity=0.319 Sum_probs=195.8
Q ss_pred CCCCcCeeeecCceeEEEEEeC-C--CCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeC----Ce
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-S--GKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHK----KC 161 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~ 161 (361)
+|.+.+.||+|+||.||++... + +..||+|.+..........+.+.+|+.+++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999764 3 77899999875433323346678899999999 599999999976543 45
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++++||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899885 68888886544 589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCC----Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCc------------chh
Q 042457 242 LLHSDSS----NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP------------KIM 304 (361)
Q Consensus 242 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------------~~~ 304 (361)
....... ......|+..|+|||.+.+ ..++.++|+||+|+++|++++|+.||........ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543221 1223458889999998765 4688999999999999999999999875432100 000
Q ss_pred Hhhhhc--------ccCCCC-CC-ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 305 LIDLLD--------QRAPSP-ID-DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 305 ~~~~~~--------~~~~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
...... .....+ .. ..........+.+++.+||+.||.+|||+.|+++|||++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 000000 000000 00 000000123588999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=283.85 Aligned_cols=268 Identities=24% Similarity=0.322 Sum_probs=202.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC---C--CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-CCe
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP---S--GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 161 (361)
-..|+....||+|.||.||++.-. + ...+|+|+++........-....+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346888999999999999999432 2 2379999998775433333556789999999999999999999887 778
Q ss_pred EEEEEEeccCCChhhhhccCC--ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC----CCeEEe
Q 042457 162 MFLIYKYMRRGSLFCVLRNDD--EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK----LEAFVA 235 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~----~~~kl~ 235 (361)
+++++||.+. +|...++..+ ....++......|+.||+.|+.|||++ -+.||||||.||||..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999976 8888876432 234688889999999999999999999 89999999999999887 999999
Q ss_pred eecCccccCCCCC---Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCccc-------C--Ccc
Q 042457 236 DFGVARLLHSDSS---NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSS-------F--NPK 302 (361)
Q Consensus 236 Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-------~--~~~ 302 (361)
|+|+++.+...-. .....+-|..|.|||.+.+. .|+.+.|||+.|||+.||+|-.+-|..... + +.-
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999998865432 22345679999999988864 689999999999999999999888754321 0 000
Q ss_pred hhHhhhhcccCCC--------CC------------CChh-hHH-------HHHHHHHHHhhhcCCCCCCCCCccccccCC
Q 042457 303 IMLIDLLDQRAPS--------PI------------DDQT-VIQ-------DIILVSKIAFACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 303 ~~~~~~~~~~~~~--------~~------------~~~~-~~~-------~~~~l~~li~~cl~~dP~~RPs~~eil~hp 354 (361)
....+++...... |. .+.. ... ......+|+.++|.+||.+|.|++|.++|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 0111111110000 00 0000 000 001266889999999999999999999999
Q ss_pred CCCCC
Q 042457 355 EINPS 359 (361)
Q Consensus 355 ~~~~~ 359 (361)
||.+.
T Consensus 339 yF~~d 343 (438)
T KOG0666|consen 339 YFTED 343 (438)
T ss_pred ccccC
Confidence 99875
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=290.07 Aligned_cols=237 Identities=22% Similarity=0.421 Sum_probs=185.9
Q ss_pred eeeecCceeEEEEEeCC--------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 96 CIGTGGYGSVYRAQLPS--------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.||+|+||.||+|.... ...+++|.+..... ...+.+..|+.+++.++|||++++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR--NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhH--HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 58999999999996532 23488888754332 234678899999999999999999999999899999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC--------eEEeeecC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE--------AFVADFGV 239 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~--------~kl~Dfg~ 239 (361)
|+++|+|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++. ++++|||+
T Consensus 80 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 80 YVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred cCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999976543 578999999999999999999999 9999999999999987765 58999998
Q ss_pred ccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCC-CCCCCcccCCcchhHhhhhcccCCCCC
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGR-HPGDLLSSFNPKIMLIDLLDQRAPSPI 317 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (361)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+....... ...........+.
T Consensus 155 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (258)
T cd05078 155 SITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK----KLQFYEDRHQLPA 226 (258)
T ss_pred ccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----HHHHHHccccCCC
Confidence 865432 222457788999999876 45789999999999999999984 5654332211 1112222222221
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
... ..+.+++.+||+.||++|||++++++.
T Consensus 227 ~~~------~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 227 PKW------TELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCc------HHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 111 247899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=289.27 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=194.7
Q ss_pred CCCcCeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------ 160 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 160 (361)
|.+.+.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999653 3688999999776544444677889999999999999999999887542
Q ss_pred eEEEEEEeccCCChhhhhccCC---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDD---EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
..++++||+++|+|.+++.... ....+++...+.++.|++.||+|||+. +++|+||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999988874321 223578899999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-C
Q 042457 238 GVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-A 313 (361)
Q Consensus 238 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~ 313 (361)
|+++........ .....++..|++||.+.+..++.++||||||+++|||++ |+.||..... ......+.... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~ 234 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIKGNRL 234 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCCcC
Confidence 998865432211 112234578999999988888999999999999999999 8888764332 11111111111 1
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.. ....+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~------~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 KQPPD------CLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11111 12258899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=291.12 Aligned_cols=245 Identities=28% Similarity=0.419 Sum_probs=191.8
Q ss_pred CeeeecCceeEEEEEeCC-------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 95 YCIGTGGYGSVYRAQLPS-------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
+.||+|+||.||+|+..+ +..+|+|.+...... .....+.+|+.+++.++||||+++++++...+..+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD-QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch-hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 358999999999997642 257999988654322 224678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCC----ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-----CeEEeeec
Q 042457 168 YMRRGSLFCVLRNDD----EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-----EAFVADFG 238 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-----~~kl~Dfg 238 (361)
|+++++|.+++.... ....+++.+++.++.|++.||.|||+. +++|+||+|+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 999999999987532 122478999999999999999999998 999999999999999877 89999999
Q ss_pred CccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CC
Q 042457 239 VARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-AP 314 (361)
Q Consensus 239 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~ 314 (361)
++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~~~~~ 233 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVTAGGRLQ 233 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHhcCCccC
Confidence 98765332211 112235678999999998899999999999999999998 99998643321 1111111111 11
Q ss_pred CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.+.. ....+.+++.+||+.+|.+|||++++++
T Consensus 234 ~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 234 KPEN------CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred Cccc------chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1111 1235789999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=281.46 Aligned_cols=257 Identities=24% Similarity=0.317 Sum_probs=215.7
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
.-++|+..+.||+|.||.|-+++- .+|+.+|+|+++.... ..+.......|-++|+..+||.+..+--.++..+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 346788999999999999999954 4799999999986542 23335677889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||..||.|.-+|.... .+++...+.+-..|+.||.|||++ +|+.||||.+|.|+|.+|.+||+|||+++.--
T Consensus 246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999998765 688889999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.........+||+.|+|||++....|..+.|.|.+|++||||++|+.||...+. +....-++......|.....
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~kFPr~ls~--- 393 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDLKFPRTLSP--- 393 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhccCCccCCH---
Confidence 666667788999999999999999999999999999999999999999875432 22222233333333333222
Q ss_pred HHHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
+...|+...|.+||.+|. .++||.+|+||..
T Consensus 394 ---eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 394 ---EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred ---HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 256677789999999998 6889999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=284.15 Aligned_cols=260 Identities=20% Similarity=0.332 Sum_probs=212.3
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 154 (361)
..++.+...+++....+.+|.||.||.|.| ++.+.|.+|.++....+.+ ...+..|..++..+.|||+.++.+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQ-v~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQ-VNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHH-HHHHHHHHHHHhcCcCCCccceeE
Confidence 456777888899999999999999999944 3456688898887665443 678899999999999999999999
Q ss_pred EEeeC-CeEEEEEEeccCCChhhhhc-----cCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC
Q 042457 155 FCLHK-KCMFLIYKYMRRGSLFCVLR-----NDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228 (361)
Q Consensus 155 ~~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~ 228 (361)
++.++ ...++++.++.-|+|..+|. +......++..+...++.|++.|++|||.+ +++|.||..+|+++|+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 99875 46899999999999999998 444455788899999999999999999999 9999999999999999
Q ss_pred CCCeEEeeecCccccCCCCCCc--ccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhH
Q 042457 229 KLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIML 305 (361)
Q Consensus 229 ~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 305 (361)
..++||+|=.+++.+.....+. ........||+||.+.+..|+.++||||||++||||+| |+.|+.+.++++....+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 9999999999999876544332 11224568999999999999999999999999999999 99998776654433333
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.+-. +...|... +.++..++.-||+.+|++||+++|+..
T Consensus 512 kdGy--RlaQP~NC------PDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 512 KDGY--RLAQPFNC------PDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred hccc--eecCCCCC------cHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 2221 22333332 235888888999999999999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.73 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=197.7
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee---------
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--------- 158 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------- 158 (361)
.+|+....||+||||.||+++.+ ||+.+|||++.... +......+.+|+..+++++|||||+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 46777888999999999999654 89999999998776 44456778899999999999999999821100
Q ss_pred --------------------------------------------------------------------------------
Q 042457 159 -------------------------------------------------------------------------------- 158 (361)
Q Consensus 159 -------------------------------------------------------------------------------- 158 (361)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred C------------------------------CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc
Q 042457 159 K------------------------------KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208 (361)
Q Consensus 159 ~------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~ 208 (361)
+ ..+||-||||+..+|.++++.+.... .....++++++|++||+|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 0 12578899999988888887765211 356788999999999999999
Q ss_pred CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC------------------CCCCCccccccccccccccccccc--
Q 042457 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH------------------SDSSNRTVVAGTHGYIAPELAYTM-- 268 (361)
Q Consensus 209 ~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~-- 268 (361)
. +++||||||.||++|++..+||+|||+++... .+....+..+||.-|+|||++.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998721 001123456799999999998754
Q ss_pred -ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCc
Q 042457 269 -VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM 347 (361)
Q Consensus 269 -~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 347 (361)
.|+.|+|+||+|++|+||+. ||. ...+....+.++.+...+.+.+ ........-.++|.+++++||.+|||+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~LR~g~iP~~~~--f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFG--TSMERASILTNLRKGSIPEPAD--FFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhcccCCCCCCcc--cccccchHHHHHHHHHhcCCCccCCCH
Confidence 49999999999999999984 333 1222233344455555555411 111222234688999999999999999
Q ss_pred cccccCCCCCC
Q 042457 348 RRSFPNPEINP 358 (361)
Q Consensus 348 ~eil~hp~~~~ 358 (361)
.|+|++.||-.
T Consensus 866 ~eLL~s~llpp 876 (1351)
T KOG1035|consen 866 TELLNSELLPP 876 (1351)
T ss_pred HHHhhccCCCc
Confidence 99999999863
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.14 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=208.7
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeC--------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeee
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLP--------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLY 153 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 153 (361)
.+++..++..+.+.||+|.||.|++|... ....||||.++..... ...+.+..|+++|+.+ +|+|++.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 56677777777889999999999999642 1457999999887766 4578899999999998 599999999
Q ss_pred EEEeeCCeEEEEEEeccCCChhhhhccCC-----------cc--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCC
Q 042457 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDD-----------EA--IQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDIS 220 (361)
Q Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~--~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk 220 (361)
|+|...+..++|+||+..|+|.++|+..+ .. ..++....+.++.|||.||+||++. +++||||.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence 99999999999999999999999998765 00 1388999999999999999999999 99999999
Q ss_pred CCCeeeCCCCCeEEeeecCccccCCCCCCc-cccc--ccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCc
Q 042457 221 SNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVA--GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLL 296 (361)
Q Consensus 221 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~ 296 (361)
++|||+..+..+||+|||+++......... .... -...|||||.+....++.++||||||++||||+| |..||...
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999998765443332 2222 2456999999999999999999999999999999 99998752
Q ss_pred ccCCcchhHhhhhcc-cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 297 SSFNPKIMLIDLLDQ-RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 297 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.. .......+.++ +...|.... .++.++++.||+.+|++||++.|+.+
T Consensus 526 ~~--~~~l~~~l~~G~r~~~P~~c~------~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 526 PP--TEELLEFLKEGNRMEQPEHCS------DEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred Cc--HHHHHHHHhcCCCCCCCCCCC------HHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 21 11112222232 223333322 24889999999999999999998764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=315.51 Aligned_cols=147 Identities=27% Similarity=0.443 Sum_probs=131.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||+|... +++.||+|++..... .......+..|+.++..++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999765 689999999875432 2333467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
||+.+++|.+++.... .+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997654 578899999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=256.90 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=205.0
Q ss_pred CCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|...++||+|.||+||+|+ +++++.||+|+++..+.....-....+|+-+++.++|.|||++++....++...+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556789999999999995 45689999999987776555557788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
|.. +|..+..+-++ .++......++.|+++||.++|++ ++.||||||.|.|++.+|..|++|||+++.+.-+-.
T Consensus 83 cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 955 88888776544 588899999999999999999999 999999999999999999999999999998765554
Q ss_pred Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc----CC--------
Q 042457 249 NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR----AP-------- 314 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~----~~-------- 314 (361)
......-|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|...+..++.......+... .+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 45555678999999998865 47889999999999999998 666665433222111111111110 00
Q ss_pred ---CCCCChhhHHHH-----HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 315 ---SPIDDQTVIQDI-----ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 315 ---~~~~~~~~~~~~-----~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+.......+..+ ..=.+++++.+.-+|.+|.++++.++||||.+
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 000111112111 11356778888899999999999999999976
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=302.78 Aligned_cols=266 Identities=24% Similarity=0.421 Sum_probs=220.2
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCL 157 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 157 (361)
.++.+...+..|++...||.|.+|.||+++ .++|+.+|+|++....... ++...|.++++.. +|||++.++|++.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 344555667789999999999999999995 4578999999987766543 5667889999987 6999999999987
Q ss_pred e-----CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCe
Q 042457 158 H-----KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEA 232 (361)
Q Consensus 158 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~ 232 (361)
. ++.+|||||||.+|+.-+++++.. ...+.|..+..|+..++.|+.+||.+ .++|||+|-.|||++.++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 5 467999999999999999998765 44799999999999999999999999 99999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccccccccccccc-----ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh
Q 042457 233 FVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-----VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID 307 (361)
Q Consensus 233 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 307 (361)
||.|||++..+......+....||+.|||||++... .|+..+|+||||++..||--|.+|+-+.- +-..+..
T Consensus 163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH---PmraLF~ 239 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH---PMRALFL 239 (953)
T ss_pred EEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc---hhhhhcc
Confidence 999999999988777777788899999999998643 36779999999999999999999965433 2223333
Q ss_pred hhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 308 LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+..+.++... .+..|. .++.++|..||.+|-++||++.++|+|||+++
T Consensus 240 IpRNPPPkLk-rp~kWs--~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 240 IPRNPPPKLK-RPKKWS--KKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CCCCCCcccc-chhhHH--HHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 3333332222 222332 25889999999999999999999999999984
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=278.68 Aligned_cols=228 Identities=21% Similarity=0.201 Sum_probs=182.2
Q ss_pred cCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCChhhhh
Q 042457 100 GGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVL 178 (361)
Q Consensus 100 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 178 (361)
|.+|.||++.. .+|+.+|+|++..... +..|...+....|||++++++++...+..+++|||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999965 4688999999875432 223445555567999999999999999999999999999999998
Q ss_pred ccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccccccccc
Q 042457 179 RNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258 (361)
Q Consensus 179 ~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 258 (361)
.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+....... ....++..
T Consensus 77 ~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~ 147 (237)
T cd05576 77 SKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENM 147 (237)
T ss_pred HHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCcc
Confidence 7654 489999999999999999999999 99999999999999999999999999876553321 22335677
Q ss_pred ccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcC
Q 042457 259 YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLR 338 (361)
Q Consensus 259 y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 338 (361)
|+|||...+..++.++|+||+|+++|||++|+.|+........ . ......+.. ....+.+++.+|++
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----~--~~~~~~~~~------~~~~~~~li~~~l~ 214 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----T--HTTLNIPEW------VSEEARSLLQQLLQ 214 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----c--ccccCCccc------CCHHHHHHHHHHcc
Confidence 9999998888889999999999999999999988653221000 0 000011111 11247889999999
Q ss_pred CCCCCCCCc-----cccccCCCC
Q 042457 339 SKPKSRPTM-----RRSFPNPEI 356 (361)
Q Consensus 339 ~dP~~RPs~-----~eil~hp~~ 356 (361)
.||++|||+ +++++||||
T Consensus 215 ~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 215 FNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCHHHhcCCCccchHHHHcCCCC
Confidence 999999997 899999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=327.81 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=209.1
Q ss_pred hcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
+-++.....||.|.||.||.| ..++|...|+|.++.............+|..++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 345667788999999999999 5567999999998777665555677889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|||++|+|.+.++..+ ..++.-...+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999998765 456666778899999999999999 9999999999999999999999999999887654
Q ss_pred CCC----cccccccccccccccccccc---cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC-CCCCC
Q 042457 247 SSN----RTVVAGTHGYIAPELAYTMV---VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA-PSPID 318 (361)
Q Consensus 247 ~~~----~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 318 (361)
... .....||+.|||||++.+.. ...++||||+||+..||+||+.||...+..- .....+..+.. +.|..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--aIMy~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--AIMYHVAAGHKPQIPER 1465 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--HHHhHHhccCCCCCchh
Confidence 322 23456999999999987543 5568999999999999999999998655321 11222222222 22222
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
...+-.+++..||..||++|=++.|+++|-|-+
T Consensus 1466 ------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1466 ------LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred ------hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 112356888999999999999999999998865
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=294.83 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=205.2
Q ss_pred cCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 94 KYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
.+.||+|.||+||-|.. ++|+.||||++.+-.-.......+.+|+.+|++++||.||.+...|+..+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 35699999999999955 47999999999776655444578899999999999999999999999999999999999665
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCCeEEeeecCccccCCCCCC
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
-|+-.|....+ .+++.....++.||+.||.|||.+ +|+|+||||+|||+.+ .-++||+|||+++.+.. ...
T Consensus 649 MLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-ksF 722 (888)
T KOG4236|consen 649 MLEMILSSEKG--RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-KSF 722 (888)
T ss_pred HHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch-hhh
Confidence 55555554433 688888899999999999999999 9999999999999954 35799999999998854 444
Q ss_pred cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH-HH
Q 042457 250 RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI-IL 328 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 328 (361)
+...+||+.|+|||++.++.|...-|+||.|+|+|--++|..||....+.+.. ..+..-..++. +|.++ ..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAaFMyPp~------PW~eis~~ 794 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAAFMYPPN------PWSEISPE 794 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhccccccCCC------chhhcCHH
Confidence 55678999999999999999999999999999999999999998754332211 11111111111 22222 24
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
..+||...|+..-.+|-|.++-+.|||+++..
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 67899999999999999999999999999753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=284.66 Aligned_cols=263 Identities=20% Similarity=0.300 Sum_probs=206.2
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-C-C----cceeeeEEEe
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-H-R----NIVKLYGFCL 157 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~~~~~~ 157 (361)
...+++|.+...+|+|.||.|-.+.. ..+..||||+++... ...+..+-|+++++++. + | -++.+.+++.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 34488999999999999999999954 347899999997643 33466778999999993 2 3 3788888999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---------
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS--------- 228 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--------- 228 (361)
..++.|+|+|.+ |-|+.++|..++.. +++..+++.++.|+++++++||+. +++|.||||+|||+-+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence 999999999998 66999999886644 688999999999999999999999 9999999999999832
Q ss_pred -----------CCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcc
Q 042457 229 -----------KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLS 297 (361)
Q Consensus 229 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 297 (361)
+..++++|||.++.-.. .....+.|..|.|||++.+-.++..+||||+||||+|+.||...|...+
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 34578999999975432 2355678999999999999999999999999999999999999887555
Q ss_pred cCCcchhHhhhhcccC------------------CCCCC-------------------ChhhHHHHHHHHHHHhhhcCCC
Q 042457 298 SFNPKIMLIDLLDQRA------------------PSPID-------------------DQTVIQDIILVSKIAFACLRSK 340 (361)
Q Consensus 298 ~~~~~~~~~~~~~~~~------------------~~~~~-------------------~~~~~~~~~~l~~li~~cl~~d 340 (361)
+.+.-.+...++...+ ..+.. ......+...+.+|++.||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 3221112222222110 00000 0001123456899999999999
Q ss_pred CCCCCCccccccCCCCCC
Q 042457 341 PKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 341 P~~RPs~~eil~hp~~~~ 358 (361)
|.+|+|+.|+|+||||+.
T Consensus 394 P~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 394 PARRITLREALSHPFFAR 411 (415)
T ss_pred ccccccHHHHhcCHHhhc
Confidence 999999999999999985
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=285.45 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=182.3
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHH---------HHHHHHHHHHHhcCCCCcceee
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAF---------LESFQTEARLLSQIRHRNIVKL 152 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~ 152 (361)
+..++|.+.+.||+|+||.||+|...+ +..+|+|........... ......+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345689999999999999999997654 345666654332221100 0112234445667789999999
Q ss_pred eEEEeeCC----eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC
Q 042457 153 YGFCLHKK----CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228 (361)
Q Consensus 153 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~ 228 (361)
++++.... ..+++++++. .++.+.+.... ..++..+..++.|++.||+|||+. +++||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 99776543 3467777763 35555554432 357788899999999999999999 9999999999999999
Q ss_pred CCCeEEeeecCccccCCCCC-------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCc
Q 042457 229 KLEAFVADFGVARLLHSDSS-------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP 301 (361)
Q Consensus 229 ~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 301 (361)
++.++|+|||+++....... ......||+.|+|||+..+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 99999999999976632211 11234689999999999999999999999999999999999999986533211
Q ss_pred ch------hHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 302 KI------MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 302 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.. ....+.......+ . ....+.+++..|++.+|++||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKIKIK-N------ANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhhhhhccC-C------CCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11 0111111111111 1 1234889999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=293.24 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=195.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 165 (361)
++.|.+...+|.|+|+.|-.+.. .+++..++|++.....+ ..+|+.++... +||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeee
Confidence 56788888899999999999854 57888999999776322 23566665555 799999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee-CCCCCeEEeeecCccccC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL-NSKLEAFVADFGVARLLH 244 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill-~~~~~~kl~Dfg~~~~~~ 244 (361)
||.+.++-+.+.+.... .+. ..+..|+.+|+.++.|||.+ +++||||||+|||+ ++.++++|+|||.++...
T Consensus 395 ~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999998877776554 233 67778999999999999999 99999999999999 688999999999998765
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.. ....+-|..|.|||++....+++++|+||||++||+|++|+.||...... .++........... .
T Consensus 468 ~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s~----~ 534 (612)
T KOG0603|consen 468 RS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFSE----C 534 (612)
T ss_pred hh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcccc----c
Confidence 44 23345678899999999999999999999999999999999998754432 11221111111110 1
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
......+|+.+||+.||.+||++.++..||||
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11247889999999999999999999999999
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=294.44 Aligned_cols=267 Identities=18% Similarity=0.245 Sum_probs=187.1
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-----------------CCCCEEEEEEeccCcchHH------------HHHHHHHH
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-----------------PSGKIVALKKLHHSETELA------------FLESFQTE 137 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~------------~~~~~~~e 137 (361)
..++|++.++||+|+||.||+|.. .+++.||||++........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999953 2456899999875432110 01223346
Q ss_pred HHHHhcCCCCc-----ceeeeEEEee--------CCeEEEEEEeccCCChhhhhccCCc---------------------
Q 042457 138 ARLLSQIRHRN-----IVKLYGFCLH--------KKCMFLIYKYMRRGSLFCVLRNDDE--------------------- 183 (361)
Q Consensus 138 ~~~l~~l~h~n-----iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 183 (361)
+.++.+++|.+ +++++++|.. .+..++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 67777776654 4677887764 3468999999999999998864211
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC-ccccccccccccc
Q 042457 184 AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-RTVVAGTHGYIAP 262 (361)
Q Consensus 184 ~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aP 262 (361)
...+++..+..++.|++.+|.|||+. +++||||||+|||++.++.+||+|||++......... .....+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788899999999999999999 9999999999999999999999999999765432221 1122347899999
Q ss_pred cccccccc----------------------CccchhhhHHHHHHHHHhCCC-CCCCcccCCcchh-------Hhh-hhcc
Q 042457 263 ELAYTMVV----------------------TEKCDVFGFGVVALEVLMGRH-PGDLLSSFNPKIM-------LID-LLDQ 311 (361)
Q Consensus 263 E~~~~~~~----------------------~~~~Dv~slG~~l~el~tg~~-p~~~~~~~~~~~~-------~~~-~~~~ 311 (361)
|.+..... ..+.||||+||+++||++|.. |+......+.+.. ... ....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98753221 124699999999999999875 6654322211111 000 1111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhhcCCCC---CCCCCccccccCCCCCCCC
Q 042457 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKP---KSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~hp~~~~~~ 360 (361)
...... .........+|+.+|+..+| .+|+|++|+|+||||.+++
T Consensus 460 ~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~~ 507 (507)
T PLN03224 460 KYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPEF 507 (507)
T ss_pred CCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCCC
Confidence 111111 11112247788889999766 6899999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=268.11 Aligned_cols=243 Identities=28% Similarity=0.422 Sum_probs=197.0
Q ss_pred CceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCChhhhhc
Q 042457 101 GYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR 179 (361)
Q Consensus 101 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 179 (361)
+||.||+|... +|+.+++|++........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999876 489999999976654332 4788899999999999999999999999999999999999999999987
Q ss_pred cCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcccccccccc
Q 042457 180 NDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259 (361)
Q Consensus 180 ~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 259 (361)
... .+++..+..++.+++.++.+||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 80 ~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~ 152 (244)
T smart00220 80 KRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEY 152 (244)
T ss_pred hcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCC
Confidence 654 388999999999999999999999 99999999999999999999999999998765432 22334578899
Q ss_pred cccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCC
Q 042457 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRS 339 (361)
Q Consensus 260 ~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 339 (361)
++||.+.+..++.++||||||+++|++++|..||..... ... ..+.............. .....+.+++.+|+..
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~ 227 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLE-LFKKIGKPKPPFPPPEW--KISPEAKDLIRKLLVK 227 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHH-HHHHHhccCCCCccccc--cCCHHHHHHHHHHccC
Confidence 999999888889999999999999999999999865321 111 22222222111111000 0122588899999999
Q ss_pred CCCCCCCccccccCCCC
Q 042457 340 KPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 340 dP~~RPs~~eil~hp~~ 356 (361)
+|++||++.++++||||
T Consensus 228 ~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 228 DPEKRLTAEEALQHPFF 244 (244)
T ss_pred CchhccCHHHHhhCCCC
Confidence 99999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=309.17 Aligned_cols=264 Identities=25% Similarity=0.323 Sum_probs=213.3
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
..++....++|.+.+.||+|+||.|..++.. +++.+|+|++..-..- .....-|..|-++|..-+.+-|+.+.-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455667789999999999999999999764 6889999998763321 1223678899999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
++++|+|||||+||+|..++.+.. .+++..++.++..|.-||.-||+. |+|||||||+|||+|.+|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999998776 588888899999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC-Cccccccccccccccccc----c-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc-
Q 042457 239 VARLLHSDSS-NRTVVAGTHGYIAPELAY----T-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ- 311 (361)
Q Consensus 239 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~- 311 (361)
.|-.+..+.. .....+|||.|.+||++. + +.|...+|.||+||++|||+.|..||...+-.. ....+++-
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve---TY~KIm~hk 297 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE---TYGKIMNHK 297 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH---HHHHHhchh
Confidence 9988775544 355678999999999885 3 678999999999999999999999986433211 11222222
Q ss_pred -cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC---ccccccCCCCCC
Q 042457 312 -RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT---MRRSFPNPEINP 358 (361)
Q Consensus 312 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~hp~~~~ 358 (361)
.+..|.... ......+||.+.+. +|+.|.. ++++-.||||..
T Consensus 298 ~~l~FP~~~~----VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 298 ESLSFPDETD----VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred hhcCCCcccc----cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 333331111 12235666666555 6889998 999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=300.20 Aligned_cols=264 Identities=19% Similarity=0.230 Sum_probs=173.0
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-C----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEE------
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-S----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF------ 155 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------ 155 (361)
..++|.+.+.||+|+||.||+|... + +..||+|++...... +....+ .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 5678999999999999999999764 4 689999987643321 111111 1122222222222211
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCcc-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeC
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEA-----------------IQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRD 218 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~d 218 (361)
+......++|+||+.+++|.+++...... .......+..++.|++.||.|||+. +|+|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 24556799999999999999988754210 0112334567999999999999999 999999
Q ss_pred CCCCCeeeCC-CCCeEEeeecCccccCCCC-CCccccccccccccccccccc----------------------ccCccc
Q 042457 219 ISSNNILLNS-KLEAFVADFGVARLLHSDS-SNRTVVAGTHGYIAPELAYTM----------------------VVTEKC 274 (361)
Q Consensus 219 lk~~Nill~~-~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 274 (361)
|||+|||+++ ++.+||+|||+++.+.... .......+++.|+|||.+... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999986 5789999999998654322 223345688999999965322 233467
Q ss_pred hhhhHHHHHHHHHhCCCCCCCcccC------CcchhHhhhhcccCCCCCCC-hhhH----HHHHHHHHHHhhhcCCCCCC
Q 042457 275 DVFGFGVVALEVLMGRHPGDLLSSF------NPKIMLIDLLDQRAPSPIDD-QTVI----QDIILVSKIAFACLRSKPKS 343 (361)
Q Consensus 275 Dv~slG~~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~l~~li~~cl~~dP~~ 343 (361)
|||||||+||||+++..+++..... ..............+..... .... .......+|+.+||+.||++
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999999987775421100 00000000000000000000 0000 00112458999999999999
Q ss_pred CCCccccccCCCCCCC
Q 042457 344 RPTMRRSFPNPEINPS 359 (361)
Q Consensus 344 RPs~~eil~hp~~~~~ 359 (361)
|||++|+|+||||++.
T Consensus 441 R~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 441 RISAKAALAHPYFDRE 456 (566)
T ss_pred CCCHHHHhCCcCcCCC
Confidence 9999999999999863
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=290.72 Aligned_cols=203 Identities=31% Similarity=0.479 Sum_probs=174.3
Q ss_pred CCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------eEE
Q 042457 91 FDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------CMF 163 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~ 163 (361)
+...+.||+|+||.||+|+ ..+|+.||||.+..... ....+....|++++++++|+|||++++.-.... ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3445679999999999997 56899999999876432 222467789999999999999999999766543 578
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC--CCCC--eEEeeecC
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN--SKLE--AFVADFGV 239 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~~--~kl~Dfg~ 239 (361)
++||||.+|||+..|++......+++.+.+.++.+++.||.|||++ +|+||||||.||++- ++|+ -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999999987777899999999999999999999999 999999999999983 3343 69999999
Q ss_pred ccccCCCCCCccccccccccccccccc-ccccCccchhhhHHHHHHHHHhCCCCCCCccc
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSS 298 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 298 (361)
|+.++.+. ......||..|.+||+.. ...|+...|.|||||++||+.||..||.....
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99886555 455567999999999988 48899999999999999999999999975544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=267.47 Aligned_cols=265 Identities=22% Similarity=0.329 Sum_probs=200.2
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--------C
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--------K 160 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~ 160 (361)
.|.-..++|+|.||+||+++.. +|+.||+|+....+.....-....+|+++|..++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555677999999999999654 578899987655444333345667999999999999999999988643 3
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..|+|+++|+. +|..+|.+... .++..++.+++.++..||.|+|.. .|+|||+|+.|+|++.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 58999999965 88888876543 688899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC----Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC-
Q 042457 241 RLLHSDSS----NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP- 314 (361)
Q Consensus 241 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 314 (361)
+.+..... ..+..+-|..|.+||.+.+ ..|+++.|||.-||+|.||+||.+-+........-......+....+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87654322 2233456899999998876 46899999999999999999999887654432211111111111100
Q ss_pred ----------------CCCCCh--hh-HHHH------HHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 315 ----------------SPIDDQ--TV-IQDI------ILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 315 ----------------~~~~~~--~~-~~~~------~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
+|.... .. .+.. ....+|+.+++..||.+|+++.++++|.||.+..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 000000 00 0001 1467899999999999999999999999997654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=279.30 Aligned_cols=269 Identities=25% Similarity=0.382 Sum_probs=210.4
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchH-----HHHHHHHHHHHHHhcCCCCcceeeeE
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETEL-----AFLESFQTEARLLSQIRHRNIVKLYG 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~ 154 (361)
|.+-....++|-+.+.||+|||+.||++ .+...+.||||+-....... ...+...+|.++-+.++||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3344455677888899999999999999 55678899999865544322 23345678999999999999999999
Q ss_pred EEee-CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CC
Q 042457 155 FCLH-KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KL 230 (361)
Q Consensus 155 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~ 230 (361)
++.. .+..|-|+|||+|.+|.-+|+... .+++.+++.|+.||+.||.||.+. .++|+|-||||.|||+-+ .|
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 9985 457899999999999999998776 589999999999999999999976 458999999999999944 47
Q ss_pred CeEEeeecCccccCCCCCC-------cccccccccccccccccc----cccCccchhhhHHHHHHHHHhCCCCCCCcccC
Q 042457 231 EAFVADFGVARLLHSDSSN-------RTVVAGTHGYIAPELAYT----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF 299 (361)
Q Consensus 231 ~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 299 (361)
.+||+|||+++.++.+... .....||..|++||.+.- .+.+.|.||||.|||+|+.+.|+.||......
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 8999999999998766543 223468999999998753 34788999999999999999999999753321
Q ss_pred CcchhHh-hhhc---ccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 300 NPKIMLI-DLLD---QRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 300 ~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
. ..... .++. -..+....... +...+|++||++.-++|....++..||||.++.
T Consensus 691 Q-dILqeNTIlkAtEVqFP~KPvVss------eAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 691 Q-DILQENTILKATEVQFPPKPVVSS------EAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred H-HHHhhhchhcceeccCCCCCccCH------HHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 1 11111 1111 11222112111 367889999999999999999999999998753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=299.79 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=194.4
Q ss_pred CCCcCeeeecCcee-EEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEe
Q 042457 91 FDIKYCIGTGGYGS-VYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 91 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
|.-.+.+|.|+.|+ ||+|.+ +|+.||||++-... ..-..+|+..|+.- +||||+++++.-.+....|+..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 34445689999874 899999 88999999986433 24556899999987 599999999999999999999999
Q ss_pred ccCCChhhhhccCCc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---C--CCeEEeeecCccc
Q 042457 169 MRRGSLFCVLRNDDE-AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---K--LEAFVADFGVARL 242 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~--~~~kl~Dfg~~~~ 242 (361)
| ..+|.+++..... .....-...+.++.|++.||++||+. +|+||||||.|||++. + .+++|+|||+++.
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9 5599999987411 11112144578899999999999998 9999999999999965 3 4688999999998
Q ss_pred cCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 243 LHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 243 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
+..+... .....||.+|+|||++....-+.+.||||+||++|..++ |.+||.+....+. +++.+.......
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-----NIl~~~~~L~~L 735 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-----NILTGNYTLVHL 735 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-----hhhcCccceeee
Confidence 8765433 344679999999999998888889999999999999999 5999986543322 233332221111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
.+.. +. +..+||.+|++++|..||++.+||.||+|=
T Consensus 736 ~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 736 EPLP-DC--EAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 0000 11 478899999999999999999999999993
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=269.00 Aligned_cols=260 Identities=25% Similarity=0.318 Sum_probs=202.3
Q ss_pred CCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEec
Q 042457 92 DIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 92 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
+....||.|+||+|+|-.+ +.|+..|||+++....+.+ ..+++.|.+...+- +.||||+++|.+..++..|+-||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3345599999999999955 4799999999988776444 46677787765554 7899999999999999999999999
Q ss_pred cCCChhhhhccC--CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 170 RRGSLFCVLRND--DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 170 ~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
. .||..+...- -....+++.-.-.|......||.||-... .|+|||+||+|||+|..|.+||+|||++..+.. .
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-S 221 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-S 221 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH-H
Confidence 4 4665443221 11225778778888889999999999876 899999999999999999999999999976643 2
Q ss_pred CCccccccccccccccccc--ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 248 SNRTVVAGTHGYIAPELAY--TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
...+...|...|||||.+. +..|+.+|||||||++|+|+.||..|+..... .-..+..+..+.++.........+.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCccccccc
Confidence 2334456888999999875 33488999999999999999999999875443 2233444555555544333333334
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+..++.-|+-+|-++||+..+++++||++.
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 456889999999999999999999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=273.72 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=213.3
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
+-..+|.+...||+|+||.|.++..+ +.+.+|||+++.... +.+..+--+.|-++|... +-|.++++..+++..+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34456888999999999999999654 567899999987542 222345556677777766 578899999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
|.||||+.||+|--+++.-+ .+.+..+..++..||-||-+||++ +|+.||||..|||+|.+|.+||+|||+++.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999998888765 577888899999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
--.+.......+||+.|+|||++...+|+.+.|.||||++||||+.|++||+..+ .......+.+.....|...+
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI~ehnvsyPKslS-- 574 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAIMEHNVSYPKSLS-- 574 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHccCcCccccc--
Confidence 6556666777899999999999999999999999999999999999999988654 34445556555544333222
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
.+...+++..+.+.|.+|... ++|-+||||+.
T Consensus 575 ----kEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 575 ----KEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ----HHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 236677788899999999854 57889999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=277.90 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=210.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCC-EEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGK-IVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.+++.+..||-|+||.|=++..++.. .+|+|.+++..- ...+.+....|-.+|...+.|.||++|-.|.+...+|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566677999999999999885444 388888866542 3344578889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|-|-||.|+..|++.+ .++......++..+.+|++|||.+ +|+.|||||+|.++|.+|-+||.|||+++.+...
T Consensus 500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999876 688889999999999999999999 9999999999999999999999999999998766
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
....+ .+||+.|.|||++.+...+.+.|.||||+++|||++|.+||...++.. ....++.+.-..... ....
T Consensus 574 ~KTwT-FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---tYn~ILkGid~i~~P----r~I~ 645 (732)
T KOG0614|consen 574 RKTWT-FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---TYNLILKGIDKIEFP----RRIT 645 (732)
T ss_pred Cceee-ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHhhhhhhhcc----cccc
Confidence 55544 579999999999999999999999999999999999999988655422 222233222111111 1111
Q ss_pred HHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
....+|+++.+..+|.+|.- +.+|-.|-||..
T Consensus 646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 23668888999999999986 788999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=254.38 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=214.1
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 163 (361)
.-++|.+...||+|+|..|..+++. +.+.+|+|++++.-- +.+.+.=.+.|-.+.... +||.+|-+..+++.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3467999999999999999999765 577899998875421 222234455677777766 7999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+|.||++||+|--+++..+ .++++.++.+...|+-||.|||++ ||+.||||..|||+|..|.+||+|+|+++.-
T Consensus 328 fvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999988887766 689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcch-----hHhhhhcccCCCCCC
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI-----MLIDLLDQRAPSPID 318 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 318 (361)
-.+.......+||+.|.|||++.+..|....|.|++|++|+||+.|+.||+.....+++. ...-+++.+...|..
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs 481 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS 481 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence 666677778899999999999999999999999999999999999999998655433322 233444444444433
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCC------CccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRP------TMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RP------s~~eil~hp~~~~ 358 (361)
.+. ....+++.-|++||.+|. .+.++-.|+||+.
T Consensus 482 lsv------kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 482 LSV------KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred eeh------hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 222 255677789999999997 4678999999973
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=268.87 Aligned_cols=257 Identities=21% Similarity=0.330 Sum_probs=198.3
Q ss_pred CCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
-|..++.||-|+||+|.+++ .++...+|.|.+.+.+- ...+......|-++|...+.+-||++|-.|++.+++|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 36667889999999999994 44567899999876543 33345678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC--
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS-- 245 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-- 245 (361)
|++||++-++|-+-+ .+.+..++.++..+..|+++.|.. |++||||||+|||+|.+|.+||+|||+|.-+.-
T Consensus 710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999887655 688888999999999999999999 999999999999999999999999999865420
Q ss_pred -C-----CC-C---------------------------------cccccccccccccccccccccCccchhhhHHHHHHH
Q 042457 246 -D-----SS-N---------------------------------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALE 285 (361)
Q Consensus 246 -~-----~~-~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 285 (361)
. .. . ....+||+.|+|||++....++..+|.||.|+||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0 00 0 011358999999999999999999999999999999
Q ss_pred HHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCC---CccccccCCCCCC
Q 042457 286 VLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP---TMRRSFPNPEINP 358 (361)
Q Consensus 286 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~hp~~~~ 358 (361)
|+.|+.||.............++. ..+..+.......+....+.+ .|+ +++.|. -.+||-.||||+.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~-~~l~~~~~~~ls~e~~~li~k---Lc~--sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWR-NFLHIPYQGNLSKEALDLIQK---LCC--SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehh-hccccccccccCHHHHHHHHH---Hhc--ChhhhhcccchhhhhcCccccc
Confidence 999999998766544333322222 122222222222333223322 243 345554 4667999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.36 Aligned_cols=133 Identities=23% Similarity=0.467 Sum_probs=112.5
Q ss_pred hcCCCCcCeeeecCceeEEEEE-eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-----C---CcceeeeEEEee
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-----H---RNIVKLYGFCLH 158 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~ 158 (361)
..+|-+.++||.|-|++||++. ..+.+.||+|+.+... .+.+..+.|+++|++++ | ..||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 3788999999999999999994 4577899999987543 23466789999999884 3 369999999986
Q ss_pred C----CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC
Q 042457 159 K----KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN 227 (361)
Q Consensus 159 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~ 227 (361)
. .++|+|+|+. |.+|..++.....+ -++...+.+|+.||+.||.|||..| +|+|.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4 4799999998 77888888765543 4888999999999999999999998 999999999999993
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=262.77 Aligned_cols=270 Identities=19% Similarity=0.249 Sum_probs=209.0
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC------CCcceee
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIR------HRNIVKL 152 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~ 152 (361)
.+.-.+....+|.+....|+|-|++|.+|... .|+.||||++...... .+.=+.|+++|++|+ --|++++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 33444567789999999999999999999654 5789999999876532 244458999999995 2479999
Q ss_pred eEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CC
Q 042457 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LE 231 (361)
Q Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~ 231 (361)
+-.|.+.+++|||+|.. ..+|.+.|...+....|....+..++.|+.-||..|-.. +++|.||||.||||++. ..
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 99999999999999987 569999999887777788999999999999999999998 99999999999999876 45
Q ss_pred eEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC------------
Q 042457 232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF------------ 299 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~------------ 299 (361)
+||||||.|.....+. .+.+.-+.-|.|||++.|..|+...|+||.||.||||.||+..|......
T Consensus 576 LKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 7999999997664332 22233456799999999999999999999999999999999887644321
Q ss_pred ----------------CcchhH----hhhhccc---------CC----------CCCCChhhHHHHHHHHHHHhhhcCCC
Q 042457 300 ----------------NPKIML----IDLLDQR---------AP----------SPIDDQTVIQDIILVSKIAFACLRSK 340 (361)
Q Consensus 300 ----------------~~~~~~----~~~~~~~---------~~----------~~~~~~~~~~~~~~l~~li~~cl~~d 340 (361)
+..... .+-+.++ .| ...........+..+.+|+.+|+..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 000000 0000000 00 00000111233456889999999999
Q ss_pred CCCCCCccccccCCCCCC
Q 042457 341 PKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 341 P~~RPs~~eil~hp~~~~ 358 (361)
|++|.|..|.|+||||+.
T Consensus 734 P~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 734 PEKRITVNQALKHPFITE 751 (752)
T ss_pred hhhcCCHHHHhcCCcccC
Confidence 999999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=248.50 Aligned_cols=259 Identities=25% Similarity=0.327 Sum_probs=198.7
Q ss_pred CcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-----eEEEEE
Q 042457 93 IKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK-----CMFLIY 166 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~ 166 (361)
-.+.||.|+||.||..+. .+|+.||+|++..-......-+.+.+|++++..++|.|++..++..+-.. ++|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 345699999999999965 47999999998766554444577889999999999999999998877543 467888
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|.| ..+|...+-+.. .++-..+.-++.||++||.|||+. +|.||||||.|.|++.|...||+|||+++.-+.+
T Consensus 137 ELm-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 888 558888877655 688888999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh---------------
Q 042457 247 SS-NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL--------------- 309 (361)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--------------- 309 (361)
.. ..+..+-|..|.|||++++. .|+.+.||||.||++.|++..+..|...+.........+.+
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 32 33445578899999999874 58999999999999999999888887555432222222211
Q ss_pred -----cccCCCCCCC-----hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 310 -----DQRAPSPIDD-----QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 310 -----~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
......+... ........+...+..+++..||.+|.+..+.+.|+++.+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1111111100 000011123456777899999999999999999999865
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=238.22 Aligned_cols=257 Identities=19% Similarity=0.341 Sum_probs=196.8
Q ss_pred HhcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeC--CeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHK--KCM 162 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~ 162 (361)
..++|++.+++|+|.+++||.| ...+++.++||+++... .+.+.+|+.+|+.+. ||||+++++...+. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 3567889999999999999999 45678899999998654 367889999999996 99999999998875 457
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeeecCcc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVAR 241 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~ 241 (361)
.||+||..+.+...+.. .++...+...+.+++.||.|+|+. ||.|||+||.|+++|.. -..+|+|+|+|.
T Consensus 111 aLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 89999999988776654 577788999999999999999999 99999999999999875 468999999998
Q ss_pred ccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCC-cccCCcchhH--------------
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDL-LSSFNPKIML-------------- 305 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~-~~~~~~~~~~-------------- 305 (361)
.+..... ....+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-. .+..++....
T Consensus 182 FYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 182 FYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 8765433 333446667889998754 5678899999999999999999988742 2222111111
Q ss_pred ----------hhhhcccCCCCCC---ChhhHH-HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 306 ----------IDLLDQRAPSPID---DQTVIQ-DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 306 ----------~~~~~~~~~~~~~---~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+++......+.. .+.... ...+..+++.+.|.+|-.+|||++|.+.||||..
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1111111100000 000000 0135788999999999999999999999999975
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=247.55 Aligned_cols=259 Identities=25% Similarity=0.317 Sum_probs=194.9
Q ss_pred hcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------ 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 160 (361)
..+|.-.+.+|.|.. .|..+ ..-.++.||+|++..........+...+|..++..+.|+|+++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 345666667888887 55555 3336889999988655332333466778999999999999999999997543
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..|+|||+|. .+|...+.. .++-..+..+..|++.|+.|||+. +|+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 5799999994 588777762 477788999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh-------------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID------------- 307 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~------------- 307 (361)
+.-... ...+..+.|..|.|||++.+..+.+..||||+||++.||++|+.-|.+....+......+
T Consensus 166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 764433 345556788899999999998899999999999999999999988764332111110000
Q ss_pred ------hhcc-----------cCC---CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 308 ------LLDQ-----------RAP---SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 308 ------~~~~-----------~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
.... ..+ .+...+........+.+++.+||-.||++|.|++++|+||||+
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0000 000 0000001111233478899999999999999999999999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=268.31 Aligned_cols=261 Identities=27% Similarity=0.457 Sum_probs=212.9
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
...+|.....+|.|.||.|||++. ..++..|+|+++...... .....+|+-+++..+|+||+.++|.+...+..++.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 456788899999999999999954 478999999998765433 46677899999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
||||.+|+|.+..+-.. ++++.++...++...+|++|||+. +-+|||||-.|||+++.+.+|++|||.+..+..
T Consensus 91 MEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999999887665 689999999999999999999999 889999999999999999999999999987766
Q ss_pred CCCCcccccccccccccccc---cccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc-ccCCCCCCChh
Q 042457 246 DSSNRTVVAGTHGYIAPELA---YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD-QRAPSPIDDQT 321 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 321 (361)
.-..+....||+.|||||+. ..+.|...+|||+.|+...|+---+.|--+. .+...+.-... ...+....+..
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl---hpmr~l~LmTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL---HPMRALFLMTKSGFQPPTLKDKT 241 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc---chHHHHHHhhccCCCCCcccCCc
Confidence 55666777899999999975 3567889999999999999998777762211 11111111111 11122222222
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
.+.. .+-++++.|+.++|++|||++.+|+|||+.+.+
T Consensus 242 kws~--~fh~fvK~altknpKkRptaeklL~h~fvs~~l 278 (829)
T KOG0576|consen 242 KWSE--FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL 278 (829)
T ss_pred cchH--HHHHHHHHHhcCCCccCCChhhheeceeeccch
Confidence 3333 578999999999999999999999999998753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=232.11 Aligned_cols=212 Identities=33% Similarity=0.589 Sum_probs=185.4
Q ss_pred eeecCceeEEEEEeCC-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCChh
Q 042457 97 IGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF 175 (361)
Q Consensus 97 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~ 175 (361)
||+|++|.||++...+ |+.+++|.+....... ..+.+.+|+..++.++|++++++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999998754 8999999998765432 2467889999999999999999999999999999999999999999
Q ss_pred hhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-CCCeEEeeecCccccCCCCCCccccc
Q 042457 176 CVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLLHSDSSNRTVVA 254 (361)
Q Consensus 176 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 254 (361)
+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+..............
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 9987653 2588999999999999999999999 9999999999999999 89999999999986654332233345
Q ss_pred cccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHH
Q 042457 255 GTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIA 333 (361)
Q Consensus 255 gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 333 (361)
+...|++||..... ..+.++|+|++|++++++ ..+.+++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------~~~~~~l 194 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------PELKDLI 194 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------HHHHHHH
Confidence 77889999998776 788999999999999999 2588999
Q ss_pred hhhcCCCCCCCCCccccccCC
Q 042457 334 FACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 334 ~~cl~~dP~~RPs~~eil~hp 354 (361)
.+|++.+|++||++.++++|+
T Consensus 195 ~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 195 RKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHhhCCcccCcCHHHHhhCC
Confidence 999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=225.02 Aligned_cols=222 Identities=25% Similarity=0.362 Sum_probs=173.3
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCe
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 161 (361)
+++..+...-...||+|++|.|-+-++ .+|+..|+|++...-.... .+..+.|+++..+. .+|.+|.++|.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-QKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-HHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 344555555567799999999988854 5899999999987765444 45667788876654 79999999999999999
Q ss_pred EEEEEEeccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 162 MFLIYKYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
.++.||.| ..||..+.++. .....+++.-+-+|+..+..||.|||++. .++|||+||+|||++.+|++|+||||++
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 99999999 45776665431 11226788889999999999999999986 8999999999999999999999999998
Q ss_pred cccCCCCCCccccccccccccccccc----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAY----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
..+.. .-..+...|...|||||.+. ...|+.++||||||+.+.||.+++.||+.- ..+-..+..+++..
T Consensus 197 G~L~d-SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w--~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 197 GYLVD-SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW--GTPFQQLKQVVEEP 269 (282)
T ss_pred eeehh-hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc--CCHHHHHHHHhcCC
Confidence 76643 22333456888999999875 346889999999999999999999998732 23333444444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=273.31 Aligned_cols=200 Identities=18% Similarity=0.218 Sum_probs=144.2
Q ss_pred cCCC-CcceeeeEEE-------eeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 042457 143 QIRH-RNIVKLYGFC-------LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214 (361)
Q Consensus 143 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i 214 (361)
.++| +||++++++| .+....+.++|++ +++|.+++.... ..+++.+++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3445 5788888877 2334577888887 669999997543 2589999999999999999999999 99
Q ss_pred EEeCCCCCCeeeCCC-------------------CCeEEeeecCccccCCCC----------------CCcccccccccc
Q 042457 215 VHRDISSNNILLNSK-------------------LEAFVADFGVARLLHSDS----------------SNRTVVAGTHGY 259 (361)
Q Consensus 215 ~H~dlk~~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~----------------~~~~~~~gt~~y 259 (361)
+||||||+||||+.. +.+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 445566666654321100 001113478889
Q ss_pred cccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCC
Q 042457 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRS 339 (361)
Q Consensus 260 ~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 339 (361)
+|||++.+..++.++|||||||+||||++|..|+..... ..........+... .........++.+||++
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~L~~ 251 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHRVLPPQI-----LLNWPKEASFCLWLLHP 251 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHhhcChhh-----hhcCHHHHHHHHHhCCC
Confidence 999999999999999999999999999999988653211 11111111111110 11112356778899999
Q ss_pred CCCCCCCccccccCCCCCC
Q 042457 340 KPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 340 dP~~RPs~~eil~hp~~~~ 358 (361)
||.+|||+.|+++||||++
T Consensus 252 ~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 252 EPSCRPSMSELLQSEFINE 270 (793)
T ss_pred ChhhCcChHHHhhchhhhh
Confidence 9999999999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=221.70 Aligned_cols=199 Identities=36% Similarity=0.556 Sum_probs=172.1
Q ss_pred CCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
|.+.+.||+|++|.||++...+ ++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567889999999999998765 889999999866543 23578889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC-C
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-S 248 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 248 (361)
++++|.+++..... .+++.....++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+....... .
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999999876542 178999999999999999999999 99999999999999999999999999988765442 1
Q ss_pred Ccccccccccccccccc-cccccCccchhhhHHHHHHHHHhCCCCCCC
Q 042457 249 NRTVVAGTHGYIAPELA-YTMVVTEKCDVFGFGVVALEVLMGRHPGDL 295 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 295 (361)
......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334577889999988 667778899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=235.35 Aligned_cols=262 Identities=25% Similarity=0.372 Sum_probs=197.5
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEee
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLH 158 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 158 (361)
+....+.|..+++||+|.|++||++... .++.||+|.+...... ..+..|+++|..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3445677899999999999999999543 4678999998766543 5578999999998 58999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeee
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADF 237 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Df 237 (361)
++...+|+||+++....+++. .++...+...++.+..||+++|.. ||+|||+||+|+|.+.. +.-.|.||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999999988886 467889999999999999999999 99999999999999766 45789999
Q ss_pred cCccccCCCC--------------C------------------------------Ccccccccccccccccccc-cccCc
Q 042457 238 GVARLLHSDS--------------S------------------------------NRTVVAGTHGYIAPELAYT-MVVTE 272 (361)
Q Consensus 238 g~~~~~~~~~--------------~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~ 272 (361)
|++....... . ......||++|.|||++.. ...+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9987221000 0 0011248999999998764 55688
Q ss_pred cchhhhHHHHHHHHHhCCCCCCCcccCCc------------chhHhhhhccc---------------------------C
Q 042457 273 KCDVFGFGVVALEVLMGRHPGDLLSSFNP------------KIMLIDLLDQR---------------------------A 313 (361)
Q Consensus 273 ~~Dv~slG~~l~el~tg~~p~~~~~~~~~------------~~~~~~~~~~~---------------------------~ 313 (361)
+.||||.|+|++-+++++.||-...+... .........++ .
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 99999999999999999999843222100 00000000000 0
Q ss_pred CCCC--CChhhHHH--HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 314 PSPI--DDQTVIQD--IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 314 ~~~~--~~~~~~~~--~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.... .....+.+ ...+.+++.+|+..||.+|.|+++.|+||||.+
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0000 00000011 125789999999999999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=239.44 Aligned_cols=198 Identities=25% Similarity=0.354 Sum_probs=167.2
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc--hHH----HHHHHHHHHHHHhcCC---CCcceeeeEEEee
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET--ELA----FLESFQTEARLLSQIR---HRNIVKLYGFCLH 158 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~----~~~~~~~e~~~l~~l~---h~niv~~~~~~~~ 158 (361)
.+|...+.+|+|+||.|+.+.++ +...|+||.+.+..- +.+ .+-..-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35788899999999999999765 456799998876532 111 1123557999999997 9999999999999
Q ss_pred CCeEEEEEEec-cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 159 KKCMFLIYKYM-RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 159 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
++.+||+||-. ++-+|++++.... .+++.....|++||+.|+++||+. +|+|||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 99999999965 4558999998765 689999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCC
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGD 294 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~ 294 (361)
|.+....+.+ .....||..|.|||++.+..| ....|||++|++||.++....||-
T Consensus 715 gsaa~~ksgp--fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC--cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9987554333 345679999999999998876 457899999999999999888864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=213.23 Aligned_cols=166 Identities=19% Similarity=0.170 Sum_probs=127.3
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|+|.++++..+. .+++.+++.++.|++.||.|||+. + ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 688899876432 589999999999999999999998 5 999999999999999 99987654322
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCC---CChhhHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI---DDQTVIQDIIL 328 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 328 (361)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... ............... ...........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESVSAARS 140 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHHHhhhh
Confidence 257899999999999999999999999999999999999986543321 112222222111111 11111111125
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
+.+++.+||+.||.+|||+.|+++|+|+.
T Consensus 141 ~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 141 FADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 89999999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=215.20 Aligned_cols=244 Identities=20% Similarity=0.321 Sum_probs=182.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeE-EEeeCCeEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYG-FCLHKKCMF 163 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-~~~~~~~~~ 163 (361)
..+.|.+.+.||+|.||.+-+++++ +.+.+++|.+...... .++|.+|...--.+ .|.||+.-|+ .|+..+.+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3456888999999999999999765 5788999998776544 47888888776666 4899998776 466778889
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC--CCCCeEEeeecCcc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN--SKLEAFVADFGVAR 241 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~ 241 (361)
+++||++.|+|.+-+...+ +.+....+++.|++.|+.|||+. ++||||||.+|||+- +..++||+|||+.+
T Consensus 99 F~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999999998776643 77888899999999999999999 999999999999993 34579999999987
Q ss_pred ccCCCCCCccccccccccccccccccc-----ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCC
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTM-----VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 316 (361)
.....- .....+..|.+||..... ...+.+|+|.||++++.++||+.||......++.........++....
T Consensus 172 k~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 172 KVGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred ccCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 543221 112235578999976432 346789999999999999999999986555555554443333332221
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSR 344 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~R 344 (361)
..... ..-...+.++.++-+.++|++|
T Consensus 249 ~P~~F-~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 249 LPKKF-NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred Cchhh-cccCHHHHHHHHHhcCCccccc
Confidence 11110 0111236677778888999888
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=205.87 Aligned_cols=243 Identities=21% Similarity=0.325 Sum_probs=186.9
Q ss_pred CCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEecc
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
..+..+|.+...|+.|+|+|+ |..++.|++....-+...-++|..|.-.++-+.||||++++|.|....++.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344556889999999999995 4557778887766655556789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEe--eecCccccCCCCC
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVA--DFGVARLLHSDSS 248 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~--Dfg~~~~~~~~~~ 248 (361)
.|+|++.|+.... ...+..+..+++.++|+|++|||+.. +-|.-.-|++..+++|++.+.+|+ |-.++..
T Consensus 271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 9999999987643 35788899999999999999999873 234455789999999999988873 3222211
Q ss_pred Cccccccccccccccccccccc---CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc-cCCCCCCChhhHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVV---TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDDQTVIQ 324 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 324 (361)
.....-.+.||+||.+...+. -.++|+|||++++|||.|...||.+.+..+..... .+++ +...|....
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki--aleglrv~ippgis---- 415 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI--ALEGLRVHIPPGIS---- 415 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--hhccccccCCCCcc----
Confidence 111224678999999876653 35899999999999999999999887765433221 1111 111222211
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
..+.+|+.-|++.||.+||.+..|+
T Consensus 416 --~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 416 --RHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred --HHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1478899999999999999999886
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-28 Score=232.49 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=194.3
Q ss_pred CcCeeeecCceeEEEEEe-CCCCEEEEEEec----cCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 93 IKYCIGTGGYGSVYRAQL-PSGKIVALKKLH----HSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
....+|.|++|.|+.... ......+.|... ...........+..|+-+-..+.|+|++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 456799999998877743 344445555433 333333333447788888889999999888887777666666699
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
||++ +|..++.... .++..++..++.|+..|++|||.. |+.|||+|++|++++.++.+||+|||.+.....+.
T Consensus 402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9999998763 578888999999999999999999 99999999999999999999999999998765443
Q ss_pred CC----cccccccccccccccccccccCc-cchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 248 SN----RTVVAGTHGYIAPELAYTMVVTE-KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 248 ~~----~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
.. .....|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+..........+...........
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 32 34456899999999999888876 68999999999999999999976554433211111111111111111111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.........++-++|+.||.+|.|+++|++.+||+.
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 222344678889999999999999999999999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=203.08 Aligned_cols=166 Identities=19% Similarity=0.151 Sum_probs=128.6
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC--CCCEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP--SGKIVALKKLHHSET---ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
.....+|.+.+.||+|+||+||+|... +++.||||++..... .....+.+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 355678999999999999999999764 577889998753311 22234678999999999999999853322 2
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCC-CCCCeeeCCCCCeEEeeec
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDI-SSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg 238 (361)
+..++||||++|++|... .. .. ...++.+++++|.|||+. +|+|||| ||+|||++.++.++|+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999632 11 11 146789999999999999 9999999 9999999999999999999
Q ss_pred CccccCCCCCC--------ccccccccccccccccc
Q 042457 239 VARLLHSDSSN--------RTVVAGTHGYIAPELAY 266 (361)
Q Consensus 239 ~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 266 (361)
+++.+...... -....+++.|+|||.+.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99876543211 12345778899999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-24 Score=194.68 Aligned_cols=263 Identities=29% Similarity=0.432 Sum_probs=201.8
Q ss_pred CCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHH-HHHHHHHHHHHHhcCCCC-cceeeeEEEeeCCeEEEEEEe
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELA-FLESFQTEARLLSQIRHR-NIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 168 (361)
|.+...||.|+||.||++... ..+++|.+........ ....+.+|...++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 7899999877655432 467899999999999988 799999999877778999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-CeEEeeecCccccCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLLHSDS 247 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~~ 247 (361)
+.++++.+++........+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997766543112578889999999999999999999 999999999999999998 79999999998554433
Q ss_pred C------Ccccccccccccccccccc---cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC-C---
Q 042457 248 S------NRTVVAGTHGYIAPELAYT---MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA-P--- 314 (361)
Q Consensus 248 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~--- 314 (361)
. ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||.................... +
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 2 2355679999999999887 5788899999999999999999999665442100111111111111 1
Q ss_pred CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..............+.+++..|+..+|..|.+..+...+++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 11111000111234778888999999999999999888866543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=197.01 Aligned_cols=202 Identities=22% Similarity=0.315 Sum_probs=164.3
Q ss_pred CCCCcCeeeecCceeEEEEEeCCC--CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC----CcceeeeEEE-eeCCeE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLPSG--KIVALKKLHHSETELAFLESFQTEARLLSQIRH----RNIVKLYGFC-LHKKCM 162 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~ 162 (361)
+|.+.+.||+|+||.||.+...+. ..+|+|.-........ ..+..|..++..+.. .++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999976543 4788888765433211 146678888887762 5888888888 477788
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-----CCeEEeee
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-----LEAFVADF 237 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Df 237 (361)
++||+.+ |.+|.++..... ...++..+..+++.|++.+|.+||+. |++||||||.|+++... ..+.|.||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 9999987 889999876554 44799999999999999999999999 99999999999999765 45899999
Q ss_pred cCcc--ccCCCCC--------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCccc
Q 042457 238 GVAR--LLHSDSS--------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSS 298 (361)
Q Consensus 238 g~~~--~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 298 (361)
|+++ ....... ......||.+|++++...+...+.+.|+||++.++.|++.|..||.....
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 9998 3321111 12234599999999999999999999999999999999999999976554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-25 Score=179.11 Aligned_cols=219 Identities=18% Similarity=0.297 Sum_probs=179.5
Q ss_pred HHhcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC-CcceeeeEEEeeCCeEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH-RNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~ 163 (361)
+....|.++++||.|+||.+|.| ...+|..||||.-...... ..+.-|..+.+.+++ ..|..+..+..+...-.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 34567999999999999999999 4568999999987665543 345678888888875 67888888888888899
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC---CCeEEeeecCc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK---LEAFVADFGVA 240 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~ 240 (361)
+||+.. |.+|++++.-... .++..+.+-++-|++.-++|+|.+ +++||||||+|+|..-+ .++.++|||++
T Consensus 88 lVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence 999988 8899999876654 588999999999999999999999 99999999999999654 56789999999
Q ss_pred cccCCCCCC-------cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 241 RLLHSDSSN-------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 241 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
+.+...... .....||.+|.+-....+...+...|+=|+|.+|..+--|..||..............+.+...
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 877543321 2335699999999988888889999999999999999999999998776554444455555444
Q ss_pred C
Q 042457 314 P 314 (361)
Q Consensus 314 ~ 314 (361)
.
T Consensus 242 s 242 (341)
T KOG1163|consen 242 S 242 (341)
T ss_pred C
Confidence 3
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=215.28 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=179.4
Q ss_pred CCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHH--HhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARL--LSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++...+.||.+.|=+|.+|+.++|. |+||++-....+.. ++.|.++++- ...++|||.+++.-+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~s-L~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTIS-LRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCC-chHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777888999999999999998888 99999876653221 2333333333 455689999999888777888899999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC--
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS-- 245 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~-- 245 (361)
|..+ +|+|.+.... -+...+...|+.|++.|+.-+|.. +|+|||||.+|||++.-+.+.|+||..-+...-
T Consensus 102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9855 8998887654 477788899999999999999999 999999999999999999999999987643321
Q ss_pred C-CCCccc----cccccccccccccccc-----------ccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhh
Q 042457 246 D-SSNRTV----VAGTHGYIAPELAYTM-----------VVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDL 308 (361)
Q Consensus 246 ~-~~~~~~----~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 308 (361)
+ +..... ...-..|.|||.+... ..+++.||||+||++.||++ |++||+... .
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----------L 244 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----------L 244 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----------H
Confidence 1 111111 1233469999976431 15679999999999999999 899987321 1
Q ss_pred hcccCCCCCCChhhHHHH--HHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 309 LDQRAPSPIDDQTVIQDI--ILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
+..+.......+...+.+ ..+..++..|++.||++|.|+++.|+.
T Consensus 245 ~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111000001111100 137889999999999999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=177.44 Aligned_cols=216 Identities=19% Similarity=0.271 Sum_probs=178.4
Q ss_pred HHhcCCCCcCeeeecCceeEEEE-EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 163 (361)
+..-.|++.++||+|+||.++.| .+-+++.||||.-...... -++..|....+.| ..++|...+-+..++..-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 44567999999999999999999 4568999999976544432 3466788888877 4689999998888888889
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-----CCeEEeeec
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-----LEAFVADFG 238 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Dfg 238 (361)
||+|.. |-||++++.-++. .++..++..++.|++.-++|+|++ .+|.|||||+|+||..- ..+.++|||
T Consensus 101 LVidLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEecc
Confidence 999988 8899999887665 589999999999999999999999 99999999999999543 457899999
Q ss_pred CccccCCCCCC-------cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 239 VARLLHSDSSN-------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 239 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
+++.+..+... .....||.+||+-....+..-+.+.|+=|+|-++...+-|..||..............+-+.
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 99987654332 23356999999999999999999999999999999999999999877654444444444443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=193.99 Aligned_cols=206 Identities=25% Similarity=0.443 Sum_probs=156.9
Q ss_pred HhcCCCCcceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-EEeCC
Q 042457 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI-VHRDI 219 (361)
Q Consensus 141 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i-~H~dl 219 (361)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..++|.-...++++++.||.|||.. .| .|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 356899999999999999999999999999999999998743 3689999999999999999999988 54 99999
Q ss_pred CCCCeeeCCCCCeEEeeecCccccCC--CCCCccccccccccccccccccc-------ccCccchhhhHHHHHHHHHhCC
Q 042457 220 SSNNILLNSKLEAFVADFGVARLLHS--DSSNRTVVAGTHGYIAPELAYTM-------VVTEKCDVFGFGVVALEVLMGR 290 (361)
Q Consensus 220 k~~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~el~tg~ 290 (361)
+++|+++|..+.+||+|||+...... .........-..-|.|||.+.+. ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999877642 11111222234569999988653 1467899999999999999999
Q ss_pred CCCCCcccCCc-chhHhhhhcccCCCCCCChhhH-HHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 291 HPGDLLSSFNP-KIMLIDLLDQRAPSPIDDQTVI-QDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 291 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
.||+....... ......+.+.........-... +....+..++.+||..+|++||+++++-
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 99986443222 2222333331221111111111 2223588999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-25 Score=203.77 Aligned_cols=237 Identities=23% Similarity=0.302 Sum_probs=192.7
Q ss_pred eeecCceeEEEEE----eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 97 IGTGGYGSVYRAQ----LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 97 lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+|+|+||.|+.++ .+.|..+|.|.++..............|..++...+ ||.++++.-.++.+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999873 335778899988765432222235567888888886 99999999999999999999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcc
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 251 (361)
|.|...+.+.. .+++.........++-+++++|+. +++|+|+|++||+++.+|.+++.|||+++........
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99998887655 577788888899999999999999 9999999999999999999999999999876443332
Q ss_pred cccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHH
Q 042457 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331 (361)
Q Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 331 (361)
+||..|||||++. ....++|.||||++++||+||..||.. .....+.......|.... ..+.+
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~p~~l~------~~a~~ 216 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEMPRELS------AEARS 216 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCCchhhh------HHHHH
Confidence 7899999999987 557789999999999999999999875 334445554444443322 23677
Q ss_pred HHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 332 IAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 332 li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
++..++..+|.+|.-. .|+.+|+||+.
T Consensus 217 ~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 217 LFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 8888999999999866 68999999975
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=176.93 Aligned_cols=189 Identities=14% Similarity=0.153 Sum_probs=142.4
Q ss_pred ccccCCCCcCHHHHH--HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchH-HHHHH------HHHHHHHH
Q 042457 71 SVWNYDGRITFEEII--VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETEL-AFLES------FQTEARLL 141 (361)
Q Consensus 71 ~~~~~~~~~~~~~~~--~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~------~~~e~~~l 141 (361)
.+...+....|.++. ...++|+..+.+|.|+||.||.... ++..+|+|.+....... ..... +.+|+..+
T Consensus 11 ~~~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l 89 (232)
T PRK10359 11 TVFYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQT 89 (232)
T ss_pred EEEecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHH
Confidence 334444444555553 4688999999999999999999866 57789999997554322 22223 57899999
Q ss_pred hcCCCCcceeeeEEEeeC--------CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 042457 142 SQIRHRNIVKLYGFCLHK--------KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213 (361)
Q Consensus 142 ~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ 213 (361)
.+++|++|.....++... +..+++|||++|.+|.++.. ++. ....+++.++..+|.. +
T Consensus 90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---g 155 (232)
T PRK10359 90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---G 155 (232)
T ss_pred HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---C
Confidence 999999999999886643 35789999999999987632 222 3466999999999999 9
Q ss_pred eEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHH
Q 042457 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL 287 (361)
Q Consensus 214 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 287 (361)
++|||++|+||+++.++ ++|+|||.......+.... .+.....+..++|+||||+.+..+.
T Consensus 156 i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 156 MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH------------HHHHHhHhcccccccceeEeehHHH
Confidence 99999999999999988 9999999886542211111 1334445667899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=173.84 Aligned_cols=141 Identities=20% Similarity=0.207 Sum_probs=108.3
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHH------------------------HHHHHHHHHHHhcCCCCcc
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAF------------------------LESFQTEARLLSQIRHRNI 149 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni 149 (361)
...||+|+||.||+|...+|+.||||+++........ ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4579999999999998888999999999764321100 1122358999999987776
Q ss_pred eeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEEeCCCCCCeeeCC
Q 042457 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL-HYDCIPSIVHRDISSNNILLNS 228 (361)
Q Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~i~H~dlk~~Nill~~ 228 (361)
.....+... ..++||||++++++........ .++......++.|++.+|.++ |+. +++||||||+|||+++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC
Confidence 443332222 2389999999887765432222 588899999999999999999 688 9999999999999984
Q ss_pred CCCeEEeeecCcccc
Q 042457 229 KLEAFVADFGVARLL 243 (361)
Q Consensus 229 ~~~~kl~Dfg~~~~~ 243 (361)
+.++|+|||++...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=167.34 Aligned_cols=141 Identities=21% Similarity=0.281 Sum_probs=110.6
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchH------------------------HHHHHHHHHHHHHhcCCCCcc
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETEL------------------------AFLESFQTEARLLSQIRHRNI 149 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~h~ni 149 (361)
...||+|++|.||+|...+|+.||||++....... .....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987789999999987653210 001234578899999999887
Q ss_pred eeeeEEEeeCCeEEEEEEeccCCChhhh-hccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeC
Q 042457 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCV-LRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLN 227 (361)
Q Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~ 227 (361)
.....+.... .++||||++++++... +... .++......++.+++.++.++|+ . +++|+||||+||+++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 5444433332 4899999998865433 3322 46788899999999999999999 8 999999999999999
Q ss_pred CCCCeEEeeecCccccC
Q 042457 228 SKLEAFVADFGVARLLH 244 (361)
Q Consensus 228 ~~~~~kl~Dfg~~~~~~ 244 (361)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999998664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.6e-22 Score=170.80 Aligned_cols=234 Identities=19% Similarity=0.211 Sum_probs=149.5
Q ss_pred CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCC----------CcceeeeEEEe-
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRH----------RNIVKLYGFCL- 157 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~- 157 (361)
+.....||.|+++.||.++.. +|+.+|+|++..... .....+++.+|.-....+.+ -.++--++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344667999999999999775 589999998765443 23345777777766655432 12222222222
Q ss_pred --------eCC--------eEEEEEEeccCCChhhhhcc----CCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEe
Q 042457 158 --------HKK--------CMFLIYKYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHR 217 (361)
Q Consensus 158 --------~~~--------~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~ 217 (361)
... +.+++|+-+ .++|.+++.. ......+....++.+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 246777777 5688777542 11112345566778889999999999999 99999
Q ss_pred CCCCCCeeeCCCCCeEEeeecCccccCCCCCCcccccccccccccccccc--------cccCccchhhhHHHHHHHHHhC
Q 042457 218 DISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT--------MVVTEKCDVFGFGVVALEVLMG 289 (361)
Q Consensus 218 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg 289 (361)
||+|+|++++.+|.++|+||+........ ......+..|.+||.... -.++.+.|.|++|+++|.|++|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999999877544221 111234567899997643 2478899999999999999999
Q ss_pred CCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCC
Q 042457 290 RHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSR 344 (361)
Q Consensus 290 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 344 (361)
..||+............. .. . +..+.+..||..+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~~f~----------~C--~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEWDFS----------RC--R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGGGGT----------TS--S----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccccch----------hc--C-CcCHHHHHHHHHHccCCcccC
Confidence 999986554322221000 01 1 233458899999999999998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-21 Score=158.77 Aligned_cols=185 Identities=14% Similarity=0.079 Sum_probs=138.4
Q ss_pred CCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHH--HHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEEEEe
Q 042457 92 DIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELA--FLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
.+...|+.|+||+||.+.. .+.+++.+.+........ ....+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3466799999999998876 778888888876544211 1225789999999995 5889999886 346999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCC-CCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDI-SSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
+.|.+|...+.. ....++.|++++|.++|+. ||+|+|| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654321 1135788999999999999 9999999 7999999999999999999998554332
Q ss_pred CC-----c--------cccccccccccccccc--ccccCccchhhhHHHHHHHHHhCCCCCC
Q 042457 248 SN-----R--------TVVAGTHGYIAPELAY--TMVVTEKCDVFGFGVVALEVLMGRHPGD 294 (361)
Q Consensus 248 ~~-----~--------~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~p~~ 294 (361)
.. . .....++.|++|+... ...--...+.++-|.-+|.++|+..+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 11 0 0112466777776422 2222256789999999999999988753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-22 Score=180.07 Aligned_cols=180 Identities=21% Similarity=0.312 Sum_probs=142.8
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++.|++|...+|.++|.........++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999876666678899999999999999999 5 8999999999999999999999999998
Q ss_pred cccCCCC------CCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC
Q 042457 241 RLLHSDS------SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 241 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
....... ...+...||..||+||.+.+..|+.++||||||++|+|+++ -...++ ......++.++.+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t~~d~r~g~i 477 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RIATLTDIRDGII 477 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HHHhhhhhhcCCC
Confidence 8765544 12344569999999999999999999999999999999997 333332 1222344555555
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
++......+ .=..|+.+++...|.+||++.+.--|+|.+
T Consensus 478 p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 478 PPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred ChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 522222211 234677799999999999888888887754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.7e-20 Score=153.29 Aligned_cols=135 Identities=17% Similarity=0.186 Sum_probs=104.4
Q ss_pred CcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-----CCCcceeeeEEEeeCC---e-EE
Q 042457 93 IKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-----RHRNIVKLYGFCLHKK---C-MF 163 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~ 163 (361)
-...||+|+||.||. ...++. .+||+........ .+.+.+|+.+++.+ +||||++++|++.++. . ..
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~--~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGG--DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CcceecCCCceEEEE-CCCCcC-eEEEEEeccccch--HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 356799999999996 323444 4799886543322 36789999999999 5799999999999874 3 33
Q ss_pred EEEEe--ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEEeCCCCCCeeeCC----CCCeEEee
Q 042457 164 LIYKY--MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL-SYLHYDCIPSIVHRDISSNNILLNS----KLEAFVAD 236 (361)
Q Consensus 164 lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~Lh~~~~~~i~H~dlk~~Nill~~----~~~~kl~D 236 (361)
+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 6689999999653 24444 35678888777 999999 9999999999999963 34799999
Q ss_pred ecCc
Q 042457 237 FGVA 240 (361)
Q Consensus 237 fg~~ 240 (361)
++-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 4433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=185.31 Aligned_cols=199 Identities=25% Similarity=0.329 Sum_probs=159.2
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC---CCcceeeeEEEeeC
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR---HRNIVKLYGFCLHK 159 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 159 (361)
+.++..+.|.+.+.+|+|+||+||+|...+|+.||+|+-+...... |---.+++.+|+ -+-|..+...+.-.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4456667889999999999999999988889999999977665432 111223344444 23355555555666
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC-------CCCCe
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN-------SKLEA 232 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-------~~~~~ 232 (361)
+.-++|+||.+.|+|.+++.... .++|.-...+..|+++.+.+||.. +||||||||+|.||. ++.-+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 77899999999999999998544 689999999999999999999999 999999999999993 23458
Q ss_pred EEeeecCccccCC--CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCC
Q 042457 233 FVADFGVARLLHS--DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292 (361)
Q Consensus 233 kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 292 (361)
+|+|||.+-.+.- +.......++|-.+-.+|...|..++..+|.|.++.+++-|+.|+.-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999999866532 33344556788899999999999999999999999999999999754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=155.40 Aligned_cols=143 Identities=22% Similarity=0.223 Sum_probs=111.3
Q ss_pred CCCCcCeeeecCceeEEEEE--eCCCCEEEEEEeccCcch----------------------HHHHHHHHHHHHHHhcCC
Q 042457 90 DFDIKYCIGTGGYGSVYRAQ--LPSGKIVALKKLHHSETE----------------------LAFLESFQTEARLLSQIR 145 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~ 145 (361)
-|.+.+.||+|++|.||+|. ..+|+.||+|++...... ......+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 568999999998754311 001133568999999997
Q ss_pred CC--cceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEEeCCCCC
Q 042457 146 HR--NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS-IVHRDISSN 222 (361)
Q Consensus 146 h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-i~H~dlk~~ 222 (361)
+. .+.+++++ ...++||||+++.+|........ .+.......++.|++.++.+||+. + ++|+||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 53 33444443 23589999999988876543222 355666789999999999999999 9 999999999
Q ss_pred CeeeCCCCCeEEeeecCcccc
Q 042457 223 NILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~~ 243 (361)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 789999999998754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=159.13 Aligned_cols=189 Identities=24% Similarity=0.365 Sum_probs=134.0
Q ss_pred CCCcceeeeEEEeeC---------------------------CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHH
Q 042457 145 RHRNIVKLYGFCLHK---------------------------KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVK 197 (361)
Q Consensus 145 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 197 (361)
+|||||++.++|.+. ...|+||...+. +|..++-.+. .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence 599999999876532 357889987754 8888887653 56667788999
Q ss_pred HHHHHHHHHHcCCCCCeEEeCCCCCCeee--CCCC--CeEEeeecCccccCCC------CCCcccccccccccccccccc
Q 042457 198 SMAHALSYLHYDCIPSIVHRDISSNNILL--NSKL--EAFVADFGVARLLHSD------SSNRTVVAGTHGYIAPELAYT 267 (361)
Q Consensus 198 ~i~~~l~~Lh~~~~~~i~H~dlk~~Nill--~~~~--~~kl~Dfg~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~ 267 (361)
|+++|+.|||.+ ++.|||+|++|||+ |+|. ...|+|||.+-.-... ........|...-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999999 4444 4678999987533221 111222346778999998764
Q ss_pred cc------cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC-CCCCChhhHHHHHHHHHHHhhhcCCC
Q 042457 268 MV------VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQTVIQDIILVSKIAFACLRSK 340 (361)
Q Consensus 268 ~~------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~d 340 (361)
.+ .-.|+|.|+.|.+.||+++...||-......-+ ....-+.+++ .+...+. .+.+++...|+.|
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r~Yqe~qLPalp~~vpp------~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TRTYQESQLPALPSRVPP------VARQLVFDLLKRD 497 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hhhhhhhhCCCCcccCCh------HHHHHHHHHhcCC
Confidence 32 235899999999999999999998753321111 1111122222 2222222 3678888999999
Q ss_pred CCCCCCccc
Q 042457 341 PKSRPTMRR 349 (361)
Q Consensus 341 P~~RPs~~e 349 (361)
|++|+|.+=
T Consensus 498 pskRvsp~i 506 (598)
T KOG4158|consen 498 PSKRVSPNI 506 (598)
T ss_pred ccccCCccH
Confidence 999999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=151.22 Aligned_cols=147 Identities=19% Similarity=0.210 Sum_probs=113.5
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchH--------------------HHHHHHHHHHHHH
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETEL--------------------AFLESFQTEARLL 141 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l 141 (361)
+++......|.+.+.||+|+||.||++...+|+.||||++....... .....+..|...+
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34444455588889999999999999988889999999876433110 0112356788888
Q ss_pred hcCCCCc--ceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCC
Q 042457 142 SQIRHRN--IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDI 219 (361)
Q Consensus 142 ~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl 219 (361)
..+.|++ +.+.++. ...+++|||+++++|...... .....++.+++.++.++|+. +++|+||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 8887764 4444432 345899999999998765431 23467889999999999998 9999999
Q ss_pred CCCCeeeCCCCCeEEeeecCccccC
Q 042457 220 SSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 220 k~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
+|+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-19 Score=150.87 Aligned_cols=136 Identities=18% Similarity=0.331 Sum_probs=114.1
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcch------HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETE------LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+.||+|++|.||+|.. +|..+++|+....... ......+..|+.++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999988 7778999986543221 11124577899999999999988777777777888999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++|++|.+++.... + .+..++.+++.+|.++|+. +++|+|++|.|||++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 2 7889999999999999999 999999999999999 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.5e-19 Score=147.55 Aligned_cols=131 Identities=21% Similarity=0.372 Sum_probs=107.5
Q ss_pred eeecCceeEEEEEeCCCCEEEEEEeccCcc------hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEecc
Q 042457 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSET------ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 97 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
||+|+||.||+|.+ +|..|++|....... .....+.+..|++++..++|+++.....++...+..+++|||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 89999999999996 678899998654321 11123567789999999998876655556666677899999999
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
|++|.+.+..... .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988754321 7899999999999999 999999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=168.29 Aligned_cols=141 Identities=20% Similarity=0.286 Sum_probs=113.3
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEe-ccCcc-----hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKL-HHSET-----ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
....|...+.||+|+||.||+|.+.+.. +++|+. ..... .....+.+.+|+++++.++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445567889999999999999885444 444432 21111 1122356889999999999999998888888777
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+++++|.+++. ....++.+++++|.+||+. +++||||||+|||+ +++.++|+|||++
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 7899999999999998874 3467999999999999999 99999999999999 6779999999998
Q ss_pred ccc
Q 042457 241 RLL 243 (361)
Q Consensus 241 ~~~ 243 (361)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-19 Score=172.72 Aligned_cols=220 Identities=24% Similarity=0.305 Sum_probs=153.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..+|+.++.+..|+||.||..++. ..+.+|+|+-+ ... +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-------hhhc--cccccCCccee----------------
Confidence 357888999999999999999775 35678874322 111 0000 22222333333
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|+-...+...+. +.. +++.+++|||+. +|+|||+||+|.+++.-|.+|++|||+.+.....
T Consensus 136 -----gDc~tllk~~g~---lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGP---LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----chhhhhcccCCC---Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 455555554332 221 127899999999 9999999999999999999999999998754221
Q ss_pred C---------------CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 247 S---------------SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 247 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
. ......+||+.|.|||++....|....|.|++|+|+||.+-|+.||..... +.....++..
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd 273 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISD 273 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhh
Confidence 1 112335799999999999999999999999999999999999999875432 2333333333
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCC---CccccccCCCCCC
Q 042457 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP---TMRRSFPNPEINP 358 (361)
Q Consensus 312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~hp~~~~ 358 (361)
....+..++.... +..+++.+.|+.+|..|- .+-++-+|+||+.
T Consensus 274 ~i~wpE~dea~p~---Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 274 DIEWPEEDEALPP---EAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred hccccccCcCCCH---HHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 3333333332222 377888899999999996 5567789999974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.4e-19 Score=171.58 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=194.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC--CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP--SGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 164 (361)
...|.+.+.||+|+|+.|-..... ....+|+|.+..........+....|..+-..+. |+|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 445777778999999999888553 3445677766555433333455556777777776 9999999999999999999
Q ss_pred EEEeccCCChhhhh-ccCCccCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEEeCCCCCCeeeCCCC-CeEEeeecCcc
Q 042457 165 IYKYMRRGSLFCVL-RNDDEAIQLDWTKRVNIVKSMAHALSYLH-YDCIPSIVHRDISSNNILLNSKL-EAFVADFGVAR 241 (361)
Q Consensus 165 v~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~ 241 (361)
.++|..++++.+.+ ..... ..+....-..+.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||++.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999888 33321 2444556789999999999999 77 999999999999999999 99999999998
Q ss_pred ccCC-CCC--Ccccccc-cccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCC
Q 042457 242 LLHS-DSS--NRTVVAG-THGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316 (361)
Q Consensus 242 ~~~~-~~~--~~~~~~g-t~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 316 (361)
.+.. ... ......| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++.....+.... ..........
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~--~~~~~~~~~~ 251 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS--SWKSNKGRFT 251 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce--eecccccccc
Confidence 8765 222 2233467 999999999887 4556789999999999999999999876554332211 1111110000
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.... ........+++.+++..+|+.|.+.+++-.+||+..
T Consensus 252 ~~~~--~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 252 QLPW--NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCcc--ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000 001113567777899999999999999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=138.62 Aligned_cols=138 Identities=21% Similarity=0.260 Sum_probs=98.9
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHH----------------------HHHHHHHhcCCCC--cc
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESF----------------------QTEARLLSQIRHR--NI 149 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~--ni 149 (361)
.+.||+|+||.||+|...+|+.||||++............+ ..|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988889999999987543321111111 2455555555433 24
Q ss_pred eeeeEEEeeCCeEEEEEEeccCCChhh-hhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeC
Q 042457 150 VKLYGFCLHKKCMFLIYKYMRRGSLFC-VLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLN 227 (361)
Q Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~ 227 (361)
.+.++. ...+++|||++++.+.. .+.... .. .+...++.+++.++.++|. . +++|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444433 23589999999965432 122111 11 5678899999999999999 7 999999999999999
Q ss_pred CCCCeEEeeecCccccC
Q 042457 228 SKLEAFVADFGVARLLH 244 (361)
Q Consensus 228 ~~~~~kl~Dfg~~~~~~ 244 (361)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-16 Score=128.21 Aligned_cols=135 Identities=18% Similarity=0.154 Sum_probs=114.1
Q ss_pred CcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC--CcceeeeEEEeeCCeEEEEEEecc
Q 042457 93 IKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH--RNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..++.++| .++.+++++....+..++++||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 35679999999999999844 7899999865543 3567889999999976 589999998888888999999999
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++.+..+ +......++.+++++++++|.....+++|+|++|+||++++++.++++|||.+..
T Consensus 77 g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8877654 4566778899999999999987545799999999999999989999999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.9e-16 Score=134.68 Aligned_cols=137 Identities=18% Similarity=0.244 Sum_probs=106.1
Q ss_pred Ceee-ecCceeEEEEEeCCCCEEEEEEeccCcc-----------hHHHHHHHHHHHHHHhcCCCCcc--eeeeEEEeeCC
Q 042457 95 YCIG-TGGYGSVYRAQLPSGKIVALKKLHHSET-----------ELAFLESFQTEARLLSQIRHRNI--VKLYGFCLHKK 160 (361)
Q Consensus 95 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~ 160 (361)
..|| .|+.|+||.+.. ++..++||.+..... +......+.+|++++..++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4588 899999999988 477899998854221 11223567889999999998775 66777654432
Q ss_pred ----eEEEEEEeccC-CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEe
Q 042457 161 ----CMFLIYKYMRR-GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVA 235 (361)
Q Consensus 161 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~ 235 (361)
..++|+|++++ .+|.+++... .++.. .+.+++.++.+||+. ||+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 6898887643 24433 367899999999999 99999999999999998899999
Q ss_pred eecCcccc
Q 042457 236 DFGVARLL 243 (361)
Q Consensus 236 Dfg~~~~~ 243 (361)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.8e-16 Score=133.83 Aligned_cols=207 Identities=24% Similarity=0.333 Sum_probs=145.5
Q ss_pred HHHHhcCCCCcceeeeEEEeeCC-----eEEEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 042457 138 ARLLSQIRHRNIVKLYGFCLHKK-----CMFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCI 211 (361)
Q Consensus 138 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~ 211 (361)
..-+-.+.|.|||++..|+.+.. ...++.|||..|++..+|++.. ....+......+|+.||..||.|||+ +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 34455567999999999887643 5788999999999999998743 23357777888999999999999997 57
Q ss_pred CCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC----CCCCcccccccccccccccccccccCccchhhhHHHHHHHHH
Q 042457 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHS----DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL 287 (361)
Q Consensus 212 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 287 (361)
|.++|+++..+.|++..++-+|++--........ .........+-++|.|||+=.....+.++|||+||...+||-
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 7899999999999999999888753221111000 001112234678899999866666778999999999999998
Q ss_pred hCCCC-CCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 288 MGRHP-GDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 288 tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
-|..- ....+....+....+........ .=..++..|++.+|..||+|++++-||-+=
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeeccCc------------cccCcCcccccCCCCCCcchhhhhcCceee
Confidence 77643 33222222222222221111100 123456699999999999999999999653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.2e-16 Score=144.05 Aligned_cols=255 Identities=23% Similarity=0.219 Sum_probs=183.6
Q ss_pred cCCCCcCeeee--cCceeEEEEEe---CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 89 EDFDIKYCIGT--GGYGSVYRAQL---PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 89 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
..|.....+|. |.+|.+|.+.. .++..+|+|+-+...........=.+|+....++ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 44666788999 99999999965 4688899998544332211112223566666666 499999988888999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeee
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH----ALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADF 237 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Df 237 (361)
++-+|.+. .+|..+-..... .+.....+....+..+ |+.++|.. +++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 99999985 677776655332 3555666777777777 99999999 99999999999999999 88999999
Q ss_pred cCccccCCCCCCccc-----ccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCc--ccCCcchhHhhhhc
Q 042457 238 GVARLLHSDSSNRTV-----VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLL--SSFNPKIMLIDLLD 310 (361)
Q Consensus 238 g~~~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~--~~~~~~~~~~~~~~ 310 (361)
|+...+......... ..+...|++||.. .+-++.++|+|++|.++.+..+|..+.... ..+.+...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~------ 340 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ------ 340 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc------
Confidence 999888665533222 2577889999975 455788999999999999999887664432 11111100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 311 QRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
...+.... . .....+...+.++++.+|-.|++.+.+.+|+++...+
T Consensus 341 ~~ip~e~~-~---~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 341 GYIPLEFC-E---GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred ccCchhhh-c---CcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence 00110000 0 0111244578899999999999999999999997643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=135.80 Aligned_cols=143 Identities=21% Similarity=0.248 Sum_probs=101.0
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchH----------------------------HHH----------HHHH
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETEL----------------------------AFL----------ESFQ 135 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~----------~~~~ 135 (361)
.+.||.|++|.||+|++.+|+.||||+.+...... ... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 35799999999999999999999999986542110 000 0244
Q ss_pred HHHHHHhcC----CCCcceeeeEEEee-CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHH-HHHHHHcC
Q 042457 136 TEARLLSQI----RHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH-ALSYLHYD 209 (361)
Q Consensus 136 ~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~Lh~~ 209 (361)
.|+..+.++ +|.+-+.+-..+.+ ....++||||++|++|.++...... .. ....++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 555555554 23333333333332 3457999999999999887653211 12 23456666666 46788988
Q ss_pred CCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 210 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|++|+|++|.||+++.+++++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.9e-13 Score=128.03 Aligned_cols=169 Identities=19% Similarity=0.251 Sum_probs=128.7
Q ss_pred EeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCC
Q 042457 109 QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLD 188 (361)
Q Consensus 109 ~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~ 188 (361)
+..++.+|.|...+.... ...+...+.++.|+.++||||++++......+..|+|+|-+. .|..++.+ ++
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~ 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LG 102 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hH
Confidence 445788888888877665 334566778899999999999999999999999999999873 56666653 33
Q ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccccccccccccccccccc
Q 042457 189 WTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM 268 (361)
Q Consensus 189 ~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 268 (361)
......-+.||+.||.|||..+ +++|+++.-..|+|+..|..||++|.++..............--..|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 4566778899999999999776 89999999999999999999999999886543322211212222345666644322
Q ss_pred ccCccchhhhHHHHHHHHHhCCC
Q 042457 269 VVTEKCDVFGFGVVALEVLMGRH 291 (361)
Q Consensus 269 ~~~~~~Dv~slG~~l~el~tg~~ 291 (361)
. ...|.|-||++++|++.|..
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c--cchhhhhHHHHHHHHhCccc
Confidence 2 34699999999999999943
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.5e-13 Score=110.46 Aligned_cols=129 Identities=20% Similarity=0.196 Sum_probs=94.8
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcce-eeeEEEeeCCeEEEEEEeccCCC
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV-KLYGFCLHKKCMFLIYKYMRRGS 173 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~ 173 (361)
+.++.|.++.||+++. .+..+++|........ ...+..|+..++.+.+.+++ +++.+. ....++||||++|.+
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 4578899999999987 4778999987654321 13456888888888655544 444443 233579999999988
Q ss_pred hhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 174 LFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC--IPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
+...- . ....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++||+.+.
T Consensus 78 l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76430 0 11345789999999999983 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-13 Score=130.81 Aligned_cols=146 Identities=21% Similarity=0.249 Sum_probs=94.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCcch----------------------------H----HHHHH--
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETE----------------------------L----AFLES-- 133 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------~----~~~~~-- 133 (361)
.+|+. +.||.|++|.||+|++.+ |+.||||+.+..-.. . +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 689999999999999887 999999999754210 0 11112
Q ss_pred ----HHHHHHHHhcCC----CCcceeeeEEEee-CCeEEEEEEeccCCChhhh--hccCC-ccCCCCHHHHHHHHHHHHH
Q 042457 134 ----FQTEARLLSQIR----HRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCV--LRNDD-EAIQLDWTKRVNIVKSMAH 201 (361)
Q Consensus 134 ----~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~-~~~~l~~~~~~~i~~~i~~ 201 (361)
+..|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+. +...+ ....+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 334444444432 3333443344433 3456899999999999764 22221 00112222233333333
Q ss_pred HHHHHHcCCCCCeEEeCCCCCCeeeCCCC----CeEEeeecCccccCC
Q 042457 202 ALSYLHYDCIPSIVHRDISSNNILLNSKL----EAFVADFGVARLLHS 245 (361)
Q Consensus 202 ~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~~~~~~~ 245 (361)
... |++|+|++|.||+++.++ +++++|||++..+..
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999888 999999999877643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-13 Score=128.49 Aligned_cols=250 Identities=19% Similarity=0.185 Sum_probs=179.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe--CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL--PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 163 (361)
...+|.++..||.|.|+.|+.... .++..+++|.+...-........-..|+.+...+ .|.++++++..+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 345788899999999999999854 4688899998876554332223334566666655 5888888887777777788
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeeecCccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARL 242 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~ 242 (361)
+--|||+++++..... ....++...++++..|++.++.++|+. .++|+|++|+||++..+ +..+++|||.+..
T Consensus 343 ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccc
Confidence 9999999998875552 222577888999999999999999998 99999999999999876 7788999999864
Q ss_pred cCCCCCCccccccccccc--ccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 243 LHSDSSNRTVVAGTHGYI--APELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
+.. ......+.-+++ +++......+..+.|++|||.-+.|.++|..--..... ...+..+..+......
T Consensus 417 ~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------~~~i~~~~~p~~~~~~ 487 (524)
T KOG0601|consen 417 LAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------SLTIRSGDTPNLPGLK 487 (524)
T ss_pred cce---ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc------ceeeecccccCCCchH
Confidence 221 111222333444 45555567788899999999999999998765322111 1222333333222211
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
..+..+.+.+..+++..||.+.++..|+-|.
T Consensus 488 ------~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 488 ------LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 2356667788999999999999998887653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.2e-12 Score=104.91 Aligned_cols=138 Identities=18% Similarity=0.192 Sum_probs=98.6
Q ss_pred CeeeecCceeEEEEEeCC-------CCEEEEEEeccCcc-----------h---------HHHHHHHH----HHHHHHhc
Q 042457 95 YCIGTGGYGSVYRAQLPS-------GKIVALKKLHHSET-----------E---------LAFLESFQ----TEARLLSQ 143 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~~~~----~e~~~l~~ 143 (361)
..||.|--+.||.|...+ +..+|||+.+.+.. + ......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 47899998754211 0 01122233 78999998
Q ss_pred CCC--CcceeeeEEEeeCCeEEEEEEeccCCChhh-hhccCCccCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEEeCC
Q 042457 144 IRH--RNIVKLYGFCLHKKCMFLIYKYMRRGSLFC-VLRNDDEAIQLDWTKRVNIVKSMAHALSYL-HYDCIPSIVHRDI 219 (361)
Q Consensus 144 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~~~~i~H~dl 219 (361)
+.. -++.+.+++ ..-++||||+.++.+.. .+++. .++..+...+..+++.+|..| |.. +++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 456666654 44689999997654422 23221 244556678889999999999 788 9999999
Q ss_pred CCCCeeeCCCCCeEEeeecCccccC
Q 042457 220 SSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 220 k~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
++.||++++ +.+.|+|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 679999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.4e-13 Score=130.87 Aligned_cols=262 Identities=20% Similarity=0.237 Sum_probs=179.3
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchH-HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL-AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
...+.+.+.+-+..|.++.++.+.-. .|...+.|.......-. ...+....+-.+.-..++|-+++..-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34456667777888999999887432 34444444433222100 00111222222222233455554444444566789
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
|+++|..+++|...|++.. ..+..-.......+.+.+++||.. .+.|+|++|.|.+...++..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999998766 345455566777889999999998 7999999999999999999999999833221
Q ss_pred CC------C---------------C----------CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCC
Q 042457 244 HS------D---------------S----------SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292 (361)
Q Consensus 244 ~~------~---------------~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 292 (361)
.. . . .......+|+.|.+||...+......+|.|+.|+.++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 00 0 0 001223589999999999999999999999999999999999999
Q ss_pred CCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcc---ccccCCCCCCC
Q 042457 293 GDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR---RSFPNPEINPS 359 (361)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~---eil~hp~~~~~ 359 (361)
|..... .....++.....+.+....... ....+++...+..+|.+|-.+. ++-.||||+..
T Consensus 1035 ~na~tp---q~~f~ni~~~~~~~p~g~~~~s---~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1035 FNAETP---QQIFENILNRDIPWPEGPEEGS---YEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred CCCcch---hhhhhccccCCCCCCCCccccC---hhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 875543 3333455555555444322221 2366777788999999999999 99999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-11 Score=104.40 Aligned_cols=142 Identities=19% Similarity=0.232 Sum_probs=109.8
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC--CcceeeeEEEeeCC---eEEEEEEec
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH--RNIVKLYGFCLHKK---CMFLIYKYM 169 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~ 169 (361)
+.|+.|.++.+|++...+|..+++|........ .....+..|.++++.+++ .++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 458999999999998877788999997654331 123567889999999875 34577777776643 578999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC--------------------------------------- 210 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------- 210 (361)
+|.++.+.+.. ..++..+...++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99988876532 14677788888889999999888531
Q ss_pred --------------CCCeEEeCCCCCCeeeCC--CCCeEEeeecCcc
Q 042457 211 --------------IPSIVHRDISSNNILLNS--KLEAFVADFGVAR 241 (361)
Q Consensus 211 --------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~ 241 (361)
...++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 135799999999999998 5668899999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.8e-11 Score=96.02 Aligned_cols=132 Identities=21% Similarity=0.337 Sum_probs=100.9
Q ss_pred eeeecCceeEEEEEeCCCCEEEEEEec-cCcc-----hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 96 CIGTGGYGSVYRAQLPSGKIVALKKLH-HSET-----ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
.+++|+-+.+|.+.+ -|..+++|.-. +.-. ..-..+....|+.++.+++--.|.--.-+..+.+...++|||.
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 478999999999988 44446777532 2211 1112345678999999886555555555666777788999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
+|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++.++. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888754 246788888899999999 999999999999998875 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.5e-10 Score=92.25 Aligned_cols=146 Identities=19% Similarity=0.227 Sum_probs=104.2
Q ss_pred CcCeeeecCceeEEEEEeCCCCEEEEEEecc-Ccc-----hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 93 IKYCIGTGGYGSVYRAQLPSGKIVALKKLHH-SET-----ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~-~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
....+-||+-+.|+++.+ .|+..+||.-.. .-. ..-......+|++.+.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456688999999999999 788877775322 211 1122356778999998886444444444555666678999
Q ss_pred EeccC-CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC---CeEEeeecCccc
Q 042457 167 KYMRR-GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL---EAFVADFGVARL 242 (361)
Q Consensus 167 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~ 242 (361)
||+++ .++.+++...-... ........++..|-+.+.-||.+ +++||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 46777776543221 22233378899999999999999 999999999999996554 357999999864
Q ss_pred c
Q 042457 243 L 243 (361)
Q Consensus 243 ~ 243 (361)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.8e-12 Score=118.61 Aligned_cols=158 Identities=17% Similarity=0.188 Sum_probs=110.0
Q ss_pred HHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC---------ccccccccccccccccc
Q 042457 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---------RTVVAGTHGYIAPELAY 266 (361)
Q Consensus 196 ~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~---------~~~~~gt~~y~aPE~~~ 266 (361)
+.+++.|+.|+|... ++||++|.|++|.++.++..||+.|+.+......... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344559999999885 8999999999999999999999999988655432111 11123456899999999
Q ss_pred ccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCC
Q 042457 267 TMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP 345 (361)
Q Consensus 267 ~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 345 (361)
+...+.++|+||+|+++|.+.. |+.-+.......... ......+....... .....++.+=+.+++..++.-||
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s----~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYS----NNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhccccccccccc----ccCcHHHHHHHHHHhcCCcccCc
Confidence 9888999999999999999995 555444332211111 11111110000000 11222466777789999999999
Q ss_pred CccccccCCCCCCCC
Q 042457 346 TMRRSFPNPEINPSL 360 (361)
Q Consensus 346 s~~eil~hp~~~~~~ 360 (361)
++.+++..|||.+..
T Consensus 258 ~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 258 TLDLLLSIPFFSDPG 272 (700)
T ss_pred chhhhhcccccCCch
Confidence 999999999998864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.5e-09 Score=94.87 Aligned_cols=140 Identities=19% Similarity=0.139 Sum_probs=99.9
Q ss_pred eeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHH----------HHHHHHHHHhcCCCC--cceeeeEEEee-----C
Q 042457 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLE----------SFQTEARLLSQIRHR--NIVKLYGFCLH-----K 159 (361)
Q Consensus 97 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~----------~~~~e~~~l~~l~h~--niv~~~~~~~~-----~ 159 (361)
+-......|++..+ +|+.+.||......... ..+ .+.+|...+.++... ..++.+++... .
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 44444455778877 77889999774433111 111 367888888877432 33445555543 2
Q ss_pred CeEEEEEEeccCC-ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-------CCC
Q 042457 160 KCMFLIYKYMRRG-SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-------KLE 231 (361)
Q Consensus 160 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-------~~~ 231 (361)
...++|+|++++. +|.+++..... ...+......++.+++..+.-||.. |++|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 3478999999886 78888753211 1355667789999999999999999 9999999999999975 467
Q ss_pred eEEeeecCccc
Q 042457 232 AFVADFGVARL 242 (361)
Q Consensus 232 ~kl~Dfg~~~~ 242 (361)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.2e-10 Score=92.18 Aligned_cols=128 Identities=26% Similarity=0.342 Sum_probs=83.7
Q ss_pred eEEEEEeCCCCEEEEEEeccCcc------------------------hHHHHHHHHHHHHHHhcCCCC--cceeeeEEEe
Q 042457 104 SVYRAQLPSGKIVALKKLHHSET------------------------ELAFLESFQTEARLLSQIRHR--NIVKLYGFCL 157 (361)
Q Consensus 104 ~V~~~~~~~~~~vavK~~~~~~~------------------------~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 157 (361)
.||.|...+|..+|+|..+.... .........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999988999999998754211 111224567899999999765 456665442
Q ss_pred eCCeEEEEEEecc--CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEEeCCCCCCeeeCCCCCeEE
Q 042457 158 HKKCMFLIYKYMR--RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY-LHYDCIPSIVHRDISSNNILLNSKLEAFV 234 (361)
Q Consensus 158 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-Lh~~~~~~i~H~dlk~~Nill~~~~~~kl 234 (361)
.-.+||||++ |..+..+.... ++......++.+++..+.. +|.. +++||||++.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 2379999998 55554433322 1123456678888886665 5677 99999999999999988 9999
Q ss_pred eeecCccccC
Q 042457 235 ADFGVARLLH 244 (361)
Q Consensus 235 ~Dfg~~~~~~ 244 (361)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.1e-08 Score=91.61 Aligned_cols=195 Identities=16% Similarity=0.249 Sum_probs=127.7
Q ss_pred CCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe------eC-CeEE
Q 042457 92 DIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCL------HK-KCMF 163 (361)
Q Consensus 92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~------~~-~~~~ 163 (361)
.....||+|+-+.+|..---.+ .+-|+......... . +-...|... .||-+-.-+.+=+ +. ...-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchhhc--hhheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 3456699999999997632122 34466554433211 1 223333433 5664433122111 11 2256
Q ss_pred EEEEeccCCC-hhhhhc---cCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 164 LIYKYMRRGS-LFCVLR---NDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 164 lv~e~~~~g~-L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
++|...++.- ...+++ ....-...+|...++.++.+|.+.+-||.. |.+-||++++|+|+.+++.+.|.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence 6777766542 222221 122233579999999999999999999999 999999999999999999999988554
Q ss_pred ccccCCCCCCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhC-CCCCCCcc
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMG-RHPGDLLS 297 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~ 297 (361)
-... .+.......+|...|.+||.-. +..-+...|-|.||+++++++.| ++||....
T Consensus 164 fqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 164 FQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 3322 2222333456889999999644 34456789999999999999985 99997654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.1e-09 Score=89.52 Aligned_cols=138 Identities=23% Similarity=0.250 Sum_probs=100.1
Q ss_pred CCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcch--------------------HHHHHHHHHHHHHHhcCCCC--c
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETE--------------------LAFLESFQTEARLLSQIRHR--N 148 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~h~--n 148 (361)
..+.+.||-|.-+.||.|..++|.++|||.=+....+ .-......+|.+.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4556789999999999999999999999964332111 01123456788999988654 5
Q ss_pred ceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC
Q 042457 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228 (361)
Q Consensus 149 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~ 228 (361)
+.+.+++ +.-.+|||+.+|.-|...- ++....-.++..|++-+.-+-.. |++|||++.-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 6655554 3347999999987765432 22334445666666666666666 9999999999999999
Q ss_pred CCCeEEeeecCcccc
Q 042457 229 KLEAFVADFGVARLL 243 (361)
Q Consensus 229 ~~~~kl~Dfg~~~~~ 243 (361)
+|.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999766543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.4e-09 Score=95.77 Aligned_cols=170 Identities=17% Similarity=0.291 Sum_probs=126.0
Q ss_pred CceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee----CCeEEEEEEeccCC-Ch
Q 042457 101 GYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH----KKCMFLIYKYMRRG-SL 174 (361)
Q Consensus 101 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g-~L 174 (361)
...+.|++.. .||..|++|+++...... ...-..-++.++++.|+|+|++..++.. +..+++||+|.++. +|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3457889854 489999999994332211 1122356889999999999999998873 45689999999864 56
Q ss_pred hhhhccCC------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 175 FCVLRNDD------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 175 ~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
.++--... .....++..+|.++.|+..||.++|+. |+..+-|.+++|+++++.+++|+.-|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 55542211 122467788999999999999999999 999999999999999999999988887665
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCC
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 292 (361)
+..+.. |-+.+ -.+-|.=.||.+++.|.||..-
T Consensus 443 l~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 443 LQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 543330 11111 1356899999999999999644
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.5e-08 Score=79.97 Aligned_cols=140 Identities=16% Similarity=0.100 Sum_probs=102.0
Q ss_pred eeecCceeEEEEEeCCCCEEEEEEeccCcc-h---HHHHHHHHHHHHHHhcCCC--CcceeeeEEEe-eC----CeEEEE
Q 042457 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSET-E---LAFLESFQTEARLLSQIRH--RNIVKLYGFCL-HK----KCMFLI 165 (361)
Q Consensus 97 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~---~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~-~~----~~~~lv 165 (361)
-|.||-+.|++..+ +|+.+-+|+-...-. . .-....|.+|+..+.++.. -.+.+.. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46688899999888 555799997652111 1 1123678899999988853 2244444 332 21 246899
Q ss_pred EEeccC-CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC--eEEeeecCccc
Q 042457 166 YKYMRR-GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE--AFVADFGVARL 242 (361)
Q Consensus 166 ~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~ 242 (361)
+|-+.+ -+|.+++.+... .+.+...+..++.+++..+.-||.. ++.|+|+.+.||+++.++. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 478888765432 2467778889999999999999999 9999999999999986667 89999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.3e-08 Score=83.48 Aligned_cols=106 Identities=22% Similarity=0.318 Sum_probs=82.8
Q ss_pred HHHHHHHHHHhcCC--CCcceeeeEEEeeCC----eEEEEEEeccCC-ChhhhhccCCccCCCCHHHHHHHHHHHHHHHH
Q 042457 132 ESFQTEARLLSQIR--HRNIVKLYGFCLHKK----CMFLIYKYMRRG-SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204 (361)
Q Consensus 132 ~~~~~e~~~l~~l~--h~niv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 204 (361)
....+|...+..+. .-...+.+++..... ..++|+|++++. +|.+++..... .+......++.+++..++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 34667777777764 233556666666532 458999999885 79998876332 556677899999999999
Q ss_pred HHHcCCCCCeEEeCCCCCCeeeCCCC---CeEEeeecCcccc
Q 042457 205 YLHYDCIPSIVHRDISSNNILLNSKL---EAFVADFGVARLL 243 (361)
Q Consensus 205 ~Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~~ 243 (361)
-||.. +++|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999998887 7899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.9e-08 Score=91.88 Aligned_cols=143 Identities=22% Similarity=0.250 Sum_probs=92.5
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcch----------------------------HHHHH----------HHHH
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETE----------------------------LAFLE----------SFQT 136 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------------~~~~~----------~~~~ 136 (361)
.-|+.++-|.||+|++.+|+.||||+.+.+-.. .+..+ ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 568999999999999999999999998653211 00011 2334
Q ss_pred HHHHHhcCC----CCcceeeeEEEee-CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHH-HHHHHcCC
Q 042457 137 EARLLSQIR----HRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHA-LSYLHYDC 210 (361)
Q Consensus 137 e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~~Lh~~~ 210 (361)
|...+.+++ +..-+++=.++.+ .+...|+|||++|..+.+....... ..+... ++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhc-
Confidence 554444442 2222333334433 4557899999999999887422211 244333 33333332 2222223
Q ss_pred CCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 211 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|++|+|..|.||+++.++++.+.|||+...+..
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999877643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.71 E-value=4e-07 Score=75.94 Aligned_cols=141 Identities=16% Similarity=0.203 Sum_probs=96.2
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHH-HHHH------HHHHHHHHhcCCC---CcceeeeEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELA-FLES------FQTEARLLSQIRH---RNIVKLYGF 155 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~e~~~l~~l~h---~niv~~~~~ 155 (361)
....+|...+.+-......|.+-.. +|..+++|..+......+ .... ..+++..+.+++. .....++..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4677888888888888888888888 778899998876543221 1111 2233444444432 233333333
Q ss_pred Eee-----CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 156 CLH-----KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 156 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
... ....+++|||++|..|.++.. ++. .+...+.+++.-||+. |++|+|..|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc
Confidence 332 234678999999998876542 222 3556678889999999 999999999999999654
Q ss_pred CeEEeeecCccc
Q 042457 231 EAFVADFGVARL 242 (361)
Q Consensus 231 ~~kl~Dfg~~~~ 242 (361)
++++||+..+.
T Consensus 173 -i~iID~~~k~~ 183 (229)
T PF06176_consen 173 -IRIIDTQGKRM 183 (229)
T ss_pred -EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.4e-07 Score=77.65 Aligned_cols=132 Identities=16% Similarity=0.185 Sum_probs=84.4
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCc--ceeeeEEEeeCCeEEEEEEeccCC
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN--IVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
..||+|..+.||+. .|..+++|....... .....+|.+.++.+..-. +.+.++++...+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 45899999999984 245678888765332 244578999998885433 467778887777788999999986
Q ss_pred C-hhhhhccCCccCCCCHHHHHHHHHHHHHHH---------------------------------------HHHHcC-CC
Q 042457 173 S-LFCVLRNDDEAIQLDWTKRVNIVKSMAHAL---------------------------------------SYLHYD-CI 211 (361)
Q Consensus 173 ~-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l---------------------------------------~~Lh~~-~~ 211 (361)
+ +...+.. +......++..+++.+ .+|... ..
T Consensus 80 ~~~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 80 RSFSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred cchhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 3 2211110 0011111111112211 222211 12
Q ss_pred CCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 212 PSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 212 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
+.++|+|+.|.||++++++ +.++||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3578999999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.4e-06 Score=73.61 Aligned_cols=155 Identities=21% Similarity=0.248 Sum_probs=100.3
Q ss_pred cCHHHHHHHhcCCCCcCee---eecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHH----------------------
Q 042457 79 ITFEEIIVATEDFDIKYCI---GTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLES---------------------- 133 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~l---g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------- 133 (361)
.+++.+....++..+.... +.|.-+.||+|...++..+|+|+.+.....-.....
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 4566666666666665554 456667899998888999999998754322111111
Q ss_pred HHHHHHHHhcCC--CCcceeeeEEEeeCCeEEEEEEeccCCC-hhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 042457 134 FQTEARLLSQIR--HRNIVKLYGFCLHKKCMFLIYKYMRRGS-LFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210 (361)
Q Consensus 134 ~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ 210 (361)
..+|+..|+++. +=.+.+-+++. .-.|||||+.... -.-.|... .+.......+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhc
Confidence 224555555542 22223333322 2368999986542 12222222 2333356778888889988888733
Q ss_pred CCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 211 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
++||+||+.-|||+. ++.+.|+|+|-+....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 7899999999887654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.1e-07 Score=91.98 Aligned_cols=203 Identities=16% Similarity=0.180 Sum_probs=141.6
Q ss_pred HHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE----EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHH
Q 042457 131 LESFQTEARLLSQIRHRNIVKLYGFCLHKKCM----FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206 (361)
Q Consensus 131 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L 206 (361)
+.....|...+.++.|+|++.+++|....... .+..+++...++...++... ..+....+.+..++..|+.|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHH
Confidence 34455677888889999999999998765433 24457888888888887665 578888899999999999999
Q ss_pred HcCCCCCeEEeCCCCC---CeeeCCCCCeEEe--eecCccccCCCCCCcccccccccccccccccccccCc--cchhhhH
Q 042457 207 HYDCIPSIVHRDISSN---NILLNSKLEAFVA--DFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE--KCDVFGF 279 (361)
Q Consensus 207 h~~~~~~i~H~dlk~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~sl 279 (361)
|+. ...|.-|..+ +--.+.++...++ ||+.......... ......+..|.++|......+.. ..|+|++
T Consensus 303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhhhhhHHHHH
Confidence 998 5555555555 4455666667766 8888776543322 22223455678888766555444 4799999
Q ss_pred HHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 280 GVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 280 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
|.....+..|..+-..... ....+.... . . .......+|+..++++|+++.+++.|+|++.
T Consensus 379 gll~~~~~~~~~i~~~~~~------~~~~l~~~~----~-----~---~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAV------PVSLLDVLS----T-----S---ELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred HHHHhhhhhcCcccccccc------hhhhhcccc----c-----h---hhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 9999999988765221110 001111100 0 0 2556666999999999999999999999875
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.2e-06 Score=71.95 Aligned_cols=142 Identities=20% Similarity=0.204 Sum_probs=82.1
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCC--cceeeeEEEee---CCeEEEEEEec
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR--NIVKLYGFCLH---KKCMFLIYKYM 169 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~ 169 (361)
+.++.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.++.. ....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 568999999999999866 68999997654 2235667888888877432 35666765543 33578999999
Q ss_pred cCCChhh----------------hh---ccC-CccCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 042457 170 RRGSLFC----------------VL---RND-DEAIQLDWTK---------RVNI------------VKSMAH-ALSYLH 207 (361)
Q Consensus 170 ~~g~L~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~~Lh 207 (361)
++..+.. .+ +.. .......+.. .... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111 0000111100 0000 111222 233333
Q ss_pred c----CCCCCeEEeCCCCCCeeeC-CCCCeEEeeecCcc
Q 042457 208 Y----DCIPSIVHRDISSNNILLN-SKLEAFVADFGVAR 241 (361)
Q Consensus 208 ~----~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~ 241 (361)
. .....++|+|+.+.||+++ +++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 1234799999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.9e-06 Score=71.38 Aligned_cols=104 Identities=23% Similarity=0.320 Sum_probs=82.8
Q ss_pred HHHHHHhcCCC-CcceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 042457 136 TEARLLSQIRH-RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214 (361)
Q Consensus 136 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i 214 (361)
.|.-+++.+++ +++.+++|+|-+ +++.||...+++...-..-..-...+|..+.+|+.++++.+.++++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57788888876 699999999943 6799999877665321110011146899999999999999999999665578
Q ss_pred EEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 215 VHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 215 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
..+|++++|+-+++++++|++|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 89999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.5e-08 Score=93.65 Aligned_cols=242 Identities=17% Similarity=0.176 Sum_probs=156.1
Q ss_pred CcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeeCCeEEEEEEeccC
Q 042457 93 IKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN-IVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
.-+.+++|++++++|.+-.-.+....+.+... ....-++++|.+++||| .++.++-+..++..+++++++.+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 34457899999999986533333345544332 33446889999999999 77888888888889999999987
Q ss_pred C-ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc
Q 042457 172 G-SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250 (361)
Q Consensus 172 g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 250 (361)
+ +-..-... ....+...+...+.+.-.++++++|+. .-+|+| ||+..+ +..+.+||+....+.... ..
T Consensus 319 ~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 319 GRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred CccccccCCh--hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 7 22211111 111344555667778888999999987 557888 777665 578999999887664432 34
Q ss_pred ccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHH
Q 042457 251 TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVS 330 (361)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 330 (361)
....+++.|+|||+...+.+....|+|++|.--.++--|-+|-..... ....+-.+.-.........+.. ..=.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~-----~~~~~g~~p~s~~L~~~~aw~~-~~~~ 461 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA-----VLPMIGNGPNSPMLTDKSAWSP-VFHR 461 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc-----ccCCCCCCCCccccchhhhcCc-cccc
Confidence 456689999999999999999999999999876777667666322100 0000000000000000000000 0000
Q ss_pred HHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 331 KIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 331 ~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+...|+...|..|+..-..+-|.+|+.
T Consensus 462 ~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 462 DFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 2344788888999998888887776654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.7e-06 Score=72.43 Aligned_cols=139 Identities=14% Similarity=0.111 Sum_probs=84.0
Q ss_pred eeecCc-eeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEEEEeccCCCh
Q 042457 97 IGTGGY-GSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 97 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L 174 (361)
|..|.+ ..||+.... +..+++|...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 444555 789999774 4778889876543 134557888887773 44466777877776678999999999877
Q ss_pred hhhhc-------------------cCCc-cCCCC--HHHHHHHHH--------------------HHHHHHHHHHc----
Q 042457 175 FCVLR-------------------NDDE-AIQLD--WTKRVNIVK--------------------SMAHALSYLHY---- 208 (361)
Q Consensus 175 ~~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------~i~~~l~~Lh~---- 208 (361)
..... .... ...+. ......... .+......|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 64321 1000 00111 000000000 01111222211
Q ss_pred CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 209 ~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 122468999999999999998778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.7e-06 Score=80.52 Aligned_cols=141 Identities=18% Similarity=0.171 Sum_probs=89.3
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcch-----------------------------HHHHH------HHHHHHH
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETE-----------------------------LAFLE------SFQTEAR 139 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------------------~~~~~------~~~~e~~ 139 (361)
+.||.-+.|.||+|++++|+.||||+-+..-.. .+..+ +|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 569999999999999999999999987653221 00011 2344444
Q ss_pred HHhcC----CCCc---ceeeeEEEee-CCeEEEEEEeccCCChhhhh--ccCCccCCCCHHHHHHHHHHHHHHHHHHHcC
Q 042457 140 LLSQI----RHRN---IVKLYGFCLH-KKCMFLIYKYMRRGSLFCVL--RNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209 (361)
Q Consensus 140 ~l~~l----~h~n---iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~ 209 (361)
-..++ .|-+ -|.+=.++.+ .....|+||||+|..+.+.- .+. .++...+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i~~~l~~~~~~qIf~~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR----GISPHDILNKLVEAYLEQIFKT-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc----CCCHHHHHHHHHHHHHHHHHhc--
Confidence 43333 3444 1222233333 34578999999999887653 333 2444443333333222222222
Q ss_pred CCCCeEEeCCCCCCeeeCC----CCCeEEeeecCccccC
Q 042457 210 CIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLH 244 (361)
Q Consensus 210 ~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg~~~~~~ 244 (361)
|++|+|=.|.||+++. ++.+.+-|||+...+.
T Consensus 321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 8999999999999983 6789999999987664
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.1e-06 Score=67.68 Aligned_cols=131 Identities=18% Similarity=0.242 Sum_probs=90.5
Q ss_pred CCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCccee-eeEEEeeCCeEEEEEEec
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK-LYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~ 169 (361)
......|++|.+|.||+|.+ .|..+|+|+-+.++. ...+..|++++..+.-.++.+ ++.|.. .++.|||.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhhhcccccEEEEeec-cCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 34456799999999999999 556799998766544 367889999999888666554 333332 23559999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCC-CCCeeeCCCCCeEEeeecCcccc
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDIS-SNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk-~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
.|-.|.+.-... + .+-+..+++..--|... ||-|+.|+ |...++-+++.+.|+||.-|+.-
T Consensus 95 ~G~~L~~~~~~~------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEIGG------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhhcc------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 988886654321 1 23344555665555666 89999887 44444444459999999988744
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.7e-05 Score=80.89 Aligned_cols=80 Identities=19% Similarity=0.329 Sum_probs=57.6
Q ss_pred cCeeeecCceeEEEEEeCCC---CEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcc--eeeeEEEeeC---CeEEE
Q 042457 94 KYCIGTGGYGSVYRAQLPSG---KIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNI--VKLYGFCLHK---KCMFL 164 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~l 164 (361)
...++.|.++.+|+....++ ..+++|+........ ....+.+|+++++.+. |.++ .+++++|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 45688899999999877654 367888765432111 1246779999999985 6654 7888888764 46789
Q ss_pred EEEeccCCCh
Q 042457 165 IYKYMRRGSL 174 (361)
Q Consensus 165 v~e~~~~g~L 174 (361)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.2e-05 Score=68.41 Aligned_cols=78 Identities=21% Similarity=0.202 Sum_probs=57.3
Q ss_pred CCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC---CcceeeeEEEeeC---CeEEEE
Q 042457 92 DIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH---RNIVKLYGFCLHK---KCMFLI 165 (361)
Q Consensus 92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~---~~~~lv 165 (361)
.-.+.||.|..+.||.....+++ +++|..+.... ...+..|.+.++.+.. -.+.+++++|... +..++|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEeccccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 33456999999999999875664 67777543111 1567789999988843 3678888888653 568999
Q ss_pred EEeccCCCh
Q 042457 166 YKYMRRGSL 174 (361)
Q Consensus 166 ~e~~~~g~L 174 (361)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.7e-05 Score=63.38 Aligned_cols=134 Identities=21% Similarity=0.325 Sum_probs=91.4
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCc--------------chHHHHHHHHHHHHHHhcCC------CCcceeee
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSE--------------TELAFLESFQTEARLLSQIR------HRNIVKLY 153 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~niv~~~ 153 (361)
...||+|+.-.||.- +++....||+..... ......++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 456999999888864 445557888887655 00111345556666555554 78999999
Q ss_pred EEEeeCCeEEEEEEeccCC------ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC
Q 042457 154 GFCLHKKCMFLIYKYMRRG------SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN 227 (361)
Q Consensus 154 ~~~~~~~~~~lv~e~~~~g------~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~ 227 (361)
|+..++...-+|+|.+.+. +|.+++.+.. ++. .+...+-+-..||-.. .|+.+|++|+||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 9999999999999987532 5677775442 444 3444455566677777 899999999999994
Q ss_pred CC--C--CeEEee-ecCc
Q 042457 228 SK--L--EAFVAD-FGVA 240 (361)
Q Consensus 228 ~~--~--~~kl~D-fg~~ 240 (361)
.. + .+.|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 33 2 466666 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.9e-05 Score=68.26 Aligned_cols=74 Identities=12% Similarity=0.223 Sum_probs=45.2
Q ss_pred CeeeecCce-eEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCC---cceeeeEEEeeC---CeEEEEEE
Q 042457 95 YCIGTGGYG-SVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR---NIVKLYGFCLHK---KCMFLIYK 167 (361)
Q Consensus 95 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e 167 (361)
+.++.|+.. .||+. +..+++|....... ...+..|.+.+..+... .+.+.++..... ...+++|+
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~~----~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAGY----AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccch----HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 346766665 58875 23477787554221 24677899888877532 344444444332 23588999
Q ss_pred eccCCChhh
Q 042457 168 YMRRGSLFC 176 (361)
Q Consensus 168 ~~~~g~L~~ 176 (361)
+++|.++.+
T Consensus 75 ~i~G~~l~~ 83 (235)
T cd05155 75 WLEGETATA 83 (235)
T ss_pred eecCCCCCc
Confidence 999987743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.2e-05 Score=63.24 Aligned_cols=127 Identities=24% Similarity=0.451 Sum_probs=91.6
Q ss_pred cCCCCcCeeeecCc-eeEEEEEeCCCCEEEEEEecc---Ccc----------hH------HHHHHHHHHHHHHhcCC---
Q 042457 89 EDFDIKYCIGTGGY-GSVYRAQLPSGKIVALKKLHH---SET----------EL------AFLESFQTEARLLSQIR--- 145 (361)
Q Consensus 89 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~----------~~------~~~~~~~~e~~~l~~l~--- 145 (361)
.+++..+.||.|.- |.||+++. +|+.+|+|.+.. ... .. ....-|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999999 788999999322 000 00 23346788888888774
Q ss_pred CCcc--eeeeEEEeeCC------------------eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHH
Q 042457 146 HRNI--VKLYGFCLHKK------------------CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205 (361)
Q Consensus 146 h~ni--v~~~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 205 (361)
+.++ |+++||..-.. ...||.||.+... .++. +-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4566 99999985431 1356777765433 1222 335667777888
Q ss_pred HHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 206 Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
+|.. +|+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 9999 9999999999987 4578999854
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.06 E-value=7.2e-05 Score=64.52 Aligned_cols=74 Identities=15% Similarity=0.150 Sum_probs=47.4
Q ss_pred CeeeecCceeEEEEEeCC--CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLPS--GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN-IVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.|..|-...+|+....+ +..+++|........ ......|+.+++.+...+ ..++++.+. + .++|||++|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence 456778888999998764 678999976543211 122336788888774333 344444332 2 479999998
Q ss_pred CChh
Q 042457 172 GSLF 175 (361)
Q Consensus 172 g~L~ 175 (361)
.++.
T Consensus 77 ~~l~ 80 (235)
T cd05157 77 RTLE 80 (235)
T ss_pred CcCC
Confidence 7763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.9e-05 Score=65.60 Aligned_cols=138 Identities=12% Similarity=0.103 Sum_probs=77.7
Q ss_pred eeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeeCCeEEEEEEeccCCChh
Q 042457 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYMRRGSLF 175 (361)
Q Consensus 97 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~ 175 (361)
+..|-.+.+|+... ++..+++|.......... -+...|..+++.+....+ .++++.+. -++|+||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALG--VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCccccccc--CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 45678889999985 667788887654322110 134578888888754333 33444332 36899999987664
Q ss_pred hh-----------------hccCC-ccCCCCHHHH-HHHHHHH---------HHHHHHHHcC-----CCCCeEEeCCCCC
Q 042457 176 CV-----------------LRNDD-EAIQLDWTKR-VNIVKSM---------AHALSYLHYD-----CIPSIVHRDISSN 222 (361)
Q Consensus 176 ~~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------~~~l~~Lh~~-----~~~~i~H~dlk~~ 222 (361)
.. ++... ...+++.... .....++ ...+..+-.. ..+.++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 11111 0111222211 1111111 1112222111 1235899999999
Q ss_pred CeeeCCCCCeEEeeecCccc
Q 042457 223 NILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~ 242 (361)
||++++++ +.++||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00022 Score=65.91 Aligned_cols=77 Identities=21% Similarity=0.195 Sum_probs=52.4
Q ss_pred CeeeecCceeEEEEEeCCC-CEEEEEEeccC-----cchHHHHHHHHHHHHHHhcCC---CCcceeeeEEEeeCCeEEEE
Q 042457 95 YCIGTGGYGSVYRAQLPSG-KIVALKKLHHS-----ETELAFLESFQTEARLLSQIR---HRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 165 (361)
+.||.|.+..||++...+| +.++||.-... .......+....|.+.|+.+. ..++.+++.+.. +..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4589999999999998777 48999984311 110112355667788887763 245666777633 557899
Q ss_pred EEeccCCC
Q 042457 166 YKYMRRGS 173 (361)
Q Consensus 166 ~e~~~~g~ 173 (361)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00062 Score=61.68 Aligned_cols=156 Identities=15% Similarity=0.134 Sum_probs=81.5
Q ss_pred CHHHHHHHhcCCCC-----cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC--Ccceee
Q 042457 80 TFEEIIVATEDFDI-----KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH--RNIVKL 152 (361)
Q Consensus 80 ~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~ 152 (361)
+.+++...-+.|.+ .+.++.|....+|+.+..+| .+++|+.. ... . +....|...+..+.. -.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~-~---~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-RLT-A---EDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-cCC-h---HHhHHHHHHHHHHHHCCCCCCcc
Confidence 34444443345544 24466677789999987665 58889875 211 1 222234444444321 113333
Q ss_pred eE------EEeeCCeEEEEEEeccCCChhhh--------------hccCCc--------cCCCCH-HHHHH---------
Q 042457 153 YG------FCLHKKCMFLIYKYMRRGSLFCV--------------LRNDDE--------AIQLDW-TKRVN--------- 194 (361)
Q Consensus 153 ~~------~~~~~~~~~lv~e~~~~g~L~~~--------------l~~~~~--------~~~l~~-~~~~~--------- 194 (361)
+. +....+..+++++|.+|..+... ++.... ...+.| .....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 12235567899999998754211 111000 001111 11111
Q ss_pred ---HH-HHHHHHHHHHHcC----CCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 195 ---IV-KSMAHALSYLHYD----CIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 195 ---i~-~~i~~~l~~Lh~~----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+ ..+...+..+... ...+++|+|+.+.||+++++...-|+||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11 1111222333211 23489999999999999977656899999874
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00035 Score=62.53 Aligned_cols=142 Identities=16% Similarity=0.115 Sum_probs=83.3
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCC--cceeeeEE------EeeCCeEEEE
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR--NIVKLYGF------CLHKKCMFLI 165 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~------~~~~~~~~lv 165 (361)
.+.+..|....+|+....+ ..+++|+.... . ......|++++..+.+. .+.+.+.. ....+..+.+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~-~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV-S----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC-C----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 3457778778999997744 46888987642 1 13455677777766432 24444432 1234567899
Q ss_pred EEeccCCChhhh----h----------ccC----Cc----cCCCCHHHHH----------HHHHHHHHHHHHHHc----C
Q 042457 166 YKYMRRGSLFCV----L----------RND----DE----AIQLDWTKRV----------NIVKSMAHALSYLHY----D 209 (361)
Q Consensus 166 ~e~~~~g~L~~~----l----------~~~----~~----~~~l~~~~~~----------~i~~~i~~~l~~Lh~----~ 209 (361)
++|++|..+... . +.. .. .....|.... .....+...+.++.. .
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 999998776330 0 100 00 0111222211 011223334445443 1
Q ss_pred CCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 210 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
...+++|+|+.|.||+++++..+.|+||+.+.
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 22379999999999999998777899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00023 Score=63.99 Aligned_cols=140 Identities=24% Similarity=0.266 Sum_probs=81.7
Q ss_pred CeeeecCceeEEEEEeCC-------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeeCCeEEEEE
Q 042457 95 YCIGTGGYGSVYRAQLPS-------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN-IVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 166 (361)
+.+..|-...+|+....+ ++.+++|........ ..+...|.+++..+...+ ..++++++.. ..|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 345667777999998755 578999997654321 134457777777774322 3445555532 3589
Q ss_pred EeccCCChhhh-h----------------ccCCcc--------CCCCHHHHHH--------------------------H
Q 042457 167 KYMRRGSLFCV-L----------------RNDDEA--------IQLDWTKRVN--------------------------I 195 (361)
Q Consensus 167 e~~~~g~L~~~-l----------------~~~~~~--------~~l~~~~~~~--------------------------i 195 (361)
||++|..+... + +..... ...-|..... +
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99988776431 1 111100 0000111111 1
Q ss_pred HHHHHHHHHHHHc------CCCCCeEEeCCCCCCeeeCCC----CCeEEeeecCcc
Q 042457 196 VKSMAHALSYLHY------DCIPSIVHRDISSNNILLNSK----LEAFVADFGVAR 241 (361)
Q Consensus 196 ~~~i~~~l~~Lh~------~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~ 241 (361)
...+...+..+.. .....++|+|+.+.||+++++ +.+.++||..+.
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 1122223334432 233478999999999999985 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.0012 Score=59.35 Aligned_cols=142 Identities=17% Similarity=0.127 Sum_probs=79.7
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCC--cceeeeEEE------eeCCeEEEEE
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR--NIVKLYGFC------LHKKCMFLIY 166 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~------~~~~~~~lv~ 166 (361)
..++.|....+|+.+..+| .+++|........ +....|.+++..+... .+.+++... ...+..++++
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRVKA----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCCCH----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 4466777789999887555 5778876543221 2233455655555321 234443321 1245678999
Q ss_pred EeccCCChhhh--------------hccCCcc---------CCCCHHHHH------------HHHHHHHHHHHHHHc---
Q 042457 167 KYMRRGSLFCV--------------LRNDDEA---------IQLDWTKRV------------NIVKSMAHALSYLHY--- 208 (361)
Q Consensus 167 e~~~~g~L~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~i~~~l~~Lh~--- 208 (361)
+|++|..+... ++..... ..-.|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99988654211 1110000 001121110 011123334555542
Q ss_pred -CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 209 -DCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 209 -~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
....+++|+|+.+.|+++++++...|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223489999999999999998777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0026 Score=56.80 Aligned_cols=137 Identities=18% Similarity=0.285 Sum_probs=85.2
Q ss_pred eeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC--CcceeeeEEEeeCC--eEEEEEEeccCC
Q 042457 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH--RNIVKLYGFCLHKK--CMFLIYKYMRRG 172 (361)
Q Consensus 97 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~g 172 (361)
+..|..-.+|..... ++.++++ ...............+|+..++.+.- --+.+.++.|.++. ..+.||+|++|.
T Consensus 33 ~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 33 ISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred ccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 333444455555543 7778888 33211112223555677888877642 34556678887766 779999999986
Q ss_pred ChhhhhccCCccCCCCHHHHHHHH-HHHHHHHHHHHcC------------------------------------------
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIV-KSMAHALSYLHYD------------------------------------------ 209 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~-~~i~~~l~~Lh~~------------------------------------------ 209 (361)
.+.+.+.... .. .+++ ..+++.|+-||+-
T Consensus 111 ~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 111 VVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred eccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 5544432211 11 1122 2555555555543
Q ss_pred --------C-----CCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 210 --------C-----IPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 210 --------~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
. .+.++|||+.+.|++++++.-+-+.||+++..-
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1 146899999999999999988999999998643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00025 Score=62.47 Aligned_cols=137 Identities=15% Similarity=0.143 Sum_probs=92.9
Q ss_pred CCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcc------------------hHHH--HHHHHHHHHHHhcCC-CC-c
Q 042457 91 FDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSET------------------ELAF--LESFQTEARLLSQIR-HR-N 148 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~--~~~~~~e~~~l~~l~-h~-n 148 (361)
+++.+.||-|.-+.+|.+-..+|++.++|.-+.... +.-. .-...+|...|+.+. |. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 677889999999999999998999999885322111 0000 113446777777774 22 2
Q ss_pred ceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC
Q 042457 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228 (361)
Q Consensus 149 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~ 228 (361)
+.+.+++ +.-++|||++.+-.|...-+- .+..+ +...+...+--|..+ |++|||.+-=||++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec------CChHH---HHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence 3344443 345899999998888755332 12222 334444445556666 9999999999999999
Q ss_pred CCCeEEeeecCcccc
Q 042457 229 KLEAFVADFGVARLL 243 (361)
Q Consensus 229 ~~~~kl~Dfg~~~~~ 243 (361)
++.++++||--+...
T Consensus 238 d~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVST 252 (465)
T ss_pred CCCEEEeechHhhcc
Confidence 999999999865443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.003 Score=56.82 Aligned_cols=142 Identities=23% Similarity=0.287 Sum_probs=94.7
Q ss_pred CcCeeeecCceeEEEEEeCCCCEEEEEEeccCcc-----------------------hHHHHH-HHHHHHHHHhcCCCCc
Q 042457 93 IKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSET-----------------------ELAFLE-SFQTEARLLSQIRHRN 148 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~-~~~~e~~~l~~l~h~n 148 (361)
+..+|..|--+.||.+.-.+|..+|||+.+.+-. ....++ =...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 4457888999999999998999999998764311 000000 1224666666665444
Q ss_pred ceeeeEEEeeCCeEEEEEEeccCCChh-hhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC
Q 042457 149 IVKLYGFCLHKKCMFLIYKYMRRGSLF-CVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN 227 (361)
Q Consensus 149 iv~~~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~ 227 (361)
|..- .-... ..-.|||+|+...... -.|+.. .++...+..+-.+++.-|.-|.+.| ++||.||+=-|+|+.
T Consensus 228 IP~P-ePIlL-k~hVLVM~FlGrdgw~aPkLKd~----~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 228 IPCP-EPILL-KNHVLVMEFLGRDGWAAPKLKDA----SLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCC-Cceee-ecceEeeeeccCCCCcCcccccc----cCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 3211 11111 1246899998533322 222222 4677778888889999999998887 899999999999987
Q ss_pred CCCCeEEeeecCcccc
Q 042457 228 SKLEAFVADFGVARLL 243 (361)
Q Consensus 228 ~~~~~kl~Dfg~~~~~ 243 (361)
+ |.+.|+|.+-+...
T Consensus 300 d-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEH 314 (520)
T ss_pred C-CEEEEEEccccccC
Confidence 6 47889998876543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00078 Score=59.65 Aligned_cols=74 Identities=19% Similarity=0.245 Sum_probs=48.1
Q ss_pred CcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC---CCcceeeeEEEeeCCeEEEEEEec
Q 042457 93 IKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR---HRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
..+.++.|....+|+.. .+++.+.||.-.... ...|..|.+-|+.+. --.+.+.+++....+..+|++||.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 34568889999999988 478889999876322 245778888887773 456778889888877789999999
Q ss_pred cCC
Q 042457 170 RRG 172 (361)
Q Consensus 170 ~~g 172 (361)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00013 Score=67.84 Aligned_cols=191 Identities=17% Similarity=0.235 Sum_probs=106.0
Q ss_pred EEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-eEEEEEEeccCCChhhhhccCCc
Q 042457 105 VYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK-CMFLIYKYMRRGSLFCVLRNDDE 183 (361)
Q Consensus 105 V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~ 183 (361)
++.|....|+.. ..-+...... ..+.....+++.+.|+|+..++.+..... ...+|+|++ +.||++.+.....
T Consensus 5 ~~~a~~~~~~~c-~nglplt~~s----~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l 78 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLTPNS----IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL 78 (725)
T ss_pred EEehhcCCCccc-cCCCcCCCcH----HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc
Confidence 455555455533 3333333322 45667788999999999999998877543 477889988 6799988865431
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcccccccccccccc
Q 042457 184 AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263 (361)
Q Consensus 184 ~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 263 (361)
.... ++ .+ ++.|-+ + .+.+| -+. .. | |-
T Consensus 79 ----~~~s----------~~----~~---~~~~~~-----~-------~~~td-~~~---t~-------------~--~~ 106 (725)
T KOG1093|consen 79 ----KDES----------LL----AH---GVLHLN-----I-------IYITD-HFL---TK-------------Y--PS 106 (725)
T ss_pred ----chhh----------hc----cc---ccceeh-----h-------hhccc-ccc---cc-------------C--CC
Confidence 1000 00 11 333321 1 22233 000 00 0 00
Q ss_pred cccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC---CCCCChhhHHHHHHHHHHHhhhcCCC
Q 042457 264 LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP---SPIDDQTVIQDIILVSKIAFACLRSK 340 (361)
Q Consensus 264 ~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~d 340 (361)
. ..+|+||||+|.++.|+..|..-+...........+......... ........++....++++.+.|+-..
T Consensus 107 ~-----~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~ 181 (725)
T KOG1093|consen 107 P-----IGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLE 181 (725)
T ss_pred C-----CCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccc
Confidence 0 114999999999999999887664322211100000000000000 00000112233345788999999999
Q ss_pred CCCCCCccccccCCCCCC
Q 042457 341 PKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 341 P~~RPs~~eil~hp~~~~ 358 (361)
|..||...++.+++-|.+
T Consensus 182 ~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 182 PIIRPLPMELSKRCSFTE 199 (725)
T ss_pred cccccchhHHhcCccHHH
Confidence 999999999999887754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=1.4e-05 Score=82.53 Aligned_cols=163 Identities=12% Similarity=-0.003 Sum_probs=118.3
Q ss_pred HHHHHHHHHHhcCCCCcceeeeEEEee--CCeEEEEEEeccCCChhhhhccCCc-cCCCCHHHHHHHHHHHHHHHHHHHc
Q 042457 132 ESFQTEARLLSQIRHRNIVKLYGFCLH--KKCMFLIYKYMRRGSLFCVLRNDDE-AIQLDWTKRVNIVKSMAHALSYLHY 208 (361)
Q Consensus 132 ~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~ 208 (361)
+....|.+..+...|+++.....-... ....+..++++.+|.+.+.+-++.. ...++..-......+......-+|.
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 445556666667789888766554443 2356889999999999988866433 2234433333333443555555555
Q ss_pred CCCC--CeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHH
Q 042457 209 DCIP--SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEV 286 (361)
Q Consensus 209 ~~~~--~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 286 (361)
..+. --+|++||+-|.++..+..++++++|+.+.............+++-|++|+......++.++|+|..|+.+|+.
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 5432 36899999999999999999999999998544444445556688889999998888899899999999999999
Q ss_pred HhCCCCCC
Q 042457 287 LMGRHPGD 294 (361)
Q Consensus 287 ~tg~~p~~ 294 (361)
--|..+|-
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88877753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0031 Score=55.75 Aligned_cols=31 Identities=23% Similarity=0.443 Sum_probs=25.6
Q ss_pred CCeEEeCCCCCCeeeCCCCC-eEEeeecCccc
Q 042457 212 PSIVHRDISSNNILLNSKLE-AFVADFGVARL 242 (361)
Q Consensus 212 ~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~ 242 (361)
+.++|+|+++.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0065 Score=55.58 Aligned_cols=139 Identities=16% Similarity=0.230 Sum_probs=78.5
Q ss_pred eeeecCceeEEEEEeCC-----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeeCCeEEEEEEec
Q 042457 96 CIGTGGYGSVYRAQLPS-----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~ 169 (361)
.+..|-...+|+..+.+ ++.+++|....... . .-+...|..+++.+...++ .++++.+... .|.+|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--L-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--e-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 34457778899987543 36789998765432 1 1223568888887754333 3455655332 589999
Q ss_pred cCCChhhh-----------------hccCC---ccCCCCHHHHHHHHHHH-----------------HHHHHHH----Hc
Q 042457 170 RRGSLFCV-----------------LRNDD---EAIQLDWTKRVNIVKSM-----------------AHALSYL----HY 208 (361)
Q Consensus 170 ~~g~L~~~-----------------l~~~~---~~~~l~~~~~~~i~~~i-----------------~~~l~~L----h~ 208 (361)
++.++... ++... .....-+.++.++..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87666421 11111 00011233333333221 1112122 21
Q ss_pred -CCCCCeEEeCCCCCCeeeCC-CCCeEEeeecCcc
Q 042457 209 -DCIPSIVHRDISSNNILLNS-KLEAFVADFGVAR 241 (361)
Q Consensus 209 -~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~ 241 (361)
.....++|+|+++.|||+++ ++.+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12236899999999999986 4679999998875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0099 Score=55.01 Aligned_cols=75 Identities=17% Similarity=0.150 Sum_probs=48.7
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEec-----cCcchHHHHHHHHHHHHHHhcCC---CCcceeeeEEEeeCCeEEEE
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLH-----HSETELAFLESFQTEARLLSQIR---HRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv 165 (361)
.+.||.|....||+.... +..++||+-. .+....-....-..|.+.|+.+. ..++.+++.++.+. .+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence 456899999999999874 5569999765 11110001223334566666553 34788888888843 5788
Q ss_pred EEeccC
Q 042457 166 YKYMRR 171 (361)
Q Consensus 166 ~e~~~~ 171 (361)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.013 Score=52.85 Aligned_cols=30 Identities=20% Similarity=0.380 Sum_probs=27.4
Q ss_pred CCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 212 PSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 212 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+++|+|+.+.|+++++++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 479999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.019 Score=51.76 Aligned_cols=29 Identities=34% Similarity=0.563 Sum_probs=25.3
Q ss_pred CCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 212 PSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 212 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+++|+|+.+.||++++ +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999988 578899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.019 Score=52.23 Aligned_cols=139 Identities=14% Similarity=0.187 Sum_probs=76.3
Q ss_pred eeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeeCCeEEEEEEeccC
Q 042457 97 IGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 97 lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~ 171 (361)
|..|-...+|+....+ +..|++|+....... .-+..+|..+++.+..-++ .++++++. .+ +|.+|+++
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~---~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY---VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCcCe---EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 4446677889886543 237889987653321 1233477888887754444 34555553 22 58999977
Q ss_pred CChhhh-----------------hccCCc--cC-CCCHHHHHHHHHHH----------------------HHHHHHH---
Q 042457 172 GSLFCV-----------------LRNDDE--AI-QLDWTKRVNIVKSM----------------------AHALSYL--- 206 (361)
Q Consensus 172 g~L~~~-----------------l~~~~~--~~-~l~~~~~~~i~~~i----------------------~~~l~~L--- 206 (361)
..+..- ++.... .. .--|..+.++..++ ..-+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665210 111110 00 11233332222221 1111111
Q ss_pred H-cC-CCCCeEEeCCCCCCeeeCC-CCCeEEeeecCccc
Q 042457 207 H-YD-CIPSIVHRDISSNNILLNS-KLEAFVADFGVARL 242 (361)
Q Consensus 207 h-~~-~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~ 242 (361)
. .. ...-++|+|+.+.|||+++ ++.++++||..+..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11 1124789999999999975 57899999998743
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.067 Score=48.39 Aligned_cols=136 Identities=20% Similarity=0.219 Sum_probs=80.2
Q ss_pred CceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC---CCc---ceeeeEEEe--eCC--eEEEEEEecc
Q 042457 101 GYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR---HRN---IVKLYGFCL--HKK--CMFLIYKYMR 170 (361)
Q Consensus 101 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~n---iv~~~~~~~--~~~--~~~lv~e~~~ 170 (361)
.-..+|+....+|+. ++|..... .+. .+...|...+..+. .+= +...-|-.. ... ..+-+++|++
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~ 111 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLP 111 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecC
Confidence 456799998877776 88988766 222 44556677776663 221 222222211 123 6788999999
Q ss_pred CCChhh-hh--------------c----cC-----CccCCCCHHH-------------HHHHHHHHHHHHHHHHcCCC--
Q 042457 171 RGSLFC-VL--------------R----ND-----DEAIQLDWTK-------------RVNIVKSMAHALSYLHYDCI-- 211 (361)
Q Consensus 171 ~g~L~~-~l--------------~----~~-----~~~~~l~~~~-------------~~~i~~~i~~~l~~Lh~~~~-- 211 (361)
|..+.. .. + .. .......|.. -.....++...+..+.+...
T Consensus 112 G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~ 191 (331)
T COG2334 112 GRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAH 191 (331)
T ss_pred CcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhh
Confidence 988873 11 0 00 0011233320 01133344444444443321
Q ss_pred --CC---eEEeCCCCCCeeeCCCCC-eEEeeecCcc
Q 042457 212 --PS---IVHRDISSNNILLNSKLE-AFVADFGVAR 241 (361)
Q Consensus 212 --~~---i~H~dlk~~Nill~~~~~-~kl~Dfg~~~ 241 (361)
.. ++|+|+.|.||+++++.. +.++||+.+.
T Consensus 192 lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 192 LPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 899999999999999985 8899999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.027 Score=51.21 Aligned_cols=75 Identities=13% Similarity=0.212 Sum_probs=45.7
Q ss_pred eeeecCceeEEEEEeCCC-CEEEEEEec----c-CcchHHHHHHHHHHHHHHhcCC--CCc-ceeeeEEEeeCCeEEEEE
Q 042457 96 CIGTGGYGSVYRAQLPSG-KIVALKKLH----H-SETELAFLESFQTEARLLSQIR--HRN-IVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~~-~~vavK~~~----~-~~~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~ 166 (361)
.||.|...-||++..++| +.|+||.-. . .....-..+...-|.+.|+... .|. +.+++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999987655 589999642 1 1111112344456777776653 343 4444433 334456899
Q ss_pred EeccCC
Q 042457 167 KYMRRG 172 (361)
Q Consensus 167 e~~~~g 172 (361)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.55 Score=42.61 Aligned_cols=93 Identities=15% Similarity=0.120 Sum_probs=52.3
Q ss_pred cCHHHHHHHhcCCCCc--C--eeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCC--ccee-
Q 042457 79 ITFEEIIVATEDFDIK--Y--CIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR--NIVK- 151 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~--~--~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~- 151 (361)
++-+.+..+.+.+.+. . ..-.+.-..||+....+|..+++|........ ......|.+.+..+... .++.
T Consensus 11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p 87 (325)
T PRK11768 11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAP 87 (325)
T ss_pred CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4555555555554332 1 12234556799998888889999987643322 24455666666655211 1222
Q ss_pred --eeE--EEeeCCeEEEEEEeccCCCh
Q 042457 152 --LYG--FCLHKKCMFLIYKYMRRGSL 174 (361)
Q Consensus 152 --~~~--~~~~~~~~~lv~e~~~~g~L 174 (361)
.-| ....++..+.++++.+|...
T Consensus 88 ~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 88 LAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred ccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 112 22234567889999987654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.073 Score=45.01 Aligned_cols=75 Identities=17% Similarity=0.219 Sum_probs=52.7
Q ss_pred CeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC---CCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR---HRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.+.-|.--..|.... +...+.||+-.. .....|..|+.-|..+. --++.+++.+-...++.|+|+||.+-
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~-----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR-----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecch-----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 3355455555666555 566788887432 22467888887777664 35577888888889999999999988
Q ss_pred CChh
Q 042457 172 GSLF 175 (361)
Q Consensus 172 g~L~ 175 (361)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 7664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.11 Score=54.52 Aligned_cols=151 Identities=17% Similarity=0.235 Sum_probs=81.2
Q ss_pred HHhcCCCCc---CeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-------CCCcceeee-E
Q 042457 86 VATEDFDIK---YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-------RHRNIVKLY-G 154 (361)
Q Consensus 86 ~~~~~~~~~---~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~-~ 154 (361)
...+.|.+. +.|+ |..-.+|+.+..+|..+++|+....... .....|...+..+ .-|.+++-. |
T Consensus 19 ~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~----~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G 93 (1013)
T PRK06148 19 LLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPR----VESDFQTAALDHLAAVAPDLPVPRLIPSLSG 93 (1013)
T ss_pred HHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccch----hHHHHHHHHHHHHHhhCCCCCcCeeeecCCC
Confidence 344455543 3353 4567889998888889999998765322 1222333444433 233333322 1
Q ss_pred ----EEee-CC--eEEEEEEeccCCChhhhhc---------------------c---CCccCCCCHHH------------
Q 042457 155 ----FCLH-KK--CMFLIYKYMRRGSLFCVLR---------------------N---DDEAIQLDWTK------------ 191 (361)
Q Consensus 155 ----~~~~-~~--~~~lv~e~~~~g~L~~~l~---------------------~---~~~~~~l~~~~------------ 191 (361)
.... ++ ..+.+++|.+|..+.+... . ......+.|..
T Consensus 94 ~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~ 173 (1013)
T PRK06148 94 ASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHF 173 (1013)
T ss_pred CeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhh
Confidence 1111 22 4677899999987754110 0 00001122211
Q ss_pred -----HHHHHHHHHHHHH-----HHHcCCCCCeEEeCCCCCCeeeCCCC--CeE-EeeecCccc
Q 042457 192 -----RVNIVKSMAHALS-----YLHYDCIPSIVHRDISSNNILLNSKL--EAF-VADFGVARL 242 (361)
Q Consensus 192 -----~~~i~~~i~~~l~-----~Lh~~~~~~i~H~dlk~~Nill~~~~--~~k-l~Dfg~~~~ 242 (361)
...++..+.+... .+. .....++|+|+.+.|||++.++ ++. |+|||.+..
T Consensus 174 i~d~~~r~~l~~~~~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 174 IDDPEDRALVERFLARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 1122223333222 121 2223799999999999999875 554 999998743
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.014 Score=49.31 Aligned_cols=29 Identities=34% Similarity=0.492 Sum_probs=20.8
Q ss_pred CeEEeCCCCCCeee-CCCCCeEEeeecCcc
Q 042457 213 SIVHRDISSNNILL-NSKLEAFVADFGVAR 241 (361)
Q Consensus 213 ~i~H~dlk~~Nill-~~~~~~kl~Dfg~~~ 241 (361)
.++|+|+.+.|||+ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 57899999999999 888999999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.085 Score=48.90 Aligned_cols=73 Identities=19% Similarity=0.257 Sum_probs=43.1
Q ss_pred eeeecCceeEEEEEeCCCC-------EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeeCCeEEEEEE
Q 042457 96 CIGTGGYGSVYRAQLPSGK-------IVALKKLHHSETELAFLESFQTEARLLSQIRHRNI-VKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 167 (361)
.|..|-...+|++...++. .|.++..... . +..-+-..|..+++.+...++ .++++.+.. +++.|
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~--~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-N--SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccCC-C--ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 4545778899999765431 2444442211 1 111223468888888865444 445555532 58999
Q ss_pred eccCCChh
Q 042457 168 YMRRGSLF 175 (361)
Q Consensus 168 ~~~~g~L~ 175 (361)
|++|..|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99988764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.057 Score=48.83 Aligned_cols=72 Identities=19% Similarity=0.306 Sum_probs=57.1
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..|++|++. |+++.. +. .-.|.+...++.+.+..++-+.... ..-|||+.-.|||++ +|++.|+||.++
T Consensus 300 y~yl~~kdh-gt~is~-ik------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-IK------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-ee------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 356666664 444432 21 3578899999999999999888776 788999999999999 999999999999
Q ss_pred ccc
Q 042457 241 RLL 243 (361)
Q Consensus 241 ~~~ 243 (361)
+.-
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 843
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.08 Score=44.55 Aligned_cols=118 Identities=14% Similarity=0.120 Sum_probs=71.2
Q ss_pred cCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCCChhhhhc
Q 042457 100 GGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR 179 (361)
Q Consensus 100 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 179 (361)
++.++.-+++.+-|. ..+|++....... ...-|..+.+++.+++ .|+++..= ....+-++.|.|-....
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----
Confidence 444555555443333 4556555443321 1245677888888775 36666521 33356788898833111
Q ss_pred cCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 180 NDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 180 ~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
. . ..++..=+..|.-.|+.. .+.+|||-.|+|||-|.+|.+||.|-+..
T Consensus 142 -------~---~-~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -------N---F-SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -------c---h-hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 0 1 112222245666778543 38999999999999999999999998743
|
The function of this family is unknown. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.017 Score=33.80 Aligned_cols=14 Identities=21% Similarity=0.190 Sum_probs=5.2
Q ss_pred HHHHHHHHHHhhhc
Q 042457 37 LILVCIFTFLCLRR 50 (361)
Q Consensus 37 ~~~~~~~~~~~~~r 50 (361)
++++++++++.+||
T Consensus 24 I~~vl~~~l~~~~r 37 (40)
T PF08693_consen 24 IIIVLGAFLFFWYR 37 (40)
T ss_pred HHHHHHHHhheEEe
Confidence 33333333333343
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.0074 Score=45.47 Aligned_cols=30 Identities=20% Similarity=0.439 Sum_probs=17.2
Q ss_pred eEEEehHHHHHHHHHHHHHHHHhhhccccc
Q 042457 25 RLVVIILPIVLLLILVCIFTFLCLRRPKVR 54 (361)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~ 54 (361)
.++.|++++++++++++++++|+.||++++
T Consensus 65 ~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 65 AIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred ceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 345566666666666666666666655544
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 361 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-47 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-47 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-28 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-27 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-27 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-27 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-27 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-26 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-26 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-26 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-26 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-26 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-26 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-26 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-26 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-26 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-24 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-23 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-22 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-22 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-22 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-20 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-20 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-16 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 2e-90
Identities = 108/286 (37%), Positives = 157/286 (54%), Gaps = 21/286 (7%)
Query: 78 RITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTE 137
R + E+ VA+++F K +G GG+G VY+ +L G +VA+K+L T+ L+ FQTE
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-FQTE 77
Query: 138 ARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSL-FCVLRNDDEAIQLDWTKRVNIV 196
++S HRN+++L GFC+ L+Y YM GS+ C+ + LDW KR I
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-RTVVAG 255
A L+YLH C P I+HRD+ + NILL+ + EA V DFG+A+L+ ++ T V G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 256 THGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN-PKIMLID------- 307
T G+IAPE T +EK DVFG+GV+ LE++ G+ DL N +ML+D
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 308 ------LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM 347
L+D D+ V Q I ++A C +S P RP M
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERPKM 299
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 1e-83
Identities = 97/313 (30%), Positives = 136/313 (43%), Gaps = 32/313 (10%)
Query: 54 RKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSG 113
+ +K T + + V R+ ++ AT +FD K+ IG G +G VY+ L G
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 114 KIVALKKLHHS----ETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169
VALK+ E F+TE LS RH ++V L GFC + M LIYKYM
Sbjct: 64 AKVALKRRTPESSQGIEE------FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 170 RRGSLFCVL-RNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228
G+L L +D + + W +R+ I A L YLH I +HRD+ S NILL+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDE 174
Query: 229 KLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEV 286
+ DFG+++ TVV GT GYI PE +TEK DV+ FGVV EV
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 287 LMGRHPGDLLSSFNP------------KIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAF 334
L R L ++D I +++ + A
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK----FGDTAV 290
Query: 335 ACLRSKPKSRPTM 347
CL + RP+M
Sbjct: 291 KCLALSSEDRPSM 303
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-75
Identities = 82/291 (28%), Positives = 133/291 (45%), Gaps = 27/291 (9%)
Query: 78 RITFEEIIVATEDFDIKYC------IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAF- 130
+F E+ T +FD + +G GG+G VY+ + VA+KKL
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72
Query: 131 -LESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDW 189
+ F E +++++ +H N+V+L GF + L+Y YM GSL L D L W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 190 TKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD--S 247
R I + A+ +++LH + +HRDI S NILL+ A ++DFG+AR +
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID 307
+ + GT Y+APE A +T K D++ FGVV LE++ G D +L+D
Sbjct: 190 VMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD---EHREPQLLLD 245
Query: 308 -----LLDQRAPSPIDD----QTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
+++ D + + +A CL K RP +++
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-64
Identities = 78/275 (28%), Positives = 135/275 (49%), Gaps = 9/275 (3%)
Query: 74 NYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLES 133
+ G + +++ + D +IK IG G +G+V+RA+ G VA+K L + +
Sbjct: 22 YFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE 80
Query: 134 FQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV 193
F E ++ ++RH NIV G + ++ +Y+ RGSL+ +L QLD +R+
Sbjct: 81 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 194 NIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
++ +A ++YLH + P IVHR++ S N+L++ K V DFG++RL S +
Sbjct: 141 SMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 254 AGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313
AGT ++APE+ EK DV+ FGV+ E+ + P L+ + + +R
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV-VAAVGFKCKRL 258
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
P + + II C ++P RP+
Sbjct: 259 EIPRNLNPQVAAIIE------GCWTNEPWKRPSFA 287
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 6e-64
Identities = 66/304 (21%), Positives = 121/304 (39%), Gaps = 42/304 (13%)
Query: 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEA 138
+ E + + + G +G V++AQL + VA+K + + ++ + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQ--NEYEV 69
Query: 139 RLLSQIRHRNIVKLYGFCLH----KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN 194
L ++H NI++ G ++LI + +GSL L+ + + W + +
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCH 125
Query: 195 IVKSMAHALSYLHYDCI-------PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
I ++MA L+YLH D P+I HRDI S N+LL + L A +ADFG+A +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 248 S--NRTVVAGTHGYIAPELA-----YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLS--- 297
S + GT Y+APE+ + + D++ G+V E+ D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 298 ------------SFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP 345
S ++ +R P D + ++ + C ++R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKR-PVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 346 TMRR 349
+
Sbjct: 305 SAGC 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-63
Identities = 71/260 (27%), Positives = 124/260 (47%), Gaps = 17/260 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
++ +++ +G G +G V +A+ K VA+K++ ++F E R LS++ H N
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER----KAFIVELRQLSRVNHPN 62
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
IVKLYG CL+ C+ + +Y GSL+ VL + ++ + ++YLH
Sbjct: 63 IVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 209 DCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
+++HRD+ N+LL + + DFG A + + +N G+ ++APE+
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEG 177
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327
+EKCDVF +G++ EV+ R P D + +IM R P + I+ ++
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237
Query: 328 LVSKIAFACLRSKPKSRPTM 347
C P RP+M
Sbjct: 238 T------RCWSKDPSQRPSM 251
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-59
Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 28/273 (10%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETE-----LAFLESFQTEARLLS 142
+ + + IG GG+G V++ +L +VA+K L ++E + + FQ E ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHA 202
+ H NIVKLYG + M + +++ G L+ L + +A + W+ ++ ++ +A
Sbjct: 79 NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAF-----VADFGVARLLHSDSSNRTVVAGTH 257
+ Y+ + P IVHRD+ S NI L S E VADFG+++ + + G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNF 190
Query: 258 GYIAPEL--AYTMVVTEKCDVFGFGVVALEVLMGRHP-GDLLSSFNPKIMLIDLLDQRAP 314
++APE A TEK D + F ++ +L G P + I +I R
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM 347
P D ++++I C PK RP
Sbjct: 251 IPEDCPPRLRNVIE------LCWSGDPKKRPHF 277
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-58
Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 24/270 (8%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELA--FLESFQTEARLLSQIRH 146
+ ++ IG GG+G VYRA G VA+K H E +E+ + EA+L + ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
NI+ L G CL + + L+ ++ R G L VL ++ VN +A ++YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYL 121
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAF--------VADFGVARLLHSDSSNRTVVAGTHG 258
H + I I+HRD+ S+NIL+ K+E + DFG+AR H + + AG +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYA 179
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318
++APE+ + ++ DV+ +GV+ E+L G P + + + P P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-AYGVAMNKLALPIPST 238
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
++ C P SRP+
Sbjct: 239 CPEPFAKLME------DCWNPDPHSRPSFT 262
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-54
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 28/274 (10%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
D +G G +G + +G+++ +K+L + E +F E +++ + H
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET--QRTFLKEVKVMRCLEHP 67
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
N++K G K + I +Y++ G+L ++++ D Q W++RV+ K +A ++YLH
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH 125
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--------------RTVV 253
+I+HRD++S+N L+ VADFG+ARL+ + + R V
Sbjct: 126 S---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 254 AGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313
G ++APE+ EK DVF FG+V E++ + L
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM 347
P + I C P+ RP+
Sbjct: 243 YCPPNCPPSFFPIT------VRCCDLDPEKRPSF 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-54
Identities = 49/264 (18%), Positives = 94/264 (35%), Gaps = 20/264 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+ + + G +++ + G + +K L + F E L H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 149 IVKLYGFCLH--KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
++ + G C LI +M GSL+ VL + +D ++ V MA +++L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-- 264
H P I ++S +++++ + A ++ V S ++APE
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG-----RMYAPAWVAPEALQ 181
Query: 265 -AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323
D++ F V+ E++ P LS+ M + L R P +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGLRPTIPPGISPHV 240
Query: 324 QDIILVSKIAFACLRSKPKSRPTM 347
++ C+ P RP
Sbjct: 241 SKLMK------ICMNEDPAKRPKF 258
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-52
Identities = 64/315 (20%), Positives = 116/315 (36%), Gaps = 55/315 (17%)
Query: 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEA 138
E + ++ + IG G YG+VY+ L + VA+K + ++F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEK 56
Query: 139 R--LLSQIRHRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCVLRNDDEAIQLDWTK 191
+ + H NI + L+ +Y GSL L DW
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVS 112
Query: 192 RVNIVKSMAHALSYLHYD------CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
+ S+ L+YLH + P+I HRD++S N+L+ + ++DFG++ L
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 246 DSSNR--------TVVAGTHGYIAPELAYTMV-------VTEKCDVFGFGVVALEVLMG- 289
+ R GT Y+APE+ V ++ D++ G++ E+ M
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 290 --RHPGDLLS--------------SFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIA 333
PG+ + +F +L+ QR P + + + +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 334 FACLRSKPKSRPTMR 348
C ++R T +
Sbjct: 293 EDCWDQDAEARLTAQ 307
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-52
Identities = 65/307 (21%), Positives = 118/307 (38%), Gaps = 33/307 (10%)
Query: 58 PTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVA 117
P F I +E + E +I IG G +G VY + G+ VA
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE-VA 59
Query: 118 LKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCV 177
++ + L++F+ E Q RH N+V G C+ + +I + +L+ V
Sbjct: 60 IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119
Query: 178 LRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237
+R+ I LD K I + + + YLH I+H+D+ S N+ ++ + + DF
Sbjct: 120 VRDAK--IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNG-KVVITDF 173
Query: 238 GVARLLHSDSSNR-----TVVAGTHGYIAPEL---------AYTMVVTEKCDVFGFGVVA 283
G+ + + R + G ++APE+ + ++ DVF G +
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233
Query: 284 LEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT--VIQDIILVSKIAFACLRSKP 341
E+ P + + ++ + P+ I DI+L C +
Sbjct: 234 YELHAREWP---FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILL------FCWAFEQ 284
Query: 342 KSRPTMR 348
+ RPT
Sbjct: 285 EERPTFT 291
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 65/286 (22%), Positives = 132/286 (46%), Gaps = 22/286 (7%)
Query: 71 SVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAF 130
++ R ++ + + IG+G +G+VY+ + G VA+K L+ +
Sbjct: 6 HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQ 63
Query: 131 LESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWT 190
L++F+ E +L + RH NI+ G+ + ++ ++ SL+ L + + +
Sbjct: 64 LQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASET--KFEMK 120
Query: 191 KRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH--SDSS 248
K ++I + A + YLH SI+HRD+ SNNI L+ + DFG+A S S
Sbjct: 121 KLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 249 NRTVVAGTHGYIAPEL---AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML 305
++G+ ++APE+ + + + DV+ FG+V E++ G+ P +++ + I +
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237
Query: 306 ID---LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ L + + ++ ++ CL+ K RP+
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRLMA------ECLKKKRDERPSFP 277
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-48
Identities = 70/302 (23%), Positives = 117/302 (38%), Gaps = 46/302 (15%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLL 141
+ I + + IG G YG V+ + G+ VA+K +E F E TE
Sbjct: 32 QRTI--AKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE---TEIYQT 85
Query: 142 SQIRHRNIVKLYGFCLHKKC----MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVK 197
+RH NI+ + ++LI Y GSL+ L++ LD + +
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAY 141
Query: 198 SMAHALSYLHYD-----CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
S L +LH + P+I HRD+ S NIL+ +AD G+A SD++ +
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 253 V----AGTHGYIAPE-LAYTMVV-----TEKCDVFGFGVVALEVLMGRHPGDLLS----- 297
GT Y+ PE L ++ D++ FG++ EV G ++
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 298 ---------SFNPKIMLIDLLDQRAPSPIDDQTVIQDII-LVSKIAFACLRSKPKSRPTM 347
S+ ++ + R P ++ + + + K+ C P SR T
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLR-P-SFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 348 RR 349
R
Sbjct: 320 LR 321
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-47
Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 40/294 (13%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
D + C+G G YG V+R G+ VA+K + + F E TE +RH
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHE 62
Query: 148 NIVKLYGFCLHKKC----MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
NI+ + + ++LI Y GSL+ L+ LD + IV S+A L
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGL 118
Query: 204 SYLHYD-----CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVVA 254
++LH + P+I HRD+ S NIL+ + +AD G+A + ++
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 255 GTHGYIAPEL------AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF--------- 299
GT Y+APE+ ++ D++ FG+V EV ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 300 -NPKIMLIDLL---DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
+P + + DQ+ P+ + + ++K+ C P +R T R
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-46
Identities = 64/293 (21%), Positives = 111/293 (37%), Gaps = 40/293 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
++ IG G +G V+R + G+ VA+K E F E E +RH N
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHEN 97
Query: 149 IVKLYGFCLHKK----CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
I+ ++L+ Y GSLF L + + + S A L+
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLA 153
Query: 205 YLHYD-----CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVVAG 255
+LH + P+I HRD+ S NIL+ +AD G+A S + G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 256 THGYIAPEL------AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP-------- 301
T Y+APE+ ++ D++ G+V E+ G + +
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273
Query: 302 ----KIMLIDLLDQRAPSPIDDQTVIQDII-LVSKIAFACLRSKPKSRPTMRR 349
+ M + +Q+ I ++ + + +++KI C + +R T R
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 62/260 (23%), Positives = 108/260 (41%), Gaps = 25/260 (9%)
Query: 96 CIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154
IG G + +VY+ + VA +L + + + F+ EA +L ++H NIV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 155 FCL----HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210
KKC+ L+ + M G+L L+ + + + + L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 211 IPSIVHRDISSNNILLNSKL-EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
P I+HRD+ +NI + + D G+A L S + V+ GT ++APE+ Y
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVI-GTPEFMAPEM-YEEK 205
Query: 270 VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV---IQDI 326
E DV+ FG+ LE+ +P S + + D+ +++I
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 327 ILVSKIAFACLRSKPKSRPT 346
I C+R R +
Sbjct: 263 IE------GCIRQNKDERYS 276
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-41
Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 31/282 (10%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
E + IG G +G + G+ +K+++ S E + E +L+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRND-----DEAIQLDWTKRVNIVKSMAHA 202
NIV+ ++++ Y G LF + E LDW + + A
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ICLA 137
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
L ++H I+HRDI S NI L + DFG+AR+L+S GT Y++P
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM--LIDLLDQRAPSPIDDQ 320
E+ K D++ G V E+ +H F M L+ + + P+
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHA------FEAGSMKNLVLKIISGSFPPVSLH 248
Query: 321 --TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360
++ ++ + P+ RP++ I +
Sbjct: 249 YSYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRI 284
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-39
Identities = 58/292 (19%), Positives = 112/292 (38%), Gaps = 51/292 (17%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
DF IG+GG+G V++A+ GK +K++ ++ E + E + L+++ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHV 64
Query: 148 NIVKLYGF----------------CLHKKCMFLIYKYMRRGSLFCVLRND-----DEAIQ 186
NIV G KC+F+ ++ +G+L + D+ +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 187 LDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
L+ + + + Y+H +++RD+ +NI L + + DFG+ L +D
Sbjct: 125 LEL------FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI 306
GT Y++PE + ++ D++ G++ E+L F
Sbjct: 176 GKRTRSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA-----FETSKFFT 229
Query: 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358
DL D D + + ++ L KP+ RP +
Sbjct: 230 DLRDGIISDIFDKK--EKTLLQ------KLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 22/282 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
ED+++ Y IGTG YG + + GKI+ K+L + A + +E LL +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 148 NIVKLYG-FCLHKKCMFLIY-KYMRRGSLFCVLRNDDEAIQLDWTKRV-NIVKSMAHALS 204
NIV+ Y I +Y G L V+ + Q + V ++ + AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 205 YLHY--DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
H D +++HRD+ N+ L+ K + DFG+AR+L+ D+S GT Y++P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM--LIDLLDQRAPSPIDDQ 320
E M EK D++ G + E+ P F L + + I +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP------FTAFSQKELAGKIREGKFRRIPYR 239
Query: 321 --TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360
+ +II L K RP++ NP I
Sbjct: 240 YSDELNEIIT------RMLNLKDYHRPSVEEILENPLILEHH 275
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 61/272 (22%), Positives = 109/272 (40%), Gaps = 34/272 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKI-VALKKLHHSETELAFLESFQTEARLLSQIRHR 147
ED + IG G +G V+ +L + VA+K + + F EAR+L Q H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHP 172
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
NIV+L G C K+ ++++ + ++ G LR + +++ + +V A + YL
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLE 230
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----AP 262
+HRD+++ N L+ K ++DFG++R +G + AP
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWTAP 284
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-----RAPSP 316
E + + DV+ FG++ E G P P + + R P P
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASP-------YPNLSNQQTREFVEKGGRLPCP 337
Query: 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ ++ C +P RP+
Sbjct: 338 ELCPDAVFRLME------QCWAYEPGQRPSFS 363
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-38
Identities = 60/272 (22%), Positives = 109/272 (40%), Gaps = 33/272 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLH-HSETELAFLESFQTEARLLSQIRH 146
+F I+ IG G + VYRA L G VALKK+ + E LL Q+ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRND-------DEAIQLDWTKRVNIVKSM 199
N++K Y + + ++ + G L ++++ E + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ------L 145
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
AL ++H ++HRDI N+ + + + D G+ R S ++ + GT Y
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 202
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM----LIDLLDQRAPS 315
++PE + K D++ G + E+ + P F M L ++Q
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYSLCKKIEQCDYP 256
Query: 316 PIDDQTVIQDII-LVSKIAFACLRSKPKSRPT 346
P+ +++ LV+ C+ P+ RP
Sbjct: 257 PLPSDHYSEELRQLVNM----CINPDPEKRPD 284
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 61/291 (20%), Positives = 124/291 (42%), Gaps = 35/291 (12%)
Query: 76 DGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQ 135
+ F+ + V + I IG+GG V++ +I A+K ++ E + L+S++
Sbjct: 15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYR 74
Query: 136 TEARLLSQIRHRN--IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV 193
E L++++ + I++LY + + + ++++ + L L+ +D +R
Sbjct: 75 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK---SIDPWERK 130
Query: 194 NIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSN- 249
+ K+M A+ +H IVH D+ N L+ KL DFG+A + D+++
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSV 183
Query: 250 -RTVVAGTHGYIAPEL-----------AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLS 297
+ GT Y+ PE ++ K DV+ G + + G+ P +
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243
Query: 298 SFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ K+ I + P + +QD++ CL+ PK R ++
Sbjct: 244 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIP 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 33/268 (12%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALK--KLHHSETELAFLESFQTEARLLSQI 144
E F IG G +G V++ + K+VA+K L +E E+ E Q E +LSQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI---EDIQQEITVLSQC 77
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN---DDEAIQLDWTKRVNIVKSMAH 201
+ K YG L +++I +Y+ GS +L D+ I I++ +
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILK 130
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
L YLH + +HRDI + N+LL+ E +ADFGVA L R GT ++A
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP-KIMLIDLLDQRAPSPIDDQ 320
PE+ K D++ G+ A+E+ G P S +P K++ L+ + P ++
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP---HSELHPMKVLF--LIPKNNPPTLEGN 242
Query: 321 --TVIQDIILVSKIAFACLRSKPKSRPT 346
+++ + CL +P RPT
Sbjct: 243 YSKPLKEFVEA------CLNKEPSFRPT 264
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 60/283 (21%), Positives = 113/283 (39%), Gaps = 39/283 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
DF+ C+G GG+G V+ A+ A+K++ ELA E E + L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHP 63
Query: 148 NIVKLYGFCLHKKCM------------FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNI 195
IV+ + L K ++ + R+ +L + + + + ++I
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS-------- 247
+A A+ +LH ++HRD+ +NI V DFG+ + D
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 248 ----SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI 303
+ T GT Y++PE + + K D+F G++ E+L +P S+ ++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP---FSTQMERV 234
Query: 304 MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ + P+ Q + ++V L P RP
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQD----MLSPSPMERPE 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 62/285 (21%), Positives = 121/285 (42%), Gaps = 35/285 (12%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLL 141
E I V + I IG+GG V++ +I A+K ++ E + L+S++ E L
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 142 SQIRH--RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
++++ I++LY + + + ++++ + L L+ +D +R + K+M
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK---SIDPWERKSYWKNM 117
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSN--RTVVA 254
A+ +H IVH D+ N L+ KL DFG+A + D+++ +
Sbjct: 118 LEAVHTIHQH---GIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQV 170
Query: 255 GTHGYIAPEL-----------AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI 303
GT Y+ PE ++ K DV+ G + + G+ P + + K+
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230
Query: 304 MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
I + P + +QD++ CL+ PK R ++
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIP 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 41/268 (15%)
Query: 96 CIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154
+G G YG VY L + +A+K++ E + + + E L ++H+NIV+ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214
+ + + + GSL +LR+ ++ + K + L YLH + I
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---I 143
Query: 215 VHRDISSNNILLNS-----KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV 269
VHRDI +N+L+N+ K+ +DFG ++ L + GT Y+APE +
Sbjct: 144 VHRDIKGDNVLINTYSGVLKI----SDFGTSKRLAGINPCTETFTGTLQYMAPE-----I 194
Query: 270 V-------TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322
+ + D++ G +E+ G+ P L + + + I +
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV--HPEIPES-- 250
Query: 323 IQDIILVSKIA--F--ACLRSKPKSRPT 346
+S A F C P R
Sbjct: 251 ------MSAEAKAFILKCFEPDPDKRAC 272
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 73/282 (25%), Positives = 128/282 (45%), Gaps = 39/282 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRA-QLPSGKIVALK--KLHHSETELAFLESFQTEARLLSQIR 145
+D++++ IG+G V A P + VA+K L +T + + E + +SQ
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---DELLKEIQAMSQCH 71
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN-----DDEAIQLDWTKRVNIVKSMA 200
H NIV Y + K ++L+ K + GS+ ++++ + ++ LD + I++ +
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL-----HSDSSNRTVVAG 255
L YLH + +HRD+ + NILL +ADFGV+ L + + R G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 256 THGYIAPELAYTMVVTE------KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL 309
T ++APE V+ + K D++ FG+ A+E+ G P + P +L+ L
Sbjct: 189 TPCWMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAP---YHKYPPMKVLMLTL 240
Query: 310 DQRAPSPIDDQTVIQDIILVSKIAF-----ACLRSKPKSRPT 346
PS + + K +F CL+ P+ RPT
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGK-SFRKMISLCLQKDPEKRPT 281
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 61/287 (21%), Positives = 120/287 (41%), Gaps = 35/287 (12%)
Query: 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEAR 139
E I V + I IG+GG V++ +I A+K ++ E + L+S++ E
Sbjct: 47 ANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 140 LLSQIRH--RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVK 197
L++++ I++LY + + + ++++ + L L+ +D +R + K
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK---SIDPWERKSYWK 162
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSN--RTV 252
+M A+ +H IVH D+ N L+ KL DFG+A + D+++ +
Sbjct: 163 NMLEAVHTIHQH---GIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDS 215
Query: 253 VAGTHGYIAPEL-----------AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP 301
G Y+ PE ++ K DV+ G + + G+ P + +
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 302 KIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
K+ I + P + +QD++ CL+ PK R ++
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIP 316
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 61/268 (22%), Positives = 116/268 (43%), Gaps = 36/268 (13%)
Query: 93 IKYCIGTGGYGSVYRAQL--PSGKI-VALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
+G G +GSV + +I VA+K L + E EA+++ Q+ + I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYI 72
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL--- 206
V+L G C + + L+ + G L L E ++ + ++ ++ + YL
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK 129
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
++ VHRD+++ N+LL ++ A ++DFG+++ L +D S A + G A
Sbjct: 130 NF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYA 181
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPID 318
PE + + DV+ +GV E L G+ P + P++ + ++Q R P +
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEV--MAFIEQGKRMECPPE 237
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ ++ C K + RP
Sbjct: 238 CPPELYALMS------DCWIYKWEDRPD 259
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 64/288 (22%), Positives = 119/288 (41%), Gaps = 44/288 (15%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
DF+ +G G +G V +A+ + A+KK+ H+E +L + +E LL+ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL---STILSEVMLLASLNH 61
Query: 147 RNIVKLYGF-------------CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV 193
+ +V+ Y K +F+ +Y G+L+ ++ + E + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYW 119
Query: 194 NIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD------- 246
+ + + ALSY+H I+HRD+ NI ++ + DFG+A+ +H
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 247 -------SSNRTVVAGTHGYIAPE-LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSS 298
S N T GT Y+A E L T EK D++ G++ E++ G +
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236
Query: 299 FNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
K+ + + P DD + + ++ + P RP
Sbjct: 237 ILKKLRSVSI---EFPPDFDDNKMKVEKKIIRL----LIDHDPNKRPG 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 65/274 (23%), Positives = 116/274 (42%), Gaps = 39/274 (14%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL----PSGKI-VALKKLHHSETELAFLESFQTEARLLSQ 143
+F +G+G +G+VY+ KI VA+K+L + + A E EA +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMAS 73
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
+ + ++ +L G CL + LI + M G L +R + I +N +A +
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGM 130
Query: 204 SYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
+YL VHRD+++ N+L+ + + DFG+A+LL ++ G +
Sbjct: 131 NYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKV 181
Query: 261 -----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--R 312
A E + T + DV+ +GV E++ G P D + +I +L++ R
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEI--SSILEKGER 237
Query: 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P P + I+ C SRP
Sbjct: 238 LPQPPICTIDVYMIMR------KCWMIDADSRPK 265
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 60/264 (22%), Positives = 117/264 (44%), Gaps = 36/264 (13%)
Query: 97 IGTGGYGSVYRAQLPSGKI---VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLY 153
+G+G +G+V + K+ VA+K L + + A + EA ++ Q+ + IV++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL---HYDC 210
G C + L+ + G L L+ + + + +V ++ + YL ++
Sbjct: 85 GICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNF-- 138
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APELA 265
VHRD+++ N+LL ++ A ++DFG+++ L +D + A THG APE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECI 192
Query: 266 YTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTV 322
+ K DV+ FGV+ E G+ P + ++ +L++ R P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEV--TAMLEKGERMGCPAGCPRE 248
Query: 323 IQDIILVSKIAFACLRSKPKSRPT 346
+ D++ C ++RP
Sbjct: 249 MYDLMN------LCWTYDVENRPG 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 78/273 (28%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGK----IVALKKLHHSETELAFLESFQTEARLLSQI 144
+ I +G G +G V +L VA+K L TE + F EA ++ Q
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQF 103
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
H NI++L G K + ++ +YM GSL LR D Q + V +++ +A +
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMK 161
Query: 205 YL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
YL Y VHRD+++ NIL+NS L V+DFG+ R+L D G I
Sbjct: 162 YLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE--AAYTTRGGKIP 213
Query: 261 ----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RA 313
+PE T DV+ +G+V EV+ G P +S N + I +D+ R
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--NQDV--IKAVDEGYRL 269
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P P+D + ++L C + +RP
Sbjct: 270 PPPMDCPAALYQLML------DCWQKDRNNRPK 296
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL---PSGKI-VALKKLHHSETELAFLESFQTEARLLSQI 144
I+ IG+G G V +L + VA+K L TE + F +EA ++ Q
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQF 107
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
H NI++L G + ++ +YM GSL LR D Q + V +++ + +
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMR 165
Query: 205 YL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
YL Y VHRD+++ N+L++S L V+DFG++R+L D T G I
Sbjct: 166 YLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKIP 217
Query: 261 ----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RA 313
APE + DV+ FGVV EVL G P ++ N + I +++ R
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--NRDV--ISSVEEGYRL 273
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P+P+ + ++L C RP
Sbjct: 274 PAPMGCPHALHQLML------DCWHKDRAQRPR 300
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 62/269 (23%), Positives = 110/269 (40%), Gaps = 36/269 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+ IG+G +G V+ + VA+K + E F EA ++ ++ H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 64
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL-- 206
+V+LYG CL + + L+ ++M G L LR + + + ++YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEE 122
Query: 207 -HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
+HRD+++ N L+ V+DFG+ R + D + T
Sbjct: 123 ACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWA 172
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPI 317
+PE+ + K DV+ FGV+ EV G+ P + S N ++ ++ + R P
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEV--VEDISTGFRLYKPR 228
Query: 318 DDQTVIQDIILVSKIAFACLRSKPKSRPT 346
T + I+ C R +P+ RP
Sbjct: 229 LASTHVYQIMN------HCWRERPEDRPA 251
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 64/267 (23%), Positives = 116/267 (43%), Gaps = 32/267 (11%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+D +GTG +G V + VA+K + + F EA+++ + H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 80
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL-- 206
+V+LYG C ++ +F+I +YM G L LR + + + + K + A+ YL
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES 138
Query: 207 -HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---AP 262
+ +HRD+++ N L+N + V+DFG++R + D T G+ + P
Sbjct: 139 KQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPP 190
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDD 319
E+ + K D++ FGV+ E+ G+ P + + N + + + Q R P
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSET--AEHIAQGLRLYRPHLA 246
Query: 320 QTVIQDIILVSKIAFACLRSKPKSRPT 346
+ I+ +C K RPT
Sbjct: 247 SEKVYTIMY------SCWHEKADERPT 267
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-34
Identities = 55/280 (19%), Positives = 101/280 (36%), Gaps = 54/280 (19%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+ +G G +G V+R + +G A+K ++ E + +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK-------KVRLEVFRVEELVACAGLSS 109
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKSMAHA 202
IV LYG + + + + GSL +++ ++ +
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-------YYLGQALEG 162
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTV-----VAGT 256
L YLH I+H D+ ++N+LL+S A + DFG A L D +++ + GT
Sbjct: 163 LEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 257 HGYIAPELAYTMVVTE-----KCDVFGFGVVALEVLMGRHPGDLLSSFNP-KIMLIDLLD 310
++APE VV K D++ + L +L G HP + + + L +
Sbjct: 220 ETHMAPE-----VVMGKPCDAKVDIWSSCCMMLHMLNGCHP---WTQYFRGPLCLKIASE 271
Query: 311 QRAPSPIDDQTVIQDIILVSKIA--F--ACLRSKPKSRPT 346
I + + LR +P R +
Sbjct: 272 PPPIREIPPS--------CAPLTAQAIQEGLRKEPVHRAS 303
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-34
Identities = 83/272 (30%), Positives = 129/272 (47%), Gaps = 33/272 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL--PSGKI---VALKKLHHSETELAFLESFQTEARLLSQ 143
+ IG G +G VY+ L SGK VA+K L TE ++ F EA ++ Q
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQ 102
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
H NI++L G K M +I +YM G+L LR D + + V +++ +A +
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGM 160
Query: 204 SYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
YL +Y VHRD+++ NIL+NS L V+DFG++R+L D +G I
Sbjct: 161 KYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214
Query: 261 ---APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAP 314
APE T DV+ FG+V EV+ G P LS N ++ + ++ R P
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEV--MKAINDGFRLP 270
Query: 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+P+D + I +++ C + + RP
Sbjct: 271 TPMDCPSAIYQLMM------QCWQQERARRPK 296
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 61/281 (21%), Positives = 116/281 (41%), Gaps = 36/281 (12%)
Query: 84 IIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQ 143
+IV F K +G G G++ + + VA+K++ E +LL +
Sbjct: 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-----PECFSFADREVQLLRE 73
Query: 144 I-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-CVLRNDDEAIQLDWTKRVNIVKSMAH 201
H N+++ + ++ ++ + +L V + D + L+ + +++
Sbjct: 74 SDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE---PITLLQQTTS 129
Query: 202 ALSYLHYDCIPSIVHRDISSNNILL-----NSKLEAFVADFGVARLLHSDSSNRTV---V 253
L++LH +IVHRD+ +NIL+ + K++A ++DFG+ + L + + V
Sbjct: 130 GLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 254 AGTHGYIAPEL---AYTMVVTEKCDVFGFGVVALEVL-MGRHP-GDLLSSFNPKIMLIDL 308
GT G+IAPE+ T D+F G V V+ G HP G + I L
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS----LQRQANILL 242
Query: 309 LDQRAPSPIDDQTVIQDII-LVSKIAFACLRSKPKSRPTMR 348
++ L+ K + P+ RP+ +
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEK----MIAMDPQKRPSAK 279
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 49/280 (17%), Positives = 108/280 (38%), Gaps = 19/280 (6%)
Query: 88 TEDFDIKYCIGTG--GYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI 144
+++ IG G +V A+ P+G+ V +++++ + Q E +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
H NIV + ++++ +M GS ++ ++ I++ + AL
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALD 142
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV-------AGTH 257
Y+H+ VHR + +++IL++ + +++ + S + VV
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 258 GYIAPELAYTMVV--TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPS 315
+++PE+ + K D++ G+ A E+ G P ML++ L+ P
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP---FKDMPATQMLLEKLNGTVPC 256
Query: 316 PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPE 355
+D T+ + + +S S T N +
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGD 296
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 61/269 (22%), Positives = 119/269 (44%), Gaps = 36/269 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
E+ + +G+G +G V + VA+K + + F EA+ + ++ H
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPK 64
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL-- 206
+VK YG C + ++++ +Y+ G L LR+ + L+ ++ + + + +++L
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLES 122
Query: 207 -HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
+ +HRD+++ N L++ L V+DFG+ R + D +
Sbjct: 123 HQF------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWS 172
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPI 317
APE+ + + K DV+ FG++ EV G+ P DL + N ++ + + Q R P
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--NSEV--VLKVSQGHRLYRPH 228
Query: 318 DDQTVIQDIILVSKIAFACLRSKPKSRPT 346
I I+ +C P+ RPT
Sbjct: 229 LASDTIYQIMY------SCWHELPEKRPT 251
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+DF+ +G G G V++ PSG ++A K + H E + A E ++L +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSP 91
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN------IVKSMAH 201
IV YG + + ++M GSL VL+ R+ + ++
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---------AGRIPEQILGKVSIAVIK 142
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
L+YL I+HRD+ +NIL+NS+ E + DFGV+ L DS + V GT Y++
Sbjct: 143 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRSYMS 198
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE + + D++ G+ +E+ +GR+P
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 64/274 (23%), Positives = 117/274 (42%), Gaps = 39/274 (14%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL----PSGKI-VALKKLHHSETELAFLESFQTEARLLSQ 143
+F +G+G +G+VY+ KI VA+K+L + + A E EA +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMAS 73
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
+ + ++ +L G CL + LI + M G L +R + + +N +A +
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGM 130
Query: 204 SYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
+YL VHRD+++ N+L+ + + DFG+A+LL ++ G +
Sbjct: 131 NYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKV 181
Query: 261 -----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--R 312
A E + T + DV+ +GV E++ G P D + +I +L++ R
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEI--SSILEKGER 237
Query: 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P P + I++ C SRP
Sbjct: 238 LPQPPICTIDVYMIMV------KCWMIDADSRPK 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 45/278 (16%)
Query: 97 IGTGGYGSVYRAQLP-----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +G V + +G+ VA+K L + + E +L + H NIVK
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHENIVK 87
Query: 152 LYGFCLHKKC--MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL--- 206
G C + LI +++ GSL L + +++ +++ + + YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR 145
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
Y VHRD+++ N+L+ S+ + + DFG+ + + +D A
Sbjct: 146 QY------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--YYTVKDDRDSPVFWYA 197
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIM----------LIDLLD 310
PE DV+ FGV E+L ++ F I L++ L
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257
Query: 311 Q--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ R P P + + ++ C +P +R +
Sbjct: 258 EGKRLPCPPNCPDEVYQLMR------KCWEFQPSNRTS 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 63/270 (23%), Positives = 117/270 (43%), Gaps = 29/270 (10%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
E ++I +G G +G VY+A+ +G + A K + E LE + E +L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDH 75
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
IVKL G H ++++ ++ G++ ++ D + + + + M AL++L
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFL 133
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H I+HRD+ + N+L+ + + +ADFGV+ R GT ++APE+
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 267 TMVVTE-----KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321
+ + K D++ G+ +E+ P NP M + L ++ P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP---HHELNP--MRVLLKIAKSDPP----- 240
Query: 322 VIQDIILVSKIAF-----ACLRSKPKSRPT 346
+ S F L P++RP+
Sbjct: 241 TLLTPSKWSV-EFRDFLKIALDKNPETRPS 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-33
Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 42/273 (15%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKI-VALKKLHHSETELAFLESFQTEARLLSQIRHR 147
D +K+ +G G YG VY + VA+K L E+ E F EA ++ +I+H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 69
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL- 206
N+V+L G C + ++I ++M G+L LR + ++ + + ++ A+ YL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 128
Query: 207 --HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---- 260
++ +HRD+++ N L+ VADFG++RL+ D T A
Sbjct: 129 KKNF------IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKW 178
Query: 261 -APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-----RA 313
APE + K DV+ FGV+ E+ G P P I L + + R
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLSQVYELLEKDYRM 231
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P + +++ AC + P RP+
Sbjct: 232 ERPEGCPEKVYELMR------ACWQWNPSDRPS 258
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 32/277 (11%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEAR-LLSQ 143
ED IG G YGSV + PSG+I+A+K++ S + + + ++
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRS 77
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV--NIVKSMAH 201
IV+ YG + ++ + M S + + + + I +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
AL++L + I+HRDI +NILL+ + DFG++ L DS +T AG Y+A
Sbjct: 137 ALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMA 193
Query: 262 PE--------LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ-- 311
PE Y + DV+ G+ E+ GR P +N + D L Q
Sbjct: 194 PERIDPSASRQGY----DVRSDVWSLGITLYELATGRFP---YPKWNS---VFDQLTQVV 243
Query: 312 RAPSPIDDQTVIQD--IILVSKIAFACLRSKPKSRPT 346
+ P + ++ ++ + CL RP
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVN-LCLTKDESKRPK 279
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 60/264 (22%), Positives = 116/264 (43%), Gaps = 36/264 (13%)
Query: 97 IGTGGYGSVYRAQL--PSGKI-VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLY 153
+G G +GSV + +I VA+K L + E EA+++ Q+ + IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLI 402
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL---HYDC 210
G C + + L+ + G L L E ++ + ++ ++ + YL ++
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKNF-- 457
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APELA 265
VHR++++ N+LL ++ A ++DFG+++ L +D S A + G APE
Sbjct: 458 ----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECI 511
Query: 266 YTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTV 322
+ + DV+ +GV E L G+ P + P++ + ++Q R P +
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEV--MAFIEQGKRMECPPECPPE 567
Query: 323 IQDIILVSKIAFACLRSKPKSRPT 346
+ ++ C K + RP
Sbjct: 568 LYALMS------DCWIYKWEDRPD 585
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 36/272 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKI-VALKKLHHSETELAFLESFQTEARLLSQIRHR 147
D +K+ +G G YG VY + VA+K L E+ E F EA ++ +I+H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHP 276
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
N+V+L G C + ++I ++M G+L LR + ++ + + ++ A+ YL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE 335
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----AP 262
+ +HR++++ N L+ VADFG++RL+ D T A AP
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAP 388
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-----RAPSP 316
E + K DV+ FGV+ E+ G P P I L + + R P
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLSQVYELLEKDYRMERP 441
Query: 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ +++ AC + P RP+
Sbjct: 442 EGCPEKVYELMR------ACWQWNPSDRPSFA 467
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 68/274 (24%), Positives = 122/274 (44%), Gaps = 44/274 (16%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+ + IG G G+VY A + +G+ VA+++++ + E E ++ + ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKN 76
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN---DDEAIQLDWTKRVNIVKSMAHAL 203
NIV L ++++ +Y+ GSL V+ D+ I + + AL
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQAL 129
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
+LH + ++HRDI S+NILL + DFG + + S R+ + GT ++APE
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 264 LAYTMVVTE-----KCDVFGFGVVALEVLMGRHPGDLLSSFNP--KIMLIDLLDQRAPSP 316
VVT K D++ G++A+E++ G P + NP + LI +P
Sbjct: 187 -----VVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYLI----ATNGTP 234
Query: 317 IDDQTVIQDIILVSKI--AF--ACLRSKPKSRPT 346
+Q+ +S I F CL + R +
Sbjct: 235 -----ELQNPEKLSAIFRDFLNRCLEMDVEKRGS 263
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-33
Identities = 77/267 (28%), Positives = 125/267 (46%), Gaps = 30/267 (11%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
E FD+ +G G YGSVY+A +G+IVA+K++ L+ E ++ Q
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDS 83
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
++VK YG ++++ +Y GS+ ++R ++ + D I++S L YL
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYL 141
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H+ +HRDI + NILLN++ A +ADFGVA L + R V GT ++APE+
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 198
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP--KIMLIDLLDQRAPSPIDDQTVIQ 324
+ D++ G+ A+E+ G+ P + +P I +I P P +
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP---YADIHPMRAIFMI----PTNPPP-----TFR 246
Query: 325 DIILVSKIAF-----ACLRSKPKSRPT 346
L S F CL P+ R T
Sbjct: 247 KPELWSD-NFTDFVKQCLVKSPEQRAT 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 50/263 (19%), Positives = 91/263 (34%), Gaps = 26/263 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RH 146
+ F +G G YG V++ + G++ A+K+ E ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
V+L ++L + SL ++ ++ AL++L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW--GYLRDTLLALAHL 173
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-- 264
H +VH D+ NI L + + DFG+ L + + G Y+APEL
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQ 229
Query: 265 -AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323
+Y DVF G+ LEV + L + + + +
Sbjct: 230 GSY----GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY--LPPEFTAGLSSE--L 281
Query: 324 QDIILVSKIAFACLRSKPKSRPT 346
+ +++ L PK R T
Sbjct: 282 RSVLV------MMLEPDPKLRAT 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 77/268 (28%), Positives = 133/268 (49%), Gaps = 33/268 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
EDF+I +G G +G+VY A+ S I+ALK L ++ + + E + S +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----NDDEAIQLDWTKRVNIVKSMAH 201
NI++LYG+ ++LI +Y G+++ L+ ++ + +A+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--------ATYITELAN 120
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
ALSY H ++HRDI N+LL S E +ADFG + +H+ SS RT + GT Y+
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLP 175
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML--IDLLDQRAPSPIDD 319
PE+ + EK D++ GV+ E L+G+ P + + + I ++ P + +
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFTFPDFVTE 232
Query: 320 QTVIQDIILVSKIAFACLRSKPKSRPTM 347
+D L+S++ L+ P RP +
Sbjct: 233 GA--RD--LISRL----LKHNPSQRPML 252
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 52/267 (19%), Positives = 106/267 (39%), Gaps = 23/267 (8%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEAR-LLSQIRH 146
D + +G+G G V++ + +G ++A+K++ + + +L
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDC 83
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
IV+ +G + +F+ + M + R I + + ++ AL YL
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGK--MTVAIVKALYYL 140
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
++HRD+ +NILL+ + + + DFG++ L D + AG Y+APE
Sbjct: 141 KEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERID 197
Query: 267 TMVVTE-----KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDD 319
T+ + DV+ G+ +E+ G+ P + ++L + + P+
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFP---YKNCKT---DFEVLTKVLQEEPPLLP 251
Query: 320 QTVIQDIILVSKIAFACLRSKPKSRPT 346
+ S + CL + RP
Sbjct: 252 GHMGFSGDFQSFVK-DCLTKDHRKRPK 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 97 IGTGGYGSVYRAQLPS-GKIVALKKLHHSETELA----FLESFQTEARLLSQIRHRNIVK 151
+G GG G VY A+ +IVALK + L+ F Q EAR +++ ++V
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMS---ETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
++ F +++ + + L +LR L + V IV+ + AL H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAPELAYTMVV 270
HRD+ NIL+++ A++ DFG+A + + GT Y+APE
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 271 TEKCDVFGFGVVALEVLMGRHP--GDLLS 297
T + D++ V E L G P GD LS
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLS 241
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 34/273 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL--PSGKI--VALKKLHH-SETELAFLESFQTEARLLSQ 143
+D + +G G +G V R + PSGK VA+K L ++ ++ F E +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
+ HRN+++LYG L M ++ + GSL LR L +A +
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGM 134
Query: 204 SYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
YL + +HRD+++ N+LL ++ + DFG+ R L + V H +
Sbjct: 135 GYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--HYVMQEHRKV 186
Query: 261 -----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIM-LIDLLDQRA 313
APE T + D + FGV E+ G+ P L+ +I+ ID +R
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKIDKEGERL 244
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P P D I ++++ C KP+ RPT
Sbjct: 245 PRPEDCPQDIYNVMV------QCWAHKPEDRPT 271
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 62/269 (23%), Positives = 123/269 (45%), Gaps = 34/269 (12%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
D IG G G V A+ SG+ VA+K + + + E E ++ +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQH 101
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN---DDEAIQLDWTKRVNIVKSMAHAL 203
N+V++Y L + ++++ ++++ G+L ++ ++E I + +++ AL
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-------VCEAVLQAL 154
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
+YLH ++HRDI S++ILL ++DFG + D R + GT ++APE
Sbjct: 155 AYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP--KIMLIDLLDQRAPSPIDDQT 321
+ + + D++ G++ +E++ G P S +P + + + +P P
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPP---YFSDSPVQAMKRL----RDSPPP----- 259
Query: 322 VIQDIILVSKI--AF--ACLRSKPKSRPT 346
+++ VS + F L P+ R T
Sbjct: 260 KLKNSHKVSPVLRDFLERMLVRDPQERAT 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 59/310 (19%), Positives = 113/310 (36%), Gaps = 47/310 (15%)
Query: 83 EIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLH-HSETELAFLESFQTEARL 140
+I+ + + +G GG+ V + L G ALK++ H + + E Q EA +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADM 79
Query: 141 LSQIRHRNIVKLYGFCL----HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV-NI 195
H NI++L +CL K +L+ + +RG+L+ + + ++ +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA- 254
+ + L +H HRD+ NILL + + + D G
Sbjct: 140 LLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 255 --------GTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK 302
T Y APEL ++ V+ E+ DV+ G V ++ G P D++
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255
Query: 303 IMLIDLLDQRAPSPIDDQ--TVIQDIILVSKIAFACLRSKPKSRPT----------MRRS 350
+ L + + P + + + ++ + + P RP ++
Sbjct: 256 VALA--VQNQLSIPQSPRHSSALWQLLN------SMMTVDPHQRPHIPLLLSQLEALQPP 307
Query: 351 FPNPEINPSL 360
P L
Sbjct: 308 APGQHTTQIL 317
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 68/273 (24%), Positives = 114/273 (41%), Gaps = 39/273 (14%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGK----IVALKKLHHSETELAFLESFQTEARLLSQI 144
E ++ CIG G +G V++ S + VA+K + ++ E F EA + Q
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQF 73
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
H +IVKL G + +++I + G L L+ ++ L + ++ AL+
Sbjct: 74 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALA 130
Query: 205 YL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
YL + VHRDI++ N+L++S + DFG++R + T + G +
Sbjct: 131 YLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLP 180
Query: 261 ----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RA 313
APE T DV+ FGV E+LM G P + N + I ++ R
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDV--IGRIENGERL 236
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P P + + ++ C P RP
Sbjct: 237 PMPPNCPPTLYSLMT------KCWAYDPSRRPR 263
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 56/300 (18%), Positives = 117/300 (39%), Gaps = 55/300 (18%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL--------PSGKIVALKKLHHSETELAFLESFQTEARL 140
ED +G G + +++ V LK L + + ESF A +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASM 65
Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMA 200
+S++ H+++V YG C+ L+ ++++ GSL L+ + I + W ++ + K +A
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLA 123
Query: 201 HALSYL---HYDCIPSIVHRDISSNNILLNSKLEAF--------VADFGVARLLHSDSSN 249
A+ +L +H ++ + NILL + + ++D G++ +
Sbjct: 124 AAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 250 RTVVAGTHGYIAPE-LAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLID 307
+ + PE + + D + FG E+ G P L + + +
Sbjct: 178 QERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRK--LQ 229
Query: 308 LLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR------RSFPNPEINPS 359
+ + P+P + + ++I C+ +P RP+ R S P++ P
Sbjct: 230 FYEDRHQLPAPKAAE--LANLIN------NCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 48/279 (17%)
Query: 97 IGTGGYGSVYRAQLP-----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +GSV + +G +VA+K+L HS + FQ E ++L + IVK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVK 88
Query: 152 LYGFCLHKKC--MFLIYKYMRRGSLFCVLRNDDEAIQ----LDWTKRVNIVKSMAHALSY 205
G + L+ +Y+ G L L+ + L ++ I K M + L
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGMEY-LGS 145
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
VHRD+++ NIL+ S+ +ADFG+A+LL D V G
Sbjct: 146 RRC------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD--YYVVREPGQSPIFWY 197
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIM----------LIDLL 309
APE + + + DV+ FGVV E+ + F + L++LL
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 310 DQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
++ R P+P + +++ C P+ RP+
Sbjct: 258 EEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPS 290
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 7e-32
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 39/273 (14%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL--PSGKI--VALKKLHHSETELAFLESFQTEARLLSQI 144
ED + +G G +G VY G+ VA+K T E F +EA ++ +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNL 70
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
H +IVKL G ++ ++I + G L L + ++++ V + A++
Sbjct: 71 DHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMA 127
Query: 205 YL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
YL + VHRDI+ NIL+ S + DFG++R + + + +
Sbjct: 128 YLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLP 177
Query: 261 ----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RA 313
+PE T DV+ F V E+L G+ P L N + I +L++ R
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE--NKDV--IGVLEKGDRL 233
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P P V+ ++ C P RP
Sbjct: 234 PKPDLCPPVLYTLMT------RCWDYDPSDRPR 260
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-32
Identities = 66/266 (24%), Positives = 110/266 (41%), Gaps = 36/266 (13%)
Query: 97 IGTGGYGSVYRAQLPSGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G +G VY L A+K L+ + F TE ++ H N++ L
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSL 155
Query: 153 YGFCLHKKC-MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL---HY 208
G CL + ++ YM+ G L +RN+ + +A + +L +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
VHRD+++ N +L+ K VADFG+AR ++ + V T + A E
Sbjct: 214 ------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-VHNKTGAKLPVKWMALE 266
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQ 320
T T K DV+ FGV+ E++ G P +++F+ + L Q R P
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRLLQPEYCP 322
Query: 321 TVIQDIILVSKIAFACLRSKPKSRPT 346
+ +++L C K + RP+
Sbjct: 323 DPLYEVML------KCWHPKAEMRPS 342
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 67/275 (24%), Positives = 110/275 (40%), Gaps = 41/275 (14%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL----PSGKI-VALKKLHHSETELAFLESFQTEARLLSQ 143
+ +G+G +G+V++ S KI V +K + +F +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHMLAIGS 71
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ----LDWTKRVNIVKSM 199
+ H +IV+L G C + L+ +Y+ GSL +R A+ L+W V I K M
Sbjct: 72 LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGM 128
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
+ L VHR++++ N+LL S + VADFGVA LL D +
Sbjct: 129 YY-LEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYSEAK 178
Query: 260 I-----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-- 311
A E + T + DV+ +GV E++ G P L ++ DLL++
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEV--PDLLEKGE 234
Query: 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
R P + +++ C RPT
Sbjct: 235 RLAQPQICTIDVYMVMV------KCWMIDENIRPT 263
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 36/269 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
E + +G G +G V+ VA+K L ++F EA L+ Q++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQR 69
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL-- 206
+V+LY ++ +++I +YM GSL L+ +L K +++ +A ++++
Sbjct: 70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEE 127
Query: 207 -HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
+Y +HRD+ + NIL++ L +ADFG+ARL+ + A
Sbjct: 128 RNY------IHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWT 177
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPI 317
APE T K DV+ FG++ E++ GR P ++ NP++ I L++ R P
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEV--IQNLERGYRMVRPD 233
Query: 318 DDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ + ++ C + +P+ RPT
Sbjct: 234 NCPEELYQLMR------LCWKERPEDRPT 256
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 42/274 (15%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
E ++ +G G +G V+ VA+K L E+F EA+++ ++RH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 323
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL-- 206
+V+LY ++ ++++ +YM +GSL L+ + L + V++ +A ++Y+
Sbjct: 324 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVER 381
Query: 207 -HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
+Y VHRD+ + NIL+ L VADFG+ARL+ +
Sbjct: 382 MNY------VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR----QGAKFPIKWT 431
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-----RAP 314
APE A T K DV+ FG++ E+ GR P P ++ ++LDQ R P
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMP 484
Query: 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
P + + D++ C R +P+ RPT
Sbjct: 485 CPPECPESLHDLMC------QCWRKEPEERPTFE 512
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 42/274 (15%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
E ++ +G G +G V+ VA+K L E+F EA+++ ++RH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 240
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL-- 206
+V+LY ++ ++++ +YM +GSL L+ + L + V++ +A ++Y+
Sbjct: 241 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVER 298
Query: 207 -HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
+Y VHRD+ + NIL+ L VADFG+ARL+ +
Sbjct: 299 MNY------VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR----QGAKFPIKWT 348
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-----RAP 314
APE A T K DV+ FG++ E+ GR P P ++ ++LDQ R P
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMP 401
Query: 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
P + + D++ C R +P+ RPT
Sbjct: 402 CPPECPESLHDLMC------QCWRKEPEERPTFE 429
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 48/273 (17%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
++ + IG G +G V G VA+K + + T AFL EA +++Q+RH N
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLA----EASVMTQLRHSN 75
Query: 149 IVKLYGFCLHKK-CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL- 206
+V+L G + +K ++++ +YM +GSL LR+ + L + + A+ YL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE 134
Query: 207 --HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---- 260
++ VHRD+++ N+L++ A V+DFG+ + S G +
Sbjct: 135 GNNF------VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPVKW 180
Query: 261 -APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-----RA 313
APE + K DV+ FG++ E+ GR P P+I L D++ + +
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYKM 233
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+P + +++ C RP+
Sbjct: 234 DAPDGCPPAVYEVMK------NCWHLDAAMRPS 260
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 34/232 (14%), Positives = 71/232 (30%), Gaps = 26/232 (11%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQ------LPSGKIVALKKLHHSETELAFLESFQ 135
E + ++ + + +G G + VY A + + LK + ++
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG--T 115
Query: 136 TEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ--LDWTKRV 193
L +K Y L + L+ + G+L + + + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 194 NIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF-----------VADFGVARL 242
+ M + + +H I+H DI +N +L + + D G +
Sbjct: 176 SFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 243 LHSDSSNRTVVA--GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+ A T G+ E+ + D FG +L G +
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 67/266 (25%), Positives = 109/266 (40%), Gaps = 36/266 (13%)
Query: 97 IGTGGYGSVYRAQLPSGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G +G VY L A+K L+ + F TE ++ H N++ L
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSL 91
Query: 153 YGFCLHKKC-MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL---HY 208
G CL + ++ YM+ G L +RN+ + +A + YL +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
VHRD+++ N +L+ K VADFG+AR ++ V T + A E
Sbjct: 150 ------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS-VHNKTGAKLPVKWMALE 202
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQ 320
T T K DV+ FGV+ E++ G P +++F+ + L Q R P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRLLQPEYCP 258
Query: 321 TVIQDIILVSKIAFACLRSKPKSRPT 346
+ +++L C K + RP+
Sbjct: 259 DPLYEVML------KCWHPKAEMRPS 278
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 63/279 (22%), Positives = 119/279 (42%), Gaps = 40/279 (14%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEAR-LLSQ 143
V +D + +G G YG V + + +PSG+I+A+K++ + + + +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRT 62
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN------IVK 197
+ V YG + +++ + M SL + +D + + I
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQ-----VIDKGQTIPEDILGKIAV 116
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
S+ AL +LH S++HRD+ +N+L+N+ + + DFG++ L D + + AG
Sbjct: 117 SIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCK 173
Query: 258 GYIAPE--------LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL 309
Y+APE Y++ K D++ G+ +E+ + R P S P L ++
Sbjct: 174 PYMAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQVV 227
Query: 310 DQRAPSPIDDQ--TVIQDIILVSKIAFACLRSKPKSRPT 346
++ +P D+ D CL+ K RPT
Sbjct: 228 EEPSPQLPADKFSAEFVDFTS------QCLKKNSKERPT 260
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 67/270 (24%), Positives = 132/270 (48%), Gaps = 38/270 (14%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
E ++ +G G +G V+ A VA+K + + E+F EA ++ ++H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHDK 244
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL-- 206
+VKL+ K+ +++I ++M +GSL L++D+ + + K ++ +A ++++
Sbjct: 245 LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 207 -HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI---AP 262
+Y +HRD+ + NIL+++ L +ADFG+AR++ + T G I AP
Sbjct: 303 RNY------IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAP 354
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-----RAPSP 316
E T K DV+ FG++ +E++ GR P P + +++ R P P
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP-------YPGMSNPEVIRALERGYRMPRP 407
Query: 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ + +I++ C +++P+ RPT
Sbjct: 408 ENCPEELYNIMM------RCWKNRPEERPT 431
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 50/276 (18%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
++ + IG G +G V G VA+K + + T AFL EA +++Q+RH N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLA----EASVMTQLRHSN 247
Query: 149 IVKLYGFCLHKK-CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL- 206
+V+L G + +K ++++ +YM +GSL LR+ + L + + A+ YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE 306
Query: 207 --HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR------TVVAGTHG 258
++ VHRD+++ N+L++ A V+DFG+ + S T
Sbjct: 307 GNNF------VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 353
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-----R 312
APE + K DV+ FG++ E+ GR P P+I L D++ + +
Sbjct: 354 --APEALREKKFSTKSDVWSFGILLWEIYSFGRVP-------YPRIPLKDVVPRVEKGYK 404
Query: 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+P + D++ C +RPT
Sbjct: 405 MDAPDGCPPAVYDVMK------NCWHLDAATRPTFL 434
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 17/206 (8%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELA----FLESFQTEARLLSQIRHRNIVK 151
+G GG +VY A+ VA+K + L+ F+ E SQ+ H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIF---IPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
+ C +L+ +Y+ +L + L +N + + + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTHGYIAPELAYTMVV 270
IVHRDI NIL++S + DFG+A+ L S +T V GT Y +PE A
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 271 TEKCDVFGFGVVALEVLMGRHP--GD 294
E D++ G+V E+L+G P G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGE 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 48/284 (16%), Positives = 93/284 (32%), Gaps = 45/284 (15%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-R 145
T +F IG+G +GSV++ G I A+K+ ++ E + + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-NDDEAIQLDWTKRVNIVKSMAHALS 204
H ++V+ + M + +Y GSL + N + +++ + L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFV-------------------ADFGVARLLHS 245
Y+H S+VH DI +NI ++ D G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 246 DSSNRTVVAGTHGYIAPE-LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM 304
S+ V G ++A E L K D+F + + ++ +I
Sbjct: 185 --SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH-EIR 241
Query: 305 LIDLLDQRAPSPIDDQ--TVIQDIILVSKIAFACLRSKPKSRPT 346
Q I +++ + P+ RP+
Sbjct: 242 ------QGRLPRIPQVLSQEFTELLK------VMIHPDPERRPS 273
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 75/280 (26%), Positives = 116/280 (41%), Gaps = 49/280 (17%)
Query: 97 IGTGGYGSVYRAQLP-----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +GSV + +G++VA+KKL HS E L F+ E +L ++H NIVK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVK 75
Query: 152 LYGFCLH--KKCMFLIYKYMRRGSLFCVLRNDDEAIQ----LDWTKRVNIVKSMAHALSY 205
G C ++ + LI +Y+ GSL L+ E I L +T I K M + L
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGMEY-LGT 132
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI----- 260
Y +HRD+++ NIL+ ++ + DFG+ ++L D G
Sbjct: 133 KRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--FFKVKEPGESPIFWY 184
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM------------LIDL 308
APE + DV+ FGVV E+ + +++ LI+L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 309 LDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
L R P P I I+ C + RP+
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRPS 278
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 93 IKYCIGTGGYGSVYRA--QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+K CI GG G +Y A + +G+ V LK L HS E + L+++ H +IV
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVVHPSIV 142
Query: 151 KLYGFCLH-----KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
+++ F H +++ +Y+ SL +L + + + + ALSY
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSY 197
Query: 206 LHYDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
LH +V+ D+ NI+L K + D G ++S + GT G+ AP
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEEQLK----LIDLGAVSRINSFGY----LYGTPGFQAP 246
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
E+ T T D++ G + +
Sbjct: 247 EIVRTG-PTVATDIYTVGRTLAALTLDLPT 275
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 72/287 (25%), Positives = 114/287 (39%), Gaps = 47/287 (16%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP-----SGKIVALKKLHHSETELAFLESFQTEARLLSQ 143
+G G +GSV + +G++VA+KKL HS E L F+ E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKS 98
Query: 144 IRHRNIVKLYGFCLHKKC--MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH 201
++H NIVK G C + LI +Y+ GSL L+ E ++D K + +
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICK 156
Query: 202 ALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHG 258
+ YL Y +HRD+++ NIL+ ++ + DFG+ ++L D G
Sbjct: 157 GMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--YYKVKEPG 208
Query: 259 YI-----APELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM--------- 304
APE + DV+ FGVV E+ + +++
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 305 ---LIDLLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
LI+LL R P P I I+ C + RP+
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRPS 309
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 39/273 (14%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL--PSGKI--VALKKLHHSETELAFLESFQTEARLLSQI 144
E ++ CIG G +G V++ P VA+K + ++ E F EA + Q
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQF 448
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
H +IVKL G + +++I + G L L+ LD + ++ AL+
Sbjct: 449 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALA 505
Query: 205 YL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI- 260
YL + VHRDI++ N+L++S + DFG++R + + + G +
Sbjct: 506 YLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKLP 555
Query: 261 ----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RA 313
APE T DV+ FGV E+LM G P + N + I ++ R
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDV--IGRIENGERL 611
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P P + + ++ C P RP
Sbjct: 612 PMPPNCPPTLYSLMT------KCWAYDPSRRPR 638
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 51/286 (17%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-R 145
F++ +G G YG VY+ + + +G++ A+K + + E E + E +L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSH 79
Query: 146 HRNIVKLYGFCLHKKCMFLIYK------YMRRGSLFCVLRN------DDEAIQLDWTKRV 193
HRNI YG + K + + + GS+ +++N +E I
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY------ 133
Query: 194 NIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
I + + LS+LH ++HRDI N+LL E + DFGV+ L R
Sbjct: 134 -ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 189
Query: 254 AGTHGYIAPELAYTMVVTE-----KCDVFGFGVVALEVLMGRHPGDLLSSFNP--KIMLI 306
GT ++APE+ + K D++ G+ A+E+ G P L +P + LI
Sbjct: 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP---LCDMHPMRALFLI 246
Query: 307 DLLDQRAPSPI--DDQ--TVIQDIILVSKIAFACLRSKPKSRPTMR 348
R P+P + Q I CL RP
Sbjct: 247 ----PRNPAPRLKSKKWSKKFQSFIES------CLVKNHSQRPATE 282
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
+ +G GG+ + + ++ A K + S + E E + + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----NDDEAIQLDWTKRVNIVKSMAH 201
+++V +GF +F++ + RR SL + + + EA R ++ +
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 152
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
YLH + + +HRD+ N+ LN LE + DFG+A + D + V+ GT YIA
Sbjct: 153 GCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE+ + + DV+ G + +L+G+ P
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 67/266 (25%), Positives = 105/266 (39%), Gaps = 36/266 (13%)
Query: 97 IGTGGYGSVYRAQLPSGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL 152
IG G +G VY + A+K L +E+F E L+ + H N++ L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-VEAFLREGLLMRGLNHPNVLAL 87
Query: 153 YGFCLHKKCM-FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL---HY 208
G L + + ++ YM G L +R+ + ++ +A + YL +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYLAEQKF 145
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----APE 263
VHRD+++ N +L+ VADFG+AR + V H + A E
Sbjct: 146 ------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYS-VQQHRHARLPVKWTALE 198
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQ 320
T T K DV+ FGV+ E+L G P + F+ L L Q R P P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----LTHFLAQGRRLPQPEYCP 254
Query: 321 TVIQDIILVSKIAFACLRSKPKSRPT 346
+ ++ C + P RPT
Sbjct: 255 DSLYQVMQ------QCWEADPAVRPT 274
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
+ +G GG+ + + ++ A K + S + E E + + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----NDDEAIQLDWTKRVNIVKSMAH 201
+++V +GF +F++ + RR SL + + + EA R ++ +
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 126
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
YLH + + +HRD+ N+ LN LE + DFG+A + D + V+ GT YIA
Sbjct: 127 GCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE+ + + DV+ G + +L+G+ P
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 67/270 (24%), Positives = 128/270 (47%), Gaps = 34/270 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
EDF + +G G + VYRA+ + +G VA+K + + ++ Q E ++ Q++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR------NDDEAIQLDWTKRVNIVKSMA 200
+I++LY + ++L+ + G + L+ +++EA + + +
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--------HFMHQII 122
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
+ YLH I +HRD++ +N+LL + +ADFG+A L + GT YI
Sbjct: 123 TGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI 179
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLMGRHP---GDLLSSFNPKIMLIDLLDQRAPSPI 317
+PE+A + DV+ G + +L+GR P + ++ N K++L D PS +
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-KVVLADY---EMPSFL 235
Query: 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTM 347
+ +D L+ ++ LR P R ++
Sbjct: 236 SIEA--KD--LIHQL----LRRNPADRLSL 257
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-30
Identities = 28/290 (9%), Positives = 61/290 (21%), Gaps = 53/290 (18%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELA-FLESFQTEARLLSQIRHRNIVKLYG 154
+ G V+ + + ALK LE +++ + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 155 FCLHKKCM--------------------------FLIYKYMRRGSLFCVLRNDDEAIQ-- 186
L+ L + D
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 187 --LDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
+ + + L +VH + +N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 245 SDSSNRTVVAGTHGYIAPEL--AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK 302
+ + Y E A T T + + G+ V P L++
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 303 IMLIDLLDQRAPSPIDDQTV------IQDIILVSKIAFACLRSKPKSRPT 346
L + + ++ +I L + R
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRLL 346
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 59/278 (21%), Positives = 104/278 (37%), Gaps = 47/278 (16%)
Query: 97 IGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK 151
+G G +G V +G++VA+K L ++ E +L + H +I+K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-RSGWKQEIDILRTLYHEHIIK 97
Query: 152 LYGFCLHKKC--MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL--- 206
G C + L+ +Y+ GSL L + + + + + ++YL
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI-----A 261
HY +HRD+++ N+LL++ + DFG+A+ + G A
Sbjct: 154 HY------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--YYRVREDGDSPVFWYA 205
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIM----------LIDLLD 310
PE DV+ FGV E+L + F I L +LL+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 311 Q--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ R P P + ++ C ++ RPT
Sbjct: 266 RGERLPRPDKCPAEVYHLMK------NCWETEASFRPT 297
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 43/297 (14%)
Query: 74 NYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGK----IVALKKLHHSETELA 129
+ + + E++++ + F + +G G +GSV AQL VA+K L +
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67
Query: 130 FLESFQTEARLLSQIRHRNIVKLYGFCL------HKKCMFLIYKYMRRGSLFCVLRN--- 180
+E F EA + + H ++ KL G L +I +M+ G L L
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 181 DDEAIQLDWTKRVNIVKSMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADF 237
+ L V + +A + YL ++ +HRD+++ N +L + VADF
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADF 181
Query: 238 GVARLLHSDSSNRTVVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVLM-GRH 291
G++R ++S R G + A E + T DV+ FGV E++ G+
Sbjct: 182 GLSRKIYSGDYYR---QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238
Query: 292 PGDLLSSFNPKIMLIDLLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
P + + + + L R P + + D++ C + PK RP+
Sbjct: 239 PYAGIENAE----IYNYLIGGNRLKQPPECMEEVYDLMY------QCWSADPKQRPS 285
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
+DFDI +G G +G+VY A+ + I+ALK L S+ + + E + S +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----NDDEAIQLDWTKRVNIVKSMAH 201
NI+++Y + +K ++L+ ++ RG L+ L+ ++ + ++ +A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS--------ATFMEELAD 125
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
AL Y H ++HRDI N+L+ K E +ADFG + +H+ S R + GT Y+
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLP 180
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE+ EK D++ GV+ E L+G P
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+G G +G VY Q+ PS VA+K L +E L+ F EA ++S+ H+NIV
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKSMAHALSYL 206
+ G L F++ + M G L LR + L +++ + +A YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 207 ---HYDCIPSIVHRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYI 260
H+ +HRDI++ N LL V DFG+AR ++ S R G +
Sbjct: 157 EENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---KGGCAML 207
Query: 261 -----APE-LAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
PE + T K D + FGV+ E+ +G P
Sbjct: 208 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 42/288 (14%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGK----IVALKKLHHSETELAFLESFQTE 137
E++++ + +G G +GSV L VA+K + + +E F +E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 138 ARLLSQIRHRNIVKLYGFCL-----HKKCMFLIYKYMRRGSLFCVLRN---DDEAIQLDW 189
A + H N+++L G C+ +I +M+ G L L + +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 190 TKRVNIVKSMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
+ + +A + YL ++ +HRD+++ N +L + VADFG+++ ++S
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200
Query: 247 SSNRTVVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFN 300
R G + A E V T K DV+ FGV E+ G P + +
Sbjct: 201 DYYR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
Query: 301 PKIMLIDLLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ D L R P D + +I+ +C R+ P RPT
Sbjct: 258 ----MYDYLLHGHRLKQPEDCLDELYEIMY------SCWRTDPLDRPT 295
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 59/301 (19%), Positives = 115/301 (38%), Gaps = 47/301 (15%)
Query: 82 EEIIVATEDFDIKYC----IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTE 137
I + +G G G+V G+ VA+K++ + F + E
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-----LIDFCDIALME 58
Query: 138 ARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVL----RNDDEAIQLDWTKR 192
+LL++ H N+++ Y + +++ + +L ++ +D+
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 193 VNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF-------------VADFGV 239
+++++ +A +++LH I+HRD+ NIL+++ ++DFG+
Sbjct: 118 ISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 240 ARLL----HSDSSNRTVVAGTHGYIAPEL-------AYTMVVTEKCDVFGFGVVALEVL- 287
+ L S +N +GT G+ APEL +T D+F G V +L
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 288 MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM 347
G+HP S I+ D + + L+S+ + P RPT
Sbjct: 235 KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQ----MIDHDPLKRPTA 290
Query: 348 R 348
Sbjct: 291 M 291
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 97 IGTGGYGSVYRAQ---LPSGKIVALKKLHHSETELA----FLESFQTEARLLSQIRHRNI 149
+G GG V+ A+ + VA+K L +LA F F+ EA+ + + H I
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLR---ADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 150 VKLY--GF--CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
V +Y G +++ +Y+ +L ++ + + + ++ AL++
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNF 131
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT---VVAGTHGYIAP 262
H + I+HRD+ NI++++ V DFG+AR + ++ T V GT Y++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLMGRHP--GD 294
E A V + DV+ G V EVL G P GD
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 6e-29
Identities = 59/264 (22%), Positives = 103/264 (39%), Gaps = 17/264 (6%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+++K +GTGG+G V R +G+ VA+K+ + E + E +++ ++ H N
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-KNRERWCLEIQIMKKLNHPN 73
Query: 149 IVKLY------GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHA 202
+V L +Y G L L + L ++ ++ A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGY 259
L YLH + I+HRD+ NI+L + + D G A+ L V GT Y
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQY 189
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319
+APEL T D + FG +A E + G P L ++ P + ++ +
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRP--FLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 320 QTVIQDIILVSKIAFACLRSKPKS 343
+ + S + S +
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILA 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 63/268 (23%), Positives = 117/268 (43%), Gaps = 30/268 (11%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELA-FLESFQTEARLLSQIR 145
+ F IG G +G+VY A+ + + ++VA+KK+ +S + + E R L ++R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
H N ++ G L + +L+ +Y GS +L + +Q + L+Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAY 169
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
LH +++HRD+ + NILL+ + DFG A ++ + GT ++APE+
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWMAPEVI 222
Query: 266 YTMVVTE---KCDVFGFGVVALEVLMGRHPGDLLSSFNP-KIMLIDLLDQRAPSPIDDQ- 320
M + K DV+ G+ +E+ + P L + N + + Q +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALY--HIAQNESPALQSGH 277
Query: 321 --TVIQDIILVSKIAFACLRSKPKSRPT 346
++ + CL+ P+ RPT
Sbjct: 278 WSEYFRNFVDS------CLQKIPQDRPT 299
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-29
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+G G +G VY VA+K ++ + + +E F EA ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVV 91
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLR-------NDDEAIQLDWTKRVNIVKSMAHAL 203
+L G + +I + M RG L LR N+ +K + + +A +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 204 SYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
+YL + VHRD+++ N ++ + DFG+ R ++ R G G +
Sbjct: 152 AYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---KGGKGLL 202
Query: 261 -----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHP 292
+PE V T DV+ FGVV E+ P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-29
Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+G G +G VY Q+ PS VA+K L +E L+ F EA ++S+ H+NIV
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 137
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKSMAHALSYL 206
+ G L F++ + M G L LR + L +++ + +A YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 207 ---HYDCIPSIVHRDISSNNILLNSKLEAFV---ADFGVARLLHSDSSNRTVVAGTHGYI 260
H+ +HRDI++ N LL V DFG+AR ++ R G +
Sbjct: 198 EENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---KGGCAML 248
Query: 261 -----APE-LAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
PE + T K D + FGV+ E+ +G P
Sbjct: 249 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 61/280 (21%), Positives = 109/280 (38%), Gaps = 50/280 (17%)
Query: 97 IGTGGYGSVYRAQLPSGK------IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+G +G VY+ L VA+K L E F+ EA L ++++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPNVV 75
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLR-------------NDDEAIQLDWTKRVNIVK 197
L G + + +I+ Y G L L + L+ V++V
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 198 SMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
+A + YL H VH+D+++ N+L+ KL ++D G+ R +++ +
Sbjct: 136 QIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK---L 186
Query: 255 GTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDL 308
+ + APE + D++ +GVV EV G P S N ++++
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQD--VVEM 242
Query: 309 LDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
+ P P D + +++ C P RP
Sbjct: 243 IRNRQVLPCPDDCPAWVYALMI------ECWNEFPSRRPR 276
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 42/225 (18%)
Query: 97 IGTGGYGSVYRAQLPSGK------IVALKKLH-HSETELAFLESFQTEARLLSQIRHRNI 149
+G G +G V+ A+ + +VA+K L SE+ + FQ EA LL+ ++H++I
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTMLQHQHI 105
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLR------------NDDEAIQLDWTKRVNIVK 197
V+ +G C + + ++++YMR G L LR D L + + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 198 SMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA 254
+A + YL H+ VHRD+++ N L+ L + DFG++R ++S R
Sbjct: 166 QVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---V 216
Query: 255 GTHGYI-----APE-LAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
G + PE + Y T + DV+ FGVV E+ G+ P
Sbjct: 217 GGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 49/222 (22%), Positives = 95/222 (42%), Gaps = 20/222 (9%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI 144
+ + + +G G +V+R + +G + A+K ++ ++ E +L ++
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 145 RHRNIVKLYGF--CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHA 202
H+NIVKL+ + LI ++ GSL+ VL A L ++ + +++ +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
+++L + IVHR+I NI+ + + DFG AR L D ++ GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEE 180
Query: 259 YIAPELAYTMVV--------TEKCDVFGFGVVALEVLMGRHP 292
Y+ P++ V+ D++ GV G P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+E + +G+G YG V + A+K + + + E +L + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDW---TKRVNIVKSMAHAL 203
NI+KLY F K+ +L+ + + G LF DE I I+K + +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELF------DEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYI 260
+YLH +IVHRD+ N+LL SK + + DFG++ + + + + GT YI
Sbjct: 150 TYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-GTAYYI 205
Query: 261 APELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
APE+ EKCDV+ GV+ +L G P
Sbjct: 206 APEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 49/222 (22%), Positives = 95/222 (42%), Gaps = 20/222 (9%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI 144
+ + + +G G +V+R + +G + A+K ++ ++ E +L ++
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKL 64
Query: 145 RHRNIVKLYGF--CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHA 202
H+NIVKL+ + LI ++ GSL+ VL A L ++ + +++ +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVAGTHG 258
+++L + IVHR+I NI+ + + DFG AR L D ++ GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEE 180
Query: 259 YIAPELAYTMVV--------TEKCDVFGFGVVALEVLMGRHP 292
Y+ P++ V+ D++ GV G P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 41/225 (18%)
Query: 97 IGTGGYGSVYRAQLPSGK------IVALKKLH-HSETELAFLESFQTEARLLSQIRHRNI 149
+G G +G V+ A+ + +VA+K L + FQ EA LL+ ++H +I
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQHEHI 79
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-------------NDDEAIQLDWTKRVNIV 196
VK YG C + ++++YM+ G L LR +L ++ ++I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 197 KSMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
+A + YL H+ VHRD+++ N L+ + L + DFG++R ++S R
Sbjct: 140 SQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR--- 190
Query: 254 AGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
G H + PE T + DV+ FGV+ E+ G+ P
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
E ++I +G G +G V + + + A+K ++ + + + E LL ++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----NDDEAIQLDWTKRVNIVKSMAH 201
NI+KL+ +++ + G LF + ++ +A I+K +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFS 132
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHG 258
++Y+H +IVHRD+ NILL SK + + DFG++ ++ + + GT
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAY 188
Query: 259 YIAPEL---AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
YIAPE+ Y EKCDV+ GV+ +L G P
Sbjct: 189 YIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 62/328 (18%), Positives = 106/328 (32%), Gaps = 84/328 (25%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
DF+ C+G GG+G V+ A+ A+K++ ELA E E + L+++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHP 64
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEA----------------------- 184
IV+ + L + +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 185 -------------IQL---------DWTKRVN------------IVKSMAHALSYLHYDC 210
IQ+ DW R I +A A+ +LH
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK- 183
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS------------NRTVVAGTHG 258
++HRD+ +NI V DFG+ + D T GT
Sbjct: 184 --GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318
Y++PE + + K D+F G++ E+L + S+ ++ +I + +
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELL---YS---FSTQMERVRIITDVRNLKFPLLF 295
Query: 319 DQTVIQDIILVSKIAFACLRSKPKSRPT 346
Q Q+ ++V L P RP
Sbjct: 296 TQKYPQEHMMVQD----MLSPSPTERPE 319
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 60/285 (21%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVA---LKKLHHSETELAFLESFQTEARLLSQI-RH 146
+G G +G V A + VA LK H++ + A + E +++S + +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS----ELKIMSHLGQH 109
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN------------ 194
NIV L G C H + +I +Y G L LR ++ D +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 195 ---IVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
+ + MA L+ + +HRD+++ N+LL + A + DFG+AR + +DS+
Sbjct: 170 SSQVAQGMAF-LASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI- 221
Query: 252 VVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP--GDLLSSFNPKI 303
+ + APE + V T + DV+ +G++ E+ +G +P G L++S
Sbjct: 222 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----- 274
Query: 304 MLIDLLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT 346
L+ + P I I+ AC +P RPT
Sbjct: 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPT 313
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 27/217 (12%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALK-----KLHHSETELAFLESFQTEARLL 141
++ + + +G G +G V +G+ A+K ++ + ES E +LL
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK----ESLLREVQLL 80
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDW---TKRVNIVKS 198
Q+ H NI+KLY F K +L+ + G LF DE I I++
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF------DEIISRKRFSEVDAARIIRQ 134
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAG 255
+ ++Y+H + IVHRD+ N+LL SK + + DFG++ + + + G
Sbjct: 135 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-G 190
Query: 256 THGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
T YIAPE+ EKCDV+ GV+ +L G P
Sbjct: 191 TAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 46/209 (22%), Positives = 89/209 (42%), Gaps = 23/209 (11%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALK---KLHHSETELAFLESFQTEARLLSQ 143
+ +++ IG G + V R +G+ A+K + + E + EA +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV-------NIV 196
++H +IV+L +++++++M L E ++ V + +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVASHYM 136
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVV 253
+ + AL Y H + +I+HRD+ + +LL SK + + FGVA L
Sbjct: 137 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 254 AGTHGYIAPELAYTMVVTEKCDVFGFGVV 282
GT ++APE+ + DV+G GV+
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 43/230 (18%), Positives = 90/230 (39%), Gaps = 35/230 (15%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSE---------------TELAFLES 133
D+ I + G + + + K ALKK S + + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 134 FQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----NDDEAIQLD 188
F+ E ++++ I++ + G + +++IY+YM S+ + + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 189 WTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248
I+KS+ ++ SY+H + +I HRD+ +NIL++ ++DFG + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDK 205
Query: 249 NRTVVAGTHGYIAPELAYTMVVTE------KCDVFGFGVVALEVLMGRHP 292
GT+ ++ PE E K D++ G+ + P
Sbjct: 206 KIKGSRGTYEFMPPE----FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
E ++I +G G +G V + + + A+K ++ + + + E LL ++ H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN--------IVKS 198
NI+KL+ +++ + G LF + I KR I+K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELF-------DEI----IKRKRFSEHDAARIIKQ 129
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAG 255
+ ++Y+H +IVHRD+ NILL SK + + DFG++ ++ + + G
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-G 185
Query: 256 THGYIAPEL---AYTMVVTEKCDVFGFGVV 282
T YIAPE+ Y EKCDV+ GV+
Sbjct: 186 TAYYIAPEVLRGTY----DEKCDVWSAGVI 211
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 97 IGTGGYGSVYRAQLPSGK---IVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKL 152
IG G +G V +A++ A+K++ ++ + F E +L ++ H NI+ L
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINL 91
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRN-------------DDEAIQLDWTKRVNIVKSM 199
G C H+ ++L +Y G+L LR + A L + ++ +
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 200 AHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
A + YL + +HRD+++ NIL+ A +ADFG++R V T
Sbjct: 152 ARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKT 199
Query: 257 HGYI-----APE-LAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
G + A E L Y+ V T DV+ +GV+ E++ +G P
Sbjct: 200 MGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 97 IGTGGYGSVYRAQLPSGK------IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIV 150
IG G +G V++A+ P +VA+K L + + FQ EA L+++ + NIV
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNIV 113
Query: 151 KLYGFCLHKKCMFLIYKYMRRGSLFCVLRN--DDEAIQLDWTKRVNIVKSMAHALSYLHY 208
KL G C K M L+++YM G L LR+ L + + + L
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 209 DCIPSI----------------VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV 252
I VHRD+++ N L+ + +ADFG++R ++S +
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-- 231
Query: 253 VAGTHGYI-----APE-LAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
A + I PE + Y T + DV+ +GVV E+ G P
Sbjct: 232 -ADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 59/253 (23%), Positives = 104/253 (41%), Gaps = 17/253 (6%)
Query: 49 RRPKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVA--TEDFDIKYCI----GTGGY 102
R V + K + + +D + V + Y I GTG +
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170
Query: 103 GSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161
G V+R + +G A K + E+ + E + +S +RH +V L+
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228
Query: 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISS 221
M +IY++M G LF + DE ++ + V ++ + L ++H + + VH D+
Sbjct: 229 MVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKP 283
Query: 222 NNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGF 279
NI+ +K + DFG+ L S + GT + APE+A V D++
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSV 342
Query: 280 GVVALEVLMGRHP 292
GV++ +L G P
Sbjct: 343 GVLSYILLSGLSP 355
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-25
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 41/227 (18%)
Query: 97 IGTGGYGSVYRAQLP--------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHR 147
+G G +G V A+ VA+K L TE + +E ++ I +H+
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 101
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-------------NDDEAIQLDWTKRVN 194
NI+ L G C +++I +Y +G+L LR N Q+ + V+
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 195 IVKSMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
+A + YL +HRD+++ N+L+ +ADFG+AR +++ +
Sbjct: 162 CTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 214
Query: 252 VVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
T+G + APE + V T + DV+ FGV+ E+ +G P
Sbjct: 215 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
TE++ + +G G + V R ++ +G+ A ++ + + + EAR+ ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR--------VNIVKS 198
NIV+L+ + +LI+ + G LF E I R + ++
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELF-------EDI----VAREYYSEADASHCIQQ 118
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAG 255
+ A+ + H +VHR++ N+LL SKL+ +ADFG+A + + AG
Sbjct: 119 ILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 256 THGYIAPEL----AYTMVVTEKCDVFGFGVV 282
T GY++PE+ Y + D++ GV+
Sbjct: 176 TPGYLSPEVLRKDPY----GKPVDLWACGVI 202
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVALKKL--HHSETELAFLESFQTEARLLSQIRHRN 148
+G G +G V +A VA+K L + S +EL +E +L Q+ H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL---RDLLSEFNVLKQVNHPH 87
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN--DDEAIQLDWTKRVNIVKSMAHALSYL 206
++KLYG C + LI +Y + GSL LR L N L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 207 HYDCIPSI----------------VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250
+ S VHRD+++ NIL+ + ++DFG++R ++ + S
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 251 TVVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
+ G I A E + + T + DV+ FGV+ E++ +G +P
Sbjct: 208 ---KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 43/228 (18%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNI 149
+G G +G V A + VA+K L S +E ++LS + H NI
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMNI 89
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN--------------- 194
V L G C +I +Y G L LR ++ T
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 195 ----IVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250
+ K MA L+ + +HRD+++ NILL + DFG+AR + +DS+
Sbjct: 150 FSYQVAKGMAF-LASKNC------IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 251 TVVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
+ + APE + V T + DV+ +G+ E+ +G P
Sbjct: 203 ---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 33/225 (14%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALK-----------KLHHSETELAFLESFQ 135
E + +G+G YG V + A+K ++ F E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 136 TEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDD-----EAIQLDWT 190
E LL + H NI+KL+ KK +L+ ++ G LF + N +A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA------ 148
Query: 191 KRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDS 247
NI+K + + YLH +IVHRDI NILL +K + DFG++ D
Sbjct: 149 --ANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
R + GT YIAPE EKCDV+ GV+ +L G P
Sbjct: 204 KLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 42/227 (18%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNI 149
+G G +G V A + + VA+K L T +E ++L I H N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHLNV 93
Query: 150 VKLYGFCLHKKC-MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS---------- 198
V L G C + +I ++ + G+L LR+ ++ K
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 199 -------MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
M L+ +HRD+++ NILL+ K + DFG+AR ++ D
Sbjct: 154 SFQVAKGMEF-LASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV- 205
Query: 252 VVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
+ APE + V T + DV+ FGV+ E+ +G P
Sbjct: 206 --RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 41/227 (18%)
Query: 97 IGTGGYGSVYRAQL--------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHR 147
+G G +G V A+ VA+K L TE + +E ++ I +H+
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 147
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-------------NDDEAIQLDWTKRVN 194
NI+ L G C +++I +Y +G+L LR N Q+ + V+
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 195 IVKSMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
+A + YL +HRD+++ N+L+ +ADFG+AR +++ +
Sbjct: 208 CTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK- 260
Query: 252 VVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
T+G + APE + V T + DV+ FGV+ E+ +G P
Sbjct: 261 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLH------HSETELAFLESFQTEARL 140
+++ + +G+G G V A + + K VA++ + S E + +TE +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLR---NDDEAIQLDWTKRVNI 195
L ++ H I+K+ F + +++ + M G LF V +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC--------KLY 244
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTV 252
M A+ YLH + I+HRD+ N+LL+S+ E + DFG +++L S RT+
Sbjct: 245 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 253 VAGTHGYIAPE-LAYTMVV--TEKCDVFGFGVV 282
GT Y+APE L D + GV+
Sbjct: 302 C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
++++D+K +G G + V R +G A K ++ + + + EAR+ +++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV--------NIVKS 198
NIV+L+ + +L++ + G LF E I R + ++
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELF-------EDI----VAREFYSEADASHCIQQ 136
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAG 255
+ +++Y H + IVHR++ N+LL SK + +ADFG+A ++ + G
Sbjct: 137 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-G 192
Query: 256 THGYIAPEL----AYTMVVTEKCDVFGFGVV 282
T GY++PE+ Y ++ D++ GV+
Sbjct: 193 TPGYLSPEVLKKDPY----SKPVDIWACGVI 219
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 53/249 (21%), Positives = 100/249 (40%), Gaps = 21/249 (8%)
Query: 54 RKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCI----GTGGYGSVYRA- 108
K + + + + + + V Y I G+G +G V+R
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 109 QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168
+ +G++ K ++ + + E +++Q+ H ++ L+ K M LI ++
Sbjct: 72 EKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129
Query: 169 MRRGSLF--CVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL 226
+ G LF E ++ + +N ++ L ++H SIVH DI NI+
Sbjct: 130 LSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMC 182
Query: 227 NSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMVVTEKCDVFGFGVVA 283
+K + V DFG+A L+ D + T + APE + V D++ GV+
Sbjct: 183 ETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDREP-VGFYTDMWAIGVLG 240
Query: 284 LEVLMGRHP 292
+L G P
Sbjct: 241 YVLLSGLSP 249
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-24
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+ F K +G+G +G V+ + SG +K ++ +++ +E + E +L + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDH 79
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR--------VNIVKS 198
NI+K++ M+++ + G L E I + ++K
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELL-------ERIVSAQARGKALSEGYVAELMKQ 132
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAG 255
M +AL+Y H +VH+D+ NIL + DFG+A L SD + G
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-G 188
Query: 256 THGYIAPEL---AYTMVVTEKCDVFGFGVV 282
T Y+APE+ T KCD++ GVV
Sbjct: 189 TALYMAPEVFKRDV----TFKCDIWSAGVV 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-24
Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 88 TEDFDIKYCI----GTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLS 142
+ F Y + G G + V R +G A K ++ + + + EAR+
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV--------N 194
+++H NIV+L+ + +L++ + G LF E I R +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-------EDI----VAREFYSEADASH 109
Query: 195 IVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRT 251
++ + +++Y H + IVHR++ N+LL SK + +ADFG+A ++ +
Sbjct: 110 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166
Query: 252 VVAGTHGYIAPEL----AYTMVVTEKCDVFGFGVV 282
GT GY++PE+ Y ++ D++ GV+
Sbjct: 167 FA-GTPGYLSPEVLKKDPY----SKPVDIWACGVI 196
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 97 IGTGGYGSVYRAQLP--------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHR 147
+G G +G V A+ VA+K L TE + +E ++ I +H+
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGKHK 135
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN-------------DDEAIQLDWTKRVN 194
NI+ L G C +++I +Y +G+L L+ + QL V+
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 195 IVKSMAHALSYL---HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
+A + YL +HRD+++ N+L+ +ADFG+AR +H +
Sbjct: 196 CAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK- 248
Query: 252 VVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
T+G + APE + + T + DV+ FGV+ E+ +G P
Sbjct: 249 --KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 48/233 (20%)
Query: 97 IGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNI 149
+G+G +G V A VA+K L +E ++++Q+ H NI
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHENI 111
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN--------------- 194
V L G C ++LI++Y G L LR+ E D + N
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 195 ---------IVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
+ K M L + VHRD+++ N+L+ + DFG+AR + S
Sbjct: 172 EDLLCFAYQVAKGMEF-LEFKSC------VHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 246 DSSNRTVVAGTHGYI-----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
DS+ + + APE + + T K DV+ +G++ E+ +G +P
Sbjct: 225 DSNYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 45/204 (22%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 90 DFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+G G +G V++ + +G +A K + + E + E +++Q+ H N
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISVMNQLDHAN 147
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLRNDD----EAIQLDWTKRVNIVKSMAHA 202
+++LY K + L+ +Y+ G LF + + + + I +K +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI--------LFMKQICEG 199
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYI 260
+ ++H I+H D+ NIL ++ + DFG+AR + GT ++
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFL 255
Query: 261 APE-LAYTMVVTEKCDVFGFGVVA 283
APE + Y V+ D++ GV+A
Sbjct: 256 APEVVNYD-FVSFPTDMWSVGVIA 278
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-23
Identities = 62/254 (24%), Positives = 100/254 (39%), Gaps = 52/254 (20%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALK---KLHHSETELAFLESFQTEARLLSQ 143
+ + +K IG G YG V A + + I A+K K + +E +TE RL+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF-------------------------CVL 178
+ H NI +LY ++ + L+ + G L C
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 179 RNDDEAIQLDWTKRV------------NIVKSMAHALSYLHYDCIPSIVHRDISSNNILL 226
N++ R NI++ + AL YLH I HRDI N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 227 NSKLEAFV--ADFGVARLLHSDSSNR----TVVAGTHGYIAPELAYTMV--VTEKCDVFG 278
++ + DFG+++ + ++ T AGT ++APE+ T KCD +
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 279 FGVVALEVLMGRHP 292
GV+ +LMG P
Sbjct: 262 AGVLLHLLLMGAVP 275
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 61/294 (20%), Positives = 108/294 (36%), Gaps = 46/294 (15%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLH-HSETELAFLESFQTEAR 139
+ + + ++ + GG+ VY AQ + SG+ ALK+L + E + + E
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVC 77
Query: 140 LLSQIR-HRNIVKLYGFCL-------HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTK 191
+ ++ H NIV+ + FL+ + +G L L+ + L
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 192 RVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
+ I A+ ++H P I+HRD+ N+LL+++ + DFG A +
Sbjct: 138 VLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 252 VVA------------GTHGYIAPELAYTM---VVTEKCDVFGFGVVALEVLMGRHP---G 293
T Y PE+ + EK D++ G + + +HP G
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
Query: 294 DLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTM 347
L N K P TV +I A L+ P+ R ++
Sbjct: 257 AKLRIVNGKY--------SIPPHDTQYTVFHSLIR------AMLQVNPEERLSI 296
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-23
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 34/211 (16%)
Query: 88 TEDFDIKYCI----GTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLS 142
D + Y + G G +G V A Q + A KK+ + + ++ F+ E ++
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI--PKYFVEDVDRFKQEIEIMK 61
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLR---NDDEAIQLDWTKRVNIVK 197
+ H NI++LY ++L+ + G LF V + + +A I+K
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMK 113
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVA 254
+ A++Y H ++ HRD+ N L + + DFG+A RT V
Sbjct: 114 DVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV- 169
Query: 255 GTHGYIAPEL---AYTMVVTEKCDVFGFGVV 282
GT Y++P++ Y +CD + GV+
Sbjct: 170 GTPYYVSPQVLEGLY----GPECDEWSAGVM 196
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-23
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
++ F+++ +G G VYR Q + K ALK L + + + +TE +L ++ H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK----KIVRTEIGVLLRLSH 107
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR--------VNIVKS 198
NI+KL + L+ + + G LF + I ++ + VK
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELF-------DRI----VEKGYYSERDAADAVKQ 156
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAG 255
+ A++YLH + IVHRD+ N+L + +ADFG+++++ +TV G
Sbjct: 157 ILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC-G 212
Query: 256 THGYIAPELAYTMVVTEKCDVFGFGVV 282
T GY APE+ + D++ G++
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGII 239
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-22
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALK-----KLHHSETELAFLESFQTEARLL 141
+ +++ +G+G + V + Q +GK A K +L S ++ E + E +L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVS-REEIEREVNIL 62
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLRN---DDEAIQLDWTKRVNIV 196
+IRH NI+ L+ +K + LI + + G LF + +DEA +
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT--------QFL 114
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTV 252
K + + YLH I H D+ NI+L K + DFG+A + + + + +
Sbjct: 115 KQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 253 VAGTHGYIAPE-LAYTMVVTEKCDVFGFGVVA 283
GT ++APE + Y + + D++ GV+
Sbjct: 172 F-GTPEFVAPEIVNYEP-LGLEADMWSIGVIT 201
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 21/246 (8%)
Query: 59 TETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVA 117
+ ++ + E+ W +++ + EDF+I IG G +G V +L + K+ A
Sbjct: 44 SPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFA 103
Query: 118 LKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFC 176
+K L+ E + A F+ E +L + I L+ ++L+ Y G L
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163
Query: 177 VLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS----KLEA 232
+L ++ + + + + M A+ +H VHRDI +NIL++ +L
Sbjct: 164 LLSKFEDRLPEEMARFY--LAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRL-- 216
Query: 233 FVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTMVVTEK-----CDVFGFGVVALEV 286
ADFG L D + ++ VA GT YI+PE+ M + CD + GV E+
Sbjct: 217 --ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274
Query: 287 LMGRHP 292
L G P
Sbjct: 275 LYGETP 280
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
E + I +G G +G V+R + S K K + T+ + E +L+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARH 60
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLRND----DEAIQLDWTKRVNIVKSMA 200
RNI+ L+ + + +I++++ +F E + + V +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV--------SYVHQVC 112
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHG 258
AL +LH +I H DI NI+ ++ + + +FG AR L + R +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPE 168
Query: 259 YIAPE-LAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y APE + + V+ D++ G + +L G +P
Sbjct: 169 YYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINP 202
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 31/213 (14%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLH------HSETELAFLESFQTEARL 140
+++ + +G+G G V A + + K VA+K + S E + +TE +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLR---NDDEAIQLDWTKRVNI 195
L ++ H I+K+ F + +++ + M G LF V +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC--------KLY 119
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTV 252
M A+ YLH + I+HRD+ N+LL+S+ E + DFG +++L S RT+
Sbjct: 120 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 253 VAGTHGYIAPE-LAYTMVV--TEKCDVFGFGVV 282
GT Y+APE L D + GV+
Sbjct: 177 C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 47/211 (22%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALK----KLHHSETELAFLESFQTEARLLS 142
+ +DI +G+G + V + + +G A K + + E + E +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLRN---DDEAIQLDWTKRVNIVK 197
Q+ H NI+ L+ ++ + LI + + G LF + ++EA + +K
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT--------SFIK 122
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVV 253
+ ++YLH I H D+ NI+L K + DFG+A + + +
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 254 AGTHGYIAPE-LAYTMVVTEKCDVFGFGVVA 283
GT ++APE + Y + + D++ GV+
Sbjct: 180 -GTPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 30/230 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
+ F+I IG G +G V Q + K+ A+K ++ + E + + E +++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 147 RNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNI-VKSMAH 201
+V L Y F + MF++ + G L L+ + E V + + +
Sbjct: 75 PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEE-------TVKLFICELVM 126
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
AL YL I+HRD+ +NILL+ + DF +A +L ++ T +AGT Y+A
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMA 182
Query: 262 PEL-------AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM 304
PE+ Y+ V D + GV A E+L GR P + SS + K +
Sbjct: 183 PEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 45/212 (21%), Positives = 86/212 (40%), Gaps = 40/212 (18%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
T+ +++K IG G Y R + A+K + S+ + + LL +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-----RDPTEEIEILLRYGQH 75
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN--------IVKS 198
NI+ L K ++++ + M+ G L + I ++ ++ +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELL-------DKIL----RQKFFSEREASAVLFT 124
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVVA 254
+ + YLH +VHRD+ +NIL + + DFG A+ L +++
Sbjct: 125 ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 255 GTHGYIAPEL----AYTMVVTEKCDVFGFGVV 282
T ++APE+ Y CD++ GV+
Sbjct: 182 YTANFVAPEVLERQGY----DAACDIWSLGVL 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALK----KLHHSETELAFLESFQTEARLLS 142
+ +DI +G+G + V + + +G A K + + E + E +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLRN---DDEAIQLDWTKRVNIVK 197
Q+ H N++ L+ ++ + LI + + G LF + ++EA + +K
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT--------SFIK 122
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRTVV 253
+ ++YLH I H D+ NI+L K + DFG+A + + +
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 254 AGTHGYIAPE-LAYTMVVTEKCDVFGFGVVA 283
GT ++APE + Y + + D++ GV+
Sbjct: 180 -GTPEFVAPEIVNYEP-LGLEADMWSIGVIT 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 62/249 (24%), Positives = 114/249 (45%), Gaps = 25/249 (10%)
Query: 59 TETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVA 117
+E + + +F W + +E+ + +DF+I IG G + V ++ +G++ A
Sbjct: 31 SELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYA 90
Query: 118 LKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLF 175
+K ++ + + + F+ E +L R I +L+ F + ++L+ +Y G L
Sbjct: 91 MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLL 149
Query: 176 CVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS----KLE 231
+L E I + + + + A+ +H VHRDI +NILL+ +L
Sbjct: 150 TLLSKFGERIPAEMARFY--LAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRL- 203
Query: 232 AFVADFGVARLLHSDSSNRTVVA-GTHGYIAPELAYTMVVTEK-------CDVFGFGVVA 283
ADFG L +D + R++VA GT Y++PE+ + CD + GV A
Sbjct: 204 ---ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 284 LEVLMGRHP 292
E+ G+ P
Sbjct: 261 YEMFYGQTP 269
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 88 TEDFDIKYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+ F +G+G + V+ Q +GK+ ALK + ++ S + E +L +I+H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKH 65
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR--------VNIVKS 198
NIV L +L+ + + G LF + I +R +++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELF-------DRI----LERGVYTEKDASLVIQQ 114
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAG 255
+ A+ YLH + IVHRD+ N+L + E + DFG++++ + + G
Sbjct: 115 VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTACG 169
Query: 256 THGYIAPELAYTMVVTEKCDVFGFGVV 282
T GY+APE+ ++ D + GV+
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 39/300 (13%), Positives = 89/300 (29%), Gaps = 60/300 (20%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSE-TELAFLESFQTEA---RLLSQIRHRNIVK 151
+G + A +G+ + + +E ++ + E RLL I+++ K
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 152 LYGFCLHKKCM------------------------FLIYKYMRRGSLFCVLRNDDEAIQ- 186
++ + + F +Y M+ +L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSST 204
Query: 187 ---LDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243
L R+ + + L+ LH+ + VH + +I+L+ + F+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 244 HSDSSNR-TVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHP--GDL 295
+ + + A + ++T D + G+ + P D
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 296 LSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPE 355
+ I + P P ++ ++ LR + R ++ PE
Sbjct: 322 ALGGSEWIF---RSCKNIPQP------VRALLE------GFLRYPKEDRLLPLQAMETPE 366
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 4e-22
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 45/227 (19%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQ-----T---EARL 140
E + IG G YG VY+AQ G+ ALKK+ LE T E +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR--------LEKEDEGIPSTTIREISI 53
Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMA 200
L +++H NIVKLY KK + L+++++ + L +L + ++ KS
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV------TAKSFL 106
Query: 201 H----ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVA 254
++Y H ++HRD+ N+L+N + E +ADFG+AR T +V
Sbjct: 107 LQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV- 162
Query: 255 GTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
T Y AP++ Y+ + D++ G + E++ G PG
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTI----DIWSVGCIFAEMVNGTPLFPGV 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-22
Identities = 48/219 (21%), Positives = 93/219 (42%), Gaps = 34/219 (15%)
Query: 85 IVATEDFDIKYCI----GTGGYGSVYRA-QLPSGKIVALK-----KLHHSETELAFLESF 134
+ E+ D Y G+G + V + + +G A K + S ++ E
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS-REDI 61
Query: 135 QTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLRN---DDEAIQLDW 189
+ E +L +I+H N++ L+ +K + LI + + G LF + ++EA
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT---- 117
Query: 190 TKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHS 245
+K + + + YLH I H D+ NI+L + + DFG+A +
Sbjct: 118 ----EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 246 DSSNRTVVAGTHGYIAPE-LAYTMVVTEKCDVFGFGVVA 283
+ + + GT ++APE + Y + + D++ GV+
Sbjct: 171 GNEFKNIF-GTPEFVAPEIVNYEP-LGLEADMWSIGVIT 207
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G YG V + + +G+IVA+KK S+ + + E +LL Q+RH N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215
C KK +L+++++ ++ L + + + + + + + H +I+
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ--KYLFQIINGIGFCHSH---NII 146
Query: 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPEL-----AYTM 268
HRDI NIL++ + DFG AR L + V T Y APEL Y
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLVGDVKYGK 204
Query: 269 VVTEKCDVFGFGVVALEVLMGR--HPGD 294
V DV+ G + E+ MG PGD
Sbjct: 205 AV----DVWAIGCLVTEMFMGEPLFPGD 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 42/223 (18%)
Query: 87 ATEDFDIKY----CIGTGGYGSVYRA-QLPSGKIVALK-------KLHHSETELAFLESF 134
+T F Y +G G V R P+ K A+K +E E+
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 135 QTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV 193
E +L ++ H NI++L FL++ M++G LF + + T++V
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-------DYL----TEKV 119
Query: 194 --------NIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
I++++ + LH +IVHRD+ NILL+ + + DFG + L
Sbjct: 120 TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 246 DSSNRTVVAGTHGYIAPE-LAYTMVV-----TEKCDVFGFGVV 282
R V GT Y+APE + +M ++ D++ GV+
Sbjct: 177 GEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-22
Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 88 TEDFDIKYCI-----GTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLL 141
E+F+ Y + G G + V + +G+ A K L E +L
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 142 SQIRHR-NIVKLYGFCLHKKCMFLIYKYMRRGSLF--CVLRNDD-----EAIQLDWTKRV 193
+ ++ L+ + + LI +Y G +F C+ + + I
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI-------- 134
Query: 194 NIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNR 250
++K + + YLH + +IVH D+ NILL+S + DFG++R + R
Sbjct: 135 RLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR 191
Query: 251 TVVAGTHGYIAPE-LAYTMVVTEKCDVFGFGVVA 283
++ GT Y+APE L Y +T D++ G++A
Sbjct: 192 EIM-GTPEYLAPEILNYDP-ITTATDMWNIGIIA 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 9e-22
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
E ++ IG G YG V++ + +G+IVA+KK SE + + E R+L Q++H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
N+V L K+ + L+++Y ++ L + K +I A+++ H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCH 119
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPEL- 264
+ +HRD+ NIL+ + DFG ARLL S V T Y +PEL
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWYRSPELL 174
Query: 265 ----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
Y V DV+ G V E+L G PG
Sbjct: 175 VGDTQYGPPV----DVWAIGCVFAELLSGVPLWPGK 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 37/223 (16%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQ-----T---EARL 140
E + +G G YG VY+A+ G+IVALK++ L++ T E L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR--------LDAEDEGIPSTAIREISL 72
Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMA 200
L ++ H NIV L ++C+ L++++M + L VL + +Q K + +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK--IYLYQLL 129
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHG 258
+++ H I+HRD+ N+L+NS +ADFG+AR + T VV T
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLW 184
Query: 259 YIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
Y AP++ Y+ V D++ G + E++ G+ PG
Sbjct: 185 YRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGKPLFPGV 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 56/241 (23%), Positives = 104/241 (43%), Gaps = 14/241 (5%)
Query: 59 TETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVA 117
+K + D F D ++ + ED+++ IG G +G V + + K+ A
Sbjct: 39 PALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYA 98
Query: 118 LKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFC 176
+K L E + + F E +++ +V+L+ + ++++ +YM G L
Sbjct: 99 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158
Query: 177 VLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVAD 236
++ N D + W + + AL +H +HRD+ +N+LL+ +AD
Sbjct: 159 LMSNYD--VPEKWARFY--TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 237 FGVARLLHSDSSNRTVVA-GTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRH 291
FG ++ + R A GT YI+PE+ +CD + GV E+L+G
Sbjct: 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
Query: 292 P 292
P
Sbjct: 272 P 272
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 67/258 (25%), Positives = 108/258 (41%), Gaps = 41/258 (15%)
Query: 51 PKVRKAKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKY----CIGTGGYGSVY 106
+ G E + G A ++F KY IG G V
Sbjct: 52 ANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVR 111
Query: 107 RA-QLPSGKIVALK-----KLHHSETEL-AFLESFQTEARLLSQIR-HRNIVKLYGFCLH 158
R +G A+K S +L E+ + E +L Q+ H +I+ L
Sbjct: 112 RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171
Query: 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRV--------NIVKSMAHALSYLHYDC 210
MFL++ MR+G LF + + T++V +I++S+ A+S+LH +
Sbjct: 172 SSFMFLVFDLMRKGELF-------DYL----TEKVALSEKETRSIMRSLLEAVSFLHAN- 219
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYTMV 269
+IVHRD+ NILL+ ++ ++DFG + L R + GT GY+APE L +M
Sbjct: 220 --NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC-GTPGYLAPEILKCSMD 276
Query: 270 VTEK-----CDVFGFGVV 282
T D++ GV+
Sbjct: 277 ETHPGYGKEVDLWACGVI 294
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 2e-21
Identities = 49/220 (22%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQ-----T---EAR 139
+ ++ IG G YG+V++A+ + +IVALK++ L+ + E
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--------LDDDDEGVPSSALREIC 53
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
LL +++H+NIV+L+ K + L++++ + L + + + + K + + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK--SFLFQL 110
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTH 257
L + H + +HRD+ N+L+N E +A+FG+AR + VV T
Sbjct: 111 LKGLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TL 165
Query: 258 GYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y P++ Y+ + D++ G + E+ P
Sbjct: 166 WYRPPDVLFGAKLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 32/199 (16%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYG 154
+G G + + S + A+K + + Q E L H NIVKL+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHE 73
Query: 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN--------IVKSMAHALSYL 206
+ FL+ + + G LF E I+ K+ + I++ + A+S++
Sbjct: 74 VFHDQLHTFLVMELLNGGELF-------ERIK----KKKHFSETEASYIMRKLVSAVSHM 122
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
H +VHRD+ N+L + + + DFG ARL D+ T Y APE
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 264 LAYTMVVTEKCDVFGFGVV 282
L E CD++ GV+
Sbjct: 180 LLNQNGYDESCDLWSLGVI 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-21
Identities = 56/273 (20%), Positives = 104/273 (38%), Gaps = 49/273 (17%)
Query: 88 TEDFDI-KYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR 145
+ + + + +G G + V L + + A+K + + E +L Q +
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQ 68
Query: 146 -HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN--------IV 196
HRN+++L F + +L+++ MR GS+ I KR + +V
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSIL-------SHIH----KRRHFNELEASVVV 117
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTV- 252
+ +A AL +LH I HRD+ NIL + + DF + + + +
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 253 ------VAGTHGYIAPELAYTMVVT-----EKCDVFGFGVVALEVLMGRHPGDLLSSFNP 301
G+ Y+APE+ ++CD++ GV+ +L G P F
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP------FVG 228
Query: 302 KIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAF 334
+ D R + Q ++ + I K F
Sbjct: 229 R-CGSDCGWDRGEACPACQNMLFESIQEGKYEF 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 39/298 (13%), Positives = 88/298 (29%), Gaps = 67/298 (22%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALK--------------------------KLHHSETELA 129
+G + A +G+ + + ++ +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 130 FLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM--FLIYKYMR--RGSLFCVLRN-DDEA 184
F L+ + + ++++ + F +Y M+ + VL +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 185 IQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244
L R+ + + L+ LH+ +VH + +I+L+ + F+ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 245 SDSSNRTVVAGTHGYIAPEL-----------AYTMVVTEKCDVFGFGVVALEVLMGRHP- 292
R V + + G+ PEL ++T D + G+V + P
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 293 -GDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
D + I R+ I ++ ++ LR + R +
Sbjct: 314 TKDAALGGSEWIF-------RSCKNIPQP--VRALLE------GFLRYPKEDRLLPLQ 356
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
E + +G G Y +VY+ + + +VALK++ E E + E LL ++H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIREVSLLKDLKHA 60
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
NIV L+ +K + L+++Y+ + L L + I + K + + L+Y H
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK--LFLFQLLRGLAYCH 117
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPEL- 264
++HRD+ N+L+N + E +ADFG+AR + VV T Y P++
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 265 ----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
Y+ + D++G G + E+ GR PG
Sbjct: 173 LGSTDYSTQI----DMWGVGCIFYEMATGRPLFPGS 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 35/216 (16%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESF-QT---EARLLSQIRHRNIVK 151
+G G + +VY+A+ + +IVA+KK+ + +T E +LL ++ H NI+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH----ALSYLH 207
L HK + L++ +M L ++ D ++ L + +K+ L YLH
Sbjct: 77 LLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLT----PSHIKAYMLMTLQGLEYLH 129
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--VVAGTHGYIAPEL- 264
I+HRD+ NN+LL+ +ADFG+A+ S + T VV T Y APEL
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELL 184
Query: 265 ----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
Y + V D++ G + E+L+ PGD
Sbjct: 185 FGARMYGVGV----DMWAVGCILAELLLRVPFLPGD 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLH-HSETELAFLESF-QT---EARLLS 142
++ IG G +G V++A+ +G+ VALKK+ +E E F T E ++L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-----GFPITALREIKILQ 71
Query: 143 QIRHRNIVKLYG--------FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN 194
++H N+V L + K ++L++ + L +L N L K
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK--R 128
Query: 195 IVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT--- 251
+++ + + L Y+H + I+HRD+ + N+L+ +ADFG+AR +++
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 252 ---VVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGR 290
VV T Y PEL Y + D++G G + E+
Sbjct: 186 TNRVV--TLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 50/236 (21%)
Query: 85 IVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESF-QT---EAR 139
+ ++ F +G G Y +VY+ +G VALK++ ++E E T E
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSE----EGTPSTAIREIS 55
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIY--------KYMRRGSLFCVLRNDDEAIQLDWTK 191
L+ +++H NIV+LY + + L++ KYM ++ R + +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL------ 109
Query: 192 RVNIVKSMAH----ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
VK L++ H + I+HRD+ N+L+N + + + DFG+AR
Sbjct: 110 ----VKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162
Query: 248 SNRT--VVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
+ + VV T Y AP++ Y+ + D++ G + E++ G+ PG
Sbjct: 163 NTFSSEVV--TLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGKPLFPGT 212
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 7e-20
Identities = 34/255 (13%), Positives = 72/255 (28%), Gaps = 45/255 (17%)
Query: 96 CIGTGGYGSVYRA---QLPSGKIVALKKLH-HSETELAFLESFQTEARLLSQIRHRNIVK 151
G ++A L + VAL + L+ + LS+I + +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 152 LYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCI 211
+ + ++ +++R GSL V + ++S+A A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVT 271
+ + + + S + VV +
Sbjct: 149 -GVALSIDHPSRVRV--------------------SIDGDVVLAYPATMPD-------AN 180
Query: 272 EKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI-ILVS 330
+ D+ G G +L+ R P + + P + +DI +S
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP---ADIDRDIPFQIS 237
Query: 331 KIAFACLRSKPKSRP 345
+A ++ R
Sbjct: 238 AVAARSVQGDGGIRS 252
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 33/201 (16%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYG 154
+G G G V + + + ALK L + E L + + +IV++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVD 122
Query: 155 FC----LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR------VNIVKSMAHALS 204
+KC+ ++ + + G LF IQ + I+KS+ A+
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELF-------SRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRTVVAGTHGYIA 261
YLH +I HRD+ N+L SK + DFG A+ S +S T T Y+A
Sbjct: 176 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPYYVA 231
Query: 262 PELAYTMVVTEKCDVFGFGVV 282
PE+ + CD++ GV+
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVI 252
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 52/233 (22%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQ-----T---EAR 139
+ + +G G YG VY+A + + VA+K++ LE + T E
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEEGVPGTAIREVS 85
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
LL +++HRNI++L H + LI++Y L + D+ + + ++KS
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVS----MRVIKSF 137
Query: 200 AH----ALSYLHYDCIPSIVHRDISSNNILLNSKLEAF-----VADFGVARLLHSDSSNR 250
+ +++ H +HRD+ N+LL+ + + DFG+AR
Sbjct: 138 LYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 251 T--VVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
T ++ T Y PE+ Y+ V D++ + E+LM PGD
Sbjct: 195 THEII--TLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKTPLFPGD 241
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-19
Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
EDF +G G + +V A+ + + A+K L + + E ++S++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS------MA 200
VKLY + ++ Y + G L +R + + +
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIV 140
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTH 257
AL YLH I+HRD+ NILLN + + DFG A++L +S + V GT
Sbjct: 141 SALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTA 196
Query: 258 GYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y++PEL + D++ G + +++ G P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 30/192 (15%)
Query: 93 IKYCIGTGGYGSVYRAQ---LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
+G G YG VY+A+ K ALK++ S E LL +++H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLRELKHPNV 80
Query: 150 VKLYGFCLHK--KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN--IVKSMAH---- 201
+ L L + ++L++ Y L+ +++ + ++ +VKS+ +
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAF----VADFGVARLLHSDSSNRT-----V 252
+ YLH + ++HRD+ NIL+ + +AD G ARL +S V
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 253 VAGTHGYIAPEL 264
V T Y APEL
Sbjct: 197 V--TFWYRAPEL 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKL------HHSETELAFLESFQTEA 138
V F +G GG+G V Q+ +GK+ A KKL +A E
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-----LNEK 235
Query: 139 RLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVK 197
++L ++ R +V L + K + L+ M G L + + +A + +
Sbjct: 236 QILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTH 257
+ L LH + IV+RD+ NILL+ ++D G+A + + + V GT
Sbjct: 295 -ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTV 349
Query: 258 GYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GY+APE+ YT D + G + E++ G+ P
Sbjct: 350 GYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKL------HHSETELAFLESFQTEA 138
+ + F +G GG+G V+ Q+ +GK+ A KKL + A E
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-----MVEK 236
Query: 139 RLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVK 197
++L+++ R IV L + K + L+ M G + + N DE R
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 198 S-MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
+ + L +LH +I++RD+ N+LL+ ++D G+A L + + AGT
Sbjct: 296 AQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGT 352
Query: 257 HGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
G++APEL Y V D F GV E++ R P
Sbjct: 353 PGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-19
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 35/211 (16%)
Query: 88 TEDFDI-KYCIGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI- 144
T+D+ + K +G G G V +G+ ALK L+ S + E Q
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQAS 79
Query: 145 RHRNIVKLYGFC----LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR------VN 194
+IV + K+C+ +I + M G LF IQ +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF-------SRIQERGDQAFTEREAAE 132
Query: 195 IVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVARLLHSDSSNRT 251
I++ + A+ +LH +I HRD+ N+L SK + + DFG A+ ++ +T
Sbjct: 133 IMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QT 188
Query: 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVV 282
T Y+APE+ + CD++ GV+
Sbjct: 189 PC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 56/278 (20%), Positives = 99/278 (35%), Gaps = 78/278 (28%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLS 142
+ + +G G +G V A + + VA+K L + + +E ++L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILI 80
Query: 143 QI-RHRNIVKLYGFCLHKKC-MFLIYKYMRRGSLFCVLRN-------------------- 180
I H N+V L G C + +I ++ + G+L LR+
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140
Query: 181 DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--------------------------- 213
AI +D +R++ + S + S +
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 214 -------------IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYI 260
+HRD+++ NILL+ K + DFG+AR ++ D +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDARL 257
Query: 261 -----APELAYTMVVTEKCDVFGFGVVALEVL-MGRHP 292
APE + V T + DV+ FGV+ E+ +G P
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 43/227 (18%)
Query: 92 DIKYC----IGTGGYGSVYRAQL-PSGKIVALKK-LHHSETELAFLESFQTEARLLSQIR 145
++ Y IG G +G VY+A+L SG++VA+KK L + E +++ ++
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLD 105
Query: 146 HRNIVKLYGF------CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS- 198
H NIV+L F + + L+ Y+ +++ V R+ A Q T V VK
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ---TLPVIYVKLY 161
Query: 199 ---MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVA 254
+ +L+Y+H I HRDI N+LL+ + DFG A+ L N + +
Sbjct: 162 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 255 GTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRH--PGD 294
+ Y APEL YT + DV+ G V E+L+G+ PGD
Sbjct: 219 -SRYYRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFPGD 260
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 60/239 (25%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ--LPSGKIVALKKLH-HSET---------ELAFLESFQT 136
+ ++ IG G YG V++A+ G+ VALK++ + E+A L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL----- 65
Query: 137 EARLLSQIRHRNIVKLY-----GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTK 191
R L H N+V+L+ + + L+++++ + D LD
Sbjct: 66 --RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----------DLTTYLDKVP 113
Query: 192 RVNI----VKSMAH----ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243
+ +K M L +LH + VHRD+ NIL+ S + +ADFG+AR+
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 244 HSDS--SNRTVVAGTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
++ VV T Y APE+ +Y V D++ G + E+ + G
Sbjct: 171 SFQMALTSV-VV--TLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRKPLFRGS 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 38/190 (20%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLH-HSETELAFLESFQT--EARLL---SQIRHRNI 149
IG G YG+VY+A+ SG VALK + + T E LL H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 150 VKLYGFCLHKKC-----MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNI----VKSMA 200
V+L C + + L+++++ + D LD + +K +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 201 H----ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVA 254
L +LH +CI VHRD+ NIL+ S +ADFG+AR+ + VV
Sbjct: 127 RQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV-VV- 181
Query: 255 GTHGYIAPEL 264
T Y APE+
Sbjct: 182 -TLWYRAPEV 190
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 42/224 (18%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLH------HSETELAFLESFQTEARLL 141
DF + IG GG+G VY + +GK+ A+K L LA E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-----LNERIML 243
Query: 142 SQI---RHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVN 194
S + IV + + H + I M G L L E +
Sbjct: 244 SLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-------ADMR 295
Query: 195 I-VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVV 253
+ L ++H +V+RD+ NILL+ ++D G+A + +V
Sbjct: 296 FYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 351
Query: 254 AGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GTHGY+APE+ AY D F G + ++L G P
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG G + V A+ + +G+ VA+K + ++ L+ E R++ + H NIVKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLR-----NDDEAIQLDWTKRVNIVKSMAHALSYLHYDC 210
+K ++LI +Y G +F L + EA + + A+ Y H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS--------KFRQIVSAVQYCHQKR 134
Query: 211 IPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL----AY 266
I VHRD+ + N+LL++ + +ADFG + G Y APEL Y
Sbjct: 135 I---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-GAPPYAAPELFQGKKY 190
Query: 267 TMVVTEKCDVFGFGVVALEVLM-GRHP 292
+ DV+ GV+ L L+ G P
Sbjct: 191 D---GPEVDVWSLGVI-LYTLVSGSLP 213
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 50/245 (20%)
Query: 78 RITFEEIIVATEDFDI--KY----CIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFL 131
+ + E + Y I +G YG+V G VA+K++ ++ ++ +
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV 64
Query: 132 ESFQT---------EARLLSQIRHRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCV 177
E RLL+ H NI+ L +H + ++L+ + MR L V
Sbjct: 65 NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQV 123
Query: 178 LRN-----DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKL 230
+ + + IQ + + L LH +VHRD+ NILL
Sbjct: 124 IHDQRIVISPQHIQY-------FMYHILLGLHVLH-----EAGVVHRDLHPGNILLADNN 171
Query: 231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALE 285
+ + DF +AR +D++ V Y APEL +T +V D++ G V E
Sbjct: 172 DITICDFNLAREDTADANKTHYVT-HRWYRAPELVMQFKGFTKLV----DMWSAGCVMAE 226
Query: 286 VLMGR 290
+ +
Sbjct: 227 MFNRK 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 49/235 (20%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKK-LHHSET---ELAFLESFQTEARLLS 142
+ F ++ G G +G+V + +G VA+KK + EL + + L+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIM-------QDLA 74
Query: 143 QIRHRNIVKLYGFCLHKK-------CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNI 195
+ H NIV+L + + ++ +Y+ +L RN +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV---APPPIL 130
Query: 196 VKS----MAHALSYLHYDCIPSIVHRDISSNNILLNS-----KLEAFVADFGVARLLHSD 246
+K + ++ LH + ++ HRDI +N+L+N KL DFG A+ L
Sbjct: 131 IKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKL----CDFGSAKKLSPS 185
Query: 247 SSNRTVVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRH--PGD 294
N + + Y APEL YT V D++ G + E+++G GD
Sbjct: 186 EPNVAYIC-SRYYRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGEPIFRGD 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 45/188 (23%), Positives = 71/188 (37%), Gaps = 25/188 (13%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKL------HHSETELAFLESFQTEARLLS 142
+ +G+G +G V+ A K V +K + E L E +LS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 143 QIRHRNIVKLYGFCLHKKCMFLIY-KYMRRGSLF--CVLR---NDDEAIQLDWTKRVNIV 196
++ H NI+K+ ++ L+ K+ LF ++ A I
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS--------YIF 136
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
+ + A+ YL I +HRDI NI++ + DFG A L T GT
Sbjct: 137 RQLVSAVGYLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-GT 192
Query: 257 HGYIAPEL 264
Y APE+
Sbjct: 193 IEYCAPEV 200
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 66/319 (20%), Positives = 120/319 (37%), Gaps = 58/319 (18%)
Query: 56 AKPTETKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGK 114
AK K++ ++F TF + + IG+G G V A +
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGD-STFT----VLKRYQNLKPIGSGAQGIVCAAYDAVLDR 88
Query: 115 IVALKKLHHSETELAFLESFQT---------EARLLSQIRHRNIVKLY------GFCLHK 159
VA+KKL FQ E L+ + H+NI+ L
Sbjct: 89 NVAIKKLS---------RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139
Query: 160 KCMFLIYKYMRRGSLFCVLRND--DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHR 217
+ ++L+ + M +L V++ + E + ++ M + +LH I+HR
Sbjct: 140 QDVYLVMELMD-ANLCQVIQMELDHERMSY-------LLYQMLCGIKHLHS---AGIIHR 188
Query: 218 DISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVF 277
D+ +NI++ S + DFG+AR + V T Y APE+ M E D++
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 247
Query: 278 GFGVVALEVLMGRH--PGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFA 335
G + E++ + PG + +I+ L +P + + +
Sbjct: 248 SVGCIMGEMVRHKILFPGR--DYIDQWNKVIEQL----GTPCPE-----FMKKLQPTVRN 296
Query: 336 CLRSKPKSRP-TMRRSFPN 353
+ ++PK T + FP+
Sbjct: 297 YVENRPKYAGLTFPKLFPD 315
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 35/220 (15%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKL------HHSETELAFLESFQTEARLL 141
+F+ +G G +G V + +G+ A+K L E TE R+L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-----HTLTENRVL 202
Query: 142 SQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNI-V 196
RH + L + + + +Y G LF L + E R
Sbjct: 203 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE-------DRARFYG 254
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
+ AL YLH + ++V+RD+ N++L+ + DFG+ + D + GT
Sbjct: 255 AEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 312
Query: 257 HGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y+APE+ Y V D +G GVV E++ GR P
Sbjct: 313 PEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 43/222 (19%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
+ FD +GTG +G V + SG A+K L + +L +E E R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-----NDDEA------IQLDWTKRVNI 195
+VKL ++++ +Y+ G +F LR ++ A I L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-------- 152
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVA 254
YLH +++RD+ N+L++ + V DFG A+ + RT +
Sbjct: 153 ------TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLC 199
Query: 255 GTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GT +APE+ Y V D + GV+ E+ G P
Sbjct: 200 GTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 50/230 (21%)
Query: 92 DIKYC----IGTGGYGSVYRAQLPSGKIVALKK-LHHSETELAFLESFQTEARLLSQIRH 146
+I Y IG G +G V++A+L VA+KK L + E +++ ++H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-------RELQIMRIVKH 91
Query: 147 RNIVKLYGF------CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS-- 198
N+V L F + + L+ +Y+ +++ R+ + Q T + ++K
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQ---TMPMLLIKLYM 147
Query: 199 --MAHALSYLHYDCIPSIVHRDISSNNILLNS-----KLEAFVADFGVARLLHSDSSNRT 251
+ +L+Y+H I HRDI N+LL+ KL DFG A++L + N +
Sbjct: 148 YQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL----IDFGSAKILIAGEPNVS 200
Query: 252 VVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGR--HPGD 294
+ + Y APEL YT + D++ G V E++ G+ PG+
Sbjct: 201 YIC-SRYYRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQPLFPGE 245
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 63/310 (20%), Positives = 117/310 (37%), Gaps = 50/310 (16%)
Query: 61 TKKTRCGDEFSVWNYDGRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALK 119
+++ + F TF + + IG+G G V A + VA+K
Sbjct: 2 GSRSKRDNNFYSVEIGD-STFT----VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK 56
Query: 120 KLHHSETELAFLESFQT-----EARLLSQIRHRNIVKLYGFCLHKKCM------FLIYKY 168
KL F E L+ + H+NI+ L +K + +++ +
Sbjct: 57 KLSR-----PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111
Query: 169 MRRGSLFCVLRN--DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL 226
M +L V++ D E + ++ M + +LH I+HRD+ +NI++
Sbjct: 112 MD-ANLCQVIQMELDHERMSY-------LLYQMLCGIKHLHS---AGIIHRDLKPSNIVV 160
Query: 227 NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEV 286
S + DFG+AR + V T Y APE+ M E D++ G + E+
Sbjct: 161 KSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 287 LMGRH--PGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSR 344
+ G PG + +I+ L +P + + + + ++PK
Sbjct: 220 IKGGVLFPGT--DHIDQWNKVIEQL----GTPCPE-----FMKKLQPTVRTYVENRPKYA 268
Query: 345 P-TMRRSFPN 353
+ + FP+
Sbjct: 269 GYSFEKLFPD 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 49/231 (21%), Positives = 85/231 (36%), Gaps = 47/231 (20%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALK------------------------KLHHSETELAFL 131
IG G YG V A A+K +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 132 ESFQTEARLLSQIRHRNIVKLYG--FCLHKKCMFLIYKYMRRGSLFCVLRND----DEAI 185
E E +L ++ H N+VKL ++ ++++++ + +G + V D+A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA- 139
Query: 186 QLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245
+ + + YLHY I+HRDI +N+L+ +ADFGV+
Sbjct: 140 -------RFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 246 DSSNRTVVAGTHGYIAPEL---AYTMVVTEKCDVFGFGVVALEVLM-GRHP 292
+ + GT ++APE + + DV+ GV L + G+ P
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT-LYCFVFGQCP 239
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 69/310 (22%), Positives = 128/310 (41%), Gaps = 70/310 (22%)
Query: 78 RITFEEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQT 136
RI + + DF +K +G G YG V A P+G+IVA+KK+ F +
Sbjct: 4 RIVYNI----SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE------PFDKPLFA 53
Query: 137 -----EARLLSQIRHRNIVKLY-----GFCLHKKCMFLIYKYMRRGSLFCVLRN---DDE 183
E ++L +H NI+ ++ + +++I + M+ L V+ D+
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDD 112
Query: 184 AIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVAR 241
IQ + A+ LH ++HRD+ +N+L+NS + V DFG+AR
Sbjct: 113 HIQY-------FIYQTLRAVKVLH-----GSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160
Query: 242 LLHSDSSNRTVVAGTHG----------YIAPEL-----AYTMVVTEKCDVFGFGVVALEV 286
++ +++ + G Y APE+ Y+ + DV+ G + E+
Sbjct: 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAEL 216
Query: 287 LMGRH--PGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSR 344
+ R PG + +++ ++ +P D ++ I S A ++S P
Sbjct: 217 FLRRPIFPGR--DYRHQLLLIFGII----GTPHSDN-DLRCIE--SPRAREYIKSLPMYP 267
Query: 345 P-TMRRSFPN 353
+ + FP
Sbjct: 268 AAPLEKMFPR 277
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYG 154
+G G +G V + +G VA+K L+ + L + + E + L RH +I+KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 155 FCLHKKCMFLIYKYMRRGSLF--CVLR---NDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
F++ +Y+ G LF + EA + + + A+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA--------RRLFQQILSAVDYCHRH 130
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
+VHRD+ N+LL++ + A +ADFG++ ++ RT G+ Y APE+
Sbjct: 131 ---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEV 181
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 49/215 (22%), Positives = 80/215 (37%), Gaps = 36/215 (16%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLH----HSETELAFLESFQTEARLLSQIRHR--NI 149
+G+GG+GSVY + VA+K + EL E LL ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 150 VKLYGFCLHKKCMFLIYKYMR-RGSLF--CVLR---NDDEAIQLDWTKRVNIVKSMAHAL 203
++L + LI + LF R ++ A + + A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--------SFFWQVLEAV 162
Query: 204 SYLHYDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
+ H ++HRDI NIL++ + E + DFG LL + T GT Y P
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPP 217
Query: 263 EL----AYTMVVTEKCDVFGFGVVALEVLM-GRHP 292
E Y V+ G++ L ++ G P
Sbjct: 218 EWIRYHRYH---GRSAAVWSLGIL-LYDMVCGDIP 248
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 19/175 (10%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYG 154
+G G +G V + +G VA+K L+ + L + + E + L RH +I+KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 155 FCLHKKCMFLIYKYMRRGSLF--CVLR---NDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
+F++ +Y+ G LF ++ E+ + + + + Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES--------RRLFQQILSGVDYCHRH 135
Query: 210 CIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
+ VHRD+ N+LL++ + A +ADFG++ ++ RT G+ Y APE+
Sbjct: 136 MV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAPEV 186
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 57/299 (19%), Positives = 118/299 (39%), Gaps = 64/299 (21%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+ +G GG G V+ A K VA+KK+ ++ + + + E +++ ++ H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV-KHALR-EIKIIRRLDH 67
Query: 147 RNIVKLY--------------GFCLHKKCMFLIYKYMRRGSLFCVLRN---DDEAIQLDW 189
NIVK++ G ++++ +YM L VL +E +L
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARL-- 124
Query: 190 TKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSK-LEAFVADFGVARLLHSD 246
+ + L Y+H S ++HRD+ N+ +N++ L + DFG+AR++
Sbjct: 125 -----FMYQLLRGLKYIH-----SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 247 SSNRTV----VAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRH--PGDL 295
S++ + T Y +P L YT + D++ G + E+L G+ G
Sbjct: 175 YSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGKTLFAGA- 228
Query: 296 LSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP-TMRRSFPN 353
++++ + P ++ D + + +R+ + + P
Sbjct: 229 -HELEQMQLILESI----PVVHEE-----DRQELLSVIPVYIRNDMTEPHKPLTQLLPG 277
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 3e-14
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 43/222 (19%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
+DF I +GTG +G V+ + +G+ A+K L L +E E +LS + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN-----DDEA------IQLDWTKRVNI 195
I++++G + +F+I Y+ G LF +LR + A + L
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------- 117
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVA 254
AL YLH I++RD+ NILL+ + DFG A+ + + T +
Sbjct: 118 ------ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLC 164
Query: 255 GTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GT YIAPE+ Y + D + FG++ E+L G P
Sbjct: 165 GTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 42/191 (21%), Positives = 75/191 (39%), Gaps = 29/191 (15%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLH----HSETELAFLESFQTEARLLSQI 144
++ + +G GG+G+V+ L VA+K + + L+ + E LL ++
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 145 R----HRNIVKLYGFCLHKKCMFLIYKYMRRGS-LF--CVLR---NDDEAIQLDWTKRVN 194
H +++L + ++ L+ + LF + + + R
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-------R-C 143
Query: 195 IVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRTVV 253
+ A+ + H +VHRDI NIL++ + A + DFG LLH T
Sbjct: 144 FFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDF 198
Query: 254 AGTHGYIAPEL 264
GT Y PE
Sbjct: 199 DGTRVYSPPEW 209
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 51/257 (19%), Positives = 91/257 (35%), Gaps = 63/257 (24%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKK-LHHSETELAFLESFQTEARLLSQ 143
+++ + + +GTG +G V + SGK ALKK L + E ++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-------RELDIMKV 56
Query: 144 IRHRNIVKLYGF---CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR----VNIV 196
+ H NI+KL + ++ ++ + +N++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 197 K---------------------SMAH----------ALSYLHYDCIPSIVHRDISSNNIL 225
M A+ ++H I HRDI N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLL 173
Query: 226 LNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIAPEL-----AYTMVVTEKCDVFGF 279
+NSK + DFG A+ L + + + Y APEL YT + D++
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPSI----DLWSI 228
Query: 280 GVVALEVLMGRH--PGD 294
G V E+++G+ G+
Sbjct: 229 GCVFGELILGKPLFSGE 245
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 67/286 (23%), Positives = 112/286 (39%), Gaps = 51/286 (17%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQT-----EARLL 141
+ + +G+G YGSV A SG+ VA+KKL F E LL
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-----PFQSEIFAKRAYRELLLL 77
Query: 142 SQIRHRNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCVLRND--DEAIQLDWTKRV 193
++H N++ L + +L+ +M+ L ++ +E IQ
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY------ 130
Query: 194 NIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
+V M L Y+H S +VHRD+ N+ +N E + DFG+AR + T
Sbjct: 131 -LVYQMLKGLKYIH-----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT 181
Query: 252 VVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRH--PGDLLSSFNPKIMLIDL 308
T Y APE+ + M + D++ G + E+L G+ G + ++ +
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--DYLDQLTQILKV 239
Query: 309 LDQRAPSPIDDQTVIQDIILVSKIAFACLRSKP-KSRPTMRRSFPN 353
P +Q + K A + ++S P R + FP
Sbjct: 240 T----GVP--GTEFVQKL--NDKAAKSYIQSLPQTPRKDFTQLFPR 277
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 64/296 (21%), Positives = 115/296 (38%), Gaps = 52/296 (17%)
Query: 77 GRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQ 135
+ +E + +G+G YG+V A +G VA+KKL+ F
Sbjct: 17 TKTAWE----VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-----PFQSELF 67
Query: 136 T-----EARLLSQIRHRNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCVLRND--- 181
E RLL +RH N++ L + + +L+ +M L +++++
Sbjct: 68 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLG 126
Query: 182 DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
++ IQ +V M L Y+H I+HRD+ N+ +N E + DFG+AR
Sbjct: 127 EDRIQF-------LVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176
Query: 242 LLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRH--PGDLLSS 298
S T T Y APE+ M T+ D++ G + E++ G+ G
Sbjct: 177 ---QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS--DH 231
Query: 299 FNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP-TMRRSFPN 353
+ ++ + +P + +Q + S A ++ P+ N
Sbjct: 232 LDQLKEIMKVT----GTPPAE--FVQRL--QSDEAKNYMKGLPELEKKDFASILTN 279
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 69/294 (23%), Positives = 113/294 (38%), Gaps = 62/294 (21%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQT-----EARLL 141
+ IG G YG V A + VA+KK+ F E ++L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQRTLREIKIL 79
Query: 142 SQIRHRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCVLRN---DDEAIQLDWTKRV 193
+ RH NI+ + ++++ M L+ +L+ ++ I
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICY------ 132
Query: 194 NIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
+ + L Y+H S ++HRD+ +N+LLN+ + + DFG+AR+ D +
Sbjct: 133 -FLYQILRGLKYIH-----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 252 V----VAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRH--PGDLLSSFN 300
VA T Y APE+ YT + D++ G + E+L R PG +
Sbjct: 187 FLTEYVA-TRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNRPIFPGK--HYLD 239
Query: 301 PKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT-MRRSFPN 353
++ +L SP Q + II + A L S P R FPN
Sbjct: 240 QLNHILGIL----GSP--SQEDLNCII--NLKARNYLLSLPHKNKVPWNRLFPN 285
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 8e-14
Identities = 49/181 (27%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G YG V A + + VA+K + + + E+ + E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRND-----DEAI----QLDWTKRVNIVKSMAHALSYL 206
+L +Y G LF + D +A QL + YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAGVVYL 121
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPE 263
H I HRDI N+LL+ + ++DFG+A + ++ R + GT Y+APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 264 L 264
L
Sbjct: 178 L 178
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 42/233 (18%), Positives = 94/233 (40%), Gaps = 38/233 (16%)
Query: 73 WNYD-GRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAF 130
W+Y+ + + +D+ + +G G Y V+ A + + + V +K L + +
Sbjct: 23 WDYESHVVEWGN----QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK 78
Query: 131 LESFQTEARLLSQIR-HRNIVKLYGFCLH---KKCMFLIYKYMRRGSLFCVLRN-DDEAI 185
E ++L +R NI+ L + + L+++++ + + D I
Sbjct: 79 -----REIKILENLRGGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI 132
Query: 186 QLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLLH 244
+ + + AL Y H I+HRD+ +N++++ + + + D+G+A H
Sbjct: 133 RF-------YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 245 SDSSNRTVVAGTHGYIAPEL-----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
VA + + PEL Y + D++ G + ++ + P
Sbjct: 183 PGQEYNVRVA-SRYFKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKL------HHSETELAFLESFQTEARLL 141
DFD +G G +G V + +G+ A+K L E TE+R+L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA-----HTVTESRVL 59
Query: 142 SQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVK 197
RH + L + + + +Y G LF L + E +R
Sbjct: 60 QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-------ERARFYG 111
Query: 198 S-MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
+ + AL YLH +V+RDI N++L+ + DFG+ + SD + GT
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 168
Query: 257 HGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
Y+APE+ Y V D +G GVV E++ GR P
Sbjct: 169 PEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 38/159 (23%), Positives = 62/159 (38%), Gaps = 32/159 (20%)
Query: 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYG 154
+G G G V + + + ALK L + E L + + +IV++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVD 78
Query: 155 FC----LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR------VNIVKSMAHALS 204
+KC+ ++ + + G LF IQ + I+KS+ A+
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELF-------SRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAF---VADFGVA 240
YLH +I HRD+ N+L SK + DFG A
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 49/181 (27%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
+G G YG V A + + VA+K + + + E+ + E + + H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRND-----DEAI----QLDWTKRVNIVKSMAHALSYL 206
+L +Y G LF + D +A QL + YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------------MAGVVYL 121
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR---TVVAGTHGYIAPE 263
H I HRDI N+LL+ + ++DFG+A + ++ R + GT Y+APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE 177
Query: 264 L 264
L
Sbjct: 178 L 178
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 28/179 (15%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYG 154
+G G +G V A + + VALK + + + E L +RH +I+KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 155 FCLHKKCMFLIYKY---------MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
+ ++ +Y + + + +DE + + A+ Y
Sbjct: 77 VITTPTDIVMVIEYAGGELFDYIVEKKRM-----TEDEG--------RRFFQQIICAIEY 123
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
H IVHRD+ N+LL+ L +ADFG++ ++ + +T G+ Y APE+
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEV 178
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 45/189 (23%), Positives = 77/189 (40%), Gaps = 38/189 (20%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALK-----KLHHSETELAFLESFQTEARLLSQIRHRNIV 150
+G G YG V + A+K KL + + E +LL ++RH+N++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPN---GEANVKKEIQLLRRLRHKNVI 69
Query: 151 KLYGFCLH--KKCMFLIYKYMRRGS--LFCVLRN----DDEAI----QLDWTKRVNIVKS 198
+L + K+ M+++ +Y G + + +A QL
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL----------- 118
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV--VAGT 256
L YLH IVH+DI N+LL + ++ GVA LH +++ T G+
Sbjct: 119 -IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 257 HGYIAPELA 265
+ PE+A
Sbjct: 175 PAFQPPEIA 183
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 31/180 (17%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGF 155
IG+G +G + + ++VA+K + E A E+ Q E +RH NIV+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI---ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 156 CLHKKCMFLIYKYMRRGSLFCVLRN-----DDEAI----QLDWTKRVNIVKSMAHALSYL 206
L + +I +Y G L+ + N +DEA QL +SY
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------------LSGVSYC 132
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAF--VADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
H I HRD+ N LL+ + DFG ++ S ++ V GT YIAPE+
Sbjct: 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 188
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 68/305 (22%), Positives = 122/305 (40%), Gaps = 66/305 (21%)
Query: 80 TFEEIIVATEDFDI--KY----CIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLE 132
TF + +++ +Y +G+G YGSV A +G VA+KKL
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS---------R 64
Query: 133 SFQT---------EARLLSQIRHRNIVKLYGFCLHKKCM------FLIYKYMRRGSLFCV 177
FQ+ E RLL ++H N++ L + + +L+ M L +
Sbjct: 65 PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNI 123
Query: 178 LRN---DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEA 232
++ D+ +Q ++ + L Y+H S I+HRD+ +N+ +N E
Sbjct: 124 VKCQKLTDDHVQF-------LIYQILRGLKYIH-----SADIIHRDLKPSNLAVNEDCEL 171
Query: 233 FVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRH 291
+ DFG+AR + T T Y APE+ M + D++ G + E+L GR
Sbjct: 172 KILDFGLAR---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
Query: 292 --PGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRP-TMR 348
PG + +++ L+ +P +++ I S+ A ++S +
Sbjct: 229 LFPGT--DHIDQLKLILRLV----GTP--GAELLKKI--SSESARNYIQSLTQMPKMNFA 278
Query: 349 RSFPN 353
F
Sbjct: 279 NVFIG 283
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 9e-13
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKL-------HHSETELAFLESFQTE 137
E F++ +G GGYG V++ + +GKI A+K L + +T + E
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA-----HTKAE 71
Query: 138 ARLLSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRV 193
+L +++H IV L Y F K ++LI +Y+ G LF L + E
Sbjct: 72 RNILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME-------DTA 123
Query: 194 NI-VKSMAHALSYLHYDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSS 248
+ ++ AL +LH I++RD+ NI+LN KL DFG+ + D +
Sbjct: 124 CFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKL----TDFGLCKESIHDGT 176
Query: 249 NRTVVAGTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GT Y+APE+ + V D + G + ++L G P
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 50/228 (21%)
Query: 89 EDFDIKYCIGTGGYGSVY----RAQLPSGKIVALKKLH------HSETELAFLESFQTEA 138
F++ +G G +G V+ + + ++ A+K L + E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT------KMER 77
Query: 139 RLLSQIRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVN 194
+L ++ H IVKL Y F K ++LI ++R G LF L + E + V
Sbjct: 78 DILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE-------EDVK 129
Query: 195 I-VKSMAHALSYLHYDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARL-LHSDSS 248
+ +A AL +LH I++RD+ NILL+ KL DFG+++ + +
Sbjct: 130 FYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKL----TDFGLSKESIDHEKK 182
Query: 249 NRTVVAGTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+ GT Y+APE+ +T D + FGV+ E+L G P
Sbjct: 183 AYSFC-GTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSE--TELAFLESFQTEARLLS 142
E+F++ +GTG YG V+ + +GK+ A+K L + + E +TE ++L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 143 QIRHRN-IVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVK 197
IR +V L Y F K + LI Y+ G LF L E V I
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE-------HEVQIYV 165
Query: 198 S-MAHALSYLHYDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRTV 252
+ AL +LH I++RDI NILL+S L DFG+++ +D + R
Sbjct: 166 GEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL----TDFGLSKEFVADETERAY 218
Query: 253 -VAGTHGYIAPEL------AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GT Y+AP++ + V D + GV+ E+L G P
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 43/196 (21%), Positives = 78/196 (39%), Gaps = 41/196 (20%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQT-----EARLL 141
+ ++I++ IGTG YG V A ++VA+KK+ F + E +L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-----RVFEDLIDCKRILREIAIL 106
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTK--RVNIVKSM 199
+++ H ++VK+ + + + L+ VL E D+ K R + +
Sbjct: 107 NRLNHDHVVKVLD-------IVIPKDVEKFDELYVVL----EIADSDFKKLFRTPVYLTE 155
Query: 200 AH----------ALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247
H + Y+H S I+HRD+ N L+N V DFG+AR +
Sbjct: 156 LHIKTLLYNLLVGVKYVH-----SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 248 SNRTVVAGTHGYIAPE 263
+ + + +
Sbjct: 211 NGNSQLPISPREDDMN 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 64/331 (19%), Positives = 119/331 (35%), Gaps = 87/331 (26%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQT-----EARLL 141
+++ IK+ IG G YG VY A + K VA+KK++ F + E +L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-----MFEDLIDCKRILREITIL 79
Query: 142 SQIRHRNIVKLYGFCLHKKC-----MFLIYKYMRRGSLFCVLRND----DEAIQLDWTKR 192
++++ I++LY + ++++ + L + + +E I+
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT----- 133
Query: 193 VNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250
I+ ++ +++H I+HRD+ N LLN V DFG+AR ++S+
Sbjct: 134 --ILYNLLLGENFIH-----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 251 TVVAGTHG----------------------YIAPEL-----AYTMVVTEKCDVFGFGVVA 283
V Y APEL YT + D++ G +
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIF 242
Query: 284 LEVLMGRHPGDLL----------SSFNPKIMLIDLLDQRAPSPIDDQTVIQDII------ 327
E+L SS P + S D +I +II
Sbjct: 243 AELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED 302
Query: 328 ----LVSKIAFACLRSKPKSRPT-MRRSFPN 353
+ ++ P +P +++ +P+
Sbjct: 303 DLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 44/216 (20%)
Query: 77 GRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQ 135
GR+ +++ +G G YG V+++ +G++VA+KK+ AF S
Sbjct: 1 GRVDRH----VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-----AFQNSTD 51
Query: 136 T-----EARLLSQIR-HRNIVKLYGFCL--HKKCMFLIYKYMRRGS-LFCVLRN---DDE 183
E +L+++ H NIV L + + ++L++ YM + L V+R +
Sbjct: 52 AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPV 109
Query: 184 AIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVAR 241
Q +V + + YLH S ++HRD+ +NILLN++ VADFG++R
Sbjct: 110 HKQY-------VVYQLIKVIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSR 157
Query: 242 LLHSDSSNRTVVAGTHGYIAPELAYTM------VVT 271
+ + + V T
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVAT 193
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 44/222 (19%), Positives = 89/222 (40%), Gaps = 42/222 (18%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR---------- 145
+G G + +V+ A+ + + VA+K + + + E+ + E +LL ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 146 -HRNIVKLYGFCLHKKC----MFLIYKYMRRGSLFCVL-RNDDEAIQLDWTKRVNIVKSM 199
+I+KL HK + ++++ + +L ++ + + I L + K+ I K +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--ISKQL 140
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF------VADFGVARLLHSDSSNRTVV 253
L Y+H C I+H DI N+L+ +AD G A +N
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN---S 195
Query: 254 AGTHGYIAPE----LAYTMVVTEKCDVFGFGVVALEVLMGRH 291
T Y +PE + D++ + E++ G
Sbjct: 196 IQTREYRSPEVLLGAPWGC----GADIWSTACLIFELITGDF 233
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 4e-11
Identities = 33/235 (14%), Positives = 62/235 (26%), Gaps = 45/235 (19%)
Query: 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEA 138
+ F + TE IG G +G V++ VA+K + +L +T
Sbjct: 11 VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 139 RLLSQI---------------RHRNIVKLYGFCLHK----KCMFLIYKYMRR-------- 171
+L +I R + L + + + +
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 172 ------GSLFCVLRNDD--------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHR 217
LF VL + +I+ + +L+ HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186
Query: 218 DISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTE 272
D+ N+LL + + S V + E +V +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD 241
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 9e-11
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 52/264 (19%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKL------HHSETELAFLESFQTEARLL 141
+DFD+ IG G Y V +L + +I A+K + + + QTE +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID-----WVQTEKHVF 63
Query: 142 SQI-RHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNI- 195
Q H +V L+ C + +F + +Y+ G L ++ E +
Sbjct: 64 EQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-------EHARFY 115
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-LHSDSSNRTVVA 254
++ AL+YLH I++RD+ +N+LL+S+ + D+G+ + L + T
Sbjct: 116 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC- 171
Query: 255 GTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD 310
GT YIAPE+ Y V D + GV+ E++ GR P F+ +
Sbjct: 172 GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP------FDIVGSSDNPDQ 221
Query: 311 QRAPSPIDDQTVIQDIILVSKIAF 334
+ + + +IL +I
Sbjct: 222 -------NTEDYLFQVILEKQIRI 238
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 45/225 (20%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVA---LKK---LHHSETELAFLESFQTEARLL 141
DF IG G +G V A+ A L+K L E + +E +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEK-----HIMSERNVL 92
Query: 142 SQ-IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNI- 195
+ ++H +V L + F K ++ + Y+ G LF L+ + E R
Sbjct: 93 LKNVKHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLE-------PRARFY 144
Query: 196 VKSMAHALSYLHYDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRT 251
+A AL YLH +IV+RD+ NILL+S L DFG+ + +S +
Sbjct: 145 AAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVL----TDFGLCKENIEHNSTTS 197
Query: 252 VVAGTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GT Y+APE+ Y V D + G V E+L G P
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 52/264 (19%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKL------HHSETELAFLESFQTEARLL 141
+DFD+ IG G Y V +L + +I A++ + + + QTE +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID-----WVQTEKHVF 106
Query: 142 SQI-RHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIV 196
Q H +V L+ C + +F + +Y+ G L ++ E +
Sbjct: 107 EQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE-------EHARFY 158
Query: 197 KS-MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-LHSDSSNRTVVA 254
+ ++ AL+YLH I++RD+ +N+LL+S+ + D+G+ + L + T
Sbjct: 159 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC- 214
Query: 255 GTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD 310
GT YIAPE+ Y V D + GV+ E++ GR P F+ +
Sbjct: 215 GTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP------FDIVGSSDNPDQ 264
Query: 311 QRAPSPIDDQTVIQDIILVSKIAF 334
+ + + +IL +I
Sbjct: 265 -------NTEDYLFQVILEKQIRI 281
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLH----HSETELAFLESFQTEARLLSQ 143
DF+ +G G +G V ++ + ++ A+K L + ++ E E R+L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV---ECTMVEKRVLAL 397
Query: 144 I-RHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH 201
+ + +L+ C ++ + +Y+ G L ++ + V +A
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAI 453
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
L +L I++RD+ +N++L+S+ +ADFG+ + D GT YIA
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 510
Query: 262 PEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE+ Y V D + FGV+ E+L G+ P
Sbjct: 511 PEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 47/221 (21%), Positives = 88/221 (39%), Gaps = 26/221 (11%)
Query: 84 IIVATEDFDIKY----CIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEA 138
+ V + +Y IG G +G V +A + VALK + + + F E
Sbjct: 88 VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEI 144
Query: 139 RLLSQIRHR------NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-NDDEAIQLDWTK 191
R+L +R + N++ + + + + ++ + +L+ +++ N + L +
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR 203
Query: 192 RVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF--VADFGVARLLHSDSSN 249
+ S+ L LH I+H D+ NILL + + V DFG + H
Sbjct: 204 K--FAHSILQCLDALH-KN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY- 257
Query: 250 RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGR 290
T + Y APE+ D++ G + E+L G
Sbjct: 258 -TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVA---LKK---LHHSETELAFLESFQTEARLL 141
EDF + +G G +G V+ A+ + + A LKK L + E E R+L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-----CTMVEKRVL 71
Query: 142 SQ-IRHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
S H + + F + +F + +Y+ G L +++ + D ++ +
Sbjct: 72 SLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEI 127
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARL-LHSDSSNRTVVAGT 256
L +LH IV+RD+ +NILL+ + + ADFG+ + + D+ T GT
Sbjct: 128 ILGLQFLHSK---GIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNTFC-GT 181
Query: 257 HGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
YIAPE+ Y V D + FGV+ E+L+G+ P
Sbjct: 182 PDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 56/259 (21%), Positives = 104/259 (40%), Gaps = 32/259 (12%)
Query: 48 LRRPKVRKAKPTETKKTRCGDEFSVWNYDG--RITFEEIIVATEDFDIKYCIGTGGYGSV 105
L + + KK R + + + E + ++I IG G +G V
Sbjct: 13 LGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKW--MDRYEIDSLIGKGSFGQV 70
Query: 106 YRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR------NIVKLYGFCLH 158
+A + VA+K + + + AFL Q E RLL + IV L +
Sbjct: 71 VKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127
Query: 159 KKCMFLIYKYMRRGSLFCVLR-NDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHR 217
+ + L+++ + +L+ +LR + + L+ T++ + M AL +L + SI+H
Sbjct: 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQQMCTALLFLATPEL-SIIHC 183
Query: 218 DISSNNILL--NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE----LAYTMVVT 271
D+ NILL + + DFG + L + Y +PE + Y +
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRF-YRSPEVLLGMPYDL--- 237
Query: 272 EKCDVFGFGVVALEVLMGR 290
D++ G + +E+ G
Sbjct: 238 -AIDMWSLGCILVEMHTGE 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 43/224 (19%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLH------HSETELAFLESFQTEARLL 141
++F+ +G G +G V A++ +G + A+K L + E TE R+L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE-----CTMTEKRIL 77
Query: 142 SQI-RHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS- 198
S H + +L F + +F + +++ G L + ++R + ++
Sbjct: 78 SLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLM---------FHIQKSRRFDEARAR 127
Query: 199 -----MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL-LHSDSSNRTV 252
+ AL +LH I++RD+ +N+LL+ + +ADFG+ + + + + T
Sbjct: 128 FYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184
Query: 253 VAGTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
GT YIAPE+ Y V D + GV+ E+L G P
Sbjct: 185 C-GTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 51/228 (22%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVA---LKK---LHHSETELAFLESFQTEARLL 141
DF+ +G G +G V ++ + ++ A LKK + + E E R+L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE-----CTMVEKRVL 74
Query: 142 SQI-RHRNIVKL-YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS- 198
+ + + +L F + ++ + +Y+ G L + R +
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLM---------YHIQQVGRFKEPHAV 124
Query: 199 -----MAHALSYLHYDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARL-LHSDSS 248
+A L +L I++RD+ +N++L+S K+ ADFG+ + + +
Sbjct: 125 FYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI----ADFGMCKENIWDGVT 177
Query: 249 NRTVVAGTHGYIAPEL----AYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+T GT YIAPE+ Y V D + FGV+ E+L G+ P
Sbjct: 178 TKTFC-GTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 56/278 (20%), Positives = 97/278 (34%), Gaps = 88/278 (31%)
Query: 89 EDFDIKYCI----GTGGYGSVYRAQ-LPSGKIVALK--KLHHSETELAFLESFQTEARLL 141
+ F+ +Y + G G + +V+ + + K VA+K K TE A E RLL
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-----LDEIRLL 87
Query: 142 SQIR--------HRNIVKLYG-FCL------HKKCMFLIYKYMRRGSLFCVL-RNDDEAI 185
+R +V+L F + H CM +++ + L + +++ + +
Sbjct: 88 KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI-CM--VFEVLGH-HLLKWIIKSNYQGL 143
Query: 186 QLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN------------------ 227
L K+ I++ + L YLH C I+H DI NILL+
Sbjct: 144 PLPCVKK--IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 228 -------------------------------SKLEAFVADFGVARLLHSDSSNRTVVAGT 256
KL+ +AD G A +H T T
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQT 256
Query: 257 HGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGD 294
Y + E+ D++ +A E+ G + +
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 53/179 (29%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALK-----KLHHSE-----TELAFLESFQTEARLLSQIRH 146
IG GG+G +Y A + S + V K+ S+ TEL F + ++ IR
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 147 RN-----IVKLYGFCLHKKCMFLIYKYM-----------------RRGSLFCVLRNDDEA 184
R + K +G LH K Y++M +R S VL+ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ---LS 158
Query: 185 IQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE--AFVADFGVAR 241
++ + L Y+H VH DI ++N+LLN K ++ D+G+A
Sbjct: 159 LR------------ILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 36/178 (20%), Positives = 69/178 (38%), Gaps = 42/178 (23%)
Query: 83 EIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLL 141
++V +F + IG G +G + + L + + VA+K L ++ L E R
Sbjct: 4 VLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHL---EYRFY 58
Query: 142 SQIRH-RNIVKLYGFCLHKKCMFLIYKYM------------RRGSLFCVLRNDDEAIQLD 188
Q+ I ++Y F K ++ + + R SL VL AIQ
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMI---AIQ-- 113
Query: 189 WTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL-----NSKLEAFVADFGVAR 241
+ + Y+H ++++RD+ N L+ ++ + DF +A+
Sbjct: 114 ----------LISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 35/176 (19%), Positives = 65/176 (36%), Gaps = 40/176 (22%)
Query: 83 EIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLL 141
E V F + IG+G +G +Y + + + VA+K E E+++
Sbjct: 2 EPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKIY 56
Query: 142 SQIR-HRNIVKLYGFCLHKKCMFLIYKYM------------RRGSLFCVLRNDDEAIQLD 188
++ I + F + L+ + R+ SL VL
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM--------- 107
Query: 189 WTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEA---FVADFGVAR 241
+ M + + ++H S +HRDI +N L+ A ++ DFG+A+
Sbjct: 108 ------LADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 31/176 (17%), Positives = 65/176 (36%), Gaps = 40/176 (22%)
Query: 83 EIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLL 141
E+ V + + IG+G +G +Y + +G+ VA+K E E+++
Sbjct: 4 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQLHIESKIY 58
Query: 142 SQIRH-RNIVKLYGFCLHKKCMFLIYKYM------------RRGSLFCVLRNDDEAIQLD 188
++ I + ++ + + R+ SL VL
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--------- 109
Query: 189 WTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEA---FVADFGVAR 241
+ M + Y+H + +HRD+ +N L+ + ++ DFG+A+
Sbjct: 110 ------LADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 34/180 (18%), Positives = 62/180 (34%), Gaps = 44/180 (24%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARL 140
+ +V + + IG G +G ++ L + + VA+K E + + E R
Sbjct: 4 QNNVVG-VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF----EPRRSDAPQLRDEYRT 58
Query: 141 LSQIRH-RNIVKLYGFCLHKKCMFLI------------YKYMRRGSLFCVLRNDDEAIQL 187
+ I +Y F L+ R+ S+ V
Sbjct: 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM-------- 110
Query: 188 DWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL------NSKLEAFVADFGVAR 241
K M + +H S+V+RDI +N L+ N+ + +V DFG+ +
Sbjct: 111 -------AAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 37/175 (21%), Positives = 62/175 (35%), Gaps = 48/175 (27%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALK--KLHHSE-----TELAFLESFQ-----TEARLLSQ 143
IG+GG+G +Y A + A K+ + E +EL F + + Q
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 144 IRHRNIVKLYGFCLH----KKCMFLI-----------YKYMRRGSLFCVLRNDDEAIQLD 188
+ + I YG L + F++ VL+ I+
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ---LGIR-- 159
Query: 189 WTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE--AFVADFGVAR 241
M L Y+H + VH DI + N+LL K ++AD+G++
Sbjct: 160 ----------MLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 48/242 (19%), Positives = 87/242 (35%), Gaps = 52/242 (21%)
Query: 84 IIVATEDFDIKY----CIGTGGYGSVYRA--QLPSGKIVALKKLHHSETELAFLESFQTE 137
+ + +Y +G G +G V VALK + + + E+ + E
Sbjct: 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLE 66
Query: 138 ARLLSQIRHR------NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-NDDEAIQLDWT 190
+L +I+ + V + + M + ++ + + + F L+ N+ + L
Sbjct: 67 INVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHV 125
Query: 191 KRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVA--------------- 235
+ + + HAL +LH + + H D+ NIL + +
Sbjct: 126 RH--MAYQLCHALRFLH-EN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 236 ----DFGVARLLHSDSSNRTVVAGTHGYIAPE----LAYTMVVTEKCDVFGFGVVALEVL 287
DFG A H + T+VA H Y PE L + CDV+ G + E
Sbjct: 181 IRVADFGSATFDHEHHT--TIVATRH-YRPPEVILELGWAQ----PCDVWSIGCILFEYY 233
Query: 288 MG 289
G
Sbjct: 234 RG 235
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 30/178 (16%), Positives = 55/178 (30%), Gaps = 51/178 (28%)
Query: 97 IGTGGYGSVYRAQ---------LPSGKIVALKKLHHS---ETELAFLESFQTEARL---- 140
G +Y A P + +LK E F + ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 141 -LSQIRHRNIVKLYGFCLH-KKCMFLI-----------YKYMRRG--SLFCVLRNDDEAI 185
L I GF +H K FL+ + S VL+
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ------ 163
Query: 186 QLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEA--FVADFGVAR 241
+ + AL +LH + VH ++++ NI ++ + ++ +A +G A
Sbjct: 164 ---------VACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 361 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.58 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.58 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.13 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.66 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.54 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.52 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.18 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.05 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.73 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.12 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.9 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.27 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.98 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.87 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.83 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 93.39 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.04 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.82 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-63 Score=448.45 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=214.6
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||+||+|+. .+|+.||||++..........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999975 479999999998766555556889999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
||+||+|.+++..... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999975432 2578999999999999999999999 99999999999999999999999999998764433
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+ .......+.....+...... ..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~~~~~~-----s~ 251 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLKIISGSFPPVSLHY-----SY 251 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCCTTS-----CH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCCCCccC-----CH
Confidence 33345679999999999999999999999999999999999999997543 23344455554443221111 12
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.+.+|+.+||++||++|||++|+|+||||++.
T Consensus 252 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 47889999999999999999999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-63 Score=443.64 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=217.2
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
+.|++.++||+|+||+||+|... +|+.||||++....... .+.+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56999999999999999999764 79999999997544322 3567899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
||++|+|.+++.+. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 152 y~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 152 FLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 99999999999754 589999999999999999999999 99999999999999999999999999999876665
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+.....+........ ..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~~~~~~~~~~---s~ 298 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNLPPRLKNLHKV---SP 298 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSSCCCCSCGGGS---CH
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCCCCCCCccccC---CH
Confidence 556667899999999999999999999999999999999999999975432 222333333322222111111 12
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.+.+|+.+||+.||++|||++|+++||||++.
T Consensus 299 ~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 299 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 47899999999999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-62 Score=430.05 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=205.5
Q ss_pred CCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee----CCeEEEEE
Q 042457 92 DIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH----KKCMFLIY 166 (361)
Q Consensus 92 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 166 (361)
++.++||+|+||+||+|... ++..||+|++..........+.|.+|++++++++|||||++++++.. .+.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999764 68899999997665555556789999999999999999999999875 34689999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEEeCCCCCCeeeCC-CCCeEEeeecCcccc
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNS-KLEAFVADFGVARLL 243 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~ 243 (361)
|||++|+|.+++.+.. .+++..+..++.||+.||+|||++ + |+||||||+|||++. ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999998654 689999999999999999999998 6 999999999999985 789999999999754
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
.. ......+||+.|||||++.+ .++.++|||||||++|||+||+.||..... .......+.....+..... .
T Consensus 183 ~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~~~~~~~~-~-- 254 (290)
T 3fpq_A 183 RA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASFDK-V-- 254 (290)
T ss_dssp CT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGGGG-C--
T ss_pred CC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCCCCCCCCc-c--
Confidence 32 23445679999999998865 699999999999999999999999964332 1122222332222211111 0
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+|+.+||++||++|||++|+++||||++.
T Consensus 255 -~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 255 -AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 11247889999999999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-61 Score=444.75 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=217.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.+.|++.++||+|+||.||+|.. .+|+.||||++....... .+.+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 35699999999999999999976 469999999997654332 356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|||+||+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 999999999999754 489999999999999999999999 9999999999999999999999999999987666
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+.....+........ .
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~~~~~~~~~~---s 374 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNLPPRLKNLHKV---S 374 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCSCTTSS---C
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHcCCCCCCcccccC---C
Confidence 5556667899999999999999999999999999999999999999975432 222333333322211111111 1
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+.+|+.+||+.||++|||+.|+|+||||++.
T Consensus 375 ~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 375 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 247889999999999999999999999999763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=429.24 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=217.8
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||+||+|+. .+|+.||||++..... .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999965 5799999999975432 2223467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|||+||+|.+++.+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999998654 699999999999999999999999 9999999999999999999999999999987543
Q ss_pred CC--CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 247 SS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...+ .......+.......+...+.
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~p~~~s~--- 259 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKIIKLEYDFPEKFFP--- 259 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCTTCCH---
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCcccCH---
Confidence 32 3345679999999999999999999999999999999999999997543 233445555555444433221
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCcccc------ccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRS------FPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~ei------l~hp~~~~ 358 (361)
.+.+|+.+||++||++|||++|+ ++||||+.
T Consensus 260 ---~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 260 ---KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp ---HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ---HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 47889999999999999999995 78999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-62 Score=432.59 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=210.0
Q ss_pred cCCCCcCeeeecCceeEEEEEe----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
++|++.+.||+|+||+||+|+. .+++.||||++............+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999965 247889999997654322223467889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|||||+||+|.+++.+.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998654 699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.........+||+.|||||++.+..++.++||||+||++|||+||+.||...+ .......+.......+...+.
T Consensus 178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~~p~~~s~--- 251 (304)
T 3ubd_A 178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKETMTMILKAKLGMPQFLSP--- 251 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCH---
T ss_pred CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCCCCCCCcCCH---
Confidence 54444555689999999999999999999999999999999999999997543 233445555555544433222
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
.+.+|+.+||++||++|||+ +|+++||||+.
T Consensus 252 ---~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 252 ---EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp ---HHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred ---HHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 37889999999999999995 69999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-61 Score=419.82 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=201.4
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999975 4699999999975432 2233467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+ +|+|.+++.+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689999987654 699999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
. ......||+.|||||++.+..+ +.++||||+||++|||+||+.||...+ .......+.......+...+
T Consensus 166 ~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~~~~~~~p~~~s----- 236 (275)
T 3hyh_A 166 N-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNISNGVYTLPKFLS----- 236 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCTTSC-----
T ss_pred C-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC-----
Confidence 2 3344679999999999988776 579999999999999999999997533 23334444444444333222
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
..+.+|+.+||+.||++|||++|+++||||+..+
T Consensus 237 -~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 237 -PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp -HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred -HHHHHHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence 2478899999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-61 Score=426.63 Aligned_cols=257 Identities=23% Similarity=0.410 Sum_probs=202.7
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
|++..+++.+.++||+|+||+||+|++.+ .||||+++......+..+.|.+|+.++++++|||||+++|+|.. +..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 34556788889999999999999998753 59999998766656667889999999999999999999999865 5689
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+|||||++|+|.++|+.... .++|.++..++.|||.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 108 iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999976543 599999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC--CCcccccccccccccccccc---cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 244 HSDS--SNRTVVAGTHGYIAPELAYT---MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 244 ~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
.... .......||+.|||||++.+ ..++.++|||||||+||||+||+.||..... .......+......+..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---RDQIIFMVGRGYASPDL 259 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHHHHHHTTCCCCCS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcCCCCCCc
Confidence 4322 22344579999999999863 4589999999999999999999999975432 22222222222211111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
..........+.+|+.+||+.||++||||.||+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 111111123588999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-60 Score=422.30 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=207.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
..++++.++||+|+||+||+|.+. +++.||||+++..... ...++|.+|+.++++++|||||+++|+|.+.+.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 345677889999999999999863 4678999999765432 234789999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~ 228 (361)
.++|||||++|+|.++|..... ...++|.++++++.|||.||+|||+. +|+||||||+||||++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 9999999999999999965321 23689999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhH
Q 042457 229 KLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIML 305 (361)
Q Consensus 229 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 305 (361)
++.+||+|||+++....... ......||++|||||++.+..++.++|||||||+||||+| |+.||..... ....
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~ 257 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV 257 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 99999999999987643322 2334568999999999999999999999999999999999 8999876543 2233
Q ss_pred hhhhcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 306 IDLLDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 306 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+..+.. +.+...+ ..+.+|+.+||+.||++||||.||+++
T Consensus 258 ~~i~~~~~~~~p~~~~------~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 258 EMIRNRQVLPCPDDCP------AWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCcccch------HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33333332 2222222 248899999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-60 Score=420.20 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=206.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
.++|.+.+.||+|+||+||+|++. ++..||||+++.... ...++|.+|+++|++++|||||+++|+|.+.+.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--NARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 467888899999999999999764 477899999976543 335789999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCC----------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC
Q 042457 162 MFLIYKYMRRGSLFCVLRNDD----------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE 231 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~ 231 (361)
.++|||||++|+|.++|+..+ ....++|.+++.++.|||.||+|||++ +|+||||||+|||+++++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999997642 234699999999999999999999999 9999999999999999999
Q ss_pred eEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhh
Q 042457 232 AFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDL 308 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 308 (361)
+||+|||+++........ .....||++|||||++.+..++.++|||||||++|||+| |+.||..... ......+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~i 243 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECI 243 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 999999999876443322 223458999999999999999999999999999999999 9999876543 2333344
Q ss_pred hcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 309 LDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 309 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
..+.. +.+...+ ..+.+|+.+||+.||++|||++||+
T Consensus 244 ~~~~~~~~p~~~~------~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 244 TQGRVLQRPRTCP------QEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HcCCCCCCCccch------HHHHHHHHHHcCCChhHCcCHHHHH
Confidence 44332 2222222 2488999999999999999999984
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=421.18 Aligned_cols=251 Identities=22% Similarity=0.275 Sum_probs=205.9
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
+.|.+.++||+|+||.||+|+. .+|+.||||+++.... ..+|+.+++.++|||||++++++.+++..|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4577888999999999999976 4699999999976433 2369999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-CeEEeeecCccccCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLLHSD 246 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~~~ 246 (361)
||+||+|.++++..+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.+...
T Consensus 131 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999998654 699999999999999999999999 999999999999999987 6999999999877543
Q ss_pred CCC-----cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 247 SSN-----RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 247 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
... ....+||+.|||||++.+..++.++|||||||++|||+||+.||....... ....+.....+......
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~- 280 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIASEPPPIREIPP- 280 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHHHSCCGGGGSCT-
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHcCCCCchhcCc-
Confidence 221 223569999999999999999999999999999999999999997654322 23333333322110000
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCcccc-------------ccCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRS-------------FPNPEINP 358 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei-------------l~hp~~~~ 358 (361)
.....+.+++.+||++||.+|||+.|+ ++|||+++
T Consensus 281 --~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 281 --SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred --cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 011247889999999999999999997 78999976
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=422.65 Aligned_cols=252 Identities=26% Similarity=0.442 Sum_probs=202.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
.++|.+.++||+|+||+||+|++. +++.||||+++.... ...++|.+|+++|++++|||||+++|+|.+.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 456777889999999999999864 478899999976543 335789999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCc------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDE------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~ 229 (361)
.++|||||++|+|.++++.... ..+++|.+++.++.|||.||+|||+. +|+||||||+|||++++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999976432 23699999999999999999999999 99999999999999999
Q ss_pred CCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHh
Q 042457 230 LEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLI 306 (361)
Q Consensus 230 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 306 (361)
+.+||+|||+++....... ......||+.|||||++.+..++.++|||||||+||||+| |+.||..... .....
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~ 271 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAID 271 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence 9999999999987644332 2234568999999999999999999999999999999999 9999876543 22233
Q ss_pred hhhccc-CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 307 DLLDQR-APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 307 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+.... .+.+...+ ..+.+|+.+||+.||++||||+||+++
T Consensus 272 ~i~~g~~~~~p~~~~------~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CITQGRELERPRACP------PEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHTCCCCCCTTCC------HHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCCCCccccc------HHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 333332 22232222 248899999999999999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=410.78 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=198.8
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-------
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------- 160 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 160 (361)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ...+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4588999999999999999975 47899999999765543 23567899999999999999999999987654
Q ss_pred -----eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEe
Q 042457 161 -----CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVA 235 (361)
Q Consensus 161 -----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~ 235 (361)
..|+|||||++|+|.+++.........++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3699999999999999998766544567788899999999999999999 99999999999999999999999
Q ss_pred eecCccccCCCCCC------------cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcch
Q 042457 236 DFGVARLLHSDSSN------------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI 303 (361)
Q Consensus 236 Dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 303 (361)
|||+++........ ....+||+.|||||++.+..++.++|||||||++|||++ ||..... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHH
Confidence 99999876543221 123469999999999999999999999999999999996 7653211 111
Q ss_pred hHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 304 MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+.....+ ....+......+|+.+||++||++|||+.|+++||||++
T Consensus 236 ~~~~~~~~~~p-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 236 TLTDVRNLKFP-----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHHTTCCC-----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHHhcCCCC-----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 12222222221 111222234678999999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-58 Score=415.72 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=214.4
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEEeCC------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC-Ccceee
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPS------GKIVALKKLHHSETELAFLESFQTEARLLSQIRH-RNIVKL 152 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~ 152 (361)
...+|++..++|++.+.||+|+||+||+|.+.. ++.||||.+....... ..+.|.+|+++|++++| ||||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-HHHHHHHHHHHHHHcCCCCcEEEE
Confidence 456788889999999999999999999997532 3579999998665443 35789999999999965 899999
Q ss_pred eEEEeeC-CeEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeC
Q 042457 153 YGFCLHK-KCMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRD 218 (361)
Q Consensus 153 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~d 218 (361)
+|+|... +..++|||||++|+|.++|+.... ...+++.+++.++.|||.||+|||++ +|+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999775 568999999999999999975422 23589999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCC
Q 042457 219 ISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDL 295 (361)
Q Consensus 219 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~ 295 (361)
|||+|||+++++.+||+|||+++........ .....||+.|||||++.+..++.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 234568999999999999999999999999999999998 9999875
Q ss_pred cccCCcchhHhhhhcc-cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 296 LSSFNPKIMLIDLLDQ-RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 296 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.... ......+..+ +++.+...+ ..+.+++.+||+.||++|||+.||++|
T Consensus 291 ~~~~--~~~~~~i~~g~~~~~p~~~~------~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 291 VKID--EEFCRRLKEGTRMRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCCS--HHHHHHHHHTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHH--HHHHHHHHcCCCCCCCccCC------HHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4321 1222222222 222222222 247889999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-57 Score=403.13 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=197.1
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC----eEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK----CMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l 164 (361)
++|.+.+.||+|+||+||+|++ +|+.||||++....... ..+..|+..+.+++|||||+++|+|.+.+ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~---~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh---HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4577888999999999999998 78999999997543221 22335666667889999999999998754 5799
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC-----IPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
|||||++|+|.++++.. .++|..+.+++.|++.||+|||++. .++|+||||||+|||++.++.+||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999999765 4899999999999999999999762 45899999999999999999999999999
Q ss_pred ccccCCCCCC----ccccccccccccccccccc------ccCccchhhhHHHHHHHHHhCCCCCCCcccCC---------
Q 042457 240 ARLLHSDSSN----RTVVAGTHGYIAPELAYTM------VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN--------- 300 (361)
Q Consensus 240 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--------- 300 (361)
++........ .....||+.|||||++.+. .++.++|||||||+||||+||+.||.......
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9876543322 2235699999999998654 46789999999999999999988765332211
Q ss_pred -c--chhHhhhhcccCCCCCCC-hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 301 -P--KIMLIDLLDQRAPSPIDD-QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 301 -~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
. ......+........... ....+....+.+|+.+||+.||++||||.||++.
T Consensus 235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1 111222233333222221 1222344568899999999999999999998763
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=413.01 Aligned_cols=260 Identities=22% Similarity=0.341 Sum_probs=207.9
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------Ce
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------KC 161 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 161 (361)
++|++.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|+.++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999965 5799999999987655555567888999999999999999999998643 57
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
+|+|||||+ |+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 899999995 68999997655 699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC----CCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc------
Q 042457 242 LLHSDS----SNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD------ 310 (361)
Q Consensus 242 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~------ 310 (361)
.+.... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..+..........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 764322 223456799999999998775 568999999999999999999999975443211111111100
Q ss_pred --------------ccCCCCCCChhhHHH-----HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 311 --------------QRAPSPIDDQTVIQD-----IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 311 --------------~~~~~~~~~~~~~~~-----~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....... ..+.. ...+.+|+.+||+.||++|||++|+|+||||++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQP---VPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp TC-----CHHHHHHSSCCCCC---CCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred hhhhhhhhhhhhhhcCCCcCC---CCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 0000000 00110 124788999999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-55 Score=399.08 Aligned_cols=259 Identities=24% Similarity=0.284 Sum_probs=202.1
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCC
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKK 160 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 160 (361)
...++|++.+.||+|+||+||+|+.+ +++.||+|.+...... ..+.+|+++++.+ +||||+++++++.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~----~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP----IRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH----HHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH----HHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 45678999999999999999999642 4678999998765432 4577899999988 6999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeeecC
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGV 239 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~ 239 (361)
..|+||||+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999999984 489999999999999999999999 99999999999999877 7999999999
Q ss_pred ccccCCCCC----------------------------Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCC
Q 042457 240 ARLLHSDSS----------------------------NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGR 290 (361)
Q Consensus 240 ~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~ 290 (361)
|+....... .....+||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 976543211 11234699999999998775 5899999999999999999999
Q ss_pred CCCCCcccCCcchhHhhhhc-------------------------------------c-cCCCCCCCh----------hh
Q 042457 291 HPGDLLSSFNPKIMLIDLLD-------------------------------------Q-RAPSPIDDQ----------TV 322 (361)
Q Consensus 291 ~p~~~~~~~~~~~~~~~~~~-------------------------------------~-~~~~~~~~~----------~~ 322 (361)
.||....+. ...+..+.. . ....+.... ..
T Consensus 245 ~Pf~~~~~~--~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 245 YPFYKASDD--LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp SSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCH--HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 998533221 000000000 0 000000000 00
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
......+.+|+.+||+.||++|||++|+|+||||++-
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0001247789999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=415.96 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=211.7
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc----hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET----ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
++|++.+.||+|+||.||+|+. .+|+.||||++..... ..........++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 5799999999999999999966 4699999999964321 1111223334567788889999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+|||||+||+|.++|...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+..
T Consensus 269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999998654 699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
.... ....+||+.|||||++.+ ..|+.++|+||+||++|||++|+.||......+.......+.......+...+.
T Consensus 343 ~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~- 419 (689)
T 3v5w_A 343 SKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP- 419 (689)
T ss_dssp SSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH-
T ss_pred CCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH-
Confidence 5432 334579999999999864 579999999999999999999999998655433333334444444443333222
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
.+.+|+.+||+.||.+|++ ++||++||||+.
T Consensus 420 -----~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 420 -----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp -----HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred -----HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 3788999999999999998 699999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-54 Score=415.12 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=214.9
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||.||+|.. .+|+.||+|.+....... .+.+.+|+.+|+.++||||+++++++.+.+.+++|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~--~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5799999999999999999965 479999999997654332 4678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC--CCeEEeeecCccccCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK--LEAFVADFGVARLLHS 245 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~~~~~~ 245 (361)
||+||+|.+++..... .+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 235 ~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 235 FMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred ecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999865432 589999999999999999999999 99999999999999854 8999999999988754
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
. ......+||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+.......+...... .
T Consensus 310 ~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~--~ 383 (573)
T 3uto_A 310 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCDWNMDDSAFSG--I 383 (573)
T ss_dssp T-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTCCCCCSGGGTT--S
T ss_pred C-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHhCCCCCCcccccC--C
Confidence 3 233445799999999999999999999999999999999999999975432 233344444333222111111 1
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+.+|+.+||+.||.+|||+.|+|+||||++
T Consensus 384 s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 124788999999999999999999999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=372.34 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=214.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++....... .+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46799999999999999999975 578999999987554332 366889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 97 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999999764 489999999999999999999999 9999999999999999999999999999877655
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.....+....... ..
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~---~~ 243 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIATNGTPELQNPEK---LS 243 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHHCSCCCSCGGG---SC
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCCCccc---cC
Confidence 55555667999999999999999999999999999999999999998754321 1122222221111111111 11
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||++|||+.|+++||||+.
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 24788999999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=375.69 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=217.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999976 58999999999776555555678889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999997654 589999999999999999999999 9999999999999999999999999999866443
Q ss_pred CCCcccccccccccccccccccccC-ccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVT-EKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
. ......||+.|+|||++.+..++ .++||||+||++|||++|+.||..... ......+.......+...+.
T Consensus 168 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~p~~~s~---- 239 (328)
T 3fe3_A 168 G-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---KELRERVLRGKYRIPFYMST---- 239 (328)
T ss_dssp C-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCTTSCH----
T ss_pred C-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCCCH----
Confidence 2 33445799999999999887765 799999999999999999999875432 33334444444443333222
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+.+++.+||+.||.+|||++|+++||||+.
T Consensus 240 --~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 240 --DCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp --HHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred --HHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 3778999999999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=371.63 Aligned_cols=266 Identities=23% Similarity=0.329 Sum_probs=210.9
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..++|++.+.||+|+||.||+|...+|+.||+|++............+.+|+.++++++||||+++++++...+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 34679999999999999999999888999999999766544444577889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++ +|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99975 78777765432 589999999999999999999999 9999999999999999999999999999877554
Q ss_pred CCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC-------
Q 042457 247 SSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID------- 318 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 318 (361)
........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.............+....
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 444455578999999998876 568999999999999999999999997655433222222222211111000
Q ss_pred ---------ChhhHH-----HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 319 ---------DQTVIQ-----DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ---------~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...... ....+.+|+.+||+.||++|||++|+++||||++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 000000 1124789999999999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=370.79 Aligned_cols=268 Identities=24% Similarity=0.372 Sum_probs=221.4
Q ss_pred CCcCHHHHHHHhcC----------CCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC
Q 042457 77 GRITFEEIIVATED----------FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIR 145 (361)
Q Consensus 77 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~ 145 (361)
..++++++..+++. |+..+.||+|+||.||+|... +|+.||||++....... .+.+.+|+.+++.++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQ 100 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHTTCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHHhCC
Confidence 45788888877764 666778999999999999875 79999999987554332 367889999999999
Q ss_pred CCcceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCee
Q 042457 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNIL 225 (361)
Q Consensus 146 h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nil 225 (361)
||||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+|||
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 999999999999999999999999999999998754 589999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH
Q 042457 226 LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML 305 (361)
Q Consensus 226 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 305 (361)
++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~ 250 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAM 250 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH
T ss_pred ECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence 9999999999999998776544444556799999999999999999999999999999999999999875432 2222
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+.....+...... .....+.+++.+||+.||++|||+.|+++||||++.
T Consensus 251 ~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 251 KRLRDSPPPKLKNSH---KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHSSCCCCTTGG---GSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHhcCCCCCcCccc---cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 222222222111111 111247889999999999999999999999999763
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=369.59 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=215.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|++.+.||+|+||.||+++.. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367899999999999999999764 689999999975421 122246788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999997654 589999999999999999999999 999999999999999999999999999986544
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.........||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+...+
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s----- 229 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIRFPRTLS----- 229 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSC-----
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC-----
Confidence 4444555679999999999999999999999999999999999999987533 22233334443333332222
Q ss_pred HHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||++|| +++|+++||||+.
T Consensus 230 -~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 230 -PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp -HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred -HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 2478899999999999999 9999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=366.93 Aligned_cols=259 Identities=25% Similarity=0.326 Sum_probs=209.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||+|+||.||+|... +++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 367999999999999999999765 78999999986544322 2366889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999997654 589999999999999999999999 9999999999999999999999999999865432
Q ss_pred C--CCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 247 S--SNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 247 ~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
. .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...........+...
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~---- 232 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYLNPWK---- 232 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHHHTTCTTSTTGG----
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHHhcccccCCccc----
Confidence 2 12234568999999999887665 77999999999999999999999755432221 112222211111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.....+.+|+.+||+.||++|||+.|+++||||++.
T Consensus 233 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 111247789999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=365.78 Aligned_cols=265 Identities=23% Similarity=0.316 Sum_probs=206.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
++|.+.+.||+|+||.||+|...+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888999999999999999888899999999976554433346788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+++ +|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 89888876432 589999999999999999999999 999999999999999999999999999987654433
Q ss_pred Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC--------------
Q 042457 249 NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA-------------- 313 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 313 (361)
......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.............
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 3444568999999999875 4589999999999999999999999975443211111111111000
Q ss_pred ---C--CCCCC-hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 314 ---P--SPIDD-QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 314 ---~--~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
. .+... .........+.+++.+||+.||++|||+.|+++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 00000 0000011247899999999999999999999999999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=372.91 Aligned_cols=258 Identities=22% Similarity=0.364 Sum_probs=212.0
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
...++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+..|..+++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44578999999999999999999764 689999999975422 222346678899999988 799999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999997654 589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
............||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+.......+.....
T Consensus 174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~~- 249 (353)
T 3txo_A 174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVVYPTWLHE- 249 (353)
T ss_dssp SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSCH-
T ss_pred cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCH-
Confidence 5444444555679999999999999999999999999999999999999987543 233444555554444332221
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCc------cccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTM------RRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~------~eil~hp~~~~ 358 (361)
.+.+++.+||+.||.+||++ +|+++||||++
T Consensus 250 -----~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 250 -----DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp -----HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred -----HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 37889999999999999999 89999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=380.08 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=217.6
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
...++|++.+.||+|+||.||++.. .+|+.+|+|++..........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467799999999999999999965 578999999998776655556789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC---CCCCeEEeeecCcc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN---SKLEAFVADFGVAR 241 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~ 241 (361)
||||+++|+|.+.+.... .+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999987654 589999999999999999999999 999999999999998 46789999999998
Q ss_pred ccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
.............||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.......+.....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 238 (444)
T 3soa_A 162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQQIKAGAYDFPSPEWD 238 (444)
T ss_dssp CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCCCCCTTTTT
T ss_pred EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhCCCCCCccccc
Confidence 776555444556799999999999998999999999999999999999999865432 22333344333322221110
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. ....+.+++.+||+.||++|||+.|+|+||||++
T Consensus 239 ~--~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 239 T--VTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp T--SCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred c--CCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 0 1124789999999999999999999999999953
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=361.84 Aligned_cols=263 Identities=21% Similarity=0.286 Sum_probs=207.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||+||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46889999999999999999764 68999999998665554455778899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++ ++.+.+..... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9976 55555443222 589999999999999999999999 99999999999999999999999999998776554
Q ss_pred CCcccccccccccccccccccc-cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc---cCC---------
Q 042457 248 SNRTVVAGTHGYIAPELAYTMV-VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ---RAP--------- 314 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~--------- 314 (361)
.......||+.|+|||++.+.. ++.++||||||+++|||++|..|+..... .......+... ...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhccc
Confidence 4555567899999999987765 79999999999999999998888532221 11111111110 000
Q ss_pred -----CCC------CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 315 -----SPI------DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 315 -----~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.+. ...........+.+|+.+||+.||++|||++|+++||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 000 000000111247899999999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=369.27 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=213.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchH----HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL----AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|.+.+.||+|+||.||++... +|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 567999999999999999999764 68999999987654321 1246788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC----CeEEeeec
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL----EAFVADFG 238 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 238 (361)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||+++++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999997654 689999999999999999999999 999999999999998877 79999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+.......+.
T Consensus 165 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~~- 239 (361)
T 2yab_A 165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITAVSYDFDE- 239 (361)
T ss_dssp SCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTCCCCCH-
T ss_pred CceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCc-
Confidence 998765432 23345699999999999998999999999999999999999999875432 2223333333322111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.........+.+|+.+||+.||.+|||+.|+++||||+.
T Consensus 240 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 240 -EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp -HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred -hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 000111234789999999999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=373.54 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=214.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 163 (361)
..++|++.+.||+|+||.||+++.. +++.||+|+++.... .....+.+..|..++.++ +||||+++++++...+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3467999999999999999999765 578899999975432 222235677899998876 8999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999997654 689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC------CcchhHhhhhcccCCCCC
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF------NPKIMLIDLLDQRAPSPI 317 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~ 317 (361)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.......+.
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 44444455667999999999999999999999999999999999999999643321 111223334444444333
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCc------cccccCCCCCC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTM------RRSFPNPEINP 358 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~hp~~~~ 358 (361)
..+. .+.+|+.+||+.||.+||++ .|+++||||+.
T Consensus 284 ~~s~------~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 284 SLSV------KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp TSCH------HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred cCCH------HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 3221 37889999999999999996 69999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=367.14 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=214.6
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCe
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 161 (361)
....++|.+.+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 455678999999999999999999775 688999999975421 112245677889998876 89999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999997644 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
.............||+.|+|||++.+..++.++|+||||+++|||++|+.||..... ......+.......+...+
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s- 242 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRMDNPFYPRWLE- 242 (345)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCTTSC-
T ss_pred hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHhCCCCCCcccC-
Confidence 654444444556799999999999999999999999999999999999999875432 2233334333333332221
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCcc-ccccCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMR-RSFPNPEINP 358 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~hp~~~~ 358 (361)
..+.+++.+||+.||++||++. ++++||||+.
T Consensus 243 -----~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 243 -----KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp -----HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred -----HHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 2478899999999999999998 9999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=360.44 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=204.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch------------------------HHHHHHHHHHHHHHh
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE------------------------LAFLESFQTEARLLS 142 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~e~~~l~ 142 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999975 46889999998754321 112356889999999
Q ss_pred cCCCCcceeeeEEEee--CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCC
Q 042457 143 QIRHRNIVKLYGFCLH--KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDIS 220 (361)
Q Consensus 143 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk 220 (361)
+++||||+++++++.. .+..++||||+++++|.+++... .+++..+..++.|++.||+|||+. +++|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999987 56799999999999998876543 589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCCeEEeeecCccccCCCCCCcccccccccccccccccccc---cCccchhhhHHHHHHHHHhCCCCCCCcc
Q 042457 221 SNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMV---VTEKCDVFGFGVVALEVLMGRHPGDLLS 297 (361)
Q Consensus 221 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~ 297 (361)
|+|||++.++.+||+|||++..............||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999987655444344557999999999987654 4778999999999999999999987543
Q ss_pred cCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 298 SFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. ......+.......+..... ...+.+++.+||+.||++|||+.|+++||||++
T Consensus 245 ~---~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 245 I---MCLHSKIKSQALEFPDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp H---HHHHHHHHHCCCCCCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred H---HHHHHHHhcccCCCCCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 2 11222222222222211111 124789999999999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=364.43 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=214.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
.++|++.+.||+|+||.||+++.. +|+.||+|++..... .....+.+..|..+++++ +||||+++++++...+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 356889999999999999999765 588999999976532 233456788999999987 89999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999997644 589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC------CcchhHhhhhcccCCCCCC
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF------NPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~ 318 (361)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+.......+..
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 4444445567999999999999999999999999999999999999999753221 1112223333443333322
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCc------cccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTM------RRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~hp~~~~ 358 (361)
.+ ..+.+++.+||+.||.+||++ .|+++||||+.
T Consensus 242 ~s------~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LS------VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SC------HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CC------HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 22 247889999999999999996 79999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=368.59 Aligned_cols=261 Identities=22% Similarity=0.336 Sum_probs=216.1
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
...++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567999999999999999999764 68999999998765555556789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC---CCeEEeeecCcc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK---LEAFVADFGVAR 241 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~~ 241 (361)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999987654 589999999999999999999999 99999999999999765 459999999998
Q ss_pred ccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.......+.....
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 255 (362)
T 2bdw_A 180 EVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAYDYPSPEWD 255 (362)
T ss_dssp CCTTCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCCTTGGG
T ss_pred EecCCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCCccccc
Confidence 765332 23345699999999999998999999999999999999999999875432 22333333333332222111
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+++.+||+.||++|||+.|+++||||+.
T Consensus 256 --~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 256 --TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp --GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred --CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 11224789999999999999999999999999964
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=360.52 Aligned_cols=265 Identities=26% Similarity=0.353 Sum_probs=208.2
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999775 58999999997776665556788899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999887654 589999999999999999999999 99999999999999999999999999998776544
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc---------------
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ--------------- 311 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------------- 311 (361)
.......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+...........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 44455578999999998876 66899999999999999999999999765432211111111110
Q ss_pred ---cCCCCCCChhh----HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 312 ---RAPSPIDDQTV----IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 312 ---~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+.+...... ......+.+++.+||+.||.+|||++|+++||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 11111100000 0112247889999999999999999999999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=365.03 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=213.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||++... +|+.||+|.+...... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc---HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 467899999999999999999764 6889999998755432 366889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC--CCCeEEeeecCccccC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS--KLEAFVADFGVARLLH 244 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~ 244 (361)
||+++++|.+++..... .+++..+..++.|++.||.|||+. +++||||||+|||++. ++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 81 EFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EeCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999999976432 589999999999999999999999 9999999999999987 7899999999998764
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.......+.. ....
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~--~~~~ 229 (321)
T 1tki_A 156 PGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEYTFDEE--AFKE 229 (321)
T ss_dssp TTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCCCHH--HHTT
T ss_pred CCC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHcCCCCCChh--hhcc
Confidence 332 23445689999999999988899999999999999999999999875432 22333333333322110 0001
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+++.+||+.||.+|||+.|+++||||++.
T Consensus 230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 12358899999999999999999999999999763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=362.98 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=204.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe----CCCCEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL----PSGKIVALKKLHHSET--ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
..++|++.+.||+|+||.||+++. .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 356799999999999999999976 4789999999976532 1223456788999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999997644 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
+.............||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+...+
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~p~~~~ 245 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTIDKILKCKLNLPPYLT 245 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCCCCCTTSC
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCCCCCC
Confidence 7654443334455789999999999998999999999999999999999999875432 2233344444333332221
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+|| ++.|+++||||+.
T Consensus 246 ------~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 246 ------QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp ------HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred ------HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 2478899999999999999 7889999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=362.55 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=207.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------ 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 160 (361)
.++|++.+.||+|+||.||+|+.. +|+.||||++...... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT-THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 356889999999999999999875 7999999999755432 23477899999999999999999999986643
Q ss_pred ---------------------------------------------------eEEEEEEeccCCChhhhhccCCccCCCCH
Q 042457 161 ---------------------------------------------------CMFLIYKYMRRGSLFCVLRNDDEAIQLDW 189 (361)
Q Consensus 161 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~ 189 (361)
..++||||+++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 37999999999999999988766556788
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC------------Ccccccccc
Q 042457 190 TKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS------------NRTVVAGTH 257 (361)
Q Consensus 190 ~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~gt~ 257 (361)
..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++....... ......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999987754421 123346899
Q ss_pred cccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhc
Q 042457 258 GYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACL 337 (361)
Q Consensus 258 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 337 (361)
.|+|||.+.+..++.++||||||+++|||++|..|+.... ...........+ .........+.+++.+||
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITDVRNLKFP-----LLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHHHHTTCCC-----HHHHHHCHHHHHHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHHhhccCCC-----cccccCChhHHHHHHHHc
Confidence 9999999999999999999999999999999987743111 111111111111 112222335788999999
Q ss_pred CCCCCCCCCccccccCCCCCC
Q 042457 338 RSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 338 ~~dP~~RPs~~eil~hp~~~~ 358 (361)
+.||++|||+.|+++||||++
T Consensus 311 ~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 311 SPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp CSSGGGSCCHHHHHHSTTCCC
T ss_pred cCCCCcCCCHHHHhhchhhhc
Confidence 999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=367.88 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=215.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
-++|.+.+.||+|+||.||++... +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999764 588999999865431 222346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+.+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999998654 589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCcccccccccccccccccc---cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 246 DSSNRTVVAGTHGYIAPELAYT---MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............+.......+...+
T Consensus 168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s-- 244 (384)
T 4fr4_A 168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS-- 244 (384)
T ss_dssp T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC--
T ss_pred C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC--
Confidence 3 23344579999999999863 45899999999999999999999999765544433333333333333332222
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCC-ccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPT-MRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs-~~eil~hp~~~~ 358 (361)
..+.+|+.+||+.||.+||+ ++++++||||+.
T Consensus 245 ----~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 245 ----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp ----HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred ----HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 24788999999999999998 899999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=358.96 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=213.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|++.+.||+|+||.||+++.. +|+.||+|++..... .....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999764 689999999875422 112346778999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998654 589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
. .....||+.|+|||++.+..++.++|+||||+++|||++|+.||..... ......+.......+...+
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~p~~~~----- 227 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYEKILNAELRFPPFFN----- 227 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHCCCCCCTTSC-----
T ss_pred c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCCC-----
Confidence 2 2345689999999999999999999999999999999999999875332 2333444444433332222
Q ss_pred HHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+|| +++|+++||||++
T Consensus 228 -~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 228 -EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp -HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred -HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 1478899999999999999 9999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=362.72 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=212.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchH----HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL----AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|.+.+.||+|+||.||++... +|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456889999999999999999764 68999999987654321 1246788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC----CeEEeeec
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL----EAFVADFG 238 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 238 (361)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997654 689999999999999999999999 999999999999998887 79999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.......+
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~-- 237 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAVNYEFE-- 237 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHTCCCCC--
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHHhcCCCcC--
Confidence 998764332 22335689999999999988999999999999999999999999865332 122222222222111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..........+.+++.+||+.||++|||+.|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 00001112347899999999999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=361.94 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=187.0
Q ss_pred CeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 95 YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
+.||+|+||.||+|... +|+.||||++.... ...+.+|+.+++.+. ||||+++++++.+....++||||+++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 67999999999999764 68999999986432 356778999999997 999999999999999999999999999
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC---CeEEeeecCccccCCCCCC
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL---EAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~~~~ 249 (361)
+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++ .+||+|||++.........
T Consensus 92 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 92 ELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp BHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999998754 689999999999999999999999 999999999999997665 7999999999876555444
Q ss_pred cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC----cchhHhhhhcccCCCCCCChhhHHH
Q 042457 250 RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN----PKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......+.......+ .......
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 243 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE--GEAWKNV 243 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC--SHHHHTS
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC--cccccCC
Confidence 455678999999999999999999999999999999999999997644321 1122223333322211 1111112
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...+.+|+.+||+.||.+|||+.|+++||||++.
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 2358899999999999999999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=364.60 Aligned_cols=254 Identities=23% Similarity=0.330 Sum_probs=207.4
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5789999999999999999975 57899999998643221 112356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+ +|+|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 788988886544 589999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
. ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ...+.......+...+
T Consensus 162 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i~~~~~~~p~~~s----- 232 (336)
T 3h4j_B 162 N-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---FKKVNSCVYVMPDFLS----- 232 (336)
T ss_dssp B-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---BCCCCSSCCCCCTTSC-----
T ss_pred c-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---HHHHHcCCCCCcccCC-----
Confidence 2 2334569999999999988776 6899999999999999999999975432211 1111111111221111
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+.+++.+||+.||.+|||++|+++||||+..
T Consensus 233 -~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 233 -PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -HHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -HHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 247889999999999999999999999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=358.45 Aligned_cols=255 Identities=21% Similarity=0.227 Sum_probs=201.8
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
..++|++.+.||+|+||+||+|... +|+.||||++............+..|+..+.++ +|+||++++++|.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999775 799999999876554443345555666666555 89999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+ +++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 6788888865432 589999999999999999999999 99999999999999999999999999987664
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ...+.....+. .....
T Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------~~~~~~~~~~~----~~~~~ 276 (311)
T 3p1a_A 209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------WQQLRQGYLPP----EFTAG 276 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------HHHHTTTCCCH----HHHTT
T ss_pred cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHhccCCCc----ccccC
Confidence 332 2334468999999998876 789999999999999999999776543221 11122211110 00111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+++.+||+.||++|||+.|+++||||+++
T Consensus 277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311 (311)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHhCccccCC
Confidence 12358899999999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=369.09 Aligned_cols=263 Identities=20% Similarity=0.274 Sum_probs=212.2
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE---LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
..++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346799999999999999999965 46899999998643211 11246788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC---eEEeeec
Q 042457 163 FLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE---AFVADFG 238 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg 238 (361)
++||||+++++|.+.+.... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988876432 223589999999999999999999999 9999999999999976654 9999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
++..............||+.|+|||++.+..++.++||||||+++|||++|+.||.... ......+..........
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHTCCCCCHH
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcCCCCCCcc
Confidence 99877654444445579999999999999899999999999999999999999987532 22223333332221110
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........+.+++.+||+.||++|||+.|+++||||++
T Consensus 255 --~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 255 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp --HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred --ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 00011235889999999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=363.60 Aligned_cols=258 Identities=20% Similarity=0.303 Sum_probs=215.5
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
...++|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+..|..++..+ +||||+++++++...+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999775 478999999875432 112246678999999988 799999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999997644 589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
............||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+...+
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s-- 245 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVAYPKSMS-- 245 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTSC--
T ss_pred cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHHHhCCCCCCCCCC--
Confidence 5444444455679999999999999999999999999999999999999987533 23334444544444333222
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+||+ ++++++||||+.
T Consensus 246 ----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 246 ----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp ----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred ----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 24788999999999999995 599999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=360.78 Aligned_cols=261 Identities=29% Similarity=0.458 Sum_probs=205.7
Q ss_pred cCHHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
....++.+..++|++.+.||+|+||.||+|+. +|+.||||++..........+.+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 34455566778899999999999999999988 78899999998776555556789999999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEEeCCCCCCeeeCCCCCeEEee
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVAD 236 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~~~~~~kl~D 236 (361)
.+..++||||+++|+|.+++........+++..++.++.|++.||+|||+. + ++||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECC
Confidence 999999999999999999998765444589999999999999999999999 8 99999999999999999999999
Q ss_pred ecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh--cccCC
Q 042457 237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL--DQRAP 314 (361)
Q Consensus 237 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~ 314 (361)
||+++.............||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .....
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCKRLE 259 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCCCCC
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCC
Confidence 99997654444344456789999999999999999999999999999999999999875432 12222221 11122
Q ss_pred CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 315 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.+...+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~------~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 260 IPRNLN------PQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp CCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccCC------HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222211 24788999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=349.97 Aligned_cols=257 Identities=25% Similarity=0.433 Sum_probs=189.2
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688999999999999999976 57899999998654321 122467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999986532 589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ............+... .
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~------~ 236 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADYEMPSFL------S 236 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCCCCCTTS------C
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhcccCCcccc------C
Confidence 333344568999999999998889999999999999999999999987543211 1111111111111111 1
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+.+++.+||+.||++|||+.++++||||++.
T Consensus 237 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 247889999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=366.23 Aligned_cols=265 Identities=17% Similarity=0.259 Sum_probs=211.9
Q ss_pred HhcCCCCcCeeeec--CceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 87 ATEDFDIKYCIGTG--GYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 87 ~~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
..++|++.+.||+| +||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 99999999775 6999999999876655555678889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++|+|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999765322 589999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCC-------CCcccccccccccccccccc--cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC
Q 042457 244 HSDS-------SNRTVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP 314 (361)
Q Consensus 244 ~~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 314 (361)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ .........+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~ 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVP 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH---HHHC------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHhcCCCC
Confidence 3221 11223468899999999887 6789999999999999999999999976443221 1111111100
Q ss_pred CCC----------------------------------------CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCC
Q 042457 315 SPI----------------------------------------DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 315 ~~~----------------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp 354 (361)
... ...........+.+|+.+||+.||++|||+.|+++||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 000 0000001123488899999999999999999999999
Q ss_pred CCCC
Q 042457 355 EINP 358 (361)
Q Consensus 355 ~~~~ 358 (361)
||++
T Consensus 336 ~f~~ 339 (389)
T 3gni_B 336 FFKQ 339 (389)
T ss_dssp GGGG
T ss_pred HHHH
Confidence 9975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=361.23 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=214.0
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+++.. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999764 689999999865432 1223467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999998654 589999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+...+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~~------ 262 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVSGKVRFPSHFS------ 262 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTCC------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC------
Confidence 234568999999999999999999999999999999999999987543 23334444444443332222
Q ss_pred HHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+||+ ++|+++||||+.
T Consensus 263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 24788999999999999999 999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=360.45 Aligned_cols=266 Identities=20% Similarity=0.318 Sum_probs=195.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||+|+||.||+|... +|+.||+|++...... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 467999999999999999999764 6899999998755422 12356789999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCC---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 167 KYMRRGSLFCVLRNDD---EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
||++ ++|.+++.... ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 59988886432 123589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC---------
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA--------- 313 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 313 (361)
...........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.............+......
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 544444445568999999999876 4689999999999999999999999975443111111111110000
Q ss_pred --------C--CCCCChhhH------HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 314 --------P--SPIDDQTVI------QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 314 --------~--~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. .+....... .....+.+++.+||+.||++|||+.|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 0 000000000 01124889999999999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=366.43 Aligned_cols=258 Identities=22% Similarity=0.283 Sum_probs=201.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||++... +|+.||+|++....... +.+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 567999999999999999999765 78999999997654332 56779999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC--eEEeeecCccccC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE--AFVADFGVARLLH 244 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~~~ 244 (361)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++. +||+|||+++...
T Consensus 96 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 96 EYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999987644 589999999999999999999999 9999999999999987765 9999999987543
Q ss_pred CCCCCcccccccccccccccccccccCcc-chhhhHHHHHHHHHhCCCCCCCcccCCcc-hhHhhhhcccCCCCCCChhh
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEK-CDVFGFGVVALEVLMGRHPGDLLSSFNPK-IMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 322 (361)
.. .......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||......... .....+.......+.....
T Consensus 170 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 247 (361)
T 3uc3_A 170 LH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI- 247 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC-
T ss_pred cc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC-
Confidence 22 22234469999999999988777655 89999999999999999999765442222 2223333333222221111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...+.+|+.+||+.||++|||+.|+++||||++.
T Consensus 248 ---s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 248 ---SPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ---CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 1247899999999999999999999999999654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=346.18 Aligned_cols=260 Identities=25% Similarity=0.336 Sum_probs=211.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||+|+||.||+|... +|+.||+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 467899999999999999999765 6899999998754432 22477889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999997654 589999999999999999999999 9999999999999999999999999999765432
Q ss_pred C--CCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 247 S--SNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 247 ~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
. .......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...........+.. .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~-~--- 232 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYLNPW-K--- 232 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHHHTTCTTSTTG-G---
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhhhcccccCch-h---
Confidence 2 12234568999999999887665 77999999999999999999999765432211 12222221111110 0
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
.....+.+++.+||+.||++|||+.|+++||||++.+
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 1112478899999999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=363.86 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=212.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||+|... +|+.||+|.+....... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh--HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999764 68899999987654322 357889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC--CCCeEEeeecCccccC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS--KLEAFVADFGVARLLH 244 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~ 244 (361)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||++. ++.+||+|||++....
T Consensus 128 E~~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp ECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EcCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999999876432 589999999999999999999999 9999999999999974 4779999999998764
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..... .
T Consensus 203 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~--~ 276 (387)
T 1kob_A 203 PDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCDWEFDEDAFS--S 276 (387)
T ss_dssp TTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCCCCCCSSTTT--T
T ss_pred CCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCccccc--c
Confidence 432 23345689999999999999999999999999999999999999875432 22222222222211111100 0
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+++.+||+.||.+|||+.|+++||||+..
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 11247899999999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=364.05 Aligned_cols=267 Identities=20% Similarity=0.276 Sum_probs=200.2
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
...++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.++++++||||+++++++...+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4457899999999999999999965 478999999998765554445678899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee-----CCCCCeEEeeecC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL-----NSKLEAFVADFGV 239 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill-----~~~~~~kl~Dfg~ 239 (361)
||||++ |+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 49999987655 589999999999999999999999 99999999999999 4555699999999
Q ss_pred ccccCCCCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCC---
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPS--- 315 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 315 (361)
+..............+|..|+|||++.+. .++.++||||||+++|||++|+.||......+...............
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 98775544444555689999999998764 48999999999999999999999987544321111111111000000
Q ss_pred ------------CCCChhhHH------HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 316 ------------PIDDQTVIQ------DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 316 ------------~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
+........ ....+.+|+.+||+.||++|||+.|+++||||++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 000000000 11347899999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=376.96 Aligned_cols=257 Identities=22% Similarity=0.298 Sum_probs=205.3
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
..++|++.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999965 4689999999875321 22224567889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999997654 68999999999999999999998 8 9999999999999999999999999999865
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+...+
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~p~~~~--- 373 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEIRFPRTLG--- 373 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCTTSC---
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCCccCC---
Confidence 4444444556799999999999999999999999999999999999999865432 2233333333333332222
Q ss_pred HHHHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
..+.+|+.+||+.||.+|| |++|+++||||+.
T Consensus 374 ---~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 374 ---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp ---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ---HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 2478899999999999999 9999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=360.93 Aligned_cols=277 Identities=37% Similarity=0.636 Sum_probs=222.5
Q ss_pred CCcCHHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 042457 77 GRITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156 (361)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 156 (361)
..+++.++....++|.+.+.||+|+||.||+|...+|+.||||++........ ...+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-HHHHHHHHHHHHhccCCCccceEEEE
Confidence 45788999999999999999999999999999988899999999976543221 23688999999999999999999999
Q ss_pred eeCCeEEEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEe
Q 042457 157 LHKKCMFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVA 235 (361)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~ 235 (361)
...+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+.++++||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998754 23359999999999999999999999877789999999999999999999999
Q ss_pred eecCccccCCCCCC-cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC-cchhHhhhhccc-
Q 042457 236 DFGVARLLHSDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN-PKIMLIDLLDQR- 312 (361)
Q Consensus 236 Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~- 312 (361)
|||++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||+...... ............
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999876543332 333458999999999988889999999999999999999999996322111 111111111110
Q ss_pred --------CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCC
Q 042457 313 --------APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 313 --------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp 354 (361)
................+.+++.+||+.||.+|||+.|+++|.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 011111122234456789999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=363.20 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=211.1
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
..++|.+.+.||+|+||.||++... +|+.||+|++...... ..+|++++.++ +||||+++++++.+.+..++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4567999999999999999999764 6889999999765432 33677888777 79999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC----CCeEEeeecCc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK----LEAFVADFGVA 240 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~ 240 (361)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+.++ +.+||+|||++
T Consensus 94 v~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp EECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999997654 589999999999999999999999 99999999999998443 35999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
..............||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.......+....
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 87755544445567899999999998888999999999999999999999999864433334444444444433221111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.. ....+.+|+.+||+.||++|||+.|+++||||++
T Consensus 248 ~~--~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NS--VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TT--SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cc--CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 00 1124788999999999999999999999999954
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=350.18 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=213.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 568999999999999999999764 6899999999776655555678889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC---eEEeeecCcccc
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE---AFVADFGVARLL 243 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~~~~~ 243 (361)
||+++++|.+.+.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999988887654 589999999999999999999999 9999999999999976655 999999999766
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+.....
T Consensus 159 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~-- 232 (284)
T 3kk8_A 159 NDSEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAYDYPSPEWD-- 232 (284)
T ss_dssp CSSCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCCTTTTT--
T ss_pred ccCcc-ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHHHhccccCCchhhc--
Confidence 43322 2335689999999999999999999999999999999999999865432 22222333332222211100
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+++.+||+.||++|||+.|+++||||++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 01124789999999999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=372.78 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=214.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356889999999999999999765 7999999998654321 12346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999997654 589999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ......+.......+...+
T Consensus 169 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s---- 240 (476)
T 2y94_A 169 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICDGIFYTPQYLN---- 240 (476)
T ss_dssp TC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHTTCCCCCTTCC----
T ss_pred cc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCcCCCccCC----
Confidence 32 2334569999999999987765 6899999999999999999999875432 2333444444433332222
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+.+|+.+||+.||.+|||+.|+++||||++.
T Consensus 241 --~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 241 --PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 147889999999999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=361.48 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=199.4
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|.+.+.||+|+||.||+|... +++.||+|++........ ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 46889999999999999999765 789999999875443211 1245579999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|++ |+|.+++..... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 997 588888876543 589999999999999999999999 99999999999999999999999999998665444
Q ss_pred CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh-----
Q 042457 248 SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT----- 321 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 321 (361)
.......+|..|+|||++.+ ..++.++||||||+++|||++|+.||......+.....................
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 44445568999999998876 568999999999999999999999997644322111111111111111000000
Q ss_pred ------------h----HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 322 ------------V----IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 322 ------------~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. ......+.+|+.+||+.||.+|||++|+++||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 0 001124789999999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=355.50 Aligned_cols=271 Identities=34% Similarity=0.510 Sum_probs=217.6
Q ss_pred cCHHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
+++.++...+++|++.+.||+|+||.||+|...+|+.||||++....... .+.+.+|+.+++.++||||+++++++..
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG--IEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH--HHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH--HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34445556788999999999999999999998889999999987654432 4778999999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDE-AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999976532 23589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh----hhhc-
Q 042457 238 GVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI----DLLD- 310 (361)
Q Consensus 238 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~----~~~~- 310 (361)
|++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............. ....
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 99986543221 2233458999999999988899999999999999999999999987544322111110 0001
Q ss_pred ---ccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCC
Q 042457 311 ---QRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 311 ---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp 354 (361)
..................+.+++.+||+.||++|||+.|++++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11111111112234455689999999999999999999998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=360.33 Aligned_cols=258 Identities=23% Similarity=0.324 Sum_probs=197.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
..++|.+.+.||+|+||.||+|... +++.||||++..... .+.+.+|+.++++++||||+++++++...+..++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3567999999999999999999775 578999999976432 35678899999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCCeEEeeecCccc
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADFGVARL 242 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~ 242 (361)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999997654 589999999999999999999999 9999999999999975 88999999999986
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......+.......+....
T Consensus 201 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~~~~~~~-- 275 (349)
T 2w4o_A 201 VEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYYFISPWW-- 275 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCCCCTTTT--
T ss_pred cCccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCccCCchh--
Confidence 54322 22345689999999999998999999999999999999999999864332 11123333333222111100
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
......+.+++.+||+.||++|||+.|+++||||++.
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0111247899999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=373.33 Aligned_cols=268 Identities=24% Similarity=0.311 Sum_probs=215.2
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCL 157 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 157 (361)
.+.++....++|++.+.||+|+||+||+|+.. +++.||+|++...... ....+.+.+|..++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556667789999999999999999999875 4788999998653221 111234788999999999999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
+.+..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999986432 589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCC-ccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 238 GVARLLHSDSSN-RTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 238 g~~~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
|+++........ .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~ 296 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNH 296 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhhc
Confidence 999776543332 23357999999999987 56789999999999999999999999975432 2222233221
Q ss_pred --cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCC--CCCccccccCCCCCC
Q 042457 312 --RAPSPIDDQTVIQDIILVSKIAFACLRSKPKS--RPTMRRSFPNPEINP 358 (361)
Q Consensus 312 --~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~hp~~~~ 358 (361)
....+...... ...+.+|+.+||..+|++ ||+++|+++||||+.
T Consensus 297 ~~~~~~p~~~~~~---s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 297 KERFQFPTQVTDV---SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp HHHCCCCSSCCCS---CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred cccccCCcccccC---CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 11211110001 114788999999988888 999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=361.98 Aligned_cols=268 Identities=22% Similarity=0.320 Sum_probs=211.6
Q ss_pred cCHHHHHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-----CCcceee
Q 042457 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-----HRNIVKL 152 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~ 152 (361)
+++.+.....++|.+.+.||+|+||.||+|.. .+++.||||++..... ..+.+..|+.+++.++ ||||+++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK---YTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH---HHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh---hhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 44555556778999999999999999999976 4788999999975432 2356778999999886 9999999
Q ss_pred eEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC----
Q 042457 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---- 228 (361)
Q Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---- 228 (361)
++++...+..++||||+ +++|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 99999999999999999 99999999765422 489999999999999999999999 9999999999999975
Q ss_pred ---------------------CCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHH
Q 042457 229 ---------------------KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL 287 (361)
Q Consensus 229 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 287 (361)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 788999999999864332 23346899999999999999999999999999999999
Q ss_pred hCCCCCCCcccCCcchhHhhhhcc-------------------------cCCCCCCChhhHHH------------HHHHH
Q 042457 288 MGRHPGDLLSSFNPKIMLIDLLDQ-------------------------RAPSPIDDQTVIQD------------IILVS 330 (361)
Q Consensus 288 tg~~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~------------~~~l~ 330 (361)
+|+.||......+........... ..+........... ...+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 999999754321111111110000 00100000000000 13477
Q ss_pred HHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 331 KIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 331 ~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
+|+.+||+.||++|||+.|+|+||||+
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=362.49 Aligned_cols=258 Identities=22% Similarity=0.376 Sum_probs=206.2
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC--CcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH--RNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l 164 (361)
..++|++.+.||+|+||.||++...+++.||||++..........+.+.+|+.+++.++| +||+++++++...+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 356689999999999999999998889999999998766555556889999999999976 999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||| +.+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 56889999998754 689999999999999999999999 999999999999997 5789999999998764
Q ss_pred CCCC--Ccccccccccccccccccc-----------cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 245 SDSS--NRTVVAGTHGYIAPELAYT-----------MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 245 ~~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ...........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~ 236 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDP 236 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHCT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHHHhcC
Confidence 4332 2234569999999999864 6788999999999999999999999875322 11222233322
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........... ..+.+++.+||+.||.+|||+.|+++||||+.
T Consensus 237 ~~~~~~~~~~~----~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 237 NHEIEFPDIPE----KDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp TSCCCCCCCSC----HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CcccCCcccCC----HHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 22211111111 14788999999999999999999999999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=347.73 Aligned_cols=257 Identities=21% Similarity=0.374 Sum_probs=215.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||++... +++.||+|.+..... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467889999999999999999765 578999999865432 233457788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999887644 689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.........||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+...+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~----- 239 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKNEYSIPKHIN----- 239 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCCCCTTSC-----
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhhccCCCccccC-----
Confidence 44444556789999999999988899999999999999999999999875432 1222223333322222211
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+.+++.+||+.||++|||+.|+++||||+..
T Consensus 240 -~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 240 -PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred -HHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 247889999999999999999999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=371.72 Aligned_cols=264 Identities=20% Similarity=0.300 Sum_probs=213.7
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
+.++....++|.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|..+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566789999999999999999999765 5889999998653211 1112447789999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
.+..++||||+++|+|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999999754 489999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC-Ccccccccccccccccccccc----cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc-
Q 042457 239 VARLLHSDSS-NRTVVAGTHGYIAPELAYTMV----VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR- 312 (361)
Q Consensus 239 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~- 312 (361)
+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+....
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~ 290 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHKN 290 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHHH
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHhccc
Confidence 9987654332 223457999999999987655 78999999999999999999999875432 22233333321
Q ss_pred -CCCCCCChhhHHHHHHHHHHHhhhcCCCCCC--CCCccccccCCCCCC
Q 042457 313 -APSPIDDQTVIQDIILVSKIAFACLRSKPKS--RPTMRRSFPNPEINP 358 (361)
Q Consensus 313 -~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~hp~~~~ 358 (361)
...+..... ...+.+|+.+||+.+|.+ ||+++||++||||+.
T Consensus 291 ~~~~p~~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 291 SLTFPDDNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HCCCCTTCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred cccCCCcccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 122211111 114788999999999988 999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=348.04 Aligned_cols=259 Identities=21% Similarity=0.357 Sum_probs=205.8
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
+|.....||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR--YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH--HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 344556899999999999975 56889999998765432 246788999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-CCCeEEeeecCccccCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-KLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~ 247 (361)
+++++|.+++........+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999998765545678999999999999999999999 9999999999999987 8999999999998765443
Q ss_pred CCcccccccccccccccccccc--cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMV--VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.......|+..|+|||.+.+.. ++.++||||||+++|||++|+.||......................+...+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 252 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS----- 252 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC-----
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC-----
Confidence 3344456899999999987643 789999999999999999999998654321111111111111111111111
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+.+++.+||+.||++|||+.|+++||||+..
T Consensus 253 -~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 253 -AEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -HHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 247889999999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=360.16 Aligned_cols=265 Identities=25% Similarity=0.361 Sum_probs=207.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 457889999999999999999765 5899999998776665555677889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999998876554 589999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc---------------
Q 042457 247 SSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD--------------- 310 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------------- 310 (361)
........||..|+|||.+.+. .++.++||||||+++|||++|+.||......+..........
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 4444455689999999998765 789999999999999999999999875543211111110000
Q ss_pred ---ccCCCCCCChhh----HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 311 ---QRAPSPIDDQTV----IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 311 ---~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+........ ......+.+|+.+||+.||++|||+.|+++||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 000000000000 011235889999999999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=348.29 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=205.4
Q ss_pred CCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee----CCeEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH----KKCMFL 164 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 164 (361)
.|.+.+.||+|+||.||+|.. .++..||+|.+..........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 477788899999999999966 467899999998765555556789999999999999999999999876 356899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEEeCCCCCCeeeC-CCCCeEEeeecCcc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLN-SKLEAFVADFGVAR 241 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~-~~~~~kl~Dfg~~~ 241 (361)
||||+++++|.+++.... .+++..++.++.|++.||.|||+. + ++|+||||+||+++ .++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999997643 589999999999999999999999 7 99999999999997 78999999999997
Q ss_pred ccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
..... ......||+.|+|||.+. ..++.++||||||+++|+|++|+.||..... .............+....
T Consensus 181 ~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~--- 252 (290)
T 1t4h_A 181 LKRAS--FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASFD--- 252 (290)
T ss_dssp GCCTT--SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGGG---
T ss_pred ccccc--ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCccccC---
Confidence 54332 233456899999999876 4589999999999999999999999875332 111122222221111111
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
......+.+++.+||+.||.+|||+.|+++||||++.
T Consensus 253 -~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 253 -KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -CCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 0111248899999999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=358.41 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=209.3
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchH------HHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETEL------AFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
..++|.+.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+.++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999964 578899999987653211 1124567899999999999999999999999
Q ss_pred CeEEEEEEeccCC-ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 160 KCMFLIYKYMRRG-SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 160 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999997665 589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (361)
++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ........+.
T Consensus 176 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~~~~~ 245 (335)
T 3dls_A 176 SAAYLERGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEAAIHPPY 245 (335)
T ss_dssp TCEECCTTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTTCCCCSS
T ss_pred cceECCCCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhhccCCCc
Confidence 9987654332 334568999999999888776 7899999999999999999999875322 1112222222
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+ ..+.+++.+||+.||++|||+.|+++||||++.
T Consensus 246 ~~~------~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 246 LVS------KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCC------HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ccC------HHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 211 147889999999999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=354.20 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=201.4
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch---HHHHHHHHHHHHHHhcC---CCCcceeeeEEEee
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE---LAFLESFQTEARLLSQI---RHRNIVKLYGFCLH 158 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~ 158 (361)
...++|++.+.||+|+||.||+|.. .+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467899999999999999999975 57899999998643211 01113455666666665 59999999999987
Q ss_pred CC-----eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeE
Q 042457 159 KK-----CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF 233 (361)
Q Consensus 159 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k 233 (361)
.. ..++||||+. ++|.+++...... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 65 5899999997 5999998765432 489999999999999999999999 999999999999999999999
Q ss_pred EeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 234 VADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 234 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.............
T Consensus 161 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 161 LADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp ECSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999998664332 33445689999999999999999999999999999999999999975443211111111111100
Q ss_pred CCCC-------------CChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 314 PSPI-------------DDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 314 ~~~~-------------~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.... ...... .....+.+++.+||+.||++|||+.|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0000 000000 112347899999999999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=360.88 Aligned_cols=256 Identities=22% Similarity=0.279 Sum_probs=205.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHH-HhcCCCCcceeeeEEEeeCCeEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARL-LSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
.++|++.+.||+|+||.||+++.. +++.||+|++..... .......+..|..+ ++.++||||+++++++...+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457999999999999999999765 588999999976542 12223456667766 567899999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997654 588999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
..........||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ......+.......+...+
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~---- 263 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILNKPLQLKPNIT---- 263 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHHHHHSCCCCCSSSC----
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcccCCCCCCC----
Confidence 444445556799999999999999999999999999999999999999875432 2333444444333332222
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCc----cccccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTM----RRSFPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~----~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+||++ .++++||||+.
T Consensus 264 --~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 264 --NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp --HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred --HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 147889999999999999998 58999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=353.69 Aligned_cols=257 Identities=21% Similarity=0.374 Sum_probs=215.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||++... +++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457888999999999999999765 578999999865432 233457788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999887643 689999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.........||..|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.......+....
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~----- 265 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KETYLRIKKNEYSIPKHIN----- 265 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCCCTTSC-----
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHhcCCCCCCccCC-----
Confidence 44444556789999999999988899999999999999999999999875432 1222222233222222211
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..+.+++.+||+.||++|||+.|+++||||+..
T Consensus 266 -~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 266 -PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred -HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 147889999999999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=364.33 Aligned_cols=257 Identities=21% Similarity=0.373 Sum_probs=206.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC--CCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR--HRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv 165 (361)
..+|.+.+.||+|+||.||++...+++.||||++..........+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999999776555555688999999999996 59999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|| +.+++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 67889999998654 689999999999999999999999 999999999999996 57899999999987643
Q ss_pred CCC--Ccccccccccccccccccc-----------cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 246 DSS--NRTVVAGTHGYIAPELAYT-----------MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 246 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......+....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~~~~ 284 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAIIDPN 284 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHCTT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHhCcc
Confidence 322 1234569999999999865 4688899999999999999999999975322 112233333332
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
......... ...+.+|+.+||+.||.+|||+.|+++||||+.
T Consensus 285 ~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 285 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp SCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ccCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 221111111 124788999999999999999999999999964
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=363.91 Aligned_cols=265 Identities=25% Similarity=0.349 Sum_probs=197.9
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCC--e
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKK--C 161 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~ 161 (361)
...++|++.+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999965 47899999998765444444577889999999997 999999999998654 6
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||++ ++|..++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 5899888754 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC---------------------CCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccC
Q 042457 242 LLHSD---------------------SSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF 299 (361)
Q Consensus 242 ~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 299 (361)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 111233468999999999876 67899999999999999999999999754432
Q ss_pred CcchhHhhhhcccC--------------------------CC-CCCChhhH-----------HHHHHHHHHHhhhcCCCC
Q 042457 300 NPKIMLIDLLDQRA--------------------------PS-PIDDQTVI-----------QDIILVSKIAFACLRSKP 341 (361)
Q Consensus 300 ~~~~~~~~~~~~~~--------------------------~~-~~~~~~~~-----------~~~~~l~~li~~cl~~dP 341 (361)
+............. .. .......+ .....+.+|+.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 11111111110000 00 00000000 001247899999999999
Q ss_pred CCCCCccccccCCCCCC
Q 042457 342 KSRPTMRRSFPNPEINP 358 (361)
Q Consensus 342 ~~RPs~~eil~hp~~~~ 358 (361)
++|||+.|+++||||+.
T Consensus 318 ~~R~t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 318 NKRISANDALKHPFVSI 334 (388)
T ss_dssp GGSCCHHHHTTSTTTTT
T ss_pred ccCCCHHHHhCCHHHHH
Confidence 99999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=362.40 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=202.7
Q ss_pred cCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 94 KYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 56799999999999975 46899999999865432 2477899999999999999999999999999999999999999
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee--CCCCCeEEeeecCccccCCCCCCc
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL--NSKLEAFVADFGVARLLHSDSSNR 250 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~ 250 (361)
+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++....... .
T Consensus 172 ~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-~ 245 (373)
T 2x4f_A 172 ELFDRIIDESY--NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-L 245 (373)
T ss_dssp EEHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-C
T ss_pred cHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-c
Confidence 99998865432 589999999999999999999999 99999999999999 6678999999999987644332 2
Q ss_pred ccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHH
Q 042457 251 TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVS 330 (361)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 330 (361)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.... ......+.
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~--~~~~~~~~ 320 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNILACRWDLEDEEF--QDISEEAK 320 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCSCSGGG--TTSCHHHH
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCChhhh--ccCCHHHH
Confidence 334689999999999988999999999999999999999999875432 2233333333322221110 01122588
Q ss_pred HHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 331 KIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 331 ~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+|+.+||+.||.+|||+.|+++||||++
T Consensus 321 ~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 321 EFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=354.81 Aligned_cols=271 Identities=19% Similarity=0.276 Sum_probs=214.3
Q ss_pred CcCHHHHHHHhcCCCCc-CeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeE
Q 042457 78 RITFEEIIVATEDFDIK-YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYG 154 (361)
Q Consensus 78 ~~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~ 154 (361)
.+.++......+.|.+. +.||+|+||.||+|... +|+.||+|++............+.+|+.+++.+ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455566777788887 88999999999999765 689999999876554333357788999999999 4699999999
Q ss_pred EEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCC
Q 042457 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLE 231 (361)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~ 231 (361)
++...+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||++. ++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCc
Confidence 99999999999999999999999865422 2689999999999999999999999 9999999999999988 789
Q ss_pred eEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+...
T Consensus 173 ~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~ 248 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQV 248 (327)
T ss_dssp EEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT
T ss_pred EEEeeCccccccCCccc-cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhc
Confidence 99999999987643322 2335689999999999999999999999999999999999999875432 1122222222
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+..... .....+.+++.+||+.||.+|||++|+++||||++
T Consensus 249 ~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 249 NVDYSEETFS--SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp CCCCCTTTTT--TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred ccccCchhhc--ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 2111111100 11124788999999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=371.73 Aligned_cols=261 Identities=24% Similarity=0.308 Sum_probs=216.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|.+.+.||+|+||.||+++.. +|+.||+|++...... ....+.+..|+.++++++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999774 6999999999654321 122467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 167 KYMRRGSLFCVLRNDDE-AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
||+++|+|.+++..... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999876432 33689999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC-cchhHhhhhcccCCCCCCChhhHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN-PKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.......+...+
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s---- 417 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS---- 417 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC----
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC----
Confidence 4444445579999999999999999999999999999999999999997654322 22233334444333332222
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+||++ +++++||||+.
T Consensus 418 --~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 418 --PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp --HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred --HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 247889999999999999975 78999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=374.30 Aligned_cols=261 Identities=21% Similarity=0.255 Sum_probs=214.3
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
..++|.+.+.||+|+||.||+|... +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467889999999999999999764 799999999865422 11223567899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++|+|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999976542 2489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh-hhhcccCCCCCCChhhH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI-DLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 323 (361)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. .+.......+...+
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s--- 413 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS--- 413 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSC---
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCC---
Confidence 332 2333579999999999999899999999999999999999999998654322222222 22222222221111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
..+.+|+.+||+.||.+|| +++|+++||||+.
T Consensus 414 ---~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 414 ---PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp ---HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred ---HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 2478899999999999999 7899999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=349.10 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=202.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||++.. .++..||+|++....... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV-PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 35689999999999999999976 468899999987654321 2467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee---CCCCCeEEeeecCccc
Q 042457 167 KYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARL 242 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~ 242 (361)
||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++|+||||+||++ +.++.+||+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999886431 123689999999999999999999999 99999999999999 4567899999999976
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
..... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||..... .....................
T Consensus 177 ~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 177 FKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCC--CCC
T ss_pred cCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCcccccccCcC
Confidence 54332 233456899999999875 5688999999999999999999999875432 111111111111111110000
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+.+++.+||+.||++|||+.|+++||||++
T Consensus 252 ---~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 ---TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 124778999999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=353.23 Aligned_cols=261 Identities=19% Similarity=0.327 Sum_probs=203.0
Q ss_pred hcCCCCc-CeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 88 TEDFDIK-YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 88 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
.+.|.+. +.||+|+||.||+|.. .+|+.||||++....... .+.+.+|+.++.++ +||||+++++++...+..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh--HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3567774 6799999999999975 478999999997654322 36788999999885 79999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC---eEEeeecCcc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE---AFVADFGVAR 241 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~~~ 241 (361)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++. +||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999997654 589999999999999999999999 9999999999999988776 9999999987
Q ss_pred ccCCCCC-------Ccccccccccccccccccc-----cccCccchhhhHHHHHHHHHhCCCCCCCcccCCc--------
Q 042457 242 LLHSDSS-------NRTVVAGTHGYIAPELAYT-----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP-------- 301 (361)
Q Consensus 242 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-------- 301 (361)
....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 1123458999999999865 5688999999999999999999999976543221
Q ss_pred ----chhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 302 ----KIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 302 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
......+.......+.. ........+.+++.+||+.||.+|||+.|+++||||++
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDK--DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHH--HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred hhHHHHHHHHHhccCcccCch--hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 11122222222222110 00011234889999999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=369.57 Aligned_cols=261 Identities=22% Similarity=0.274 Sum_probs=202.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------C
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------K 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 160 (361)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46799999999999999999965 4688999999976554445567888999999999999999999999754 3
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||++++ |.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999764 6555543 388999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH---------------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML--------------- 305 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~--------------- 305 (361)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 212 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 866432 2234457899999999999999999999999999999999999999764421111111
Q ss_pred ----hhhhcccCCC--------------CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 306 ----IDLLDQRAPS--------------PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 306 ----~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.......... +............+.+|+.+||+.||++|||++|+|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 0111111100 0011111111345889999999999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=368.40 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=214.5
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCL 157 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 157 (361)
.+++.....++|++.+.||+|+||.||+++.. +|+.||+|++..... .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45566667789999999999999999999774 789999999965322 1122345788999999999999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
+.+..|+||||+++|+|.+++...+. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999976432 589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCC-ccccccccccccccccc-------ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh
Q 042457 238 GVARLLHSDSSN-RTVVAGTHGYIAPELAY-------TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 238 g~~~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 309 (361)
|+++........ .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ......+.
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~ 283 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGKIV 283 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 999876543332 23457999999999987 35689999999999999999999999875432 22222333
Q ss_pred cc--cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCC---CCccccccCCCCCC
Q 042457 310 DQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSR---PTMRRSFPNPEINP 358 (361)
Q Consensus 310 ~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~hp~~~~ 358 (361)
.. ....+..... ....+.+|+.+||+ +|.+| |+++|+++||||+.
T Consensus 284 ~~~~~~~~p~~~~~---~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 284 HYKEHLSLPLVDEG---VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp THHHHCCCC----C---CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred hcccCcCCCccccC---CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 21 1111110000 11247889999999 99998 69999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=359.83 Aligned_cols=268 Identities=25% Similarity=0.327 Sum_probs=210.0
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET---ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
+....++|.+.+.||+|+||.||+|.. .++..||+|++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 356678899999999999999999976 4688999999865321 223357889999999999999999999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCC-------------------------------------ccCCCCHHHHHHHHHHHHHH
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDD-------------------------------------EAIQLDWTKRVNIVKSMAHA 202 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~ 202 (361)
+..++||||+++|+|.+++.... ....+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999885210 01124567788999999999
Q ss_pred HHHHHcCCCCCeEEeCCCCCCeeeCCCC--CeEEeeecCccccCCCCC----Ccccccccccccccccccc--cccCccc
Q 042457 203 LSYLHYDCIPSIVHRDISSNNILLNSKL--EAFVADFGVARLLHSDSS----NRTVVAGTHGYIAPELAYT--MVVTEKC 274 (361)
Q Consensus 203 l~~Lh~~~~~~i~H~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~ 274 (361)
|+|||+. +++||||||+||+++.++ .+||+|||++........ ......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999986543221 2334568999999999865 6788999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCC
Q 042457 275 DVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 275 Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp 354 (361)
||||||+++|||++|+.||..... ......+.......+.... ......+.+++.+||+.||.+|||+.|+++||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFENPNY--NVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTSGGG--GGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCCccc--ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 999999999999999999875443 2223333333332221111 01122488999999999999999999999999
Q ss_pred CCCCC
Q 042457 355 EINPS 359 (361)
Q Consensus 355 ~~~~~ 359 (361)
||++.
T Consensus 333 ~~~~~ 337 (345)
T 3hko_A 333 WISQF 337 (345)
T ss_dssp HHHTT
T ss_pred hhccC
Confidence 99763
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=352.43 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=212.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchH----HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL----AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|.+.+.||+|+||.||++... +|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456899999999999999999764 68999999987654321 1246788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC----CeEEeeec
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL----EAFVADFG 238 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 238 (361)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997654 589999999999999999999999 999999999999999887 79999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+.
T Consensus 165 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~- 239 (321)
T 2a2a_A 165 LAHEIEDGVE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITSVSYDFDE- 239 (321)
T ss_dssp TCEECCTTCC-CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTCCCCCH-
T ss_pred cceecCcccc-ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccccCh-
Confidence 9987654322 2334689999999999999999999999999999999999999865432 2222223222221110
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.........+.+++.+||+.||++|||+.|+++||||++
T Consensus 240 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 240 -EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp -HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred -hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 000111234789999999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=344.98 Aligned_cols=255 Identities=18% Similarity=0.249 Sum_probs=205.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
..++|.+.+.||+|+||.||+|... +++.||+|++............+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999775 799999999986544444457788999999998 99999999999999999999
Q ss_pred EEEeccCCChhhhhccCCc-cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---------------
Q 042457 165 IYKYMRRGSLFCVLRNDDE-AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS--------------- 228 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--------------- 228 (361)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976421 13589999999999999999999999 9999999999999984
Q ss_pred ----CCCeEEeeecCccccCCCCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcch
Q 042457 229 ----KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI 303 (361)
Q Consensus 229 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 303 (361)
...+||+|||.+....... ...||..|+|||.+.+. .++.++||||||+++|||++|..++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 4479999999998764332 23489999999998765 56689999999999999999998754321
Q ss_pred hHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 304 MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.....+...... ...+.+++.+||+.||++|||+.|+++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 236 QWHEIRQGRLPRIPQVL-----SQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHTTCCCCCSSCC-----CHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHHcCCCCCCCccc-----CHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 12222333222111111 1247899999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=357.40 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=206.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------- 159 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------- 159 (361)
.++|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999976 5789999999876554333345678999999999999999999999873
Q ss_pred -CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 160 -KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
+..++||||+++ +|.+.+..... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 77766655432 589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCC----CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 239 VARLLHSDS----SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 239 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
++....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....................
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998764322 22234568999999998876 4579999999999999999999999876443211111111111111
Q ss_pred CCCCCC-----------------hhhHHH------HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 314 PSPIDD-----------------QTVIQD------IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 314 ~~~~~~-----------------~~~~~~------~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
+..... ...... ...+.+|+.+||+.||++|||+.|+++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 100000 000011 1247899999999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=345.19 Aligned_cols=256 Identities=20% Similarity=0.318 Sum_probs=210.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||+|... ++..||+|++....... .+.+.+|+++++.++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 467999999999999999999764 57789999987644322 467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee---CCCCCeEEeeecCcccc
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARLL 243 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~~ 243 (361)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||++...
T Consensus 86 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 86 ELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999887654 589999999999999999999999 99999999999999 78899999999999876
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
.... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||..... ......+.......+.. ...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~--~~~ 232 (277)
T 3f3z_A 160 KPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKIREGTFTFPEK--DWL 232 (277)
T ss_dssp CTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCHH--HHT
T ss_pred cCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCCch--hhh
Confidence 4332 23345689999999987654 89999999999999999999999875432 22233333333222211 000
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+++.+||+.||++|||+.|+++||||++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 11235889999999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=345.79 Aligned_cols=254 Identities=30% Similarity=0.467 Sum_probs=207.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|++.+.||+|+||.||+|... +++.||+|++...... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999664 5779999998654321 22246788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999987654 589999999999999999999999 999999999999999999999999998865432
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+....
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~----- 231 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISRVEFTFPDFVT----- 231 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCCCTTSC-----
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHHHhCCCCCCCcCC-----
Confidence 2 22345689999999999999999999999999999999999999875432 2222222222222222211
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+|||+.|+++||||++
T Consensus 232 -~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 232 -EGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp -HHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred -HHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 13788999999999999999999999999965
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=348.07 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=212.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--CCeEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--KKCMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 164 (361)
.++|++.+.||+|+||.||++... +|+.||+|.+..........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999764 68999999998765555556789999999999999999999998864 568999
Q ss_pred EEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 165 IYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPS-----IVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~-----i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+. + ++|+||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997533 223589999999999999999999998 7 9999999999999999999999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC-CCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP-SPI 317 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 317 (361)
++..............|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.....+ .+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~ 238 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREGKFRRIPY 238 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCCCT
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhhcccccCCc
Confidence 998765443333445689999999999988899999999999999999999999875432 2222233333222 111
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.. ...+.+++.+||+.||++|||+.|+++|+|+.++
T Consensus 239 ~~------~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 239 RY------SDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TS------CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cc------CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 11 1248899999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=349.54 Aligned_cols=262 Identities=20% Similarity=0.314 Sum_probs=210.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC--eEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK--CMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l 164 (361)
.++|.+.+.||+|+||.||+|... +|+.||||++....... ..+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 457899999999999999999765 58999999997544322 2467789999999999999999999998765 7899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee----CCCCCeEEeeecCc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL----NSKLEAFVADFGVA 240 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~ 240 (361)
||||+++++|.+++........+++..++.++.|++.||+|||+. +++||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999998766544599999999999999999999999 99999999999999 78888999999999
Q ss_pred cccCCCCCCccccccccccccccccc--------ccccCccchhhhHHHHHHHHHhCCCCCCCcccCC-cchhHhhhhcc
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAY--------TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN-PKIMLIDLLDQ 311 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~ 311 (361)
+....... .....||..|+|||++. +..++.++||||||+++|||++|+.||....... .......+...
T Consensus 164 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 87654332 23346899999999876 5678999999999999999999999986543321 12222233322
Q ss_pred cCC-------------------CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCC
Q 042457 312 RAP-------------------SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 312 ~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp 354 (361)
.++ .+............+.+++.+||+.||++|||++|+|+||
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 211 1111112233444688999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=355.16 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=207.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.+.|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588899999999999999975 5789999999976532 334457789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+. |+|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 67877775432 2689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 246 DSSNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
. ....||+.|+|||++. +..++.++||||||+++|||++|+.||..... ......+.....+.......
T Consensus 207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~- 278 (348)
T 1u5q_A 207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPALQSGHW- 278 (348)
T ss_dssp B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCCCTTS-
T ss_pred C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCCCCC-
Confidence 2 2346899999999874 56789999999999999999999999865432 12222333332222111111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+.+++.+||+.||++|||+.++++||||..
T Consensus 279 ---~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 279 ---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---CHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 124788999999999999999999999999965
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=346.09 Aligned_cols=250 Identities=26% Similarity=0.466 Sum_probs=204.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 467888999999999999999764 689999999865433 33578999999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||+|||++.++.+||+|||++......
T Consensus 87 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp ECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999986433 589999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCCc--------------ccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCc--chhHhhhhc
Q 042457 247 SSNR--------------TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP--KIMLIDLLD 310 (361)
Q Consensus 247 ~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~ 310 (361)
.... ....||+.|+|||.+.+..++.++||||||+++|||++|..|+........ .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 134689999999999999999999999999999999999999865433211 111222222
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 311 QRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.... ..+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~--------~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 RYCPPNCP--------PSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HTCCTTCC--------TTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCC--------HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22221111 13788999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=349.53 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=207.4
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
...++|++.+.||+|+||.||+|... +|+.||+|.+..... .+.+.+|+.+++.++||||+++++++...+..++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 45678999999999999999999765 589999999976543 2568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999986432 2589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
..........|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...........+. ......
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~-~~~~~~-- 250 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAIFMIPTNPPPT-FRKPEL-- 250 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCCCC-CSSGGG--
T ss_pred hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhcCCCcc-cCCccc--
Confidence 5444444556899999999999989999999999999999999999998754321 1111111121111 111111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+++.+||+.||.+|||+.++++||||+..
T Consensus 251 ~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp SCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 11247899999999999999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=355.07 Aligned_cols=266 Identities=25% Similarity=0.371 Sum_probs=214.5
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc------hHHHHHHHHHHHHHHhcC-CCCcceee
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET------ELAFLESFQTEARLLSQI-RHRNIVKL 152 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~~ 152 (361)
+.......++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 4444556678999999999999999999875 799999999875432 122346788999999999 79999999
Q ss_pred eEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCe
Q 042457 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEA 232 (361)
Q Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~ 232 (361)
++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+|||++.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999997543 689999999999999999999999 99999999999999999999
Q ss_pred EEeeecCccccCCCCCCcccccccccccccccccc------cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh
Q 042457 233 FVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT------MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI 306 (361)
Q Consensus 233 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 306 (361)
||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .....
T Consensus 240 kl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~ 315 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILMLR 315 (365)
T ss_dssp EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH
T ss_pred EEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHHH
Confidence 999999998765432 2334568999999998863 3578899999999999999999999865332 22222
Q ss_pred hhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+.......+. .........+.+++.+||+.||++|||+.|+++||||++
T Consensus 316 ~i~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 316 MIMEGQYQFSS--PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHTCCCCCH--HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHhCCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 22222222110 000011224889999999999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=359.54 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=196.9
Q ss_pred cCCCCc-CeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHh-cCCCCcceeeeEEEee----CCe
Q 042457 89 EDFDIK-YCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLS-QIRHRNIVKLYGFCLH----KKC 161 (361)
Q Consensus 89 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~ 161 (361)
++|.+. +.||+|+||.||++... +|+.||||++... ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 456665 68999999999999764 6899999998643 34557787764 4589999999999876 567
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCCeEEeeec
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADFG 238 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg 238 (361)
.++||||+++|+|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 8999999999999999986432 2589999999999999999999999 9999999999999987 7889999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcc-hhHhhhhcccCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK-IMLIDLLDQRAPSPI 317 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 317 (361)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.......+.
T Consensus 210 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 210 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 998654322 233456899999999999999999999999999999999999999765433211 122222222222221
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.... .....+.+|+.+||+.||++|||+.|+++||||++
T Consensus 289 ~~~~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 289 PEWS--EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTTT--TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccc--cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 1100 01124789999999999999999999999999965
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=345.75 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=212.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.+.|.+.+.||+|+||.||+|.. .+++.||+|++....... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 45688999999999999999965 468999999987654322 2577889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999999753 589999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
........|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.....+.. .... .
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-~~~~----~ 244 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNNPPTL-EGNY----S 244 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC-CSSC----C
T ss_pred ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCCCCCC-cccc----C
Confidence 4444455789999999999999999999999999999999999999875432 112222222222111 1111 1
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+|||+.|+++||||.+
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 24789999999999999999999999999954
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=355.19 Aligned_cols=264 Identities=22% Similarity=0.278 Sum_probs=202.8
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchH---HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL---AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
..++|.+.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999775 58999999987543221 1124678999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++ +|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999976 88888876432 578889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc---cCCCCC-
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ---RAPSPI- 317 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~- 317 (361)
............+|+.|+|||.+.+. .++.++||||||+++|||++|..||......+ ....+... ......
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSS
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhhhh
Confidence 75544444556789999999998654 57899999999999999999999987543211 11111111 000000
Q ss_pred -------------CChhh-----HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 318 -------------DDQTV-----IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 318 -------------~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
..... ......+.+|+.+||+.||++|||+.|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 00000 0111358899999999999999999999999999763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=349.63 Aligned_cols=260 Identities=23% Similarity=0.400 Sum_probs=205.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
..++|++.+.||+|+||.||+|... +|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C--CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH--HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4577999999999999999999775 5889999998755432 247788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp EECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999998875332 589999999999999999999999 999999999999999999999999998754322
Q ss_pred CCCCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 246 DSSNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
.........||..|+|||.+. +..++.++||||||+++|+|++|+.||..... ............+......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~ 246 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPPTLLTPS 246 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCSSGG
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCcccCCcc
Confidence 222223346899999999873 56788999999999999999999999875432 2222222222222111111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
. ....+.+++.+||+.||.+|||+.|+++||||+..
T Consensus 247 ~---~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 247 K---WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp G---SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred c---cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 1 11247899999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=361.55 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=199.4
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc------hHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET------ELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
...++|.+.+.||+|+||.||+|.. .+++.||||++..... .......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4568899999999999999999965 4689999999875421 1112235789999999999999999999975
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC---CCeEEe
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK---LEAFVA 235 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~ 235 (361)
.+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.+ +.+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 455899999999999999987654 689999999999999999999999 99999999999999654 459999
Q ss_pred eecCccccCCCCCCcccccccccccccccccc---cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 236 DFGVARLLHSDSSNRTVVAGTHGYIAPELAYT---MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 236 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .....+....
T Consensus 285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~~~~ 361 (419)
T 3i6u_A 285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSGK 361 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHHTTC
T ss_pred ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHhcCC
Confidence 99999876432 22334568999999998753 567889999999999999999999997543221 1122222222
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..... .........+.+++.+||+.||++|||+.|+++||||++
T Consensus 362 ~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 362 YNFIP--EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CCCCH--HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCc--hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 21110 000111235889999999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=365.92 Aligned_cols=265 Identities=23% Similarity=0.299 Sum_probs=191.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-----Ce
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK-----KC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 161 (361)
.++|.+.+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999654 789999999976555555567899999999999999999999999543 56
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 578999987654 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC---------------------------Ccccccccccccccccc-cccccCccchhhhHHHHHHHHHh-----
Q 042457 242 LLHSDSS---------------------------NRTVVAGTHGYIAPELA-YTMVVTEKCDVFGFGVVALEVLM----- 288 (361)
Q Consensus 242 ~~~~~~~---------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~t----- 288 (361)
....... ......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7643221 12334689999999976 56679999999999999999999
Q ss_pred ------CCCCCCCcccCCc-----------------chhH---hhhh--------------------cccCCCC-CCC-h
Q 042457 289 ------GRHPGDLLSSFNP-----------------KIML---IDLL--------------------DQRAPSP-IDD-Q 320 (361)
Q Consensus 289 ------g~~p~~~~~~~~~-----------------~~~~---~~~~--------------------~~~~~~~-~~~-~ 320 (361)
|+.+|........ ...+ .+++ ....... ... .
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 5555543221000 0000 0000 0000000 000 0
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
........+.+|+.+||+.||++|||++|+|+||||++.
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 000012247899999999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=379.06 Aligned_cols=258 Identities=20% Similarity=0.307 Sum_probs=217.9
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 162 (361)
...++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34567999999999999999999764 688999999875321 122246678899999988 799999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999998654 589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
............||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+...+.
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~- 567 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVAYPKSMSK- 567 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHSSCCCCCTTSCH-
T ss_pred cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHHHHHHHhCCCCCCccCCH-
Confidence 5444444556679999999999999999999999999999999999999987543 334455555555544433222
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCc-----cccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTM-----RRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~hp~~~~ 358 (361)
.+.+|+.+||+.||++||++ +||++||||+.
T Consensus 568 -----~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 568 -----EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp -----HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred -----HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 47889999999999999998 99999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=353.81 Aligned_cols=254 Identities=25% Similarity=0.416 Sum_probs=206.9
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe--------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL--------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCL 157 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 157 (361)
..++|.+.+.||+|+||.||+|.. .++..||||+++..... ...+.+.+|+.+++.+ +||||++++++|.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-HHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-HHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 356789999999999999999975 23557999999765443 3457899999999999 8999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCe
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNI 224 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Ni 224 (361)
..+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 99999999999999999999976431 23589999999999999999999999 999999999999
Q ss_pred eeCCCCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCc
Q 042457 225 LLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNP 301 (361)
Q Consensus 225 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 301 (361)
|++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--- 311 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 999999999999999986654332 2233456789999999999999999999999999999999 9999875432
Q ss_pred chhHhhhhcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 302 KIMLIDLLDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 302 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
......+..... ..+... ...+.+++.+||+.||.+|||+.|++++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~------~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 312 EELFKLLKEGHRMDKPANC------TNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGHHHHHHTTCCCCCCTTS------CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222222221 122111 1248889999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=338.78 Aligned_cols=267 Identities=30% Similarity=0.509 Sum_probs=217.8
Q ss_pred CCcCHHHHHHHhcCCCCc------CeeeecCceeEEEEEeCCCCEEEEEEeccCc--chHHHHHHHHHHHHHHhcCCCCc
Q 042457 77 GRITFEEIIVATEDFDIK------YCIGTGGYGSVYRAQLPSGKIVALKKLHHSE--TELAFLESFQTEARLLSQIRHRN 148 (361)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~n 148 (361)
..++++++..++++|... +.||+|+||.||+|.. +++.||+|++.... ......+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 347899999999999877 8999999999999987 78899999986542 22233577899999999999999
Q ss_pred ceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC
Q 042457 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228 (361)
Q Consensus 149 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~ 228 (361)
|+++++++...+..++||||+++++|.+++........+++..++.++.|++.||.|||+. +++|+||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999997655445799999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh
Q 042457 229 KLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI 306 (361)
Q Consensus 229 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 306 (361)
++.+||+|||++......... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.............
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999866443222 223468999999998765 57899999999999999999999997654322111111
Q ss_pred h-----------hhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 307 D-----------LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 307 ~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
. ....... .........+.+++.+||+.||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCS-----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHhhhhhhhhhhhcccccc-----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 1111111 1122334568899999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=355.91 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=201.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------ 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 160 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46789999999999999999976 47999999999765544455678899999999999999999999998763
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+ +++|.+++... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 88999998763 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh----------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL---------- 309 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---------- 309 (361)
+..... .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||......+.........
T Consensus 176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 176 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 875432 233568999999998877 678999999999999999999999997544311110000000
Q ss_pred ----------cccCCCCCCC--hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 310 ----------DQRAPSPIDD--QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 310 ----------~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.......... .........+.+|+.+||+.||.+|||+.|+++||||++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 0000000000 000001124789999999999999999999999999976
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=369.98 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=205.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|++.+.||+|+||.||+|... ++..||+|++............+.+|+.+++.++||||+++++++...+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999764 6889999999765433333467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC---CCeEEeeecCcccc
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK---LEAFVADFGVARLL 243 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~~~~ 243 (361)
||+++|+|.+.+.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999998887554 589999999999999999999999 99999999999999764 45999999999876
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
.... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ......+.......+.... .
T Consensus 190 ~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~--~ 262 (494)
T 3lij_A 190 ENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGKYTFDSPEW--K 262 (494)
T ss_dssp BTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCCSGGG--T
T ss_pred CCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCchhc--c
Confidence 5432 233456999999999876 5689999999999999999999999875432 2233333333332221111 0
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+++.+||+.||.+|||+.|+|+||||++
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 11124789999999999999999999999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=342.03 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=210.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357889999999999999999765 5778999998654321 11236788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999997654 589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+...+
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~----- 236 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHRRIVNVDLKFPPFLS----- 236 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCCCCTTSC-----
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHHHHhccccCCCCcCC-----
Confidence 2 22345689999999999998999999999999999999999999875432 1222233333322222211
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+++.+||+.||.+|||+.|+++||||++
T Consensus 237 -~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 237 -DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp -HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred -HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 24788999999999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=341.48 Aligned_cols=257 Identities=22% Similarity=0.374 Sum_probs=204.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+.+|+..++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467899999999999999999775 789999999865432 122346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999997654 589999999999999999999999 999999999999999999999999999976643
Q ss_pred CCCCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ......+.......+...+
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~---- 235 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLFKKIRGGVFYIPEYLN---- 235 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCTTSC----
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhcCcccCchhcC----
Confidence 32 2233468999999999887665 6899999999999999999999875322 2222233333222222211
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
..+.+++.+||+.||++|||+.|+++||||++.+
T Consensus 236 --~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 236 --RSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred --HHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 2478899999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=360.22 Aligned_cols=264 Identities=24% Similarity=0.322 Sum_probs=202.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-----Ce
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK-----KC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 161 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46799999999999999999965 4688999999986655555567899999999999999999999999876 56
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 59999997654 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC----------------------Ccccccccccccccccc-cccccCccchhhhHHHHHHHHHhCCCCCCCc--
Q 042457 242 LLHSDSS----------------------NRTVVAGTHGYIAPELA-YTMVVTEKCDVFGFGVVALEVLMGRHPGDLL-- 296 (361)
Q Consensus 242 ~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~-- 296 (361)
....... ......||+.|+|||++ .+..++.++|||||||++|||++|..||...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 7644321 12445789999999985 5667999999999999999999866554321
Q ss_pred ---------ccCC--c------------chh-----------------------HhhhhcccCC-CCCCChhh-HHHHHH
Q 042457 297 ---------SSFN--P------------KIM-----------------------LIDLLDQRAP-SPIDDQTV-IQDIIL 328 (361)
Q Consensus 297 ---------~~~~--~------------~~~-----------------------~~~~~~~~~~-~~~~~~~~-~~~~~~ 328 (361)
+... . ... .......... .+...... ......
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 1000 0 000 0000000000 00000000 001234
Q ss_pred HHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 329 VSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 329 l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
+.+|+.+||+.||++|||++|+|+||||++
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 789999999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=356.40 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=208.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEe----CCCCEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCC
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL----PSGKIVALKKLHHSET--ELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKK 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 160 (361)
.++|.+.+.||+|+||.||+++. .+|+.||||+++.... .....+.+..|+.+++.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46799999999999999999976 4789999999865321 111124566899999999 6999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997654 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-Ccccccccccccccccccc--cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcch-hHhhhhcccCCCC
Q 042457 241 RLLHSDSS-NRTVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI-MLIDLLDQRAPSP 316 (361)
Q Consensus 241 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 316 (361)
+....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ....+.....+.+
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence 86543222 2233568999999999875 347889999999999999999999997544322222 2222333333322
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
.... ..+.+|+.+||+.||.+|| |++|+++||||++
T Consensus 287 ~~~~------~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 287 QEMS------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp TTSC------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cccC------HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 2221 2478899999999999999 9999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=350.57 Aligned_cols=263 Identities=20% Similarity=0.316 Sum_probs=210.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchH---------------HHHHHHHHHHHHHhcCCCCcceee
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETEL---------------AFLESFQTEARLLSQIRHRNIVKL 152 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~niv~~ 152 (361)
.++|.+.+.||+|+||.||+|.. +|+.||+|.+....... ...+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999998 99999999986542211 012678899999999999999999
Q ss_pred eEEEeeCCeEEEEEEeccCCChhhh------hccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCee
Q 042457 153 YGFCLHKKCMFLIYKYMRRGSLFCV------LRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNIL 225 (361)
Q Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nil 225 (361)
++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ . +++|+||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 55421 2368999999999999999999999 8 9999999999999
Q ss_pred eCCCCCeEEeeecCccccCCCCCCccccccccccccccccccc-ccCc-cchhhhHHHHHHHHHhCCCCCCCcccCCcch
Q 042457 226 LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VVTE-KCDVFGFGVVALEVLMGRHPGDLLSSFNPKI 303 (361)
Q Consensus 226 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 303 (361)
++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||...... ..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 999999999999999876433 23345689999999998877 5666 999999999999999999998754331 22
Q ss_pred hHhhhhcccCCCCCCCh-------------hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 304 MLIDLLDQRAPSPIDDQ-------------TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 304 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.......+.... ........+.+++.+||+.||.+|||+.|+++||||++.
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 22233333222221000 000112247899999999999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=360.97 Aligned_cols=257 Identities=11% Similarity=0.024 Sum_probs=187.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHH---HHHhcCCCCcceeee-------EE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEA---RLLSQIRHRNIVKLY-------GF 155 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 155 (361)
..+|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+ ..++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 445888999999999999999764 789999999987654 334456677784 45555 799988755 44
Q ss_pred EeeC-----------------CeEEEEEEeccCCChhhhhccCCccCCCCHHHH------HHHHHHHHHHHHHHHcCCCC
Q 042457 156 CLHK-----------------KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKR------VNIVKSMAHALSYLHYDCIP 212 (361)
Q Consensus 156 ~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~Lh~~~~~ 212 (361)
+... ...++||||++ |+|.+++...+. .+.+..+ ..++.|++.||+|||+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 4433 33899999998 899999986432 2445555 77889999999999999
Q ss_pred CeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcccccccccccccccccc--cccCccchhhhHHHHHHHHHhCC
Q 042457 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGR 290 (361)
Q Consensus 213 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~ 290 (361)
+|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986532 1223456799999999987 77999999999999999999999
Q ss_pred CCCCCcccCCcchhH----hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 291 HPGDLLSSFNPKIML----IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 291 ~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.||............ ..........+... .....+.+|+.+||+.||++|||+.|+++||||++
T Consensus 291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT----PLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSS----CCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCCcCcccccchhhhhhhhccccccchhhcc----CCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 999865432111110 00011111111100 11124888999999999999999999999999964
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=339.43 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=212.9
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-------hHHHHHHHHHHHHHHhcCC-CCcceeeeEEEe
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-------ELAFLESFQTEARLLSQIR-HRNIVKLYGFCL 157 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~ 157 (361)
..++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999764 688999999875431 1233467889999999995 999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
..+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999997643 689999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccccccccccc------ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAY------TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
|++....... ......++..|+|||.+. ...++.++||||||+++|||++|+.||..... ......+...
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT
T ss_pred cchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHHHHhcC
Confidence 9998764332 233456899999999875 45678899999999999999999999865432 2222333333
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
....+..... .....+.+++.+||+.||.+|||+.|+++||||++..
T Consensus 245 ~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 NYQFGSPEWD--DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCCCTTTGG--GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred CcccCccccc--ccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 3222211111 1122488999999999999999999999999998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=345.49 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=208.8
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
..++|.+.+.||+|+||.||++... +|+.||+|.+....... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR--DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3567899999999999999999764 78999999997654322 35688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee---CCCCCeEEeeecCccc
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARL 242 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~ 242 (361)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++ ++++.+||+|||++..
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 85 MQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp ECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999987544 589999999999999999999999 99999999999999 7889999999999875
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.......+.....
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~- 232 (304)
T 2jam_A 159 EQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFEKIKEGYYEFESPFWD- 232 (304)
T ss_dssp CCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHCCCCCCTTTTT-
T ss_pred cCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCCCCccccc-
Confidence 432 223345689999999999999999999999999999999999999875432 22223333332221111000
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+++.+||+.||++|||+.|+++||||+.
T Consensus 233 -~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 233 -DISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp -TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred -cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 11124889999999999999999999999999965
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=361.42 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=202.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC------CCCcceeeeEEEeeCC
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQI------RHRNIVKLYGFCLHKK 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~ 160 (361)
..+|++.+.||+|+||.||+|... +++.||||++..... ..+.+..|+.+++.+ +|+||+++++++...+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR---FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc---hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 457999999999999999999654 588999999976432 235666777777766 5779999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC--eEEeeec
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE--AFVADFG 238 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg 238 (361)
..++||||+. ++|.+++...... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999996 6898888765422 489999999999999999999999 9999999999999999887 9999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc--------
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD-------- 310 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------- 310 (361)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..........
T Consensus 248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 99764322 2234689999999999999999999999999999999999999875443111000000000
Q ss_pred ----------cc-CC--------------------------CCCCChhhHHH------HHHHHHHHhhhcCCCCCCCCCc
Q 042457 311 ----------QR-AP--------------------------SPIDDQTVIQD------IILVSKIAFACLRSKPKSRPTM 347 (361)
Q Consensus 311 ----------~~-~~--------------------------~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPs~ 347 (361)
.. .+ .+.. ...+.. ...+.+|+.+||+.||++|||+
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPE-SREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTT-CSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCcc-chhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 00 00 0000 000100 1347899999999999999999
Q ss_pred cccccCCCCCCCC
Q 042457 348 RRSFPNPEINPSL 360 (361)
Q Consensus 348 ~eil~hp~~~~~~ 360 (361)
.|+|+||||++.+
T Consensus 404 ~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 404 GQALRHPWLRRRL 416 (429)
T ss_dssp HHHHTSTTTC---
T ss_pred HHHhCChhhccCC
Confidence 9999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=348.01 Aligned_cols=263 Identities=25% Similarity=0.402 Sum_probs=204.8
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEee--
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLH-- 158 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-- 158 (361)
++....++|++.+.||+|+||.||+|.. .+|+.||+|++...... .+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3345677899999999999999999976 47899999998765433 26678999999998 79999999999987
Q ss_pred ----CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEE
Q 042457 159 ----KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFV 234 (361)
Q Consensus 159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl 234 (361)
.+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 4678999999999999999976432 2689999999999999999999999 9999999999999999999999
Q ss_pred eeecCccccCCCCCCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh
Q 042457 235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 235 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 309 (361)
+|||++..............|+..|+|||++. +..++.++||||||+++|+|++|+.||..... ......+.
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~ 247 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP 247 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh
Confidence 99999987654333344456899999999986 56688999999999999999999999865432 11222222
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 310 DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+....... ...+.+++.+||+.||.+|||+.|+++||||++.
T Consensus 248 ~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 248 RNPAPRLKSKKW----SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HSCCCCCSCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cCccccCCcccc----CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 222221111111 1247899999999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=346.54 Aligned_cols=251 Identities=28% Similarity=0.446 Sum_probs=202.8
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
..++|.+.+.||+|+||.||+|... .+..||||.+...... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 3467888999999999999999774 3456999999865433 3357899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999976533 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCC
Q 042457 243 LHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPI 317 (361)
Q Consensus 243 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 317 (361)
....... .....+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+... ..+.+.
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~ 277 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRLPAPM 277 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCCCCT
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCCCCCC
Confidence 6543322 222345778999999998899999999999999999999 9999865432 2222222222 122222
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+ ..+.+++.+||+.||++|||+.|+++
T Consensus 278 ~~~------~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 278 GCP------HALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TCC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcC------HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 24888999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=338.08 Aligned_cols=250 Identities=23% Similarity=0.442 Sum_probs=207.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..++|++.+.||+|+||.||+|...++..||+|++....... +.+.+|+.++++++||||+++++++...+..++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 456789999999999999999999888899999998665443 56889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999976432 589999999999999999999999 9999999999999999999999999999866443
Q ss_pred CCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCC-CCCCChhhH
Q 042457 247 SSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQTVI 323 (361)
Q Consensus 247 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 323 (361)
... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ............. .+...+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~--- 231 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHRLYRPHLAS--- 231 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCCCCTTSC---
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCCCCCCCcCh---
Confidence 322 222345678999999998889999999999999999999 9999875443 2222222222221 111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.+++.+||+.||++|||+.|++++
T Consensus 232 ---~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 232 ---DTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ---HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 248889999999999999999999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=353.31 Aligned_cols=273 Identities=22% Similarity=0.308 Sum_probs=205.8
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcc---------hHHHHHHHHHHHHHHhcCCCCcce
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSET---------ELAFLESFQTEARLLSQIRHRNIV 150 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~niv 150 (361)
...++....++|.+.+.||+|+||.||+|...+|+.||||++..... .....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45677888999999999999999999999888899999999865322 122347789999999999999999
Q ss_pred eeeEEEeeC-----CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCee
Q 042457 151 KLYGFCLHK-----KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNIL 225 (361)
Q Consensus 151 ~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nil 225 (361)
++++++... ...++||||++ |+|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 999999643 36899999997 588877765432 589999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeeecCccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh
Q 042457 226 LNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM 304 (361)
Q Consensus 226 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 304 (361)
++.++.+||+|||++....... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999997543322 2334568899999998876 6789999999999999999999999975432111100
Q ss_pred Hhh--------------------hhcccCC-CCCCChh--hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 305 LID--------------------LLDQRAP-SPIDDQT--VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 305 ~~~--------------------~~~~~~~-~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
... ....... .+..... .......+.+|+.+||+.||++|||+.|+++||||++.
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 000 0001000 0000000 00112347899999999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=368.92 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=209.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
..++|.+.+.||+|+||.||++... +|+.||||++............+.+|+.++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999764 789999999864332222246788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC---CCCCeEEeeecCccc
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN---SKLEAFVADFGVARL 242 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~ 242 (361)
|||+++++|.+.+.... .+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999887654 589999999999999999999999 999999999999995 456799999999986
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......+.......+.....
T Consensus 174 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~- 247 (486)
T 3mwu_A 174 FQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYAFDLPQWR- 247 (486)
T ss_dssp BCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCSCSGGGG-
T ss_pred CCCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCcccC-
Confidence 64332 2334569999999999875 589999999999999999999999875432 22333333333322221111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+++.+||+.||.+|||+.|+|+||||++
T Consensus 248 -~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 248 -TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp -GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 11224789999999999999999999999999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=350.54 Aligned_cols=265 Identities=24% Similarity=0.414 Sum_probs=193.3
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEeCCCC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEe
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCL 157 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 157 (361)
+++.+..++|.+.+.||+|+||.||+|...... .||||++..........+.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 344556778999999999999999999765432 7999999876444444688999999999999999999999998
Q ss_pred eCCeE------EEEEEeccCCChhhhhccCC---ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC
Q 042457 158 HKKCM------FLIYKYMRRGSLFCVLRNDD---EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228 (361)
Q Consensus 158 ~~~~~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~ 228 (361)
..... ++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC
Confidence 87654 99999999999999986432 222589999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhH
Q 042457 229 KLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIML 305 (361)
Q Consensus 229 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 305 (361)
++.+||+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~ 249 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIY 249 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh---HHHH
Confidence 999999999999876443321 223346788999999999999999999999999999999 9999875443 2222
Q ss_pred hhhhcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCC-------ccccccCCCCCC
Q 042457 306 IDLLDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPT-------MRRSFPNPEINP 358 (361)
Q Consensus 306 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-------~~eil~hp~~~~ 358 (361)
..+..... ..+.... ..+.+++.+||+.||++||| ++++++|||+..
T Consensus 250 ~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 250 NYLIGGNRLKQPPECM------EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp HHHHTTCCCCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred HHHhcCCCCCCCCccC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 22222221 2221111 24889999999999999999 888889999965
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=343.74 Aligned_cols=259 Identities=23% Similarity=0.335 Sum_probs=208.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchH----HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL----AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|.+.+.||+|+||.||++... +|+.||+|.+....... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456899999999999999999775 68999999987643211 1246788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC----CeEEeeec
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL----EAFVADFG 238 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 238 (361)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997643 689999999999999999999999 999999999999998877 79999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-- 231 (283)
T 3bhy_A 158 IAHKIEAGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAVNYDFD-- 231 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCCCC--
T ss_pred cceeccCCCc-ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhcccCCc--
Confidence 9987643322 2334589999999999988999999999999999999999999875432 122222222221111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..........+.+++.+||+.||++|||+.|+++||||++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 0000111234889999999999999999999999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=354.05 Aligned_cols=258 Identities=22% Similarity=0.283 Sum_probs=199.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------ 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 160 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999965 46889999999765544455678889999999999999999999998765
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 78777752 488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc----------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD---------- 310 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 310 (361)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..
T Consensus 175 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 175 RTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHHH
T ss_pred ccccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 7654322 2234568999999999999899999999999999999999999997543211 1111111
Q ss_pred ------------ccCC--------------CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 311 ------------QRAP--------------SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 311 ------------~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.... .+............+.+|+.+||+.||++|||++|+++||||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0000 01111111222346889999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=339.26 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=207.9
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+..++|.+.+.||+|+||.||+|...+++.||+|++....... +.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 3456789999999999999999998889999999998765443 5688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999976543 589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCC-CCCCChhh
Q 042457 246 DSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQTV 322 (361)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 322 (361)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+...... .+...+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~-- 233 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRLYKPRLAS-- 233 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCCCTTSC--
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCccCCCCCcCC--
Confidence 221 1223346778999999998899999999999999999999 9999875432 2222233322221 111111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.+++.+||+.||++|||+.|+++|
T Consensus 234 ----~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 234 ----THVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 247889999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=368.21 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=212.7
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
..++|++.+.||+|+||.||++... +|+.||||++..... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3567999999999999999999765 789999999865432 12234778899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee---CCCCCeEEeeecCcc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL---NSKLEAFVADFGVAR 241 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~ 241 (361)
||||+.+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999987654 589999999999999999999999 99999999999999 567899999999998
Q ss_pred ccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChh
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (361)
...... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||..... ......+.......+.....
T Consensus 178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 252 (484)
T 3nyv_A 178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKVEKGKYTFELPQWK 252 (484)
T ss_dssp HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCSGGGG
T ss_pred Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCCCCCcccc
Confidence 765433 3344569999999998866 689999999999999999999999875432 22333333333322221111
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+.+|+.+||+.||.+|||+.|+++||||++
T Consensus 253 --~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 253 --KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp --GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred --cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 11224789999999999999999999999999963
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=353.88 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=208.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||++... +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC-HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 467899999999999999999765 689999999976543 333577899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.... .+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.+||+|||++......
T Consensus 111 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred ECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999997654 5899999999999999999999832 7999999999999999999999999998755322
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcch-----------------------
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI----------------------- 303 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~----------------------- 303 (361)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1223468999999999999999999999999999999999999987533211000
Q ss_pred ----------------hHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 304 ----------------MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 304 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+.....+...... ....+.+|+.+||+.||++|||+.|+++||||++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV----FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCccc----ccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 00111111111111000 1124889999999999999999999999999964
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=363.15 Aligned_cols=250 Identities=16% Similarity=0.168 Sum_probs=194.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHH---HHHhcCCCCcceeee-------EE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEA---RLLSQIRHRNIVKLY-------GF 155 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 155 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+ ..++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999986 4699999999874421 222357788999 555566899999998 66
Q ss_pred EeeCC-----------------eEEEEEEeccCCChhhhhccCCc----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 042457 156 CLHKK-----------------CMFLIYKYMRRGSLFCVLRNDDE----AIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214 (361)
Q Consensus 156 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i 214 (361)
+...+ ..++||||+ +|+|.+++..... ...+++..++.++.|++.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66543 278999999 6899999976421 11244688889999999999999999 99
Q ss_pred EEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccccccccccccccccccc-----------ccCccchhhhHHHHH
Q 042457 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-----------VVTEKCDVFGFGVVA 283 (361)
Q Consensus 215 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l 283 (361)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||+++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999999999999999985322 2333456 999999999887 899999999999999
Q ss_pred HHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 284 LEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 284 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
|||++|+.||.......... .+.... ...+ ..+.+++.+||+.||++|||+.|+++||||++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~---~~~~~~----~~~~------~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSE---WIFRSC----KNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSG---GGGSSC----CCCC------HHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchh---hhhhhc----cCCC------HHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999997544322111 111111 1111 24788999999999999999999999999964
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=354.68 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=190.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------C
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------K 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 160 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46799999999999999999964 5789999999976554444567888999999999999999999999754 5
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++++|++ +++|.+++... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 78999988753 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh----------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL---------- 309 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---------- 309 (361)
+..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+.........
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 180 RHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 765332 233568999999999876 678999999999999999999999997644321111111110
Q ss_pred ----------cccCCCCCCChhh--HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 310 ----------DQRAPSPIDDQTV--IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 310 ----------~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
......+...... ......+.+|+.+||+.||.+|||+.|+|+||||++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 0000000000000 001134789999999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=347.17 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=202.9
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC----e
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK----C 161 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 161 (361)
...++|++.+.||+|+||.||+|+. .++.||||++...... ...+..|+.++++++||||+++++++.... .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchH---HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 4457899999999999999999988 4889999999755432 245566899999999999999999998754 4
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCCeEEeCCCCCCeeeCCCCCeEE
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC-------IPSIVHRDISSNNILLNSKLEAFV 234 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-------~~~i~H~dlk~~Nill~~~~~~kl 234 (361)
.++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++++||||||+|||++.++.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 79999999999999999764 4899999999999999999999862 238999999999999999999999
Q ss_pred eeecCccccCCCCCC--cccccccccccccccccc-----cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcc-----
Q 042457 235 ADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYT-----MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK----- 302 (361)
Q Consensus 235 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~----- 302 (361)
+|||+++........ .....||+.|+|||++.+ ..++.++||||||+++|||+||+.||.........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543322 233568999999999876 45677899999999999999999998754332111
Q ss_pred --------hhHhhhhcccCCCCCCC-hhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 303 --------IMLIDLLDQRAPSPIDD-QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 303 --------~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
................. .........+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11111111211111111 112233445899999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=367.64 Aligned_cols=259 Identities=27% Similarity=0.364 Sum_probs=208.2
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchH-----------HHHHHHHHHHHHHhcCCCCcceeeeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETEL-----------AFLESFQTEARLLSQIRHRNIVKLYG 154 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~~~~ 154 (361)
..++|.+.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999764 67899999987643221 23467889999999999999999999
Q ss_pred EEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC---C
Q 042457 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL---E 231 (361)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~ 231 (361)
++......++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999887654 589999999999999999999999 999999999999998775 6
Q ss_pred eEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
+||+|||++....... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||..... ......+...
T Consensus 188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~ 262 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKVEKG 262 (504)
T ss_dssp EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC
T ss_pred EEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcC
Confidence 9999999998765432 333456999999999876 4689999999999999999999999875432 2233333333
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+.. ........+.+|+.+||+.||.+|||+.|+|+||||++
T Consensus 263 ~~~~~~~--~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 263 KYYFDFN--DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp CCCCCHH--HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCcc--ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 3222111 00011234889999999999999999999999999964
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=355.39 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=206.0
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
+.+..++|.+.+.||+|+||.||+|... +++.||||.++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 3455678889999999999999999875 789999999875533 23346788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++|+|.++++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 999999999999999975432 589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCC
Q 042457 243 LHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPID 318 (361)
Q Consensus 243 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (361)
....... .....++..|+|||.+.+..++.++||||||+++|||+| |..||...... .....+... ..+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 339 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFVEKGGRLPCPEL 339 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHHHTTCCCCCCTT
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCCCCCC
Confidence 4332111 112235778999999998899999999999999999998 99998754321 111112111 2222222
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.+ ..+.+++.+||+.||++|||+.++++
T Consensus 340 ~~------~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 340 CP------DAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC------HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11 24788999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=341.10 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=195.9
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
..++|++.+.||+|+||.||++.. .+|+.||+|++..........+.+.++...++.++||||+++++++...+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999976 5789999999987655554445566666678889999999999999999999999
Q ss_pred EEeccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 166 YKYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|||++ |+|.+++... .....+++..++.++.|++.||+|||++. +++||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 4887776541 11236899999999999999999999843 89999999999999999999999999997664
Q ss_pred CCCCCcccccccccccccccc----cccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 245 SDSSNRTVVAGTHGYIAPELA----YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||..... .............+......
T Consensus 162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 162 DDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHSCCCCCCTTT
T ss_pred ccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhccCCCCccccc
Confidence 332 22334689999999995 566789999999999999999999999874322 12222222332222211111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. ...+.+++.+||+.||++|||+.|+++||||+.
T Consensus 239 ~----~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 239 F----SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred C----CHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 1 124789999999999999999999999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=346.80 Aligned_cols=268 Identities=25% Similarity=0.408 Sum_probs=191.2
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
+.+..++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 4566788999999999999999999754 6889999998654332 2246788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccC-----CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 163 FLIYKYMRRGSLFCVLRND-----DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
++||||+++++|.+++... .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence 9999999999999998641 1123589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCC-----Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 238 GVARLLHSDSS-----NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 238 g~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
|++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 242 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLMLTLQN 242 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHTS
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHHHhcc
Confidence 99876643221 1233468999999998875 568999999999999999999999987644321 11112222
Q ss_pred cCCCCCCChh----hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 312 RAPSPIDDQT----VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 312 ~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+....... .......+.+++.+||+.||.+|||+.|+++||||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 1111100000 0001124788999999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=352.51 Aligned_cols=263 Identities=23% Similarity=0.357 Sum_probs=211.3
Q ss_pred cCHHHHHHHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCccee
Q 042457 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVK 151 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 151 (361)
+...+++...++|.+.+.||+|+||.||+|.+ .+++.||||++....... ..+.+.+|++++.++ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-HHHHHHHHHHHHHhhcCCcceee
Confidence 45677788899999999999999999999963 346789999997654433 357789999999999 7899999
Q ss_pred eeEEEeeCCe-EEEEEEeccCCChhhhhccCCc-----------------------------------------------
Q 042457 152 LYGFCLHKKC-MFLIYKYMRRGSLFCVLRNDDE----------------------------------------------- 183 (361)
Q Consensus 152 ~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 183 (361)
+++++...+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999988654 8999999999999999976532
Q ss_pred ----------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 184 ----------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 184 ----------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 11288999999999999999999999 99999999999999999999999999998664433
Q ss_pred C--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCChhhH
Q 042457 248 S--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQTVI 323 (361)
Q Consensus 248 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 323 (361)
. ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... ........... ...+....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~--- 322 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRMRAPDYTT--- 322 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHHHHHHHHTCCCCCCTTCC---
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--HHHHHHHHcCCCCCCCCCCC---
Confidence 2 2233567889999999999999999999999999999998 99998754321 11112222221 11111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.+++.+||+.||.+|||+.|+++|
T Consensus 323 ---~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 323 ---PEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 247889999999999999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=351.10 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=194.3
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
..++|.+.+.||+|+||.||+|+.. ++..||||.++..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 3467999999999999999999764 5778999999765433 3357899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++|+|.++++.... .+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 999999999999999976542 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCC
Q 042457 243 LHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPI 317 (361)
Q Consensus 243 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 317 (361)
....... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+... ..+.+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~~~~ 273 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLPPPM 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECCCCT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCc
Confidence 6543221 112235678999999999999999999999999999998 9999875432 1222222222 122222
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 274 ~~~------~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 274 DCP------AALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TCB------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccc------HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 211 24889999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=344.59 Aligned_cols=257 Identities=18% Similarity=0.280 Sum_probs=202.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEee--CCeEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLH--KKCMF 163 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~ 163 (361)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 36789999999999999999965 578999999997543 256889999999997 9999999999998 56789
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-CeEEeeecCccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARL 242 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~ 242 (361)
+||||+++++|.+++. .+++..+..++.|++.||+|||+. +++||||||+|||++.++ .+||+|||+++.
T Consensus 110 lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 9999999999999885 488899999999999999999999 999999999999999776 899999999986
Q ss_pred cCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh----------Hhhhhcc
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM----------LIDLLDQ 311 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~----------~~~~~~~ 311 (361)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... .......
T Consensus 181 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 181 YHPGQE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp CCTTCC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCCCc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 644332 334468999999999876 6789999999999999999999999853221100000 0000000
Q ss_pred -cCCC--------------C----CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 312 -RAPS--------------P----IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 312 -~~~~--------------~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.... . ............+.+|+.+||+.||++|||++|+++||||++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 0000 0 0000000012358899999999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=347.45 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=206.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-----Ce
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK-----KC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 161 (361)
.++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 467999999999999999999754 6889999999754432 3357788999999999999999999999765 36
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||+. ++|.+++... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999997 5899988754 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---cccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc------
Q 042457 242 LLHSDSSN---RTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ------ 311 (361)
Q Consensus 242 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------ 311 (361)
........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+...........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 76433221 233468999999998654 45899999999999999999999999765432211111111100
Q ss_pred --------------cCCCCCCChh--hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 312 --------------RAPSPIDDQT--VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 312 --------------~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.......... .......+.+|+.+||+.||++|||+.|+++||||++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0000000000 00011347899999999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=338.01 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=197.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhc--CCCCcceeeeEEEeeC----C
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQ--IRHRNIVKLYGFCLHK----K 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~ 160 (361)
..++|.+.+.||+|+||.||+|.. +|+.||||++..... ..+..|.+++.. ++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE-----KSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH-----HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc-----hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 356799999999999999999988 789999999865432 445556666665 7999999999997653 4
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEEeCCCCCCeeeCCCCCe
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH--------YDCIPSIVHRDISSNNILLNSKLEA 232 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~i~H~dlk~~Nill~~~~~~ 232 (361)
..++||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +++||||||+|||++.++.+
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence 589999999999999999654 5899999999999999999999 77 99999999999999999999
Q ss_pred EEeeecCccccCCCCCC----ccccccccccccccccccc------ccCccchhhhHHHHHHHHHhC----------CCC
Q 042457 233 FVADFGVARLLHSDSSN----RTVVAGTHGYIAPELAYTM------VVTEKCDVFGFGVVALEVLMG----------RHP 292 (361)
Q Consensus 233 kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg----------~~p 292 (361)
||+|||+++........ .....||+.|+|||.+.+. .++.++||||||+++|||+|| +.|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 99999999766443322 2234689999999998876 566799999999999999999 788
Q ss_pred CCCcccCCcchh-Hhhhh--cccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 293 GDLLSSFNPKIM-LIDLL--DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 293 ~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
|........... ..... ....+..............+.+++.+||+.||++|||+.|+++
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 765433222211 11111 1111111111112234456899999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=338.88 Aligned_cols=252 Identities=24% Similarity=0.430 Sum_probs=205.7
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
.+..++|++.+.||+|+||.||++...++..||+|++....... +.+.+|++++++++||||+++++++...+..++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 34567899999999999999999999888899999998765443 568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++++|.+++..... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EECCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEeccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999976432 589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCC-CCCCChh
Q 042457 245 SDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQT 321 (361)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 321 (361)
.... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+...... .+...+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~- 247 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLYRPHLAS- 247 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCCCCTTCC-
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhcccCCCCCCcCC-
Confidence 3211 1222346778999999998889999999999999999998 9999875443 2222222222211 111111
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.+++.+||+.||.+|||++|+++|
T Consensus 248 -----~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 -----EKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -----HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 248889999999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=343.21 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=202.9
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc------hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET------ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
..++|.+.+.||+|+||.||+|... +++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999764 578999999875432 112234578999999999999999999998766
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC---eEEee
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE---AFVAD 236 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~D 236 (361)
+ .++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 899999999999999987654 689999999999999999999999 9999999999999987654 99999
Q ss_pred ecCccccCCCCCCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 237 FGVARLLHSDSSNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 237 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||........ ....+.....
T Consensus 161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~ 237 (322)
T 2ycf_A 161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITSGKY 237 (322)
T ss_dssp CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHHTCC
T ss_pred Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHhCcc
Confidence 9999866432 1223346899999999864 56788999999999999999999999975443211 1112222221
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
... ..........+.+++.+||+.||++|||+.|+++||||++
T Consensus 238 ~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 238 NFI--PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CCC--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ccC--chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 110 0000011235889999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=342.98 Aligned_cols=265 Identities=22% Similarity=0.384 Sum_probs=208.9
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC--CCcceeeeEEEee
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR--HRNIVKLYGFCLH 158 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~ 158 (361)
++.+....++|.+.+.||+|+||.||++...+++.||+|++..........+.+.+|+.++++++ |+||+++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33444567789999999999999999999888999999999776555555688999999999997 5999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
.+..++||| +.+++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 66889999998654 689999999999999999999999 9999999999999965 799999999
Q ss_pred CccccCCCCCC--cccccccccccccccccc-----------cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH
Q 042457 239 VARLLHSDSSN--RTVVAGTHGYIAPELAYT-----------MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML 305 (361)
Q Consensus 239 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 305 (361)
++......... .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~ 249 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKL 249 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHH
Confidence 99866433221 233468999999999865 4678899999999999999999999875432 11122
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
................ ...+.+++.+||+.||.+|||+.|+++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 250 HAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHhcccccCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 2222222211111111 1247889999999999999999999999999763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=337.50 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=204.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCcceeeeEEEe--eCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE--LAFLESFQTEARLLSQIRHRNIVKLYGFCL--HKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~ 162 (361)
.++|.+.+.||+|+||.||++... +++.||+|++...... ....+.+.+|+.+++.++||||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999764 6889999998754321 123477899999999999999999999984 45578
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||++++ |.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 6666654332 2689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--Ccccccccccccccccccccc--cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 243 LHSDSS--NRTVVAGTHGYIAPELAYTMV--VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 243 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
...... ......||..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ......+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~ 235 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKLFENIGKGSYAIPGD 235 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCCCCCSS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHHHHHHhcCCCCCCCc
Confidence 643222 223446899999999987643 47799999999999999999999875332 22223333333322222
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.. ..+.+++.+||+.||.+|||+.|+++||||++.
T Consensus 236 ~~------~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 236 CG------PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp SC------HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred cC------HHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 21 247889999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=349.77 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=202.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE----
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM---- 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---- 162 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46799999999999999999965 4689999999987655555567889999999999999999999999887654
Q ss_pred --EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 163 --FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 163 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 688877743 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh------------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID------------ 307 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~------------ 307 (361)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.......
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 192 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 765332 233468999999999877 7789999999999999999999999975442111110000
Q ss_pred --------hhcccCCCCCCChhh--HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 308 --------LLDQRAPSPIDDQTV--IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 308 --------~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........+...... ......+.+|+.+||+.||++|||+.|+++||||++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 000001111100000 011235889999999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=347.42 Aligned_cols=269 Identities=21% Similarity=0.251 Sum_probs=192.1
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
+......++|.+.+.||+|+||.||+|... +|+.||||++....... ..+.+++..++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 455667789999999999999999999764 68999999986543322 34567788888899999999999997644
Q ss_pred e-------EEEEEEeccCCChhhhhcc-CCccCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEEeCCCCCCeeeCC-C
Q 042457 161 C-------MFLIYKYMRRGSLFCVLRN-DDEAIQLDWTKRVNIVKSMAHALSYLH--YDCIPSIVHRDISSNNILLNS-K 229 (361)
Q Consensus 161 ~-------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~~~~i~H~dlk~~Nill~~-~ 229 (361)
. .++||||++++ |...+.. ......+++..+..++.|++.||.||| +. +|+||||||+|||++. +
T Consensus 93 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 3 78999999875 4333321 122236899999999999999999999 88 9999999999999997 8
Q ss_pred CCeEEeeecCccccCCCCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhh
Q 042457 230 LEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDL 308 (361)
Q Consensus 230 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 308 (361)
+.+||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...............
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp TEEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CcEEEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 9999999999987654332 2344689999999988654 4899999999999999999999999764431111111110
Q ss_pred hccc--------CCCCCC------ChhhH---------HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 309 LDQR--------APSPID------DQTVI---------QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 309 ~~~~--------~~~~~~------~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.... .+.... ....+ .....+.+|+.+||+.||.+|||+.|+++||||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 0000 000000 00000 01235889999999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=338.40 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=210.9
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
....++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999765 6899999998765443333577889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC---CCeEEeeecCc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK---LEAFVADFGVA 240 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~~ 240 (361)
+|+||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998886544 589999999999999999999999 99999999999999764 46999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ......+.......+....
T Consensus 172 ~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~ 246 (287)
T 2wei_A 172 TCFQQNTK-MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYAFDLPQW 246 (287)
T ss_dssp GTBCCCSS-CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCSGGG
T ss_pred eeecCCCc-cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCchhh
Confidence 86643322 233458899999998765 489999999999999999999999875432 2222333333222211110
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
......+.+++.+||+.||++|||+.|+++||||++
T Consensus 247 --~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 247 --RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred --hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 011124789999999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=354.88 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=187.2
Q ss_pred cCCCC-cCeeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--CCeE
Q 042457 89 EDFDI-KYCIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--KKCM 162 (361)
Q Consensus 89 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 162 (361)
+.|.+ .++||+|+||.||+|... +++.||+|++...... ..+.+|+.+++.++||||+++++++.. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34665 457999999999999865 5789999999765443 457789999999999999999999965 6789
Q ss_pred EEEEEeccCCChhhhhccCC------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee----CCCCCe
Q 042457 163 FLIYKYMRRGSLFCVLRNDD------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL----NSKLEA 232 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~ 232 (361)
++||||+. ++|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 47777765321 122489999999999999999999999 99999999999999 677899
Q ss_pred EEeeecCccccCCCC---CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCC------cc
Q 042457 233 FVADFGVARLLHSDS---SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN------PK 302 (361)
Q Consensus 233 kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------~~ 302 (361)
||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999999998764322 12234568999999999877 458999999999999999999999996443210 00
Q ss_pred hhHhhhhcccCCCCCCC--h----------------------hhHH--------HHHHHHHHHhhhcCCCCCCCCCcccc
Q 042457 303 IMLIDLLDQRAPSPIDD--Q----------------------TVIQ--------DIILVSKIAFACLRSKPKSRPTMRRS 350 (361)
Q Consensus 303 ~~~~~~~~~~~~~~~~~--~----------------------~~~~--------~~~~l~~li~~cl~~dP~~RPs~~ei 350 (361)
..+..+........... . .... ....+.+|+.+||+.||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11111111000000000 0 0000 01247789999999999999999999
Q ss_pred ccCCCCCCC
Q 042457 351 FPNPEINPS 359 (361)
Q Consensus 351 l~hp~~~~~ 359 (361)
|+||||++.
T Consensus 332 L~hp~f~~~ 340 (405)
T 3rgf_A 332 MQDPYFLED 340 (405)
T ss_dssp HTSGGGTSS
T ss_pred hcChhhccC
Confidence 999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=348.33 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=202.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe----
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC---- 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 161 (361)
.++|++.+.||+|+||.||++.. .+++.||||++..... .......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999975 5789999999976533 33445678999999999999999999999887543
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 499999999999999997654 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC---CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 242 LLHSDSS---NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 242 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..............+.
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~- 240 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDPIPPS- 240 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCCCCHH-
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCCCcc-
Confidence 6644322 22334589999999999999999999999999999999999999875432 1222222222211110
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
.........+.+++.+||+.||++||+..+++.|+|++
T Consensus 241 -~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 241 -ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp -HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 00000122478999999999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=355.40 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=198.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------e
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------C 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 161 (361)
..+|.+.+.||+|+||.||+|+..++..||+|++...... ..+|+.+++.++||||+++++++...+ .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4568999999999999999999877777999988654322 236899999999999999999997543 3
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC-CCCCeEEeeecCc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN-SKLEAFVADFGVA 240 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~ 240 (361)
.++||||++++.+............+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 789999998765544332222223689999999999999999999999 999999999999998 7899999999999
Q ss_pred cccCCCCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh----------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL---------- 309 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---------- 309 (361)
+....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+.........
T Consensus 190 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 87644332 2334689999999988764 58999999999999999999999997654321111111100
Q ss_pred ------cccCCCCCCChhh----HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 310 ------DQRAPSPIDDQTV----IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 310 ------~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+........ ......+.+|+.+||+.||.+|||+.|+++||||++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 0011100000000 001135889999999999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=337.38 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=197.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-------- 158 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 158 (361)
.++|++.+.||+|+||.||+|.. .+|+.||||.+.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 56789999999999999999976 478999999996432 335778899999999999999999998865
Q ss_pred -----CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeE
Q 042457 159 -----KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF 233 (361)
Q Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~k 233 (361)
.+..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+|
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 3568999999999999999976432 578899999999999999999999 999999999999999999999
Q ss_pred EeeecCccccCCCC--------------CCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCccc
Q 042457 234 VADFGVARLLHSDS--------------SNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSS 298 (361)
Q Consensus 234 l~Dfg~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 298 (361)
|+|||++....... .......|+..|+|||.+.+. .++.++||||||+++|||++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 99999997654221 112334589999999998754 68999999999999999998 4432111
Q ss_pred CCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 299 FNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.......+.......+.... ......+.+++.+||+.||.+|||+.|+++||||+..
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 234 --RVNILKKLRSVSIEFPPDFD--DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp --HHHHHHHHHSTTCCCCTTCC--TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred --HHHHHHhccccccccCcccc--ccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 11111222222111111111 1112247889999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=346.13 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=202.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe--CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC---CCCcceeeeEEEe----
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL--PSGKIVALKKLHHSETELAFLESFQTEARLLSQI---RHRNIVKLYGFCL---- 157 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~---- 157 (361)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 4688999999865433221123455666666655 8999999999997
Q ss_pred -eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEee
Q 042457 158 -HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVAD 236 (361)
Q Consensus 158 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~D 236 (361)
.....++||||++ |+|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 699999876432 2489999999999999999999999 999999999999999999999999
Q ss_pred ecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc----
Q 042457 237 FGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR---- 312 (361)
Q Consensus 237 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 312 (361)
||++....... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||...................
T Consensus 164 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99997654222 2233468999999999998899999999999999999999999987543211111111000000
Q ss_pred -----------CC---CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 313 -----------AP---SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 313 -----------~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.. ..............+.+++.+||+.||++|||+.|+++||||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 00 00000000011124789999999999999999999999999976
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=346.24 Aligned_cols=260 Identities=23% Similarity=0.367 Sum_probs=207.9
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeCC------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEE
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLPS------GKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGF 155 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 155 (361)
+++...++|.+.+.||+|+||.||+|.... +..||+|.+...... ...+.+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 455667889999999999999999997642 247999999765543 2357789999999999 89999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCc-----------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCe
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDE-----------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNI 224 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Ni 224 (361)
+...+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence 9999999999999999999999875321 23579999999999999999999999 999999999999
Q ss_pred eeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCc
Q 042457 225 LLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNP 301 (361)
Q Consensus 225 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 301 (361)
|++.++.+||+|||++......... .....+|..|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-- 273 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-- 273 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--
Confidence 9999999999999999866443322 223456789999999988899999999999999999999 99998754321
Q ss_pred chhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 302 KIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
................... ...+.+++.+||+.||.+|||+.|++++
T Consensus 274 -~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 274 -SKFYKLVKDGYQMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp -HHHHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HHHHHHHhcCCCCCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 1222222222211111111 1247889999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=345.28 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=210.1
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 154 (361)
+..+....++|.+.+.||+|+||.||+|... +++.||+|.+...... ...+.+.+|+.+++.++||||+++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-HHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3444556789999999999999999999764 3478999999865433 33578999999999999999999999
Q ss_pred EEeeCCeEEEEEEeccCCChhhhhccCCc---------------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 042457 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDDE---------------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213 (361)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ 213 (361)
++...+..++||||+++++|.+++..... ...+++.+++.++.|++.||.|||+. +
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ 194 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 194 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 99999999999999999999999976421 13689999999999999999999999 9
Q ss_pred eEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC--CCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CC
Q 042457 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDS--SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GR 290 (361)
Q Consensus 214 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~ 290 (361)
++||||||+|||++.++.+||+|||++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999997654322 12233457889999999998899999999999999999999 99
Q ss_pred CCCCCcccCCcchhHhhhhcccCCC-CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 291 HPGDLLSSFNPKIMLIDLLDQRAPS-PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 291 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.||..... ......+....... +...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 275 ~p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 275 QPYYGMAH---EEVIYYVRDGNILACPENCP------LELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CTTTTSCH---HHHHHHHHTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCCh---HHHHHHHhCCCcCCCCCCCC------HHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99875432 22223333332221 11111 248889999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=350.71 Aligned_cols=257 Identities=26% Similarity=0.369 Sum_probs=206.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
..++|.+.+.||+|+||.||+|.+. +++.||||++....... ....+.+|+.++++++||||+++++++....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-DELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-hHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3567899999999999999999853 46689999997554332 3467889999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCC----ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC---CeE
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDD----EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL---EAF 233 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---~~k 233 (361)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999997643 123589999999999999999999999 999999999999999554 599
Q ss_pred EeeecCccccCCCC--CCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhc
Q 042457 234 VADFGVARLLHSDS--SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLD 310 (361)
Q Consensus 234 l~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 310 (361)
|+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+..
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i~~ 301 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVTS 301 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHT
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc
Confidence 99999997653222 22233457889999999999999999999999999999998 9999875432 222222332
Q ss_pred ccCC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 311 QRAP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 311 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
.... .+...+ ..+.+++.+||+.||++|||+.+++++.++
T Consensus 302 ~~~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 302 GGRMDPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp TCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCccCC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2221 111111 247889999999999999999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=346.99 Aligned_cols=261 Identities=24% Similarity=0.384 Sum_probs=207.4
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEE
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGF 155 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 155 (361)
+++...++|.+.+.||+|+||.||+|.. .++..||+|.+...... ...+.+.+|+.+++++ +||||++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH-HHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3456678899999999999999999975 24568999999754322 2346788999999999 89999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCcc--------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEA--------------------IQLDWTKRVNIVKSMAHALSYLHYDCIPSIV 215 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~ 215 (361)
+...+..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +++
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 194 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 194 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 99999999999999999999999765421 2479999999999999999999999 999
Q ss_pred EeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCC
Q 042457 216 HRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHP 292 (361)
Q Consensus 216 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p 292 (361)
||||||+|||++.++.+||+|||++......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999866443322 233457889999999988899999999999999999998 9999
Q ss_pred CCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCC
Q 042457 293 GDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp 354 (361)
|..... .................... ...+.+++.+||+.||.+|||+.|++++.
T Consensus 275 ~~~~~~---~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 275 YPGIPV---DANFYKLIQNGFKMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp STTCCC---SHHHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccCCc---HHHHHHHHhcCCCCCCCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 875432 11222222222211111111 12488899999999999999999998763
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=342.51 Aligned_cols=260 Identities=18% Similarity=0.326 Sum_probs=205.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEe--CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCC------cceeeeEEEeeC
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL--PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR------NIVKLYGFCLHK 159 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~ 159 (361)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++.++|+ +++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46799999999999999999975 368899999997543 2246778899988888655 499999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-----------
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS----------- 228 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~----------- 228 (361)
+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999 8899999876542 2588999999999999999999999 9999999999999987
Q ss_pred --------CCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC
Q 042457 229 --------KLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN 300 (361)
Q Consensus 229 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 300 (361)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999764332 233468999999999999899999999999999999999999997543321
Q ss_pred cchhHhhhhcccC------------------CCCCCC-----------------hhhHHHHHHHHHHHhhhcCCCCCCCC
Q 042457 301 PKIMLIDLLDQRA------------------PSPIDD-----------------QTVIQDIILVSKIAFACLRSKPKSRP 345 (361)
Q Consensus 301 ~~~~~~~~~~~~~------------------~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RP 345 (361)
............. ...... .........+.+++.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 1111111111000 000000 00011234588999999999999999
Q ss_pred CccccccCCCCCC
Q 042457 346 TMRRSFPNPEINP 358 (361)
Q Consensus 346 s~~eil~hp~~~~ 358 (361)
|+.|+++||||++
T Consensus 322 t~~ell~hp~f~~ 334 (339)
T 1z57_A 322 TLREALKHPFFDL 334 (339)
T ss_dssp CHHHHTTSGGGGG
T ss_pred CHHHHhcCHHHHH
Confidence 9999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=348.24 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=203.1
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CC-----cceeeeEEEeeC
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HR-----NIVKLYGFCLHK 159 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~ 159 (361)
..++|.+.+.||+|+||.||+|... +++.||||++.... .....+..|+.+++.++ |+ +++++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 4578999999999999999999754 68899999997543 22466778888888774 44 499999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC--CCCCeEEeee
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN--SKLEAFVADF 237 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Df 237 (361)
+..++||||+. ++|.+++...... .+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 5999998765422 589999999999999999999942 11899999999999994 5788999999
Q ss_pred cCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhh---------
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDL--------- 308 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--------- 308 (361)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+........
T Consensus 206 G~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 206 GSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999876432 23346899999999999999999999999999999999999999754321110000000
Q ss_pred ---------hcccC----------------CCCCC---------------------ChhhHHHHHHHHHHHhhhcCCCCC
Q 042457 309 ---------LDQRA----------------PSPID---------------------DQTVIQDIILVSKIAFACLRSKPK 342 (361)
Q Consensus 309 ---------~~~~~----------------~~~~~---------------------~~~~~~~~~~l~~li~~cl~~dP~ 342 (361)
..... ..+.. ......+...+.+|+.+||+.||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 00000 00000 000112223588999999999999
Q ss_pred CCCCccccccCCCCCCC
Q 042457 343 SRPTMRRSFPNPEINPS 359 (361)
Q Consensus 343 ~RPs~~eil~hp~~~~~ 359 (361)
+|||++|+|+||||++.
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=348.07 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=208.3
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEe--------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQL--------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGF 155 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 155 (361)
.+..++|.+.+.||+|+||.||+|.. .++..||||++...... ...+.+.+|+++++.+ +||||++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-HHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 45567899999999999999999975 23457999999766443 3357889999999999 89999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCC
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~ 222 (361)
+...+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 9999999999999999999999976431 23589999999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccC
Q 042457 223 NILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSF 299 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~ 299 (361)
|||++.++.+||+|||+++....... ......+|..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~- 299 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 299 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999986644322 2233457889999999999999999999999999999999 9999875432
Q ss_pred CcchhHhhhhcccCC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 300 NPKIMLIDLLDQRAP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 300 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
......+...... .+... ...+.+++.+||+.||++|||+.|++++
T Consensus 300 --~~~~~~~~~~~~~~~~~~~------~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 300 --EELFKLLKEGHRMDKPSNC------TNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp --HHHHHHHHTTCCCCCCSSC------CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCccC------CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222222222211 11111 1248889999999999999999999865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=346.06 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=203.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-----Ce
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK-----KC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 161 (361)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 467999999999999999999764 688999999975443 23346788999999999999999999998764 67
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||+. ++|.+++... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 6899888753 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC----------cccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhh--
Q 042457 242 LLHSDSSN----------RTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDL-- 308 (361)
Q Consensus 242 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-- 308 (361)
........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 76432211 122458999999998754 67899999999999999999999999754421110000000
Q ss_pred -------------------hcccCCCCCCChh--hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 309 -------------------LDQRAPSPIDDQT--VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 309 -------------------~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.......+..... .......+.+++.+||+.||++|||+.|+++||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0000000000000 0011234789999999999999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=349.73 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=198.2
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC----
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK---- 159 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 159 (361)
....++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 45677899999999999999999965 57999999998755322 23799999999999999999998543
Q ss_pred ----------------------------------CeEEEEEEeccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHH
Q 042457 160 ----------------------------------KCMFLIYKYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALS 204 (361)
Q Consensus 160 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~ 204 (361)
...++||||++ ++|.+.+... .....+++..+..++.|++.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34889999998 4777666531 11226899999999999999999
Q ss_pred HHHcCCCCCeEEeCCCCCCeeeC-CCCCeEEeeecCccccCCCCCCccccccccccccccccccc-ccCccchhhhHHHH
Q 042457 205 YLHYDCIPSIVHRDISSNNILLN-SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVV 282 (361)
Q Consensus 205 ~Lh~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~ 282 (361)
|||+. +|+||||||+|||++ .++.+||+|||+++...... ......+|..|+|||.+.+. .++.++||||+||+
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 999999999999997 68899999999998764433 23344689999999988764 48999999999999
Q ss_pred HHHHHhCCCCCCCcccCCcchhHhhhhcc--------------cCCCCCCChhhHH------HHHHHHHHHhhhcCCCCC
Q 042457 283 ALEVLMGRHPGDLLSSFNPKIMLIDLLDQ--------------RAPSPIDDQTVIQ------DIILVSKIAFACLRSKPK 342 (361)
Q Consensus 283 l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~ 342 (361)
+|||++|+.||......+........... ....+......+. ....+.+|+.+||+.||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999765432211111111000 0000000000010 112478999999999999
Q ss_pred CCCCccccccCCCCCC
Q 042457 343 SRPTMRRSFPNPEINP 358 (361)
Q Consensus 343 ~RPs~~eil~hp~~~~ 358 (361)
+|||+.|+++||||++
T Consensus 312 ~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDH 327 (383)
T ss_dssp GSCCHHHHHTSGGGHH
T ss_pred hCCCHHHHhcCHHHHH
Confidence 9999999999999963
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=337.60 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=199.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|++.+.||+|+||.||++.. .+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999975 4689999999865432 334457899999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999997654 689999999999999999999999 999999999999999999999999999987644
Q ss_pred CCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 246 DSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............+... ......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~ 239 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA---VSIAIKHIQDSVPNVT-TDVRKD 239 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---HHHHHHHHSSCCCCHH-HHSCTT
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhhccCCCcc-hhcccC
Confidence 332 22335689999999999999999999999999999999999999875432 1112222222221100 000001
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+.+++.+||+.||.+||+..+.+.
T Consensus 240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~ 267 (294)
T 4eqm_A 240 IPQSLSNVILRATEKDKANRYKTIQEMK 267 (294)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCSSHHHHH
T ss_pred CCHHHHHHHHHHhcCCHhHccccHHHHH
Confidence 1224888999999999999995444433
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=338.35 Aligned_cols=248 Identities=27% Similarity=0.461 Sum_probs=194.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.++|++.+.||+|+||.||+|+. .++.||+|.+..... .+.+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE----RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTH----HHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhH----HHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 45688899999999999999988 578899999865432 4678899999999999999999998874 4799999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC-eEEeeecCccccCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE-AFVADFGVARLLHSD 246 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~ 246 (361)
|+++++|.+++........+++..++.++.|+++||+|||+....+++||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999987665446889999999999999999999932228999999999999988886 799999999765332
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC-CCCCChhhHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQTVIQD 325 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 325 (361)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..........+ .+...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~------ 229 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNGTRPPLIKNL------ 229 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHTTCCCCCBTTC------
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhcCCCCCccccc------
Confidence 22345899999999999999999999999999999999999999754332111 11112222111 11111
Q ss_pred HHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 124788999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=352.64 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=201.8
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-eEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK-CMFL 164 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~l 164 (361)
+..++|.+.+.||+|+||.||+|.+ .|+.||||+++.... .+.|.+|+.++++++||||+++++++...+ ..++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCTT----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCchH----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 4557788899999999999999998 578999999986542 367889999999999999999999988765 7999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++|+|.++++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999999986532 2478999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCCChhh
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDDQTV 322 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 322 (361)
.. .....++..|+|||.+.+..++.++||||||+++|||+| |+.||......+ ....+..+ +.+.+...+
T Consensus 341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~~~~~~p~~~~-- 412 (450)
T 1k9a_A 341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKMDAPDGCP-- 412 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHHHTTCCCCCCTTCC--
T ss_pred cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCCCCCcCC--
Confidence 22 122356889999999999999999999999999999999 999987654322 22222222 222222211
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+.+++.+||+.||++|||+.++++
T Consensus 413 ----~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 413 ----PAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 24888999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=337.82 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=207.0
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
...++|.+.+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 4467899999999999999999965 3457899999976543 33357889999999999999999999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCc---------------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeC
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDE---------------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRD 218 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~d 218 (361)
+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++|+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999976432 12488999999999999999999999 999999
Q ss_pred CCCCCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCC
Q 042457 219 ISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDL 295 (361)
Q Consensus 219 lk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~ 295 (361)
|||+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876443321 223346788999999998889999999999999999999 9999875
Q ss_pred cccCCcchhHhhhhcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 296 LSSFNPKIMLIDLLDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
... ......+..... ..+... ...+.+++.+||+.||++|||+.|++++
T Consensus 256 ~~~---~~~~~~~~~~~~~~~~~~~------~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 256 IPP---ERLFNLLKTGHRMERPDNC------SEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCG---GGHHHHHHTTCCCCCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCH---HHHHHHhhcCCcCCCCccC------CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 443 112222222211 111111 1248899999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=357.93 Aligned_cols=254 Identities=26% Similarity=0.457 Sum_probs=207.6
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
+++++..++|.+.+.||+|+||.||+|.+.++..||||+++..... .+.+.+|+.++++++||||+++++++. .+.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 4456677889999999999999999999988899999999865443 478999999999999999999999987 567
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||+++|+|.++++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 8999999999999999975432 2578999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCC
Q 042457 242 LLHSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPID 318 (361)
Q Consensus 242 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (361)
....... ......++..|+|||++....++.++||||||+++|||+| |+.||..... ......+... +.+.+..
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~~~~ 409 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRMPRPEN 409 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCCCCCTT
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCC
Confidence 7643211 1122346778999999998899999999999999999999 9999875432 1222222222 2222222
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
. ...+.+++.+||+.||++|||+++|++
T Consensus 410 ~------~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 C------PEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp S------CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C------CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1 124889999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=329.82 Aligned_cols=252 Identities=29% Similarity=0.501 Sum_probs=192.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETE--LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|++.+.||+|+||.||+|.. .|+.||||++...... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46788999999999999999998 5889999998765332 22346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC--------CCCeEEeee
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS--------KLEAFVADF 237 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~--------~~~~kl~Df 237 (361)
|||+++++|.+++... .+++..++.++.|++.||+|||+....+++||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998643 5899999999999999999999992222999999999999986 678999999
Q ss_pred cCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCC
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (361)
|++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..............+.
T Consensus 161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVAMNKLALPI 235 (271)
T ss_dssp CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHTSCCCCCC
T ss_pred Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhhhcCCCCCCC
Confidence 9997654332 2234689999999999988999999999999999999999999875432 2222222222222221
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.... ...+.+++.+||+.||.+|||+.|++++
T Consensus 236 ~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 236 PSTC----PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Cccc----CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1111 1248899999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=343.88 Aligned_cols=253 Identities=17% Similarity=0.221 Sum_probs=204.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... +.+..|+.+++.+ +||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46799999999999999999975 57899999998755432 4577899999999 999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC-----eEEeeecCc
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE-----AFVADFGVA 240 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg~~ 240 (361)
|||+ +++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EEeC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 9999 9999999986432 689999999999999999999999 9999999999999998887 999999999
Q ss_pred cccCCCCCC-------cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 241 RLLHSDSSN-------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 241 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.......+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 876443321 2345699999999999999999999999999999999999999987654333332333322222
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+.. ........+.+++..||+.||.+||++.+|++
T Consensus 238 ~~~~~--~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIE--VLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHH--HHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHH--HHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11110 00000115889999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=351.85 Aligned_cols=260 Identities=24% Similarity=0.316 Sum_probs=195.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------C
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------K 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 160 (361)
..+|.+.+.||+|+||.||+|... +|+.||||++..... ...+|+++++.++||||+++++++... .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 346888999999999999999775 689999999865432 233699999999999999999998642 2
Q ss_pred eEEEEEEeccCCChhhhhccC-CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-CCeEEeeec
Q 042457 161 CMFLIYKYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFG 238 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg 238 (361)
..++||||+++ +|.+.+... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 36799999976 555554321 1123689999999999999999999999 99999999999999965 568999999
Q ss_pred CccccCCCCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh--------
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL-------- 309 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-------- 309 (361)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+........+
T Consensus 203 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 203 SAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9987644332 2335689999999998764 78999999999999999999999997644321111111110
Q ss_pred ---ccc---CCCCCCChhhHH------HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 310 ---DQR---APSPIDDQTVIQ------DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 310 ---~~~---~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
... ...+......+. ....+.+|+.+||+.||.+|||+.|+++||||++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 000 000000000111 1135889999999999999999999999999964
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=338.38 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=209.0
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFC 156 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 156 (361)
+....++|.+.+.||+|+||.||+|.. .+++.||+|.+...... ...+.+.+|+.+++++ +||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 345567899999999999999999974 35678999999865543 2357889999999999 899999999999
Q ss_pred eeCCeEEEEEEeccCCChhhhhccCCc---------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCC
Q 042457 157 LHKKCMFLIYKYMRRGSLFCVLRNDDE---------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISS 221 (361)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~ 221 (361)
...+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 999999999999999999999976532 12489999999999999999999999 999999999
Q ss_pred CCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCccc
Q 042457 222 NNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSS 298 (361)
Q Consensus 222 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~ 298 (361)
+||+++.++.+||+|||++......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999999876544332 223446788999999988899999999999999999999 9999875432
Q ss_pred CCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 299 FNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
. .................. ....+.+++.+||+.||.+|||+.|++++
T Consensus 254 ~---~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 D---SKFYKMIKEGFRMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp S---HHHHHHHHHTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred h---hHHHHHhccCCCCCCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 1 112222222211111111 11248889999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=343.63 Aligned_cols=259 Identities=23% Similarity=0.327 Sum_probs=201.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe-----
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC----- 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 161 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 45788899999999999999976 468999999997765555556788999999999999999999999987654
Q ss_pred -EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 162 -MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 162 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
.++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 588887743 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh------------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID------------ 307 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~------------ 307 (361)
...... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.......
T Consensus 174 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 174 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred cCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 765322 233468999999998876 6789999999999999999999999875432110000000
Q ss_pred --------hhcccCC--CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 308 --------LLDQRAP--SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 308 --------~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....... ..............+.+++.+||+.||++|||+.|+++||||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000000 00000000011224889999999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=349.16 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=201.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC--------CCcceeeeEEEe-
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR--------HRNIVKLYGFCL- 157 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~- 157 (361)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999965 468899999997543 22467889999999885 788999999998
Q ss_pred ---eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC----
Q 042457 158 ---HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL---- 230 (361)
Q Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~---- 230 (361)
.....++||||+ +++|.+.+..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 456799999999 5566555544321 25899999999999999999999864 799999999999998775
Q ss_pred ---------------------------------------------CeEEeeecCccccCCCCCCcccccccccccccccc
Q 042457 231 ---------------------------------------------EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265 (361)
Q Consensus 231 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 265 (361)
.+||+|||++...... .....||..|+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence 7999999999876432 2334689999999999
Q ss_pred cccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcch---hH---hhhhcccC-----------------------C--
Q 042457 266 YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKI---ML---IDLLDQRA-----------------------P-- 314 (361)
Q Consensus 266 ~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~---~~---~~~~~~~~-----------------------~-- 314 (361)
.+..++.++|||||||++|||++|+.||.......... .. ........ .
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999997544322110 00 01000000 0
Q ss_pred CCCC--------ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 315 SPID--------DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 315 ~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+.. ..........+.+|+.+||+.||++|||+.|+|+||||++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000 0001233346889999999999999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=327.76 Aligned_cols=248 Identities=20% Similarity=0.292 Sum_probs=202.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 165 (361)
.++|.+.+.||+|+||.||+|.. +|+.||+|++..........+.+.+|+.++++++||||+++++++... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 45788999999999999999998 588999999987765555567899999999999999999999999887 778999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
|||+++|+|.+++..... ..+++..++.++.|++.||+|||+. + ++|+||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999986542 2589999999999999999999998 7 999999999999999999999999987543
Q ss_pred CCCCCCcccccccccccccccccccccCc---cchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTE---KCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
.. ....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||..... ...................
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALEGLRPTIPPG 235 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHSCCCCCCCTT
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhcCCCCCCCCC
Confidence 22 2235789999999988765554 79999999999999999999875432 2222222222221111111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
. ...+.+++.+||+.||++|||++|+++
T Consensus 236 ~----~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 236 I----SPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 124889999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=335.35 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=195.5
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
.++..++|.+.+.||+|+||.||+|...+ .||+|++..........+.+.+|+.+++.++||||+++++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 34567789999999999999999998743 599999987766666678899999999999999999999965 455689
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999999965443 589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCC--CCccccccccccccccccc---ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 244 HSDS--SNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 244 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
.... .......||+.|+|||.+. +..++.++||||||+++|||++|+.||...... .................
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTSCCCCTT
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccccCcchh
Confidence 4322 2223356899999999886 567888999999999999999999998754331 11112222222111111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
. ........+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 249 K-VRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp S-SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h-ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 00011224889999999999999999999885
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.59 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=207.6
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeCC-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
.+++..++|.+.+.||+|+||.||+|.+.. +..||||.++..... .+.|.+|+.++++++||||++++++|...+.
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 344556778888999999999999998764 889999999865443 4678999999999999999999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||+++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence 9999999999999999976432 2589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC--CCCC
Q 042457 242 LLHSDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA--PSPI 317 (361)
Q Consensus 242 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 317 (361)
........ .....++..|+|||++.+..++.++||||||+++|||+| |+.||...... . ....+.... ..+.
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~-~~~~~~~~~~~~~~~ 442 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q-VYELLEKDYRMERPE 442 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G-HHHHHHTTCCCCCCT
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---H-HHHHHHcCCCCCCCC
Confidence 76443221 222345778999999998899999999999999999999 99998754422 1 122222221 1121
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+ ..+.+|+.+||+.||++|||+.+|++
T Consensus 443 ~~~------~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 443 GCP------EKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TCC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC------HHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 111 24788999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=340.86 Aligned_cols=251 Identities=24% Similarity=0.421 Sum_probs=195.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|++.+.||+|+||.||+|... +|+ .||+|.+..... ....+.+.+|+.++++++||||++++++|.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 466889999999999999999753 444 368888765432 223477899999999999999999999998765 7
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++++||+++|+|.+++..... .+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 899999999999999976543 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 243 LHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 243 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
....... .....+|..|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+......+...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~~~~~~~ 242 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQPP 242 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHTTCCCCCCT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----HHHHHHcCCCCCCCc
Confidence 6543322 223446789999999999999999999999999999999 999987544321 222222221111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.. ...+.+++.+||+.||.+|||+.|++++
T Consensus 243 ~~----~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 243 IC----TIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TB----CHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred cC----CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11 1247889999999999999999999865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=337.31 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=198.6
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK-- 159 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-- 159 (361)
..++|++.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 356789999999999999999974 3688999999976543 3357889999999999999999999999654
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 458999999999999999976543 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCC---CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC-------C--cch---h
Q 042457 240 ARLLHSDSS---NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF-------N--PKI---M 304 (361)
Q Consensus 240 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-------~--~~~---~ 304 (361)
+........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+...... . ... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987644322 122334677899999999999999999999999999999999997643210 0 000 1
Q ss_pred Hhhhhccc--CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 305 LIDLLDQR--APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 305 ~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
........ .+.+... ...+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGC------PDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTCCCCCCTTC------CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCcCCCCcCc------CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11111111 1112111 124888999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=327.98 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=198.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHH-----HHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELA-----FLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
.++|++.+.||+|+||.||+|.. .+++.||+|++........ ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46789999999999999999976 4789999999865443211 1167889999999999999999999997665
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEEeCCCCCCeeeCCCCC-----eEE
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLE-----AFV 234 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~~~~~-----~kl 234 (361)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+. + ++|+||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 699999999999988865443 689999999999999999999999 8 999999999999988776 999
Q ss_pred eeecCccccCCCCCCcccccccccccccccc--cccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 235 ADFGVARLLHSDSSNRTVVAGTHGYIAPELA--YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 235 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
+|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||......... .........
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~ 246 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMIREEG 246 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHHHHSC
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHHhccC
Confidence 99999975432 23345689999999998 4556789999999999999999999999754432211 112222222
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
......... ...+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LRPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 221111111 124889999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=332.06 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=206.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..++|.+.+.||+|+||.||++...+++.||+|.+....... +.+.+|+++++.++||||+++++++...+..++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 456788999999999999999998888999999998765433 57889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CCCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999976532 589999999999999999999999 9999999999999999999999999999765332
Q ss_pred C-CCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCC-CCCCChhhH
Q 042457 247 S-SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQTVI 323 (361)
Q Consensus 247 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 323 (361)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+...... .+...
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~---- 230 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRLYKPRLA---- 230 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCCCTTS----
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhcCCcCCCCccC----
Confidence 1 11222346778999999988889999999999999999999 8999875432 2222223222211 11111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
...+.+++.+||+.||++|||+.+++++
T Consensus 231 --~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 231 --STHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --cHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1247889999999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=333.15 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=193.8
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
.+..++|++.+.||+|+||.||+|.... +..||+|.+..... ....+.+.+|+..+++++||||+++++++. .+
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 3456789999999999999999997643 45799999876543 233577899999999999999999999985 45
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred ccEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence 68999999999999999976532 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCC
Q 042457 241 RLLHSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPI 317 (361)
Q Consensus 241 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 317 (361)
........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+.... .+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 240 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGERLPMPP 240 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTCCCCCCT
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHHHcCCCCCCCC
Confidence 87644322 1223346788999999988899999999999999999997 99998754432 2222222222 11111
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+ ..+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCP------PTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC------HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111 247889999999999999999998864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=335.59 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=209.0
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK 160 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 160 (361)
+++....++|.+.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 344556788999999999999999999775 4888999999765443 467889999999999999999999999999
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CEEEEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999999976432 2589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC-cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCC
Q 042457 241 RLLHSDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPI 317 (361)
Q Consensus 241 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 317 (361)
......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .....+.... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~ 235 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKDYRMERPE 235 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHTTCCCCCCT
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhccCCCCCCC
Confidence 876543322 233456788999999998899999999999999999999 99998754332 1112222211 11111
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~------~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 236 GCP------EKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TCC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC------HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 111 24889999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=336.85 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=206.2
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC--------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP--------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGF 155 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 155 (361)
....++|.+.+.||+|+||.||+|... ++..||+|++...... ...+.+.+|+.+++++ +||||++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-HHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 345678999999999999999999763 5678999999765433 3357789999999999 89999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCC
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~ 222 (361)
+...+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+. +++|+||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 9999999999999999999999976532 12489999999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccC
Q 042457 223 NILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSF 299 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~ 299 (361)
||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~- 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV- 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-
Confidence 999999999999999999876543321 223346788999999988889999999999999999999 9999875432
Q ss_pred CcchhHhhhhcccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 300 NPKIMLIDLLDQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 300 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
......+..... ..+... ...+.+++.+||+.||.+|||+.|++++
T Consensus 266 --~~~~~~~~~~~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 --EELFKLLKEGHRMDKPANC------TNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp --HHHHHHHHHTCCCCCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHHhcCCCCCCCccC------CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112222222211 111111 1247889999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=339.78 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=178.5
Q ss_pred HhcCCCCcC-eeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee----CC
Q 042457 87 ATEDFDIKY-CIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH----KK 160 (361)
Q Consensus 87 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~ 160 (361)
..++|.+.+ .||+|+||.||+|... +|+.||||++..... ........++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK------ARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH------HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 456788855 5999999999999765 689999999875422 11223344567799999999999986 44
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCCeEEeee
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADF 237 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Df 237 (361)
..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence 58999999999999999986542 2589999999999999999999999 9999999999999976 455999999
Q ss_pred cCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh-HhhhhcccCCCC
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM-LIDLLDQRAPSP 316 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 316 (361)
|++...... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||........... ...+.......+
T Consensus 176 g~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3fhr_A 176 GFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253 (336)
T ss_dssp TTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred ccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence 999765432 22344689999999999888899999999999999999999999975443221111 111111111111
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.... ......+.+++.+||+.||.+|||+.|+++||||++.
T Consensus 254 ~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 254 NPEW--SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TTTS--TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred chhh--ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 1000 0111247899999999999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=338.33 Aligned_cols=259 Identities=21% Similarity=0.293 Sum_probs=196.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEe---------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCL--------- 157 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--------- 157 (361)
.++|.+.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh--HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 467889999999999999999775 489999999876543 33578889999999999999999999874
Q ss_pred -----eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC-CCCC
Q 042457 158 -----HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN-SKLE 231 (361)
Q Consensus 158 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~ 231 (361)
..+..++||||++ |+|.+++... .+++..++.++.|++.||+|||+. +++|+||||+||+++ +++.
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3467899999997 6999998653 589999999999999999999999 999999999999997 5679
Q ss_pred eEEeeecCccccCCCC---CCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh
Q 042457 232 AFVADFGVARLLHSDS---SNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID 307 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 307 (361)
+||+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~ 236 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQL 236 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence 9999999998764321 12233457889999998765 678999999999999999999999987544211 1111
Q ss_pred hhccc----------------------CCCCCCChh--hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 308 LLDQR----------------------APSPIDDQT--VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 308 ~~~~~----------------------~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
+.... ...+..... .......+.+++.+||+.||++|||+.|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 11110 000000000 00012358899999999999999999999999999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=341.56 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=206.2
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchH----HHHHHHHHHHHHHhcCC--CCcceeeeE
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETEL----AFLESFQTEARLLSQIR--HRNIVKLYG 154 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~~~~ 154 (361)
.+.....++|.+.+.||+|+||.||+|.. .+|+.||||.+....... ...+.+..|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34445567899999999999999999965 578899999987543211 11234567899999986 599999999
Q ss_pred EEeeCCeEEEEEEeccC-CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC-CCCCe
Q 042457 155 FCLHKKCMFLIYKYMRR-GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN-SKLEA 232 (361)
Q Consensus 155 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~~ 232 (361)
++...+..++|+|++.+ ++|.+++.... .+++..++.++.|++.||+|||+. +++||||||+|||++ +++.+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCE
Confidence 99999999999999976 89999987643 689999999999999999999999 999999999999999 78899
Q ss_pred EEeeecCccccCCCCCCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc
Q 042457 233 FVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311 (361)
Q Consensus 233 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 311 (361)
||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ....
T Consensus 190 kL~Dfg~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~~~~ 258 (320)
T 3a99_A 190 KLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRG 258 (320)
T ss_dssp EECCCTTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHHC
T ss_pred EEeeCcccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------hhcc
Confidence 999999998764332 233468999999999876665 6789999999999999999999864321 1122
Q ss_pred cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 312 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
....+...+ ..+.+++.+||+.||++|||+.|+++||||++.+
T Consensus 259 ~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 259 QVFFRQRVS------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CCCCSSCCC------HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cccccccCC------HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 222111111 2478899999999999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=338.99 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=196.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCE----EEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKI----VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|++.+.||+|+||.||+|... +++. ||+|.+...... .....+.+|+.+++.++||||+++++++. .+..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 456888999999999999999764 4543 888887544321 11245678999999999999999999986 4568
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999999976533 588899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCC
Q 042457 243 LHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPID 318 (361)
Q Consensus 243 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (361)
...... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+... ....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLEKGERLAQPQI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHHTTCBCCCCTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHHcCCCCCCCCc
Confidence 654332 2234557889999999998999999999999999999999 999987644321 11112111 1222222
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
... .+.+++.+||+.||.+|||+.|++++
T Consensus 242 ~~~------~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTI------DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCT------TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcH------HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 37788999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=353.96 Aligned_cols=253 Identities=27% Similarity=0.455 Sum_probs=202.2
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.+++..++|.+.+.||+|+||.||+|.+.++..||||+++..... .+.|.+|+.++++++||||+++++++.. +..
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 345667789999999999999999999988888999999865543 3678999999999999999999999876 668
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 999999999999999975321 2589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCCC
Q 042457 243 LHSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDD 319 (361)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 319 (361)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+... +.+.+...
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~~~~~ 406 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRMPCPPEC 406 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTS
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC
Confidence 643322 1223346788999999998899999999999999999999 9999875432 1222222222 12222221
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.||++|||++++++
T Consensus 407 ------~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 407 ------PESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 124788999999999999999999886
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=354.07 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=193.3
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
+...+|...+.||+|+||+||.....+|+.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 44567888999999999997665556899999999865433 2245799999998 79999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-----CCCeEEeeecC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-----KLEAFVADFGV 239 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~ 239 (361)
||||+. |+|.+++..... ...+..+..++.|++.||.|||+. +|+||||||+|||++. ...+||+|||+
T Consensus 96 v~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999996 599999976543 244445678999999999999999 9999999999999943 34688999999
Q ss_pred ccccCCCC---CCccccccccccccccccc---ccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc
Q 042457 240 ARLLHSDS---SNRTVVAGTHGYIAPELAY---TMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 240 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
++...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... ..........
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----~~~~~~~~~~ 245 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGAC 245 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----HHHHHHTTCC
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----HHHHHHhccC
Confidence 98765332 2233456999999999987 4567889999999999999999 9999854321 1111111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........ ......+.+|+.+||+.||.+|||+.|+++||||+.
T Consensus 246 ~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 246 SLDCLHPE--KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp CCTTSCTT--CHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred CccccCcc--ccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 11111111 112234778999999999999999999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=332.80 Aligned_cols=255 Identities=17% Similarity=0.206 Sum_probs=205.2
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++...... +.+.+|+..++.+ +|+|++++++++......++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 356799999999999999999975 57899999998654432 4567899999999 79999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC-----eEEeeecC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE-----AFVADFGV 239 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg~ 239 (361)
||||+ +++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++. +||+|||+
T Consensus 84 v~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99999 9999999986532 589999999999999999999999 9999999999999987766 99999999
Q ss_pred ccccCCCCC-------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc
Q 042457 240 ARLLHSDSS-------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR 312 (361)
Q Consensus 240 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 312 (361)
+........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 987654322 1234568999999999999999999999999999999999999998755433333333322221
Q ss_pred CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 313 APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 313 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.. .........+.+++.+||+.||++|||+++|++
T Consensus 238 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 238 QSTPLR-ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHSCHH-HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCccHH-HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 111100 000011225889999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=330.36 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=204.7
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
+.+..++|++.+.||+|+||.||+|...++..||+|.+...... .+.+.+|+++++.++||||+++++++.. +..+
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 34556789999999999999999999888889999999765443 3678899999999999999999999874 4589
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 99999999999999975421 2589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCC-CCCCCh
Q 042457 244 HSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQ 320 (361)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 320 (361)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+...... .+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~- 235 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMVRPDNC- 235 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTC-
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccCCCCcccc-
Confidence 54332 1223346788999999988889999999999999999999 9999875432 1222222222111 11111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.||++|||+.++++
T Consensus 236 -----~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 -----PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 124889999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=331.37 Aligned_cols=265 Identities=25% Similarity=0.390 Sum_probs=201.2
Q ss_pred cCHHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC--CCCcceeeeEEE
Q 042457 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI--RHRNIVKLYGFC 156 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~ 156 (361)
..........++|++.+.||+|+||.||+|+. .|+.||||++..... ..+..|.+++... +||||+++++++
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 34444555678899999999999999999988 489999999865432 3344566666554 899999999999
Q ss_pred eeC----CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEEeCCCCCCeeeC
Q 042457 157 LHK----KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC-----IPSIVHRDISSNNILLN 227 (361)
Q Consensus 157 ~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~i~H~dlk~~Nill~ 227 (361)
... ...++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++++||||||+|||++
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 987 6899999999999999999754 4899999999999999999999762 33899999999999999
Q ss_pred CCCCeEEeeecCccccCCCCCC----cccccccccccccccccccccCcc------chhhhHHHHHHHHHhC--------
Q 042457 228 SKLEAFVADFGVARLLHSDSSN----RTVVAGTHGYIAPELAYTMVVTEK------CDVFGFGVVALEVLMG-------- 289 (361)
Q Consensus 228 ~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~~l~el~tg-------- 289 (361)
.++.+||+|||++......... .....||+.|+|||++.+...+.. +||||||+++|||+||
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 9999999999999766443322 123468999999999887766655 9999999999999999
Q ss_pred --CCCCCCcccCCcchh-Hhhhh-cccCCCCCC-ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 290 --RHPGDLLSSFNPKIM-LIDLL-DQRAPSPID-DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 290 --~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
+.||........... ..... ......... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 566554333222211 11111 111111111 11122344568999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=348.98 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=191.4
Q ss_pred CCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEEEe
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.+++++ +||||+++++++...+..++||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 345567899999999987766689999999986532 24567899999876 899999999999999999999999
Q ss_pred ccCCChhhhhccCCccC----CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC-------------CC
Q 042457 169 MRRGSLFCVLRNDDEAI----QLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-------------LE 231 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~-------------~~ 231 (361)
+. |+|.+++....... ..++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 69999997654211 113334678999999999999999 99999999999999654 48
Q ss_pred eEEeeecCccccCCCCCC----cccccccccccccccccc-------cccCccchhhhHHHHHHHHHh-CCCCCCCcccC
Q 042457 232 AFVADFGVARLLHSDSSN----RTVVAGTHGYIAPELAYT-------MVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSF 299 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~ 299 (361)
+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999876543321 223569999999999865 668999999999999999999 99998653321
Q ss_pred CcchhHhhhhcccCCCCC-CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 300 NPKIMLIDLLDQRAPSPI-DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. ..+.......+. ...........+.+++.+||+.||.+|||+.|+++||||.+
T Consensus 247 ~-----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 247 E-----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp H-----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred H-----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1 122222211111 11111223345889999999999999999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=333.96 Aligned_cols=259 Identities=20% Similarity=0.295 Sum_probs=189.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||.||+|... +|+.||||++..........+.+..+..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999775 6899999999876655444455556666788889999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
||+ ++.+..+..... ..+++..+..++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 555555554322 258999999999999999999998 5 899999999999999999999999999976543
Q ss_pred CCCCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 246 DSSNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
.. ......+++.|+|||.+. +..++.++||||||+++|||++|+.||..... .............+......
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 254 (318)
T 2dyl_A 178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPLLPGHM 254 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCCCCSSS
T ss_pred Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCCCCccC
Confidence 32 223346899999999984 55688899999999999999999999875322 12222333333222111100
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
. ....+.+++.+||+.||.+|||+.|+++||||++
T Consensus 255 ~---~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 255 G---FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp C---CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred C---CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 0 1124788999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=328.49 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=202.8
Q ss_pred hcCCCCcC-eeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 88 TEDFDIKY-CIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 88 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
.++|.+.. .||+|+||.||+|... ++..||+|++...... ...+.+.+|+++++.++||||+++++++ ..+..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 45566666 8999999999999753 5778999999875433 3457899999999999999999999999 556689
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++++|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999999975432 589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-CCCCC
Q 042457 244 HSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-PSPID 318 (361)
Q Consensus 244 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 318 (361)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..... ..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~ 237 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMECPPE 237 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCCCCCTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCcCCCCCC
Confidence 443321 222346789999999988889999999999999999999 9999875432 222222222221 11111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNP 354 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp 354 (361)
. ...+.+++.+||+.||++|||+.+++++.
T Consensus 238 ~------~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 238 C------PPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp C------CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred c------CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1 12488899999999999999999998763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=338.05 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=210.9
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeee
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLY 153 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 153 (361)
..+++.+..++|.+.+.||+|+||.||+|... +++.||+|.+...... .....+.+|+.+++.++||||++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 34455677889999999999999999999653 3678999999765443 2346788999999999999999999
Q ss_pred EEEeeCCeEEEEEEeccCCChhhhhccCCc-------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee
Q 042457 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDE-------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL 226 (361)
Q Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill 226 (361)
+++...+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+. +++||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 999999999999999999999999875321 13579999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcch
Q 042457 227 NSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKI 303 (361)
Q Consensus 227 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~ 303 (361)
+.++.+||+|||++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~ 248 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQ 248 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HH
Confidence 99999999999999765433221 222346889999999998889999999999999999999 8999875432 22
Q ss_pred hHhhhhcccCC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 304 MLIDLLDQRAP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 304 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
....+...... .+... ...+.+++.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 249 VLRFVMEGGLLDKPDNC------PDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHTTCCCCCCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCcCCCCCCC------CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22222222221 11111 1247889999999999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=335.71 Aligned_cols=261 Identities=25% Similarity=0.407 Sum_probs=199.0
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 156 (361)
++++....++|.+.+.||+|+||.||+|... ++..||+|.+..........+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3444566788999999999999999999653 345899999987665555567899999999999999999999999
Q ss_pred eeCC-----eEEEEEEeccCCChhhhhccC---CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC
Q 042457 157 LHKK-----CMFLIYKYMRRGSLFCVLRND---DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS 228 (361)
Q Consensus 157 ~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~ 228 (361)
...+ ..++||||+++++|.+++... .....+++..++.++.|++.||.|||+. +++||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 8765 359999999999999998432 1233689999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhH
Q 042457 229 KLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIML 305 (361)
Q Consensus 229 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 305 (361)
++.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ....
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~ 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMY 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHH
Confidence 99999999999986644322 2233456889999999999999999999999999999999 8899875433 2222
Q ss_pred hhhhcccCC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 306 IDLLDQRAP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 306 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+...... .+... ...+.+++.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 260 DYLLHGHRLKQPEDC------LDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTTCCCCCBTTC------CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccc------cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222221 11111 1248899999999999999999999865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=331.91 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=201.1
Q ss_pred HHHHHhcCCCCcC-eeeecCceeEEEEEe---CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 83 EIIVATEDFDIKY-CIGTGGYGSVYRAQL---PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 83 ~~~~~~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
++....++|.+.+ .||+|+||.||+|.+ .+++.||||++..........+.+.+|+.+++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3344556788887 899999999999954 2467899999987655444567899999999999999999999999 5
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
.+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence 667899999999999999998654 589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-
Q 042457 239 VARLLHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA- 313 (361)
Q Consensus 239 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~- 313 (361)
++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~ 239 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM 239 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC
Confidence 99876543322 122345688999999988889999999999999999999 9999875433 112222222221
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+... ...+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 GCPAGC------PREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCCTTC------CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111111 124889999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.41 Aligned_cols=260 Identities=21% Similarity=0.322 Sum_probs=202.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CC-CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCc------ceeeeEEEeeC
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SG-KIVALKKLHHSETELAFLESFQTEARLLSQIRHRN------IVKLYGFCLHK 159 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~ 159 (361)
.++|.+.+.||+|+||.||+|... ++ +.||+|++..... ..+.+..|+.+++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK---YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc---chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 568999999999999999999764 34 6899999975432 2467788999999887655 99999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee-------------
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL------------- 226 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill------------- 226 (361)
+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 9999999999 6666666654432 2589999999999999999999999 99999999999999
Q ss_pred ------CCCCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC
Q 042457 227 ------NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN 300 (361)
Q Consensus 227 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 300 (361)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999764332 233468999999999999999999999999999999999999997544321
Q ss_pred cchhHhhhhcccC------------------CCCCCC-----------------hhhHHHHHHHHHHHhhhcCCCCCCCC
Q 042457 301 PKIMLIDLLDQRA------------------PSPIDD-----------------QTVIQDIILVSKIAFACLRSKPKSRP 345 (361)
Q Consensus 301 ~~~~~~~~~~~~~------------------~~~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RP 345 (361)
............+ ...... .........+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 1111111111000 000000 00011123588999999999999999
Q ss_pred CccccccCCCCCC
Q 042457 346 TMRRSFPNPEINP 358 (361)
Q Consensus 346 s~~eil~hp~~~~ 358 (361)
|+.|+++||||++
T Consensus 327 t~~e~l~hp~f~~ 339 (355)
T 2eu9_A 327 TLAEALLHPFFAG 339 (355)
T ss_dssp CHHHHTTSGGGGG
T ss_pred CHHHHhcChhhcC
Confidence 9999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=334.98 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=196.8
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchH----HHHHHHHHHHHHHhcC----CCCcceeee
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETEL----AFLESFQTEARLLSQI----RHRNIVKLY 153 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~~~ 153 (361)
+.....++|.+.+.||+|+||.||+|.. .+|+.||+|++....... .....+..|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455678899999999999999999976 468899999997654211 1123455788888888 899999999
Q ss_pred EEEeeCCeEEEEEEe-ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC-CCCC
Q 042457 154 GFCLHKKCMFLIYKY-MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN-SKLE 231 (361)
Q Consensus 154 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~-~~~~ 231 (361)
+++...+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 999999999999999 78999999997644 589999999999999999999999 999999999999999 8899
Q ss_pred eEEeeecCccccCCCCCCcccccccccccccccccccccC-ccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc
Q 042457 232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVT-EKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD 310 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 310 (361)
+||+|||++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||.... ....
T Consensus 179 ~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~ 247 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EILE 247 (312)
T ss_dssp EEECCCSSCEECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH
T ss_pred EEEEEcchhhhcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HHhh
Confidence 9999999998765432 2334589999999998766654 58999999999999999999986432 1122
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 311 QRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.....+.... ..+.+++.+||+.||++|||+.|+++||||++.
T Consensus 248 ~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 248 AELHFPAHVS------PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TCCCCCTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred hccCCcccCC------HHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 2222221111 247889999999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=329.39 Aligned_cols=258 Identities=21% Similarity=0.305 Sum_probs=194.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCc-chHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35689999999999999999975 578999999997533 2334457889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 166 YKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986521 123589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
..........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........+.....+......
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~---- 262 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPLPSDH---- 262 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSCCCCTTT----
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCCCCcccc----
Confidence 444434445689999999999998999999999999999999999999864322 111122222222222111111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
....+.+++.+||+.||.+|||+.+++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11248899999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=344.25 Aligned_cols=260 Identities=20% Similarity=0.318 Sum_probs=206.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC--eEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK--CMFL 164 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l 164 (361)
.++|.+.+.||+|+||.||+|... +|+.||||++....... ..+.+.+|++++++++||||+++++++...+ ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 457899999999999999999765 58999999997543322 2466789999999999999999999998765 6899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee----CCCCCeEEeeecCc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL----NSKLEAFVADFGVA 240 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~ 240 (361)
||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999998765544599999999999999999999999 99999999999999 77788999999999
Q ss_pred cccCCCCCCcccccccccccccccccc--------cccCccchhhhHHHHHHHHHhCCCCCCCcccC-CcchhHhhhhcc
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYT--------MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF-NPKIMLIDLLDQ 311 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~ 311 (361)
+...... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||...... ........+...
T Consensus 164 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 8764332 2233468999999998865 56788999999999999999999998754432 222223333333
Q ss_pred cCCC-------------------CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 312 RAPS-------------------PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 312 ~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.++. +............+.+++.+||+.||++|||++|+++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2211 1111112334446889999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=333.45 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=211.2
Q ss_pred cCHHHHHHHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCccee
Q 042457 79 ITFEEIIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVK 151 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 151 (361)
....++....++|.+.+.||+|+||.||+|.. .+++.||||++...... ...+.+.+|+.+++++ +||||++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCeee
Confidence 34566777788999999999999999999964 35688999999765443 2346789999999999 7999999
Q ss_pred eeEEEeeCC-eEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEe
Q 042457 152 LYGFCLHKK-CMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHR 217 (361)
Q Consensus 152 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~ 217 (361)
+++++...+ ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++|+
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999998755 48999999999999999976542 12278999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCC
Q 042457 218 DISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGD 294 (361)
Q Consensus 218 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~ 294 (361)
||||+||+++.++.+||+|||++......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999999866443322 233457889999999999999999999999999999998 999987
Q ss_pred CcccCCcchhHhhhhccc-CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 295 LLSSFNPKIMLIDLLDQR-APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..... ......+.... ...+...+ ..+.+++.+||+.||.+|||+.|+++|
T Consensus 253 ~~~~~--~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 253 GVKID--EEFCRRLKEGTRMRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TCCCS--HHHHHHHHHTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchh--HHHHHHhccCccCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54321 11122222221 11111111 247889999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=329.02 Aligned_cols=245 Identities=21% Similarity=0.424 Sum_probs=197.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC-C-------CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS-G-------KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
.++|.+.+.||+|+||.||+|.... + ..||+|.+...... ..+.+.+|+.++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--YSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG--GHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 4678899999999999999996543 3 46999998654432 347789999999999999999999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC--------
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE-------- 231 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~-------- 231 (361)
+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+. +++||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999986542 489999999999999999999999 9999999999999988887
Q ss_pred eEEeeecCccccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCC-CCCCcccCCcchhHhhhh
Q 042457 232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRH-PGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~-p~~~~~~~~~~~~~~~~~ 309 (361)
+||+|||++..... .....+|..|+|||.+.+ ..++.++||||||+++|||++|.. |+..... .......
T Consensus 160 ~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~~~~~~ 231 (289)
T 4fvq_A 160 IKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----QRKLQFY 231 (289)
T ss_dssp EEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHHH
T ss_pred eeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch----HHHHHHh
Confidence 99999999865422 233457889999999887 778999999999999999999554 4433221 1112222
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 310 DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
......+..... .+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 EDRHQLPAPKAA------ELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HTTCCCCCCSSC------TTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hccCCCCCCCCH------HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 222222222211 37889999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=340.88 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=190.3
Q ss_pred CCCCcCeeeecCceeEEEEEeC--CC--CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-CCeEEE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP--SG--KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCMFL 164 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l 164 (361)
.|.+.+.||+|+||.||+|... ++ ..||+|.+...... ...+.+.+|+.++++++||||++++++|.. .+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS-HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4666789999999999999753 22 36899998754332 335789999999999999999999999765 457899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++|+|.++++.... .+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999976543 578999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCC----CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-CCCCC
Q 042457 245 SDSS----NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-PSPID 318 (361)
Q Consensus 245 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 318 (361)
.... ......++..|+|||.+.+..++.++||||||+++|||+| |..||......+. ...+..... ..+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~~~~~~~~~p~~ 320 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQGRRLLQPEY 320 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHHHTTCCCCCCTT
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHHHcCCCCCCCCC
Confidence 3321 1223456788999999999999999999999999999999 7778765543322 222222222 12211
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+ ..+.+++.+||+.||++|||+.|++++
T Consensus 321 ~~------~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 321 CP------DPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC------HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11 248889999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.70 Aligned_cols=263 Identities=23% Similarity=0.286 Sum_probs=183.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHH-HHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEAR-LLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||+|... +|+.||||++........ ...+..|+. +++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 467899999999999999999774 689999999986654333 344555555 77788999999999999999999999
Q ss_pred EEeccCCChhhhhccC--CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 166 YKYMRRGSLFCVLRND--DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
|||+++ +|.+++... .....+++..+..++.|++.||.|||+.. +++|+||||+||+++.++.+||+|||++...
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999975 777776531 11236899999999999999999999853 7999999999999999999999999999766
Q ss_pred CCCCCCcccccccccccccccc----cccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 244 HSDSSNRTVVAGTHGYIAPELA----YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
.... ......||..|+|||.+ .+..++.++||||||+++|||++|+.||....... ...........+....
T Consensus 177 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~- 252 (327)
T 3aln_A 177 VDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVVKGDPPQLSN- 252 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCCCCCCC-
T ss_pred cccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHhcCCCCCCCC-
Confidence 4332 22233689999999998 45678999999999999999999999987543211 1111122221111110
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.........+.+++.+||+.||.+|||+.|+++||||++
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 000001124889999999999999999999999999953
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=341.23 Aligned_cols=263 Identities=18% Similarity=0.296 Sum_probs=201.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-----------CCcceeeeEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-----------HRNIVKLYGF 155 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~ 155 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+.++++++ |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc---chhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 46799999999999999999975 5789999999975432 2366788999988876 8999999999
Q ss_pred EeeCC----eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC----
Q 042457 156 CLHKK----CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN---- 227 (361)
Q Consensus 156 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---- 227 (361)
+...+ ..+++||++ +++|.+++...... .+++..+..++.|++.||+|||+++ +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 98754 789999999 89999998764322 4899999999999999999999953 899999999999994
Q ss_pred --CCCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCc---c
Q 042457 228 --SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP---K 302 (361)
Q Consensus 228 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---~ 302 (361)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ .
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999866432 2234689999999999999999999999999999999999999975432110 0
Q ss_pred hhHhhhhcccCCCC---------------------------CC---------ChhhHHHHHHHHHHHhhhcCCCCCCCCC
Q 042457 303 IMLIDLLDQRAPSP---------------------------ID---------DQTVIQDIILVSKIAFACLRSKPKSRPT 346 (361)
Q Consensus 303 ~~~~~~~~~~~~~~---------------------------~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs 346 (361)
.....+.......+ .. ..........+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11111110000000 00 0001223446889999999999999999
Q ss_pred ccccccCCCCCCCC
Q 042457 347 MRRSFPNPEINPSL 360 (361)
Q Consensus 347 ~~eil~hp~~~~~~ 360 (361)
+.|+++||||++.+
T Consensus 328 ~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 328 AGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHTCGGGTTCT
T ss_pred HHHHhhChhhhccc
Confidence 99999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=331.39 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=208.1
Q ss_pred CcCHHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhc--CCCCcceeeeEE
Q 042457 78 RITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQ--IRHRNIVKLYGF 155 (361)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~ 155 (361)
...+.......++|.+.+.||+|+||.||+|.. +|+.||||++.... ...+..|.+++.. ++||||++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 345555566778999999999999999999998 68999999986432 2556788888877 789999999999
Q ss_pred EeeCC----eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEEeCCCCCC
Q 042457 156 CLHKK----CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH--------YDCIPSIVHRDISSNN 223 (361)
Q Consensus 156 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~~~~i~H~dlk~~N 223 (361)
+.... ..++||||+++|+|.+++... .+++..++.++.|++.||.||| +. +++|+||||+|
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N 177 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN 177 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence 98876 789999999999999999754 4899999999999999999999 77 99999999999
Q ss_pred eeeCCCCCeEEeeecCccccCCCCCC----ccccccccccccccccccc------ccCccchhhhHHHHHHHHHhC----
Q 042457 224 ILLNSKLEAFVADFGVARLLHSDSSN----RTVVAGTHGYIAPELAYTM------VVTEKCDVFGFGVVALEVLMG---- 289 (361)
Q Consensus 224 ill~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg---- 289 (361)
||++.++.+||+|||++......... .....||+.|+|||.+.+. .++.++||||||+++|||+||
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 99999999999999999876543321 2334689999999998765 344789999999999999999
Q ss_pred ------CCCCCCcccCCcc--hhHhhhhcccCCCCCCC-hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 290 ------RHPGDLLSSFNPK--IMLIDLLDQRAPSPIDD-QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 290 ------~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..||......... .....+........... .........+.+++.+||+.||++|||+.|+++|
T Consensus 258 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 7787654432221 12222222222222221 1122444568999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=329.75 Aligned_cols=255 Identities=21% Similarity=0.345 Sum_probs=199.1
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--C
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--K 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~ 160 (361)
.++|++.+.||+|+||.||+|.+ .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++... +
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 45588899999999999999983 46889999999755422 2346788999999999999999999999876 6
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 68999999999999999965432 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCccc--------CCcc---hhHh
Q 042457 241 RLLHSDSS---NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSS--------FNPK---IMLI 306 (361)
Q Consensus 241 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~--------~~~~---~~~~ 306 (361)
........ ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+..... .... ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 87654432 22334578889999999999999999999999999999999998643210 0000 1111
Q ss_pred hhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.........+.... ....+.+++.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLPCPPN----CPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCCCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCCCCCC----CCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11111111111111 1124889999999999999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=328.84 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=194.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
-++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467999999999999999999764 688999999876533 233457789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999997654 589999999999999999999999 999999999999999999999999999876644
Q ss_pred CCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 246 DSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..........+.+.... ..
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~--~~ 260 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIPRPSTVR--PG 260 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCCCGGGTS--TT
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCCCccccC--CC
Confidence 322 223446899999999999999999999999999999999999998754321 12222222221110000 00
Q ss_pred HHHHHHHHHhhhcCCCCCCCC-Ccccccc
Q 042457 325 DIILVSKIAFACLRSKPKSRP-TMRRSFP 352 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RP-s~~eil~ 352 (361)
....+.+++.+||+.||++|| |++++++
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 112478899999999999999 8888764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=325.66 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=197.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCC----CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-CCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSG----KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~ 162 (361)
..+|.+.+.||+|+||.||+|...++ ..+|+|.+...... ...+.+.+|+.++++++||||+++++++.. .+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34688889999999999999976432 35899998765443 335778999999999999999999999654 5678
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999976432 589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCC----CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCC-CC
Q 042457 243 LHSDSS----NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAP-SP 316 (361)
Q Consensus 243 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 316 (361)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+ ........... .+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQGRRLLQP 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHHTTCCCCCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHhcCCCCCCC
Confidence 643221 1233457789999999999899999999999999999999 566665443322 22222222221 11
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~------~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 255 EYCP------DPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCC------HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 24888999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=332.71 Aligned_cols=251 Identities=30% Similarity=0.459 Sum_probs=197.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC-----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS-----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|.+.+.||+|+||.||+|.... +..||+|.+...... .....+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 4567778999999999999997542 235999999765433 3356789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999976432 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCC
Q 042457 243 LHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPI 317 (361)
Q Consensus 243 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 317 (361)
....... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+... ..+.+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~~~~~ 273 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRLPTPM 273 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCCCT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCcCCCcc
Confidence 6443221 122345778999999998899999999999999999999 9999865432 2222222222 122222
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+ ..+.+++.+||+.||.+|||+.+++++
T Consensus 274 ~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCP------SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCB------HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCC------HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 211 247889999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=325.28 Aligned_cols=254 Identities=15% Similarity=0.262 Sum_probs=201.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEE-eeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC-LHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++...... +.+.+|+.+++.++|+++++.++.+ ...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 56799999999999999999975 57899999998765432 4577999999999988877666665 556788999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee---CCCCCeEEeeecCccc
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARL 242 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~ 242 (361)
|||+ +++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+|||+ +.++.+||+|||++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999 9999999974432 589999999999999999999999 99999999999999 4888999999999987
Q ss_pred cCCCCCC-------cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCC
Q 042457 243 LHSDSSN-------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPS 315 (361)
Q Consensus 243 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 315 (361)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 6543321 234568999999999999999999999999999999999999998655433333333332222111
Q ss_pred CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 316 PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
+... ........+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 PIEV-LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHH-HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chHH-HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1000 00001124889999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.59 Aligned_cols=258 Identities=27% Similarity=0.383 Sum_probs=203.9
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
+..++|.+.+.||+|+||.||+|.. .++..||||.+...... .....+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch-hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 3467899999999999999999974 35778999999755433 2346788999999999999999999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCc----cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCCe
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDE----AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEA 232 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~ 232 (361)
+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999976532 13589999999999999999999999 9999999999999984 4569
Q ss_pred EEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhh
Q 042457 233 FVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 233 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 309 (361)
||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+.
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~ 259 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFVT 259 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHHh
Confidence 9999999976543322 2233457889999999988899999999999999999998 9999875432 22222222
Q ss_pred cccCC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 310 DQRAP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 310 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..... .+...+ ..+.+++.+||+.||.+|||+.++++++|+
T Consensus 260 ~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 260 SGGRMDPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp TTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCCCCCCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 22221 111111 247889999999999999999999988764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=326.00 Aligned_cols=256 Identities=15% Similarity=0.257 Sum_probs=198.8
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEE-eeCCeEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC-LHKKCMF 163 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~ 163 (361)
...++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+..|+.+++.++|++++..++.+ ...+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 3457899999999999999999975 57889999987654332 3477899999999988877777666 5677889
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee---CCCCCeEEeeecCc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL---NSKLEAFVADFGVA 240 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~ 240 (361)
+||||+ +++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+|||+ +.++.+||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 999999 9999999975432 589999999999999999999999 99999999999999 78899999999999
Q ss_pred cccCCCCC-------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 241 RLLHSDSS-------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 241 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 87654332 12345689999999999999999999999999999999999999987654443333333322222
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+... ........+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 STPIEV-LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHH-HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cchhhh-hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 111000 00000125889999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=324.65 Aligned_cols=251 Identities=26% Similarity=0.341 Sum_probs=199.1
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
..++|.+.+.||+|+||.||+|...+ +..||+|.+...... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence 45679999999999999999997532 236999998765432 3357889999999999999999999998754 56
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++++|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 899999999999999976432 589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCCC
Q 042457 243 LHSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDD 319 (361)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 319 (361)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+... ..+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 239 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEKGDRLPKPDLC 239 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHHTCCCCCCTTC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhcCCCCCCCCCC
Confidence 644322 2233456789999999988889999999999999999998 999987543321 12222222 12222111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
+ ..+.+++.+||+.||++|||+.|++++
T Consensus 240 ~------~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 P------PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C------HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1 248889999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=329.62 Aligned_cols=257 Identities=21% Similarity=0.351 Sum_probs=199.1
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee----CC
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH----KK 160 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~ 160 (361)
+..++|.+.+.||+|+||.||++.. .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 4567899999999999999999976 5789999999865433 335778899999999999999999999973 34
Q ss_pred eEEEEEEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 7899999999999999987521 123689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC---------cccccccccccccccccccc---cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh
Q 042457 240 ARLLHSDSSN---------RTVVAGTHGYIAPELAYTMV---VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID 307 (361)
Q Consensus 240 ~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 307 (361)
+......... .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........... ..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~ 259 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-LA 259 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-HH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-HH
Confidence 8765321111 12234689999999987543 68899999999999999999999864322111111 11
Q ss_pred hhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 308 LLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
. ......+..... ...+.+++.+||+.||.+|||+.+++++
T Consensus 260 ~-~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 V-QNQLSIPQSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp H-HCC--CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred h-hccCCCCccccC----CHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 1 111111111111 1248899999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=332.11 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=203.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEe--eCC
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCL--HKK 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~ 160 (361)
.++|++.+.||+|+||.||++++ .+++.||||++...... ..+.+.+|++++++++||||+++++++. ..+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH--HHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 46789999999999999999984 46889999999765433 3477899999999999999999999987 456
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred eEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 68999999999999999976432 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC-----------CcchhHh
Q 042457 241 RLLHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF-----------NPKIMLI 306 (361)
Q Consensus 241 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-----------~~~~~~~ 306 (361)
......... .....+|..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 876543321 22345788899999999888999999999999999999999997543210 0001111
Q ss_pred hhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.........+.... ....+.+++.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQRLPAPPA----CPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhcccCCCCCCc----ccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11222111111111 11248899999999999999999999654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=328.74 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=200.1
Q ss_pred CCCcCeeeecCceeEEEEEeC-----CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC--CeEE
Q 042457 91 FDIKYCIGTGGYGSVYRAQLP-----SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK--KCMF 163 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 163 (361)
|++.+.||+|+||.||++.+. +|+.||||++...... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP-QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh-HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 488999999999999998653 6789999999866432 3357789999999999999999999999984 6789
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++++|.+++... .+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 112 lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999999765 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC-------Cc----chhHhhhh
Q 042457 244 HSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF-------NP----KIMLIDLL 309 (361)
Q Consensus 244 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-------~~----~~~~~~~~ 309 (361)
...... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 543321 23345788899999999889999999999999999999999998643210 00 00111222
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 310 DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
......+..... ...+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ERGERLPRPDKC----PAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccCCCCCccc----cHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 222211111111 124889999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=337.75 Aligned_cols=253 Identities=17% Similarity=0.248 Sum_probs=195.5
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCC------CCEEEEEEeccCcchHHH---------HHHHHHHHHHHhcCCCCccee
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPS------GKIVALKKLHHSETELAF---------LESFQTEARLLSQIRHRNIVK 151 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~ 151 (361)
..++|.+.+.||+|+||.||+|...+ ++.||||++......... ...+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999997754 478999998765432110 122445666778889999999
Q ss_pred eeEEEeeC----CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC
Q 042457 152 LYGFCLHK----KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN 227 (361)
Q Consensus 152 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~ 227 (361)
+++++... ...++||||+ +++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99999875 4589999999 9999999976532 689999999999999999999999 999999999999998
Q ss_pred --CCCCeEEeeecCccccCCCCCC-------cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCccc
Q 042457 228 --SKLEAFVADFGVARLLHSDSSN-------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSS 298 (361)
Q Consensus 228 --~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 298 (361)
.++.+||+|||+++.+...... .....||+.|+|||++.+..++.++||||||+++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999776432211 1234599999999999999999999999999999999999999975322
Q ss_pred CCcchh---------HhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 299 FNPKIM---------LIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 299 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...... .....+...+.. . ....+.+++..||+.||.+|||+.+|++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAA-N------APGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTT-C------CCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccc-c------CHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 110000 011111111100 0 0124889999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=356.44 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=204.1
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
++..++|.+.+.||+|+||.||+|.+.++..||||+++..... .+.|.+|+.++++++|+||+++++++.. +..++
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3445667788899999999999999988888999999865543 3678999999999999999999999876 66899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999975321 2589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCCCChh
Q 042457 245 SDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDDQT 321 (361)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 321 (361)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+... +.+.+...
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~~~~~~-- 489 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRMPCPPEC-- 489 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTC--
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCC--
Confidence 3211 1122346778999999998899999999999999999999 9999875432 1222222222 12222211
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
...+.+|+.+||+.||++|||+++|++.
T Consensus 490 ----~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 490 ----PESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1247889999999999999999998864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.08 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=196.1
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CC---CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE-EE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SG---KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM-FL 164 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~l 164 (361)
.|...+.||+|+||.||+|... ++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 3555688999999999999753 22 37999998764433 3357889999999999999999999999876655 99
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
+|||+.+++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 101 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999976432 589999999999999999999999 99999999999999999999999999997653
Q ss_pred CCC----CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCC-CCCcccCCcchhHhhhhcccC-CCCCC
Q 042457 245 SDS----SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP-GDLLSSFNPKIMLIDLLDQRA-PSPID 318 (361)
Q Consensus 245 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~-~~~~~ 318 (361)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..| |..... ......+..... +.+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 252 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQGRRLPQPEY 252 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHHHTTCCCCCCTT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHHHhhcCCCCCCCcc
Confidence 321 122334578899999999999999999999999999999995555 443222 222222222221 11111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.+ ..+.+++.+||+.||.+|||++++++
T Consensus 253 ~~------~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 253 CP------DSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch------HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 24889999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=352.92 Aligned_cols=263 Identities=24% Similarity=0.279 Sum_probs=204.5
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee------CCe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH------KKC 161 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~ 161 (361)
++|.+.+.||+|+||.||+|.. .+|+.||||++..... ....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6799999999999999999976 4689999999876533 3335778999999999999999999998765 667
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC---eEEeeec
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE---AFVADFG 238 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg 238 (361)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+. +++||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998765545688999999999999999999999 9999999999999987765 8999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccC-----------CcchhHhh
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF-----------NPKIMLID 307 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-----------~~~~~~~~ 307 (361)
++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||...... ........
T Consensus 170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998764433 233456899999999999999999999999999999999999998643110 00000000
Q ss_pred hhcc------cCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 308 LLDQ------RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 308 ~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
...+ ..+.+.... ......+.+++.+||+.||++|||+.|+++||||++
T Consensus 249 ~l~g~~~~~~~lp~p~~l~--~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLS--GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCC--GGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhccccccccccCCchhhc--hhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0111 111111111 112335889999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=325.45 Aligned_cols=246 Identities=24% Similarity=0.413 Sum_probs=202.0
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-------
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH------- 158 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 158 (361)
...+|++.+.||+|+||.||+|... +|+.||+|.+.... +.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4567999999999999999999875 79999999997654 245689999999999999999998864
Q ss_pred ---------CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC
Q 042457 159 ---------KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229 (361)
Q Consensus 159 ---------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~ 229 (361)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 3458999999999999999975422 2689999999999999999999999 99999999999999999
Q ss_pred CCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh
Q 042457 230 LEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 230 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 309 (361)
+.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+.... .......
T Consensus 159 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~~~ 232 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFFTDLR 232 (284)
T ss_dssp TEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHHHHHH
T ss_pred CCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHHHHhh
Confidence 999999999998765432 2233468999999999999899999999999999999999998864221 1111222
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 310 DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
....+... + ..+.+++.+||+.||.+|||+.|++++++.
T Consensus 233 ~~~~~~~~--~------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 233 DGIISDIF--D------KKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp TTCCCTTS--C------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccC--C------HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22221111 1 137789999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=331.21 Aligned_cols=250 Identities=24% Similarity=0.420 Sum_probs=193.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCE----EEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKI----VALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|++.+.||+|+||.||+|... +++. ||+|.+...... ...+.+.+|+.+++.++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC-CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 467999999999999999999753 4543 577877544322 22477889999999999999999999998765 7
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
+++++|+.+|+|.+++..... .+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred eEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 899999999999999976543 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 243 LHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 243 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
....... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... ...........+...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~ 242 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQPP 242 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHTTCCCCCCT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcCCCCCCCc
Confidence 6433222 223446778999999999999999999999999999999 999987644322 222222221111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.. ...+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 243 IC----TIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TB----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC----CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 114788999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=355.73 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=195.5
Q ss_pred cCCCCcC-eeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 89 EDFDIKY-CIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 89 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
+++.+.+ .||+|+||.||+|.+. ++..||||+++..... ...+.+.+|++++++++||||++++++|.. +..++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 3444444 7999999999999763 4567999999765332 235789999999999999999999999976 56899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++|+|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 413 v~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999975432 589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCC
Q 042457 245 SDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDD 319 (361)
Q Consensus 245 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 319 (361)
..... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.... ...+...
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~~~p~~~ 564 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMECPPEC 564 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHHTTCCCCCCTTC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCCCCCcC
Confidence 33221 122335688999999998999999999999999999998 9999876443 22222222222 2222211
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
+ ..+.+++.+||+.||++|||+.++++
T Consensus 565 ~------~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 565 P------PELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp C------HHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred C------HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1 24889999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=333.04 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=193.7
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHH--HhcCCCCcceeeeEEEee-----C
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARL--LSQIRHRNIVKLYGFCLH-----K 159 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~-----~ 159 (361)
..++|.+.+.||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++|+||+++++.+.. .
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 346789999999999999999987 789999999975432 333444444 445899999999986653 2
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeEEeCCCCCCeeeCCCCCeE
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC------IPSIVHRDISSNNILLNSKLEAF 233 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------~~~i~H~dlk~~Nill~~~~~~k 233 (361)
...++||||+++|+|.+++.... .++..+..++.|++.||+|||+.. .++|+||||||+|||++.++.+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 35789999999999999997653 588999999999999999999873 33899999999999999999999
Q ss_pred EeeecCccccCCCCC--------Ccccccccccccccccccc-------cccCccchhhhHHHHHHHHHhCCCCCCCccc
Q 042457 234 VADFGVARLLHSDSS--------NRTVVAGTHGYIAPELAYT-------MVVTEKCDVFGFGVVALEVLMGRHPGDLLSS 298 (361)
Q Consensus 234 l~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 298 (361)
|+|||++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 1223468999999999876 4667899999999999999999777543222
Q ss_pred CCc-chh-------------Hhhhh---cccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccc------cCCC
Q 042457 299 FNP-KIM-------------LIDLL---DQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSF------PNPE 355 (361)
Q Consensus 299 ~~~-~~~-------------~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil------~hp~ 355 (361)
... ... ..... ..+...+............+.+++.+||+.||++|||++|++ .++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 111 000 00000 111111111111122334589999999999999999999994 4677
Q ss_pred CCC
Q 042457 356 INP 358 (361)
Q Consensus 356 ~~~ 358 (361)
-++
T Consensus 321 ~~~ 323 (336)
T 3g2f_A 321 ERN 323 (336)
T ss_dssp CC-
T ss_pred Hhc
Confidence 654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=357.72 Aligned_cols=242 Identities=23% Similarity=0.361 Sum_probs=194.7
Q ss_pred CeeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
+.||+|+||.||+|.+. +++.||||+++.........+.+.+|+.++++++||||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999552 46789999998765544456789999999999999999999999965 458999999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC---
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--- 248 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 248 (361)
|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997654 689999999999999999999999 999999999999999999999999999987654332
Q ss_pred CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCChhhHHHH
Q 042457 249 NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQTVIQDI 326 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 326 (361)
......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.... ...+...+
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~~~p~~~~------ 598 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERMGCPAGCP------ 598 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTCC------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCC------
Confidence 1222346788999999999999999999999999999998 9999875443 12222222222 22222211
Q ss_pred HHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
..+.+++.+||+.||++|||+.++++
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 24889999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=330.39 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=199.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCE--EEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKI--VALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 163 (361)
.++|.+.+.||+|+||.||+|... +|.. +|+|.+...... ...+.+.+|+++++++ +||||+++++++...+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch-HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 367899999999999999999764 4554 499988754322 2346788999999999 8999999999999999999
Q ss_pred EEEEeccCCChhhhhccCC-------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 164 LIYKYMRRGSLFCVLRNDD-------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
+||||+++++|.+++.... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999997653 223689999999999999999999999 999999999999999999
Q ss_pred CeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhh
Q 042457 231 EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLL 309 (361)
Q Consensus 231 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 309 (361)
.+||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.
T Consensus 180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGG
T ss_pred eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHHHHHhh
Confidence 9999999998743221 11223346789999999988889999999999999999998 9999875432 12222222
Q ss_pred cccC-CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 310 DQRA-PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 310 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.... ..+...+ ..+.+++.+||+.||.+|||+.|++++
T Consensus 256 ~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCC------HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2211 1111111 248899999999999999999999865
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=334.61 Aligned_cols=259 Identities=17% Similarity=0.194 Sum_probs=193.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC----CCCEEEEEEeccCcchHH---------HHHHHHHHHHHHhcCCCCcceeeeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP----SGKIVALKKLHHSETELA---------FLESFQTEARLLSQIRHRNIVKLYG 154 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~ 154 (361)
.++|.+.+.||+|+||.||+|... ++..+|+|+......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999875 578899999876543211 1134667889999999999999999
Q ss_pred EEee----CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC
Q 042457 155 FCLH----KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL 230 (361)
Q Consensus 155 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~ 230 (361)
++.. ....++||||+ +++|.+++.... .+++..++.++.|++.||+|||+. +++||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9988 67899999999 999999998655 689999999999999999999999 999999999999998877
Q ss_pred --CeEEeeecCccccCCCCC-------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCc
Q 042457 231 --EAFVADFGVARLLHSDSS-------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP 301 (361)
Q Consensus 231 --~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 301 (361)
.+||+|||+++.+..... ......||..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987643211 12345689999999999999999999999999999999999999964221111
Q ss_pred ch-hHhhhhcccCCCCCCCh-hhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 302 KI-MLIDLLDQRAPSPIDDQ-TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 302 ~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.. ..........+...... ........+.+++.+||+.||++|||++++++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 00 00111111111000000 000111258899999999999999999998753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=322.79 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=194.3
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-CeEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK-KCMFL 164 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~l 164 (361)
...++|++.+.||+|+||.||+++. +|+.||+|.+..... .+.+.+|+.++++++||||+++++++... +..++
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhH----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 3457799999999999999999988 588999999976542 36788999999999999999999997654 47899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999999999999975432 1378999999999999999999999 99999999999999999999999999987553
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-CCCCCChhh
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-PSPIDDQTV 322 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 322 (361)
... ....++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+..... ..+...
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~--- 239 (278)
T 1byg_A 169 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYKMDAPDGC--- 239 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTTCCCCCCTTC---
T ss_pred ccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCCCCcccC---
Confidence 322 22357889999999988889999999999999999998 9999875432 222222222211 111111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.||++|||+.|+++
T Consensus 240 ---~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 240 ---PPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 124888999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=328.00 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=201.2
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-----CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC-
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-----PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK- 160 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 160 (361)
..++|++.+.||+|+||.||++.+ .+|+.||+|++...... ..+.+.+|+.++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH--HHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 456788999999999999999984 36889999999765433 3578899999999999999999999987654
Q ss_pred -eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 161 -CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 161 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
..++||||+++++|.+++..... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 68999999999999999976542 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCccc-------CCc--ch---h
Q 042457 240 ARLLHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSS-------FNP--KI---M 304 (361)
Q Consensus 240 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-------~~~--~~---~ 304 (361)
+......... .....++..|+|||.+.+..++.++||||||+++|||+||..|+..... ... .. .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 9876544321 1223467789999999888899999999999999999999998753210 000 00 1
Q ss_pred Hhhhhccc--CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 305 LIDLLDQR--APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 305 ~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
....+... .+.+... ...+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGC------PDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTCCCCCCTTC------CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCCCCCCCCcc------cHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11122211 1111111 124888999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=327.87 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=184.0
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEe-----
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCL----- 157 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~----- 157 (361)
.....+|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--HHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34456899999999999999999976 4789999999865543 23467889999999996 999999999994
Q ss_pred ---eCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEEeCCCCCCeeeCCCCCe
Q 042457 158 ---HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLNSKLEA 232 (361)
Q Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~~~~~~ 232 (361)
.....+++|||+. |+|.+++........+++..++.++.|++.||+|||+. + ++|+||||+|||++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence 3345899999995 79988887533333699999999999999999999998 8 9999999999999999999
Q ss_pred EEeeecCccccCCCCCC------------cccccccccccccccc---cccccCccchhhhHHHHHHHHHhCCCCCCCcc
Q 042457 233 FVADFGVARLLHSDSSN------------RTVVAGTHGYIAPELA---YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLS 297 (361)
Q Consensus 233 kl~Dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 297 (361)
||+|||++......... .....+|+.|+|||++ .+..++.++||||||+++|||++|+.||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999876543221 1134589999999988 56778899999999999999999999987543
Q ss_pred cCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 298 SFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
... ........+...... ..+.+++.+||+.||.+|||+.|++++
T Consensus 258 ~~~-------~~~~~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 258 KLR-------IVNGKYSIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ---------------CCCCTTCCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHH-------hhcCcccCCcccccc----hHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 211 111111111111100 137789999999999999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=329.44 Aligned_cols=245 Identities=14% Similarity=0.144 Sum_probs=195.3
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEE------eCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC---CCcceeeeEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQ------LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR---HRNIVKLYGF 155 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~ 155 (361)
....++|.+.+.||+|+||.||+|. ..+++.||+|++..... .++..|..+++.++ |+||++++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-----WEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH-----HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh-----hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 3456789999999999999999993 45688999999976542 45677888888776 9999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCC--ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-----
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDD--EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS----- 228 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~----- 228 (361)
+...+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 999999999999999999999997421 223699999999999999999999999 9999999999999998
Q ss_pred ------CCCeEEeeecCccccCCC--CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCC
Q 042457 229 ------KLEAFVADFGVARLLHSD--SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN 300 (361)
Q Consensus 229 ------~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 300 (361)
++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 899999999999765322 223344569999999999999999999999999999999999999985433211
Q ss_pred cchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccc
Q 042457 301 PKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRS 350 (361)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 350 (361)
.. ........ .. ...+.+++..|++.+|.+|++..+.
T Consensus 293 --~~----~~~~~~~~-~~------~~~~~~~~~~~l~~~p~~r~~~~~~ 329 (365)
T 3e7e_A 293 --CK----PEGLFRRL-PH------LDMWNEFFHVMLNIPDCHHLPSLDL 329 (365)
T ss_dssp --EE----ECSCCTTC-SS------HHHHHHHHHHHHCCCCTTCCCCHHH
T ss_pred --ee----echhcccc-Cc------HHHHHHHHHHHcCCCCCCcchHHHH
Confidence 00 11111111 11 1246788889999999999655443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=335.41 Aligned_cols=253 Identities=19% Similarity=0.211 Sum_probs=196.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCC---------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCccee-------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPS---------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVK------- 151 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------- 151 (361)
.++|.+.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4679999999999999999997753 789999998754 34678999999999999988
Q ss_pred --------eeEEEee-CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCC
Q 042457 152 --------LYGFCLH-KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222 (361)
Q Consensus 152 --------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~ 222 (361)
+++++.. .+..++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~ 188 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE 188 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence 6778876 67899999999 999999998652 22699999999999999999999999 9999999999
Q ss_pred CeeeCCCC--CeEEeeecCccccCCCCC-------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCC
Q 042457 223 NILLNSKL--EAFVADFGVARLLHSDSS-------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPG 293 (361)
Q Consensus 223 Nill~~~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 293 (361)
|||++.++ .+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 899999999976643221 123346899999999999989999999999999999999999999
Q ss_pred CCcccCCcchh--HhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 294 DLLSSFNPKIM--LIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 294 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
........... ........................+.+++.+||+.||++|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 76532111111 111111111110000000000124889999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=318.73 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=193.7
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeC--CCC--EEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLP--SGK--IVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
..++|++.+.||+|+||.||+|.+. +++ .||+|++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3567999999999999999999753 333 689999875432 2234578899999999999999999999998765
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++|+||+++++|.+++..... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8899999999999999976432 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCC
Q 042457 242 LLHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317 (361)
Q Consensus 242 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (361)
........ .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.......+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~ 246 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGERLPR 246 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCCCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHccCCCCCC
Confidence 76543322 223456778999999988889999999999999999999 9999875432 2222233222222111
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
... ....+.+++.+||+.||.+|||+.+++++
T Consensus 247 ~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 247 PED----CPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcC----cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111 11248899999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=328.42 Aligned_cols=259 Identities=22% Similarity=0.371 Sum_probs=201.0
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK 159 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 159 (361)
..+++.+..++|.+.+.||+|+||.||+|...+ .+|+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345555667889999999999999999998743 499999876543333335677899999999999999999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
+..++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+||+++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999976542 588999999999999999999999 999999999999998 67999999999
Q ss_pred ccccCCC-----CCCcccccccccccccccccc---------cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH
Q 042457 240 ARLLHSD-----SSNRTVVAGTHGYIAPELAYT---------MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML 305 (361)
Q Consensus 240 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 305 (361)
+...... ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~ 252 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAII 252 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence 8754321 122233458999999998864 3578899999999999999999999875432 2222
Q ss_pred hhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 306 IDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.....+....... ...+.+++.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 253 WQMGTGMKPNLSQIGM----GKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp HHHHTTCCCCCCCSSC----CTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred HHhccCCCCCCCcCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 2222222221111100 1137889999999999999999998853
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=333.43 Aligned_cols=254 Identities=17% Similarity=0.266 Sum_probs=201.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC-CcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH-RNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv 165 (361)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+..|+++++.++| +++..+..++...+..++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 46799999999999999999975 57899999988765443 346789999999976 5666666677778889999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee---CCCCCeEEeeecCccc
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL---NSKLEAFVADFGVARL 242 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~~ 242 (361)
|||+ +++|.+++..... .+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 me~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 9999 9999999975432 589999999999999999999999 99999999999999 6889999999999987
Q ss_pred cCCCCCC-------cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCC
Q 042457 243 LHSDSSN-------RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPS 315 (361)
Q Consensus 243 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 315 (361)
....... .....||..|+|||.+.+..++.++|||||||++|||++|+.||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 6543321 224568999999999999999999999999999999999999998755433333332222221111
Q ss_pred CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 316 PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
... .........+.+++..||+.||++||++.+|++
T Consensus 236 ~~~-~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 SIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CHH-HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHH-HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000 000001235889999999999999999998874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=314.71 Aligned_cols=235 Identities=22% Similarity=0.332 Sum_probs=182.2
Q ss_pred cCCCCc-CeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHH-hcCCCCcceeeeEEEee----CCe
Q 042457 89 EDFDIK-YCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLL-SQIRHRNIVKLYGFCLH----KKC 161 (361)
Q Consensus 89 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~ 161 (361)
++|.+. +.||+|+||.||++.. .+|+.||+|++... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 456666 6799999999999976 57899999999643 3456788877 56699999999999987 677
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCCeEEeeec
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADFG 238 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg 238 (361)
.++||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999986532 2589999999999999999999999 9999999999999998 7889999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhH-hhhhcccCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIML-IDLLDQRAPSPI 317 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 317 (361)
++.... +..++.++||||||+++|||++|+.||............ ..........+
T Consensus 166 ~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 222 (299)
T 3m2w_A 166 FAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP- 222 (299)
T ss_dssp TCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC-
T ss_pred cccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC-
Confidence 986432 234678999999999999999999999754432111000 01111111111
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..........+.+++.+||+.||.+|||+.|+++||||++
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 223 -NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp -HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred -chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 0000111235889999999999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=345.69 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=201.8
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
+..+..++|.+.+.||+|+||.||+|.+.. +..||+|.+...... ...+.+.+|+.++++++||||+++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 444556778889999999999999997642 457999998764432 33578999999999999999999999985
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
.+..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 4568999999999999999975432 589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCC
Q 042457 239 VARLLHSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APS 315 (361)
Q Consensus 239 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~ 315 (361)
+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ......+.... .+.
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~~~ 613 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERLPM 613 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCCCC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCCCC
Confidence 9987644322 1223446789999999988899999999999999999997 9999875432 22222222222 222
Q ss_pred CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 316 PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 316 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
+...+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 614 ~~~~~------~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 614 PPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Ccccc------HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22211 247889999999999999999998753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=329.33 Aligned_cols=250 Identities=15% Similarity=0.165 Sum_probs=186.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCC-Cccee---------eeEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRH-RNIVK---------LYGF 155 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~---------~~~~ 155 (361)
..+|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++| +|... ....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999974 5799999999874332 22234678899999999987 32111 1111
Q ss_pred ------------Eee-----CCeEEEEEEeccCCChhhhhcc----CCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 042457 156 ------------CLH-----KKCMFLIYKYMRRGSLFCVLRN----DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSI 214 (361)
Q Consensus 156 ------------~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i 214 (361)
+.. ....+++|+.+ +++|.++++. ......+++..++.++.|++.||+|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 111 12356777765 6899988842 11122578889999999999999999999 99
Q ss_pred EEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCcccccccccccccccc----------cccccCccchhhhHHHHHH
Q 042457 215 VHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA----------YTMVVTEKCDVFGFGVVAL 284 (361)
Q Consensus 215 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slG~~l~ 284 (361)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999998765332 333456 999999998 5666889999999999999
Q ss_pred HHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 285 EVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 285 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
||++|+.||........ ...+..... ..+ ..+.+|+.+||+.||++|||+.|+++||||++
T Consensus 309 elltg~~Pf~~~~~~~~---~~~~~~~~~----~~~------~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG---SEWIFRSCK----NIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHSSCCCCTTGGGSC---SGGGGSSCC----CCC------HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHCCCCCCCcchhhh---HHHHHhhcc----cCC------HHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999976543221 111122111 111 24889999999999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.29 Aligned_cols=239 Identities=23% Similarity=0.349 Sum_probs=195.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC--CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe----
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP--SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC---- 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 161 (361)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ....+.+..|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 478999999999999999999764 689999999875443 2335678899999999999999999999998665
Q ss_pred -EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 162 -MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 162 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
.|+||||+++++|.+++.. .+++.+++.++.||+.||.|||+. +|+||||||+|||++.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987754 589999999999999999999999 99999999999999986 8999999999
Q ss_pred cccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCCh
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (361)
+..... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||...... ..+ ...
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------~~~---~~~ 288 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------GLP---EDD 288 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------SCC---TTC
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------ccc---ccc
Confidence 876433 3346899999999887654 88999999999999999999887642210 001 111
Q ss_pred hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 321 TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 321 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
........+.+++.+||+.||.+||+..+.+.|+|+
T Consensus 289 ~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 289 PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 112223458899999999999999999888887764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=321.60 Aligned_cols=250 Identities=14% Similarity=0.156 Sum_probs=190.8
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcc------hHHHHHHHHHHHHHHhcCC---------CCccee
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSET------ELAFLESFQTEARLLSQIR---------HRNIVK 151 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~ 151 (361)
..++|.+.+.||+|+||.||+|+. +|+.||||++..... .....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356789999999999999999988 789999999976532 1122366778888888875 777777
Q ss_pred eeEEEe-----------------e-------------CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHH
Q 042457 152 LYGFCL-----------------H-------------KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH 201 (361)
Q Consensus 152 ~~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~ 201 (361)
+.+.+. . .+..++||||+++|++.+.+.+. .+++..+..++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----CCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----CCCHHHHHHHHHHHHH
Confidence 766543 2 67899999999999877766442 5899999999999999
Q ss_pred HHHHHH-cCCCCCeEEeCCCCCCeeeCCCC--------------------CeEEeeecCccccCCCCCCccccccccccc
Q 042457 202 ALSYLH-YDCIPSIVHRDISSNNILLNSKL--------------------EAFVADFGVARLLHSDSSNRTVVAGTHGYI 260 (361)
Q Consensus 202 ~l~~Lh-~~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 260 (361)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~ 244 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeeccc
Confidence 999999 88 999999999999999887 8999999999876432 346999999
Q ss_pred ccccccccccCccchhhhHHHH-HHHHHhCCCCCCCcccCCcchhHhhhhcc-cCCCCCCChhhHHHHHHHHHHHhhhcC
Q 042457 261 APELAYTMVVTEKCDVFGFGVV-ALEVLMGRHPGDLLSSFNPKIMLIDLLDQ-RAPSPIDDQTVIQDIILVSKIAFACLR 338 (361)
Q Consensus 261 aPE~~~~~~~~~~~Dv~slG~~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~ 338 (361)
|||++.+.. +.++||||+|++ .+++++|..||...... ......+... .................+.+|+.+||+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhc
Confidence 999998766 889999998777 77788899997532100 0011122211 111111222223344568999999999
Q ss_pred CCCCCCCCccccc-cCCCCC
Q 042457 339 SKPKSRPTMRRSF-PNPEIN 357 (361)
Q Consensus 339 ~dP~~RPs~~eil-~hp~~~ 357 (361)
.| |++|+| +||||+
T Consensus 322 ~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 322 FS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SS-----SHHHHHHHCGGGC
T ss_pred cC-----CHHHHHhcCCCcC
Confidence 76 999999 999996
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=300.24 Aligned_cols=227 Identities=13% Similarity=0.076 Sum_probs=179.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+..+++++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999775 489999999976543 234457889999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++++|.++++.. ....++.+++.|++.||+|||+. +|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999643 35567889999999999999999 99999999999999999999998553
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
|++| ++.++||||||+++|||+||+.||......................+. ......
T Consensus 175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 232 (286)
T 3uqc_A 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA--DIDRDI 232 (286)
T ss_dssp -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH--HHCTTS
T ss_pred -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh--hcccCC
Confidence 3332 578999999999999999999999865542211111111111111000 000011
Q ss_pred HHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+.+++.+||+.||++| |+.|+++
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 1248899999999999999 9999885
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=281.75 Aligned_cols=186 Identities=15% Similarity=0.071 Sum_probs=133.0
Q ss_pred eeecCceeEEEE-EeCCCCEEEEEEeccCc--------chHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEEEE
Q 042457 97 IGTGGYGSVYRA-QLPSGKIVALKKLHHSE--------TELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 97 lg~G~~g~V~~~-~~~~~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.+.|+.|.+..+ +.-.|+.+++|.+.... ......++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 344555544443 23357889999996542 1223456799999999999 6999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||++|++|.+++...+ +++.. +|+.||+.||+|+|++ ||+||||||+|||+++++.+||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999998765 46654 5899999999999999 9999999999999999999999999999887666
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCC
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 292 (361)
.......+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 555666789999999999865 457789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=243.66 Aligned_cols=185 Identities=17% Similarity=0.220 Sum_probs=147.9
Q ss_pred CcCeeeecCceeEEEEEeCCCCEEEEEEeccCcc------hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 93 IKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSET------ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
..+.||+|+||.||+|.. .++.+++|+...... .....+.+.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356799999999999965 678899998654321 1122456899999999999999997777777888889999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++++|.+++.. +..++.|+++||.|||++ +|+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999875 458999999999999999 9999999999999999 9999999999877543
Q ss_pred CCC-------cccccccccccccccccc--cccCccchhhhHHHHHHHHHhCCCCCC
Q 042457 247 SSN-------RTVVAGTHGYIAPELAYT--MVVTEKCDVFGFGVVALEVLMGRHPGD 294 (361)
Q Consensus 247 ~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~ 294 (361)
... .....||+.|+|||++.. ..|+...|+||..+-..+-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 221 134579999999999876 667888999999999999888777653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.7e-26 Score=199.70 Aligned_cols=154 Identities=14% Similarity=0.157 Sum_probs=122.2
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchH----------------HHHHHHHHHHHHHhcCCC
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETEL----------------AFLESFQTEARLLSQIRH 146 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h 146 (361)
.+......|.+.+.||+|+||.||+|...+|+.||+|.++...... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 3344455677789999999999999988789999999996543211 12467889999999999
Q ss_pred CcceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeee
Q 042457 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILL 226 (361)
Q Consensus 147 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill 226 (361)
| +++.+++.. +..++||||+++++|.+ +... ....++.|++.||.|||+. +++||||||+|||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~---------~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl 226 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRVE---------NPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 226 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCCS---------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cchh---------hHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence 5 677775544 45699999999999998 4321 2347999999999999999 99999999999999
Q ss_pred CCCCCeEEeeecCccccCCCCCCcccccccccccccccccc
Q 042457 227 NSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267 (361)
Q Consensus 227 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 267 (361)
+ ++.+||+|||+++. +..++|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE-------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE-------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE-------------CCCCCHHHHHHH
Confidence 9 99999999999863 334788888643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4e-21 Score=167.45 Aligned_cols=138 Identities=22% Similarity=0.257 Sum_probs=105.6
Q ss_pred CCCcCeeeecCceeEEEEEe-CCCCE--EEEEEeccCcch----------------------HHHHHHHHHHHHHHhcCC
Q 042457 91 FDIKYCIGTGGYGSVYRAQL-PSGKI--VALKKLHHSETE----------------------LAFLESFQTEARLLSQIR 145 (361)
Q Consensus 91 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~ 145 (361)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ......+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999987 68888 999987543211 011236788999999998
Q ss_pred CCcc--eeeeEEEeeCCeEEEEEEeccC-C----ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEEe
Q 042457 146 HRNI--VKLYGFCLHKKCMFLIYKYMRR-G----SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH-YDCIPSIVHR 217 (361)
Q Consensus 146 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~~~~i~H~ 217 (361)
|+++ ...+++ +..++||||+.+ | +|.++... .++.....++.|++.+|.||| +. +++||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8754 333332 346899999942 4 55554322 223456789999999999999 88 99999
Q ss_pred CCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 218 DISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 218 dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4e-19 Score=161.10 Aligned_cols=140 Identities=11% Similarity=0.120 Sum_probs=100.3
Q ss_pred CCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcc----------------hHHHH----HHHHHHHHHHhcCCCCcc
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSET----------------ELAFL----ESFQTEARLLSQIRHRNI 149 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------~~~~~----~~~~~e~~~l~~l~h~ni 149 (361)
-|++...||.|++|.||+|...+|+.||||+++.... ..... .....|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3889999999999999999988999999998754211 00000 112345666666644433
Q ss_pred eeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC
Q 042457 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229 (361)
Q Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~ 229 (361)
.-..-+.... .+|||||++|++|..+.... ....++.|++.+|.+||+. +++||||||.|||++++
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~~~---------~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSSVP---------DPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCCCS---------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcccH---------HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 2111121222 37999999998887654321 2356889999999999999 99999999999999877
Q ss_pred C----------CeEEeeecCcccc
Q 042457 230 L----------EAFVADFGVARLL 243 (361)
Q Consensus 230 ~----------~~kl~Dfg~~~~~ 243 (361)
+ .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3789999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=5.4e-13 Score=116.14 Aligned_cols=143 Identities=13% Similarity=0.058 Sum_probs=111.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 166 (361)
-..|.+...++.|+.+.||+... +|+.+++|......... ...+.+|+.+++.+. +.++.++++++...+..++||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 35687778888888899999986 46889999986532111 135778899998884 677889999999989999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC------------------------------------ 210 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------ 210 (361)
||++|.+|.+.+.. ......++.++++++..||+..
T Consensus 90 e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999876421 1123478899999999999811
Q ss_pred --------------------CCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 211 --------------------IPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 211 --------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.3e-12 Score=110.78 Aligned_cols=128 Identities=19% Similarity=0.134 Sum_probs=97.0
Q ss_pred eecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCc--ceeeeEEEeeCCeEEEEEEeccCCChh
Q 042457 98 GTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN--IVKLYGFCLHKKCMFLIYKYMRRGSLF 175 (361)
Q Consensus 98 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~ 175 (361)
+.|..+.||++...+|+.+++|...... ...+..|+..++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 3555699999988778889999976541 134668888888885434 556888888888899999999998884
Q ss_pred hhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 042457 176 CVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC--------------------------------------------- 210 (361)
Q Consensus 176 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------------- 210 (361)
... .+ ...++.++++.|..||+..
T Consensus 104 --~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 --SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp --TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred --cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 221 12 2357788888888888752
Q ss_pred ----------CCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 211 ----------IPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 211 ----------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.2e-11 Score=109.07 Aligned_cols=143 Identities=17% Similarity=0.284 Sum_probs=106.4
Q ss_pred CcCeeeecCceeEEEEEeCCCCEEEEEEec--cCcchHHHHHHHHHHHHHHhcCC--CCcceeeeEEEeeC---CeEEEE
Q 042457 93 IKYCIGTGGYGSVYRAQLPSGKIVALKKLH--HSETELAFLESFQTEARLLSQIR--HRNIVKLYGFCLHK---KCMFLI 165 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv 165 (361)
..+.++.|.++.||+.... +..+++|+.. ..... .....+..|..+++.+. +..+.++++++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3566899999999999885 4678888876 32211 11246778999999886 45688899988876 458999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC----------------------------------- 210 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~----------------------------------- 210 (361)
|||++|..+.+... ..++..++..++.++++.|+.||+..
T Consensus 120 me~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999988854211 13678888999999999999999731
Q ss_pred --------------------CCCeEEeCCCCCCeeeCCCCC--eEEeeecCccc
Q 042457 211 --------------------IPSIVHRDISSNNILLNSKLE--AFVADFGVARL 242 (361)
Q Consensus 211 --------------------~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~ 242 (361)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=2e-10 Score=102.01 Aligned_cols=185 Identities=20% Similarity=0.188 Sum_probs=120.7
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCc--ceeeeEEEeeCC---eEEEEEE
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRN--IVKLYGFCLHKK---CMFLIYK 167 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e 167 (361)
.+.++.|.+..||+.. ..+++|..... .....+..|...++.+. +.. +.+.+......+ ..|+||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999864 45889986532 22467888999998873 332 344555544333 3589999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC------------------------------------- 210 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------- 210 (361)
+++|.++...... .++..++..++.++++.++.||+..
T Consensus 97 ~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 97 KIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred ccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999988653221 3677778888889999888888621
Q ss_pred ------------------CCCeEEeCCCCCCeeeCC--CCCeEEeeecCccccCCCCCCcccc--------------ccc
Q 042457 211 ------------------IPSIVHRDISSNNILLNS--KLEAFVADFGVARLLHSDSSNRTVV--------------AGT 256 (361)
Q Consensus 211 ------------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~--------------~gt 256 (361)
.+.++|+|+++.||++++ +..+.|+||+.+........-.... ...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 135899999999999988 4567899999886532110000000 000
Q ss_pred ccccc-cccccccccCccchhhhHHHHHHHHHhCCCCC
Q 042457 257 HGYIA-PELAYTMVVTEKCDVFGFGVVALEVLMGRHPG 293 (361)
Q Consensus 257 ~~y~a-PE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 293 (361)
.+... |+.... ...-.+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01111 221111 112368999999999999998774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=1.2e-07 Score=82.47 Aligned_cols=134 Identities=20% Similarity=0.157 Sum_probs=97.1
Q ss_pred eeeecCce-eEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEEEEeccCC
Q 042457 96 CIGTGGYG-SVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 96 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g 172 (361)
.+..|..| .||+.... ++..+++|+-.... ...+..|...|+.+. +-.+.++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~-----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV-----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH-----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC-----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34556665 68988664 46679999865321 356778998888774 334778889999999999999999998
Q ss_pred ChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------------
Q 042457 173 SLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC------------------------------------------ 210 (361)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------------ 210 (361)
++.+..... ......+..+++..|.-||...
T Consensus 106 ~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 106 TAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 887654322 1223456667777777777531
Q ss_pred -------------CCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 211 -------------IPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 211 -------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0237999999999999987777799999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=5.1e-07 Score=80.03 Aligned_cols=136 Identities=17% Similarity=0.109 Sum_probs=93.5
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCC---cceeeeEEEe-eCCeEEEEEEec
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR---NIVKLYGFCL-HKKCMFLIYKYM 169 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~ 169 (361)
...++.|....||+. |..+++|.... ......+..|..+++.+.+. .+.+.+.++. ..+..++|||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 345788888899988 56688888532 12246788999999998642 3566666664 345678999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD---------------------------------------- 209 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---------------------------------------- 209 (361)
+|.++.+..-. .++..+...++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 96 QGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 99888653211 234444555555555555555542
Q ss_pred -----------------CCCCeEEeCCCCCCeeeCC---CCC-eEEeeecCccc
Q 042457 210 -----------------CIPSIVHRDISSNNILLNS---KLE-AFVADFGVARL 242 (361)
Q Consensus 210 -----------------~~~~i~H~dlk~~Nill~~---~~~-~kl~Dfg~~~~ 242 (361)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 47999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=5.5e-07 Score=81.60 Aligned_cols=82 Identities=6% Similarity=-0.040 Sum_probs=54.4
Q ss_pred Cee-eecCceeEEEEEeC-------CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCC-C--CcceeeeEEEeeC---
Q 042457 95 YCI-GTGGYGSVYRAQLP-------SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIR-H--RNIVKLYGFCLHK--- 159 (361)
Q Consensus 95 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--- 159 (361)
+.| +.|....+|+.... ++..+++|....... .......+..|..+++.+. + -.+.++++++...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 77888999998764 267789998654320 0000134557777777773 2 3567788887665
Q ss_pred CeEEEEEEeccCCChhh
Q 042457 160 KCMFLIYKYMRRGSLFC 176 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~ 176 (361)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35789999999887754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.6e-05 Score=71.21 Aligned_cols=139 Identities=17% Similarity=0.284 Sum_probs=77.2
Q ss_pred eeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-----CCCcceeee-E--EEeeCCeEEEEEE
Q 042457 96 CIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-----RHRNIVKLY-G--FCLHKKCMFLIYK 167 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~e 167 (361)
.|+.|..+.||+....+| .+++|+..... ..+..|..+++.+ ..|.++... | +....+..+++|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRPE------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSCH------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCCH------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 355567889999988655 48999887532 1222334444433 234443311 1 1234667899999
Q ss_pred eccCCChhh--------------hhcc--CC---c------cCCCCHHHHH-----------------------------
Q 042457 168 YMRRGSLFC--------------VLRN--DD---E------AIQLDWTKRV----------------------------- 193 (361)
Q Consensus 168 ~~~~g~L~~--------------~l~~--~~---~------~~~l~~~~~~----------------------------- 193 (361)
|++|..+.. .++. .. . .....|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999876530 0111 00 0 0012332210
Q ss_pred --HHHHHHHHHHHHHHc----------CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 194 --NIVKSMAHALSYLHY----------DCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 194 --~i~~~i~~~l~~Lh~----------~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+...+..++.+|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666653 022489999999999999888899999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.6e-05 Score=70.32 Aligned_cols=138 Identities=20% Similarity=0.197 Sum_probs=91.9
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC---CCcceeeeEEEeeCCeEEEEEEecc
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR---HRNIVKLYGFCLHKKCMFLIYKYMR 170 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~ 170 (361)
.+.|+.|....+|+... ++..+++|+..... ...+..|...|+.+. ...+.+.++++...+..++||||++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 45689999999999987 56788899875431 356778888888773 3568888898888888999999999
Q ss_pred CCChhh-----------hhccCCc-------------------cCCCCHHHHH---HHHH----------------HHHH
Q 042457 171 RGSLFC-----------VLRNDDE-------------------AIQLDWTKRV---NIVK----------------SMAH 201 (361)
Q Consensus 171 ~g~L~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~~----------------~i~~ 201 (361)
+..+.. .|+.... ...-+|.... ++.. .++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 886521 1111110 0012455332 1111 1111
Q ss_pred H-HHHHHc-CCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 202 A-LSYLHY-DCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 202 ~-l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
. ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223432 2346899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.02 E-value=1.6e-05 Score=69.53 Aligned_cols=80 Identities=18% Similarity=0.182 Sum_probs=56.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC---CcceeeeEEEeeCCeEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH---RNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~lv 165 (361)
..+.-...+|.|..+.||+.+..||+.|++|+........ ...|..|+..|+.+.. -.+.+++++. ..++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4455567799999999999999999999999875443221 2456788888887742 1244455442 24789
Q ss_pred EEeccCCCh
Q 042457 166 YKYMRRGSL 174 (361)
Q Consensus 166 ~e~~~~g~L 174 (361)
|||.+++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.7e-05 Score=72.85 Aligned_cols=77 Identities=10% Similarity=0.110 Sum_probs=47.7
Q ss_pred cCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc---h--HHHHHHHHHHHHHHhcCCC--Cc-ceeeeEEEeeCCeEEE
Q 042457 94 KYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET---E--LAFLESFQTEARLLSQIRH--RN-IVKLYGFCLHKKCMFL 164 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~--~~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~l 164 (361)
.+.+|.|.++.||++... +++.+++|....... . ....+.+..|.+.++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 456899999999999754 468899998643211 0 0012345678888877632 33 3455544 3445689
Q ss_pred EEEeccCC
Q 042457 165 IYKYMRRG 172 (361)
Q Consensus 165 v~e~~~~g 172 (361)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00011 Score=67.96 Aligned_cols=77 Identities=10% Similarity=0.012 Sum_probs=46.2
Q ss_pred CCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCccccc--cccccccccccccc---ccCccchhhhHHHHHHHH
Q 042457 212 PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVA--GTHGYIAPELAYTM---VVTEKCDVFGFGVVALEV 286 (361)
Q Consensus 212 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el 286 (361)
+.++|||+++.|||++.++ +.++||+.+..-... ..-.... -...|++|+..... ......++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3899999999999998876 999999988643211 0000000 11345666544311 111234555777778877
Q ss_pred HhCC
Q 042457 287 LMGR 290 (361)
Q Consensus 287 ~tg~ 290 (361)
+++.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00043 Score=61.33 Aligned_cols=158 Identities=12% Similarity=0.087 Sum_probs=85.3
Q ss_pred cCHHHHHHHhcCCCCc-----CeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCc--cee
Q 042457 79 ITFEEIIVATEDFDIK-----YCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN--IVK 151 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~ 151 (361)
++.+++...-..|.+. +.|+.|....+|+....+| .+++|........ +.+..|..+++.+...+ +.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~----~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH----HHHHHHHHHHHHHHHCCCCCCc
Confidence 4455665555557652 3356688889999988666 5889988653111 23445666665553111 233
Q ss_pred eeEE------EeeCCeEEEEEEeccCCChhhh--------------hccC----Ccc--CC---CCHHHHHH--------
Q 042457 152 LYGF------CLHKKCMFLIYKYMRRGSLFCV--------------LRND----DEA--IQ---LDWTKRVN-------- 194 (361)
Q Consensus 152 ~~~~------~~~~~~~~lv~e~~~~g~L~~~--------------l~~~----~~~--~~---l~~~~~~~-------- 194 (361)
++.. ....+..+++++|++|..+... ++.. ... .. ..|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 1234567899999998764210 1110 000 00 11322110
Q ss_pred ----HHHHHHHHHHHHHcC----CCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 195 ----IVKSMAHALSYLHYD----CIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 195 ----i~~~i~~~l~~Lh~~----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
+...+...+..++.. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001134445555432 12379999999999999987666899998774
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00086 Score=59.53 Aligned_cols=141 Identities=13% Similarity=0.131 Sum_probs=79.2
Q ss_pred eeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC--CcceeeeEE-----EeeCCeEEEEEEe
Q 042457 96 CIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH--RNIVKLYGF-----CLHKKCMFLIYKY 168 (361)
Q Consensus 96 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~-----~~~~~~~~lv~e~ 168 (361)
.++ |....||+....+|+.+++|......... +.+..|...++.+.. -.+.+++.. ....+..+++++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 466 77889999988778789999986432221 345566766666531 123444432 2234567889999
Q ss_pred ccCCChhh----h----------hcc----CC--ccCCCCHHHH----HHH---------------HHHHHHHHHHHHcC
Q 042457 169 MRRGSLFC----V----------LRN----DD--EAIQLDWTKR----VNI---------------VKSMAHALSYLHYD 209 (361)
Q Consensus 169 ~~~g~L~~----~----------l~~----~~--~~~~l~~~~~----~~i---------------~~~i~~~l~~Lh~~ 209 (361)
++|..+.. . ++. .. .....++... ..+ ...+...+..+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98865421 0 110 00 0111232211 001 11111222233221
Q ss_pred ----CCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 210 ----CIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 210 ----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
....++|||+++.||+++ + .+.++||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223689999999999999 4 899999987753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00029 Score=63.92 Aligned_cols=140 Identities=19% Similarity=0.238 Sum_probs=81.4
Q ss_pred CeeeecCceeEEEEEeCC--------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEE
Q 042457 95 YCIGTGGYGSVYRAQLPS--------GKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 165 (361)
+.|..|-...+|+....+ ++.+++|+....... .....+|..+++.+. +.-..++++.+.. .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 356668888999998752 478999986332111 245568888888774 2223566666543 289
Q ss_pred EEeccCCChhhh-h----------------ccCC--ccCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 042457 166 YKYMRRGSLFCV-L----------------RNDD--EAIQLD--WTKRVNIVKSMAH-------------------ALSY 205 (361)
Q Consensus 166 ~e~~~~g~L~~~-l----------------~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~l~~ 205 (361)
+||++|..|..- + +... ...... |.++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998765321 1 1111 011122 4555555544322 1222
Q ss_pred ----HHcC-CCCCeEEeCCCCCCeeeCCC----CCeEEeeecCcc
Q 042457 206 ----LHYD-CIPSIVHRDISSNNILLNSK----LEAFVADFGVAR 241 (361)
Q Consensus 206 ----Lh~~-~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~ 241 (361)
|... ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3222 22368999999999999876 689999999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00023 Score=63.48 Aligned_cols=31 Identities=35% Similarity=0.443 Sum_probs=27.0
Q ss_pred CCeEEeCCCCCCeeeCCC----CCeEEeeecCccc
Q 042457 212 PSIVHRDISSNNILLNSK----LEAFVADFGVARL 242 (361)
Q Consensus 212 ~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~ 242 (361)
..++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999875 6789999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00017 Score=66.90 Aligned_cols=73 Identities=21% Similarity=0.273 Sum_probs=48.4
Q ss_pred cCeeeecCceeEEEEEeCC--------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeeCCeEEE
Q 042457 94 KYCIGTGGYGSVYRAQLPS--------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI-VKLYGFCLHKKCMFL 164 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~l 164 (361)
.+.|+.|....+|+....+ +..+++|+...... .+.+..|..+++.+...++ .++++.+.. .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 3457778889999998753 57899998844221 1334468888887743333 566665542 38
Q ss_pred EEEeccCCCh
Q 042457 165 IYKYMRRGSL 174 (361)
Q Consensus 165 v~e~~~~g~L 174 (361)
|+||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00027 Score=62.17 Aligned_cols=71 Identities=13% Similarity=0.079 Sum_probs=43.0
Q ss_pred cCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeeCCeEEEEEEec-cC
Q 042457 94 KYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYM-RR 171 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~ 171 (361)
.+.|+.|....+|+. ..+++|+....... ......|...++.+...++ .++++++ .+.-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 567888999999999 45888987643211 1122356766666632222 4555543 33347899999 66
Q ss_pred CCh
Q 042457 172 GSL 174 (361)
Q Consensus 172 g~L 174 (361)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 555
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0014 Score=61.03 Aligned_cols=73 Identities=18% Similarity=0.161 Sum_probs=46.3
Q ss_pred CeeeecCceeEEEEEeCC-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcc-eeeeEEEeeCCeEEEEEEeccCC
Q 042457 95 YCIGTGGYGSVYRAQLPS-GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI-VKLYGFCLHKKCMFLIYKYMRRG 172 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g 172 (361)
+.|+.|-...+|+....+ +..+++|+........ -....|..+++.+...++ .++++.+. + .+|+||++|.
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 457778889999998865 4778899874322110 112478888888754444 56777663 2 2599999876
Q ss_pred Ch
Q 042457 173 SL 174 (361)
Q Consensus 173 ~L 174 (361)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 55
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00046 Score=62.50 Aligned_cols=73 Identities=14% Similarity=0.076 Sum_probs=42.8
Q ss_pred CeeeecCceeEEEEEeCC---------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCc-ceeeeEEEeeCCeEEE
Q 042457 95 YCIGTGGYGSVYRAQLPS---------GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN-IVKLYGFCLHKKCMFL 164 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~l 164 (361)
..++.|....+|+....+ +..+++|+....... ......|...++.+...+ ..++++.. . -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 346778888999998754 268888987543221 112346777777664223 34566544 2 268
Q ss_pred EEEeccCCCh
Q 042457 165 IYKYMRRGSL 174 (361)
Q Consensus 165 v~e~~~~g~L 174 (361)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0033 Score=56.18 Aligned_cols=31 Identities=23% Similarity=0.461 Sum_probs=27.4
Q ss_pred CCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 212 PSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 212 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0052 Score=50.50 Aligned_cols=104 Identities=17% Similarity=0.081 Sum_probs=65.9
Q ss_pred CCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCCc
Q 042457 171 RGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250 (361)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 250 (361)
.-+|.+.|+..+. ++++.+++.++.|.+.+|.-+-.... . ..+=+.|..|++..+|.+...+ +.+.
T Consensus 32 ~vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 3478888876543 79999999999999999887732111 1 1222346889999999987764 1110
Q ss_pred ccccccccccccccccccccCccchhhhHHHHHHHHHhCCCC
Q 042457 251 TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292 (361)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 292 (361)
.....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122356888653 3446788999999999998863333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0076 Score=55.43 Aligned_cols=73 Identities=7% Similarity=0.014 Sum_probs=46.2
Q ss_pred CeeeecCceeEEEEEeCC--------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEE
Q 042457 95 YCIGTGGYGSVYRAQLPS--------GKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 165 (361)
+.+..|-...+|+....+ +..+++|+....... ..+..+|..+++.+. +.-..++++.+ .+ +.|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence 457678888999998753 578999986543211 112346777777664 22234555533 22 689
Q ss_pred EEeccCCCh
Q 042457 166 YKYMRRGSL 174 (361)
Q Consensus 166 ~e~~~~g~L 174 (361)
+||++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998765
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0059 Score=35.97 Aligned_cols=26 Identities=27% Similarity=0.356 Sum_probs=12.3
Q ss_pred ehHHHHHHHHHHHHHHHHhhhccccc
Q 042457 29 IILPIVLLLILVCIFTFLCLRRPKVR 54 (361)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~~~r~~~~ 54 (361)
.+++.+++++++++++++++||++.+
T Consensus 16 gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 16 GMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 34443444444444555555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.27 E-value=0.0064 Score=35.71 Aligned_cols=26 Identities=19% Similarity=0.447 Sum_probs=12.2
Q ss_pred hHHHHHHHHHHHHHHHHhhhcccccc
Q 042457 30 ILPIVLLLILVCIFTFLCLRRPKVRK 55 (361)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~~r~~~~~ 55 (361)
+++.+++++++++++++++||++.++
T Consensus 16 VVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 16 VIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred ehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 33334444444445555555554433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.98 E-value=0.0088 Score=35.06 Aligned_cols=26 Identities=12% Similarity=0.368 Sum_probs=10.7
Q ss_pred EEehHHHHHHHHHHHHHHHHhhhcccc
Q 042457 27 VVIILPIVLLLILVCIFTFLCLRRPKV 53 (361)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~r~~~ 53 (361)
+.++++ +++++++++.+++++||++.
T Consensus 15 a~~vVG-vll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 15 ISAVVG-ILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHH-HHHHHHHHHHHHHHHHHHCS
T ss_pred HHHHHH-HHHHHHHHHHHHhheehhhh
Confidence 334444 33333333344444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.87 E-value=0.081 Score=48.25 Aligned_cols=30 Identities=30% Similarity=0.473 Sum_probs=24.9
Q ss_pred CeEEeCCCCCCeee------CCCCCeEEeeecCccc
Q 042457 213 SIVHRDISSNNILL------NSKLEAFVADFGVARL 242 (361)
Q Consensus 213 ~i~H~dlk~~Nill------~~~~~~kl~Dfg~~~~ 242 (361)
.++|+|+.+.|||+ +++..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.83 E-value=0.085 Score=43.22 Aligned_cols=118 Identities=7% Similarity=0.096 Sum_probs=81.4
Q ss_pred CCCcceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCe
Q 042457 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNI 224 (361)
Q Consensus 145 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Ni 224 (361)
.||++++. .+-...+.+.+-++.-+++.=...++ .++...+++++.+|+....+++.+ +|--|.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 57888876 45556666555555443222222232 478899999999999998777644 7889999999
Q ss_pred eeCCCCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCc
Q 042457 225 LLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLL 296 (361)
Q Consensus 225 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 296 (361)
+++.++.+++.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+..
T Consensus 111 ~f~~~~~p~i~~RGik~~l-----------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV-----------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp EECTTSCEEESCCEETTTB-----------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred EEcCCCCEEEEEccCccCC-----------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9999999999988875432 222 1122223446778888999999887643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=93.39 E-value=0.011 Score=55.19 Aligned_cols=63 Identities=19% Similarity=0.138 Sum_probs=18.6
Q ss_pred CcCeeeecCceeEEEEEeCC-CCEEEE------EEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 93 IKYCIGTGGYGSVYRAQLPS-GKIVAL------KKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 93 ~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
+.+.|| ||.||+|.+.. ..+||+ |..+......+....+.+|..+++.++|+|+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 445676 99999998854 367888 7776554444445678889999999999999999887764
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.04 E-value=0.024 Score=32.30 Aligned_cols=25 Identities=24% Similarity=0.304 Sum_probs=14.1
Q ss_pred EEEehHHHHHHHHHHHHHHHHhhhc
Q 042457 26 LVVIILPIVLLLILVCIFTFLCLRR 50 (361)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~r 50 (361)
++.+++++++.+++++.++++++||
T Consensus 13 IAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 13 IVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred eeeeehHHHHHHHHHHHHHHHHeec
Confidence 3445555555556566666666555
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.82 E-value=0.36 Score=39.62 Aligned_cols=116 Identities=15% Similarity=0.124 Sum_probs=78.8
Q ss_pred CCCcceeeeEEEeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeEEeCCCCCC
Q 042457 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS-YLHYDCIPSIVHRDISSNN 223 (361)
Q Consensus 145 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~Lh~~~~~~i~H~dlk~~N 223 (361)
.||++ -...-.+++.+.+.++--+++.=...++ .++...+++++.+++.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 3334456677777677654443333343 4788899999999998877 6664 4788999999
Q ss_pred eeeCCCCCeEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCC
Q 042457 224 ILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDL 295 (361)
Q Consensus 224 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 295 (361)
+++|.++.+++.-.|+-..+ +|.-. ++.-=.-.+=+++..++.++..|+.
T Consensus 115 L~f~~~~~p~i~hRGi~~~l-----------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL-----------------PPDEW-----DDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp EEECTTCCEEESCCEETTTB-----------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EEEeCCCcEEEEEcCCcccC-----------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999988875432 23211 1112234567788888888887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 361 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-63
Identities = 66/272 (24%), Positives = 129/272 (47%), Gaps = 16/272 (5%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLL 141
++ + + IG+G +G+VY+ + VA+K L+ + L++F+ E +L
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 142 SQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH 201
+ RH NI+ G+ + ++ ++ SL+ L + + + K ++I + A
Sbjct: 59 RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQ 115
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTHGY 259
+ YLH SI+HRD+ SNNI L+ L + DFG+A + S + ++G+ +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 260 IAPELAYTM---VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316
+APE+ + + DV+ FG+V E++ G+ P S+ N + +I ++ + SP
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSP 229
Query: 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ + ++ CL+ K RP
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFP 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-61
Identities = 70/266 (26%), Positives = 122/266 (45%), Gaps = 14/266 (5%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
ED+++ Y IGTG YG + + GKI+ K+L + A + +E LL +++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 148 NIVKLYGFCLHK--KCMFLIYKYMRRGSLFCVLRNDDEAIQ-LDWTKRVNIVKSMAHALS 204
NIV+ Y + + ++++ +Y G L V+ + Q LD + ++ + AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 205 YLHY--DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAP 262
H D +++HRD+ N+ L+ K + DFG+AR+L+ D+S GT Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 263 ELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322
E M EK D++ G + E+ P S + + +R P D+
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE-- 241
Query: 323 IQDIILVSKIAFACLRSKPKSRPTMR 348
+ +II L K RP++
Sbjct: 242 LNEIIT------RMLNLKDYHRPSVE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-59
Identities = 59/270 (21%), Positives = 111/270 (41%), Gaps = 9/270 (3%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI 144
+ +DF+ +G G G V++ PSG ++A K +H A E ++L +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHEC 61
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
IV YG + + ++M GSL VL+ ++ + ++ L+
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLT 118
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
YL I+HRD+ +NIL+NS+ E + DFGV+ L +N V GT Y++PE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSPER 174
Query: 265 AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324
+ + D++ G+ +E+ +GR+P + ++M ++ A
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNP 354
+ + + + + P
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 6e-59
Identities = 61/261 (23%), Positives = 116/261 (44%), Gaps = 16/261 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
E + +G G +G V+ VA+K L ++F EA L+ Q++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQR 69
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+V+LY + +++I +YM GSL L+ I+L K +++ +A ++++
Sbjct: 70 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-RTVVAGTHGYIAPELAYT 267
+HRD+ + NIL++ L +ADFG+ARL+ + R + APE
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327
T K DV+ FG++ E++ + I + +R + +++
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPDNCPEELY 240
Query: 328 LVSKIAFACLRSKPKSRPTMR 348
++ C + +P+ RPT
Sbjct: 241 ---QLMRLCWKERPEDRPTFD 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-57
Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 19/262 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE-LAFLESFQTEARLLSQIRH 146
EDF+I +G G +G+VY A+ S I+ALK L ++ E + E + S +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
NI++LYG+ ++LI +Y G+++ L+ + D + + +A+ALSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H ++HRDI N+LL S E +ADFG + H+ SS RT + GT Y+ PE+
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIE 177
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
+ EK D++ GV+ E L+G+ P + + + P +D+
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFPDFVTEGARDL 234
Query: 327 ILVSKIAFACLRSKPKSRPTMR 348
I L+ P RP +R
Sbjct: 235 IS------RLLKHNPSQRPMLR 250
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-56
Identities = 62/262 (23%), Positives = 113/262 (43%), Gaps = 18/262 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+D +GTG +G V + VA+K + + F EA+++ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 60
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+V+LYG C ++ +F+I +YM G L LR + + + + K + A+ YL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES 118
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGTHGYIAPELAYT 267
+HRD+++ N L+N + V+DFG++R + D +V + PE+
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 268 MVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
+ K D++ FGV+ E+ +G+ P + + N + R P + I
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQGLRLYRPHLASEKVYTI 233
Query: 327 ILVSKIAFACLRSKPKSRPTMR 348
+ +C K RPT +
Sbjct: 234 MY------SCWHEKADERPTFK 249
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 3e-55
Identities = 57/261 (21%), Positives = 104/261 (39%), Gaps = 16/261 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+ IG+G +G V+ + VA+K + E F EA ++ ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 61
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+V+LYG CL + + L++++M G L LR + + + + Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEG---MAY 116
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV-VAGTHGYIAPELAYT 267
++HRD+++ N L+ V+DFG+ R + D + + +PE+
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327
+ K DV+ FGV+ EV S N +++ R P T + I+
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFRLYKPRLASTHVYQIM 235
Query: 328 LVSKIAFACLRSKPKSRPTMR 348
C + +P+ RP
Sbjct: 236 N------HCWKERPEDRPAFS 250
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (453), Expect = 2e-54
Identities = 80/288 (27%), Positives = 126/288 (43%), Gaps = 33/288 (11%)
Query: 80 TFEEIIVATEDFD---------IKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSET 126
TFE+ A +F I+ IG G +G V L VA+K L T
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 127 ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQ 186
E F +EA ++ Q H N++ L G + +I ++M GSL LR +D Q
Sbjct: 68 E-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124
Query: 187 LDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
+ V +++ +A + YL VHRD+++ NIL+NS L V+DFG++R L D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 247 SSNRTVVA-----GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFN 300
+S+ T + + APE T DV+ +G+V EV+ G P ++ N
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--N 239
Query: 301 PKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
++ D R P P+D + + ++L C + RP
Sbjct: 240 QDVINAIEQDYRLPPPMDCPSALHQLML------DCWQKDRNHRPKFG 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-54
Identities = 64/264 (24%), Positives = 113/264 (42%), Gaps = 21/264 (7%)
Query: 91 FDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
FDI+ IG G + +VY+ + VA +L + + + F+ EA +L ++H NI
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 150 VKLYGFCL----HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
V+ Y KKC+ L+ + M G+L L+ + + + + L +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQF 127
Query: 206 LHYDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLLHSDSSNRTVVAGTHGYIAPEL 264
LH P I+HRD+ +NI + + D G+A L +S V GT ++APE+
Sbjct: 128 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEM 184
Query: 265 AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324
Y E DV+ FG+ LE+ +P N + + P+ D + +
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 325 DIILVSKIAFACLRSKPKSRPTMR 348
++ C+R R +++
Sbjct: 242 VKEIIEG----CIRQNKDERYSIK 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 4e-54
Identities = 63/261 (24%), Positives = 115/261 (44%), Gaps = 16/261 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
E ++ +G G +G V+ VA+K L E+F EA+++ ++RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEK 73
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+V+LY + ++++ +YM +GSL L+ + + V++ +A ++Y+
Sbjct: 74 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER 131
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD-SSNRTVVAGTHGYIAPELAYT 267
VHRD+ + NIL+ L VADFG+ARL+ + + R + APE A
Sbjct: 132 MNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327
T K DV+ FG++ E+ ++D +++ P +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVERGYRMPCPPECPES--- 242
Query: 328 LVSKIAFACLRSKPKSRPTMR 348
+ + C R +P+ RPT
Sbjct: 243 -LHDLMCQCWRKEPEERPTFE 262
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 4e-54
Identities = 61/282 (21%), Positives = 122/282 (43%), Gaps = 27/282 (9%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+ + IG G G+VY A + +G+ VA+++++ + E E ++ + ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKN 76
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
NIV L ++++ +Y+ GSL V+ +D + + + AL +L
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFL 132
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H + ++HRDI S+NILL + DFG + + S R+ + GT ++APE+
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
K D++ G++A+E++ G P + NP L + P + + +
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 327 I-LVSKIAFACLRSKPKSRPTM---------RRSFPNPEINP 358
+++ CL + R + + + P + P
Sbjct: 247 RDFLNR----CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 7e-54
Identities = 58/261 (22%), Positives = 112/261 (42%), Gaps = 20/261 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
++ + IG G +G V G VA+K + + T ++F EA +++Q+RH N
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA----QAFLAEASVMTQLRHSN 61
Query: 149 IVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
+V+L G + K ++++ +YM +GSL LR+ ++ L + + A+ YL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE 120
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYT 267
+ VHRD+++ N+L++ A V+DFG+ + SS + + APE
Sbjct: 121 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALRE 174
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327
+ K DV+ FG++ E+ + + + +P + +++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYEVM 233
Query: 328 LVSKIAFACLRSKPKSRPTMR 348
C RP+
Sbjct: 234 K------NCWHLDAAMRPSFL 248
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 8e-54
Identities = 61/275 (22%), Positives = 119/275 (43%), Gaps = 23/275 (8%)
Query: 82 EEIIVATEDFDI-KYCIGTGGYGSVYRAQL---PSGKIVALKKLHHSETELAFLESFQTE 137
+++ + ++ I +G G +GSV + VA+K L + A E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMRE 59
Query: 138 ARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVK 197
A+++ Q+ + IV+L G C + + L+ + G L L E ++ + ++
Sbjct: 60 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLH 116
Query: 198 SMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---RTVVA 254
++ + YL + VHRD+++ N+LL ++ A ++DFG+++ L +D S R+
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 255 GTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRA 313
+ APE + + DV+ +GV E L G+ P + P++M +R
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGKRM 231
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
P + + ++ C K + RP
Sbjct: 232 ECPPECPPELYALMS------DCWIYKWEDRPDFL 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-53
Identities = 63/268 (23%), Positives = 111/268 (41%), Gaps = 21/268 (7%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+ ++I +G G +G VY+AQ + + A K + E LE + E +L+ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDH 68
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
NIVKL ++ ++++ ++ G++ V+ + L ++ + K AL+YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYL 126
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H I+HRD+ + NIL + +ADFGV+ R GT ++APE+
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 267 TMV-----VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT 321
K DV+ G+ +E+ P NP +L+ + P+
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPP---HHELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 322 VIQDII-LVSKIAFACLRSKPKSRPTMR 348
+ + K CL +R T
Sbjct: 241 WSSNFKDFLKK----CLEKNVDARWTTS 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (448), Expect = 2e-53
Identities = 62/268 (23%), Positives = 117/268 (43%), Gaps = 26/268 (9%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHS-ETELAFLESFQTEARLLSQIR 145
+ F IG G +G+VY A+ + + ++VA+KK+ +S + + E R L ++R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
H N ++ G L + +L+ +Y + + + L + + L+Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
LH +++HRD+ + NILL+ + DFG A ++ +S GT ++APE+
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVI 183
Query: 266 YTM---VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQT- 321
M K DV+ G+ +E+ + P L + N L + +P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 322 -VIQDIILVSKIAFACLRSKPKSRPTMR 348
++ + +CL+ P+ RPT
Sbjct: 241 EYFRNFVD------SCLQKIPQDRPTSE 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (445), Expect = 3e-53
Identities = 64/273 (23%), Positives = 118/273 (43%), Gaps = 16/273 (5%)
Query: 78 RITFEEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQT 136
+++ + D +K+ +G G YG VY VA+K L E+ E F
Sbjct: 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLK 62
Query: 137 EARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIV 196
EA ++ +I+H N+V+L G C + ++I ++M G+L LR + ++ + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 121
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAG 255
++ A+ YL + +HRD+++ N L+ VADFG++RL+ D+
Sbjct: 122 TQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 256 THGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPS 315
+ APE + K DV+ FGV+ E+ + +LL++
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRM 235
Query: 316 PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ + V ++ AC + P RP+
Sbjct: 236 ERPEGCPEK----VYELMRACWQWNPSDRPSFA 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 4e-53
Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 34/284 (11%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLS 142
+G G +G V A + VA+K L S E+ +E ++LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLS 81
Query: 143 QI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN---------------DDEAIQ 186
+ H NIV L G C +I +Y G L LR +D+ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 187 LDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
LD ++ +A +++L + +HRD+++ NILL + DFG+AR + +D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 247 SSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM 304
S+ + ++APE + V T + DV+ +G+ E+ + K
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 305 LIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ R SP + DI+ C + P RPT +
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFK 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-52
Identities = 64/264 (24%), Positives = 102/264 (38%), Gaps = 17/264 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
ED+D+ +G G YG V A + + VA+K + E+ + E + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHE 63
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
N+VK YG +L +Y G LF + D I + + + YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTHGYIAPELA 265
I HRDI N+LL+ + ++DFG+A + ++ R + GT Y+APEL
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 266 YTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324
E DV+ G+V +L G P D S + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 325 DIILVSKIAFACLRSKPKSRPTMR 348
++ L P +R T+
Sbjct: 238 ALLH------KILVENPSARITIP 255
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-52
Identities = 57/259 (22%), Positives = 113/259 (43%), Gaps = 22/259 (8%)
Query: 97 IGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLY 153
+G+G +G+V + K VA+K L + + A + EA ++ Q+ + IV++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 154 GFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213
G C + M L+ + G L L+ + + + +V ++ + YL +
Sbjct: 75 GICEAESWM-LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SN 127
Query: 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---RTVVAGTHGYIAPELAYTMVV 270
VHRD+++ N+LL ++ A ++DFG+++ L +D + +T + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 271 TEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILV 329
+ K DV+ FGV+ E G+ P + ++ + +R P + D++
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGERMGCPAGCPREMYDLMN- 244
Query: 330 SKIAFACLRSKPKSRPTMR 348
C ++RP
Sbjct: 245 -----LCWTYDVENRPGFA 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (433), Expect = 2e-51
Identities = 64/298 (21%), Positives = 120/298 (40%), Gaps = 42/298 (14%)
Query: 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESF 134
+ + + IG G +G V++A+ P +VA+K L + F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADF 63
Query: 135 QTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN-------------- 180
Q EA L+++ + NIVKL G C K M L+++YM G L LR+
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 181 -------DDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAF 233
L +++ I + +A ++YL VHRD+++ N L+ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVK 180
Query: 234 VADFGVARLLHSDSSNR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRH 291
+ADFG++R ++S + A ++ PE + T + DV+ +GVV E+
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 292 PGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV-IQDIILVSKIAFACLRSKPKSRPTMR 348
+ ++ + D + ++ + + +++ C P RP+
Sbjct: 241 QPY--YGMAHEEVIYYVRDGNILACPENCPLELYNLMR------LCWSKLPADRPSFC 290
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-51
Identities = 59/272 (21%), Positives = 103/272 (37%), Gaps = 19/272 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
EDF +G G + +V A+ L + + A+K L + + E ++S++ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
VKLY + ++ Y + G L +R D T + AL YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPEL 264
H I+HRD+ NILLN + + DFG A++L +S GT Y++PEL
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 265 AYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324
+ D++ G + +++ G P + N ++ ++ P +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPP---FRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356
D++ L R +
Sbjct: 239 DLVE------KLLVLDATKRLGCEEMEGYGPL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-51
Identities = 63/292 (21%), Positives = 113/292 (38%), Gaps = 40/292 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
++ IG G +G V+R + G+ VA+K E F E E +RH N
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHEN 58
Query: 149 IVKLYGFC----LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
I+ ++L+ Y GSLF L + + + S A L+
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLA 114
Query: 205 YLHYDCI-----PSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN----RTVVAG 255
+LH + + P+I HRD+ S NIL+ +AD G+A S + G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 256 THGYIAPELAYTMV------VTEKCDVFGFGVVALEVLMGRHPGDLLSSF---------- 299
T Y+APE+ + ++ D++ G+V E+ G + +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 300 --NPKIMLIDLLDQRAPSPIDDQTVIQDII-LVSKIAFACLRSKPKSRPTMR 348
+ + M + +Q+ I ++ + + +++KI C + +R T
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-50
Identities = 60/289 (20%), Positives = 113/289 (39%), Gaps = 39/289 (13%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPS------GKIVALKKLHHSETELAFLESFQTEARLLS 142
E+ + +G+G +G V A VA+K L + E+ +E ++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMT 95
Query: 143 QI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN--------------------D 181
Q+ H NIV L G C ++LI++Y G L LR+ +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 182 DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
++ L + + +A + +L + S VHRD+++ N+L+ + DFG+AR
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 242 LLHSDSSNRTV--VAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSF 299
+ SDS+ ++APE + + T K DV+ +G++ E+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 300 NPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ + + P I I+ +C + RP+
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQ------SCWAFDSRKRPSFP 315
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-50
Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 21/271 (7%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQLPSG-----KIVALKKLHHSETELAFLESFQTEARL 140
+ + IG G +G VY+ L + VA+K L TE F EA +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGI 62
Query: 141 LSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMA 200
+ Q H NI++L G K M +I +YM G+L LR D + + V +++ +A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIA 120
Query: 201 HALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---RTVVAGTH 257
+ Y + VHRD+++ NIL+NS L V+DFG++R+L D +
Sbjct: 121 AGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 258 GYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317
+ APE T DV+ FG+V EV+ S N ++M R P+P+
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAINDGFRLPTPM 236
Query: 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
D + I +++ C + + RP
Sbjct: 237 DCPSAIYQLMM------QCWQQERARRPKFA 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-49
Identities = 61/293 (20%), Positives = 111/293 (37%), Gaps = 28/293 (9%)
Query: 69 EFSVWNYDGRITFEEIIVATEDFDIKY--CIGTGGYGSVYRAQLPSGK----IVALKKLH 122
+ S N + + +++ + + IG G +G VY L A+K L+
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 123 HSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCMFLIYKYMRRGSLFCVLRND 181
+ F TE ++ H N++ L G CL + ++ YM+ G L
Sbjct: 65 RITDI-GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF--IR 121
Query: 182 DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241
+E + +A + + VHRD+++ N +L+ K VADFG+AR
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 242 LLHSDS----SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLS 297
++ N+T ++A E T T K DV+ FGV+ E++ P
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----- 233
Query: 298 SFNPKIMLIDLLDQ--RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
P + D+ + + + + ++ C K + RP+
Sbjct: 234 -PYPDVNTFDITVYLLQGRRLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFS 282
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-49
Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 20/272 (7%)
Query: 85 IVATEDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLH-HSETELAFLESFQTEAR 139
++ +D + +G G +G V R + + VA+K L ++ ++ F E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
+ + HRN+++LYG M ++ + GSL LR L R +
Sbjct: 64 AMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQV 120
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN---RTVVAGT 256
A + YL +HRD+++ N+LL ++ + DFG+ R L + + +
Sbjct: 121 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 257 HGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316
+ APE T + D + FGV E+ + + + + ID +R P P
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237
Query: 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
D I ++++ C KP+ RPT
Sbjct: 238 EDCPQDIYNVMV------QCWAHKPEDRPTFV 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 165 bits (419), Expect = 1e-48
Identities = 60/263 (22%), Positives = 109/263 (41%), Gaps = 16/263 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+ +DI +GTG +G V+R +G A K + + E+ + E + +S +RH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 83
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
+V L+ M +IY++M G LF + DE ++ + V ++ + L ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
+ VH D+ NI+ +K + DFG+ L S + GT + APE+A
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVA 197
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325
V D++ GV++ +L G P + + + + D
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 326 IILVSKIAFACLRSKPKSRPTMR 348
+ K L + P +R T+
Sbjct: 257 KDFIRK----LLLADPNTRMTIH 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-48
Identities = 60/277 (21%), Positives = 111/277 (40%), Gaps = 29/277 (10%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSG---KIVALKKLHHSETELAFLESFQTEARLLSQI- 144
D + IG G +G V +A++ A+K++ ++ F E +L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLG 68
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN-------------DDEAIQLDWTK 191
H NI+ L G C H+ ++L +Y G+L LR + A L +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 192 RVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT 251
++ +A + Y +HRD+++ NIL+ A +ADFG++R +T
Sbjct: 129 LLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKT 184
Query: 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ 311
+ ++A E V T DV+ +GV+ E++ + ++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGY 243
Query: 312 RAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
R P++ + D++ C R KP RP+
Sbjct: 244 RLEKPLNCDDEVYDLMR------QCWREKPYERPSFA 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 165 bits (418), Expect = 2e-48
Identities = 56/263 (21%), Positives = 109/263 (41%), Gaps = 16/263 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+ +DI +G+G +G V+R +G++ K ++ + + E +++Q+ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHP 86
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
++ L+ K M LI +++ G LF + +D ++ + +N ++ L ++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH 144
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
SIVH DI NI+ +K + V DFG+A L+ D + T + APE+
Sbjct: 145 E---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIV 200
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325
V D++ GV+ +L G P + + D +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 326 IILVSKIAFACLRSKPKSRPTMR 348
+ L+ +P+ R T+
Sbjct: 260 KDFIKN----LLQKEPRKRLTVH 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-48
Identities = 58/263 (22%), Positives = 111/263 (42%), Gaps = 18/263 (6%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETEL-AFLESFQTEARLLS-QIR 145
EDF + +G G +G V+ A+ + + A+K L + +E E R+LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 146 HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSY 205
H + ++ K+ +F + +Y+ G L +++ + D ++ + L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118
Query: 206 LHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
LH IV+RD+ +NILL+ +ADFG+ + + GT YIAPE+
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325
D + FGV+ E+L+G+ P + + + + P + +D
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
Query: 326 IILVSKIAFACLRSKPKSRPTMR 348
+++ +P+ R +R
Sbjct: 233 LLV------KLFVREPEKRLGVR 249
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-48
Identities = 65/266 (24%), Positives = 110/266 (41%), Gaps = 21/266 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQI 144
E ++ CIG G +G V++ S VA+K + ++ + E F EA + Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65
Query: 145 RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALS 204
H +IVKL G + +++I + G L LD + ++ AL+
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALA 122
Query: 205 YLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR-TVVAGTHGYIAPE 263
YL VHRDI++ N+L++S + DFG++R + + + + ++APE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322
T DV+ FGV E+LM G P + N ++ +R P P +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIENGERLPMPPNCPPT 237
Query: 323 IQDIILVSKIAFACLRSKPKSRPTMR 348
+ ++ C P RP
Sbjct: 238 LYSLMT------KCWAYDPSRRPRFT 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 1e-47
Identities = 57/262 (21%), Positives = 102/262 (38%), Gaps = 11/262 (4%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+ +D + +GTG + V A+ + K+VA+K + E S + E +L +I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKH 66
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
NIV L ++LI + + G LF + ++ + A+ YL
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYL 123
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H I + + L+ + ++DFG++++ S T GT GY+APE+
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-GTPGYVAPEVLA 182
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
++ D + GV+A +L G P + I + SP D
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 327 ILVSKIAFACLRSKPKSRPTMR 348
+ + P+ R T
Sbjct: 242 DFIRH----LMEKDPEKRFTCE 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-46
Identities = 63/266 (23%), Positives = 111/266 (41%), Gaps = 23/266 (8%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
E + I +G G +G V+R S K K + T+ + E +L+ RHR
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHR 61
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
NI+ L+ + + +I++++ +F + A +L+ + V+ V + AL +LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH 119
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFV--ADFGVARLLHSDSSNRTVVAGTHGYIAPELA 265
+I H DI NI+ ++ + + +FG AR L + R + Y APE+
Sbjct: 120 S---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEVH 175
Query: 266 YTMVVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIMLIDL-LDQRAPSPIDDQTV 322
VV+ D++ G + +L G +P + IM + D+ A I +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE-- 233
Query: 323 IQDIILVSKIAFACLRSKPKSRPTMR 348
D + L + KSR T
Sbjct: 234 AMDFVD------RLLVKERKSRMTAS 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-46
Identities = 62/272 (22%), Positives = 118/272 (43%), Gaps = 23/272 (8%)
Query: 85 IVATEDFDIKYCIGTGGYGSVYRAQ-LPSGK----IVALKKLHHSETELAFLESFQTEAR 139
I+ +F +G+G +G+VY+ +P G+ VA+K+L + + + EA
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAY 63
Query: 140 LLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
+++ + + ++ +L G CL + LI + M G L + + +N +
Sbjct: 64 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQI 120
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR--TVVAGTH 257
A ++YL +VHRD+++ N+L+ + + DFG+A+LL ++
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 258 GYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316
++A E + T + DV+ +GV E++ G P D + +I I +R P P
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGERLPQP 235
Query: 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ I++ C SRP R
Sbjct: 236 PICTIDVYMIMV------KCWMIDADSRPKFR 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (394), Expect = 2e-45
Identities = 60/263 (22%), Positives = 102/263 (38%), Gaps = 20/263 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
+DF I +GTG +G V+ + +G+ A+K L L +E E +LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
I++++G + +F+I Y+ G LF + A L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELF------SLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
Y I++RD+ NILL+ + DFG A+ + + GT YIAPE+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
T + D + FG++ E+L G P N +L+ P ++D+
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP---FYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231
Query: 327 ILVSKIAFACLRSKPKSRPTMRR 349
+ + R +
Sbjct: 232 LS------RLITRDLSQRLGNLQ 248
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (388), Expect = 6e-45
Identities = 61/269 (22%), Positives = 118/269 (43%), Gaps = 22/269 (8%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLH-HSETELAFLESFQTEARLLSQIR 145
++ +++ +G GG V+ A+ L + VA+K L + +F F+ EA+ + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 146 HRNIVKLYGFCLHK----KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH 201
H IV +Y + +++ +Y+ +L ++ + + + + + +A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV---IAD 119
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT---VVAGTHG 258
A L++ I+HRD+ NI++++ V DFG+AR + ++ T V GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318
Y++PE A V + DV+ G V EVL G P S + + + P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIPPSAR 237
Query: 319 DQTVIQDII-LVSKIAFACLRSKPKSRPT 346
+ + D+ +V K L P++R
Sbjct: 238 HEGLSADLDAVVLK----ALAKNPENRYQ 262
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-44
Identities = 58/282 (20%), Positives = 111/282 (39%), Gaps = 26/282 (9%)
Query: 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQ 135
+E VA E + +G G +G VY VA+K ++ + + F
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 71
Query: 136 TEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLR-------NDDEAIQLD 188
EA ++ + ++V+L G + +I + M RG L LR N+
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 189 WTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248
+K + + +A ++YL+ + VHRD+++ N ++ + DFG+ R ++
Sbjct: 132 LSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 249 NR--TVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI 306
R +++PE V T DV+ FGVV E+ + + +L
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLR 246
Query: 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+++ D+ + ++ C + PK RP+
Sbjct: 247 FVMEGGLLDKPDN--CPDMLF---ELMRMCWQYNPKMRPSFL 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-43
Identities = 53/269 (19%), Positives = 106/269 (39%), Gaps = 21/269 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLH----HSETELAFLESFQTEARLLSQ 143
+ +D +G+G + V + + +G A K + S E + E +L +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
I+H N++ L+ +K + LI + + G LF D + + + + L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF------DFLAEKESLTEEEATEFLKQIL 123
Query: 204 SYLHYDCIPSIVHRDISSNNILLNS----KLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
+ ++Y I H D+ NI+L K + DFG+A + + + + GT +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEF 182
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319
+APE+ + + D++ GV+ +L G P L + + + ++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAVNYEFEDEYFS 241
Query: 320 QTVIQDIILVSKIAFACLRSKPKSRPTMR 348
T + + L PK R T++
Sbjct: 242 NTSALAKDFIRR----LLVKDPKKRMTIQ 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (382), Expect = 3e-43
Identities = 55/267 (20%), Positives = 92/267 (34%), Gaps = 20/267 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLH----HSETELAFLESFQTEARLLSQ 143
DF + IG GG+G VY + +GK+ A+K L + + + L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
IV + + I M G L L + L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGL 120
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
++H +V+RD+ NILL+ ++D G+A + +V GTHGY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 264 -LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322
L + D F G + ++L G P + + + L P
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 323 IQDIILVSKIAFACLRSKPKSRPTMRR 349
++ ++ L+ R
Sbjct: 236 LRSLLE------GLLQRDVNRRLGCLG 256
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-43
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 37/285 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPS--------GKIVALKKLHHSETELAFLESFQTEARL 140
+ + +G G +G V A+ VA+K L TE L +E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 141 LSQI-RHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRN-------------DDEAIQ 186
+ I +H+NI+ L G C +++I +Y +G+L L+ + Q
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 187 LDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246
L V+ +A + Y +HRD+++ N+L+ +ADFG+AR +H
Sbjct: 132 LSSKDLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 247 SSNRT--VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVL-MGRHPGDLLSSFNPKI 303
+ ++APE + + T + DV+ FGV+ E+ +G P + ++
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEEL 246
Query: 304 MLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
+ R P + + ++ C + P RPT +
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFK 285
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (372), Expect = 1e-42
Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 27/275 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLH-------HSETELAFLESFQTEARL 140
E+++ K +G G V R P+ K A+K + +E E+ E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 141 LSQIR-HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
L ++ H NI++L FL++ M++G LF L + L + I++++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRAL 119
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGY 259
+ LH I VHRD+ NILL+ + + DFG + L R V GT Y
Sbjct: 120 LEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-GTPSY 175
Query: 260 IAPELAYTMVV------TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313
+APE+ + ++ D++ GV+ +L G P + +I + +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQF 234
Query: 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
SP D LVS+ L +P+ R T
Sbjct: 235 GSPEWDDYSDTVKDLVSR----FLVVQPQKRYTAE 265
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-41
Identities = 61/267 (22%), Positives = 101/267 (37%), Gaps = 17/267 (6%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQ 143
V DFD +G G +G V + +G+ A+K L + TE+R+L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 144 IRHRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHAL 203
RH + L + + +Y G LF L + + A +
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFY---GAEIV 115
Query: 204 SYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE 263
S L Y +V+RDI N++L+ + DFG+ + SD + GT Y+APE
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 264 LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323
+ D +G GVV E++ GR P + + + + +L + P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 324 QDIILVSKIAFACLRSKPKSRPTMRRS 350
+ ++ L+ PK R S
Sbjct: 233 KSLLA------GLLKKDPKQRLGGGPS 253
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-41
Identities = 59/282 (20%), Positives = 103/282 (36%), Gaps = 31/282 (10%)
Query: 89 EDFDIKYCIGTGGYGSVYRA------QLPSGKIVALKKLHHSETELAFLESFQTEARLLS 142
+ + +G G +G V A + + + VA+K L T L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 143 QIRHRNIVKLYGFCLHK-KCMFLIYKYMRRGSLFCVLRN-------------DDEAIQLD 188
H N+V L G C + +I ++ + G+L LR+ D L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 189 WTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248
+ +A + +L +HRD+++ NILL+ K + DFG+AR ++ D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 249 N--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI 306
+ ++APE + V T + DV+ FGV+ E+ + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 307 DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
R +P + +L C +P RPT
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTML------DCWHGEPSQRPTFS 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (363), Expect = 3e-41
Identities = 60/281 (21%), Positives = 110/281 (39%), Gaps = 27/281 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
E + IG G YG VY+AQ G+ ALKK+ + + + E +L +++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
IVKLY KK + L+++++ + + + L+ + L+ + Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVT---AKSFLLQLLNGIAY 115
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAYT 267
++HRD+ N+L+N + E +ADFG+AR T T Y AP+ L +
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 268 MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327
+ D++ G + E++ G +S + + + +L + T +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 328 LVSKIAFA--------------------CLRSKPKSRPTMR 348
+ L+ P R T +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-41
Identities = 65/296 (21%), Positives = 108/296 (36%), Gaps = 38/296 (12%)
Query: 97 IGTGGYGSVYRAQ-LPSGKIVALKKL---HHSETELAFLESFQTEARLLSQIRHRNIVKL 152
+G G + +VY+A+ + +IVA+KK+ H SE + + E +LL ++ H NI+ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 153 YGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIP 212
HK + L++ +M + N + K M L L Y
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAY-----MLMTLQGLEYLHQH 119
Query: 213 SIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTM-VVT 271
I+HRD+ NN+LL+ +ADFG+A+ S + T T Y APEL + +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 272 EKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSK 331
D++ G + E+L+ S + + + L D + D +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 332 IAF-------------------ACLRSKPKSRPTMR--------RSFPNPEINPSL 360
P +R T + P P L
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-40
Identities = 61/282 (21%), Positives = 106/282 (37%), Gaps = 27/282 (9%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
E+F IG G YG VY+A+ +G++VALKK+ + E LL ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
NIVKL + ++L+++++ + + + I L K + L L
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGLA 116
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPE-LAY 266
+ ++HRD+ N+L+N++ +ADFG+AR T T Y APE L
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
+ D++ G + E++ R S + + L T + D
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 327 IL----------------VSKIAF----ACLRSKPKSRPTMR 348
+ + L P R + +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (350), Expect = 3e-39
Identities = 38/273 (13%), Positives = 94/273 (34%), Gaps = 31/273 (11%)
Query: 91 FDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
+ + IG+G +G +Y + +G+ VA+K E+++ ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVG 64
Query: 150 VKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYD 209
+ +C + ++ + SL + + + + M + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS- 121
Query: 210 CIPSIVHRDISSNNILLNSK---LEAFVADFGVARLLHSDSSN-------RTVVAGTHGY 259
+ +HRD+ +N L+ ++ DFG+A+ ++ + GT Y
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 260 IAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319
+ + + + D+ G V + +G P L + + + +++ +PI+
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 320 QT-----VIQDIILVSKIAFACLRSKPKSRPTM 347
+ C + +P
Sbjct: 240 LCKGYPSEFATYLN------FCRSLRFDDKPDY 266
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-39
Identities = 60/273 (21%), Positives = 114/273 (41%), Gaps = 29/273 (10%)
Query: 89 EDFDI-KYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQI-R 145
+D+ + +G G G V + + + ALK L + E L + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQ 63
Query: 146 HRNIVKLYGFC----LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH 201
+IV++ +KC+ ++ + + G LF +++ + + I+KS+
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGE 122
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLE---AFVADFGVARLLHSDSSNRTVVAGTHG 258
A+ YLH +I HRD+ N+L SK + DFG A+ S +S T T
Sbjct: 123 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-YTPY 178
Query: 259 YIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP--GDLLSSFNPKIMLIDLLDQRAPSP 316
Y+APE+ + CD++ GV+ +L G P + + +P + + Q
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 317 IDDQTVIQDII-LVSKIAFACLRSKPKSRPTMR 348
+ V +++ L+ L+++P R T+
Sbjct: 239 PEWSEVSEEVKMLIRN----LLKTEPTQRMTIT 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-39
Identities = 60/290 (20%), Positives = 111/290 (38%), Gaps = 34/290 (11%)
Query: 87 ATEDFDIKYCIGTGGYGSVYRAQ--LPSGKIVALKKLHHSETELAFLESFQTEA---RLL 141
A + ++ IG G YG V++A+ G+ VALK++ E S E R L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 142 SQIRHRNIVKLYGFCL-----HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIV 196
H N+V+L+ C + + L+++++ + + + + + +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMM 122
Query: 197 KSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGT 256
+ L +LH + VHRD+ NIL+ S + +ADFG+AR+ + +VV T
Sbjct: 123 FQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-VT 178
Query: 257 HGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316
Y APE+ D++ G + E+ + S + ++D++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 317 IDDQTVIQDIILVSKIAFA------------------CLRSKPKSRPTMR 348
+ SK A CL P R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-39
Identities = 53/268 (19%), Positives = 95/268 (35%), Gaps = 31/268 (11%)
Query: 90 DFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHS----ETELAFLESFQTEARLLSQI 144
+ + +G+GG+GSVY + VA+K + EL E LL ++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 145 R--HRNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHA 202
+++L + LI + + A+Q + +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-----FWQV 119
Query: 203 LSYLHYDCIPSIVHRDISSNNILLN-SKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
L + + ++HRDI NIL++ ++ E + DFG LL + T GT Y
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSP 177
Query: 262 PE-LAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQ 320
PE + Y V+ G++ +++ G P + + + +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF-------RQRVSSE 230
Query: 321 TVIQDIILVSKIAFACLRSKPKSRPTMR 348
Q +I CL +P RPT
Sbjct: 231 --CQHLIR------WCLALRPSDRPTFE 250
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 1e-38
Identities = 53/263 (20%), Positives = 103/263 (39%), Gaps = 20/263 (7%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSE-TELAFLESFQTEARLLSQIRH 146
+ FD +GTG +G V + SG A+K L + +L +E E R+L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
+VKL ++++ +Y+ G +F LR + + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H +++RD+ N+L++ + V DFG A+ + + GT +APE+
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIIL 211
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326
+ + D + GV+ E+ G P + P + ++ + P + ++D+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP---FFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 327 ILVSKIAFACLRSKPKSRPTMRR 349
+ L+ R +
Sbjct: 269 LR------NLLQVDLTKRFGNLK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 8e-38
Identities = 44/206 (21%), Positives = 92/206 (44%), Gaps = 8/206 (3%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+ ++ IG G YG+V++A+ + +IVALK++ + + S E LL +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLH 207
NIV+L+ K + L++++ + + + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLG 115
Query: 208 YDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY- 266
+ +++HRD+ N+L+N E +A+FG+AR + T Y P++ +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHP 292
+ + D++ G + E+ P
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-37
Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 17/211 (8%)
Query: 90 DFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN 148
+ IG G +G VY+A+L SG++VA+KK+ + E +++ ++ H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 149 IVKLYGFCLH------KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHA 202
IV+L F + + L+ Y+ L + + +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 203 LSYLHYDCIPSIVHRDISSNNILLNSKLEAF-VADFGVARLLHSDSSNRTVVAGTHGYIA 261
L+Y+H I HRDI N+LL+ + DFG A+ L N + + +
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+ T DV+ G V E+L+G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-37
Identities = 66/275 (24%), Positives = 115/275 (41%), Gaps = 23/275 (8%)
Query: 86 VATEDFDIKYCIGTGGYGSVYRAQL----PSGKIVALKKLHHSE--TELAFLESFQTEAR 139
V E+F++ +GTG YG V+ + +GK+ A+K L + + E +TE +
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 140 LLSQIRHR-NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKS 198
+L IR +V L+ + + LI Y+ G LF L + + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------ 134
Query: 199 MAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRT-VVAGTH 257
+ + L + I++RDI NILL+S + DFG+++ +D + R GT
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 258 GYIAPELAYTMV--VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID-LLDQRAP 314
Y+AP++ + D + GV+ E+L G P + N + + +L P
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254
Query: 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR 349
P + + +D+I L PK R
Sbjct: 255 YPQEMSALAKDLIQ------RLLMKDPKKRLGCGP 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-36
Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 9/210 (4%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
+ IG G YG V A + VA+KK+ E + + + E ++L + RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRH 65
Query: 147 RNIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYL 206
NI+ + + Y+ + L + L + + L Y+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTV---VAGTHGYIAPE 263
H +++HRD+ +N+LLN+ + + DFG+AR+ D + T Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 264 LAYT-MVVTEKCDVFGFGVVALEVLMGRHP 292
+ T+ D++ G + E+L R
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (328), Expect = 4e-36
Identities = 43/274 (15%), Positives = 82/274 (29%), Gaps = 29/274 (10%)
Query: 91 FDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRN- 148
+ + IG G +G ++ L + + VA+K + E R +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTG 62
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
I +Y F L+ + + + K M + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE 119
Query: 209 DCIPSIVHRDISSNNILLNSKLE-----AFVADFGVARLLHSDSSN-------RTVVAGT 256
S+V+RDI +N L+ +V DFG+ + + + ++GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 257 HGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRH--PGDLLSSFNPKIMLIDLLDQRAP 314
Y++ + + D+ G V + L G G ++ K I Q P
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236
Query: 315 SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMR 348
++ K + P
Sbjct: 237 LRELCAGFPEEFY---KYMHYARNLAFDATPDYD 267
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-36
Identities = 60/297 (20%), Positives = 106/297 (35%), Gaps = 43/297 (14%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
++ IG G +G V++A+ +G+ VALKK+ + F + E ++L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 148 NIVKLYGFCL--------HKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSM 199
N+V L C K ++L++ + + + L KRV M
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV-----M 123
Query: 200 AHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS----NRTVVAG 255
L+ L+Y I+HRD+ + N+L+ +ADFG+AR + T
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 256 THGYIAPE-LAYTMVVTEKCDVFGFGVVALEVLMGRHP-----------------GDLLS 297
T Y PE L D++G G + E+ G +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 298 SFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFA------CLRSKPKSRPTMR 348
P + +L ++ + V + + +A L P R
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 6e-33
Identities = 47/297 (15%), Positives = 104/297 (35%), Gaps = 26/297 (8%)
Query: 71 SVWNYDG-RITFEEIIVATEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETEL 128
W+Y+ + + +D+ + +G G Y V+ A + + + V +K L +
Sbjct: 20 EYWDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--- 72
Query: 129 AFLESFQTEARLLSQIR-HRNIVKLYGFCLH--KKCMFLIYKYMRRGSLFCVLRNDDEAI 185
+ + E ++L +R NI+ L + L+++++ + +
Sbjct: 73 --KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----- 125
Query: 186 QLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLH 244
L + + AL Y H I HRD+ +N++++ + + + D+G+A H
Sbjct: 126 -LTDYDIRFYMYEILKALDYCHSMGIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM 304
VA + L + D++ G + ++ + P +
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQ 239
Query: 305 LIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSLL 361
L+ + + D +I L + R K S ++P L
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-32
Identities = 60/304 (19%), Positives = 105/304 (34%), Gaps = 37/304 (12%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+ +G+G YG+V A +G VA+KKL+ F + E RLL +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 148 NIVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRND-DEAIQLDWTKRVNIVKSMAHALSYL 206
N++ L + + + + +L + +V M L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 207 HYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAY 266
H I HRD+ N+ +N E + DFG+AR +DS V +
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAPEVILN 192
Query: 267 TMVVTEKCDVFGFGVVALEVLMGRHP-----------------GDLLSSFNPKIMLIDLL 309
M T+ D++ G + E++ G+ G + F ++ +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 310 DQRAPSPIDDQTVIQDIIL-VSKIAF----ACLRSKPKSRPTMR--------RSFPNPEI 356
+ P ++ I+ S +A L + R T S + E
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312
Query: 357 NPSL 360
P +
Sbjct: 313 EPQV 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-31
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 17/211 (8%)
Query: 89 EDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHR 147
+ + IG+G G V A + VA+KKL + E L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 148 NIVKLYGFCLHKKCM------FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH 201
NI+ L +K + +L+ + M + D + ++ M
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------RMSYLLYQMLC 130
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
+ +LH I+HRD+ +NI++ S + DFG+AR S T T Y A
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRA 186
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
PE+ M E D++ G + E++ +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-30
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 15/211 (7%)
Query: 88 TEDFDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH 146
E + +G+G YGSV A +G VA+KKL + + E RLL ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 147 RNIVKLYGFC-----LHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAH 201
N++ L L + + ++ L +++ +L ++ +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILR 132
Query: 202 ALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNRTVVAGTHGYIA 261
L Y+H I HRD+ +N+ +N E + DFG+AR H+D VA
Sbjct: 133 GLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAP 187
Query: 262 PELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
+ M + D++ G + E+L GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 101 bits (252), Expect = 7e-25
Identities = 37/221 (16%), Positives = 85/221 (38%), Gaps = 26/221 (11%)
Query: 91 FDIKYCIGTGGYGSVYRAQ-LPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI 149
+ + +G G + +V+ A+ + + VA+K + + + E+ + E +LL ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADN 71
Query: 150 VKLYGFCLH---------------KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVN 194
K + + ++++ + L + + + I L + K+
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ-- 129
Query: 195 IVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK-LEAFVADFGVARLLHSDSSNRT-- 251
I K + L Y+H C I+H DI N+L+ + +A L ++ +
Sbjct: 130 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 252 VVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHP 292
T Y +PE+ D++ + E++ G
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.5 bits (203), Expect = 3e-19
Identities = 24/162 (14%), Positives = 55/162 (33%), Gaps = 18/162 (11%)
Query: 97 IGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFL--------ESFQTEARLLSQIRHRN 148
+G G +V+ +K T + F A ++ R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 149 IVKLYGFCLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY 208
+ KL G + K + ++ L + E ++ ++ + ++ ++
Sbjct: 68 LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 209 DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSNR 250
IVH D+S N+L+ S+ ++ DF + + +
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWRE 159
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 361 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.4 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.22 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.16 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-61 Score=424.14 Aligned_cols=259 Identities=25% Similarity=0.330 Sum_probs=211.1
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 5789999999999999999976 46899999998765432 224678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999997654 699999999999999999999999 99999999999999999999999999998764433
Q ss_pred C--Cccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 248 S--NRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 248 ~--~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
. ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||........ .................
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~---- 231 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYLNPWKK---- 231 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHHHHTTCTTSTTGGG----
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCCCCCCcccc----
Confidence 2 2344679999999999988775 5789999999999999999999975443221 12222222221111111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
....+.+|+.+||+.||++|||++|+++||||++.+
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 112477899999999999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=422.19 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=215.7
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||+||+|.. .+|+.||||++....... .+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999975 579999999987554332 3678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 98 y~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999999988654 589999999999999999999999 99999999999999999999999999999876655
Q ss_pred CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHHH
Q 042457 248 SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDII 327 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (361)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.....+....... ...
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~---~s~ 244 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPELQNPEK---LSA 244 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCCSSGGG---SCH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCCCCccc---CCH
Confidence 555667799999999999999999999999999999999999999975432 22223333322221111111 112
Q ss_pred HHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 328 LVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 328 ~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.+.+|+.+||+.||++|||++|+++||||+.
T Consensus 245 ~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 4789999999999999999999999999963
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-60 Score=417.31 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=203.3
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--CCeEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH--KKCMFLI 165 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 165 (361)
++|++.+.||+|+||+||+|+. .+|+.||+|.+..........+.+.+|++++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999965 578999999998776555556789999999999999999999999875 4568999
Q ss_pred EEeccCCChhhhhccCC-ccCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 166 YKYMRRGSLFCVLRNDD-EAIQLDWTKRVNIVKSMAHALSYLHYDC--IPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
||||++|+|.+++.... ....+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 2336999999999999999999999862 11499999999999999999999999999998
Q ss_pred cCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCC-CCChh
Q 042457 243 LHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP-IDDQT 321 (361)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 321 (361)
............||+.|+|||++.+..++.++|||||||++|||+||+.||...+. ......+.....+.. ...+
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~s- 239 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREGKFRRIPYRYS- 239 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHTCCCCCCTTSC-
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCCCCCcccC-
Confidence 76555555567799999999999999999999999999999999999999975432 233334444433221 1111
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEI 356 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~ 356 (361)
..+.+|+.+||+.||++|||+.|+++|||+
T Consensus 240 -----~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 240 -----DELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----HHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 248889999999999999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-60 Score=414.09 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=214.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||+||+|... +|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46889999999999999999764 689999999865432 2223467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999997654 689999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+.......+...+
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s------ 228 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFTFPDFVT------ 228 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCCCCTTSC------
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCccCC------
Confidence 2344579999999999999999999999999999999999999997543 23333444444443332222
Q ss_pred HHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
..+.+|+.+||++||++|||++|+++||||+.
T Consensus 229 ~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 229 EGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 24788999999999999999999999999964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-60 Score=417.35 Aligned_cols=258 Identities=24% Similarity=0.362 Sum_probs=213.6
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
+.|++.+.||+|+||+||+|.. .+|+.||||++....... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG--GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH--HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4688999999999999999976 468999999997654332 4678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.+++.+... .+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 90 y~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 90 FCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999998765332 589999999999999999999999 99999999999999999999999999997654332
Q ss_pred CCccccccccccccccccc-----ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 248 SNRTVVAGTHGYIAPELAY-----TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
.......||+.|+|||++. +..++.++|||||||++|||+||+.||..... ......+.....+.......
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~- 240 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLLKIAKSEPPTLAQPSR- 240 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHHHHHSCCCCCSSGGG-
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCCCCCcccc-
Confidence 2334457999999999874 45678999999999999999999999875443 23344444443332221111
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+|+.+||+.||++|||++|+++||||+..
T Consensus 241 --~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 241 --WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp --SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11247899999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-59 Score=409.52 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=204.5
Q ss_pred CCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee----CCeEEEEE
Q 042457 92 DIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH----KKCMFLIY 166 (361)
Q Consensus 92 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 166 (361)
++.++||+|+||+||+|... +++.||+|.+..........+.+.+|++++++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999764 68899999997765444556789999999999999999999999875 34689999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEEeCCCCCCeeeC-CCCCeEEeeecCcccc
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPS--IVHRDISSNNILLN-SKLEAFVADFGVARLL 243 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~--i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~ 243 (361)
||+++|+|.+++.+.. .+++..++.++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999997654 689999999999999999999998 7 99999999999996 5789999999999764
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... .......+.....+.... .
T Consensus 166 ~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~~~~~~~~-~--- 236 (270)
T d1t4ha_ 166 RA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASFD-K--- 236 (270)
T ss_dssp CT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCCGGGG-G---
T ss_pred cC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHcCCCCcccC-c---
Confidence 32 23345679999999998865 589999999999999999999999864332 122222333222221111 1
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEIN 357 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~ 357 (361)
.....+.+|+.+||++||++|||++|+++|||||
T Consensus 237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 1112478899999999999999999999999997
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-59 Score=409.22 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=212.7
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999976 4789999999865432 2223467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999987655 699999999999999999999999 9999999999999999999999999999877543
Q ss_pred CC--CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 247 SS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+ .......+.......+...+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s---- 234 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQKIIKLEYDFPEKFF---- 234 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTTCCCCCTTCC----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHHHHHcCCCCCCccCC----
Confidence 32 2334579999999999999999999999999999999999999997543 23334445554444332222
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCcccc------ccCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRS------FPNPEINP 358 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~ei------l~hp~~~~ 358 (361)
..+.+|+.+||+.||++|||++|+ ++||||+.
T Consensus 235 --~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 235 --PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp --HHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred --HHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 247889999999999999999995 78999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-59 Score=409.18 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=203.0
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
++..++|.+.+.||+|+||+||+|++++ .||||+++.........+.|.+|+.++++++||||++++|++.. +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 4456789999999999999999998743 59999997665545556889999999999999999999998865 45899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
||||+++|+|.+++..... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 v~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999976543 589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC--Ccccccccccccccccccc---cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCC
Q 042457 245 SDSS--NRTVVAGTHGYIAPELAYT---MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDD 319 (361)
Q Consensus 245 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (361)
.... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... .............+...
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHHTSCCCCGG
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH---HHHHHHHhcCCCCCcch
Confidence 4322 2334568999999999864 35789999999999999999999998754431 12222222221111111
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.........+.+|+.+||+.||++|||++||+++
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1111112358899999999999999999999876
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-58 Score=410.08 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=198.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.+.|++.+.||+|+||+||+|... +|+.||||++........ ...+.+|+.++++++||||+++++++.+++..|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 466999999999999999999764 689999999976543322 356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC---CCCCeEEeeecCcccc
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN---SKLEAFVADFGVARLL 243 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~~ 243 (361)
|||++|+|.+++...+ .+++..+..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997654 699999999999999999999999 999999999999994 5789999999999865
Q ss_pred CCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+......
T Consensus 161 ~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~- 235 (307)
T d1a06a_ 161 DPGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQILKAEYEFDSPYWDD- 235 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHTTCCCCCTTTTTT-
T ss_pred cCCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCCCCCccccC-
Confidence 4332 23345799999999999999999999999999999999999999975432 223334444333222111111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+.+|+.+||++||++|||++|+++||||++
T Consensus 236 -~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 236 -ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp -SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred -CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1124789999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-59 Score=420.22 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=209.7
Q ss_pred HhcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
..++|++.+.||+|+||+||+|.. .+|+.||+|+++..... ...+.+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467899999999999999999976 47899999998765432 2346788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|||+++|+|.+++.+.. .+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999997654 58999999999999999999996 5 79999999999999999999999999998664
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHh------------------
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLI------------------ 306 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~------------------ 306 (361)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.............
T Consensus 157 ~~~--~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 157 DSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HHT--C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CCc--cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 322 234579999999999999999999999999999999999999996533211000000
Q ss_pred --------------------hhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 307 --------------------DLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 307 --------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.......+........ ...+.+|+.+||+.||.+|||++|+|+||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF---SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTB---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccC---CHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0000000000000000 124788999999999999999999999999964
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-58 Score=409.25 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=211.7
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
+.|+..+.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4589999999999999999975 5788999999876543 3444577999999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
|||++|+|..++.... .+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987765544 689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCcccccccccccccccccc---cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhH
Q 042457 247 SSNRTVVAGTHGYIAPELAYT---MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVI 323 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (361)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.....+.......
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~-- 239 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPALQSGHW-- 239 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCCSCTTS--
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCCCCCCC--
Confidence 233569999999999864 4589999999999999999999999875432 22333444444333222111
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...+.+|+.+||+.||++|||++|+|+||||++.
T Consensus 240 --s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 240 --SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred --CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 1248899999999999999999999999999653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-57 Score=411.40 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=214.9
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||.||+|.. .+|+.||||++....... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH--HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5799999999999999999976 478999999997654432 4778899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC--CCCCeEEeeecCccccCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN--SKLEAFVADFGVARLLHS 245 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~ 245 (361)
||++|+|.+++.+... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+..
T Consensus 104 ~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 104 FMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred cCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999865432 589999999999999999999999 999999999999995 457899999999987654
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..... ..
T Consensus 179 ~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~--~~ 252 (350)
T d1koaa2 179 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCDWNMDDSAFS--GI 252 (350)
T ss_dssp T-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCSCCGGGG--GC
T ss_pred c-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCccccc--CC
Confidence 3 333456799999999999999999999999999999999999999875432 23334444433322221111 11
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...+.+|+.+||+.||++|||++|+|+||||++.
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 1247899999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=403.76 Aligned_cols=259 Identities=23% Similarity=0.322 Sum_probs=213.8
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE----LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999976 57999999998654321 12347789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC----CeEEeeec
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL----EAFVADFG 238 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg 238 (361)
++|||||++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997654 699999999999999999999999 999999999999998776 49999999
Q ss_pred CccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+..
T Consensus 163 ~a~~~~~~~~-~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~ 238 (293)
T d1jksa_ 163 LAHKIDFGNE-FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAVNYEFEDE 238 (293)
T ss_dssp TCEECTTSCB-CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHTTCCCCCHH
T ss_pred hhhhcCCCcc-ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCCCCch
Confidence 9987654332 3345689999999999999999999999999999999999999875432 22233333333221111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........+.+|+.+||+.||++|||++|+++||||++
T Consensus 239 --~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 239 --YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp --HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred --hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00111224789999999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-57 Score=409.09 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=214.5
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||.||+|.. .+|+.||||++....... .+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH--HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4699999999999999999975 579999999987654332 4678899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC--CCCCeEEeeecCccccCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN--SKLEAFVADFGVARLLHS 245 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~~~~~ 245 (361)
||++|+|.+++..... .+++.+++.++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||++.....
T Consensus 107 ~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 107 FLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999999988765432 589999999999999999999999 999999999999997 678999999999987754
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+.......+...... .
T Consensus 182 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~--~ 255 (352)
T d1koba_ 182 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCDWEFDEDAFSS--V 255 (352)
T ss_dssp TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCCCCCCSSTTTT--S
T ss_pred CC-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCcccccC--C
Confidence 32 33445789999999999999999999999999999999999999975432 223333443333222211111 1
Q ss_pred HHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
...+.+|+.+||+.||.+|||++|+|+||||+..
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1247899999999999999999999999999853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-57 Score=406.93 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=218.7
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999975 5799999999975432 1223467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999998765 689999999999999999999999 9999999999999999999999999999877655
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+. ......+.......+...+.
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i~~~~~~~p~~~s~----- 230 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIRFPRTLSP----- 230 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCTTSCH-----
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHHHHHHhcCCCCCCccCCH-----
Confidence 5555667899999999999999999999999999999999999999875432 33344444444444433222
Q ss_pred HHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
.+.+|+.+||++||.+||+ ++|+++||||++
T Consensus 231 -~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 231 -EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp -HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred -HHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 3788999999999999995 899999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-58 Score=402.52 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=209.1
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
+++..++|++.+.||+|+||+||+|.+++++.||||+++..... .+.|.+|++++++++|||||+++|++.+ +..+
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34556789999999999999999999988889999999765543 3678999999999999999999998865 5579
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++|+|.+++..... ..+++..+++++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 99999999999998765432 2589999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc-CCCCCCChh
Q 042457 244 HSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQT 321 (361)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 321 (361)
..... ......||+.|+|||++.+..++.++|||||||++|||+||..|+.... ........+.... ...+...+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~i~~~~~~~~p~~~~- 236 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLERGYRMVRPDNCP- 236 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTCCCCCCTTCC-
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcCCCCCcccCh-
Confidence 54332 2334568899999999998999999999999999999999655543221 1222223333322 22222111
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCcccccc--CCCCC
Q 042457 322 VIQDIILVSKIAFACLRSKPKSRPTMRRSFP--NPEIN 357 (361)
Q Consensus 322 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--hp~~~ 357 (361)
..+.+|+.+||+.||++|||++||++ ++||.
T Consensus 237 -----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 237 -----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 24789999999999999999999998 67764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=397.29 Aligned_cols=249 Identities=24% Similarity=0.403 Sum_probs=197.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.++|++.+.||+|+||+||+|.+.+++.||||+++...... ++|.+|++++++++||||++++|+|...+..++|||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 35788899999999999999999888999999997655432 678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|.+++..... .+++..++.++.|+|.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred ecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999999876543 589999999999999999999999 99999999999999999999999999998765433
Q ss_pred CC-cccccccccccccccccccccCccchhhhHHHHHHHHHhC-CCCCCCcccCCcchhHhhhhcccC-CCCCCChhhHH
Q 042457 248 SN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMG-RHPGDLLSSFNPKIMLIDLLDQRA-PSPIDDQTVIQ 324 (361)
Q Consensus 248 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 324 (361)
.. .....||+.|+|||++.+..++.++|||||||++|||+|+ ++||.... .......+..... ..+...+
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~~~~~~~~p~~~~---- 228 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRLYKPRLAS---- 228 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHHHTCCCCCCTTSC----
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHHhcCCCCCccccC----
Confidence 22 3335689999999999999999999999999999999995 55554322 1222233333222 2222211
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.+++.+||+.||++|||++||++|
T Consensus 229 --~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 229 --THVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 247899999999999999999999876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-57 Score=401.84 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=214.7
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5689999999999999999976 4699999999865432 2223577889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||++||+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999988765 578899999999999999999999 9999999999999999999999999999876433
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...+ .......+.......+...+.
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~----- 226 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNAELRFPPFFNE----- 226 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHCCCCCCTTSCH-----
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---HHHHHHHHHcCCCCCCCCCCH-----
Confidence 234579999999999999999999999999999999999999997543 233344444444443332221
Q ss_pred HHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
.+.+++.+||++||.+|| |++++++||||++
T Consensus 227 -~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 227 -DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp -HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred -HHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 378899999999999996 9999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-56 Score=393.30 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=215.1
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch-------HHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeC
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE-------LAFLESFQTEARLLSQIR-HRNIVKLYGFCLHK 159 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 159 (361)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999975 57899999998765321 223456889999999997 99999999999999
Q ss_pred CeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 160 KCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
+..|+||||+++|+|.++++... .+++.+++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997654 699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccccccccccc------cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 240 ARLLHSDSSNRTVVAGTHGYIAPELAYT------MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 240 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
++...... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......+.....
T Consensus 157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~~i~~~~~ 232 (277)
T d1phka_ 157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIMSGNY 232 (277)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC
T ss_pred eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHHHHHhCCC
Confidence 98775433 3344579999999998753 3467899999999999999999999975432 223334444433
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
..+...... ....+.+|+.+||++||++|||++|+++||||++.+
T Consensus 233 ~~~~~~~~~--~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~~ 277 (277)
T d1phka_ 233 QFGSPEWDD--YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 277 (277)
T ss_dssp CCCTTTGGG--SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred CCCCccccc--CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHhC
Confidence 222211111 112488999999999999999999999999999853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-57 Score=391.32 Aligned_cols=249 Identities=24% Similarity=0.433 Sum_probs=211.0
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
.++|++.+.||+|+||+||+|++++++.||||+++...... ++|.+|+.++++++||||++++|+|.+++..++|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 36899999999999999999999888899999998765443 678999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+++|+|..++..... .+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 80 y~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred ccCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999998766543 588999999999999999999999 99999999999999999999999999998765443
Q ss_pred C-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCChhhHH
Q 042457 248 S-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQTVIQ 324 (361)
Q Consensus 248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 324 (361)
. ......+|..|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+.... .+.+...+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~~p~~~~---- 227 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLYRPHLAS---- 227 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCCCCTTCC----
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCCCCCccccc----
Confidence 3 2334568999999999999999999999999999999998 8999876543 22233333322 22222211
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.+|+.+||+.||++|||++|+++|
T Consensus 228 --~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 228 --EKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 248899999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=400.05 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=214.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcc-hHHHHHHHHHHHHHHh-cCCCCcceeeeEEEeeCCeEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSET-ELAFLESFQTEARLLS-QIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 165 (361)
++|.+.+.||+|+||+||+|... +|+.||||+++.... .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999664 689999999965321 1122355667777665 68999999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +++||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997654 589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQD 325 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
.........||+.|+|||++.+..++.++|||||||++|||+||+.||...+. ......+.......+...+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i~~~~~~~p~~~s----- 227 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRMDNPFYPRWLE----- 227 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCTTSC-----
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCccCC-----
Confidence 55556667899999999999999999999999999999999999999975432 3333444444443332222
Q ss_pred HHHHHHHHhhhcCCCCCCCCCcc-ccccCCCCCC
Q 042457 326 IILVSKIAFACLRSKPKSRPTMR-RSFPNPEINP 358 (361)
Q Consensus 326 ~~~l~~li~~cl~~dP~~RPs~~-eil~hp~~~~ 358 (361)
..+.+|+.+||+.||++|||+. |+++||||++
T Consensus 228 -~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 228 -KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp -HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred -HHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 1378999999999999999996 8999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-57 Score=398.60 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=211.0
Q ss_pred CHHHHHHHhcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee
Q 042457 80 TFEEIIVATEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH 158 (361)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 158 (361)
+++++++..++|++.+.||+|+||+||+|.+. +|+.||||+++..... .++|.+|+.++++++|||||+++|+|.+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 34456667788999999999999999999775 5889999999765543 3678999999999999999999999999
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
.+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CCeeEEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccc
Confidence 9999999999999999999875432 2689999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC-cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCC
Q 042457 239 VARLLHSDSSN-RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317 (361)
Q Consensus 239 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (361)
+++........ .....|++.|+|||++.+..++.++|||||||++|||++|..|+..... .....+.+......+.
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---~~~~~~~i~~~~~~~~ 237 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKDYRMER 237 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTTCCCCC
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---HHHHHHHHhcCCCCCC
Confidence 99876544332 2334588999999999999999999999999999999997766543221 1122223322222111
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.... ...+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~----~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 238 PEGC----PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cccc----hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1111 124889999999999999999999976
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.5e-56 Score=403.08 Aligned_cols=256 Identities=21% Similarity=0.261 Sum_probs=208.2
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETE----LAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
++|++.+.||+|+||.||+|+.. +|+.||||++...... .........++.+++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999764 6999999998643221 111122334577888889999999999999999999
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999997654 588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhh
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTV 322 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (361)
.... .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+...............+...+
T Consensus 158 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s-- 233 (364)
T d1omwa3 158 SKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS-- 233 (364)
T ss_dssp SSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSC--
T ss_pred CCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC--
Confidence 5432 334569999999999864 56899999999999999999999999865543332222233333332222222
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 323 IQDIILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 323 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
..+.+|+.+||+.||++||| ++|+++||||+.
T Consensus 234 ----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 234 ----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp ----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred ----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 14788999999999999999 699999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=394.29 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=197.8
Q ss_pred CeeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEeccC
Q 042457 95 YCIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYMRR 171 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 171 (361)
++||+|+||+||+|.+. .++.||||+++....+....+.|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999764 34679999997655544556789999999999999999999999965 457899999999
Q ss_pred CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC--
Q 042457 172 GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN-- 249 (361)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 249 (361)
|+|.++++... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999998655 699999999999999999999999 9999999999999999999999999999876544332
Q ss_pred -cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCChhhHHHH
Q 042457 250 -RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQTVIQDI 326 (361)
Q Consensus 250 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 326 (361)
.....||++|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+..+. ++.+...+
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~~~p~~~~------ 236 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERMGCPAGCP------ 236 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCCCCTTCC------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCCCCCCcccC------
Confidence 223468999999999999999999999999999999998 8999876443 22222233322 22222221
Q ss_pred HHHHHHHhhhcCCCCCCCCCcccc---ccCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRPTMRRS---FPNPEI 356 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RPs~~ei---l~hp~~ 356 (361)
..+.+|+.+||+.||++|||+++| |+|+|+
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 247899999999999999999998 456654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-56 Score=394.57 Aligned_cols=250 Identities=29% Similarity=0.468 Sum_probs=194.6
Q ss_pred cCCCCcCeeeecCceeEEEEEeCC-C---CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPS-G---KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 164 (361)
++|++.+.||+|+||+||+|.+.. | ..||||.+...... ...+.|.+|+.+|++++|||||+++|+|...+..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 456677899999999999997642 3 25899998765443 335789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLH 244 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 244 (361)
|||||++|+|.+++..... .+++.+++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998876543 589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-----cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcc-cCCCCC
Q 042457 245 SDSSN-----RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQ-RAPSPI 317 (361)
Q Consensus 245 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 317 (361)
..... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+... +.+.+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~ 256 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQDYRLPPPM 256 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCCCT
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCc
Confidence 43322 122357899999999999999999999999999999998 8999875443 2222233222 222222
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+ ..+.+|+.+||+.||++|||+.||+++
T Consensus 257 ~~~------~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 257 DCP------SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TCC------HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cch------HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 222 247889999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-56 Score=400.62 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=215.1
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4699999999999999999976 4799999999864332 2233467889999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSD 246 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 246 (361)
||+.+|+|..++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999987654 589999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHHHH
Q 042457 247 SSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDI 326 (361)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (361)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.... .......+.......+...+.
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~----- 263 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVSGKVRFPSHFSS----- 263 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCTTCCH-----
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHHHHhcCCCCCCccCCH-----
Confidence 234579999999999999999999999999999999999999997543 233444455554444333222
Q ss_pred HHHHHHHhhhcCCCCCCCC-----CccccccCCCCCC
Q 042457 327 ILVSKIAFACLRSKPKSRP-----TMRRSFPNPEINP 358 (361)
Q Consensus 327 ~~l~~li~~cl~~dP~~RP-----s~~eil~hp~~~~ 358 (361)
.+.+++.+||+.||.+|+ |++|+++||||+.
T Consensus 264 -~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 264 -DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp -HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred -HHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 378899999999999994 9999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=392.71 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=204.9
Q ss_pred hcCCCCcC-eeeecCceeEEEEEeC---CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 88 TEDFDIKY-CIGTGGYGSVYRAQLP---SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 88 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
.++|.+.+ +||+|+||+||+|.+. ++..||||+++..... ...+.|.+|++++++++|||||+++|+|.. +..+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 45566666 4999999999999763 3457999999765443 335789999999999999999999999875 4589
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+||||+++|+|.+++...+. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 85 lvmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999999865432 689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-CCCCC
Q 042457 244 HSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-PSPID 318 (361)
Q Consensus 244 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 318 (361)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ......+..+.. +.+..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~~~p~~ 236 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMECPPE 236 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCCCCCTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCCc
Confidence 543322 233458899999999999999999999999999999998 9999976543 222333333322 22222
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccc---ccCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRS---FPNPEI 356 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei---l~hp~~ 356 (361)
.+ ..+.+|+.+||+.||++|||+.+| |+|+|+
T Consensus 237 ~~------~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 237 CP------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22 247899999999999999999998 456654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=398.31 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=213.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIY 166 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 166 (361)
.++|.+.+.||+|+||+||+|... +|+.||||+++..... ...+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 357899999999999999999764 6889999999765433 256789999999999999999999999999999999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC--CCeEEeeecCccccC
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK--LEAFVADFGVARLLH 244 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~~~~~ 244 (361)
|||+||+|.+++..... .+++.++..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 81 E~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 81 EFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999976542 589999999999999999999999 99999999999999854 579999999998764
Q ss_pred CCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCCChhhHH
Q 042457 245 SDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPIDDQTVIQ 324 (361)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (361)
... ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||..... ......+.......+... ...
T Consensus 156 ~~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~--~~~ 229 (321)
T d1tkia_ 156 PGD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEYTFDEEA--FKE 229 (321)
T ss_dssp TTC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCCCCHHH--HTT
T ss_pred cCC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCChhh--ccC
Confidence 332 23445689999999999999999999999999999999999999875432 233344444433322110 001
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 325 DIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 325 ~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
....+.+|+.+||+.||++|||++|+++||||++.
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 12247899999999999999999999999999764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-56 Score=392.89 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=207.3
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKY 168 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 168 (361)
++|++.+.||+|+||+||+|+.++|+.||||++..........+.+.+|+.++++++||||+++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57899999999999999999998999999999977654444457889999999999999999999999999999999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
+.++.+..+..... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98887777766554 699999999999999999999999 999999999999999999999999999988765555
Q ss_pred Ccccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcc----------------
Q 042457 249 NRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQ---------------- 311 (361)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------- 311 (361)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+...........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 5555678999999998865 45689999999999999999999999754321110000000000
Q ss_pred -cCC--CCCCChh-hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 312 -RAP--SPIDDQT-VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 312 -~~~--~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
... .+..... .......+.+|+.+||+.||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 000 0000000 0000124789999999999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-56 Score=395.89 Aligned_cols=261 Identities=22% Similarity=0.243 Sum_probs=202.4
Q ss_pred cCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchH---HHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEEec
Q 042457 94 KYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETEL---AFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYKYM 169 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 169 (361)
.+.||+|+||+||+|.. .+|+.||||+++...... ...+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46799999999999976 468999999987544321 12346889999999999999999999999999999999999
Q ss_pred cCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCCC
Q 042457 170 RRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSSN 249 (361)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 249 (361)
.++++..+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9988877765443 588889999999999999999999 9999999999999999999999999999877665555
Q ss_pred cccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC--------------
Q 042457 250 RTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP-------------- 314 (361)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 314 (361)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......+......+.......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 555679999999998865 45799999999999999999999998754432211111111100000
Q ss_pred CCCCChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 315 SPIDDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 315 ~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
......... .....+.+|+.+||+.||++|||++|+|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 000000000 0113478999999999999999999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=392.80 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=204.9
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999975 579999999997655443345788899999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
|+.++.+........ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997654443333322 2589999999999999999999999 99999999999999999999999999998876655
Q ss_pred CCcccccccccccccccccccc-cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh---------------hhcc
Q 042457 248 SNRTVVAGTHGYIAPELAYTMV-VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID---------------LLDQ 311 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---------------~~~~ 311 (361)
.......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+..+....... ....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 5566667999999999876655 57899999999999999999999975432110000000 0000
Q ss_pred cCCCCCCChhhH-----HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 312 RAPSPIDDQTVI-----QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 312 ~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
....+....... .....+.+|+.+||+.||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 000000000000 01134788999999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=397.12 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=206.5
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeCC-C-----CEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEe
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLPS-G-----KIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCL 157 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 157 (361)
++..++|++.+.||+|+||+||+|++.. + ..||+|.+...... .....+.+|+.++.++ +|||||++++++.
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-HHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 4556789999999999999999997642 2 26999998654432 2246788999999998 8999999999999
Q ss_pred eCCeEEEEEEeccCCChhhhhccCCc--------------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEe
Q 042457 158 HKKCMFLIYKYMRRGSLFCVLRNDDE--------------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHR 217 (361)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~ 217 (361)
+.+..++|||||++|+|.++++.... ...+++..++.++.||+.||+|||++ +|+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 99999999999999999999976432 13589999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCC
Q 042457 218 DISSNNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGD 294 (361)
Q Consensus 218 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~ 294 (361)
||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 234568999999999999999999999999999999998 899987
Q ss_pred CcccCCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 295 LLSSFNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.... ...+..++......+..... ...+.+|+.+||+.||++|||++||++|
T Consensus 269 ~~~~---~~~~~~~~~~~~~~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPV---DANFYKLIQNGFKMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCC---SHHHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCH---HHHHHHHHhcCCCCCCCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5433 22233333333222211111 1248899999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-56 Score=389.43 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=203.5
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEE
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 165 (361)
+..++|++.+.||+|+||+||+|.+++++.||||+++..... .+.|.+|+.++++++|||||+++|+|.+ +..++|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 345789999999999999999999988889999999765543 3679999999999999999999999865 557999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++|+|..++..... ..++|.+++.++.||+.||+|||+. +++||||||+|||+++++++||+|||+++....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp ECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999999999988875432 2589999999999999999999999 999999999999999999999999999987643
Q ss_pred CC-CCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhccc-CCCCCCChhhH
Q 042457 246 DS-SNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQR-APSPIDDQTVI 323 (361)
Q Consensus 246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 323 (361)
.. .......||+.|+|||++.+..++.++||||||+++|||+||..|+..... ....+..+.... .+.+...+
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~--- 240 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGYRMPCPPECP--- 240 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCCCCCCTTSC---
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHhcCCCCCCcccC---
Confidence 33 223345689999999999999999999999999999999996665433221 122222232222 22222211
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCcccccc--CCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFP--NPEINP 358 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~--hp~~~~ 358 (361)
..+.+++.+||+.||++|||+++|++ ++||..
T Consensus 241 ---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 241 ---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 24889999999999999999999998 888854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=394.16 Aligned_cols=258 Identities=23% Similarity=0.314 Sum_probs=204.2
Q ss_pred hcCCCCcC-eeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCcceeeeEEEee----CC
Q 042457 88 TEDFDIKY-CIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQ-IRHRNIVKLYGFCLH----KK 160 (361)
Q Consensus 88 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~ 160 (361)
.++|.+.. .||+|+||.||+|.. .+|+.||||+++.. ..+.+|+.++.+ .+||||+++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 35788775 599999999999965 57899999998643 345678888655 589999999999876 45
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC---CCCeEEeee
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS---KLEAFVADF 237 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~---~~~~kl~Df 237 (361)
..|+|||||+||+|.+++..... ..+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 68999999999999999976432 2589999999999999999999999 9999999999999975 467999999
Q ss_pred cCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh-HhhhhcccCCCC
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM-LIDLLDQRAPSP 316 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 316 (361)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........... ...+.......+
T Consensus 159 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 159 GFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp TTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred ceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 9998765433 23445799999999999999999999999999999999999999975543222111 111222222221
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.. ........+.+|+.+||+.||++|||+.|+++||||++.
T Consensus 238 ~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 238 NP--EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp TT--HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred Cc--ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 11 111223358899999999999999999999999999653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-55 Score=384.09 Aligned_cols=251 Identities=28% Similarity=0.416 Sum_probs=196.4
Q ss_pred hcCCCCcCeeeecCceeEEEEEeCCC-----CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLPSG-----KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.+.|+..+.||+|+||+||+|.+.++ ..||||++....... ....|.+|+.++++++|||||+++|++.+.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-HHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 45688889999999999999976532 369999997655433 346799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+.++++.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999988875543 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC---CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC-CCCCC
Q 042457 243 LHSDSS---NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA-PSPID 318 (361)
Q Consensus 243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 318 (361)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ........+.++.. +.+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~~~~~~ 237 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRLPTPMD 237 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCCCCCTT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHhccCCCCCchh
Confidence 654332 2233458999999999999999999999999999999999665543222 12222333333322 22222
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
. ...+.+|+.+||+.||++|||+.||++
T Consensus 238 ~------~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 C------PSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp C------BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred h------HHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1 124889999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=384.22 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=203.5
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcch----HHHHHHHHHHHHHHhcCC--CCcceeeeEEEeeCC
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETE----LAFLESFQTEARLLSQIR--HRNIVKLYGFCLHKK 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 160 (361)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ......+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999975 57899999998653211 111233568999999886 899999999999999
Q ss_pred eEEEEEEeccC-CChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-CCCeEEeeec
Q 042457 161 CMFLIYKYMRR-GSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-KLEAFVADFG 238 (361)
Q Consensus 161 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg 238 (361)
..++||||+.+ +++.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 99999999976 57777776544 689999999999999999999999 9999999999999985 4789999999
Q ss_pred CccccCCCCCCccccccccccccccccccccc-CccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCC
Q 042457 239 VARLLHSDSSNRTVVAGTHGYIAPELAYTMVV-TEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPI 317 (361)
Q Consensus 239 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (361)
+++..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ++.......+.
T Consensus 157 ~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i~~~~~~~~~ 225 (273)
T d1xwsa_ 157 SGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFFRQ 225 (273)
T ss_dssp TCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHCCCCCSS
T ss_pred cceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HHhhcccCCCC
Confidence 99865432 2344579999999999887665 567899999999999999999987432 12222222222
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
..+ ..+.+|+.+||+.||++|||++|+++||||++.+
T Consensus 226 ~~s------~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 226 RVS------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp CCC------HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CCC------HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 222 2478899999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=379.38 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=195.7
Q ss_pred HHhcCCCCcCeeeecCceeEEEEEeCC----CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCe
Q 042457 86 VATEDFDIKYCIGTGGYGSVYRAQLPS----GKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKC 161 (361)
Q Consensus 86 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 161 (361)
+..++|++.+.||+|+||.||+|.+.. +..||||.++..... ...+.+.+|+.++++++||||++++|++. .+.
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 456789999999999999999997643 346899998655443 33578999999999999999999999996 466
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.++||||+++|+|.+++..... .+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 8999999999999998765443 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-CCCCC
Q 042457 242 LLHSDSS-NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-PSPID 318 (361)
Q Consensus 242 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 318 (361)
....... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||..... ......+..+.. +.+..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~~~~~~~~~~~ 233 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERLPMPPN 233 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCCCCCCTT
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCCCCC
Confidence 7654332 2334568899999999999999999999999999999998 8999876543 222333333322 22222
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
.+ ..+.+|+.+||+.||++|||+.||+++
T Consensus 234 ~~------~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 234 CP------PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC------HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11 248899999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=377.80 Aligned_cols=246 Identities=25% Similarity=0.400 Sum_probs=195.4
Q ss_pred HhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-CCeEEEE
Q 042457 87 ATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCMFLI 165 (361)
Q Consensus 87 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 165 (361)
..++|++.+.||+|+||.||+|.+ .|+.||||+++.... .+.+.+|++++++++||||++++|+|.+ .+..++|
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 356788899999999999999998 578999999976543 3678899999999999999999999965 4568999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCC
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHS 245 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 245 (361)
|||+++|+|.+++..... ..+++..+++++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999975432 2589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccC-CCCCCChhhH
Q 042457 246 DSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRA-PSPIDDQTVI 323 (361)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 323 (361)
. .....++..|+|||++.+..++.++||||||+++|||+| |+.||..... ......+..+.. +.+...+
T Consensus 156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~--- 226 (262)
T d1byga_ 156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYKMDAPDGCP--- 226 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTTCCCCCCTTCC---
T ss_pred C---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCCCCccCC---
Confidence 2 233457889999999999999999999999999999998 7888765432 222333333222 2222211
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..+.+|+.+||+.||.+|||+.+++++
T Consensus 227 ---~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 ---PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 247899999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=384.49 Aligned_cols=264 Identities=23% Similarity=0.362 Sum_probs=199.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CC-CCEEEEEEeccCcchHHHHHHHHHHHHHHhcC---CCCcceeeeEEEee----
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PS-GKIVALKKLHHSETELAFLESFQTEARLLSQI---RHRNIVKLYGFCLH---- 158 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---- 158 (361)
.++|++.+.||+|+||+||+|.. .+ ++.||||+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999976 34 56799999865433222223455677666654 89999999999864
Q ss_pred -CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeee
Q 042457 159 -KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADF 237 (361)
Q Consensus 159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 237 (361)
....+++|||+.++++......... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 2468999999998877654443322 589999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhc-------
Q 042457 238 GVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLD------- 310 (361)
Q Consensus 238 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~------- 310 (361)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+..........
T Consensus 161 g~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 998765332 233445799999999999999999999999999999999999999975432111100000000
Q ss_pred ------------ccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 311 ------------QRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 311 ------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+. ..........+.+|+.+||++||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0000000 0000001124778999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-53 Score=380.16 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=210.3
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeE
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYG 154 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 154 (361)
+.+++...++|++.+.||+|+||+||+|++. +++.||||++...... ...+.|.+|++++++++||||+++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-HHHHHHHHHHHHHHhcCCCCccccee
Confidence 4566677889999999999999999999763 4578999999765443 33578999999999999999999999
Q ss_pred EEeeCCeEEEEEEeccCCChhhhhccCC---------------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 042457 155 FCLHKKCMFLIYKYMRRGSLFCVLRNDD---------------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPS 213 (361)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~ 213 (361)
+|...+..+++|||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence 9999999999999999999999986432 123489999999999999999999999 9
Q ss_pred eEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHhCC-
Q 042457 214 IVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGR- 290 (361)
Q Consensus 214 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~- 290 (361)
++||||||+|||++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 99999999999999999999999999986644322 223456889999999999999999999999999999999985
Q ss_pred CCCCCcccCCcchhHhhhhcccCCC-CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 291 HPGDLLSSFNPKIMLIDLLDQRAPS-PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 291 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.||..... ......+.++..+. +...+ ..+.+|+.+||+.||++||||.||++
T Consensus 241 ~p~~~~~~---~e~~~~v~~~~~~~~p~~~~------~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 241 QPYYGMAH---EEVIYYVRDGNILACPENCP------LELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CTTTTSCH---HHHHHHHHTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCH---HHHHHHHHcCCCCCCCccch------HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 56664332 23333444443322 21211 24789999999999999999999964
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=380.49 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=197.9
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCC----EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGK----IVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMF 163 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 163 (361)
.+|++.+.||+|+||+||+|.+. +|+ .||+|+++..... ...+.|.+|+.++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46899999999999999999764 444 5899988654332 2357899999999999999999999999875 467
Q ss_pred EEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcccc
Q 042457 164 LIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLL 243 (361)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 243 (361)
+++|++.+|+|.+++..... .+++..+++++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 88999999999988876543 689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhccc-CCCCCCC
Q 042457 244 HSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQR-APSPIDD 319 (361)
Q Consensus 244 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 319 (361)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||+...... ....+..+. .+.+...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~~~~~~~~p~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGERLPQPPIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHHHTCCCCCCTTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCCCCCCCccc
Confidence 544332 233458999999999999999999999999999999999 899987554321 222222222 2222222
Q ss_pred hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 320 QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 320 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
+ ..+.+|+.+||+.||++|||+.||++|
T Consensus 239 ~------~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 239 T------IDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp C------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C------HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 2 247889999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=372.98 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=201.1
Q ss_pred cCeeeecCceeEEEEEeCCC----CEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee-CCeEEEEEEe
Q 042457 94 KYCIGTGGYGSVYRAQLPSG----KIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-KKCMFLIYKY 168 (361)
Q Consensus 94 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 168 (361)
.++||+|+||+||+|.+.++ ..||||+++.... ....+.|.+|++++++++||||++++|+|.. ++..++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46799999999999987542 2589999975443 3335789999999999999999999999876 4689999999
Q ss_pred ccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCCC
Q 042457 169 MRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDSS 248 (361)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 248 (361)
|++|+|.+++..... .+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred eecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999876543 578889999999999999999999 999999999999999999999999999987654322
Q ss_pred C----cccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCC-CCCCChhhH
Q 042457 249 N----RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAP-SPIDDQTVI 323 (361)
Q Consensus 249 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 323 (361)
. .....||..|+|||.+.+..++.++||||||+++|||+||+.||..... .......+..+..+ .+...+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~~~p~~~~--- 260 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLLQPEYCP--- 260 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCCCCTTCC---
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCCCcccCc---
Confidence 1 2234689999999999999999999999999999999998777654332 12222333333222 222211
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCccccccC------CCCCCC
Q 042457 324 QDIILVSKIAFACLRSKPKSRPTMRRSFPN------PEINPS 359 (361)
Q Consensus 324 ~~~~~l~~li~~cl~~dP~~RPs~~eil~h------p~~~~~ 359 (361)
..+.+|+.+||+.||++|||+.||++| .|+.++
T Consensus 261 ---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 261 ---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred ---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 248899999999999999999999988 666654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=379.54 Aligned_cols=267 Identities=19% Similarity=0.266 Sum_probs=202.9
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEee--------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLH-------- 158 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 158 (361)
-++|++.+.||+|+||+||+|.. .+|+.||||++............+.+|+.+|++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36799999999999999999976 579999999987665444445778899999999999999999999865
Q ss_pred CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeec
Q 042457 159 KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFG 238 (361)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 238 (361)
.+..++||||+.++.+........ .++...+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 345899999998887765554433 588899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC----Cccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 239 VARLLHSDSS----NRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 239 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
++........ ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9977653221 22334689999999998754 689999999999999999999999975433111111111111100
Q ss_pred CC--------------------CCCChhhH---HHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCCC
Q 042457 314 PS--------------------PIDDQTVI---QDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPSL 360 (361)
Q Consensus 314 ~~--------------------~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~~ 360 (361)
+. ........ .....+.+|+.+||+.||++|||++|+|+||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 00 00000000 0112367899999999999999999999999998643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=373.07 Aligned_cols=265 Identities=20% Similarity=0.298 Sum_probs=212.0
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeEEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCMFLIYK 167 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 167 (361)
++|++.+.||+|+||+||+|+. .+|+.||||+++.........+.+.+|+.+++.++||||+++++++.+.+..+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4789999999999999999975 578999999997665555556889999999999999999999999999999999999
Q ss_pred eccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccccCCCC
Q 042457 168 YMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARLLHSDS 247 (361)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 247 (361)
++.+++|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988887654 688999999999999999999999 99999999999999999999999999998876655
Q ss_pred CCcccccccccccccccccccc-cCccchhhhHHHHHHHHHhCCCCCCCcccCCcchh-Hhhhhcc--------------
Q 042457 248 SNRTVVAGTHGYIAPELAYTMV-VTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIM-LIDLLDQ-------------- 311 (361)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~-------------- 311 (361)
.......++..|+|||.+.+.. ++.++||||+||++|||++|+.||........... .......
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 5555566788999999887654 68999999999999999999999743222110000 0000000
Q ss_pred -cC----CC-CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 312 -RA----PS-PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 312 -~~----~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
.. .. .............+.+|+.+||+.||.+|||++|+|+||||++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 00 00 00000000011247789999999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=375.27 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=197.9
Q ss_pred HHHHHHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeee
Q 042457 81 FEEIIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLY 153 (361)
Q Consensus 81 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 153 (361)
..++++..++|++.+.||+|+||.||+|.+. +++.||||+++....... .+.+..|...+.++ +|+||+.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~-~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH-HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH-HHHHHHHHHHHHhhcCCCeEEEee
Confidence 3556677788999999999999999999753 346899999976554333 46677888877776 689999999
Q ss_pred EEEeeC-CeEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCC
Q 042457 154 GFCLHK-KCMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDI 219 (361)
Q Consensus 154 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dl 219 (361)
+++... +..++|||||++|+|.++++.... ...+++.+++.++.||++||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998765 468999999999999999975421 23589999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHhC-CCCCCCc
Q 042457 220 SSNNILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMG-RHPGDLL 296 (361)
Q Consensus 220 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~ 296 (361)
||+|||+++++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||+|| ..||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654332 23345699999999999999999999999999999999996 5677643
Q ss_pred ccCCcchhHhhhhccc-CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 297 SSFNPKIMLIDLLDQR-APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 297 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
... ......+..+. .+.+...+ ..+.+++.+||+.||++|||++|+++|
T Consensus 241 ~~~--~~~~~~~~~~~~~~~~~~~~------~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 241 KID--EEFCRRLKEGTRMRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCS--HHHHHHHHHTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHH--HHHHHHHhcCCCCCCCccCC------HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 321 11122222222 22222111 247899999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=370.90 Aligned_cols=252 Identities=24% Similarity=0.381 Sum_probs=193.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEeC--CC--CEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCCeE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQLP--SG--KIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKKCM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 162 (361)
.++|++.+.||+|+||.||+|++. ++ ..||||++..... .....+.|.+|+.++++++||||++++|+|.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 467999999999999999999753 23 3689999875433 23345789999999999999999999999976 467
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
++||||+++|++.+++..... .+++..++.++.|+|.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999988765433 589999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCC---cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 243 LHSDSSN---RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 243 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
....... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~ 237 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGERLPRP 237 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCCCCCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHHHHhCCCCCCCc
Confidence 7544332 223457889999999999999999999999999999998 8999875432 22333343333222221
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
.... ..+.+|+.+||+.||++|||+.||++
T Consensus 238 ~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 238 EDCP----QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccc----HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 24889999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6e-53 Score=371.25 Aligned_cols=257 Identities=22% Similarity=0.356 Sum_probs=199.3
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcc-hHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC----e
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSET-ELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK----C 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 161 (361)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999975 5799999999976543 3344578999999999999999999999998754 3
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.|+||||+++++|.+++...+ .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 899999999999999887654 689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCC---CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCCCC
Q 042457 242 LLHSDSS---NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSPID 318 (361)
Q Consensus 242 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (361)
....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..............+..
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~ 236 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDPIPPSA 236 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCCCCGGG
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---HHHHHHHHhcCCCCCch
Confidence 6543322 23445699999999999999999999999999999999999999975432 22233333332221111
Q ss_pred ChhhHHHHHHHHHHHhhhcCCCCCCCC-CccccccCCCC
Q 042457 319 DQTVIQDIILVSKIAFACLRSKPKSRP-TMRRSFPNPEI 356 (361)
Q Consensus 319 ~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~hp~~ 356 (361)
... .....+.+++.+||++||++|| |++++ .|+|+
T Consensus 237 ~~~--~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 237 RHE--GLSADLDAVVLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp TSS--SCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred hcc--CCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence 000 0112488999999999999999 55555 45443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=371.87 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=195.5
Q ss_pred cCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC----eEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK----CMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l 164 (361)
++|.+.+.||+|+||.||+|++ +|+.||||++....... .....|+..+..++||||++++|+|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~---~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH---HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4577788999999999999998 78999999997543221 22234555556789999999999998754 5899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEEeCCCCCCeeeCCCCCeEEeeecC
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC-----IPSIVHRDISSNNILLNSKLEAFVADFGV 239 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 239 (361)
||||+++|+|.+++++. .++|..+++++.|+|.||+|||+.. ..+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999865 4899999999999999999999731 23999999999999999999999999999
Q ss_pred ccccCCCCC----Cccccccccccccccccccc------ccCccchhhhHHHHHHHHHhCCCCCCCcccCC---------
Q 042457 240 ARLLHSDSS----NRTVVAGTHGYIAPELAYTM------VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFN--------- 300 (361)
Q Consensus 240 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--------- 300 (361)
++....... ......||+.|+|||++.+. .++.++|||||||+||||+||..||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 987754332 22345699999999998654 36779999999999999999998875432211
Q ss_pred ---cchhHhhhhcccCCCCCC-ChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 301 ---PKIMLIDLLDQRAPSPID-DQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 301 ---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
..........+....... ..........+.+|+.+||+.||++|||+.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111112222222222221 11223344568899999999999999999999763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=376.62 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=213.3
Q ss_pred HHHHHhcCCCCcCeeeecCceeEEEEEeC------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEE
Q 042457 83 EIIVATEDFDIKYCIGTGGYGSVYRAQLP------SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFC 156 (361)
Q Consensus 83 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 156 (361)
+|++..++|.+.+.||+|+||+||+|.+. +++.||||+++..... .....|.+|++++++++||||++++|+|
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-HHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 45566788999999999999999999763 3578999999765443 3356789999999999999999999999
Q ss_pred eeCCeEEEEEEeccCCChhhhhccC-------CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCC
Q 042457 157 LHKKCMFLIYKYMRRGSLFCVLRND-------DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSK 229 (361)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~ 229 (361)
...+..++||||+++|+|.+++... .....+++..+.+++.|+++||.|||++ +|+||||||+|||++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence 9999999999999999999988642 2223579999999999999999999999 99999999999999999
Q ss_pred CCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHhCC-CCCCCcccCCcchhHh
Q 042457 230 LEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGR-HPGDLLSSFNPKIMLI 306 (361)
Q Consensus 230 ~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~ 306 (361)
+++||+|||+++........ .....+|+.|+|||.+.+..++.++||||||+++|||+||. .||.... ......
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~---~~~~~~ 246 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLR 246 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---HHHHHH
Confidence 99999999999876443322 23345899999999999999999999999999999999984 6765432 233333
Q ss_pred hhhcccCC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc------CCCCC
Q 042457 307 DLLDQRAP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP------NPEIN 357 (361)
Q Consensus 307 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~------hp~~~ 357 (361)
.+.+...+ .+...+ ..+.+++.+||+.||++|||++||++ +|+|+
T Consensus 247 ~i~~~~~~~~p~~~~------~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 247 FVMEGGLLDKPDNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HHHTTCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HHHhCCCCCCcccch------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 44443332 222211 24889999999999999999999997 66664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=373.12 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=199.8
Q ss_pred cCCCCcCeeeecCceeEEEEEeCC-CC--EEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEEeeCCeEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLPS-GK--IVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFCLHKKCMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 164 (361)
++|++.+.||+|+||.||+|.+.+ |. .||||++...... ...+.|.+|+++++++ +||||++++|+|.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 678889999999999999997753 43 5788887644332 2346799999999998 79999999999999999999
Q ss_pred EEEeccCCChhhhhccC-------------CccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCC
Q 042457 165 IYKYMRRGSLFCVLRND-------------DEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLE 231 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~ 231 (361)
||||+++|+|.++++.. .....+++..+.+++.||+.||.|||+. +++||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 99999999999999754 2234699999999999999999999999 9999999999999999999
Q ss_pred eEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCC-CCCCCcccCCcchhHhhhhc
Q 042457 232 AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGR-HPGDLLSSFNPKIMLIDLLD 310 (361)
Q Consensus 232 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~ 310 (361)
+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|. .||.... .......+..
T Consensus 166 ~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~i~~ 241 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQ 241 (309)
T ss_dssp EEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHGGG
T ss_pred eEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHHHHHh
Confidence 9999999997653322 223446899999999999999999999999999999999965 5665432 2223333333
Q ss_pred ccCC-CCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccC
Q 042457 311 QRAP-SPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPN 353 (361)
Q Consensus 311 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~h 353 (361)
+..+ .+...+ ..+.+|+.+||+.||++|||++||+++
T Consensus 242 ~~~~~~~~~~~------~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLNCD------DEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCCCCTTBC------HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCccCC------HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3222 222211 248899999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=379.17 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=199.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC------
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK------ 160 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 160 (361)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999975 46999999999866555555678899999999999999999999998754
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCc
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVA 240 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 240 (361)
..++||||+ +.+|..+.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 479999999 66777776543 599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhh-----------
Q 042457 241 RLLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDL----------- 308 (361)
Q Consensus 241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~----------- 308 (361)
+..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...............
T Consensus 169 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 169 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 876433 334568999999998876 45689999999999999999999999754321110000000
Q ss_pred ---------hcccCCCCCCC--hhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 309 ---------LDQRAPSPIDD--QTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 309 ---------~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........... .........+.+|+.+||+.||.+|||++|+|+||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 00000000000 000000124678999999999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=370.62 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=208.2
Q ss_pred HHHHhcCCCCcCeeeecCceeEEEEEe------CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEEE
Q 042457 84 IIVATEDFDIKYCIGTGGYGSVYRAQL------PSGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGFC 156 (361)
Q Consensus 84 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 156 (361)
+++..++|++.+.||+|+||.||+|++ .+++.||||+++...... ....+.+|+.+++++ +|||||+++|+|
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-EREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH-HHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 456678899999999999999999975 346789999997655433 356789999999998 699999999999
Q ss_pred eeCCeEEEEEEeccCCChhhhhccCC---------------ccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCC
Q 042457 157 LHKKCMFLIYKYMRRGSLFCVLRNDD---------------EAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISS 221 (361)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~ 221 (361)
.+.+..++|||||++|+|.++++... ....+++..+..++.||+.||+|||++ +++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 99999999999999999999987532 223589999999999999999999999 999999999
Q ss_pred CCeeeCCCCCeEEeeecCccccCCCCCC--cccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCccc
Q 042457 222 NNILLNSKLEAFVADFGVARLLHSDSSN--RTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSS 298 (361)
Q Consensus 222 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~ 298 (361)
+||+++.++.+|++|||+++........ .....||+.|+|||.+.+..++.++||||||+++|||+| |.+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 233568999999999999999999999999999999999 5555543322
Q ss_pred CCcchhHhhhhcccCCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 299 FNPKIMLIDLLDQRAPSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
...+..++............ ...+.+|+.+||+.||++|||+.||++
T Consensus 254 ---~~~~~~~i~~~~~~~~~~~~----~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 ---DSKFYKMIKEGFRMLSPEHA----PAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp ---SHHHHHHHHHTCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHHhcCCCCCCcccc----cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22233333333222221111 124889999999999999999999885
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=375.22 Aligned_cols=264 Identities=20% Similarity=0.275 Sum_probs=200.6
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeCC----eE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHKK----CM 162 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 162 (361)
+.+|++.+.||+|+||+||+|.. .+|+.||||++...... ...+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35699999999999999999965 58999999999765433 33567889999999999999999999997653 23
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
+++++++.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4555667799999999754 589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC---Cccccccccccccccccc-ccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhh---------
Q 042457 243 LHSDSS---NRTVVAGTHGYIAPELAY-TMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLL--------- 309 (361)
Q Consensus 243 ~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--------- 309 (361)
...... ......||+.|+|||++. +..++.++||||+||++|||++|+.||......+.........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 644322 233456899999999875 4567889999999999999999999997544211111000000
Q ss_pred -----------cccCCCCCCChh--hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 310 -----------DQRAPSPIDDQT--VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 310 -----------~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
............ .......+.+|+.+||+.||.+|||++|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000000000000 00001247889999999999999999999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=370.04 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=202.7
Q ss_pred HHHhcCCCCcCeeeecCceeEEEEEeC--------CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCcceeeeEE
Q 042457 85 IVATEDFDIKYCIGTGGYGSVYRAQLP--------SGKIVALKKLHHSETELAFLESFQTEARLLSQI-RHRNIVKLYGF 155 (361)
Q Consensus 85 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 155 (361)
.+..++|.+.+.||+|+||.||+|+.. ++..||||+++...... ....+.+|...+.++ +||||++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-HHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 355678999999999999999999652 23479999997655433 356788898888888 89999999999
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCc-------------cCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCC
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDE-------------AIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSN 222 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~ 222 (361)
|.+++..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 9999999999999999999999975431 23589999999999999999999999 9999999999
Q ss_pred CeeeCCCCCeEEeeecCccccCCCCC--CcccccccccccccccccccccCccchhhhHHHHHHHHHh-CCCCCCCcccC
Q 042457 223 NILLNSKLEAFVADFGVARLLHSDSS--NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLM-GRHPGDLLSSF 299 (361)
Q Consensus 223 Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~ 299 (361)
|||++.++.+||+|||+++....... ......+++.|+|||.+.++.++.++||||||+++|||++ |..||.....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 99999999999999999987754332 2344568999999999999999999999999999999998 7888865433
Q ss_pred CcchhHhhhhccc-CCCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCcccccc
Q 042457 300 NPKIMLIDLLDQR-APSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFP 352 (361)
Q Consensus 300 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 352 (361)
......+..+. ++.+...+ ..+.+|+.+||+.||++|||+.||++
T Consensus 244 --~~~~~~i~~~~~~~~p~~~~------~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 --EELFKLLKEGHRMDKPSNCT------NELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp --HHHHHHHHTTCCCCCCSSCC------HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCccch------HHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 22222222222 22222211 24889999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=377.01 Aligned_cols=259 Identities=23% Similarity=0.291 Sum_probs=196.3
Q ss_pred CCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------CeE
Q 042457 90 DFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------KCM 162 (361)
Q Consensus 90 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 162 (361)
+|...++||+|+||+||+|+.. +|+.||||++...... ..+|++++++++||||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5788889999999999999764 6999999999765432 23799999999999999999998653 247
Q ss_pred EEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-CeEEeeecCcc
Q 042457 163 FLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-EAFVADFGVAR 241 (361)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~ 241 (361)
++||||++++.+..+.........+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 89999998765444433222333699999999999999999999999 999999999999999775 89999999998
Q ss_pred ccCCCCCCcccccccccccccccccc-cccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhh------------
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYT-MVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDL------------ 308 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~------------ 308 (361)
....... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+........
T Consensus 172 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 172 QLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp ECCTTSC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hccCCcc-cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 7654332 334568999999998764 56899999999999999999999999754431111000000
Q ss_pred ----hcccCCCCCCCh----hhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 309 ----LDQRAPSPIDDQ----TVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 309 ----~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
.....+...... ........+.+|+.+||+.||++|||+.|+|+||||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 000000000000 00001124788999999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=372.64 Aligned_cols=258 Identities=26% Similarity=0.370 Sum_probs=208.8
Q ss_pred cCCCCcCeeeecCceeEEEEEe----CCCCEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCC-CcceeeeEEEeeCCe
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL----PSGKIVALKKLHHSET--ELAFLESFQTEARLLSQIRH-RNIVKLYGFCLHKKC 161 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 161 (361)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999964 2588999999865321 11123567899999999976 899999999999999
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+++|||+.+|+|.+++.... .+....+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999998765 577889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCC-Cccccccccccccccccccc--ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh-hhcccCCCCC
Q 042457 242 LLHSDSS-NRTVVAGTHGYIAPELAYTM--VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID-LLDQRAPSPI 317 (361)
Q Consensus 242 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 317 (361)
....... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....... ......+.+.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 7644332 33445789999999988654 467899999999999999999999986655443333322 2222232222
Q ss_pred CChhhHHHHHHHHHHHhhhcCCCCCCCCC-----ccccccCCCCCC
Q 042457 318 DDQTVIQDIILVSKIAFACLRSKPKSRPT-----MRRSFPNPEINP 358 (361)
Q Consensus 318 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~hp~~~~ 358 (361)
..+ ..+.+|+.+||++||.+||| ++|+++||||++
T Consensus 258 ~~s------~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 258 EMS------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp TSC------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCC------HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 222 24788999999999999994 799999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=370.78 Aligned_cols=260 Identities=22% Similarity=0.268 Sum_probs=197.1
Q ss_pred cCCCCcCeeeecCceeEEEEEeC-CCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC------Ce
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQLP-SGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK------KC 161 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 161 (361)
++|++.+.||+|+||+||+|... +|+.||||++............+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999764 699999999987655555567889999999999999999999999643 67
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.|+||||+.++.+.. +.. .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~-~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHH-HTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHh-hhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 899999997665544 322 589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcc-------------------
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK------------------- 302 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------------------- 302 (361)
..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+.....
T Consensus 168 ~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 65433 2334456899999999999999999999999999999999999999644321100
Q ss_pred hhHhhhhcccCCC--------------CCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 303 IMLIDLLDQRAPS--------------PIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 303 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
............. +............+.+|+.+||+.||++|||++|+|+||||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0011111111111 1111111223345789999999999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.2e-51 Score=367.70 Aligned_cols=256 Identities=18% Similarity=0.270 Sum_probs=199.6
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeC--CeEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHK--KCMFL 164 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l 164 (361)
++|++.+.||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++|+.++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5799999999999999999976 578999999997543 256789999999995 99999999999854 56899
Q ss_pred EEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCC-CeEEeeecCcccc
Q 042457 165 IYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKL-EAFVADFGVARLL 243 (361)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 243 (361)
||||+++++|..+.+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 999999999987643 589999999999999999999999 999999999999998655 6899999999876
Q ss_pred CCCCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCc-chhHhhh-------------
Q 042457 244 HSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNP-KIMLIDL------------- 308 (361)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~------------- 308 (361)
.... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ .......
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 181 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred cCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 5433 23445689999999987765 479999999999999999999999864332100 0000000
Q ss_pred -----------hcccCCCC----CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCCC
Q 042457 309 -----------LDQRAPSP----IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINPS 359 (361)
Q Consensus 309 -----------~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~~ 359 (361)
........ ............+.+|+.+||+.||++|||++|+|+||||++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 00000000 0000000011247889999999999999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=369.40 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=201.7
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceeeeEEEeeC-----Ce
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKLYGFCLHK-----KC 161 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~ 161 (361)
+++|++.+.||+|+||+||+|.. .+|+.||||++..........+.+.+|+++++.++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999975 5799999999987665555567888999999999999999999998743 34
Q ss_pred EEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 162 MFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+++++++.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 56778888899999999654 599999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCccccccccccccccccccc-ccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhh-------------
Q 042457 242 LLHSDSSNRTVVAGTHGYIAPELAYTM-VVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLID------------- 307 (361)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~------------- 307 (361)
.... ......|+..|+|||...+. .++.++||||+||++|+|++|+.||...+..........
T Consensus 170 ~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 170 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 5432 23345689999999986664 468899999999999999999999975432111100000
Q ss_pred -------hhcccCCCCCCChh--hHHHHHHHHHHHhhhcCCCCCCCCCccccccCCCCCC
Q 042457 308 -------LLDQRAPSPIDDQT--VIQDIILVSKIAFACLRSKPKSRPTMRRSFPNPEINP 358 (361)
Q Consensus 308 -------~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~hp~~~~ 358 (361)
........+..... .......+.+|+.+||+.||.+|||++|+|+||||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 00000000000000 0001124778999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-48 Score=341.80 Aligned_cols=257 Identities=15% Similarity=0.239 Sum_probs=192.2
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcceee-eEEEeeCCeEEEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNIVKL-YGFCLHKKCMFLIY 166 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~ 166 (361)
++|++.+.||+|+||.||+|+. .+|+.||||++...... .++..|+++++.++|+|++.. .++....+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5699999999999999999975 56899999998765432 346789999999987765555 55556778899999
Q ss_pred EeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeC---CCCCeEEeeecCcccc
Q 042457 167 KYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLN---SKLEAFVADFGVARLL 243 (361)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~~~~ 243 (361)
||+ ++++...+..... .+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++.+
T Consensus 83 e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEc-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999 5566655544332 589999999999999999999999 999999999999985 4567999999999877
Q ss_pred CCCCC-------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccCCCC
Q 042457 244 HSDSS-------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRAPSP 316 (361)
Q Consensus 244 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 316 (361)
..... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......................+
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 54322 12345699999999999999999999999999999999999999986554333322222221111110
Q ss_pred CCChhhHHHHHHHHHHHhhhcCCCCCCCCCccc---cccCCCC
Q 042457 317 IDDQTVIQDIILVSKIAFACLRSKPKSRPTMRR---SFPNPEI 356 (361)
Q Consensus 317 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e---il~hp~~ 356 (361)
.. .........+.+++.+||+.||++||++.+ +|+|+|.
T Consensus 237 ~~-~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 IE-VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HH-HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hh-HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00 000001134889999999999999999875 4666654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-46 Score=333.46 Aligned_cols=253 Identities=17% Similarity=0.207 Sum_probs=199.2
Q ss_pred hcCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC-CcceeeeEEEeeCCeEEEE
Q 042457 88 TEDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH-RNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 88 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv 165 (361)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+|++.++.++| +|++.+++++......++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 46899999999999999999975 46899999998654432 346678889998865 8999999999999999999
Q ss_pred EEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCC-----CCCeEEeeecCc
Q 042457 166 YKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNS-----KLEAFVADFGVA 240 (361)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~~ 240 (361)
|||+ +++|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence 9999 7899988876543 589999999999999999999999 9999999999999964 578999999999
Q ss_pred cccCCCCC-------CcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcchhHhhhhcccC
Q 042457 241 RLLHSDSS-------NRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPKIMLIDLLDQRA 313 (361)
Q Consensus 241 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 313 (361)
+....... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..............+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 87643221 12345699999999999999999999999999999999999999986554443333222222211
Q ss_pred CCCCCChhhHHHHHHHHHHHhhhcCCCCCCCCCccccc
Q 042457 314 PSPIDDQTVIQDIILVSKIAFACLRSKPKSRPTMRRSF 351 (361)
Q Consensus 314 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 351 (361)
..+.. ......+..+.+++..|++.+|++||+++.+.
T Consensus 234 ~~~~~-~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 234 STPLR-ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HSCHH-HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred CCChH-HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 11100 00000112488899999999999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-45 Score=334.21 Aligned_cols=262 Identities=18% Similarity=0.225 Sum_probs=193.2
Q ss_pred cCCCCcCeeeecCceeEEEEEe-CCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-----------CCcceeeeEEE
Q 042457 89 EDFDIKYCIGTGGYGSVYRAQL-PSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-----------HRNIVKLYGFC 156 (361)
Q Consensus 89 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~ 156 (361)
.+|++.+.||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~---~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH---HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc---hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3589999999999999999975 57999999999765432 356678888887775 57899999988
Q ss_pred ee--CCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEEeCCCCCCeeeCCCCC--
Q 042457 157 LH--KKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHY-DCIPSIVHRDISSNNILLNSKLE-- 231 (361)
Q Consensus 157 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~~~~i~H~dlk~~Nill~~~~~-- 231 (361)
.. ....+++++++..+..............+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 65 35677778777666544443333333468999999999999999999998 6 8999999999999976543
Q ss_pred ----eEEeeecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHHHHHHhCCCCCCCcccCCcc---hh
Q 042457 232 ----AFVADFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVALEVLMGRHPGDLLSSFNPK---IM 304 (361)
Q Consensus 232 ----~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~~ 304 (361)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||......... ..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999998765332 23356899999999999999999999999999999999999998754321100 00
Q ss_pred Hh---hhhcc-----------------------cCCC-CCCC---------hhhHHHHHHHHHHHhhhcCCCCCCCCCcc
Q 042457 305 LI---DLLDQ-----------------------RAPS-PIDD---------QTVIQDIILVSKIAFACLRSKPKSRPTMR 348 (361)
Q Consensus 305 ~~---~~~~~-----------------------~~~~-~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 348 (361)
.. ..+.. .... .... .........+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 00 00000 0000 0000 00112334688999999999999999999
Q ss_pred ccccCCCCCCC
Q 042457 349 RSFPNPEINPS 359 (361)
Q Consensus 349 eil~hp~~~~~ 359 (361)
|+|+||||++.
T Consensus 324 e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 324 GLVNHPWLKDT 334 (362)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhcCcccCCC
Confidence 99999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5.8e-26 Score=187.05 Aligned_cols=171 Identities=13% Similarity=0.157 Sum_probs=121.4
Q ss_pred CCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcc----------------hHHHHHHHHHHHHHHhcCCCCcceeeeEE
Q 042457 92 DIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSET----------------ELAFLESFQTEARLLSQIRHRNIVKLYGF 155 (361)
Q Consensus 92 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 155 (361)
.+.+.||+|+||+||+|...+|+.||||+++.... ..........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45678999999999999988999999998753211 11122345578889999999999988765
Q ss_pred EeeCCeEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEEeCCCCCCeeeCCCCCeEEe
Q 042457 156 CLHKKCMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDCIPSIVHRDISSNNILLNSKLEAFVA 235 (361)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~~~~i~H~dlk~~Nill~~~~~~kl~ 235 (361)
.. .+++|||+++..+.. ++......++.|++++++|||+. +|+||||||+|||++++ .++|+
T Consensus 83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 32 379999998866543 23344567999999999999999 99999999999999965 58999
Q ss_pred eecCccccCCCCCCcccccccccccccccccccccCccchhhhHHHHH
Q 042457 236 DFGVARLLHSDSSNRTVVAGTHGYIAPELAYTMVVTEKCDVFGFGVVA 283 (361)
Q Consensus 236 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l 283 (361)
|||++.....+.... ........ -.+ +....|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~-~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-ILERDVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHH-HHHHHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHH-HHHHHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 999997654322110 00000000 011 1245678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.74 E-value=2.2e-08 Score=84.58 Aligned_cols=149 Identities=13% Similarity=0.075 Sum_probs=100.8
Q ss_pred HHHHHHhcCCCCcCeeeecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCC
Q 042457 82 EEIIVATEDFDIKYCIGTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKK 160 (361)
Q Consensus 82 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 160 (361)
.++...-+.|+..+..+.++.+.||+... +++.+++|+........ ...+.+|...++.+. +--+.+++.++..++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 34445556676655544444578999876 56667888876443221 134567777777663 434677888888889
Q ss_pred eEEEEEEeccCCChhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------
Q 042457 161 CMFLIYKYMRRGSLFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC------------------------------ 210 (361)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------ 210 (361)
..++||++.+|.++.+...... ....++.++++.++.||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred ceEEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999999988865443211 12345666677777777531
Q ss_pred --------------------------CCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 211 --------------------------IPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 211 --------------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0237899999999999987667799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.40 E-value=3.2e-07 Score=76.84 Aligned_cols=129 Identities=19% Similarity=0.117 Sum_probs=86.5
Q ss_pred eeecCc-eeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC--CCcceeeeEEEeeCCeEEEEEEeccCCC
Q 042457 97 IGTGGY-GSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIR--HRNIVKLYGFCLHKKCMFLIYKYMRRGS 173 (361)
Q Consensus 97 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~ 173 (361)
+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.++++++.+.+..++||++++|.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 444554 678999988888899998765432 23556777776653 2346778888888888999999998877
Q ss_pred hhhhhccCCccCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------
Q 042457 174 LFCVLRNDDEAIQLDWTKRVNIVKSMAHALSYLHYDC------------------------------------------- 210 (361)
Q Consensus 174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~------------------------------------------- 210 (361)
+.+.. ... ...+.++++.|.-||+..
T Consensus 93 ~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 93 LLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 64321 111 112333444444444320
Q ss_pred ------------CCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 211 ------------IPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 211 ------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
.+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1247999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.88 E-value=2.4e-05 Score=69.51 Aligned_cols=78 Identities=12% Similarity=0.135 Sum_probs=45.9
Q ss_pred CeeeecCceeEEEEEeCC-CCEEEEEEeccC-----cchHHHHHHHHHHHHHHhcCC-C--CcceeeeEEEeeCCeEEEE
Q 042457 95 YCIGTGGYGSVYRAQLPS-GKIVALKKLHHS-----ETELAFLESFQTEARLLSQIR-H--RNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~lv 165 (361)
+.||.|....||+....+ ++.++||.-... ............|.+.++.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999997654 678999964321 100001123345777776552 2 345555554 34456789
Q ss_pred EEeccCCCh
Q 042457 166 YKYMRRGSL 174 (361)
Q Consensus 166 ~e~~~~g~L 174 (361)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.52 E-value=0.0002 Score=61.61 Aligned_cols=135 Identities=14% Similarity=0.142 Sum_probs=76.1
Q ss_pred eeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCcc--eeee-----EEEeeCCeEEEEEEeccCCChh
Q 042457 103 GSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRHRNI--VKLY-----GFCLHKKCMFLIYKYMRRGSLF 175 (361)
Q Consensus 103 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~g~L~ 175 (361)
-.||+++..+|+.+++|..+....+. +++..|...+..+...++ +..+ ......+..+.++++.+|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 57999999999999999986543332 456677777776632221 1111 1223456688899998775432
Q ss_pred hh----h--------------ccC--CccCCCCHH----------------------HHHHHHHHHHHHHHHHH-cCCCC
Q 042457 176 CV----L--------------RND--DEAIQLDWT----------------------KRVNIVKSMAHALSYLH-YDCIP 212 (361)
Q Consensus 176 ~~----l--------------~~~--~~~~~l~~~----------------------~~~~i~~~i~~~l~~Lh-~~~~~ 212 (361)
.. + ... ......++. .....+..+...+.-.- .....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 10 0 000 001111211 11222233333322221 22234
Q ss_pred CeEEeCCCCCCeeeCCCCCeEEeeecCccc
Q 042457 213 SIVHRDISSNNILLNSKLEAFVADFGVARL 242 (361)
Q Consensus 213 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 242 (361)
+++|+|+.+.|||++++ ..++||+.+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45899998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.22 E-value=0.00061 Score=60.17 Aligned_cols=72 Identities=21% Similarity=0.245 Sum_probs=48.0
Q ss_pred CeeeecCceeEEEEEeCC--------CCEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCcceeeeEEEeeCCeEEEE
Q 042457 95 YCIGTGGYGSVYRAQLPS--------GKIVALKKLHHSETELAFLESFQTEARLLSQIR-HRNIVKLYGFCLHKKCMFLI 165 (361)
Q Consensus 95 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 165 (361)
+.|+.|-.-.+|+...++ ++.|.+++....... ....+|..+++.+. +.-..++++++.. .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~----idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE----SHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH----HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh----hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 467778889999998754 356777776533221 33457888888774 3334577777643 578
Q ss_pred EEeccCCCh
Q 042457 166 YKYMRRGSL 174 (361)
Q Consensus 166 ~e~~~~g~L 174 (361)
+||++|..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.16 E-value=0.00081 Score=57.29 Aligned_cols=158 Identities=11% Similarity=0.021 Sum_probs=82.6
Q ss_pred cCHHHHHHHhcCCCCcCee-----eecCceeEEEEEeCCCCEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC-----Cc
Q 042457 79 ITFEEIIVATEDFDIKYCI-----GTGGYGSVYRAQLPSGKIVALKKLHHSETELAFLESFQTEARLLSQIRH-----RN 148 (361)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~n 148 (361)
++.+++...-.+|.+.+.. ..|---+.|+.+.++|+ +++|+....... +.+..|.+++..+.. |.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~----~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH----HHHHHHHHHHHhhhhccccccc
Confidence 4667788778889876543 34555788999886665 899988653221 223345555555532 22
Q ss_pred ceeee-E--EEeeCCeEEEEEEeccCCChhhhh--------------c----cC--CccCCC------------------
Q 042457 149 IVKLY-G--FCLHKKCMFLIYKYMRRGSLFCVL--------------R----ND--DEAIQL------------------ 187 (361)
Q Consensus 149 iv~~~-~--~~~~~~~~~lv~e~~~~g~L~~~l--------------~----~~--~~~~~l------------------ 187 (361)
.+... | +.........++.+..+....... + .. ......
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 22111 1 122234566677776654432110 0 00 000000
Q ss_pred CHHHHHHHHHHHHHHHHHHHcC-CCCCeEEeCCCCCCeeeCCCCCeEEeeecCcc
Q 042457 188 DWTKRVNIVKSMAHALSYLHYD-CIPSIVHRDISSNNILLNSKLEAFVADFGVAR 241 (361)
Q Consensus 188 ~~~~~~~i~~~i~~~l~~Lh~~-~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 241 (361)
........+......+.-.+.. ...+++|+|+.+.||+++++...-|+||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011112222222333333221 22379999999999999998777899999874
|